data_2gzy_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2gzy _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 89.6 mt . . . . . 0 CA--C 1.536 0.428 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 35.8 t -100.81 165.99 2.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 125.691 1.596 . . . . 0.0 107.897 -174.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.31 141.65 50.58 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 177.106 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -151.73 168.09 26.15 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 122.979 0.511 . . . . 0.0 111.569 176.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 40.0 p -140.55 -176.45 4.64 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.981 2.113 . . . . 0.0 107.204 174.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -48.97 -32.63 9.46 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.687 1.195 . . . . 0.0 113.256 179.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 27.3 mp0 -61.13 -32.85 72.55 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 126.233 1.813 . . . . 0.0 112.5 -177.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 12.3 m -143.78 -6.57 0.77 Allowed 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 115.12 1.526 . . . . 0.0 115.12 -169.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -55.62 -36.1 66.59 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 119.856 1.207 . . . . 0.0 110.98 178.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.0 m -68.71 -38.86 80.56 Favored 'General case' 0 N--CA 1.453 -0.306 0 O-C-N 122.226 -0.296 . . . . 0.0 111.22 -178.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.61 -46.2 76.64 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 175.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -64.03 -38.51 91.33 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 122.995 0.518 . . . . 0.0 111.311 -175.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 29.4 p -79.12 0.73 26.97 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -177.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 59.9 m -112.23 33.16 5.04 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.171 0.988 . . . . 0.0 112.044 -171.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 59.3 mt-10 -132.1 -3.24 3.55 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 -176.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 167.45 -162.3 36.1 Favored Glycine 0 C--N 1.334 0.443 0 CA-C-N 119.346 0.976 . . . . 0.0 111.046 -172.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 40.3 t -74.27 127.56 36.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 N-CA-C 105.55 -2.019 . . . . 0.0 105.55 167.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 24.8 t -137.18 115.13 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 -175.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 8.2 tt -88.01 147.01 25.2 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 168.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -132.56 153.35 51.07 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 177.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -132.92 99.12 4.49 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 -178.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -76.37 112.5 12.95 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 173.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 7.1 p-90 -139.36 174.75 10.19 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 123.132 0.573 . . . . 0.0 111.934 -168.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -153.67 147.42 18.53 Favored Pre-proline 0 CA--C 1.538 0.515 0 C-N-CA 125.276 1.43 . . . . 0.0 107.527 168.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.03 -20.57 14.77 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.807 2.338 . . . . 0.0 113.272 -170.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -78.83 -8.21 58.6 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 121.595 -0.691 . . . . 0.0 111.975 178.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 44.5 t -92.94 117.45 30.07 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -53.91 -58.1 13.86 Favored Glycine 0 CA--C 1.531 1.049 0 CA-C-O 118.727 -1.041 . . . . 0.0 112.152 177.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -51.19 -33.33 43.93 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 123.457 2.771 . . . . 0.0 115.607 178.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 90.6 m -60.31 -37.66 81.28 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 119.729 1.15 . . . . 0.0 111.668 174.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 43.2 mtmt -78.61 -33.54 47.33 Favored 'General case' 0 C--N 1.333 -0.118 0 O-C-N 121.764 -0.585 . . . . 0.0 109.98 177.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 26.5 mmt -65.32 -38.73 91.06 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 119.12 0.873 . . . . 0.0 111.439 177.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 12.0 tt -78.17 -14.86 14.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-N 118.877 0.762 . . . . 0.0 111.379 179.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.06 -49.88 89.63 Favored Pre-proline 0 CA--C 1.541 0.62 0 CA-C-O 117.437 -1.268 . . . . 0.0 113.545 -177.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -64.16 -28.49 64.84 Favored 'Trans proline' 0 C--N 1.351 0.662 0 CA-C-N 121.952 1.733 . . . . 0.0 112.401 176.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.2 t -68.37 -39.39 80.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 119.256 0.935 . . . . 0.0 109.457 176.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 48.4 mt -67.69 -34.88 77.77 Favored 'General case' 0 C--O 1.226 -0.15 0 O-C-N 121.517 -0.74 . . . . 0.0 110.636 174.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -68.29 -33.92 75.23 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 119.262 0.937 . . . . 0.0 111.44 173.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 50.2 mm-40 -62.32 -45.61 92.43 Favored 'General case' 0 N--CA 1.457 -0.094 0 O-C-N 120.922 -1.112 . . . . 0.0 109.583 170.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -63.86 -35.34 80.3 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 118.827 0.74 . . . . 0.0 111.668 176.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -66.35 -36.73 83.64 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 119.055 0.843 . . . . 0.0 111.035 177.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -69.8 -44.96 68.97 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 121.643 -0.661 . . . . 0.0 110.907 175.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -81.22 -33.6 32.77 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.983 0.913 . . . . 0.0 112.114 -169.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 52.2 mtt -140.62 -2.94 1.33 Allowed 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.541 1.136 . . . . 0.0 112.884 -169.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -75.14 47.55 1.97 Allowed Glycine 0 CA--C 1.528 0.885 0 C-N-CA 125.671 1.605 . . . . 0.0 113.517 -173.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -150.66 -40.71 0.13 Allowed 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 128.999 2.919 . . . . 0.0 107.176 169.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -63.55 -32.68 74.21 Favored 'General case' 0 C--N 1.343 0.314 0 C-N-CA 124.472 1.109 . . . . 0.0 110.546 168.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -135.67 160.95 36.93 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 125.719 1.608 . . . . 0.0 110.193 172.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -98.73 151.15 21.07 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.968 1.307 . . . . 0.0 107.879 171.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 15.7 mt -122.5 133.8 67.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 N-CA-C 105.839 -1.912 . . . . 0.0 105.839 174.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 8.0 t -128.4 116.12 40.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 C-N-CA 123.396 0.679 . . . . 0.0 109.556 -176.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 64.7 mmtt -75.14 140.41 43.35 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 168.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 8.3 tt -150.89 125.94 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -96.95 123.96 40.8 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 121.044 -1.035 . . . . 0.0 110.382 -168.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 23.3 m -61.67 -22.76 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -171.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -73.33 -28.83 62.29 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 120.052 1.296 . . . . 0.0 110.775 175.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -92.81 -33.98 14.05 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.446 1.099 . . . . 0.0 111.158 -171.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -112.59 33.76 4.76 Favored 'General case' 0 C--O 1.222 -0.344 0 C-N-CA 125.039 1.336 . . . . 0.0 109.914 -177.21 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.84 -39.89 54.54 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.542 1.137 . . . . 0.0 111.89 -175.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -65.23 -48.82 72.0 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.305 1.042 . . . . 0.0 111.656 174.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.34 -40.48 81.53 Favored 'General case' 0 C--O 1.223 -0.304 0 C-N-CA 123.906 0.882 . . . . 0.0 110.828 -175.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -61.97 -42.95 99.7 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.294 -0.879 . . . . 0.0 109.26 174.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -57.1 -27.42 57.33 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 123.963 0.792 . . . . 0.0 113.137 172.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 14.2 ttmm -60.84 -21.85 63.62 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 118.747 1.274 . . . . 0.0 111.451 176.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -120.06 9.8 11.28 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.206 1.403 . . . . 0.0 110.624 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 68.76 22.74 75.58 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 124.407 1.003 . . . . 0.0 113.33 -177.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 89.8 t -91.58 125.48 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 -179.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 5.9 mmt -148.63 26.85 0.92 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.714 1.605 . . . . 0.0 109.437 169.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 22.3 m -141.1 152.91 45.14 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 126.318 1.847 . . . . 0.0 107.167 -179.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -144.82 156.99 55.55 Favored Pre-proline 0 CA--C 1.54 0.583 0 C-N-CA 123.885 0.874 . . . . 0.0 110.262 -171.155 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -67.8 138.88 45.56 Favored 'Cis proline' 0 C--N 1.349 0.566 0 CA-C-N 119.788 0.96 . . . . 0.0 109.649 -10.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 54.5 m -130.16 118.08 20.89 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 174.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 61.1 mt -90.21 144.03 26.23 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 174.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.5 mp -124.65 155.91 38.39 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 169.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 94.1 t -126.67 130.46 71.63 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 N-CA-C 104.077 -2.564 . . . . 0.0 104.077 168.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.1 mp -127.13 156.23 42.09 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 126.234 1.814 . . . . 0.0 106.732 176.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 75.1 tttt -147.17 119.93 8.64 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 -177.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.7 t70 47.39 35.81 4.36 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.16 1.384 . . . . 0.0 113.588 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 108.88 -2.64 31.83 Favored Glycine 0 CA--C 1.527 0.781 0 CA-C-O 118.154 -1.359 . . . . 0.0 115.971 168.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -129.96 144.43 51.32 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 119.943 1.871 . . . . 0.0 110.208 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.7 p -66.79 138.1 23.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 C-N-CA 123.865 0.866 . . . . 0.0 108.765 173.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 35.7 m -129.12 -17.55 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 C-N-CA 125.346 1.459 . . . . 0.0 110.803 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.34 162.97 40.86 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 119.898 1.226 . . . . 0.0 111.559 172.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 85.1 m -151.08 142.12 23.06 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.118 1.767 . . . . 0.0 108.61 176.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 15.1 m -148.85 155.98 41.68 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.588 1.555 . . . . 0.0 108.869 -178.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 37.1 t -132.89 147.98 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 -174.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.75 175.47 49.39 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 124.426 1.012 . . . . 0.0 112.028 177.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -59.91 155.03 17.35 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.281 1.033 . . . . 0.0 110.566 174.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -141.44 145.65 38.79 Favored Pre-proline 0 C--O 1.233 0.235 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 168.003 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -71.89 160.43 47.81 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 122.62 2.213 . . . . 0.0 109.832 169.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -55.26 -47.52 75.34 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 118.742 -0.647 . . . . 0.0 111.116 -178.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -63.62 -43.5 96.68 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 118.555 0.616 . . . . 0.0 110.679 -170.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.98 -43.44 92.62 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 122.802 0.441 . . . . 0.0 110.743 176.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 45.2 tp -66.44 -42.36 87.75 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 119.307 -0.378 . . . . 0.0 110.346 -177.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.5 pp0? -72.62 -29.24 63.31 Favored 'General case' 0 C--N 1.337 0.064 0 CA-C-N 118.89 0.768 . . . . 0.0 110.505 179.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -65.89 -49.24 68.75 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 174.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 58.8 tp -55.58 -44.45 76.9 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.361 0.664 . . . . 0.0 110.454 178.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.41 ' HA ' ' NE2' ' A' ' 103' ' ' HIS . 48.5 t -68.53 -49.32 66.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 CA-C-O 119.538 -0.268 . . . . 0.0 110.52 -178.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -62.43 -27.18 68.92 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 119.143 0.883 . . . . 0.0 112.004 -173.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -65.15 -20.6 66.53 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 117.703 -1.141 . . . . 0.0 113.196 174.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . 0.41 ' NE2' ' HA ' ' A' ' 100' ' ' VAL . 8.1 p80 -116.55 2.37 13.04 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 120.32 1.418 . . . . 0.0 113.511 -179.287 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 80.8 mt . . . . . 0 C--O 1.248 1.012 0 CA-C-N 119.764 1.166 . . . . 0.0 108.144 170.225 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 93.7 mt . . . . . 0 CA--C 1.536 0.418 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 32.5 t -123.43 167.03 17.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 -173.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.5 mtmt -135.19 145.38 47.65 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 175.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -147.79 171.02 16.36 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.291 0.636 . . . . 0.0 110.083 176.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 81.3 p -133.79 178.33 7.03 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 171.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -47.25 -30.49 3.07 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 119.906 1.23 . . . . 0.0 113.187 176.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -58.3 -34.38 70.49 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.691 1.596 . . . . 0.0 112.752 179.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 12.8 m -145.42 -2.83 0.75 Allowed 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 114.833 1.42 . . . . 0.0 114.833 -169.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -54.08 -36.82 63.56 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 119.186 0.903 . . . . 0.0 111.005 178.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.3 m -67.47 -38.67 84.78 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 122.472 0.309 . . . . 0.0 111.387 -178.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.42 -45.25 76.65 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 175.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -64.94 -37.55 88.0 Favored 'General case' 0 C--O 1.231 0.121 0 C-N-CA 122.451 0.3 . . . . 0.0 111.381 -176.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 22.4 p -76.48 -1.65 28.29 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 71.1 m -107.72 33.55 4.01 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.55 1.14 . . . . 0.0 111.977 -171.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -133.39 1.53 3.45 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -177.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 165.66 -165.67 38.08 Favored Glycine 0 C--N 1.336 0.563 0 CA-C-O 118.796 -1.002 . . . . 0.0 111.242 -176.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 88.9 t -73.87 134.25 29.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 N-CA-C 103.678 -2.712 . . . . 0.0 103.678 166.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 39.4 t -134.65 117.57 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 -175.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 62.3 tp -87.85 97.33 10.86 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 173.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.59 146.41 40.41 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 170.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -133.93 94.52 3.28 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 124.818 1.247 . . . . 0.0 107.735 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -71.29 113.36 8.24 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 106.301 -1.741 . . . . 0.0 106.301 172.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 6.3 p-90 -138.26 175.12 9.85 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 123.333 0.653 . . . . 0.0 110.962 -169.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -152.16 146.26 18.34 Favored Pre-proline 0 CA--C 1.536 0.431 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 168.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.31 -17.99 18.44 Favored 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 122.833 2.356 . . . . 0.0 113.377 -171.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -82.29 -8.53 59.64 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 121.53 -0.731 . . . . 0.0 111.997 176.288 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 42.0 t -88.12 126.32 35.05 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -61.42 -59.6 9.63 Favored Glycine 0 CA--C 1.531 1.083 0 CA-C-O 118.491 -1.172 . . . . 0.0 111.661 177.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_exo -49.04 -37.87 38.51 Favored 'Trans proline' 0 CA--C 1.535 0.566 0 C-N-CA 123.683 2.922 . . . . 0.0 115.094 177.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 86.1 m -59.17 -34.16 71.79 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 119.244 0.929 . . . . 0.0 112.793 175.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -84.94 -34.89 22.39 Favored 'General case' 0 N--CA 1.461 0.093 0 CA-C-O 118.942 -0.552 . . . . 0.0 109.996 176.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 85.1 mtp -60.92 -38.56 86.22 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 118.853 0.752 . . . . 0.0 110.993 177.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.0 tt -78.77 -14.62 13.68 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-N 118.549 0.613 . . . . 0.0 111.787 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.58 -50.84 84.65 Favored Pre-proline 0 CA--C 1.544 0.725 0 CA-C-N 120.116 1.325 . . . . 0.0 113.393 -177.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -64.88 -29.24 58.46 Favored 'Trans proline' 0 C--N 1.35 0.645 0 CA-C-N 121.887 1.709 . . . . 0.0 112.179 176.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.5 t -66.11 -42.68 91.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 123.425 0.69 . . . . 0.0 109.327 177.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 85.3 mt -65.62 -36.1 82.73 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 118.715 -0.66 . . . . 0.0 110.432 174.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -65.86 -36.6 83.9 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 119.534 1.061 . . . . 0.0 111.511 175.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -64.94 -43.52 92.49 Favored 'General case' 0 CA--C 1.529 0.146 0 O-C-N 121.162 -0.962 . . . . 0.0 110.086 173.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 31.6 tp -64.58 -38.87 92.5 Favored 'General case' 0 CA--C 1.532 0.276 0 O-C-N 122.252 -0.28 . . . . 0.0 110.522 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -64.32 -43.61 94.15 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 124.164 0.985 . . . . 0.0 110.476 177.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -61.68 -29.07 69.85 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 121.482 -0.761 . . . . 0.0 111.796 174.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -89.88 -35.53 15.57 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.907 0.883 . . . . 0.0 112.698 -174.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 40.6 mtt -136.5 -0.24 2.43 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -169.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -70.19 42.28 0.5 Allowed Glycine 0 CA--C 1.535 1.306 0 C-N-CA 126.914 2.197 . . . . 0.0 115.856 -169.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -143.21 -43.6 0.29 Allowed 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 126.849 2.06 . . . . 0.0 108.789 168.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 58.6 mtmt -72.06 -20.63 61.64 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.73 0.812 . . . . 0.0 111.28 169.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.9 tp -133.32 153.21 51.78 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 128.584 2.753 . . . . 0.0 106.704 -177.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -118.61 154.87 31.94 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 168.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 21.7 mt -122.37 134.7 64.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 104.921 -2.252 . . . . 0.0 104.921 172.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 79.3 t -128.9 109.75 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 -177.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -70.42 138.95 51.67 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 169.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 13.2 tt -144.85 108.25 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 176.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 62.6 t0 -78.44 115.37 18.11 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 123.631 0.772 . . . . 0.0 109.012 -175.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 29.4 m -60.76 -24.85 33.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 123.0 0.52 . . . . 0.0 112.278 -176.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -72.59 -0.79 13.83 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.804 0.842 . . . . 0.0 112.292 179.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -131.07 7.36 4.65 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.189 1.396 . . . . 0.0 110.591 170.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 63.4 m-80 -142.41 44.94 1.64 Allowed 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.599 1.16 . . . . 0.0 110.318 -168.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.487 ' H ' ' NE2' ' A' ' 61' ' ' GLN . 0.4 OUTLIER -56.09 -47.6 77.73 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.266 1.027 . . . . 0.0 108.764 176.885 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 38.5 mp0 -67.17 -47.8 69.9 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 125.231 1.412 . . . . 0.0 109.411 -175.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.53 -47.57 72.48 Favored 'General case' 0 C--O 1.222 -0.356 0 C-N-CA 122.759 0.424 . . . . 0.0 110.168 -176.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.2 -44.03 96.5 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 119.004 0.82 . . . . 0.0 109.313 -179.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -58.1 -27.44 59.96 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 123.948 0.785 . . . . 0.0 112.923 174.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 31.1 ttmt -59.1 -26.21 64.48 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 118.615 1.208 . . . . 0.0 111.448 177.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -117.01 11.56 14.31 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.698 1.199 . . . . 0.0 111.097 179.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 69.82 22.73 77.02 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 124.265 0.936 . . . . 0.0 113.163 -178.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 97.9 t -93.06 135.04 28.9 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 179.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -155.35 28.0 0.4 Allowed 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.33 1.052 . . . . 0.0 109.686 168.104 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 22.8 m -139.06 152.66 47.73 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 126.407 1.883 . . . . 0.0 106.819 178.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -144.13 157.08 57.76 Favored Pre-proline 0 CA--C 1.542 0.641 0 CA-C-O 118.392 -0.813 . . . . 0.0 110.176 -169.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -67.54 137.97 40.35 Favored 'Cis proline' 0 C--N 1.349 0.59 0 CA-C-N 119.933 1.012 . . . . 0.0 109.84 -10.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 53.1 m -129.67 119.5 23.62 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 174.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 96.4 mt -96.61 133.71 40.76 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.6 mp -119.53 130.66 55.29 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 105.203 -2.147 . . . . 0.0 105.203 169.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 16.5 t -93.63 121.35 44.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 103.286 -2.857 . . . . 0.0 103.286 169.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.8 mp -112.23 160.68 17.38 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 170.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -142.28 129.85 21.41 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 169.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.9 t70 42.85 37.55 1.11 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.183 1.393 . . . . 0.0 113.62 175.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 109.81 -6.67 31.26 Favored Glycine 0 CA--C 1.528 0.863 0 CA-C-O 117.97 -1.461 . . . . 0.0 115.482 169.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -132.04 148.41 52.5 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 120.316 2.058 . . . . 0.0 110.901 -175.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.3 t -67.35 137.95 23.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 176.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 35.7 m -127.42 -18.68 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 125.451 1.5 . . . . 0.0 111.051 176.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.62 170.47 22.33 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 120.099 1.318 . . . . 0.0 110.977 171.258 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 99.4 m -147.51 150.63 34.92 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 125.587 1.555 . . . . 0.0 109.075 177.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 58.6 m -150.06 159.25 44.55 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.931 1.692 . . . . 0.0 108.791 171.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 34.9 t -133.17 145.1 34.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 179.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 85.44 177.18 50.55 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 123.709 0.671 . . . . 0.0 111.897 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -62.83 146.95 51.45 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.049 0.939 . . . . 0.0 110.354 177.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 68.0 mttt -143.78 143.17 22.32 Favored Pre-proline 0 CA--C 1.533 0.306 0 C-N-CA 124.989 1.316 . . . . 0.0 107.714 169.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -74.49 159.85 42.43 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 123.221 2.614 . . . . 0.0 110.691 177.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.9 tmpt? -61.02 -34.44 74.83 Favored 'General case' 0 C--O 1.225 -0.205 0 O-C-N 121.453 -0.779 . . . . 0.0 111.222 -175.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -62.5 -37.42 85.95 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.924 0.783 . . . . 0.0 111.561 178.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.18 -42.89 71.83 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 118.068 0.394 . . . . 0.0 110.442 174.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 91.1 mt -64.75 -41.6 95.78 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-O 119.263 -0.398 . . . . 0.0 110.622 -178.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.2 pp0? -70.25 -31.76 69.3 Favored 'General case' 0 CA--C 1.527 0.073 0 CA-C-N 118.83 0.741 . . . . 0.0 110.305 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -65.37 -49.59 68.73 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 175.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 59.2 tp -56.66 -43.43 80.37 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.945 0.898 . . . . 0.0 110.748 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 43.8 t -68.13 -49.18 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 CA-C-O 118.668 -0.682 . . . . 0.0 110.365 178.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.35 -26.1 68.32 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 120.005 1.275 . . . . 0.0 112.431 -175.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 39.8 mmtm -64.84 -17.05 63.92 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 118.029 -0.986 . . . . 0.0 113.073 171.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 92.0 m-70 -118.45 -12.49 9.83 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 119.777 1.171 . . . . 0.0 113.656 179.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 60.2 mt . . . . . 0 C--O 1.248 1.019 0 CA-C-N 120.464 1.484 . . . . 0.0 109.786 172.737 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 83.7 mt . . . . . 0 CA--C 1.541 0.62 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 42.2 t -131.9 170.59 19.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 125.949 1.699 . . . . 0.0 106.917 -174.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 34.0 ttmt -141.93 147.62 37.34 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 176.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -150.78 173.51 14.12 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 123.725 0.81 . . . . 0.0 110.236 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 76.6 p -131.59 175.13 9.43 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.137 1.375 . . . . 0.0 107.298 172.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -51.78 -30.48 23.09 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 120.134 1.333 . . . . 0.0 112.886 -176.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 25.3 mp0 -65.32 -27.96 68.97 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.738 2.015 . . . . 0.0 113.353 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 36.8 p -133.11 -15.87 2.53 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 114.317 1.228 . . . . 0.0 114.317 -168.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -54.2 -34.7 61.21 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 125.402 1.481 . . . . 0.0 111.019 178.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.4 p -64.89 -49.36 70.79 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 123.589 0.756 . . . . 0.0 110.949 -179.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.78 -44.78 96.34 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 122.908 0.483 . . . . 0.0 109.791 177.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -66.11 -37.89 86.87 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 119.263 -0.399 . . . . 0.0 111.616 -176.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 28.1 p -78.82 -1.48 35.06 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 118.67 0.668 . . . . 0.0 112.473 -178.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 59.1 m -106.06 33.0 4.02 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.421 1.089 . . . . 0.0 111.761 -171.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -133.06 -0.22 3.38 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -177.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 167.21 -167.35 39.8 Favored Glycine 0 C--N 1.337 0.614 0 CA-C-N 119.413 1.006 . . . . 0.0 111.563 -174.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 68.9 t -73.77 125.9 33.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 104.601 -2.37 . . . . 0.0 104.601 166.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.3 t -129.86 120.93 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 -174.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -94.01 105.66 17.66 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 105.851 -1.907 . . . . 0.0 105.851 -179.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -94.9 102.55 14.4 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -177.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -82.4 95.25 7.6 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 123.862 0.865 . . . . 0.0 108.705 175.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 45.8 m-85 -75.53 116.72 16.55 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 169.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 7.5 p-90 -141.61 176.81 8.6 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 123.498 0.719 . . . . 0.0 111.498 -170.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -153.68 146.29 17.48 Favored Pre-proline 0 CA--C 1.538 0.509 0 C-N-CA 124.856 1.262 . . . . 0.0 107.717 168.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.92 -19.02 16.37 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.882 2.388 . . . . 0.0 113.264 -171.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -78.74 -7.13 57.46 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 118.689 0.677 . . . . 0.0 112.067 177.158 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 46.6 t -94.98 119.1 32.93 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -178.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -55.47 -58.35 14.34 Favored Glycine 0 CA--C 1.531 1.076 0 CA-C-O 118.56 -1.133 . . . . 0.0 111.779 176.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_exo -49.45 -34.7 33.96 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 123.665 2.91 . . . . 0.0 115.603 177.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 92.7 m -60.6 -44.16 96.58 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 119.78 1.173 . . . . 0.0 111.423 173.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 45.2 mtmt -72.27 -30.91 65.28 Favored 'General case' 0 CA--C 1.529 0.146 0 O-C-N 121.682 -0.636 . . . . 0.0 110.427 178.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 63.0 mtt -67.48 -40.98 85.3 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 118.766 0.712 . . . . 0.0 111.302 176.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.7 tt -78.54 -19.25 13.31 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-N 119.168 0.895 . . . . 0.0 111.415 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.18 -51.01 72.28 Favored Pre-proline 0 CA--C 1.546 0.823 0 CA-C-N 119.895 1.225 . . . . 0.0 114.011 -178.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -65.5 -28.56 53.62 Favored 'Trans proline' 0 C--N 1.351 0.663 0 CA-C-N 121.897 1.713 . . . . 0.0 112.44 175.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 6.6 t -67.33 -37.58 79.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 118.903 0.774 . . . . 0.0 109.542 175.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 96.0 mt -67.74 -34.64 77.24 Favored 'General case' 0 C--O 1.226 -0.136 0 O-C-N 121.493 -0.754 . . . . 0.0 110.685 172.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -64.13 -38.29 90.54 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 119.758 1.163 . . . . 0.0 111.229 172.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -65.94 -37.88 87.17 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 121.092 -1.005 . . . . 0.0 110.384 173.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 46.7 tp -66.6 -36.37 82.45 Favored 'General case' 0 C--O 1.227 -0.13 0 CA-C-N 118.56 0.618 . . . . 0.0 110.512 177.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -65.71 -41.5 92.24 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 118.953 0.797 . . . . 0.0 110.28 174.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -63.9 -29.72 70.87 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 121.796 -0.565 . . . . 0.0 112.13 174.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -87.47 -39.32 15.31 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.141 0.976 . . . . 0.0 112.215 -175.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 16.5 mmt -133.58 -1.27 3.13 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 124.527 1.131 . . . . 0.0 113.76 -167.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -62.1 -7.56 13.67 Favored Glycine 0 CA--C 1.535 1.297 0 CA-C-N 121.193 1.815 . . . . 0.0 114.419 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -79.57 -22.29 43.98 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.674 1.99 . . . . 0.0 112.11 173.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -130.4 -10.03 4.13 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 126.46 1.904 . . . . 0.0 111.465 -171.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -135.74 164.08 28.72 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 126.515 1.926 . . . . 0.0 108.306 -177.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -121.54 142.05 50.45 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 169.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 17.0 mt -105.71 137.78 34.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 105.139 -2.171 . . . . 0.0 105.139 170.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 90.2 t -127.38 114.49 36.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 105.785 -1.931 . . . . 0.0 105.785 175.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.65 141.23 44.63 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 169.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 11.8 tt -151.63 125.58 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 175.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -81.97 129.22 34.72 Favored 'General case' 0 N--CA 1.466 0.325 0 O-C-N 121.586 -0.696 . . . . 0.0 109.446 -178.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 15.4 m -67.81 -34.34 66.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -174.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -76.52 -34.58 58.57 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 119.055 0.843 . . . . 0.0 109.768 -174.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -73.04 -16.21 61.5 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.668 0.787 . . . . 0.0 111.958 172.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 62.7 m-80 -140.22 50.85 1.7 Allowed 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 119.312 0.96 . . . . 0.0 111.182 -168.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -57.2 -36.8 71.31 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.533 0.733 . . . . 0.0 109.68 178.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -64.02 -28.51 69.85 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 125.095 1.358 . . . . 0.0 112.466 -178.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.3 -45.65 8.1 Favored 'General case' 0 C--O 1.222 -0.346 0 CA-C-N 118.573 0.624 . . . . 0.0 109.991 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.53 -45.75 89.17 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 119.484 1.038 . . . . 0.0 110.073 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -62.74 -21.91 63.58 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 124.195 0.902 . . . . 0.0 112.571 175.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.5 ttmm -59.32 -22.07 60.71 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 118.52 1.16 . . . . 0.0 111.617 174.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -121.46 11.34 10.65 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.917 1.287 . . . . 0.0 110.728 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 68.19 27.32 73.77 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 124.147 0.88 . . . . 0.0 112.801 -177.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 65.7 t -100.8 135.71 35.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.54 28.5 0.44 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.546 1.138 . . . . 0.0 109.466 168.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 42.2 m -133.52 156.49 47.69 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 126.257 1.823 . . . . 0.0 107.262 175.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -145.8 159.15 48.02 Favored Pre-proline 0 CA--C 1.539 0.541 0 C-N-CA 124.243 1.017 . . . . 0.0 110.205 -169.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.5 140.05 50.77 Favored 'Cis proline' 0 C--N 1.349 0.583 0 CA-C-N 119.938 1.014 . . . . 0.0 109.923 -10.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 61.5 m -135.0 129.03 33.52 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 106.395 -1.706 . . . . 0.0 106.395 177.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 56.3 mt -108.72 104.07 13.28 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 105.903 -1.888 . . . . 0.0 105.903 -177.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -78.76 141.95 37.39 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 105.374 -2.084 . . . . 0.0 105.374 168.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.2 t -118.95 116.82 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 N-CA-C 103.378 -2.823 . . . . 0.0 103.378 174.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 8.1 mp -111.85 159.86 17.93 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 175.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -141.7 127.9 19.76 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 170.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.8 t70 43.74 38.61 2.09 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.062 1.345 . . . . 0.0 113.323 175.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 104.64 -4.78 43.21 Favored Glycine 0 CA--C 1.53 0.969 0 CA-C-O 117.962 -1.466 . . . . 0.0 115.169 169.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -130.92 150.42 52.09 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 120.269 2.034 . . . . 0.0 110.98 -176.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.2 p -66.08 140.15 20.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 C-N-CA 123.803 0.841 . . . . 0.0 109.476 177.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 28.4 m -127.16 -19.54 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 C-N-CA 125.479 1.512 . . . . 0.0 110.865 173.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.87 168.33 26.03 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 120.399 1.454 . . . . 0.0 111.382 169.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 60.8 m -143.63 136.04 27.03 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.023 1.729 . . . . 0.0 107.216 169.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 38.4 m -140.57 152.51 45.55 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.92 1.288 . . . . 0.0 108.436 -177.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 38.5 t -133.48 147.53 31.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 -171.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.02 174.35 49.54 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 124.25 0.929 . . . . 0.0 112.229 175.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -61.33 148.09 42.52 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 123.784 0.834 . . . . 0.0 110.744 179.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -152.11 142.2 14.87 Favored Pre-proline 0 CA--C 1.533 0.324 0 C-N-CA 125.922 1.689 . . . . 0.0 106.999 -178.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -74.4 156.77 45.69 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 122.44 2.093 . . . . 0.0 110.612 174.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.5 tmpt? -58.31 -36.43 73.34 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 123.636 0.774 . . . . 0.0 110.982 -179.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 23.7 tp10 -65.91 -36.71 84.15 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 118.506 0.594 . . . . 0.0 111.441 -174.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.02 -42.96 79.87 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 122.926 0.49 . . . . 0.0 110.681 174.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 91.3 mt -65.68 -43.98 87.64 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 119.096 -0.478 . . . . 0.0 110.123 -177.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.8 pp0? -68.21 -30.0 68.97 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 118.909 0.777 . . . . 0.0 110.543 179.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -65.99 -50.22 65.04 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 175.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 54.9 tp -56.92 -44.32 82.31 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.063 0.545 . . . . 0.0 110.648 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 42.7 t -63.36 -50.73 77.53 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 C-N-CA 123.461 0.704 . . . . 0.0 109.717 178.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -65.66 -26.19 67.69 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 119.386 0.994 . . . . 0.0 112.403 -175.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -67.22 -36.71 82.24 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 118.78 -0.629 . . . . 0.0 111.214 170.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 79.8 m-70 -80.64 -24.51 38.97 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 118.078 -0.963 . . . . 0.0 113.378 178.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 65.8 mt . . . . . 0 C--O 1.248 1.015 0 CA-C-N 119.707 1.14 . . . . 0.0 110.155 177.699 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 84.5 mt . . . . . 0 CA--C 1.534 0.353 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 23.3 t -105.85 160.69 5.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 125.573 1.549 . . . . 0.0 107.379 -175.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.41 140.48 52.65 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 176.294 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -136.98 172.24 13.31 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.041 0.937 . . . . 0.0 110.498 179.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.0 p -129.6 173.56 10.49 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 125.739 1.616 . . . . 0.0 107.861 178.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -52.34 -35.56 51.23 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 119.509 1.049 . . . . 0.0 111.721 174.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 5.4 mp0 -75.86 -31.25 59.21 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -177.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 32.6 p -110.83 -14.93 13.91 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 -169.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -51.0 -39.56 56.03 Favored 'General case' 0 C--N 1.334 -0.078 0 C-N-CA 124.573 1.149 . . . . 0.0 110.224 173.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.2 m -74.09 -23.19 59.3 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -174.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.88 -48.39 18.45 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 169.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -66.96 -36.39 82.1 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 122.807 0.443 . . . . 0.0 111.965 -170.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 42.9 p -82.85 7.8 14.21 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 112.527 0.565 . . . . 0.0 112.527 -176.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 40.8 m -121.68 34.57 5.14 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.596 0.758 . . . . 0.0 112.216 -169.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -135.39 1.75 2.92 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -176.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 169.0 -165.86 39.25 Favored Glycine 0 C--N 1.333 0.408 0 N-CA-C 110.409 -1.076 . . . . 0.0 110.409 -171.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 1.5 t -78.82 133.01 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 N-CA-C 104.324 -2.473 . . . . 0.0 104.324 168.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 23.8 t -139.63 146.15 25.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 -173.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 9.0 tt -122.55 135.87 54.74 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 105.807 -1.923 . . . . 0.0 105.807 169.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -129.67 121.3 26.7 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 -174.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -96.08 102.55 14.36 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 125.504 1.522 . . . . 0.0 108.585 -177.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -76.41 116.84 17.48 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 169.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 6.9 p-90 -145.88 178.82 7.89 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.619 0.767 . . . . 0.0 110.898 -169.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -158.51 150.28 17.08 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 125.606 1.562 . . . . 0.0 107.054 167.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.18 -18.72 20.7 Favored 'Trans proline' 0 CA--C 1.532 0.417 0 C-N-CA 122.754 2.303 . . . . 0.0 113.478 -170.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -79.39 -11.12 59.93 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 118.94 0.791 . . . . 0.0 112.483 176.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 45.8 t -85.53 119.26 25.68 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -57.01 -58.26 15.51 Favored Glycine 0 CA--C 1.531 1.093 0 CA-C-O 118.622 -1.099 . . . . 0.0 111.632 174.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -49.95 -36.14 42.95 Favored 'Trans proline' 0 CA--C 1.536 0.618 0 C-N-CA 123.571 2.848 . . . . 0.0 115.309 176.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 98.4 m -59.39 -46.06 89.73 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 119.87 1.214 . . . . 0.0 111.306 173.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 46.1 mtmt -70.35 -30.26 67.16 Favored 'General case' 0 N--CA 1.462 0.168 0 O-C-N 121.511 -0.743 . . . . 0.0 110.844 178.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 87.2 mtp -67.32 -43.08 82.5 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 118.922 0.783 . . . . 0.0 110.98 175.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 8.3 tt -78.84 -18.91 13.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-N 119.048 0.84 . . . . 0.0 111.378 -178.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.33 -52.44 59.28 Favored Pre-proline 0 CA--C 1.544 0.743 0 CA-C-O 117.5 -1.238 . . . . 0.0 113.986 -178.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.03 -30.35 56.53 Favored 'Trans proline' 0 C--N 1.349 0.58 0 CA-C-N 121.931 1.725 . . . . 0.0 112.103 177.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 6.3 t -64.82 -42.68 95.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 118.762 0.71 . . . . 0.0 109.085 176.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 61.1 mt -67.14 -34.97 78.71 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 118.603 -0.713 . . . . 0.0 110.981 176.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -65.59 -40.39 92.64 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 119.553 1.07 . . . . 0.0 111.004 174.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -63.95 -42.87 97.18 Favored 'General case' 0 CA--C 1.53 0.188 0 O-C-N 121.405 -0.809 . . . . 0.0 109.875 174.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 25.8 tp -62.8 -39.15 93.39 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 122.845 0.458 . . . . 0.0 110.794 178.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -66.83 -38.89 87.28 Favored 'General case' 0 C--N 1.333 -0.116 0 O-C-N 121.448 -0.782 . . . . 0.0 110.856 177.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -64.45 -23.06 67.15 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 121.86 -0.525 . . . . 0.0 111.895 173.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -96.88 -30.9 12.86 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.784 1.234 . . . . 0.0 112.46 -176.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 19.0 mmt -129.73 -9.31 4.49 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 117.825 -1.084 . . . . 0.0 113.606 -168.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -48.49 -30.53 8.42 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 125.955 1.74 . . . . 0.0 115.985 -169.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -79.31 -38.63 34.82 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.296 1.038 . . . . 0.0 111.495 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -85.23 -26.17 26.86 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 124.7 1.2 . . . . 0.0 110.801 -178.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -148.44 124.39 10.66 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 125.016 1.326 . . . . 0.0 108.807 -177.253 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -72.36 148.14 45.58 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 176.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 22.8 mt -122.07 133.58 67.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 172.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 9.2 t -127.01 153.11 35.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 124.689 1.196 . . . . 0.0 108.196 -173.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 65.4 mmtt -118.9 141.17 48.89 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 126.085 1.754 . . . . 0.0 107.975 177.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 14.9 tt -145.54 120.8 3.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-O 121.358 0.599 . . . . 0.0 109.538 172.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -80.9 110.47 16.46 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 123.911 0.885 . . . . 0.0 108.823 -179.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 24.0 m -64.47 -25.5 38.08 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-O 118.986 -0.53 . . . . 0.0 112.427 -174.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -70.98 -12.94 61.82 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 119.14 0.882 . . . . 0.0 111.68 -178.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -120.03 -5.28 10.04 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.239 1.416 . . . . 0.0 110.979 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 60.9 m-80 -146.06 36.66 1.03 Allowed 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.217 1.007 . . . . 0.0 110.551 -168.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.404 ' H ' ' NE2' ' A' ' 61' ' ' GLN . 1.2 pm0 -59.07 -25.34 63.67 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.973 0.909 . . . . 0.0 111.487 179.219 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 59.6 mp0 -60.13 -32.44 71.02 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.028 1.731 . . . . 0.0 111.29 175.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.39 -48.81 14.72 Favored 'General case' 0 C--O 1.223 -0.326 0 CA-C-N 118.38 0.536 . . . . 0.0 110.0 172.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.23 -45.99 89.04 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 118.798 0.726 . . . . 0.0 110.278 -171.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -61.92 -23.99 64.22 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 124.166 0.889 . . . . 0.0 112.821 176.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.6 ttmm -59.18 -28.13 66.34 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 118.612 1.206 . . . . 0.0 111.295 175.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -115.84 11.01 15.45 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.776 1.23 . . . . 0.0 111.033 178.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 70.36 18.3 75.08 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 124.603 1.096 . . . . 0.0 113.738 -178.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 98.8 t -84.12 134.23 27.43 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 176.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -155.45 32.2 0.37 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.413 1.085 . . . . 0.0 109.09 166.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 23.3 m -138.01 151.45 47.91 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 126.824 2.05 . . . . 0.0 106.245 176.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 28.2 pt -147.3 159.58 41.73 Favored Pre-proline 0 CA--C 1.542 0.669 0 C-N-CA 124.041 0.937 . . . . 0.0 109.472 -169.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -66.65 142.07 57.91 Favored 'Cis proline' 0 N--CA 1.458 -0.559 0 N-CA-C 109.529 -0.989 . . . . 0.0 109.529 -10.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 26.7 m -132.43 129.07 38.8 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 178.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 50.1 mt -112.05 109.53 19.33 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 -174.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.5 mp -87.51 151.75 22.77 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 106.171 -1.788 . . . . 0.0 106.171 167.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 15.7 t -123.78 132.12 71.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 N-CA-C 104.131 -2.544 . . . . 0.0 104.131 169.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.3 mp -132.99 160.01 38.36 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 125.918 1.687 . . . . 0.0 107.254 -175.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -147.2 127.52 13.94 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.1 t70 59.13 -19.26 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 128.052 2.541 . . . . 0.0 116.298 177.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 162.17 -0.91 0.06 OUTLIER Glycine 0 CA--C 1.532 1.102 0 CA-C-O 118.141 -1.366 . . . . 0.0 114.4 173.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -134.26 151.01 51.05 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 120.239 2.02 . . . . 0.0 110.45 -173.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 42.4 t -64.84 139.95 20.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 C-N-CA 124.238 1.015 . . . . 0.0 108.373 175.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 33.6 m -121.17 -21.97 3.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 125.208 1.403 . . . . 0.0 110.593 172.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -158.02 164.2 36.99 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 119.79 1.177 . . . . 0.0 111.584 174.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 69.7 m -144.1 138.45 28.25 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.777 1.631 . . . . 0.0 108.205 172.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 44.6 m -143.38 153.48 42.74 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.695 1.598 . . . . 0.0 108.594 -178.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 40.2 t -133.69 146.46 31.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -174.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.63 174.46 45.81 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 124.633 1.111 . . . . 0.0 112.443 173.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 61.3 t80 -62.66 143.91 56.85 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.597 0.759 . . . . 0.0 109.99 176.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 44.7 mttm -145.29 148.26 37.06 Favored Pre-proline 0 C--O 1.235 0.29 0 C-N-CA 125.226 1.41 . . . . 0.0 107.994 169.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -74.1 159.88 43.61 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 123.062 2.508 . . . . 0.0 110.626 176.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 11.0 ttpt -58.32 -38.54 77.32 Favored 'General case' 0 C--O 1.223 -0.293 0 O-C-N 121.825 -0.547 . . . . 0.0 111.021 -177.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -59.93 -39.27 84.91 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.416 0.686 . . . . 0.0 111.558 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.13 -42.02 73.13 Favored 'General case' 0 N--CA 1.452 -0.346 0 O-C-N 122.17 -0.331 . . . . 0.0 110.483 175.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 90.9 mt -67.83 -37.57 82.08 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 119.014 -0.517 . . . . 0.0 111.056 -178.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.8 pp0? -71.48 -29.62 65.04 Favored 'General case' 0 CA--C 1.526 0.036 0 CA-C-N 119.523 1.056 . . . . 0.0 110.297 177.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -65.46 -49.59 68.55 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 174.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 52.0 tp -54.35 -46.06 72.87 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.831 0.852 . . . . 0.0 110.635 177.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 25.2 t -63.26 -53.06 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.83 -25.4 67.89 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 119.021 0.828 . . . . 0.0 112.457 -174.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 61.3 mtpt -66.74 -23.04 66.04 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 118.024 -0.989 . . . . 0.0 112.552 172.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -110.46 -13.55 14.24 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 119.765 1.166 . . . . 0.0 113.384 -179.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 56.5 mt . . . . . 0 C--O 1.249 1.073 0 CA-C-N 119.871 1.214 . . . . 0.0 109.449 170.041 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 89.3 mt . . . . . 0 C--O 1.236 0.347 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 38.7 t -101.18 166.42 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 125.494 1.518 . . . . 0.0 107.581 -173.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.4 mppt? -128.63 143.37 50.93 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 106.079 -1.822 . . . . 0.0 106.079 177.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -144.79 169.72 17.48 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 118.341 0.518 . . . . 0.0 110.976 175.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.6 p -134.01 170.09 16.15 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 172.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -52.66 -25.59 11.31 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 119.98 1.264 . . . . 0.0 112.317 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 69.4 mm-40 -63.71 -33.07 74.84 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.474 1.51 . . . . 0.0 112.516 -179.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.6 m -140.29 -4.93 1.28 Allowed 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -171.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -50.39 -39.74 47.7 Favored 'General case' 0 N--CA 1.457 -0.081 0 C-N-CA 125.328 1.451 . . . . 0.0 110.665 173.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.9 m -66.9 -36.42 82.24 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 118.003 0.365 . . . . 0.0 111.618 -176.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.12 -46.59 70.46 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 174.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -64.07 -38.69 91.99 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 122.784 0.434 . . . . 0.0 111.431 -175.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 30.9 p -79.35 -0.37 32.34 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -176.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 64.8 m -109.28 34.48 3.73 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.456 1.102 . . . . 0.0 111.614 -173.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -132.11 -0.21 3.75 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 -178.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 165.43 -167.97 39.2 Favored Glycine 0 C--N 1.336 0.546 0 CA-C-N 119.16 0.891 . . . . 0.0 111.042 -174.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 94.3 t -71.17 132.42 33.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 N-CA-C 104.558 -2.386 . . . . 0.0 104.558 166.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.3 t -135.57 118.62 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 -176.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -87.93 124.39 33.64 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 105.372 -2.085 . . . . 0.0 105.372 172.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -117.12 105.53 12.36 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -81.86 99.99 9.35 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 175.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -76.14 116.71 17.1 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 168.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 7.0 p-90 -144.86 179.53 7.27 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.59 0.756 . . . . 0.0 111.415 -169.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -158.48 152.32 19.57 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 125.648 1.579 . . . . 0.0 107.197 167.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -76.83 -16.96 16.0 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.835 2.357 . . . . 0.0 113.467 -169.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -79.14 -11.65 59.98 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.898 0.772 . . . . 0.0 111.986 177.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 41.7 t -87.52 121.46 29.98 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 178.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -58.71 -56.16 26.8 Favored Glycine 0 CA--C 1.532 1.121 0 CA-C-O 118.76 -1.022 . . . . 0.0 111.936 175.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_exo -49.35 -39.51 43.87 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 123.496 2.797 . . . . 0.0 115.077 175.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 69.8 m -58.58 -34.33 70.96 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 119.125 0.875 . . . . 0.0 112.864 175.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 45.6 mtmt -81.29 -42.25 20.9 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 8.2 ptt? -70.64 -24.2 62.66 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 119.358 0.981 . . . . 0.0 112.532 -176.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 8.0 tt -77.16 -18.14 14.43 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-N 119.602 1.092 . . . . 0.0 111.574 173.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.05 -48.51 95.88 Favored Pre-proline 0 CA--C 1.539 0.521 0 CA-C-O 117.287 -1.34 . . . . 0.0 113.417 -177.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -63.28 -31.28 73.93 Favored 'Trans proline' 0 C--N 1.35 0.614 0 CA-C-N 121.938 1.728 . . . . 0.0 112.143 175.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 6.6 t -66.54 -41.13 87.97 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-N 119.249 0.931 . . . . 0.0 109.521 177.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 63.4 mt -66.63 -32.82 74.38 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-O 118.813 -0.613 . . . . 0.0 110.912 174.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -68.66 -35.81 77.73 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 119.669 1.122 . . . . 0.0 111.304 173.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 -64.92 -39.42 93.49 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 120.903 -1.123 . . . . 0.0 109.886 171.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 24.4 tp -66.57 -35.86 81.25 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 121.604 -0.685 . . . . 0.0 110.969 176.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -65.76 -38.56 89.41 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.739 0.815 . . . . 0.0 110.632 175.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -66.71 -38.34 86.52 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.783 -0.573 . . . . 0.0 111.03 173.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -74.48 -43.0 58.04 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.026 0.93 . . . . 0.0 111.764 -174.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 42.6 mtt -142.8 3.03 1.41 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 117.849 -1.072 . . . . 0.0 113.742 -168.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -74.49 50.9 2.15 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 126.056 1.788 . . . . 0.0 113.641 -172.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -154.29 -41.16 0.09 Allowed 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 129.697 3.199 . . . . 0.0 107.327 169.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 48.0 mtpt -64.12 -33.74 76.45 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.599 1.16 . . . . 0.0 110.529 169.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -131.36 165.3 23.77 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.839 1.656 . . . . 0.0 109.679 169.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -102.88 149.68 24.26 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 170.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 20.3 mt -117.84 136.43 55.04 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 N-CA-C 105.036 -2.209 . . . . 0.0 105.036 170.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 63.8 t -129.66 138.56 53.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 -178.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 60.0 mmtt -97.77 139.34 33.79 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.859 1.264 . . . . 0.0 108.219 169.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 12.6 tt -149.17 128.56 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 CA-C-O 121.306 0.574 . . . . 0.0 109.555 175.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -83.73 127.19 33.61 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.546 0.739 . . . . 0.0 110.269 -175.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 13.5 m -67.92 -26.95 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 -173.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -83.54 -41.01 18.41 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 119.903 1.229 . . . . 0.0 109.634 -175.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -70.62 -25.22 62.94 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.355 0.662 . . . . 0.0 111.08 174.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -127.42 43.8 3.05 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.748 1.219 . . . . 0.0 109.74 -172.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.15 -36.44 51.45 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 126.666 1.986 . . . . 0.0 111.285 175.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -65.48 -40.28 92.93 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 124.012 0.925 . . . . 0.0 111.483 176.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.59 -43.32 48.9 Favored 'General case' 0 C--O 1.222 -0.356 0 CA-C-N 119.406 1.003 . . . . 0.0 110.111 -178.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -61.62 -46.17 90.97 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 119.205 0.911 . . . . 0.0 109.719 176.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -60.74 -22.42 59.62 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 124.456 1.027 . . . . 0.0 113.069 175.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 7.7 ttmm -59.92 -20.38 57.05 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 118.629 1.215 . . . . 0.0 111.503 175.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -124.36 10.37 8.59 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.353 1.461 . . . . 0.0 110.627 178.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 64.9 22.85 68.89 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.542 1.067 . . . . 0.0 113.226 -174.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 61.1 t -88.74 153.6 3.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 118.331 1.065 . . . . 0.0 109.198 178.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -161.04 -22.83 0.06 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 127.5 2.32 . . . . 0.0 109.86 167.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.5 m -63.6 153.15 36.8 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 124.312 1.045 . . . . 0.0 109.721 171.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 28.2 pt -146.58 156.25 48.91 Favored Pre-proline 0 CA--C 1.542 0.637 0 C-N-CA 124.141 0.976 . . . . 0.0 109.617 -178.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -68.41 140.49 56.43 Favored 'Cis proline' 0 N--CA 1.457 -0.625 0 N-CA-C 109.011 -1.188 . . . . 0.0 109.011 -11.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 54.4 m -131.17 125.28 32.61 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 178.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 40.6 mt -104.26 104.14 14.0 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 -176.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -78.27 143.64 36.87 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 105.726 -1.953 . . . . 0.0 105.726 168.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.8 t -120.29 118.41 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 103.489 -2.782 . . . . 0.0 103.489 172.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 8.8 mp -114.6 160.12 19.66 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 175.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -143.12 128.15 18.51 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 170.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.8 t70 44.01 37.79 1.94 Allowed 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.102 1.361 . . . . 0.0 113.39 175.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 104.86 -4.48 42.22 Favored Glycine 0 CA--C 1.528 0.857 0 CA-C-O 118.083 -1.398 . . . . 0.0 115.247 169.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -129.82 149.58 51.5 Favored 'General case' 0 C--N 1.34 0.162 0 CA-C-N 120.19 1.995 . . . . 0.0 110.755 -177.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.9 p -66.19 140.77 18.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 C-N-CA 123.765 0.826 . . . . 0.0 109.312 177.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 35.5 m -127.14 -19.54 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 C-N-CA 125.481 1.512 . . . . 0.0 110.8 173.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.35 167.59 28.47 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 120.227 1.376 . . . . 0.0 111.392 169.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 78.0 m -143.71 134.0 24.54 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 126.253 1.821 . . . . 0.0 107.243 169.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 39.0 m -141.41 153.8 45.24 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 124.898 1.279 . . . . 0.0 108.666 -176.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.1 t -132.95 148.67 31.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -172.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.08 170.61 46.08 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 124.407 1.003 . . . . 0.0 112.468 172.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -65.34 133.38 51.27 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 123.475 0.71 . . . . 0.0 109.54 175.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -134.73 144.02 48.89 Favored Pre-proline 0 CA--C 1.534 0.342 0 C-N-CA 126.111 1.764 . . . . 0.0 106.626 176.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -72.12 158.89 51.27 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 122.754 2.303 . . . . 0.0 110.553 176.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 9.9 ttpt -57.42 -37.41 72.71 Favored 'General case' 0 C--O 1.223 -0.321 0 O-C-N 121.719 -0.613 . . . . 0.0 111.133 -177.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -61.05 -37.38 82.41 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 118.528 0.604 . . . . 0.0 111.728 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -72.15 -41.76 66.74 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 122.748 0.419 . . . . 0.0 110.604 175.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 81.2 mt -64.04 -43.36 95.78 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 119.317 -0.373 . . . . 0.0 110.295 -179.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.9 pp0? -70.16 -30.43 67.58 Favored 'General case' 0 C--O 1.228 -0.067 0 CA-C-N 118.835 0.743 . . . . 0.0 110.11 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -64.75 -49.41 70.91 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 175.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 60.2 tp -57.14 -45.73 83.32 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.553 0.741 . . . . 0.0 110.507 178.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 40.0 t -62.88 -49.05 85.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 CA-C-O 119.029 -0.51 . . . . 0.0 109.941 179.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.62 -25.89 68.16 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 119.414 1.006 . . . . 0.0 112.543 -175.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -66.2 -19.36 65.81 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 118.068 -0.968 . . . . 0.0 112.811 171.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -113.07 -16.41 12.63 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 119.877 1.217 . . . . 0.0 113.528 -178.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 70.7 mt . . . . . 0 C--O 1.248 1.019 0 CA-C-N 119.972 1.26 . . . . 0.0 109.713 172.531 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 78.0 mt . . . . . 0 CA--C 1.538 0.485 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.7 t -131.49 165.25 32.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 124.877 1.271 . . . . 0.0 107.902 -168.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -127.12 142.43 51.51 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 174.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -148.32 171.19 16.39 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 124.302 1.041 . . . . 0.0 108.807 169.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 70.4 p -133.84 178.37 7.0 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 171.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -45.95 -31.15 2.05 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.487 1.115 . . . . 0.0 113.31 176.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -58.87 -34.46 71.64 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.321 1.848 . . . . 0.0 112.998 179.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.2 m -145.5 -3.61 0.71 Allowed 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 -169.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -54.33 -36.01 63.32 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.305 1.042 . . . . 0.0 110.84 177.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.8 m -67.01 -34.54 77.95 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 122.884 0.474 . . . . 0.0 111.9 -179.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -70.14 -45.85 65.94 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 175.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -64.35 -37.91 89.17 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 119.47 -0.3 . . . . 0.0 111.443 -175.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 20.2 p -75.98 1.16 16.07 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -178.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 52.0 m -117.51 37.12 4.0 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.294 1.037 . . . . 0.0 111.913 -169.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -130.97 -2.17 4.08 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 163.17 -165.88 36.76 Favored Glycine 0 C--N 1.335 0.498 0 N-CA-C 110.149 -1.18 . . . . 0.0 110.149 -172.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 87.5 t -68.53 141.0 18.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 105.758 -1.941 . . . . 0.0 105.758 166.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 62.4 t -141.97 142.97 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 107.194 -1.409 . . . . 0.0 107.194 -178.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 56.6 tp -112.71 99.22 7.76 Favored 'General case' 0 CA--C 1.521 -0.158 0 N-CA-C 106.573 -1.639 . . . . 0.0 106.573 173.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.06 144.12 40.95 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 170.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -129.26 95.55 4.07 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 125.393 1.477 . . . . 0.0 107.263 178.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -75.31 116.41 16.0 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 173.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 12.1 p-90 -135.72 175.15 9.85 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 124.069 0.947 . . . . 0.0 110.17 -173.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -148.62 146.27 21.92 Favored Pre-proline 0 CA--C 1.533 0.314 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 169.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -74.0 -15.78 23.24 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.808 2.339 . . . . 0.0 113.863 -169.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -93.24 -6.09 48.43 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.812 0.845 . . . . 0.0 112.126 178.13 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 42.3 t -85.41 116.49 23.76 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 -178.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -55.75 -55.03 30.97 Favored Glycine 0 CA--C 1.532 1.15 0 CA-C-O 118.671 -1.072 . . . . 0.0 112.236 175.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -50.26 -36.34 46.55 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 123.254 2.636 . . . . 0.0 115.219 175.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 92.9 m -59.91 -40.28 88.26 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 119.937 1.244 . . . . 0.0 111.713 172.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 61.9 mttm -66.28 -38.9 88.85 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 121.475 -0.766 . . . . 0.0 110.01 175.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 98.5 mmm -67.45 -41.84 84.07 Favored 'General case' 0 N--CA 1.461 0.089 0 C-N-CA 122.84 0.456 . . . . 0.0 111.423 -177.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 8.7 tt -76.63 -20.97 14.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-N 118.511 0.596 . . . . 0.0 111.054 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -52.48 -51.22 74.92 Favored Pre-proline 0 CA--C 1.544 0.749 0 CA-C-N 119.646 1.112 . . . . 0.0 113.88 -175.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -67.24 -26.2 42.26 Favored 'Trans proline' 0 C--N 1.349 0.555 0 CA-C-N 121.925 1.723 . . . . 0.0 112.295 177.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.8 t -67.6 -37.95 79.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-N 119.307 0.958 . . . . 0.0 109.359 173.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 90.1 mt -67.13 -36.14 81.23 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-O 118.621 -0.704 . . . . 0.0 110.663 173.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -62.71 -42.91 99.89 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 119.472 1.033 . . . . 0.0 110.642 172.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -62.86 -37.18 85.82 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 121.307 -0.871 . . . . 0.0 110.651 176.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -65.6 -39.88 92.05 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 123.437 0.695 . . . . 0.0 109.897 176.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -63.7 -42.0 98.04 Favored 'General case' 0 C--N 1.332 -0.152 0 C-N-CA 123.948 0.899 . . . . 0.0 110.586 174.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 62.0 mm-40 -65.96 -28.31 68.81 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 121.361 -0.837 . . . . 0.0 111.536 176.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -86.73 -41.05 14.45 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.238 1.015 . . . . 0.0 112.154 -177.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 75.4 mmm -135.63 -2.81 2.39 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.368 1.067 . . . . 0.0 113.799 -167.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.47 44.0 0.74 Allowed Glycine 0 N--CA 1.471 0.98 0 C-N-CA 127.453 2.454 . . . . 0.0 115.166 -169.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -147.24 -37.49 0.21 Allowed 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 127.09 2.156 . . . . 0.0 108.621 169.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -63.06 -31.3 72.4 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.95 1.3 . . . . 0.0 110.108 168.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -138.29 166.71 23.5 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 126.553 1.941 . . . . 0.0 109.698 170.161 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 15.3 ptpt -109.26 155.39 21.18 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 167.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 15.5 mt -105.8 141.31 21.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 171.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 24.1 t -126.02 107.8 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 177.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 11.7 mmmm -73.75 137.12 43.76 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 173.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 15.6 tt -147.27 115.15 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 49.0 t0 -83.26 115.85 22.15 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.681 0.793 . . . . 0.0 109.031 -175.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 34.1 m -59.14 -26.72 34.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 123.048 0.539 . . . . 0.0 112.416 -176.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -72.05 -2.0 16.76 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.776 0.831 . . . . 0.0 112.493 -178.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -131.78 7.56 4.43 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.878 1.271 . . . . 0.0 110.706 172.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 67.4 m-80 -142.01 45.77 1.66 Allowed 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.117 0.967 . . . . 0.0 110.774 -168.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.504 ' H ' ' NE2' ' A' ' 61' ' ' GLN . 0.4 OUTLIER -57.38 -45.35 84.56 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.043 0.937 . . . . 0.0 108.768 175.647 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -69.46 -31.84 70.39 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.252 1.421 . . . . 0.0 111.598 -172.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -82.09 -49.55 10.06 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 118.411 0.55 . . . . 0.0 109.845 175.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.75 -45.08 91.45 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 119.152 0.887 . . . . 0.0 109.931 -173.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -61.92 -23.55 63.69 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 124.041 0.829 . . . . 0.0 112.778 175.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.5 ttmm -59.32 -27.19 65.67 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 118.798 1.299 . . . . 0.0 111.284 175.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -117.39 12.39 14.23 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.805 1.242 . . . . 0.0 110.932 179.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 69.51 18.66 73.88 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 124.598 1.094 . . . . 0.0 113.719 -179.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 86.0 t -84.35 131.57 33.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 176.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.89 27.25 0.48 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.436 1.094 . . . . 0.0 109.741 168.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 24.7 m -140.39 153.63 46.42 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 126.882 2.073 . . . . 0.0 106.515 177.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -146.59 159.88 43.11 Favored Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 124.159 0.983 . . . . 0.0 109.728 -169.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -66.93 136.93 33.55 Favored 'Cis proline' 0 N--CA 1.457 -0.628 0 CA-C-N 120.081 1.065 . . . . 0.0 109.501 -11.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 52.9 m -132.63 121.17 22.78 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 178.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 82.2 mt -99.34 132.14 44.87 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.4 mp -117.18 129.29 55.85 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 105.444 -2.058 . . . . 0.0 105.444 170.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.2 t -93.44 126.4 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 N-CA-C 103.39 -2.819 . . . . 0.0 103.39 169.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.6 mp -119.24 159.81 23.36 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 174.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -145.84 124.75 12.71 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 173.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.4 t70 44.51 40.15 3.73 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.475 1.51 . . . . 0.0 113.267 174.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 98.57 5.96 56.59 Favored Glycine 0 CA--C 1.527 0.813 0 CA-C-O 118.792 -1.004 . . . . 0.0 114.574 169.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 81.9 mm-40 -128.16 144.09 51.09 Favored 'General case' 0 CA--C 1.521 -0.142 0 CA-C-N 119.262 1.531 . . . . 0.0 108.949 177.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.7 t -68.26 136.47 26.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 169.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 22.9 m -120.15 -20.73 4.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 117.856 -1.068 . . . . 0.0 110.479 174.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.54 164.76 38.24 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 119.711 1.141 . . . . 0.0 111.634 173.379 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 95.8 m -145.3 137.74 25.91 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.546 1.538 . . . . 0.0 108.381 175.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 44.6 m -145.06 153.13 41.13 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.04 1.736 . . . . 0.0 108.176 -178.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 40.6 t -133.19 148.21 31.21 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -174.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.83 177.13 46.81 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 123.858 0.742 . . . . 0.0 112.375 176.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -58.99 147.73 33.34 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 124.491 1.116 . . . . 0.0 110.745 178.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -155.23 147.7 17.7 Favored Pre-proline 0 CA--C 1.533 0.311 0 C-N-CA 125.272 1.429 . . . . 0.0 107.686 169.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.85 157.87 47.11 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.668 2.245 . . . . 0.0 111.34 -177.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 4.7 ttpt -60.68 -34.97 75.13 Favored 'General case' 0 C--O 1.223 -0.312 0 C-N-CA 123.909 0.884 . . . . 0.0 111.673 -178.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -64.67 -42.58 95.27 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 119.425 1.011 . . . . 0.0 111.822 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.14 -43.03 75.2 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 122.828 0.451 . . . . 0.0 110.364 177.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 38.8 tp -67.81 -40.71 83.81 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 119.111 -0.471 . . . . 0.0 110.714 -177.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.5 pp0? -67.79 -32.15 72.51 Favored 'General case' 0 C--O 1.222 -0.393 0 CA-C-O 117.856 -1.068 . . . . 0.0 109.578 175.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -67.34 -43.66 80.98 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 119.436 1.016 . . . . 0.0 109.268 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 58.0 tp -57.05 -51.81 67.8 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.409 0.684 . . . . 0.0 109.681 175.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 28.7 t -58.54 -48.86 84.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 123.461 0.705 . . . . 0.0 110.481 178.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -57.44 -46.43 83.6 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 126.501 1.92 . . . . 0.0 110.699 -176.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -59.41 -34.27 72.25 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 118.656 -0.688 . . . . 0.0 112.368 174.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 79.8 m-70 -81.2 -18.12 47.27 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 82.3 mt . . . . . 0 C--O 1.249 1.064 0 CA-C-N 119.93 1.241 . . . . 0.0 110.185 178.653 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 90.8 mt . . . . . 0 CA--C 1.535 0.39 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 38.8 t -110.45 165.18 6.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 -174.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.93 134.93 41.12 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 -179.333 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -146.66 170.9 16.0 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.106 0.412 . . . . 0.0 111.299 178.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 76.2 p -137.32 174.41 10.63 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.416 1.487 . . . . 0.0 108.111 179.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -47.34 -33.27 5.6 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 119.997 1.271 . . . . 0.0 113.11 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 26.8 mp0 -61.4 -33.71 74.14 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.677 1.591 . . . . 0.0 112.875 -179.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.5 m -142.82 -1.82 1.08 Allowed 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 -169.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -52.72 -41.45 63.96 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.078 0.951 . . . . 0.0 110.13 175.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.6 m -65.45 -27.67 68.68 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.558 0.743 . . . . 0.0 112.433 -178.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -78.49 -27.62 46.22 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.788 0.835 . . . . 0.0 111.088 176.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -81.6 -40.95 22.23 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.031 0.532 . . . . 0.0 111.137 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 39.2 p -74.84 -2.91 28.86 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -174.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.0 p -108.71 29.54 7.34 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.762 1.225 . . . . 0.0 112.883 -169.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -131.27 -0.34 4.07 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 113.588 0.958 . . . . 0.0 113.588 -175.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 166.15 -166.38 38.72 Favored Glycine 0 C--N 1.336 0.547 0 CA-C-N 119.21 0.913 . . . . 0.0 110.848 -174.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 98.3 t -72.4 132.14 33.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 104.829 -2.285 . . . . 0.0 104.829 166.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 39.0 t -135.75 118.1 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 -176.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 63.1 tp -88.73 97.91 11.4 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 173.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.37 149.37 36.96 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 169.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -133.36 98.24 4.18 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 175.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -73.97 114.95 12.87 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 172.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 7.8 p-90 -138.02 175.03 9.94 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 123.49 0.716 . . . . 0.0 110.754 -169.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -152.14 147.16 19.3 Favored Pre-proline 0 CA--C 1.535 0.399 0 C-N-CA 124.563 1.145 . . . . 0.0 107.934 169.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.45 -21.02 17.65 Favored 'Trans proline' 0 CA--C 1.532 0.397 0 C-N-CA 122.795 2.33 . . . . 0.0 113.348 -171.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -82.74 -8.2 59.6 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 118.685 0.675 . . . . 0.0 112.045 178.363 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 44.3 t -90.32 120.75 31.72 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 -179.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -57.03 -58.21 15.78 Favored Glycine 0 CA--C 1.531 1.057 0 CA-C-O 118.707 -1.051 . . . . 0.0 112.086 178.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -50.35 -35.07 43.14 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 123.519 2.812 . . . . 0.0 115.271 177.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 97.8 m -60.51 -33.13 72.19 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 119.451 1.023 . . . . 0.0 112.299 175.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 46.2 mtmt -85.04 -34.66 22.25 Favored 'General case' 0 C--N 1.333 -0.12 0 C-N-CA 123.043 0.537 . . . . 0.0 109.914 176.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 26.4 mmt -63.15 -34.96 78.74 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 119.137 0.88 . . . . 0.0 111.593 176.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.7 tt -81.19 -7.87 10.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-N 118.729 0.695 . . . . 0.0 111.667 178.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.44 -50.78 86.16 Favored Pre-proline 0 CA--C 1.541 0.618 0 O-C-N 120.635 -1.291 . . . . 0.0 112.494 178.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -64.07 -33.02 63.48 Favored 'Trans proline' 0 C--N 1.351 0.681 0 CA-C-N 121.844 1.694 . . . . 0.0 112.283 176.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 19.5 t -59.18 -47.76 89.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 119.1 0.864 . . . . 0.0 109.643 173.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 58.9 mt -65.87 -36.89 84.7 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 118.941 -0.552 . . . . 0.0 110.63 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -66.97 -37.6 84.54 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 119.013 0.824 . . . . 0.0 111.303 176.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -68.06 -39.23 83.04 Favored 'General case' 0 C--N 1.331 -0.2 0 O-C-N 121.091 -1.006 . . . . 0.0 110.377 174.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.48 -43.37 97.51 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 176.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -61.23 -42.25 98.28 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.839 0.856 . . . . 0.0 110.519 177.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -67.93 -13.44 62.17 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.703 0.801 . . . . 0.0 112.795 177.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -108.46 -32.09 7.55 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.226 1.01 . . . . 0.0 112.457 -178.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 19.5 mtt -140.2 2.25 1.88 Allowed 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 117.877 -1.059 . . . . 0.0 113.071 -169.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.3 44.63 0.74 Allowed Glycine 0 CA--C 1.532 1.136 0 C-N-CA 126.599 2.047 . . . . 0.0 114.561 -174.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -152.43 -40.3 0.11 Allowed 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 128.951 2.9 . . . . 0.0 107.615 171.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -63.21 -35.94 82.0 Favored 'General case' 0 C--N 1.343 0.319 0 C-N-CA 124.7 1.2 . . . . 0.0 110.451 169.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -133.99 165.29 25.38 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 125.925 1.69 . . . . 0.0 109.75 171.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -106.91 152.52 23.81 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.168 1.387 . . . . 0.0 107.758 170.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.2 mt -117.38 136.22 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 N-CA-C 105.582 -2.007 . . . . 0.0 105.582 171.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 58.1 t -131.65 114.51 25.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 -177.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 48.0 mmtt -74.26 144.56 44.59 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 169.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 13.4 tt -147.77 115.59 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 170.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 44.7 t0 -81.03 112.97 18.91 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.961 0.905 . . . . 0.0 109.224 -175.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 30.5 m -62.27 -21.87 27.86 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-O 118.425 -0.798 . . . . 0.0 113.02 -174.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -72.3 -6.53 43.82 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 120.012 1.278 . . . . 0.0 112.559 -178.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -126.35 4.21 6.99 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.344 1.058 . . . . 0.0 110.505 169.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -142.4 30.8 1.53 Allowed 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.389 1.076 . . . . 0.0 111.528 -168.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.407 ' CD ' ' H ' ' A' ' 61' ' ' GLN . 3.8 pm0 -55.44 -31.56 62.02 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 124.557 1.143 . . . . 0.0 110.435 169.676 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -65.08 -51.85 59.02 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 124.192 0.997 . . . . 0.0 110.173 176.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -67.17 -43.81 81.32 Favored 'General case' 0 C--O 1.222 -0.357 0 O-C-N 121.965 -0.46 . . . . 0.0 109.924 -178.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -61.63 -45.08 95.61 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 118.611 0.642 . . . . 0.0 109.596 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -59.86 -25.32 61.43 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 124.403 1.001 . . . . 0.0 112.903 175.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 8.5 ttmm -58.41 -23.37 57.1 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 118.621 1.21 . . . . 0.0 111.509 174.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -122.51 12.74 10.08 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.251 1.42 . . . . 0.0 110.894 178.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 70.88 17.45 75.32 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 124.552 1.073 . . . . 0.0 113.914 -179.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 95.4 t -85.55 137.16 21.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 176.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 6.6 tpt -153.49 25.14 0.52 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.092 0.957 . . . . 0.0 109.559 168.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 20.1 m -140.24 154.99 47.06 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 126.403 1.881 . . . . 0.0 107.297 -178.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -145.62 158.26 50.4 Favored Pre-proline 0 CA--C 1.542 0.663 0 C-N-CA 123.743 0.817 . . . . 0.0 110.376 -169.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.14 138.86 43.49 Favored 'Cis proline' 0 C--N 1.35 0.625 0 N-CA-C 109.512 -0.995 . . . . 0.0 109.512 -10.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 53.0 m -131.25 115.93 16.97 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 175.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 90.1 mt -89.86 136.39 33.07 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 176.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.0 mp -122.05 131.06 53.79 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 105.32 -2.104 . . . . 0.0 105.32 169.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 16.1 t -95.21 124.48 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 N-CA-C 103.062 -2.94 . . . . 0.0 103.062 168.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.9 mp -116.96 158.63 23.76 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 173.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 74.2 tttt -144.77 127.51 16.24 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 174.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 29.3 t70 46.83 33.47 2.19 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.248 1.419 . . . . 0.0 113.839 174.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 115.72 -7.97 19.71 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-O 118.096 -1.391 . . . . 0.0 115.082 168.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -133.2 146.09 51.18 Favored 'General case' 0 C--N 1.339 0.119 0 CA-C-N 120.071 1.935 . . . . 0.0 110.598 -174.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 5.8 p -65.48 137.34 25.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 172.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 34.9 m -123.58 -21.38 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 C-N-CA 125.338 1.455 . . . . 0.0 110.573 177.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -156.64 165.55 35.95 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.727 1.149 . . . . 0.0 110.999 174.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 98.9 m -143.74 149.41 37.08 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.761 1.624 . . . . 0.0 108.746 178.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 73.3 m -149.94 155.34 39.8 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.713 1.605 . . . . 0.0 108.306 171.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 40.8 t -132.93 144.93 35.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 -174.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.54 175.85 49.55 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 124.153 0.882 . . . . 0.0 111.716 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -62.47 149.3 43.12 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.428 0.691 . . . . 0.0 110.376 176.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 42.1 mttm -141.5 145.4 37.54 Favored Pre-proline 0 C--O 1.233 0.215 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 168.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -71.63 158.28 53.89 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 122.253 1.969 . . . . 0.0 109.879 172.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.2 tmpt? -62.67 -35.2 78.9 Favored 'General case' 0 N--CA 1.457 -0.117 0 O-C-N 121.686 -0.634 . . . . 0.0 111.601 -176.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -68.3 -35.07 77.27 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 119.125 0.875 . . . . 0.0 111.177 -177.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.9 -41.37 78.35 Favored 'General case' 0 N--CA 1.454 -0.233 0 O-C-N 121.86 -0.525 . . . . 0.0 110.498 171.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 45.7 tp -64.41 -40.18 95.27 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 119.34 -0.362 . . . . 0.0 110.694 -178.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.8 pp0? -70.97 -32.86 69.84 Favored 'General case' 0 C--O 1.226 -0.144 0 CA-C-N 118.994 0.815 . . . . 0.0 110.363 176.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -65.79 -37.17 85.56 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 118.63 0.65 . . . . 0.0 109.445 177.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 61.4 tp -63.33 -55.9 20.82 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.282 0.633 . . . . 0.0 110.055 171.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 25.2 t -61.53 -44.0 97.87 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 C-N-CA 123.384 0.673 . . . . 0.0 110.783 -172.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.78 -28.15 69.25 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 118.769 0.713 . . . . 0.0 112.326 -170.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 35.2 mtmm -73.37 -27.84 61.7 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 118.914 -0.565 . . . . 0.0 112.462 175.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -87.55 -20.57 26.26 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 118.365 -0.826 . . . . 0.0 112.456 -179.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 74.2 mt . . . . . 0 C--O 1.249 1.075 0 CA-C-N 119.192 0.905 . . . . 0.0 109.779 174.152 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 91.2 mt . . . . . 0 CA--C 1.538 0.492 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 25.2 t -124.41 166.32 19.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 125.94 1.696 . . . . 0.0 106.503 -174.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 11.2 mtmt -134.94 146.96 49.63 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 174.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -144.95 170.93 15.19 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 123.32 0.648 . . . . 0.0 110.166 175.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 80.7 p -133.7 175.62 9.28 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 170.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -49.73 -29.67 8.03 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 119.257 0.935 . . . . 0.0 113.32 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -59.02 -34.25 71.67 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.769 2.027 . . . . 0.0 112.477 179.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.4 m -143.17 -2.42 1.0 Allowed 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 114.299 1.222 . . . . 0.0 114.299 -170.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -52.73 -38.82 61.39 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 124.027 0.931 . . . . 0.0 111.038 176.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.6 m -68.36 -39.01 81.98 Favored 'General case' 0 N--CA 1.453 -0.323 0 O-C-N 122.187 -0.321 . . . . 0.0 111.23 -177.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.12 -44.55 79.63 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 175.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 61.8 mm-40 -63.14 -42.29 99.46 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 122.939 0.495 . . . . 0.0 110.856 -177.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 22.4 p -75.7 3.02 10.54 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -177.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 58.2 m -111.8 36.17 3.4 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.758 1.223 . . . . 0.0 111.688 -173.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -128.69 -3.97 5.28 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -179.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 162.88 -164.02 35.64 Favored Glycine 0 C--N 1.336 0.549 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 -172.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 82.0 t -71.51 133.43 31.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 105.095 -2.187 . . . . 0.0 105.095 166.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 31.9 t -137.5 125.52 31.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 107.065 -1.458 . . . . 0.0 107.065 -177.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 63.6 tp -92.61 98.37 11.39 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 173.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.74 145.23 40.99 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 169.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -133.17 96.74 3.81 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 124.993 1.317 . . . . 0.0 107.712 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -75.98 115.29 15.53 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 173.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 6.7 p-90 -138.08 175.76 9.29 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 123.47 0.708 . . . . 0.0 110.453 -171.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -150.19 143.79 16.91 Favored Pre-proline 0 CA--C 1.534 0.351 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 169.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.88 -23.63 21.98 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.334 2.023 . . . . 0.0 113.34 -169.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -81.38 -8.39 59.73 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 118.629 0.65 . . . . 0.0 112.499 178.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 52.7 t -84.86 115.38 22.73 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -178.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -52.35 -56.16 18.69 Favored Glycine 0 CA--C 1.531 1.087 0 CA-C-O 118.685 -1.064 . . . . 0.0 112.231 176.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_exo -51.41 -35.38 54.51 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 123.1 2.533 . . . . 0.0 115.195 174.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 97.5 m -63.26 -40.24 96.86 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 119.85 1.205 . . . . 0.0 111.409 172.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -64.65 -39.74 94.23 Favored 'General case' 0 N--CA 1.465 0.288 0 O-C-N 121.364 -0.835 . . . . 0.0 110.2 173.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 62.2 mtt -65.62 -38.62 89.95 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 123.088 0.555 . . . . 0.0 111.277 -177.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.6 tt -80.43 -18.47 12.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-N 118.819 0.736 . . . . 0.0 111.56 -178.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -52.45 -49.96 82.67 Favored Pre-proline 0 CA--C 1.544 0.749 0 CA-C-N 119.821 1.191 . . . . 0.0 113.567 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -65.69 -30.7 50.49 Favored 'Trans proline' 0 C--N 1.352 0.745 0 CA-C-N 121.873 1.705 . . . . 0.0 112.422 176.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 28.3 t -61.96 -44.48 98.97 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 119.409 1.004 . . . . 0.0 108.98 174.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 92.9 mt -64.44 -38.19 90.14 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-O 118.832 -0.604 . . . . 0.0 110.541 177.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -64.67 -40.37 95.3 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.428 1.013 . . . . 0.0 111.555 175.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -69.61 -35.41 75.25 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 121.16 -0.962 . . . . 0.0 110.69 176.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 9.3 tp -66.89 -39.66 87.55 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.434 0.693 . . . . 0.0 110.381 176.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -64.16 -42.3 96.8 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 123.778 0.831 . . . . 0.0 110.052 176.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -61.8 -31.0 71.19 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 121.629 -0.669 . . . . 0.0 112.229 173.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -85.07 -40.21 17.07 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.792 0.837 . . . . 0.0 112.497 -176.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 38.9 mtt -138.2 4.45 2.46 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 114.025 1.121 . . . . 0.0 114.025 -167.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.38 38.85 0.58 Allowed Glycine 0 CA--C 1.534 1.229 0 C-N-CA 126.487 1.994 . . . . 0.0 115.788 -169.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -140.69 -43.45 0.4 Allowed 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 125.775 1.63 . . . . 0.0 109.421 169.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 52.0 pttt -69.93 -22.74 63.16 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 119.228 -0.415 . . . . 0.0 111.88 170.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -136.96 163.67 30.14 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 125.584 1.554 . . . . 0.0 107.287 165.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 57.2 pttt -124.98 159.94 30.08 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 123.536 0.735 . . . . 0.0 109.069 168.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 22.7 mt -111.87 137.67 43.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 105.503 -2.036 . . . . 0.0 105.503 -178.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 87.2 t -127.06 109.57 20.94 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.13 144.93 44.68 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 171.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 14.7 tt -148.42 117.62 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 173.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -81.2 116.41 21.08 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -176.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 31.0 m -61.78 -26.51 40.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-O 119.061 -0.495 . . . . 0.0 112.031 -177.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -73.4 0.85 11.04 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.917 0.887 . . . . 0.0 112.074 -179.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -130.82 0.75 4.33 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.872 1.269 . . . . 0.0 111.035 170.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -141.39 48.66 1.65 Allowed 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.503 1.121 . . . . 0.0 109.769 -168.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.539 ' H ' ' NE2' ' A' ' 61' ' ' GLN . 0.4 OUTLIER -54.14 -44.94 71.82 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.642 1.577 . . . . 0.0 108.803 177.535 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -64.09 -47.51 79.76 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 125.825 1.65 . . . . 0.0 109.884 -175.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.451 ' HA ' ' HE3' ' A' ' 66' ' ' LYS . 0.7 OUTLIER -69.44 -43.18 73.87 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-O 119.298 -0.382 . . . . 0.0 110.153 -176.006 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -61.76 -46.57 89.04 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 119.239 0.927 . . . . 0.0 109.615 176.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -58.22 -26.39 58.74 Favored Glycine 0 CA--C 1.532 1.094 0 C-N-CA 124.165 0.888 . . . . 0.0 113.053 175.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.451 ' HE3' ' HA ' ' A' ' 63' ' ' THR . 28.9 ttmt -57.95 -21.5 44.38 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.33 1.452 . . . . 0.0 111.937 177.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -127.6 13.17 6.97 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.86 1.264 . . . . 0.0 110.638 178.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 69.83 19.02 74.78 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 124.667 1.127 . . . . 0.0 113.664 -178.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 96.3 t -82.19 137.93 20.3 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 175.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -153.16 25.02 0.54 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.901 1.28 . . . . 0.0 109.499 168.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 20.4 m -139.51 154.82 47.77 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 126.412 1.885 . . . . 0.0 107.32 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -146.18 160.31 43.13 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 124.345 1.058 . . . . 0.0 109.544 -170.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -66.86 139.24 44.48 Favored 'Cis proline' 0 C--N 1.35 0.632 0 N-CA-C 109.285 -1.083 . . . . 0.0 109.285 -11.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 51.3 m -131.9 118.59 20.01 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 177.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 88.3 mt -96.3 134.27 39.64 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 106.63 -1.619 . . . . 0.0 106.63 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.9 mp -119.54 128.37 53.87 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 104.793 -2.299 . . . . 0.0 104.793 169.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 15.5 t -93.58 125.26 46.18 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 103.104 -2.924 . . . . 0.0 103.104 168.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.7 mp -118.36 159.38 23.52 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 173.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 75.9 tttt -144.22 124.23 13.58 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 174.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.7 t70 45.76 36.76 2.93 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.44 1.496 . . . . 0.0 113.423 175.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 107.45 -2.28 34.62 Favored Glycine 0 CA--C 1.527 0.806 0 CA-C-O 118.089 -1.395 . . . . 0.0 115.365 168.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -130.39 147.36 52.08 Favored 'General case' 0 C--N 1.339 0.126 0 CA-C-N 120.08 1.94 . . . . 0.0 110.246 -178.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 16.8 t -67.66 137.61 24.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 107.813 -1.181 . . . . 0.0 107.813 175.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 29.0 m -119.63 -20.26 4.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 124.827 1.251 . . . . 0.0 110.537 173.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -156.85 162.26 39.69 Favored 'General case' 0 C--N 1.346 0.417 0 CA-C-N 119.642 1.11 . . . . 0.0 111.242 173.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 87.0 m -143.49 137.92 28.86 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.645 1.578 . . . . 0.0 108.356 174.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 29.3 m -145.39 153.22 40.98 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.933 1.693 . . . . 0.0 108.44 -178.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 40.9 t -133.07 145.21 34.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -175.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.91 175.52 46.79 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 124.462 1.029 . . . . 0.0 111.844 178.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -62.29 148.5 44.77 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.727 0.811 . . . . 0.0 110.377 176.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 46.3 mttm -142.01 146.1 38.95 Favored Pre-proline 0 C--O 1.233 0.195 0 C-N-CA 124.93 1.292 . . . . 0.0 107.733 168.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -72.87 161.21 44.28 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 122.746 2.297 . . . . 0.0 110.266 173.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -56.16 -43.78 78.68 Favored 'General case' 0 C--O 1.223 -0.326 0 CA-C-O 118.626 -0.702 . . . . 0.0 110.683 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -65.65 -37.78 87.49 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 119.162 0.892 . . . . 0.0 111.458 -169.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.53 -43.97 71.93 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 122.904 0.481 . . . . 0.0 110.639 174.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 29.6 tp -67.15 -41.77 85.48 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 122.568 0.347 . . . . 0.0 110.76 -175.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.2 pp0? -70.55 -32.69 70.22 Favored 'General case' 0 N--CA 1.456 -0.138 0 O-C-N 121.798 -0.564 . . . . 0.0 109.866 177.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -63.43 -48.05 79.38 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 176.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 51.1 tp -60.17 -44.4 95.07 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 122.824 0.45 . . . . 0.0 110.696 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 26.3 t -58.06 -47.48 86.76 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 175.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.71 -25.09 67.79 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 119.078 0.854 . . . . 0.0 112.675 -177.284 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -66.02 -23.65 66.6 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 119.048 0.84 . . . . 0.0 112.479 169.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -107.85 -16.52 14.29 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 119.478 1.035 . . . . 0.0 113.242 -174.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 80.7 mt . . . . . 0 C--O 1.249 1.068 0 CA-C-N 119.484 1.038 . . . . 0.0 109.681 172.248 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 91.8 mt . . . . . 0 CA--C 1.539 0.551 0 N-CA-C 107.3 -1.371 . . . . 0.0 107.3 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 36.7 t -120.03 170.68 9.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 -174.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 27.8 mtpt -137.31 149.84 47.34 Favored 'General case' 0 CA--C 1.518 -0.268 0 O-C-N 120.732 -1.23 . . . . 0.0 108.679 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -151.01 170.36 19.54 Favored 'General case' 0 C--N 1.331 -0.196 0 O-C-N 123.489 0.493 . . . . 0.0 111.66 176.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.3 p -136.51 174.11 10.97 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.863 1.665 . . . . 0.0 107.205 172.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -47.08 -33.3 4.83 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 119.917 1.235 . . . . 0.0 113.243 -179.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 26.9 mp0 -60.68 -31.45 70.71 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.075 1.75 . . . . 0.0 113.109 -179.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.3 m -140.41 -2.57 1.41 Allowed 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -170.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -54.79 -37.94 66.68 Favored 'General case' 0 CA--C 1.528 0.098 0 C-N-CA 124.191 0.997 . . . . 0.0 111.03 178.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.4 p -63.09 -50.53 70.18 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.653 0.781 . . . . 0.0 110.788 179.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.31 -44.44 92.57 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 122.972 0.509 . . . . 0.0 110.159 178.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -66.58 -37.76 85.6 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-O 119.2 -0.428 . . . . 0.0 111.403 -177.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 34.2 p -80.21 3.35 21.02 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 118.607 0.64 . . . . 0.0 112.451 -178.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 51.2 m -111.73 32.78 5.19 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.598 1.159 . . . . 0.0 112.346 -172.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -132.58 -0.44 3.55 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -177.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 165.92 -167.09 39.01 Favored Glycine 0 C--N 1.334 0.452 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 -174.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 97.4 t -71.91 133.3 32.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 104.56 -2.385 . . . . 0.0 104.56 166.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 38.6 t -136.49 121.77 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 -176.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 56.6 tp -96.45 98.0 9.89 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 173.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.2 156.16 33.87 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 169.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -139.38 100.04 3.89 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 125.382 1.473 . . . . 0.0 107.547 179.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -75.05 115.52 14.76 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 169.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 8.6 p-90 -137.0 174.72 10.31 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 123.554 0.742 . . . . 0.0 110.237 -174.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -153.96 148.02 18.96 Favored Pre-proline 0 CA--C 1.535 0.402 0 N-CA-C 107.753 -1.202 . . . . 0.0 107.753 169.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -73.52 -22.46 18.31 Favored 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 122.574 2.183 . . . . 0.0 113.22 -169.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -79.43 -5.55 54.94 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 118.623 0.647 . . . . 0.0 112.356 179.047 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 45.2 t -95.12 110.51 22.45 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 -175.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -51.03 -53.21 27.97 Favored Glycine 0 CA--C 1.533 1.215 0 CA-C-O 118.801 -0.999 . . . . 0.0 112.74 176.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_exo -52.34 -34.19 59.32 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 122.858 2.372 . . . . 0.0 114.846 174.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 80.9 m -67.39 -39.8 85.6 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 120.185 1.357 . . . . 0.0 111.146 172.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -59.88 -34.34 73.03 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 121.051 -1.031 . . . . 0.0 110.262 173.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 26.2 mmt -73.88 -37.12 64.83 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 123.043 0.537 . . . . 0.0 111.48 177.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.2 tp -70.68 -23.27 23.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 119.408 1.004 . . . . 0.0 110.935 179.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.81 -54.95 46.28 Favored Pre-proline 0 CA--C 1.543 0.701 0 CA-C-O 117.775 -1.107 . . . . 0.0 113.006 -177.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -66.55 -28.41 45.29 Favored 'Trans proline' 0 C--N 1.349 0.576 0 CA-C-N 121.703 1.644 . . . . 0.0 112.499 177.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 97.8 t -62.87 -43.61 99.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 119.607 1.094 . . . . 0.0 109.335 174.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 89.5 mt -69.28 -35.03 75.63 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-O 118.585 -0.722 . . . . 0.0 111.112 178.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -65.51 -41.23 93.39 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 119.526 1.057 . . . . 0.0 110.883 174.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -59.43 -45.23 92.13 Favored 'General case' 0 N--CA 1.455 -0.196 0 O-C-N 121.479 -0.763 . . . . 0.0 110.4 171.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.2 tp -64.36 -38.93 92.76 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 122.869 0.468 . . . . 0.0 110.698 -178.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -65.3 -41.78 93.72 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.524 0.73 . . . . 0.0 110.611 177.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -66.91 -36.3 81.94 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 122.067 -0.396 . . . . 0.0 111.252 176.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -73.96 -49.66 23.58 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.231 1.013 . . . . 0.0 111.013 -175.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 7.9 ptp -146.06 10.53 1.17 Allowed 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 -167.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.68 52.02 1.54 Allowed Glycine 0 CA--C 1.526 0.764 0 C-N-CA 126.53 2.014 . . . . 0.0 113.156 -178.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -148.66 -39.42 0.16 Allowed 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 128.229 2.612 . . . . 0.0 107.697 169.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 58.7 mtmt -65.95 -29.71 70.16 Favored 'General case' 0 C--N 1.345 0.375 0 C-N-CA 123.58 0.752 . . . . 0.0 110.68 168.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -131.96 162.65 30.18 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 125.138 1.375 . . . . 0.0 110.324 168.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -99.28 154.91 17.8 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.018 1.327 . . . . 0.0 107.538 169.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 12.8 mt -120.83 137.37 54.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 N-CA-C 105.704 -1.961 . . . . 0.0 105.704 170.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 84.6 t -133.61 114.1 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-N 119.048 0.84 . . . . 0.0 108.963 -174.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 56.7 mmtt -73.73 143.29 46.18 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 121.853 -0.529 . . . . 0.0 109.845 170.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 13.0 tt -151.35 149.68 13.86 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 N-CA-C 107.699 -1.222 . . . . 0.0 107.699 170.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -123.33 118.04 26.62 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 120.958 -1.089 . . . . 0.0 109.808 -169.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 30.5 m -55.13 -29.48 22.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 124.233 1.013 . . . . 0.0 113.027 -174.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -69.76 -9.09 53.24 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.874 0.869 . . . . 0.0 112.424 -175.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -132.07 6.05 4.22 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.838 1.255 . . . . 0.0 110.953 176.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 67.1 m-80 -141.21 46.7 1.72 Allowed 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.957 0.903 . . . . 0.0 110.679 -168.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.476 ' H ' ' NE2' ' A' ' 61' ' ' GLN . 0.5 OUTLIER -55.09 -43.94 74.45 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.908 0.883 . . . . 0.0 108.947 173.616 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -68.38 -31.73 71.31 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 125.48 1.512 . . . . 0.0 111.63 -171.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -84.68 -47.54 10.37 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 118.31 0.504 . . . . 0.0 109.918 176.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -64.22 -45.17 89.4 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 119.216 0.916 . . . . 0.0 109.904 -175.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -61.1 -24.97 63.77 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 124.009 0.814 . . . . 0.0 112.409 176.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.4 ttmm -58.99 -26.44 64.5 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 118.348 1.074 . . . . 0.0 111.533 176.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -114.83 10.47 16.48 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.606 1.162 . . . . 0.0 111.146 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 71.15 31.43 66.45 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 123.649 0.642 . . . . 0.0 112.418 -178.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 98.1 t -111.05 138.27 40.03 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 C-N-CA 125.073 1.349 . . . . 0.0 107.835 -178.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 8.6 tpt -153.97 30.75 0.45 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.034 0.934 . . . . 0.0 108.989 167.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 19.3 m -139.21 158.8 43.54 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 126.401 1.88 . . . . 0.0 107.671 -178.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -143.43 158.62 57.17 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 123.956 0.903 . . . . 0.0 110.013 -173.285 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -66.75 138.36 39.85 Favored 'Cis proline' 0 N--CA 1.457 -0.631 0 N-CA-C 108.786 -1.275 . . . . 0.0 108.786 -11.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 99.1 m -132.31 112.73 12.46 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 174.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 95.6 mt -83.46 141.77 31.43 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 175.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -128.8 127.27 41.63 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 104.133 -2.543 . . . . 0.0 104.133 -178.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.0 t -112.57 121.72 65.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 104.235 -2.506 . . . . 0.0 104.235 -176.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.2 mp -127.46 159.32 34.87 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 77.2 tttt -146.08 124.15 12.12 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 177.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.0 t70 45.16 35.94 1.91 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.438 1.495 . . . . 0.0 113.441 175.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 105.54 1.71 40.48 Favored Glycine 0 CA--C 1.527 0.794 0 CA-C-O 118.092 -1.393 . . . . 0.0 115.074 169.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -130.69 145.2 51.87 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 120.082 1.941 . . . . 0.0 109.921 179.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.7 p -69.0 140.67 18.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 C-N-CA 123.769 0.827 . . . . 0.0 109.19 174.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 35.5 m -128.02 -17.95 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 125.69 1.596 . . . . 0.0 110.681 178.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -160.1 167.28 28.14 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 120.389 1.45 . . . . 0.0 111.545 169.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 52.7 m -145.4 141.53 28.52 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.054 1.742 . . . . 0.0 107.549 169.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 14.7 m -145.84 146.55 31.18 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 124.215 1.006 . . . . 0.0 108.631 -178.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 39.8 t -127.41 148.8 32.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 -170.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.99 172.55 39.57 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 124.185 0.897 . . . . 0.0 111.589 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -61.22 153.75 25.31 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.225 0.61 . . . . 0.0 110.762 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -153.41 148.25 19.65 Favored Pre-proline 0 CA--C 1.533 0.301 0 C-N-CA 125.082 1.353 . . . . 0.0 107.677 169.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.51 162.41 41.47 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.644 2.23 . . . . 0.0 111.013 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -53.97 -43.8 70.23 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-O 118.574 -0.727 . . . . 0.0 110.952 177.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -63.59 -42.14 98.3 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 119.059 0.845 . . . . 0.0 111.369 -169.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.58 -41.71 88.11 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 123.096 0.558 . . . . 0.0 110.854 175.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 30.9 tp -68.1 -41.95 81.02 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 119.549 -0.262 . . . . 0.0 110.911 -176.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.7 pp0? -71.15 -30.81 66.92 Favored 'General case' 0 N--CA 1.457 -0.113 0 CA-C-N 118.512 0.596 . . . . 0.0 110.044 177.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -63.1 -50.03 72.12 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 174.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 66.9 tp -58.04 -46.54 85.19 Favored 'General case' 0 C--N 1.334 -0.09 0 C-N-CA 123.723 0.809 . . . . 0.0 110.31 -178.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 42.9 t -63.7 -49.08 83.73 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-O 118.561 -0.733 . . . . 0.0 109.783 179.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.05 -26.89 68.76 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 119.725 1.148 . . . . 0.0 112.268 -176.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -68.22 -26.83 65.91 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 118.323 -0.846 . . . . 0.0 112.384 171.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 77.0 m-70 -95.23 -19.84 19.7 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 119.571 1.078 . . . . 0.0 113.368 178.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 61.3 mt . . . . . 0 C--O 1.248 0.982 0 CA-C-N 119.781 1.173 . . . . 0.0 109.745 175.296 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 90.5 mt . . . . . 0 C--O 1.236 0.384 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 40.9 t -104.38 167.58 2.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 -174.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 5.9 mptt -137.13 138.51 40.37 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 -178.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -144.91 170.22 16.55 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.068 0.461 . . . . 0.0 111.656 -179.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 70.8 p -137.08 173.5 11.63 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.725 1.61 . . . . 0.0 107.48 177.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -49.75 -32.43 13.7 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 119.836 1.198 . . . . 0.0 112.979 -178.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 26.2 mp0 -63.82 -30.75 71.81 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.098 1.759 . . . . 0.0 112.778 -178.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.6 m -138.47 -4.93 1.61 Allowed 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 -169.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -54.92 -37.48 66.43 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 124.039 0.935 . . . . 0.0 110.821 177.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.3 p -62.94 -50.98 68.7 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 123.861 0.865 . . . . 0.0 110.835 178.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.22 -44.29 92.3 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.019 0.527 . . . . 0.0 110.081 178.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -66.03 -38.67 89.0 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-O 119.237 -0.411 . . . . 0.0 111.294 -177.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 28.8 p -78.62 1.41 22.79 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 118.528 0.604 . . . . 0.0 112.58 -179.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 50.4 m -110.29 32.61 5.02 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.57 1.148 . . . . 0.0 112.27 -172.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -132.17 -0.17 3.73 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -178.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 165.51 -167.69 39.1 Favored Glycine 0 C--N 1.336 0.54 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 -174.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 97.4 t -71.24 134.23 30.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 N-CA-C 104.687 -2.338 . . . . 0.0 104.687 166.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 40.4 t -136.8 120.85 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 -175.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 61.6 tp -95.35 96.91 9.45 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 173.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.24 157.76 32.28 Favored 'General case' 0 N--CA 1.444 -0.732 0 O-C-N 121.831 -0.543 . . . . 0.0 109.7 169.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -139.92 99.26 3.65 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 125.558 1.543 . . . . 0.0 107.436 178.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -73.96 117.14 15.4 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 169.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 8.2 p-90 -138.2 173.4 11.65 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 123.396 0.678 . . . . 0.0 110.883 -174.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -153.47 149.13 20.71 Favored Pre-proline 0 C--O 1.238 0.46 0 C-N-CA 126.416 1.886 . . . . 0.0 105.957 169.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -75.68 -21.97 14.11 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.695 2.263 . . . . 0.0 113.251 -169.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -78.32 -7.84 57.71 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 118.541 0.609 . . . . 0.0 112.521 -176.141 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 37.5 t -100.16 108.78 20.99 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 -178.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -46.47 -51.21 12.53 Favored Glycine 0 CA--C 1.533 1.215 0 CA-C-O 118.425 -1.208 . . . . 0.0 113.767 -178.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -49.81 -31.51 26.41 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 123.443 2.762 . . . . 0.0 115.885 176.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 61.6 m -62.5 -40.94 98.34 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 120.409 1.459 . . . . 0.0 110.782 173.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -67.88 -37.75 82.18 Favored 'General case' 0 N--CA 1.462 0.144 0 O-C-N 121.729 -0.607 . . . . 0.0 109.933 175.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 64.3 mtt -65.66 -40.5 92.5 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 118.202 0.455 . . . . 0.0 111.165 -178.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 10.1 tt -80.87 -19.03 11.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 118.666 0.667 . . . . 0.0 111.619 -177.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -52.35 -51.53 71.55 Favored Pre-proline 0 CA--C 1.543 0.686 0 CA-C-O 117.529 -1.224 . . . . 0.0 113.632 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.1 -30.45 55.87 Favored 'Trans proline' 0 C--N 1.351 0.683 0 CA-C-N 121.874 1.705 . . . . 0.0 112.037 177.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 14.0 t -63.6 -44.61 98.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 119.126 0.875 . . . . 0.0 109.157 176.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 78.5 mt -65.59 -36.38 83.58 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 118.917 -0.563 . . . . 0.0 110.731 177.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -66.05 -38.88 89.47 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 119.266 0.939 . . . . 0.0 111.203 175.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -67.38 -37.52 83.27 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 121.087 -1.008 . . . . 0.0 110.344 174.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 16.0 tp -66.34 -39.11 89.01 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.348 0.659 . . . . 0.0 110.551 177.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -65.1 -40.07 94.03 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.014 0.926 . . . . 0.0 110.708 175.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -66.84 -36.45 82.37 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.942 -0.474 . . . . 0.0 111.306 175.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -72.35 -53.47 12.25 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.921 0.889 . . . . 0.0 110.987 -178.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 11.6 ptp -144.44 15.63 1.64 Allowed 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 114.212 1.189 . . . . 0.0 114.212 -167.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.35 53.94 1.14 Allowed Glycine 0 CA--C 1.529 0.965 0 C-N-CA 126.124 1.821 . . . . 0.0 112.092 175.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -153.51 -40.93 0.1 Allowed 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 129.41 3.084 . . . . 0.0 107.281 172.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -63.95 -35.24 80.03 Favored 'General case' 0 C--N 1.343 0.311 0 C-N-CA 124.04 0.936 . . . . 0.0 110.176 168.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -131.04 165.34 23.43 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 125.34 1.456 . . . . 0.0 110.473 169.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -102.06 154.64 18.8 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 169.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.6 mt -120.58 137.45 54.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 170.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 66.7 t -134.02 115.94 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-N 119.2 0.909 . . . . 0.0 109.502 -175.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 65.7 mmtt -74.89 145.04 43.05 Favored 'General case' 0 C--O 1.235 0.303 0 O-C-N 121.233 -0.917 . . . . 0.0 109.783 169.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 12.4 tt -151.33 141.7 15.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 169.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -98.49 128.08 44.69 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 121.488 -0.757 . . . . 0.0 110.063 -173.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 15.9 m -67.99 -27.42 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 114.51 1.3 . . . . 0.0 114.51 -173.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -80.62 -41.32 24.09 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 120.072 1.305 . . . . 0.0 109.41 -175.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -71.75 -26.26 62.38 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.413 0.685 . . . . 0.0 111.18 175.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 -128.39 43.43 3.14 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.735 1.214 . . . . 0.0 109.864 -170.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.79 -39.67 62.55 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 126.697 1.999 . . . . 0.0 111.049 176.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -64.02 -46.02 86.33 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 123.615 0.766 . . . . 0.0 110.335 176.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.519 ' HA ' ' HE3' ' A' ' 66' ' ' LYS . 0.3 OUTLIER -69.89 -41.93 74.09 Favored 'General case' 0 C--O 1.222 -0.369 0 CA-C-N 118.69 0.677 . . . . 0.0 110.74 -175.979 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.77 -45.16 93.99 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 119.307 0.958 . . . . 0.0 109.273 176.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -57.53 -27.9 59.01 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 123.838 0.733 . . . . 0.0 112.778 174.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.519 ' HE3' ' HA ' ' A' ' 63' ' ' THR . 25.0 ttmt -59.51 -19.94 51.83 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.458 1.503 . . . . 0.0 111.96 178.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -125.3 12.41 8.19 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.659 1.184 . . . . 0.0 110.915 179.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 71.52 32.6 64.52 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 123.713 0.673 . . . . 0.0 112.722 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 90.8 t -111.18 139.05 36.96 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 C-N-CA 125.054 1.342 . . . . 0.0 108.003 -178.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 8.6 tpt -155.26 30.29 0.39 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.408 1.083 . . . . 0.0 108.989 167.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 18.2 m -136.96 158.96 43.27 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 126.181 1.792 . . . . 0.0 107.919 -177.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -144.8 155.57 56.01 Favored Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 123.354 0.662 . . . . 0.0 111.152 -170.293 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -69.73 140.14 58.67 Favored 'Cis proline' 0 N--CA 1.458 -0.599 0 N-CA-C 108.653 -1.326 . . . . 0.0 108.653 -11.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 96.3 m -130.68 113.11 13.76 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 176.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 94.4 mt -81.18 144.71 31.43 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 175.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.9 126.4 36.06 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 103.949 -2.611 . . . . 0.0 103.949 -179.036 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 5.2 t -109.52 122.33 63.96 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.42 0 N-CA-C 104.227 -2.509 . . . . 0.0 104.227 -179.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.4 mp -125.86 159.8 31.55 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 179.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -145.41 126.44 14.6 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 175.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.0 t70 44.41 35.65 1.39 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.368 1.467 . . . . 0.0 113.55 174.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 106.48 0.19 37.35 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-O 118.004 -1.442 . . . . 0.0 115.07 169.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -130.69 145.82 52.02 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-N 120.13 1.965 . . . . 0.0 110.216 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 10.0 p -70.03 140.98 17.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 C-N-CA 123.845 0.858 . . . . 0.0 109.435 174.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 32.5 m -129.94 -17.61 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 125.734 1.613 . . . . 0.0 110.788 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -160.29 168.56 25.05 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 120.422 1.465 . . . . 0.0 111.696 169.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 53.9 m -146.84 141.85 27.06 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.072 1.749 . . . . 0.0 108.023 170.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 18.7 m -146.16 152.86 39.94 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 124.77 1.228 . . . . 0.0 108.864 -177.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 32.8 t -130.15 148.85 33.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-N 119.155 0.888 . . . . 0.0 108.691 -171.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 80.62 179.72 53.0 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 124.098 0.856 . . . . 0.0 111.994 176.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -62.07 150.69 37.58 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.773 0.829 . . . . 0.0 110.759 177.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.41 147.74 29.17 Favored Pre-proline 0 CA--C 1.531 0.233 0 C-N-CA 124.893 1.277 . . . . 0.0 107.739 167.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -74.1 160.71 42.27 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 123.207 2.604 . . . . 0.0 110.452 174.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 75.3 tttt -55.18 -41.32 71.74 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 118.816 -0.612 . . . . 0.0 110.515 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -59.74 -41.7 91.54 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 118.516 0.598 . . . . 0.0 110.871 -174.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.14 -43.36 87.3 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.03 0.532 . . . . 0.0 110.792 176.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 61.1 mt -64.29 -45.88 86.06 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 119.141 -0.457 . . . . 0.0 109.945 -179.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 2.9 pp0? -71.12 -27.57 63.68 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.799 0.727 . . . . 0.0 110.676 -177.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -67.72 -50.16 58.89 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 173.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 60.9 tp -58.26 -47.47 83.48 Favored 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 123.235 0.614 . . . . 0.0 109.975 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 44.4 t -62.66 -46.94 95.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 CA-C-O 117.995 -1.002 . . . . 0.0 109.696 -179.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -60.24 -34.71 74.06 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 120.073 1.306 . . . . 0.0 111.315 -177.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 48.2 mmtm -71.07 -10.09 59.16 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 118.045 -0.978 . . . . 0.0 113.468 175.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -108.17 -17.03 14.13 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 119.982 1.264 . . . . 0.0 113.383 172.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 64.8 mt . . . . . 0 C--O 1.25 1.109 0 CA-C-N 120.239 1.381 . . . . 0.0 109.761 174.293 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 79.5 mt . . . . . 0 CA--C 1.539 0.551 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 31.5 t -114.34 167.56 7.0 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 125.939 1.696 . . . . 0.0 107.104 -174.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 9.2 mtmt -132.75 147.79 52.32 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 176.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -148.59 169.7 19.75 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.545 0.738 . . . . 0.0 110.426 176.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 77.8 p -135.53 174.94 10.06 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.562 1.145 . . . . 0.0 107.918 171.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -47.7 -31.03 4.29 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 119.964 1.256 . . . . 0.0 112.928 178.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -58.76 -33.33 70.17 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.374 1.87 . . . . 0.0 112.791 179.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.7 m -142.95 -3.09 0.99 Allowed 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 114.217 1.192 . . . . 0.0 114.217 -169.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -53.8 -37.45 63.53 Favored 'General case' 0 C--O 1.23 0.065 0 C-N-CA 124.435 1.094 . . . . 0.0 111.105 179.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.4 p -61.53 -53.63 53.8 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.808 0.843 . . . . 0.0 110.658 179.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.25 -43.76 88.01 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.018 0.527 . . . . 0.0 110.28 179.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -65.97 -35.51 80.79 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 119.081 -0.485 . . . . 0.0 111.746 -177.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 32.1 p -85.75 1.14 50.75 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -178.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 40.5 m -115.24 32.48 6.02 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -169.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -144.02 17.54 1.76 Allowed 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 177.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 172.6 -169.23 42.37 Favored Glycine 0 C--N 1.339 0.711 0 O-C-N 121.329 -0.857 . . . . 0.0 112.151 174.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 1.8 t -78.65 134.35 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 104.106 -2.553 . . . . 0.0 104.106 168.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 25.5 t -139.62 138.4 39.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 -172.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 42.6 tp -114.02 97.6 6.47 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 173.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.95 157.55 33.01 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 169.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -138.31 99.4 3.84 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 125.27 1.428 . . . . 0.0 107.259 177.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -72.5 115.66 12.03 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 169.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 9.3 p-90 -137.19 175.53 9.53 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.704 0.801 . . . . 0.0 110.373 -172.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -152.3 146.58 18.55 Favored Pre-proline 0 CA--C 1.535 0.399 0 C-N-CA 124.491 1.117 . . . . 0.0 107.994 169.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.25 -19.3 17.46 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.801 2.334 . . . . 0.0 113.299 -171.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -82.36 -7.47 59.63 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 121.537 -0.727 . . . . 0.0 111.961 177.566 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 48.6 t -92.07 120.76 32.99 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -57.0 -58.32 15.19 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-O 118.656 -1.08 . . . . 0.0 111.925 177.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -49.63 -36.33 40.5 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 123.653 2.902 . . . . 0.0 115.157 177.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 95.8 m -60.16 -36.66 78.07 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 119.429 1.013 . . . . 0.0 112.313 175.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 46.3 mtmt -80.48 -35.35 34.93 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-O 118.986 -0.53 . . . . 0.0 109.893 177.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 26.4 mmt -64.36 -39.23 93.47 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 118.967 0.803 . . . . 0.0 111.304 178.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 8.4 tt -76.46 -13.21 14.6 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 CA-C-N 118.824 0.738 . . . . 0.0 111.349 179.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -57.17 -52.22 75.79 Favored Pre-proline 0 CA--C 1.541 0.631 0 CA-C-O 117.515 -1.231 . . . . 0.0 113.21 -177.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.71 -28.86 60.06 Favored 'Trans proline' 0 C--N 1.351 0.685 0 CA-C-N 121.873 1.704 . . . . 0.0 112.418 176.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 10.5 t -65.08 -44.17 95.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 177.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 61.6 mt -68.12 -33.22 74.1 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 118.056 -0.973 . . . . 0.0 111.138 175.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -65.48 -43.76 89.23 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 120.036 1.289 . . . . 0.0 110.578 174.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -59.79 -42.57 93.69 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 118.77 0.714 . . . . 0.0 110.031 175.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 37.7 tp -65.0 -39.17 93.06 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 122.529 0.332 . . . . 0.0 110.903 178.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -64.43 -41.86 96.34 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 124.566 1.147 . . . . 0.0 110.477 178.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 65.0 mm-40 -65.73 -26.07 67.58 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.634 -0.666 . . . . 0.0 111.578 176.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -91.98 -31.08 15.75 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.749 1.22 . . . . 0.0 112.908 -177.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 19.3 mmt -126.07 -11.26 6.49 Favored 'General case' 0 C--O 1.226 -0.171 0 CA-C-O 117.697 -1.144 . . . . 0.0 113.483 -168.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -45.54 -35.14 5.37 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 126.287 1.899 . . . . 0.0 115.923 -170.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -76.06 -37.97 57.64 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.04 0.936 . . . . 0.0 111.519 -178.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 29.2 mtmt -83.79 -27.46 28.81 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 125.27 1.428 . . . . 0.0 110.444 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -151.14 122.18 7.68 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 124.542 1.137 . . . . 0.0 109.847 -170.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -74.28 151.92 39.77 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.911 0.885 . . . . 0.0 108.978 174.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.9 mt -122.46 134.02 66.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 N-CA-C 105.985 -1.858 . . . . 0.0 105.985 172.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 41.1 t -131.6 113.26 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -171.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 60.3 mmtt -74.2 143.17 45.3 Favored 'General case' 0 C--O 1.235 0.319 0 O-C-N 121.505 -0.747 . . . . 0.0 109.557 170.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 11.7 tt -150.13 121.38 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 173.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -86.86 116.85 25.21 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 121.393 -0.817 . . . . 0.0 109.384 -174.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 29.9 m -58.69 -28.02 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-N 118.674 0.67 . . . . 0.0 112.713 -176.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -71.99 -7.96 51.74 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 119.26 0.936 . . . . 0.0 112.059 -177.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -123.23 2.38 9.18 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.3 1.44 . . . . 0.0 110.513 173.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -146.54 36.45 0.98 Allowed 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 124.683 1.193 . . . . 0.0 111.026 -168.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.407 ' H ' ' NE2' ' A' ' 61' ' ' GLN . 1.6 pm0 -58.22 -30.41 66.46 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.333 0.653 . . . . 0.0 110.236 173.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 59.3 mp0 -62.16 -55.08 32.35 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.406 1.482 . . . . 0.0 109.685 174.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.86 -43.91 74.41 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 119.377 -0.344 . . . . 0.0 110.164 -174.44 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.83 -45.4 92.79 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 118.71 0.686 . . . . 0.0 109.583 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -59.6 -25.34 60.85 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.122 0.868 . . . . 0.0 112.748 175.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 9.9 ttmm -59.44 -23.54 62.77 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.575 1.187 . . . . 0.0 111.405 175.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -118.8 11.07 12.55 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.162 1.385 . . . . 0.0 110.984 178.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 68.62 20.53 74.03 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 124.23 0.919 . . . . 0.0 113.346 -176.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 91.0 t -90.52 133.67 31.65 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 177.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 7.2 tpt -154.7 30.73 0.42 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.778 0.831 . . . . 0.0 109.621 167.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 45.1 m -135.36 156.79 48.36 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 126.36 1.864 . . . . 0.0 106.834 172.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -145.16 158.27 52.07 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 123.935 0.894 . . . . 0.0 109.992 -170.309 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -67.7 136.78 35.11 Favored 'Cis proline' 0 C--N 1.349 0.591 0 CA-C-N 120.085 1.066 . . . . 0.0 109.784 -10.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 70.4 m -132.26 113.95 13.85 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 176.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 88.5 mt -82.39 145.5 29.85 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 175.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -129.61 124.7 34.38 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 104.263 -2.495 . . . . 0.0 104.263 179.387 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.5 t -106.69 124.34 62.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 N-CA-C 104.031 -2.581 . . . . 0.0 104.031 -178.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.7 mp -127.16 160.21 31.93 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.517 1.127 . . . . 0.0 108.102 178.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -148.18 128.03 13.48 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 174.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.0 t70 42.64 38.3 1.26 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.211 1.404 . . . . 0.0 113.276 179.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.72 6.67 60.62 Favored Glycine 0 CA--C 1.527 0.842 0 CA-C-O 118.777 -1.013 . . . . 0.0 114.726 171.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -121.82 143.05 49.63 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 119.333 1.567 . . . . 0.0 108.881 176.177 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 78.1 t -67.24 139.4 21.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 169.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.1 m -124.95 -21.55 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 CA-C-O 117.513 -1.232 . . . . 0.0 110.484 174.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -158.41 166.67 31.67 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 120.288 1.404 . . . . 0.0 111.846 174.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 72.4 m -144.24 139.5 28.71 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.89 1.676 . . . . 0.0 107.569 169.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 20.2 m -146.13 153.18 40.39 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.588 1.155 . . . . 0.0 109.035 -174.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 30.7 t -131.7 150.53 34.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 CA-C-N 119.04 0.836 . . . . 0.0 108.993 -170.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.8 169.17 45.16 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 124.693 1.139 . . . . 0.0 112.76 170.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -62.16 134.95 57.24 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 172.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 33.2 mttp -144.34 146.99 35.15 Favored Pre-proline 0 C--O 1.233 0.215 0 C-N-CA 125.364 1.466 . . . . 0.0 107.759 176.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -75.28 157.38 41.62 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 123.007 2.471 . . . . 0.0 110.96 -176.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.7 tmpt? -60.47 -33.67 72.91 Favored 'General case' 0 C--O 1.224 -0.266 0 O-C-N 121.698 -0.626 . . . . 0.0 111.241 -175.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -62.58 -37.16 85.13 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 118.967 0.803 . . . . 0.0 111.823 178.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -72.27 -40.63 67.47 Favored 'General case' 0 N--CA 1.452 -0.35 0 O-C-N 121.85 -0.531 . . . . 0.0 110.655 174.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 52.7 mt -65.89 -41.37 91.61 Favored 'General case' 0 N--CA 1.455 -0.201 0 O-C-N 122.057 -0.402 . . . . 0.0 110.253 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.7 pp0? -69.95 -30.17 67.48 Favored 'General case' 0 C--O 1.227 -0.081 0 CA-C-N 118.932 0.787 . . . . 0.0 110.272 178.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -63.86 -49.98 70.63 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 174.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 65.3 tp -57.63 -43.76 85.06 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.804 0.841 . . . . 0.0 110.726 178.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 24.7 t -61.94 -53.56 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 177.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.34 -26.16 68.35 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 119.082 0.856 . . . . 0.0 112.272 -175.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -67.3 -18.69 65.29 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 117.869 -1.062 . . . . 0.0 112.837 172.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -115.88 -13.0 11.35 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 119.929 1.241 . . . . 0.0 113.69 178.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 43.7 mt . . . . . 0 C--O 1.249 1.075 0 CA-C-N 120.284 1.402 . . . . 0.0 109.63 170.903 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 88.3 mt . . . . . 0 C--O 1.236 0.378 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 36.6 t -98.5 166.89 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 125.285 1.434 . . . . 0.0 107.504 -175.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 6.1 mptt -137.07 135.96 37.96 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 179.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -147.17 170.76 16.55 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 122.92 0.488 . . . . 0.0 110.9 -178.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.9 p -137.5 174.6 10.42 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.958 1.303 . . . . 0.0 108.047 177.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -45.99 -34.22 3.87 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.776 1.23 . . . . 0.0 113.17 179.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 26.8 mp0 -62.1 -31.81 72.31 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.901 1.681 . . . . 0.0 113.1 -178.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.5 m -139.98 -5.07 1.32 Allowed 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 -170.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -55.87 -35.61 66.67 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 124.097 0.959 . . . . 0.0 111.236 178.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.4 p -63.53 -48.6 76.85 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.895 0.878 . . . . 0.0 111.097 178.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.71 -44.5 96.5 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 122.938 0.495 . . . . 0.0 109.876 177.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -65.43 -38.41 89.8 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 119.39 -0.338 . . . . 0.0 111.502 -177.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 22.2 p -78.04 -0.16 26.86 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -178.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 60.0 m -108.65 32.87 4.54 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.466 1.106 . . . . 0.0 112.033 -171.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -132.54 -1.98 3.44 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -176.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 167.28 -166.36 39.2 Favored Glycine 0 C--N 1.337 0.593 0 CA-C-N 119.338 0.972 . . . . 0.0 110.854 -173.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 97.1 t -72.81 130.18 35.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 N-CA-C 104.554 -2.387 . . . . 0.0 104.554 166.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 38.1 t -134.82 116.85 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 -175.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 57.2 tp -84.57 139.6 31.99 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 169.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -133.1 113.61 12.94 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 -177.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -92.38 96.72 10.42 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 178.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -73.46 114.45 11.7 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 105.053 -2.202 . . . . 0.0 105.053 169.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 7.6 p-90 -138.03 175.9 9.17 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 123.499 0.72 . . . . 0.0 110.973 -169.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -152.47 145.15 17.16 Favored Pre-proline 0 CA--C 1.534 0.358 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 168.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -71.92 -23.26 22.28 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 122.421 2.081 . . . . 0.0 113.383 -169.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -80.91 -8.17 59.67 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 118.58 0.627 . . . . 0.0 112.653 179.617 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 49.1 t -91.62 110.58 21.9 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 -177.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -49.46 -53.92 18.47 Favored Glycine 0 CA--C 1.533 1.218 0 CA-C-O 118.693 -1.059 . . . . 0.0 113.085 179.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_exo -51.65 -32.58 45.43 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 123.223 2.615 . . . . 0.0 115.35 175.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 89.4 m -62.76 -35.46 79.88 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.908 1.231 . . . . 0.0 111.432 173.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -71.01 -41.04 71.42 Favored 'General case' 0 N--CA 1.463 0.191 0 O-C-N 121.642 -0.662 . . . . 0.0 109.626 173.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 26.5 mmt -64.42 -34.94 79.35 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 118.455 0.571 . . . . 0.0 111.75 -176.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 8.8 tt -82.19 -10.36 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-N 118.549 0.613 . . . . 0.0 111.707 178.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -57.04 -49.99 90.79 Favored Pre-proline 0 CA--C 1.543 0.692 0 CA-C-O 117.568 -1.206 . . . . 0.0 112.644 178.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -65.55 -31.46 50.61 Favored 'Trans proline' 0 C--N 1.351 0.687 0 CA-C-N 121.71 1.646 . . . . 0.0 112.476 176.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 23.1 t -59.48 -44.98 94.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 119.679 1.127 . . . . 0.0 109.638 172.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 75.8 mt -67.48 -36.71 81.66 Favored 'General case' 0 C--O 1.226 -0.184 0 CA-C-O 118.925 -0.56 . . . . 0.0 110.671 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -68.0 -37.7 81.76 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 119.369 0.986 . . . . 0.0 111.469 176.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -64.21 -37.08 86.17 Favored 'General case' 0 N--CA 1.456 -0.126 0 O-C-N 121.345 -0.847 . . . . 0.0 110.323 173.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 11.1 tp -72.48 -38.88 68.06 Favored 'General case' 0 N--CA 1.446 -0.633 0 O-C-N 121.816 -0.553 . . . . 0.0 110.556 178.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -65.21 -42.93 93.03 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.748 0.819 . . . . 0.0 110.147 -179.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -74.07 -13.55 60.86 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 -176.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 65.3 mt-10 -103.64 -33.6 8.92 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.52 1.128 . . . . 0.0 113.058 179.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 42.8 mtt -137.77 -0.39 2.13 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 117.997 -1.001 . . . . 0.0 113.027 -169.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.09 43.67 0.84 Allowed Glycine 0 CA--C 1.533 1.157 0 C-N-CA 126.766 2.127 . . . . 0.0 114.695 -172.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -149.0 -39.76 0.15 Allowed 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 128.443 2.697 . . . . 0.0 107.78 169.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -63.56 -34.76 78.51 Favored 'General case' 0 C--N 1.343 0.307 0 C-N-CA 124.623 1.169 . . . . 0.0 110.369 169.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -132.73 164.32 27.03 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 125.719 1.608 . . . . 0.0 109.622 168.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -103.16 151.43 22.61 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 169.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 17.4 mt -119.04 136.37 56.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 N-CA-C 105.301 -2.111 . . . . 0.0 105.301 170.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 45.7 t -128.48 135.04 63.5 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 107.524 -1.288 . . . . 0.0 107.524 -179.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 61.3 mmtt -92.31 142.63 27.25 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 169.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 17.5 tt -147.25 115.52 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-O 121.375 0.607 . . . . 0.0 109.382 171.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -82.27 112.8 19.6 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.827 0.851 . . . . 0.0 109.33 -175.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 32.9 m -59.85 -26.01 34.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-N 118.515 0.598 . . . . 0.0 112.539 -175.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -72.57 -1.59 16.59 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.571 0.749 . . . . 0.0 112.237 -178.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -131.57 6.77 4.43 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.418 1.487 . . . . 0.0 110.498 172.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 67.8 m-80 -143.31 46.44 1.52 Allowed 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.334 1.054 . . . . 0.0 110.645 -168.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.493 ' H ' ' NE2' ' A' ' 61' ' ' GLN . 0.4 OUTLIER -57.45 -44.02 84.45 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.92 0.888 . . . . 0.0 109.082 175.994 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -67.38 -29.9 69.55 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 125.612 1.565 . . . . 0.0 111.55 -173.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.07 -47.33 11.04 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 119.031 -0.509 . . . . 0.0 109.736 175.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.69 -45.89 90.69 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 119.572 1.078 . . . . 0.0 110.304 -176.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -61.81 -22.61 62.34 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 123.728 0.68 . . . . 0.0 112.721 176.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.7 ttmm -61.19 -25.62 67.16 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 118.532 1.166 . . . . 0.0 111.423 177.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -116.51 11.18 14.75 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.758 1.223 . . . . 0.0 110.703 179.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 67.6 26.36 73.72 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.145 0.879 . . . . 0.0 112.781 -176.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 89.3 t -99.1 154.25 4.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-N 118.18 0.99 . . . . 0.0 109.158 179.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -162.57 -24.0 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 127.252 2.221 . . . . 0.0 109.492 167.469 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 8.0 m -63.69 150.58 44.04 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 123.896 0.878 . . . . 0.0 109.112 170.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -145.22 155.9 54.35 Favored Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 124.256 1.022 . . . . 0.0 108.998 176.32 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.39 140.78 50.27 Favored 'Cis proline' 0 N--CA 1.456 -0.678 0 CA-C-N 119.916 1.006 . . . . 0.0 109.541 -10.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 54.4 m -131.93 121.51 24.11 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 176.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 52.7 mt -95.53 102.3 14.09 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 179.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -81.01 143.27 32.64 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 167.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.7 t -125.51 126.1 69.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 104.289 -2.485 . . . . 0.0 104.289 174.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.9 mp -126.79 160.77 29.92 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 124.994 1.318 . . . . 0.0 107.976 -178.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -144.89 125.89 14.51 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 175.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.0 t70 44.81 36.96 2.04 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.279 1.432 . . . . 0.0 113.469 175.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 105.68 -2.26 39.17 Favored Glycine 0 CA--C 1.528 0.885 0 CA-C-O 118.055 -1.414 . . . . 0.0 115.126 169.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -130.58 148.72 52.41 Favored 'General case' 0 C--N 1.338 0.099 0 CA-C-N 120.159 1.98 . . . . 0.0 110.516 -178.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 52.5 t -66.19 140.47 19.49 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 C-N-CA 124.053 0.941 . . . . 0.0 108.773 177.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 35.3 m -124.62 -18.39 3.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 125.398 1.479 . . . . 0.0 110.917 172.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.96 165.4 32.12 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 120.318 1.417 . . . . 0.0 111.429 169.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 56.3 m -144.05 133.05 22.77 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.892 1.677 . . . . 0.0 107.077 169.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 17.8 m -143.61 152.93 42.0 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.875 1.27 . . . . 0.0 108.481 -176.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 28.6 t -131.22 150.29 34.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-N 119.145 0.884 . . . . 0.0 108.794 -170.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.73 174.27 46.33 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 124.518 1.056 . . . . 0.0 112.173 176.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -59.58 152.12 22.88 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 123.623 0.769 . . . . 0.0 110.806 177.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -153.38 146.73 18.03 Favored Pre-proline 0 C--O 1.233 0.232 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 168.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.2 158.18 52.44 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.172 1.915 . . . . 0.0 110.332 177.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 4.8 ttpt -59.3 -33.95 71.71 Favored 'General case' 0 C--O 1.224 -0.288 0 C-N-CA 123.462 0.705 . . . . 0.0 111.551 179.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -64.51 -39.91 94.66 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 119.106 0.866 . . . . 0.0 111.946 -179.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.32 -41.2 70.18 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 122.735 0.414 . . . . 0.0 110.389 175.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 28.0 tp -66.75 -40.3 88.24 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 122.638 0.375 . . . . 0.0 110.744 -177.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.8 pp0? -69.43 -31.17 69.33 Favored 'General case' 0 C--O 1.227 -0.106 0 CA-C-N 118.821 0.737 . . . . 0.0 110.164 176.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -64.91 -47.72 76.73 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 176.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 63.6 tp -57.86 -46.67 84.49 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.354 0.662 . . . . 0.0 110.381 178.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 23.4 t -62.37 -49.27 84.61 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 CA-C-O 119.061 -0.495 . . . . 0.0 110.029 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.46 -26.96 68.67 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 119.171 0.896 . . . . 0.0 112.215 -175.557 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 61.6 mtpt -67.86 -29.76 68.97 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 118.597 -0.716 . . . . 0.0 112.041 171.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 86.1 m-70 -90.87 -21.35 21.46 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.259 0.936 . . . . 0.0 113.244 179.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 65.9 mt . . . . . 0 C--O 1.249 1.053 0 CA-C-N 119.569 1.077 . . . . 0.0 109.88 175.472 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 79.8 mt . . . . . 0 CA--C 1.54 0.593 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.6 t -119.48 167.53 12.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 125.348 1.459 . . . . 0.0 107.767 -168.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.7 tppp? -128.5 145.88 50.98 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 177.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -146.19 168.73 20.29 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 123.24 0.616 . . . . 0.0 110.332 171.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 72.0 p -135.44 173.57 11.57 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.584 1.553 . . . . 0.0 106.938 174.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -52.44 -30.5 29.92 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 119.701 1.137 . . . . 0.0 113.01 -176.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 26.0 mp0 -62.75 -30.73 71.66 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.097 1.759 . . . . 0.0 112.817 179.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.5 m -139.15 -3.78 1.55 Allowed 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -169.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 61.3 t80 -54.65 -37.79 66.12 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 123.938 0.895 . . . . 0.0 111.035 177.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.4 p -63.04 -50.5 70.42 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.671 0.788 . . . . 0.0 110.76 179.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.21 -44.87 92.26 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.017 0.527 . . . . 0.0 110.081 178.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -66.03 -37.89 87.0 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 119.348 -0.358 . . . . 0.0 111.445 -177.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 27.8 p -79.66 0.44 30.27 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 118.513 0.597 . . . . 0.0 112.549 -178.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.5 m -110.23 32.27 5.27 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.418 1.087 . . . . 0.0 112.312 -172.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 -131.81 2.22 4.04 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -177.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 167.34 -165.62 38.73 Favored Glycine 0 C--N 1.334 0.428 0 O-C-N 121.414 -0.804 . . . . 0.0 111.185 -176.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 1.9 t -76.66 134.86 27.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 104.275 -2.491 . . . . 0.0 104.275 168.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 30.2 t -138.34 141.57 37.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -172.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 58.9 tp -113.53 97.96 6.77 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 106.02 -1.844 . . . . 0.0 106.02 173.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.21 149.06 37.29 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 170.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -133.16 99.0 4.42 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 107.2 -1.408 . . . . 0.0 107.2 177.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -76.63 114.97 15.96 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 173.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 7.3 p-90 -138.84 175.89 9.17 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 123.401 0.68 . . . . 0.0 110.85 -169.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -151.61 146.66 19.05 Favored Pre-proline 0 CA--C 1.535 0.394 0 C-N-CA 124.53 1.132 . . . . 0.0 107.98 169.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.25 -17.85 18.68 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.962 2.441 . . . . 0.0 113.515 -169.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -84.81 -7.21 59.28 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 118.789 0.722 . . . . 0.0 112.088 177.439 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 54.1 t -87.82 117.08 26.41 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 -178.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -55.82 -55.72 27.52 Favored Glycine 0 CA--C 1.531 1.092 0 CA-C-O 118.691 -1.061 . . . . 0.0 112.201 175.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -51.15 -34.58 48.64 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 123.256 2.637 . . . . 0.0 115.434 176.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 97.7 m -60.92 -35.78 77.58 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 119.96 1.255 . . . . 0.0 111.672 173.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.1 mttm -70.14 -40.94 74.51 Favored 'General case' 0 N--CA 1.464 0.266 0 O-C-N 121.52 -0.737 . . . . 0.0 109.692 173.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 26.3 mmt -64.71 -38.17 90.07 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 118.231 0.469 . . . . 0.0 111.487 -176.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 10.8 tt -79.16 -15.97 13.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-N 118.394 0.543 . . . . 0.0 111.51 179.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.9 -48.97 94.46 Favored Pre-proline 0 CA--C 1.541 0.598 0 CA-C-O 117.472 -1.251 . . . . 0.0 113.597 -177.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.06 -27.73 49.67 Favored 'Trans proline' 0 C--N 1.35 0.632 0 CA-C-N 122.087 1.781 . . . . 0.0 112.461 176.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 6.0 t -66.42 -41.13 88.23 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-N 119.346 0.975 . . . . 0.0 109.059 174.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 66.0 mt -67.03 -34.28 77.37 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 118.745 -0.645 . . . . 0.0 110.961 175.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -69.45 -36.55 76.71 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 119.482 1.037 . . . . 0.0 111.496 174.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 44.0 mm-40 -61.17 -46.73 89.3 Favored 'General case' 0 CA--C 1.528 0.098 0 O-C-N 121.137 -0.977 . . . . 0.0 109.233 171.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -62.11 -35.96 80.3 Favored 'General case' 0 C--O 1.224 -0.255 0 C-N-CA 122.857 0.463 . . . . 0.0 111.557 177.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -65.28 -41.88 93.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 119.27 0.941 . . . . 0.0 110.427 176.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -68.01 -36.97 80.87 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 122.823 0.449 . . . . 0.0 111.634 178.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -93.35 -30.1 15.29 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.014 0.926 . . . . 0.0 112.426 -169.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 20.0 mmt -136.95 -3.41 2.02 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.39 1.476 . . . . 0.0 112.706 -169.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -52.12 -28.74 26.88 Favored Glycine 0 CA--C 1.538 1.469 0 CA-C-N 120.945 1.702 . . . . 0.0 113.277 177.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -73.67 -29.32 62.24 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.844 1.658 . . . . 0.0 111.434 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 55.3 mmtt -97.82 -25.97 14.86 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 125.444 1.498 . . . . 0.0 110.651 -177.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -150.58 126.11 10.2 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.095 0.958 . . . . 0.0 110.038 -167.357 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -73.76 152.49 40.34 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 175.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 17.6 mt -125.72 130.97 72.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 N-CA-C 105.645 -1.983 . . . . 0.0 105.645 175.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 22.0 t -132.07 113.66 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -170.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 48.2 mmtt -73.86 143.29 45.92 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 170.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 15.4 tt -149.02 125.34 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 169.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -80.28 128.57 33.69 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 22.5 m -70.02 -31.59 48.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 -173.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -77.6 -35.36 52.95 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 119.136 0.88 . . . . 0.0 109.755 -175.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -72.98 -15.9 61.53 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.861 0.864 . . . . 0.0 111.869 172.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 63.3 m-80 -139.77 51.97 1.72 Allowed 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 119.227 0.921 . . . . 0.0 111.044 -168.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -56.56 -38.66 72.22 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.791 0.836 . . . . 0.0 109.55 179.673 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -66.49 -27.74 68.02 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.946 1.298 . . . . 0.0 112.553 -177.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.42 -45.53 9.89 Favored 'General case' 0 C--O 1.222 -0.373 0 CA-C-N 118.809 0.731 . . . . 0.0 109.725 178.47 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.79 -46.9 85.85 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.271 0.941 . . . . 0.0 109.792 179.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -61.77 -22.37 61.95 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 124.48 1.038 . . . . 0.0 112.746 175.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.7 ttmm -57.84 -23.08 51.16 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 118.778 1.289 . . . . 0.0 111.852 174.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -125.76 13.58 8.01 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.688 1.195 . . . . 0.0 110.375 179.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 68.65 20.12 73.71 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 124.661 1.124 . . . . 0.0 113.689 -178.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 97.9 t -84.83 136.28 23.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 176.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -155.42 29.02 0.39 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.732 1.213 . . . . 0.0 109.258 167.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 20.8 m -138.15 154.41 49.17 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 126.678 1.991 . . . . 0.0 106.864 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -145.31 158.72 50.73 Favored Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 123.866 0.867 . . . . 0.0 110.143 -169.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -67.92 140.74 56.03 Favored 'Cis proline' 0 C--N 1.349 0.573 0 N-CA-C 109.168 -1.128 . . . . 0.0 109.168 -11.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 54.7 m -131.67 118.28 19.8 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 177.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 89.4 mt -93.54 137.98 32.28 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 178.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.0 mp -121.22 130.34 53.64 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 105.238 -2.134 . . . . 0.0 105.238 169.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.8 t -94.35 127.73 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 103.571 -2.751 . . . . 0.0 103.571 168.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.6 mp -125.33 160.42 29.37 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 125.198 1.399 . . . . 0.0 107.792 176.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -149.32 125.08 10.48 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.8 t70 44.88 34.98 1.34 Allowed 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.304 1.441 . . . . 0.0 113.714 177.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 109.71 -1.72 30.5 Favored Glycine 0 CA--C 1.527 0.785 0 CA-C-O 118.033 -1.426 . . . . 0.0 115.588 168.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -131.06 145.18 51.93 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 120.13 1.965 . . . . 0.0 110.288 -178.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.3 p -66.86 138.45 22.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 172.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 27.1 m -127.03 -16.47 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 125.68 1.592 . . . . 0.0 110.682 178.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.44 164.3 38.42 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 119.871 1.214 . . . . 0.0 110.902 169.18 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 93.9 m -146.37 137.83 24.61 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.461 1.505 . . . . 0.0 108.421 176.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 19.7 m -146.24 152.98 40.07 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.413 1.485 . . . . 0.0 108.691 -176.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 40.3 t -133.03 146.43 32.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 -173.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 85.49 178.62 50.51 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 124.451 1.024 . . . . 0.0 111.89 178.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -60.26 152.86 23.83 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.173 0.989 . . . . 0.0 110.575 174.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -141.42 148.2 49.65 Favored Pre-proline 0 C--O 1.234 0.257 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 168.282 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -71.56 158.59 53.38 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 122.381 2.054 . . . . 0.0 110.22 171.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -55.31 -45.97 76.28 Favored 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 123.397 0.679 . . . . 0.0 111.042 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -64.33 -42.04 96.49 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 118.345 0.521 . . . . 0.0 111.248 -169.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.0 -42.51 89.65 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 122.897 0.479 . . . . 0.0 110.878 175.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 43.3 tp -69.16 -41.01 77.8 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 119.233 -0.413 . . . . 0.0 110.744 -176.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.7 pp0? -70.8 -30.12 66.49 Favored 'General case' 0 C--N 1.337 0.058 0 CA-C-N 119.022 0.828 . . . . 0.0 110.303 176.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -64.07 -49.22 73.16 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 175.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 67.6 tp -57.65 -46.1 84.64 Favored 'General case' 0 CA--C 1.527 0.095 0 C-N-CA 123.869 0.867 . . . . 0.0 110.349 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 19.6 t -60.06 -53.45 48.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 177.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -63.35 -28.88 70.3 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 118.78 0.718 . . . . 0.0 112.395 -175.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -68.12 -32.13 72.2 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 118.475 -0.774 . . . . 0.0 111.958 173.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 58.0 m-70 -89.75 -16.73 29.66 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 119.326 0.966 . . . . 0.0 113.296 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 65.5 mt . . . . . 0 C--O 1.249 1.073 0 CA-C-N 119.737 1.153 . . . . 0.0 109.847 173.032 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 21.2 mt . . . . . 0 CA--C 1.539 0.532 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 25.6 t -140.44 167.59 18.04 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 128.069 2.547 . . . . 0.0 105.678 -176.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.0 mtmt -125.62 144.36 50.62 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 173.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -144.8 170.1 16.77 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 122.913 0.485 . . . . 0.0 110.622 176.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 73.7 p -135.63 173.35 11.81 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 176.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -49.27 -32.38 10.75 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 119.669 1.122 . . . . 0.0 113.138 -177.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 25.3 mp0 -62.04 -31.58 71.99 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.408 1.883 . . . . 0.0 112.777 -179.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.3 m -139.92 -4.26 1.38 Allowed 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 -171.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -53.57 -37.59 63.07 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 124.305 1.042 . . . . 0.0 111.006 176.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.0 m -67.29 -38.83 85.66 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 122.49 0.316 . . . . 0.0 111.286 -178.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.18 -45.2 77.68 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 175.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -64.54 -37.12 86.46 Favored 'General case' 0 C--O 1.231 0.116 0 C-N-CA 122.64 0.376 . . . . 0.0 111.374 -175.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 19.9 p -77.28 -1.39 29.52 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 179.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 67.9 m -108.65 33.29 4.28 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.448 1.099 . . . . 0.0 111.933 -171.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -132.65 0.62 3.61 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -177.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 166.31 -165.55 38.31 Favored Glycine 0 C--N 1.336 0.535 0 CA-C-N 119.367 0.985 . . . . 0.0 111.424 -175.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 97.3 t -73.77 127.73 35.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 N-CA-C 104.6 -2.37 . . . . 0.0 104.6 166.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 39.2 t -133.72 122.64 43.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 -174.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 18.3 tp -87.8 139.22 30.75 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 105.84 -1.911 . . . . 0.0 105.84 168.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -125.01 113.67 18.1 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 -179.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -94.1 90.41 6.38 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 125.337 1.455 . . . . 0.0 108.391 -178.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -72.1 113.22 8.89 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 169.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 7.9 p-90 -138.79 176.42 8.71 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 123.561 0.744 . . . . 0.0 111.068 -169.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -151.84 146.6 18.85 Favored Pre-proline 0 CA--C 1.535 0.379 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 169.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.35 -20.17 16.45 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 122.744 2.296 . . . . 0.0 113.494 -171.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -81.95 -7.84 59.63 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 121.526 -0.734 . . . . 0.0 111.823 176.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 52.0 t -88.12 117.32 26.92 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -55.58 -57.92 16.4 Favored Glycine 0 CA--C 1.531 1.067 0 CA-C-O 118.572 -1.126 . . . . 0.0 111.598 173.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -49.89 -36.32 42.96 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 123.569 2.846 . . . . 0.0 115.434 177.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 98.0 m -60.02 -45.51 92.55 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 119.886 1.221 . . . . 0.0 111.418 173.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 46.5 mtmt -70.86 -30.58 67.02 Favored 'General case' 0 CA--C 1.53 0.174 0 O-C-N 121.465 -0.772 . . . . 0.0 110.639 178.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 86.5 mtp -68.37 -42.54 79.03 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 118.685 0.675 . . . . 0.0 111.226 176.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 7.4 tt -76.82 -21.45 14.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-N 119.1 0.863 . . . . 0.0 111.115 -178.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.17 -51.28 64.11 Favored Pre-proline 0 CA--C 1.546 0.823 0 CA-C-N 119.737 1.153 . . . . 0.0 113.915 -177.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.28 -30.5 54.23 Favored 'Trans proline' 0 C--N 1.349 0.59 0 CA-C-N 121.866 1.702 . . . . 0.0 112.364 176.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 6.8 t -65.49 -37.87 81.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-N 119.334 0.97 . . . . 0.0 109.521 174.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 82.6 mt -68.24 -33.41 74.33 Favored 'General case' 0 C--O 1.225 -0.213 0 CA-C-O 118.569 -0.729 . . . . 0.0 110.844 173.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -66.65 -36.13 81.81 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.836 1.198 . . . . 0.0 111.405 172.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 55.4 mm-40 -65.93 -39.05 90.17 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 120.808 -1.182 . . . . 0.0 110.149 172.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 46.9 tp -66.5 -36.66 83.27 Favored 'General case' 0 C--O 1.226 -0.144 0 O-C-N 121.648 -0.658 . . . . 0.0 110.731 175.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -66.29 -37.47 85.5 Favored 'General case' 0 N--CA 1.454 -0.238 0 O-C-N 121.586 -0.696 . . . . 0.0 111.096 176.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -64.36 -33.42 75.8 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.376 -0.828 . . . . 0.0 111.305 171.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -79.0 -39.16 34.83 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.301 1.04 . . . . 0.0 112.139 -177.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 21.2 mmt -133.5 -7.23 2.9 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 -166.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.97 -3.85 12.48 Favored Glycine 0 CA--C 1.531 1.079 0 CA-C-N 120.474 1.488 . . . . 0.0 115.142 -174.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -82.29 -27.5 32.3 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.518 1.527 . . . . 0.0 111.751 172.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -129.04 -1.77 5.19 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.837 1.655 . . . . 0.0 112.624 -172.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -139.38 155.87 47.37 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 126.828 2.051 . . . . 0.0 106.906 177.329 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -110.01 151.35 27.27 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 173.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 18.3 mt -119.72 136.7 56.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 105.064 -2.198 . . . . 0.0 105.064 170.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 99.5 t -126.24 115.14 41.43 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 -176.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 10.3 mmmm -75.19 140.88 43.59 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 171.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 16.6 tt -148.92 113.91 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 173.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 60.6 t0 -77.24 117.18 18.51 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 -178.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 30.6 m -62.88 -27.35 42.93 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -175.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -69.18 -28.87 66.79 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 119.331 0.969 . . . . 0.0 110.768 -178.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -93.62 -7.72 43.16 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.63 1.172 . . . . 0.0 111.073 177.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -141.38 47.12 1.7 Allowed 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 124.549 1.14 . . . . 0.0 109.929 -168.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.433 ' CD ' ' H ' ' A' ' 61' ' ' GLN . 1.4 mp0 -58.39 -40.9 83.6 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.315 1.046 . . . . 0.0 109.024 -177.294 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -63.21 -45.12 93.17 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.497 1.119 . . . . 0.0 110.399 179.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.469 ' HA ' ' HE3' ' A' ' 66' ' ' LYS . 0.8 OUTLIER -69.01 -43.77 74.14 Favored 'General case' 0 C--O 1.221 -0.433 0 CA-C-N 118.729 0.695 . . . . 0.0 110.362 -176.752 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.16 -45.68 92.31 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 119.166 0.894 . . . . 0.0 109.417 176.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -58.11 -26.37 58.44 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 124.232 0.92 . . . . 0.0 113.081 174.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.469 ' HE3' ' HA ' ' A' ' 63' ' ' THR . 27.4 ttmt -57.82 -21.54 42.84 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.459 1.504 . . . . 0.0 111.908 177.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -127.81 12.84 6.83 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.88 1.272 . . . . 0.0 110.532 179.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 68.95 20.18 74.34 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 124.558 1.075 . . . . 0.0 113.544 -177.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 85.2 t -85.35 137.08 21.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 176.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -157.66 28.9 0.28 Allowed 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.512 1.125 . . . . 0.0 109.523 167.043 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 44.1 m -135.08 154.06 51.81 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 126.317 1.847 . . . . 0.0 106.89 174.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -146.32 160.2 43.04 Favored Pre-proline 0 CA--C 1.543 0.688 0 C-N-CA 124.565 1.146 . . . . 0.0 109.273 -170.15 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -66.93 139.84 47.75 Favored 'Cis proline' 0 C--N 1.349 0.553 0 CA-C-N 120.161 1.093 . . . . 0.0 109.77 -10.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 41.5 m -132.99 133.79 43.61 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 178.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 78.6 mt -119.28 103.08 9.17 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 -172.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.7 mp -84.87 146.01 27.52 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 106.822 -1.548 . . . . 0.0 106.822 168.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.4 t -111.33 127.87 68.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 103.633 -2.728 . . . . 0.0 103.633 169.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.7 mp -127.0 158.62 36.44 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.308 1.443 . . . . 0.0 107.445 179.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -145.77 127.16 14.94 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 175.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.9 t70 44.3 37.44 1.98 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.389 1.476 . . . . 0.0 113.616 174.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.87 5.25 47.76 Favored Glycine 0 CA--C 1.527 0.783 0 CA-C-O 118.59 -1.117 . . . . 0.0 114.861 169.138 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 82.1 mm-40 -130.13 141.44 50.68 Favored 'General case' 0 CA--C 1.522 -0.105 0 CA-C-N 119.52 1.66 . . . . 0.0 109.133 178.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.5 p -69.25 137.42 24.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 169.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 25.3 m -125.21 -20.48 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 C-N-CA 124.989 1.316 . . . . 0.0 110.328 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.21 167.1 31.49 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 119.545 1.066 . . . . 0.0 111.454 175.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 80.7 m -148.43 141.05 24.47 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.55 1.54 . . . . 0.0 108.738 176.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 21.3 m -144.63 155.88 43.83 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.988 1.715 . . . . 0.0 108.309 177.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 39.5 t -133.81 149.72 30.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 -176.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.09 172.3 47.08 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 124.385 0.993 . . . . 0.0 112.449 172.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -63.92 131.19 46.93 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 123.59 0.756 . . . . 0.0 109.291 175.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -136.1 143.73 45.23 Favored Pre-proline 0 CA--C 1.534 0.35 0 C-N-CA 126.095 1.758 . . . . 0.0 107.035 179.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -74.68 156.83 44.43 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.691 2.26 . . . . 0.0 110.917 178.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.6 tmpt? -58.98 -36.24 74.54 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 123.449 0.699 . . . . 0.0 111.247 -177.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -67.52 -35.15 78.55 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 118.838 0.744 . . . . 0.0 111.269 -175.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.03 -42.61 72.73 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 122.886 0.474 . . . . 0.0 110.485 173.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 84.5 mt -67.05 -41.39 86.56 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-O 118.902 -0.57 . . . . 0.0 110.392 -178.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.0 pp0? -68.22 -30.8 69.95 Favored 'General case' 0 C--O 1.228 -0.075 0 CA-C-N 119.274 0.943 . . . . 0.0 110.247 177.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -65.41 -47.75 75.21 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 176.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 59.2 tp -58.47 -43.35 88.89 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.269 0.627 . . . . 0.0 110.652 178.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 39.6 t -61.22 -50.63 79.68 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 C-N-CA 123.103 0.561 . . . . 0.0 109.593 176.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -63.88 -26.89 68.81 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 118.975 0.807 . . . . 0.0 112.284 -175.346 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 62.1 mtpt -67.17 -18.55 65.32 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 118.056 -0.973 . . . . 0.0 112.997 171.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -114.34 -10.09 12.71 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 119.856 1.207 . . . . 0.0 113.658 -179.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 80.3 mt . . . . . 0 C--O 1.251 1.161 0 CA-C-N 120.032 1.287 . . . . 0.0 109.723 172.314 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 92.6 mt . . . . . 0 C--O 1.236 0.345 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 40.5 t -105.33 166.48 3.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 -174.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 5.8 mptt -138.55 134.69 34.18 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 -178.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -143.45 170.7 15.3 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 122.935 0.494 . . . . 0.0 110.791 -179.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.1 p -135.29 171.71 14.05 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 178.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -49.5 -32.42 12.2 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 119.808 1.186 . . . . 0.0 113.021 -176.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 25.2 mp0 -63.48 -30.35 71.49 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.716 2.007 . . . . 0.0 112.923 -179.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.6 m -138.61 -6.7 1.5 Allowed 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 114.358 1.244 . . . . 0.0 114.358 -172.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -56.22 -34.83 66.69 Favored 'General case' 0 C--N 1.333 -0.122 0 C-N-CA 124.606 1.162 . . . . 0.0 111.11 178.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.4 p -62.75 -48.47 79.07 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 123.649 0.78 . . . . 0.0 111.062 178.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.33 -44.88 96.44 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 122.78 0.432 . . . . 0.0 109.862 177.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -65.14 -37.6 87.93 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 119.274 -0.393 . . . . 0.0 111.546 -176.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.3 p -78.93 0.25 28.16 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 118.595 0.634 . . . . 0.0 112.533 -179.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 48.8 m -112.03 34.43 4.24 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.406 1.082 . . . . 0.0 111.962 -171.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -131.78 -1.35 3.79 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -178.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 166.41 -167.09 39.27 Favored Glycine 0 C--N 1.335 0.518 0 CA-C-N 119.198 0.908 . . . . 0.0 110.872 -172.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 76.9 t -72.3 134.06 30.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 104.874 -2.269 . . . . 0.0 104.874 167.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 38.8 t -137.12 119.25 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 -176.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 60.5 tp -88.75 97.44 11.14 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 170.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.47 149.41 36.79 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 169.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -133.21 98.41 4.25 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 176.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -73.97 113.45 11.16 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 172.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 6.0 p-90 -136.26 175.89 9.19 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 123.721 0.808 . . . . 0.0 110.219 -169.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -149.89 144.98 18.22 Favored Pre-proline 0 CA--C 1.534 0.345 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 169.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.37 -21.91 22.38 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 122.438 2.092 . . . . 0.0 113.471 -170.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -83.84 -8.24 59.26 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 118.693 0.679 . . . . 0.0 112.228 178.609 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 53.7 t -85.15 117.63 24.22 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -178.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -54.58 -57.11 18.93 Favored Glycine 0 CA--C 1.532 1.154 0 CA-C-O 118.651 -1.083 . . . . 0.0 112.137 176.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -50.86 -35.87 50.57 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 123.18 2.586 . . . . 0.0 115.093 175.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 90.7 m -62.1 -37.05 83.6 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 119.676 1.126 . . . . 0.0 111.882 173.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -69.63 -42.07 74.79 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 118.804 0.729 . . . . 0.0 109.851 172.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 62.0 mtt -62.36 -38.01 87.9 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 122.948 0.499 . . . . 0.0 111.159 -175.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 10.9 tt -78.86 -16.04 13.54 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-N 118.569 0.622 . . . . 0.0 111.848 -178.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.03 -51.22 82.38 Favored Pre-proline 0 CA--C 1.544 0.728 0 CA-C-N 120.069 1.304 . . . . 0.0 113.57 -178.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -64.3 -30.31 63.69 Favored 'Trans proline' 0 C--N 1.351 0.672 0 CA-C-N 121.769 1.667 . . . . 0.0 111.872 176.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.4 t -64.82 -42.14 94.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-N 118.908 0.776 . . . . 0.0 109.56 176.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 66.2 mt -66.88 -32.98 74.59 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 118.347 -0.835 . . . . 0.0 110.734 175.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -68.29 -37.95 81.17 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 120.206 1.366 . . . . 0.0 111.49 173.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -64.62 -31.55 72.82 Favored 'General case' 0 C--N 1.334 -0.095 0 O-C-N 121.225 -0.922 . . . . 0.0 110.99 172.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 18.5 tp -76.82 -38.81 53.17 Favored 'General case' 0 N--CA 1.448 -0.56 0 O-C-N 121.82 -0.55 . . . . 0.0 110.857 174.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -64.73 -36.59 84.77 Favored 'General case' 0 C--O 1.23 0.068 0 C-N-CA 124.354 1.062 . . . . 0.0 110.654 -178.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -76.48 -22.03 55.05 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 121.894 -0.504 . . . . 0.0 111.977 -177.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 89.0 mt-10 -94.33 -34.7 12.71 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.462 1.105 . . . . 0.0 113.158 178.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 32.8 mtt -136.76 -4.55 1.99 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 118.046 -0.978 . . . . 0.0 113.263 -169.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -76.34 49.81 2.7 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 125.878 1.704 . . . . 0.0 113.11 -173.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -154.98 -40.69 0.09 Allowed 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 129.678 3.191 . . . . 0.0 106.915 171.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 57.3 mttp -61.62 -36.98 82.29 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.291 1.436 . . . . 0.0 109.817 168.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -134.02 165.5 24.9 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 126.545 1.938 . . . . 0.0 109.603 170.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -101.48 151.66 21.69 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.428 1.091 . . . . 0.0 108.135 171.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 18.7 mt -116.48 134.75 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 N-CA-C 105.118 -2.178 . . . . 0.0 105.118 170.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 87.2 t -132.43 117.57 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -176.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 55.6 mmtt -75.7 144.91 41.31 Favored 'General case' 0 C--O 1.235 0.303 0 O-C-N 121.695 -0.628 . . . . 0.0 109.663 169.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 15.3 tt -148.19 119.13 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 169.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 50.9 t0 -82.72 114.13 20.86 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.969 0.907 . . . . 0.0 109.924 -174.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 25.0 m -63.02 -22.89 31.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 -174.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -66.01 -30.54 71.1 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 119.016 0.826 . . . . 0.0 111.275 -175.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -99.66 -39.29 8.34 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 123.267 0.627 . . . . 0.0 109.73 173.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 -89.45 46.29 1.36 Allowed 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 124.268 1.027 . . . . 0.0 111.245 -169.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -56.11 -43.02 77.73 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 126.624 1.97 . . . . 0.0 108.816 179.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 30.7 mm-40 -67.5 -27.38 66.95 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 125.112 1.365 . . . . 0.0 112.306 -177.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.45 -46.01 9.49 Favored 'General case' 0 C--O 1.222 -0.392 0 CA-C-N 118.599 0.636 . . . . 0.0 109.687 179.519 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.87 -46.03 89.78 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 119.321 0.964 . . . . 0.0 109.624 179.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -60.65 -24.17 61.74 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 124.095 0.855 . . . . 0.0 112.862 175.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.2 ttmm -58.13 -23.49 55.28 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 118.573 1.187 . . . . 0.0 112.056 176.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -124.87 13.05 8.5 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.734 1.214 . . . . 0.0 110.487 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 68.96 19.61 73.83 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 124.538 1.066 . . . . 0.0 113.691 -178.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 96.5 t -84.28 135.63 24.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 176.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.18 28.22 0.46 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.586 1.154 . . . . 0.0 109.372 168.019 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 22.5 m -138.12 152.76 49.05 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 126.704 2.002 . . . . 0.0 106.77 178.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -145.72 160.09 45.31 Favored Pre-proline 0 CA--C 1.541 0.602 0 C-N-CA 124.058 0.943 . . . . 0.0 109.905 -169.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -66.94 139.52 46.19 Favored 'Cis proline' 0 C--N 1.349 0.601 0 N-CA-C 109.366 -1.051 . . . . 0.0 109.366 -11.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 51.9 m -132.0 117.74 18.8 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 177.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 95.4 mt -92.8 136.7 33.01 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 179.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.8 mp -121.09 130.92 53.96 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 105.061 -2.2 . . . . 0.0 105.061 169.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.5 t -93.56 124.24 45.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 103.196 -2.89 . . . . 0.0 103.196 168.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.9 mp -118.75 159.01 24.45 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 173.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 73.7 tttt -145.2 126.73 15.06 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 173.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.7 t70 44.33 38.62 2.58 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.395 1.478 . . . . 0.0 113.484 175.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 101.21 5.33 52.86 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-O 118.598 -1.112 . . . . 0.0 114.862 169.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 82.1 mm-40 -130.49 142.31 50.49 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 119.513 1.657 . . . . 0.0 109.142 178.051 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.2 p -68.54 138.32 22.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 169.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 33.0 m -126.75 -20.68 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 125.062 1.345 . . . . 0.0 110.478 179.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -153.08 166.9 31.01 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 119.73 1.15 . . . . 0.0 111.339 171.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 96.1 m -148.67 141.04 24.19 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.577 1.551 . . . . 0.0 108.732 177.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 16.0 m -147.68 156.62 42.96 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.565 1.546 . . . . 0.0 108.611 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 40.6 t -132.99 149.41 31.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -174.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.66 173.99 45.8 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 124.424 1.011 . . . . 0.0 112.299 176.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -59.02 150.74 23.89 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.165 0.986 . . . . 0.0 110.68 177.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -153.94 147.27 18.2 Favored Pre-proline 0 CA--C 1.532 0.279 0 C-N-CA 125.057 1.343 . . . . 0.0 107.514 169.199 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.3 159.28 47.27 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.761 2.307 . . . . 0.0 110.81 179.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 2.9 ttpp -57.44 -36.51 71.49 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.898 0.879 . . . . 0.0 111.51 -177.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -62.4 -36.2 81.59 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.471 0.578 . . . . 0.0 112.059 177.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.79 -40.6 69.11 Favored 'General case' 0 N--CA 1.453 -0.31 0 O-C-N 121.924 -0.485 . . . . 0.0 110.814 174.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 42.7 mt -64.18 -43.44 95.11 Favored 'General case' 0 N--CA 1.457 -0.08 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -179.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.0 pp0? -68.89 -31.66 70.74 Favored 'General case' 0 C--O 1.226 -0.149 0 CA-C-N 118.62 0.645 . . . . 0.0 110.258 178.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -64.23 -49.57 71.41 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 176.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 58.9 tp -57.16 -44.69 83.7 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.372 0.669 . . . . 0.0 110.476 178.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 37.3 t -65.42 -47.34 87.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 CA-C-O 118.946 -0.549 . . . . 0.0 110.638 179.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.29 -25.52 68.09 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 119.606 1.094 . . . . 0.0 112.341 -175.181 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -66.1 -16.42 63.93 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 117.897 -1.049 . . . . 0.0 113.167 171.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -121.64 -10.51 8.77 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 119.96 1.255 . . . . 0.0 113.822 -177.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 66.6 mt . . . . . 0 C--O 1.25 1.101 0 CA-C-N 120.114 1.325 . . . . 0.0 109.39 169.958 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 81.8 mt . . . . . 0 CA--C 1.538 0.503 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 20.3 t -124.69 169.45 16.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 106.106 -1.812 . . . . 0.0 106.106 -172.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.82 153.25 49.65 Favored 'General case' 0 C--O 1.234 0.274 0 O-C-N 120.809 -1.182 . . . . 0.0 109.168 171.498 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -147.73 171.15 16.13 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 123.687 0.795 . . . . 0.0 110.047 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 72.9 p -134.62 173.22 11.9 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 175.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -51.69 -30.76 23.33 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 119.644 1.111 . . . . 0.0 112.977 -176.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 26.1 mp0 -62.13 -31.64 72.14 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.061 1.744 . . . . 0.0 112.728 179.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.4 m -139.61 -2.93 1.52 Allowed 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 114.475 1.287 . . . . 0.0 114.475 -169.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 58.2 t80 -53.63 -38.5 64.12 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 123.95 0.9 . . . . 0.0 110.773 176.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.4 m -66.37 -41.82 88.88 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 122.691 0.397 . . . . 0.0 111.205 -178.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.83 -45.26 86.91 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 176.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -65.3 -37.49 87.3 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 122.568 0.347 . . . . 0.0 111.247 -176.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.9 p -78.32 0.49 25.26 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 60.0 m -109.34 32.23 5.15 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.375 1.07 . . . . 0.0 112.302 -173.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -132.44 3.72 3.93 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -177.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 166.59 -166.68 39.12 Favored Glycine 0 C--N 1.335 0.498 0 O-C-N 121.339 -0.85 . . . . 0.0 111.162 -177.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.2 t -76.2 136.12 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 103.717 -2.698 . . . . 0.0 103.717 167.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 40.5 t -137.29 139.58 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 -172.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -117.73 97.2 5.72 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 105.331 -2.1 . . . . 0.0 105.331 176.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.56 154.83 28.49 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 172.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -135.7 98.95 4.05 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 125.718 1.607 . . . . 0.0 107.015 -179.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -73.87 116.39 14.43 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 169.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 9.1 p-90 -137.47 175.06 9.94 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.015 0.926 . . . . 0.0 110.759 -172.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -151.83 146.8 19.05 Favored Pre-proline 0 CA--C 1.538 0.485 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 169.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.25 -17.14 21.84 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.835 2.357 . . . . 0.0 113.625 -169.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -85.0 -6.49 59.33 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 118.715 0.689 . . . . 0.0 112.494 178.097 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 42.4 t -91.16 117.98 30.06 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 118.997 0.817 . . . . 0.0 109.066 -176.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -56.84 -54.02 39.78 Favored Glycine 0 CA--C 1.532 1.103 0 CA-C-O 118.812 -0.993 . . . . 0.0 112.414 176.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -50.53 -36.39 49.27 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 123.19 2.594 . . . . 0.0 115.272 174.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 98.6 m -60.6 -36.62 79.02 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 120.03 1.286 . . . . 0.0 111.831 173.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 59.9 mttm -69.8 -42.94 73.07 Favored 'General case' 0 N--CA 1.464 0.231 0 O-C-N 121.601 -0.687 . . . . 0.0 109.591 174.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 74.2 mtm -64.65 -35.01 79.65 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 118.987 -0.53 . . . . 0.0 111.771 -176.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 11.7 tt -80.94 -16.46 12.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-N 119.095 0.861 . . . . 0.0 111.811 179.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.53 -49.0 91.01 Favored Pre-proline 0 CA--C 1.543 0.709 0 CA-C-O 117.526 -1.226 . . . . 0.0 113.643 -179.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.52 -27.43 46.34 Favored 'Trans proline' 0 C--N 1.35 0.608 0 CA-C-N 122.048 1.767 . . . . 0.0 112.572 176.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.3 t -66.65 -40.41 86.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 119.226 0.921 . . . . 0.0 109.18 174.026 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 62.8 mt -66.94 -35.59 80.32 Favored 'General case' 0 CA--C 1.529 0.159 0 O-C-N 121.688 -0.632 . . . . 0.0 110.888 175.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -68.48 -36.2 78.62 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 119.269 0.941 . . . . 0.0 111.422 174.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -62.04 -43.17 99.42 Favored 'General case' 0 C--N 1.332 -0.158 0 O-C-N 121.122 -0.986 . . . . 0.0 109.903 171.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -65.26 -35.02 79.74 Favored 'General case' 0 N--CA 1.456 -0.171 0 O-C-N 121.93 -0.481 . . . . 0.0 111.509 176.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -65.7 -38.63 89.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 119.044 0.838 . . . . 0.0 110.357 175.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -68.91 -38.03 79.33 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 121.323 -0.861 . . . . 0.0 111.737 175.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -85.99 -36.16 19.96 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.258 1.023 . . . . 0.0 112.064 -171.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.431 ' SD ' ' HE2' ' A' ' 49' ' ' LYS . 19.0 mmt -135.57 -8.37 2.19 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.169 1.387 . . . . 0.0 112.626 -168.042 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.5 -21.41 54.32 Favored Glycine 0 CA--C 1.532 1.123 0 CA-C-N 120.321 1.419 . . . . 0.0 114.577 -171.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -76.79 -18.51 58.37 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.626 1.97 . . . . 0.0 112.134 -179.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.431 ' HE2' ' SD ' ' A' ' 46' ' ' MET . 14.8 pttm -134.02 -2.07 2.93 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 126.56 1.944 . . . . 0.0 112.239 -173.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -145.2 120.22 10.04 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 125.996 1.718 . . . . 0.0 107.424 174.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -73.07 150.99 41.86 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 176.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 16.9 mt -121.97 132.7 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 N-CA-C 105.892 -1.892 . . . . 0.0 105.892 173.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 48.0 t -132.15 111.75 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-N 118.687 0.676 . . . . 0.0 109.495 -170.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 61.2 mmtt -72.86 142.27 47.96 Favored 'General case' 0 C--O 1.234 0.288 0 O-C-N 121.551 -0.718 . . . . 0.0 109.49 171.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 11.9 tt -151.26 131.36 3.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 171.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -87.44 129.64 34.98 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 121.375 -0.828 . . . . 0.0 109.579 -177.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.0 m -66.31 -36.21 76.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 -174.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -75.0 -35.44 62.02 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 119.146 0.885 . . . . 0.0 109.762 -173.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -74.14 -15.67 61.02 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.699 0.799 . . . . 0.0 112.043 173.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 60.1 m-80 -141.11 49.61 1.65 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 119.523 1.056 . . . . 0.0 111.558 -167.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -56.82 -38.8 73.12 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.956 0.902 . . . . 0.0 109.478 179.563 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -65.87 -28.2 68.78 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 125.034 1.334 . . . . 0.0 112.572 -178.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.43 -44.23 10.89 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-N 118.673 0.67 . . . . 0.0 109.797 179.036 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.23 -46.58 86.3 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 119.017 0.826 . . . . 0.0 109.731 178.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -60.94 -24.17 62.4 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 124.166 0.889 . . . . 0.0 112.466 175.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.9 ttmm -58.52 -22.07 54.11 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.298 1.039 . . . . 0.0 111.966 175.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -122.19 12.03 10.22 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.659 1.184 . . . . 0.0 110.854 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 70.78 31.8 67.22 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 123.743 0.687 . . . . 0.0 112.573 -178.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 94.9 t -111.08 139.22 35.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 C-N-CA 124.962 1.305 . . . . 0.0 107.825 -178.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 9.1 tpt -155.23 30.09 0.39 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.372 1.069 . . . . 0.0 108.807 167.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 19.3 m -138.39 157.01 47.06 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 126.335 1.854 . . . . 0.0 107.456 -177.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -144.33 157.35 56.56 Favored Pre-proline 0 CA--C 1.54 0.569 0 CA-C-O 118.462 -0.78 . . . . 0.0 110.79 -169.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -66.81 139.76 46.91 Favored 'Cis proline' 0 N--CA 1.458 -0.575 0 N-CA-C 109.335 -1.064 . . . . 0.0 109.335 -11.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 85.0 m -133.6 116.07 15.44 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 174.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 72.7 mt -86.46 144.68 27.16 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 175.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -129.24 126.82 39.95 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 104.261 -2.496 . . . . 0.0 104.261 -178.068 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.1 t -111.33 123.52 67.26 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.414 0 N-CA-C 104.367 -2.457 . . . . 0.0 104.367 -175.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.0 mp -129.65 161.75 29.87 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 124.525 1.13 . . . . 0.0 108.236 -177.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 63.0 tttm -149.03 127.34 12.16 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 176.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.8 t70 43.39 35.27 0.87 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.428 1.491 . . . . 0.0 113.684 176.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 105.38 1.74 40.95 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-O 118.11 -1.383 . . . . 0.0 115.224 169.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -130.34 145.79 51.83 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 120.044 1.922 . . . . 0.0 110.089 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.6 p -69.37 141.45 17.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 C-N-CA 123.924 0.89 . . . . 0.0 109.306 174.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 35.6 m -129.42 -18.32 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 C-N-CA 125.709 1.604 . . . . 0.0 110.693 178.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -161.06 169.46 22.41 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 120.543 1.52 . . . . 0.0 111.669 170.149 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 54.5 m -145.82 144.65 30.4 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.07 1.748 . . . . 0.0 108.01 169.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 15.8 m -146.86 150.2 34.78 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 124.636 1.174 . . . . 0.0 108.83 -178.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 39.9 t -129.61 148.21 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -171.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.55 179.06 51.92 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 124.015 0.817 . . . . 0.0 111.708 178.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -62.43 151.58 36.73 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.539 0.736 . . . . 0.0 110.623 176.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.35 145.91 33.98 Favored Pre-proline 0 C--O 1.234 0.253 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 167.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -70.91 163.57 38.73 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.658 2.238 . . . . 0.0 110.173 173.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -54.78 -44.66 73.92 Favored 'General case' 0 C--O 1.224 -0.266 0 CA-C-O 118.585 -0.722 . . . . 0.0 110.694 179.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -63.81 -41.62 97.85 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 118.849 0.75 . . . . 0.0 111.319 -169.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.54 -42.71 82.25 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 123.22 0.608 . . . . 0.0 110.893 176.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 42.4 tp -69.37 -40.25 77.55 Favored 'General case' 0 N--CA 1.451 -0.416 0 O-C-N 122.124 -0.36 . . . . 0.0 110.808 -177.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.5 pp0? -71.71 -29.32 64.43 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 118.888 0.767 . . . . 0.0 110.062 176.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -64.04 -49.29 72.95 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 174.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 59.1 tp -57.33 -44.14 83.96 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 123.751 0.82 . . . . 0.0 110.515 178.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 11.1 t -62.19 -52.1 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 176.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.83 -25.15 67.78 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 119.095 0.861 . . . . 0.0 112.313 -175.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -67.74 -17.14 64.45 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 117.938 -1.03 . . . . 0.0 113.004 171.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -114.2 -15.07 12.25 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 120.017 1.281 . . . . 0.0 113.182 176.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 53.2 mt . . . . . 0 C--O 1.249 1.067 0 CA-C-N 119.403 1.001 . . . . 0.0 109.493 169.387 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 89.8 mt . . . . . 0 C--O 1.236 0.392 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 39.0 t -107.05 167.19 3.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 -174.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 5.7 mptt -138.47 136.53 36.27 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 -177.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -144.84 169.75 17.45 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 123.035 0.534 . . . . 0.0 110.957 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 75.8 p -133.71 176.75 8.27 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.989 1.316 . . . . 0.0 108.162 177.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -51.05 -31.97 20.4 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 120.307 1.412 . . . . 0.0 112.773 -178.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 24.3 mp0 -67.93 -25.9 65.7 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.664 1.985 . . . . 0.0 112.792 -178.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 51.7 p -135.92 -17.56 1.64 Allowed 'General case' 0 C--O 1.234 0.241 0 N-CA-C 115.343 1.608 . . . . 0.0 115.343 -168.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -53.89 -34.81 60.56 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 124.909 1.283 . . . . 0.0 110.869 179.021 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.0 m -70.22 -37.91 75.13 Favored 'General case' 0 N--CA 1.453 -0.282 0 O-C-N 122.303 -0.248 . . . . 0.0 111.116 -176.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.15 -45.82 72.49 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 174.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -64.61 -37.39 87.39 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 119.283 -0.389 . . . . 0.0 111.468 -174.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.7 p -78.38 -0.11 27.81 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -178.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 62.1 m -111.38 33.76 4.5 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.228 1.011 . . . . 0.0 111.999 -170.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -132.21 -1.29 3.63 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 -177.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 166.67 -166.87 39.27 Favored Glycine 0 C--N 1.335 0.523 0 N-CA-C 110.686 -0.966 . . . . 0.0 110.686 -173.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 72.9 t -72.01 134.72 29.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 104.695 -2.335 . . . . 0.0 104.695 166.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.1 t -137.56 124.11 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 -176.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 61.6 tp -94.46 97.94 10.51 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 173.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.97 150.01 35.91 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 170.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -132.89 99.77 4.7 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 125.375 1.47 . . . . 0.0 107.262 175.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -76.95 114.57 15.89 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 172.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 9.1 p-90 -137.7 175.05 9.94 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 123.273 0.629 . . . . 0.0 110.689 -169.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -152.93 146.78 18.34 Favored Pre-proline 0 CA--C 1.535 0.397 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 168.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -73.49 -22.27 18.6 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.613 2.208 . . . . 0.0 113.187 -169.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -81.88 -7.21 59.59 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.398 0.679 . . . . 0.0 112.28 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 48.4 t -93.12 110.61 22.1 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 -177.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -50.09 -52.18 27.69 Favored Glycine 0 CA--C 1.533 1.205 0 CA-C-O 118.852 -0.971 . . . . 0.0 113.024 177.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_exo -51.3 -34.73 50.81 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 123.13 2.553 . . . . 0.0 115.366 173.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 93.6 m -62.53 -37.0 84.38 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 120.182 1.355 . . . . 0.0 111.428 173.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -69.05 -43.14 75.27 Favored 'General case' 0 N--CA 1.463 0.198 0 O-C-N 121.722 -0.611 . . . . 0.0 109.704 173.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 75.1 mtm -65.28 -33.65 76.49 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 118.439 0.563 . . . . 0.0 111.911 -176.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.4 tt -82.0 -15.44 12.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-N 119.152 0.887 . . . . 0.0 111.852 179.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.27 -48.94 93.02 Favored Pre-proline 0 CA--C 1.544 0.725 0 CA-C-O 117.593 -1.194 . . . . 0.0 113.331 179.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.07 -28.68 56.98 Favored 'Trans proline' 0 C--N 1.351 0.665 0 CA-C-N 121.88 1.707 . . . . 0.0 112.412 175.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 16.5 t -65.91 -40.19 86.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 119.569 1.077 . . . . 0.0 109.491 174.06 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 70.3 mt -67.51 -33.25 74.69 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-O 118.657 -0.687 . . . . 0.0 110.855 176.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -68.56 -36.0 78.18 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.443 1.02 . . . . 0.0 111.583 172.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 -61.9 -45.34 94.17 Favored 'General case' 0 C--O 1.227 -0.097 0 O-C-N 120.839 -1.163 . . . . 0.0 109.426 171.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -61.73 -36.22 80.33 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 118.523 0.601 . . . . 0.0 111.511 174.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -66.03 -37.51 86.06 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 118.919 0.781 . . . . 0.0 110.691 178.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -70.7 -45.81 64.28 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 122.993 0.517 . . . . 0.0 111.169 176.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -79.78 -33.2 40.78 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.469 1.107 . . . . 0.0 111.738 -169.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.413 ' HA ' ' HE3' ' A' ' 49' ' ' LYS . 22.2 mmt -139.95 -9.01 1.18 Allowed 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 117.808 -1.092 . . . . 0.0 113.842 -168.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -75.21 47.83 2.03 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 126.134 1.826 . . . . 0.0 114.569 -169.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -150.95 -39.75 0.13 Allowed 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 128.129 2.572 . . . . 0.0 107.584 169.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.413 ' HE3' ' HA ' ' A' ' 46' ' ' MET . 41.4 mtmt -65.22 -30.7 71.61 Favored 'General case' 0 C--N 1.342 0.28 0 C-N-CA 124.492 1.117 . . . . 0.0 110.651 169.041 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -134.25 164.37 27.54 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 125.486 1.514 . . . . 0.0 110.198 169.522 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -99.26 152.46 19.9 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 124.673 1.189 . . . . 0.0 108.182 172.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 19.0 mt -118.41 136.32 55.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 N-CA-C 105.488 -2.041 . . . . 0.0 105.488 172.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 79.1 t -133.17 117.76 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 119.054 0.843 . . . . 0.0 108.802 -176.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 55.1 mmtt -76.29 145.16 39.81 Favored 'General case' 0 C--O 1.234 0.284 0 O-C-N 121.672 -0.642 . . . . 0.0 109.859 169.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 16.0 tt -148.76 119.03 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 169.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -82.24 116.72 21.9 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -177.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 33.9 m -62.19 -25.83 38.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -174.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -66.1 -29.96 70.38 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 119.513 1.051 . . . . 0.0 110.949 -177.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -100.75 -3.27 30.42 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.298 1.039 . . . . 0.0 110.99 179.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 -141.65 43.48 1.73 Allowed 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.715 1.206 . . . . 0.0 109.942 -168.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.448 ' CD ' ' H ' ' A' ' 61' ' ' GLN . 1.0 OUTLIER -58.33 -41.5 84.71 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.804 1.242 . . . . 0.0 108.77 -177.937 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -64.5 -42.97 95.51 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.91 0.884 . . . . 0.0 110.509 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.498 ' HA ' ' HE3' ' A' ' 66' ' ' LYS . 0.5 OUTLIER -68.94 -44.04 73.86 Favored 'General case' 0 C--O 1.221 -0.397 0 CA-C-N 118.776 0.716 . . . . 0.0 110.255 -177.519 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.3 -45.1 94.77 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 119.094 0.861 . . . . 0.0 109.347 176.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -57.46 -27.53 58.41 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 124.077 0.846 . . . . 0.0 112.702 174.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.498 ' HE3' ' HA ' ' A' ' 63' ' ' THR . 25.7 ttmt -58.49 -21.22 51.06 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.656 1.582 . . . . 0.0 111.924 178.566 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -126.61 13.74 7.53 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.657 1.183 . . . . 0.0 110.687 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 71.71 32.56 64.05 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 123.775 0.702 . . . . 0.0 112.754 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 93.6 t -109.85 137.87 40.08 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 C-N-CA 124.806 1.243 . . . . 0.0 107.756 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 8.4 tpt -155.95 31.45 0.35 Allowed 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.355 1.062 . . . . 0.0 108.804 166.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 20.4 m -138.27 152.39 48.5 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 126.779 2.031 . . . . 0.0 106.643 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -146.11 159.08 47.14 Favored Pre-proline 0 CA--C 1.54 0.592 0 C-N-CA 123.95 0.9 . . . . 0.0 110.02 -169.417 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -67.17 138.94 43.95 Favored 'Cis proline' 0 C--N 1.349 0.59 0 CA-C-N 119.956 1.02 . . . . 0.0 109.691 -10.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 54.9 m -132.36 116.9 17.43 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 177.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 81.0 mt -92.45 137.13 32.63 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 177.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.6 mp -122.39 132.47 54.39 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 105.74 -1.948 . . . . 0.0 105.74 169.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 17.0 t -95.58 125.9 48.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 103.09 -2.929 . . . . 0.0 103.09 168.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.8 mp -120.72 159.18 25.91 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 125.422 1.489 . . . . 0.0 107.322 175.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -146.28 125.12 12.66 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 176.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.9 t70 45.81 35.66 2.39 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.311 1.444 . . . . 0.0 113.694 175.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 110.04 -2.53 30.02 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-O 118.055 -1.414 . . . . 0.0 115.484 168.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -131.57 144.43 51.08 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 120.081 1.941 . . . . 0.0 110.2 -178.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 5.3 p -65.72 137.16 25.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 171.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 34.3 m -121.12 -21.5 3.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 125.175 1.39 . . . . 0.0 110.433 176.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -157.31 162.73 39.14 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 119.701 1.137 . . . . 0.0 111.312 174.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 90.6 m -136.57 149.28 47.99 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.383 1.873 . . . . 0.0 108.416 175.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 30.4 m -147.35 152.81 38.82 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 126.267 1.827 . . . . 0.0 107.834 170.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 41.3 t -133.13 144.44 36.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 -175.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 80.22 179.83 52.86 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 123.907 0.765 . . . . 0.0 111.582 -179.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -62.97 147.7 49.78 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.683 0.793 . . . . 0.0 110.667 178.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 69.2 mttt -142.37 147.66 44.28 Favored Pre-proline 0 CA--C 1.531 0.233 0 C-N-CA 125.713 1.605 . . . . 0.0 106.898 168.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -73.2 159.44 47.27 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.581 2.187 . . . . 0.0 110.459 176.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 17.1 ptmt -55.55 -48.94 73.94 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 112.257 0.465 . . . . 0.0 112.257 -177.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -61.9 -39.29 91.46 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 123.59 0.756 . . . . 0.0 110.868 -169.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.64 -42.8 73.78 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 122.823 0.449 . . . . 0.0 110.855 176.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 46.5 tp -68.66 -38.42 80.39 Favored 'General case' 0 N--CA 1.451 -0.41 0 O-C-N 122.039 -0.413 . . . . 0.0 110.857 -178.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.4 pp0? -72.06 -29.47 64.17 Favored 'General case' 0 C--N 1.339 0.118 0 CA-C-N 119.174 0.897 . . . . 0.0 110.314 175.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -63.5 -48.85 75.89 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 174.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 59.3 tp -58.59 -44.97 90.0 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.191 0.596 . . . . 0.0 110.558 179.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.6 t -60.22 -51.43 73.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 C-N-CA 122.898 0.479 . . . . 0.0 109.74 177.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.37 -27.99 69.39 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 118.893 0.77 . . . . 0.0 112.121 -176.57 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -68.56 -25.87 65.12 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 118.303 -0.856 . . . . 0.0 112.345 172.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 75.5 m-70 -96.69 -16.98 20.63 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 119.68 1.127 . . . . 0.0 113.421 178.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 67.8 mt . . . . . 0 C--O 1.25 1.115 0 CA-C-N 119.813 1.188 . . . . 0.0 109.665 173.543 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 86.7 mt . . . . . 0 CA--C 1.537 0.477 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 35.7 t -122.68 167.1 16.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 -175.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 6.1 mtmt -132.34 143.76 50.08 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 176.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -144.89 170.43 16.16 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 123.12 0.568 . . . . 0.0 110.246 175.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 77.4 p -134.62 173.61 11.48 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.915 1.286 . . . . 0.0 107.636 177.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -50.49 -30.65 13.33 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 119.271 0.941 . . . . 0.0 113.132 -177.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 26.9 mp0 -64.25 -32.23 73.74 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.13 1.772 . . . . 0.0 112.794 -179.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.2 m -140.02 -5.57 1.29 Allowed 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 -169.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -52.26 -38.8 59.22 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 124.355 1.062 . . . . 0.0 110.786 175.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.4 m -67.75 -36.15 80.01 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 122.675 0.39 . . . . 0.0 111.656 -176.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.92 -45.99 69.41 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 175.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -64.03 -35.23 80.03 Favored 'General case' 0 C--O 1.231 0.11 0 C-N-CA 123.06 0.544 . . . . 0.0 111.721 -174.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 22.3 p -82.44 2.09 34.33 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.611 0.764 . . . . 0.0 112.955 -178.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 48.7 m -118.07 35.61 4.67 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 118.891 0.769 . . . . 0.0 112.726 -169.224 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -145.89 14.3 1.34 Allowed 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 176.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 172.08 -168.54 41.64 Favored Glycine 0 C--N 1.34 0.771 0 O-C-N 121.17 -0.956 . . . . 0.0 111.698 176.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 61.0 t -74.81 133.74 30.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 N-CA-C 104.498 -2.408 . . . . 0.0 104.498 167.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 38.1 t -139.63 117.32 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 -174.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 64.4 tp -88.25 97.29 10.94 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 173.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.05 147.77 38.46 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 169.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -133.73 98.9 4.31 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 125.172 1.389 . . . . 0.0 107.539 176.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -75.81 114.88 14.91 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 105.893 -1.891 . . . . 0.0 105.893 173.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 9.2 p-90 -137.49 175.21 9.81 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.478 0.711 . . . . 0.0 110.81 -169.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -152.92 147.43 19.06 Favored Pre-proline 0 CA--C 1.537 0.446 0 C-N-CA 124.602 1.161 . . . . 0.0 107.897 169.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.3 -21.57 17.41 Favored 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 122.8 2.333 . . . . 0.0 113.423 -170.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -81.71 -9.3 59.68 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 118.665 0.666 . . . . 0.0 112.051 178.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 51.0 t -88.28 117.1 26.95 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -179.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -54.4 -57.65 16.34 Favored Glycine 0 CA--C 1.531 1.05 0 CA-C-O 118.565 -1.13 . . . . 0.0 111.888 176.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_exo -49.37 -35.44 35.49 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 123.703 2.935 . . . . 0.0 115.736 177.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 84.5 m -60.56 -37.85 82.61 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 119.941 1.246 . . . . 0.0 111.65 174.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 45.9 mtmt -79.88 -31.21 40.34 Favored 'General case' 0 CA--C 1.529 0.151 0 O-C-N 121.674 -0.641 . . . . 0.0 110.29 177.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 63.6 mtt -65.06 -38.86 92.21 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.994 0.816 . . . . 0.0 111.278 175.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 10.2 tt -80.95 -16.94 12.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 118.887 0.767 . . . . 0.0 111.632 -179.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -52.32 -49.8 83.14 Favored Pre-proline 0 CA--C 1.544 0.716 0 CA-C-O 117.506 -1.235 . . . . 0.0 113.777 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -64.98 -31.52 55.78 Favored 'Trans proline' 0 C--N 1.35 0.649 0 CA-C-N 121.92 1.722 . . . . 0.0 112.236 176.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 20.2 t -63.44 -43.61 98.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-N 119.106 0.866 . . . . 0.0 109.049 175.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 71.9 mt -65.17 -36.16 83.36 Favored 'General case' 0 C--O 1.227 -0.115 0 CA-C-O 118.849 -0.596 . . . . 0.0 110.954 177.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -65.94 -38.09 87.71 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 119.273 0.942 . . . . 0.0 111.279 174.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -68.2 -38.86 82.41 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 121.133 -0.98 . . . . 0.0 110.456 174.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.91 -42.26 99.73 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.001 0.92 . . . . 0.0 109.421 177.15 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -63.15 -45.01 93.9 Favored 'General case' 0 C--O 1.226 -0.132 0 C-N-CA 123.718 0.807 . . . . 0.0 110.449 176.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -61.69 -30.5 70.78 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 121.705 -0.622 . . . . 0.0 111.989 176.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -85.99 -40.01 16.28 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.893 0.877 . . . . 0.0 112.133 -175.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 17.8 mmt -135.68 1.11 2.78 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 -167.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.3 47.51 1.11 Allowed Glycine 0 CA--C 1.53 1.022 0 C-N-CA 127.224 2.345 . . . . 0.0 114.625 -169.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -149.71 -40.1 0.14 Allowed 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 128.552 2.741 . . . . 0.0 108.032 171.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -62.81 -38.8 92.14 Favored 'General case' 0 C--N 1.342 0.263 0 C-N-CA 124.633 1.173 . . . . 0.0 110.218 169.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -133.31 165.22 25.33 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.418 1.487 . . . . 0.0 110.294 173.264 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -104.81 155.11 19.19 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.726 1.61 . . . . 0.0 107.453 171.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 17.9 mt -117.52 135.78 56.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 N-CA-C 105.242 -2.132 . . . . 0.0 105.242 169.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 91.3 t -130.96 113.78 25.27 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -177.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 44.4 mmtt -73.78 144.25 45.69 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 169.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 15.2 tt -148.06 118.03 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 169.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -82.51 115.44 21.5 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 -176.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 27.8 m -62.49 -24.79 36.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 N-CA-C 112.519 0.562 . . . . 0.0 112.519 -175.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -70.48 -10.62 59.65 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 119.318 0.963 . . . . 0.0 112.083 -178.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -122.95 1.09 9.25 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.645 1.178 . . . . 0.0 110.889 175.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -145.65 36.88 1.08 Allowed 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.636 1.174 . . . . 0.0 110.128 -169.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -59.07 -29.25 67.19 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.579 0.752 . . . . 0.0 110.551 177.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 59.6 mp0 -59.97 -49.48 77.5 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.504 1.522 . . . . 0.0 110.041 173.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.63 -41.87 68.32 Favored 'General case' 0 C--O 1.222 -0.392 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 -175.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -61.14 -46.78 89.14 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 119.057 0.844 . . . . 0.0 109.775 176.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -59.19 -24.55 58.9 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 124.312 0.958 . . . . 0.0 112.856 175.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 8.9 ttmm -59.38 -20.82 57.77 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.764 1.225 . . . . 0.0 111.791 176.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -125.6 13.11 8.08 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.199 1.4 . . . . 0.0 110.473 177.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 68.52 21.63 74.59 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 124.554 1.074 . . . . 0.0 113.524 -177.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 87.3 t -89.34 154.39 3.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-N 118.308 1.054 . . . . 0.0 109.372 178.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -162.23 -24.01 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.898 2.079 . . . . 0.0 109.404 167.097 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 8.8 m -63.51 149.3 46.51 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 123.571 0.749 . . . . 0.0 109.114 169.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -144.31 155.46 57.77 Favored Pre-proline 0 CA--C 1.541 0.614 0 C-N-CA 124.176 0.99 . . . . 0.0 108.925 176.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -66.69 140.24 48.84 Favored 'Cis proline' 0 N--CA 1.457 -0.643 0 CA-C-N 120.003 1.037 . . . . 0.0 109.584 -10.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 52.7 m -131.63 117.81 19.19 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 175.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 93.1 mt -93.79 135.24 35.3 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 178.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.5 mp -122.9 129.45 51.64 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 104.713 -2.329 . . . . 0.0 104.713 169.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 48.1 t -94.84 120.94 44.96 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.416 0 N-CA-C 103.361 -2.829 . . . . 0.0 103.361 168.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.9 mp -108.41 159.26 16.81 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 169.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -146.34 123.91 11.78 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 106.738 -1.579 . . . . 0.0 106.738 175.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.0 t70 42.21 40.67 1.82 Allowed 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.032 1.333 . . . . 0.0 113.08 179.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.67 9.66 59.77 Favored Glycine 0 CA--C 1.529 0.962 0 CA-C-O 118.584 -1.12 . . . . 0.0 114.957 171.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -126.55 139.81 52.92 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 119.552 1.676 . . . . 0.0 108.472 177.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 18.5 t -68.01 134.28 30.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 106.711 -1.589 . . . . 0.0 106.711 169.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.6 m -124.89 -18.61 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 124.41 1.084 . . . . 0.0 110.898 177.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.22 165.17 36.55 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 119.619 1.1 . . . . 0.0 110.955 174.065 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 97.5 m -149.32 149.28 30.65 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.209 1.403 . . . . 0.0 109.108 177.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.9 m -149.87 156.25 41.46 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 126.018 1.727 . . . . 0.0 108.929 172.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.9 t -133.58 144.46 35.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 -179.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.1 -178.45 53.61 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 123.647 0.641 . . . . 0.0 111.567 -178.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -62.33 149.0 43.39 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.786 0.834 . . . . 0.0 110.678 177.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 25.3 mttp -142.32 142.11 23.0 Favored Pre-proline 0 C--O 1.234 0.248 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 168.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -72.5 162.93 40.04 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 122.646 2.23 . . . . 0.0 110.458 175.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -54.64 -46.2 73.92 Favored 'General case' 0 C--O 1.223 -0.295 0 C-N-CA 123.073 0.549 . . . . 0.0 110.82 -179.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -64.84 -41.13 95.97 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 118.356 0.525 . . . . 0.0 111.05 -169.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.28 -45.45 80.41 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 122.651 0.38 . . . . 0.0 110.539 176.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 46.5 tp -65.75 -42.42 90.93 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 123.037 0.535 . . . . 0.0 110.436 -176.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -68.37 -32.78 73.1 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 118.715 0.689 . . . . 0.0 109.818 178.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -67.64 -46.8 71.39 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 118.835 0.743 . . . . 0.0 109.446 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.0 tt -54.16 -42.75 69.95 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.385 1.074 . . . . 0.0 109.569 175.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 25.2 t -63.84 -50.67 76.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-O 117.499 -1.239 . . . . 0.0 110.548 175.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -56.12 -46.18 79.24 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 120.718 1.599 . . . . 0.0 110.279 -176.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -57.21 -15.0 4.84 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.228 1.011 . . . . 0.0 113.225 178.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 78.8 m-70 -121.09 -5.06 9.51 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 177.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 53.9 mt . . . . . 0 C--O 1.248 1.008 0 CA-C-N 120.106 1.321 . . . . 0.0 109.113 169.959 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 77.3 mt . . . . . 0 CA--C 1.54 0.564 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.4 t -129.22 169.88 19.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 -173.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.26 153.46 50.34 Favored 'General case' 0 C--O 1.233 0.235 0 O-C-N 120.791 -1.193 . . . . 0.0 108.994 169.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -144.71 175.5 10.12 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 123.886 0.874 . . . . 0.0 109.939 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 70.6 p -133.13 177.36 7.73 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.798 1.239 . . . . 0.0 107.947 174.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -53.97 -25.94 23.33 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 119.547 1.067 . . . . 0.0 112.553 176.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 48.2 mm-40 -73.34 -25.17 60.5 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.091 1.356 . . . . 0.0 112.522 -178.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 33.2 p -135.15 -11.99 2.18 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 115.634 1.716 . . . . 0.0 115.634 -167.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -53.96 -35.79 62.17 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 124.194 0.998 . . . . 0.0 110.852 179.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.7 m -70.81 -34.92 72.24 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 122.686 0.394 . . . . 0.0 111.48 -177.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -72.94 -32.74 65.46 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 123.556 0.742 . . . . 0.0 110.625 176.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -79.05 -39.59 33.53 Favored 'General case' 0 N--CA 1.453 -0.319 0 O-C-N 122.003 -0.435 . . . . 0.0 111.505 -177.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 25.2 p -78.11 -0.64 28.97 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -174.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 28.7 p -110.46 30.94 6.33 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.269 1.028 . . . . 0.0 112.834 -169.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -131.48 -0.13 4.0 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 113.58 0.955 . . . . 0.0 113.58 -175.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 165.73 -166.29 38.46 Favored Glycine 0 C--N 1.336 0.559 0 CA-C-N 119.358 0.981 . . . . 0.0 110.886 -174.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 88.6 t -71.73 129.82 35.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 N-CA-C 105.212 -2.144 . . . . 0.0 105.212 166.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 25.4 t -133.11 116.66 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 -176.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 63.9 tp -88.21 96.83 10.7 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 174.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.06 148.54 37.9 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 170.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -133.51 96.76 3.78 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 125.031 1.332 . . . . 0.0 107.419 177.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -74.53 113.81 12.21 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 172.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 6.6 p-90 -137.63 176.72 8.45 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 123.435 0.694 . . . . 0.0 110.532 -169.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -155.72 147.75 17.36 Favored Pre-proline 0 C--O 1.237 0.446 0 C-N-CA 125.793 1.637 . . . . 0.0 106.731 169.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.94 -20.49 15.01 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.99 2.46 . . . . 0.0 113.3 -170.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -79.37 -7.59 58.47 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 118.528 0.604 . . . . 0.0 112.381 -179.616 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 44.0 t -95.56 122.25 38.1 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -178.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -56.87 -57.48 19.44 Favored Glycine 0 CA--C 1.531 1.046 0 CA-C-O 118.623 -1.098 . . . . 0.0 112.098 178.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_exo -48.37 -36.19 29.73 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 123.756 2.971 . . . . 0.0 115.8 177.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 79.8 m -59.6 -31.82 69.83 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 119.875 1.216 . . . . 0.0 112.504 175.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt -88.32 -33.88 17.85 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 123.445 0.698 . . . . 0.0 109.737 177.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 62.3 mtt -61.65 -37.07 82.68 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.935 0.789 . . . . 0.0 111.264 175.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 10.9 tt -80.08 -14.04 13.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-N 118.603 0.638 . . . . 0.0 111.928 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.97 -48.35 94.14 Favored Pre-proline 0 CA--C 1.543 0.685 0 CA-C-O 117.403 -1.284 . . . . 0.0 113.411 -178.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -65.03 -29.15 57.14 Favored 'Trans proline' 0 C--N 1.349 0.592 0 CA-C-N 121.996 1.749 . . . . 0.0 112.607 175.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 12.9 t -66.71 -40.45 86.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 119.343 0.974 . . . . 0.0 109.305 174.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 91.6 mt -66.72 -35.69 80.72 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-O 118.756 -0.64 . . . . 0.0 110.845 175.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -68.04 -36.06 79.28 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 119.481 1.037 . . . . 0.0 111.288 174.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 45.3 mm-40 -63.88 -43.91 94.62 Favored 'General case' 0 CA--C 1.529 0.151 0 O-C-N 121.05 -1.031 . . . . 0.0 109.958 171.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -63.3 -36.54 84.0 Favored 'General case' 0 C--O 1.226 -0.181 0 C-N-CA 123.129 0.572 . . . . 0.0 111.109 176.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -64.71 -42.7 95.07 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 118.636 0.653 . . . . 0.0 109.995 176.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -65.91 -33.39 75.72 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.708 -0.62 . . . . 0.0 112.377 175.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -89.27 -32.48 17.37 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.093 0.957 . . . . 0.0 112.274 -172.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.511 ' SD ' ' HE2' ' A' ' 49' ' ' LYS . 22.5 mmt -136.25 -11.54 1.92 Allowed 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.879 1.271 . . . . 0.0 112.663 -168.361 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.42 2.88 18.79 Favored Glycine 0 CA--C 1.53 0.988 0 CA-C-N 120.827 1.649 . . . . 0.0 114.545 -172.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -90.2 -17.15 28.06 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 127.126 2.17 . . . . 0.0 111.766 170.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.511 ' HE2' ' SD ' ' A' ' 46' ' ' MET . 14.9 pttm -138.94 6.4 2.41 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 127.072 2.149 . . . . 0.0 112.466 -174.244 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -145.85 163.96 33.41 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 129.144 2.978 . . . . 0.0 105.998 175.314 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -121.05 154.91 35.46 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 125.231 1.412 . . . . 0.0 107.359 173.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 15.7 mt -123.4 135.28 63.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 N-CA-C 105.179 -2.156 . . . . 0.0 105.179 174.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 88.3 t -132.1 111.19 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -174.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 38.6 mmtt -71.65 142.55 49.9 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 169.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 15.7 tt -148.64 119.78 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 170.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 50.7 t0 -80.26 115.88 20.05 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 123.561 0.745 . . . . 0.0 109.138 -177.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 28.6 m -60.95 -30.25 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-N 118.227 0.467 . . . . 0.0 111.889 -177.268 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -76.16 2.68 12.4 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.986 0.914 . . . . 0.0 112.024 -176.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -129.89 -4.13 4.59 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.69 1.596 . . . . 0.0 110.743 173.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -141.34 47.55 1.69 Allowed 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.287 1.035 . . . . 0.0 109.938 -168.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.503 ' H ' ' NE2' ' A' ' 61' ' ' GLN . 0.3 OUTLIER -52.47 -43.35 64.92 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.587 1.555 . . . . 0.0 109.427 177.958 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 33.3 mp0 -67.35 -27.97 67.57 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 126.206 1.802 . . . . 0.0 111.903 -174.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.41 ' HA ' ' HE2' ' A' ' 66' ' ' LYS . 0.2 OUTLIER -88.39 -46.2 9.36 Favored 'General case' 0 C--O 1.22 -0.481 0 CA-C-N 118.474 0.579 . . . . 0.0 109.614 178.722 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.8 -47.41 83.55 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.859 0.754 . . . . 0.0 109.683 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -61.46 -22.41 61.32 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 124.514 1.054 . . . . 0.0 112.846 175.108 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.41 ' HE2' ' HA ' ' A' ' 63' ' ' THR . 5.9 ttmm -57.61 -24.14 54.8 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 118.811 1.306 . . . . 0.0 111.771 174.669 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -125.4 14.74 8.27 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.851 1.26 . . . . 0.0 110.304 178.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 70.12 19.09 75.34 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 124.849 1.214 . . . . 0.0 114.038 -179.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 84.6 t -81.31 127.63 39.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 177.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 8.6 mmt -147.5 29.42 0.94 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.892 1.677 . . . . 0.0 108.735 169.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 17.0 m -142.85 152.18 41.88 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 126.681 1.993 . . . . 0.0 106.734 179.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -145.64 157.56 51.48 Favored Pre-proline 0 CA--C 1.54 0.576 0 C-N-CA 123.832 0.853 . . . . 0.0 109.914 -171.199 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -67.57 141.73 59.84 Favored 'Cis proline' 0 N--CA 1.459 -0.548 0 CA-C-N 119.852 0.983 . . . . 0.0 109.581 -10.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 55.2 m -131.78 116.4 17.22 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 176.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 93.3 mt -91.4 136.84 32.82 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 178.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.2 mp -120.68 130.84 54.27 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 105.098 -2.186 . . . . 0.0 105.098 169.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 25.5 t -93.72 121.09 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 103.016 -2.957 . . . . 0.0 103.016 169.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.8 mp -115.86 158.62 22.67 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 172.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -146.19 126.2 13.68 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 175.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.6 t70 44.75 38.31 2.75 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.263 1.425 . . . . 0.0 113.364 175.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.76 6.89 54.12 Favored Glycine 0 CA--C 1.53 0.982 0 CA-C-O 118.561 -1.133 . . . . 0.0 114.345 169.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -129.01 138.43 51.93 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 119.432 1.616 . . . . 0.0 108.764 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.7 p -68.96 135.91 27.43 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 168.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.4 m -125.3 -19.64 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 C-N-CA 124.543 1.137 . . . . 0.0 110.476 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.18 167.38 30.57 Favored 'General case' 0 C--N 1.344 0.369 0 CA-C-N 119.588 1.086 . . . . 0.0 111.182 174.146 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 97.4 m -147.22 149.32 32.68 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.571 1.548 . . . . 0.0 108.789 178.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 66.2 m -150.59 156.25 41.0 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.494 1.518 . . . . 0.0 108.691 172.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 40.6 t -132.59 144.46 36.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -177.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 83.84 179.4 51.98 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 124.007 0.813 . . . . 0.0 111.711 -179.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -61.89 150.59 37.05 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.845 0.858 . . . . 0.0 110.61 176.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 40.8 mttm -140.68 144.84 37.68 Favored Pre-proline 0 C--O 1.233 0.213 0 C-N-CA 125.007 1.323 . . . . 0.0 107.518 168.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -72.66 161.54 43.68 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.63 2.22 . . . . 0.0 110.327 173.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -55.16 -47.74 74.72 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 123.089 0.556 . . . . 0.0 110.957 -178.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -63.51 -43.6 96.73 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 118.218 0.463 . . . . 0.0 111.516 -168.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.46 -42.81 87.0 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.106 0.563 . . . . 0.0 110.954 178.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 42.7 tp -67.75 -42.46 81.76 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 110.27 -0.27 . . . . 0.0 110.27 -178.163 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.7 pp0? -69.48 -34.35 74.2 Favored 'General case' 0 N--CA 1.454 -0.273 0 O-C-N 121.567 -0.708 . . . . 0.0 109.605 177.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -60.14 -45.94 91.35 Favored 'General case' 0 C--N 1.339 0.115 0 CA-C-N 119.41 1.004 . . . . 0.0 108.532 176.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 61.0 tp -58.09 -39.9 79.78 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.558 0.743 . . . . 0.0 110.888 176.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 56.0 t -63.56 -48.93 84.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-O 118.498 -0.763 . . . . 0.0 110.517 175.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 24.4 m-80 -58.08 -40.8 81.99 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 120.239 1.381 . . . . 0.0 109.908 179.268 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -62.82 -13.83 38.28 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 117.904 -1.046 . . . . 0.0 113.13 -178.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 70.4 m-70 -124.28 -19.57 5.48 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.248 0.978 0 CA-C-N 120.302 1.41 . . . . 0.0 109.914 178.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 81.8 mt . . . . . 0 CA--C 1.535 0.382 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 48.4 t -109.09 167.19 4.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 125.827 1.651 . . . . 0.0 106.915 -173.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 5.7 mptt -138.68 137.84 37.2 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 -176.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -149.01 171.76 15.85 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 122.973 0.509 . . . . 0.0 110.863 -179.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.5 p -136.63 173.23 11.93 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 125.598 1.559 . . . . 0.0 107.695 -176.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -50.55 -27.06 6.01 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.644 1.178 . . . . 0.0 112.634 176.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 49.0 mm-40 -65.18 -32.64 74.43 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 125.15 1.38 . . . . 0.0 112.104 -178.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.4 m -143.4 -5.48 0.84 Allowed 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 115.103 1.52 . . . . 0.0 115.103 -171.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -54.04 -35.47 62.0 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 119.48 1.036 . . . . 0.0 111.276 179.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.7 m -67.0 -41.64 86.36 Favored 'General case' 0 N--CA 1.452 -0.345 0 O-C-N 122.065 -0.397 . . . . 0.0 111.197 -178.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.62 -43.82 79.48 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 176.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -62.12 -38.49 89.13 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 123.503 0.721 . . . . 0.0 111.074 -176.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 25.9 p -81.55 3.53 24.64 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -178.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 50.4 m -120.46 36.79 4.45 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.384 1.074 . . . . 0.0 112.156 -169.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -142.5 12.48 1.93 Allowed 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 176.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 174.73 -166.59 38.44 Favored Glycine 0 C--N 1.339 0.709 0 O-C-N 121.191 -0.943 . . . . 0.0 111.629 179.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.1 t -80.09 125.11 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 103.281 -2.859 . . . . 0.0 103.281 167.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 22.9 t -136.8 118.73 19.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 -171.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 35.0 tp -87.93 147.49 25.04 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 168.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -135.34 154.06 51.64 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 176.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -134.48 98.9 4.2 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 -175.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -74.88 117.19 16.45 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 169.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 6.0 p-90 -145.72 179.53 7.38 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.441 0.697 . . . . 0.0 111.205 -170.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -159.96 151.78 16.79 Favored Pre-proline 0 CA--C 1.538 0.51 0 C-N-CA 125.896 1.678 . . . . 0.0 107.024 167.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -75.75 -18.46 17.15 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.851 2.367 . . . . 0.0 113.319 -169.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -80.01 -10.92 59.81 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 118.721 0.691 . . . . 0.0 112.044 178.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 50.9 t -88.74 119.19 29.0 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 178.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -56.23 -57.74 17.7 Favored Glycine 0 CA--C 1.531 1.049 0 CA-C-O 118.808 -0.995 . . . . 0.0 111.954 176.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -51.16 -32.9 41.91 Favored 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 123.375 2.717 . . . . 0.0 115.651 177.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 88.2 m -59.57 -42.5 92.6 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 119.905 1.229 . . . . 0.0 111.323 173.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 44.1 mtmt -74.12 -30.39 62.28 Favored 'General case' 0 CA--C 1.529 0.139 0 O-C-N 121.801 -0.562 . . . . 0.0 110.476 177.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 89.8 mtp -65.75 -40.54 92.19 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 119.001 0.819 . . . . 0.0 111.242 175.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 12.3 tt -80.97 -16.27 12.45 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-N 119.158 0.89 . . . . 0.0 111.603 -179.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.9 -50.17 75.91 Favored Pre-proline 0 CA--C 1.545 0.767 0 CA-C-O 117.494 -1.241 . . . . 0.0 114.003 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.68 -28.74 52.1 Favored 'Trans proline' 0 C--N 1.35 0.652 0 CA-C-N 122.044 1.766 . . . . 0.0 112.691 176.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 13.8 t -66.89 -40.56 86.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-N 119.027 0.831 . . . . 0.0 109.143 174.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 46.1 mt -66.88 -36.52 82.48 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 118.604 -0.712 . . . . 0.0 110.694 176.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -65.87 -40.5 91.68 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 119.279 0.945 . . . . 0.0 110.897 173.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 30.6 mm-40 -59.5 -42.21 91.64 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 119.068 0.849 . . . . 0.0 110.406 173.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.65 -36.2 83.03 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 123.263 0.625 . . . . 0.0 111.364 176.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -65.04 -45.44 85.42 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 123.633 0.773 . . . . 0.0 109.918 175.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 73.5 mm-40 -65.44 -27.69 68.7 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.923 -0.486 . . . . 0.0 111.95 178.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -92.12 -37.42 12.76 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.366 1.066 . . . . 0.0 112.193 -175.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 20.7 mmt -128.77 -9.67 4.98 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 124.241 1.017 . . . . 0.0 113.372 -167.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -50.06 -25.24 7.44 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 126.233 1.873 . . . . 0.0 115.351 -175.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -75.58 -28.29 58.89 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 124.829 1.252 . . . . 0.0 112.07 -176.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.63 -4.76 7.09 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 125.665 1.586 . . . . 0.0 112.984 -175.474 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -144.96 123.43 12.38 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 124.499 1.12 . . . . 0.0 108.095 172.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -80.39 154.81 27.47 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 176.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 29.4 mt -127.76 130.91 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 N-CA-C 105.516 -2.031 . . . . 0.0 105.516 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.9 t -129.53 116.84 40.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 118.485 0.584 . . . . 0.0 109.723 -171.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt -74.17 143.89 45.05 Favored 'General case' 0 C--O 1.236 0.347 0 O-C-N 121.477 -0.765 . . . . 0.0 109.558 170.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 10.6 tt -150.34 129.8 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 170.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -86.8 126.96 34.97 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 121.411 -0.806 . . . . 0.0 109.69 -176.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 12.4 m -67.72 -32.57 57.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -174.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -75.62 -35.39 60.52 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 119.31 0.959 . . . . 0.0 109.78 -175.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -78.57 -15.17 58.86 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.279 0.632 . . . . 0.0 111.901 175.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 48.5 m-80 -140.87 50.78 1.64 Allowed 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 119.194 0.906 . . . . 0.0 110.562 -168.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.425 ' CD ' ' H ' ' A' ' 61' ' ' GLN . 1.1 mp0 -58.69 -43.06 89.87 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.459 1.103 . . . . 0.0 109.49 -174.627 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -64.0 -41.48 97.46 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.327 1.051 . . . . 0.0 110.751 -176.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.05 -43.71 70.68 Favored 'General case' 0 C--O 1.222 -0.348 0 CA-C-N 118.633 0.651 . . . . 0.0 109.821 -177.574 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.27 -44.01 97.52 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 118.94 0.791 . . . . 0.0 109.461 176.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -57.46 -27.69 58.59 Favored Glycine 0 CA--C 1.534 1.233 0 C-N-CA 124.325 0.964 . . . . 0.0 112.635 174.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 24.8 ttmt -59.21 -21.64 59.8 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.983 1.313 . . . . 0.0 111.777 177.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -120.38 10.58 11.26 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.981 1.312 . . . . 0.0 111.009 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 70.21 32.14 68.95 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 123.694 0.664 . . . . 0.0 112.319 -177.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 86.7 t -110.88 134.67 52.43 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 C-N-CA 124.762 1.225 . . . . 0.0 107.92 -178.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 8.4 tpt -155.7 32.16 0.36 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.36 1.064 . . . . 0.0 108.976 167.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 20.2 m -137.47 155.91 48.76 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 126.787 2.035 . . . . 0.0 106.724 179.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 29.8 pt -145.7 157.63 51.15 Favored Pre-proline 0 CA--C 1.541 0.602 0 CA-C-O 118.716 -0.659 . . . . 0.0 111.069 -168.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -67.33 141.71 58.84 Favored 'Cis proline' 0 N--CA 1.458 -0.574 0 N-CA-C 109.022 -1.184 . . . . 0.0 109.022 -11.085 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 58.2 m -136.12 131.0 34.18 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 176.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -103.61 143.94 32.1 Favored 'General case' 0 N--CA 1.437 -1.123 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 -176.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -125.45 137.39 53.98 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 104.382 -2.451 . . . . 0.0 104.382 178.105 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 11.1 t -127.29 127.97 69.71 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.593 0 N-CA-C 105.036 -2.209 . . . . 0.0 105.036 177.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.8 mp -130.15 157.96 41.01 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 -177.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -142.58 121.77 13.0 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 175.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.2 t70 44.06 37.55 1.86 Allowed 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.689 1.196 . . . . 0.0 112.476 -172.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.2 -6.29 82.59 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-O 118.839 -0.978 . . . . 0.0 114.473 174.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -90.04 128.51 36.3 Favored 'General case' 0 CA--C 1.522 -0.113 0 CA-C-N 119.407 1.603 . . . . 0.0 106.874 175.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 71.0 t -63.99 134.56 28.77 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 168.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 32.9 m -122.94 -20.48 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 124.749 1.219 . . . . 0.0 110.547 176.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.63 161.41 41.6 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 119.999 1.272 . . . . 0.0 111.869 172.13 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 70.7 m -147.63 133.68 19.27 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.249 1.82 . . . . 0.0 106.913 169.02 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 16.9 m -146.13 152.4 39.22 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.018 0.927 . . . . 0.0 109.396 -172.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 42.6 t -129.13 148.94 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-N 119.431 1.014 . . . . 0.0 108.919 -170.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.27 175.38 50.03 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 124.536 1.065 . . . . 0.0 112.358 174.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -57.91 154.37 12.44 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.907 0.883 . . . . 0.0 110.594 176.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -152.28 144.36 16.57 Favored Pre-proline 0 CA--C 1.53 0.207 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 169.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_endo -71.64 163.39 39.13 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.582 2.188 . . . . 0.0 110.339 175.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -54.69 -46.25 74.08 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-O 118.855 -0.593 . . . . 0.0 110.636 -179.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -64.38 -40.24 95.44 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 118.451 0.569 . . . . 0.0 111.122 -169.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.57 -45.13 76.48 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 122.823 0.449 . . . . 0.0 110.688 177.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 50.9 tp -67.59 -40.99 84.77 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 122.899 0.479 . . . . 0.0 110.403 -176.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.8 pp0? -71.6 -31.26 66.72 Favored 'General case' 0 N--CA 1.457 -0.121 0 CA-C-N 118.614 0.643 . . . . 0.0 110.127 177.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 20.2 tp10 -65.41 -48.27 73.37 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 176.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 10.3 tt -57.1 -44.88 83.63 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.266 0.626 . . . . 0.0 110.374 178.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 4.8 t -60.55 -48.6 87.84 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 123.056 0.542 . . . . 0.0 110.392 176.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.4 -20.94 66.2 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 118.839 0.745 . . . . 0.0 112.843 -175.214 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 57.5 mmtt -60.62 -35.55 76.43 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 118.386 0.539 . . . . 0.0 111.1 169.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 94.2 m-70 -97.7 -22.49 16.41 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.647 0.779 . . . . 0.0 112.697 -172.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 70.7 mt . . . . . 0 C--O 1.247 0.959 0 CA-C-O 118.237 -0.887 . . . . 0.0 109.485 172.409 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.9 mmt . . . . . 0 N--CA 1.48 1.037 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -153.75 144.11 22.3 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 169.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 89.6 mt -77.39 146.89 7.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 35.8 t -100.81 165.99 2.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 125.691 1.596 . . . . 0.0 107.897 -174.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.31 141.65 50.58 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 177.106 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -151.73 168.09 26.15 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 122.979 0.511 . . . . 0.0 111.569 176.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 40.0 p -140.55 -176.45 4.64 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.981 2.113 . . . . 0.0 107.204 174.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -48.97 -32.63 9.46 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.687 1.195 . . . . 0.0 113.256 179.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 27.3 mp0 -61.13 -32.85 72.55 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 126.233 1.813 . . . . 0.0 112.5 -177.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 12.3 m -143.78 -6.57 0.77 Allowed 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 115.12 1.526 . . . . 0.0 115.12 -169.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -55.62 -36.1 66.59 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 119.856 1.207 . . . . 0.0 110.98 178.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.0 m -68.71 -38.86 80.56 Favored 'General case' 0 N--CA 1.453 -0.306 0 O-C-N 122.226 -0.296 . . . . 0.0 111.22 -178.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.61 -46.2 76.64 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 175.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -64.03 -38.51 91.33 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 122.995 0.518 . . . . 0.0 111.311 -175.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 29.4 p -79.12 0.73 26.97 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -177.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 59.9 m -112.23 33.16 5.04 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.171 0.988 . . . . 0.0 112.044 -171.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 59.3 mt-10 -132.1 -3.24 3.55 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 -176.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 167.45 -162.3 36.1 Favored Glycine 0 C--N 1.334 0.443 0 CA-C-N 119.346 0.976 . . . . 0.0 111.046 -172.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 40.3 t -74.27 127.56 36.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 N-CA-C 105.55 -2.019 . . . . 0.0 105.55 167.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 24.8 t -137.18 115.13 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 -175.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 8.2 tt -88.01 147.01 25.2 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 168.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -132.56 153.35 51.07 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 177.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -132.92 99.12 4.49 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 -178.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -76.37 112.5 12.95 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 173.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 7.1 p-90 -139.36 174.75 10.19 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 123.132 0.573 . . . . 0.0 111.934 -168.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -153.67 147.42 18.53 Favored Pre-proline 0 CA--C 1.538 0.515 0 C-N-CA 125.276 1.43 . . . . 0.0 107.527 168.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.03 -20.57 14.77 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.807 2.338 . . . . 0.0 113.272 -170.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -78.83 -8.21 58.6 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 121.595 -0.691 . . . . 0.0 111.975 178.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 44.5 t -92.94 117.45 30.07 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -53.91 -58.1 13.86 Favored Glycine 0 CA--C 1.531 1.049 0 CA-C-O 118.727 -1.041 . . . . 0.0 112.152 177.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -51.19 -33.33 43.93 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 123.457 2.771 . . . . 0.0 115.607 178.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 90.6 m -60.31 -37.66 81.28 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 119.729 1.15 . . . . 0.0 111.668 174.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 43.2 mtmt -78.61 -33.54 47.33 Favored 'General case' 0 C--N 1.333 -0.118 0 O-C-N 121.764 -0.585 . . . . 0.0 109.98 177.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 26.5 mmt -65.32 -38.73 91.06 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 119.12 0.873 . . . . 0.0 111.439 177.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 12.0 tt -78.17 -14.86 14.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-N 118.877 0.762 . . . . 0.0 111.379 179.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.06 -49.88 89.63 Favored Pre-proline 0 CA--C 1.541 0.62 0 CA-C-O 117.437 -1.268 . . . . 0.0 113.545 -177.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -64.16 -28.49 64.84 Favored 'Trans proline' 0 C--N 1.351 0.662 0 CA-C-N 121.952 1.733 . . . . 0.0 112.401 176.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.2 t -68.37 -39.39 80.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 119.256 0.935 . . . . 0.0 109.457 176.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 48.4 mt -67.69 -34.88 77.77 Favored 'General case' 0 C--O 1.226 -0.15 0 O-C-N 121.517 -0.74 . . . . 0.0 110.636 174.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -68.29 -33.92 75.23 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 119.262 0.937 . . . . 0.0 111.44 173.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 50.2 mm-40 -62.32 -45.61 92.43 Favored 'General case' 0 N--CA 1.457 -0.094 0 O-C-N 120.922 -1.112 . . . . 0.0 109.583 170.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -63.86 -35.34 80.3 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 118.827 0.74 . . . . 0.0 111.668 176.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -66.35 -36.73 83.64 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 119.055 0.843 . . . . 0.0 111.035 177.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -69.8 -44.96 68.97 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 121.643 -0.661 . . . . 0.0 110.907 175.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -81.22 -33.6 32.77 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.983 0.913 . . . . 0.0 112.114 -169.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 52.2 mtt -140.62 -2.94 1.33 Allowed 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.541 1.136 . . . . 0.0 112.884 -169.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -75.14 47.55 1.97 Allowed Glycine 0 CA--C 1.528 0.885 0 C-N-CA 125.671 1.605 . . . . 0.0 113.517 -173.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -150.66 -40.71 0.13 Allowed 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 128.999 2.919 . . . . 0.0 107.176 169.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -63.55 -32.68 74.21 Favored 'General case' 0 C--N 1.343 0.314 0 C-N-CA 124.472 1.109 . . . . 0.0 110.546 168.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -135.67 160.95 36.93 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 125.719 1.608 . . . . 0.0 110.193 172.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -98.73 151.15 21.07 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.968 1.307 . . . . 0.0 107.879 171.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 15.7 mt -122.5 133.8 67.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 N-CA-C 105.839 -1.912 . . . . 0.0 105.839 174.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 8.0 t -128.4 116.12 40.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 C-N-CA 123.396 0.679 . . . . 0.0 109.556 -176.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 64.7 mmtt -75.14 140.41 43.35 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 168.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 8.3 tt -150.89 125.94 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -96.95 123.96 40.8 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 121.044 -1.035 . . . . 0.0 110.382 -168.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 23.3 m -61.67 -22.76 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -171.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -73.33 -28.83 62.29 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 120.052 1.296 . . . . 0.0 110.775 175.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -92.81 -33.98 14.05 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.446 1.099 . . . . 0.0 111.158 -171.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -112.59 33.76 4.76 Favored 'General case' 0 C--O 1.222 -0.344 0 C-N-CA 125.039 1.336 . . . . 0.0 109.914 -177.21 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.84 -39.89 54.54 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.542 1.137 . . . . 0.0 111.89 -175.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -65.23 -48.82 72.0 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.305 1.042 . . . . 0.0 111.656 174.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.34 -40.48 81.53 Favored 'General case' 0 C--O 1.223 -0.304 0 C-N-CA 123.906 0.882 . . . . 0.0 110.828 -175.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -61.97 -42.95 99.7 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.294 -0.879 . . . . 0.0 109.26 174.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -57.1 -27.42 57.33 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 123.963 0.792 . . . . 0.0 113.137 172.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 14.2 ttmm -60.84 -21.85 63.62 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 118.747 1.274 . . . . 0.0 111.451 176.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -120.06 9.8 11.28 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.206 1.403 . . . . 0.0 110.624 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 68.76 22.74 75.58 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 124.407 1.003 . . . . 0.0 113.33 -177.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 89.8 t -91.58 125.48 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 -179.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 5.9 mmt -148.63 26.85 0.92 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.714 1.605 . . . . 0.0 109.437 169.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 22.3 m -141.1 152.91 45.14 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 126.318 1.847 . . . . 0.0 107.167 -179.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -144.82 156.99 55.55 Favored Pre-proline 0 CA--C 1.54 0.583 0 C-N-CA 123.885 0.874 . . . . 0.0 110.262 -171.155 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -67.8 138.88 45.56 Favored 'Cis proline' 0 C--N 1.349 0.566 0 CA-C-N 119.788 0.96 . . . . 0.0 109.649 -10.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 54.5 m -130.16 118.08 20.89 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 174.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 61.1 mt -90.21 144.03 26.23 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 174.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.5 mp -124.65 155.91 38.39 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 169.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 94.1 t -126.67 130.46 71.63 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 N-CA-C 104.077 -2.564 . . . . 0.0 104.077 168.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.1 mp -127.13 156.23 42.09 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 126.234 1.814 . . . . 0.0 106.732 176.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 75.1 tttt -147.17 119.93 8.64 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 -177.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.7 t70 47.39 35.81 4.36 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.16 1.384 . . . . 0.0 113.588 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 108.88 -2.64 31.83 Favored Glycine 0 CA--C 1.527 0.781 0 CA-C-O 118.154 -1.359 . . . . 0.0 115.971 168.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -129.96 144.43 51.32 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 119.943 1.871 . . . . 0.0 110.208 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.7 p -66.79 138.1 23.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 C-N-CA 123.865 0.866 . . . . 0.0 108.765 173.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 35.7 m -129.12 -17.55 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 C-N-CA 125.346 1.459 . . . . 0.0 110.803 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.34 162.97 40.86 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 119.898 1.226 . . . . 0.0 111.559 172.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 85.1 m -151.08 142.12 23.06 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.118 1.767 . . . . 0.0 108.61 176.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 15.1 m -148.85 155.98 41.68 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.588 1.555 . . . . 0.0 108.869 -178.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 37.1 t -132.89 147.98 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 -174.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.75 175.47 49.39 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 124.426 1.012 . . . . 0.0 112.028 177.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -59.91 155.03 17.35 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.281 1.033 . . . . 0.0 110.566 174.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -141.44 145.65 38.79 Favored Pre-proline 0 C--O 1.233 0.235 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 168.003 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -71.89 160.43 47.81 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 122.62 2.213 . . . . 0.0 109.832 169.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -55.26 -47.52 75.34 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 118.742 -0.647 . . . . 0.0 111.116 -178.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -63.62 -43.5 96.68 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 118.555 0.616 . . . . 0.0 110.679 -170.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.98 -43.44 92.62 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 122.802 0.441 . . . . 0.0 110.743 176.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 45.2 tp -66.44 -42.36 87.75 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 119.307 -0.378 . . . . 0.0 110.346 -177.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.5 pp0? -72.62 -29.24 63.31 Favored 'General case' 0 C--N 1.337 0.064 0 CA-C-N 118.89 0.768 . . . . 0.0 110.505 179.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -65.89 -49.24 68.75 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 174.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 58.8 tp -55.58 -44.45 76.9 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.361 0.664 . . . . 0.0 110.454 178.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.41 ' HA ' ' NE2' ' A' ' 103' ' ' HIS . 48.5 t -68.53 -49.32 66.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 CA-C-O 119.538 -0.268 . . . . 0.0 110.52 -178.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -62.43 -27.18 68.92 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 119.143 0.883 . . . . 0.0 112.004 -173.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -65.15 -20.6 66.53 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 117.703 -1.141 . . . . 0.0 113.196 174.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.41 ' NE2' ' HA ' ' A' ' 100' ' ' VAL . 8.1 p80 -116.55 2.37 13.04 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 120.32 1.418 . . . . 0.0 113.511 -179.287 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 80.8 mt . . . . . 0 C--O 1.248 1.012 0 CA-C-N 119.764 1.166 . . . . 0.0 108.144 170.225 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.3 mpp? . . . . . 0 N--CA 1.482 1.17 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -157.8 144.08 17.59 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 125.263 1.425 . . . . 0.0 107.294 168.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 93.7 mt -75.34 153.67 6.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 174.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 32.5 t -123.43 167.03 17.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 -173.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.5 mtmt -135.19 145.38 47.65 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 175.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -147.79 171.02 16.36 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.291 0.636 . . . . 0.0 110.083 176.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 81.3 p -133.79 178.33 7.03 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 171.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -47.25 -30.49 3.07 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 119.906 1.23 . . . . 0.0 113.187 176.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -58.3 -34.38 70.49 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.691 1.596 . . . . 0.0 112.752 179.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 12.8 m -145.42 -2.83 0.75 Allowed 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 114.833 1.42 . . . . 0.0 114.833 -169.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -54.08 -36.82 63.56 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 119.186 0.903 . . . . 0.0 111.005 178.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.3 m -67.47 -38.67 84.78 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 122.472 0.309 . . . . 0.0 111.387 -178.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.42 -45.25 76.65 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 175.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -64.94 -37.55 88.0 Favored 'General case' 0 C--O 1.231 0.121 0 C-N-CA 122.451 0.3 . . . . 0.0 111.381 -176.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 22.4 p -76.48 -1.65 28.29 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 71.1 m -107.72 33.55 4.01 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.55 1.14 . . . . 0.0 111.977 -171.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -133.39 1.53 3.45 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -177.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 165.66 -165.67 38.08 Favored Glycine 0 C--N 1.336 0.563 0 CA-C-O 118.796 -1.002 . . . . 0.0 111.242 -176.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 88.9 t -73.87 134.25 29.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 N-CA-C 103.678 -2.712 . . . . 0.0 103.678 166.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 39.4 t -134.65 117.57 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 -175.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 62.3 tp -87.85 97.33 10.86 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 173.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.59 146.41 40.41 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 170.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -133.93 94.52 3.28 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 124.818 1.247 . . . . 0.0 107.735 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -71.29 113.36 8.24 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 106.301 -1.741 . . . . 0.0 106.301 172.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 6.3 p-90 -138.26 175.12 9.85 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 123.333 0.653 . . . . 0.0 110.962 -169.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -152.16 146.26 18.34 Favored Pre-proline 0 CA--C 1.536 0.431 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 168.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.31 -17.99 18.44 Favored 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 122.833 2.356 . . . . 0.0 113.377 -171.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -82.29 -8.53 59.64 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 121.53 -0.731 . . . . 0.0 111.997 176.288 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 42.0 t -88.12 126.32 35.05 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -61.42 -59.6 9.63 Favored Glycine 0 CA--C 1.531 1.083 0 CA-C-O 118.491 -1.172 . . . . 0.0 111.661 177.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_exo -49.04 -37.87 38.51 Favored 'Trans proline' 0 CA--C 1.535 0.566 0 C-N-CA 123.683 2.922 . . . . 0.0 115.094 177.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 86.1 m -59.17 -34.16 71.79 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 119.244 0.929 . . . . 0.0 112.793 175.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -84.94 -34.89 22.39 Favored 'General case' 0 N--CA 1.461 0.093 0 CA-C-O 118.942 -0.552 . . . . 0.0 109.996 176.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 85.1 mtp -60.92 -38.56 86.22 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 118.853 0.752 . . . . 0.0 110.993 177.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.0 tt -78.77 -14.62 13.68 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-N 118.549 0.613 . . . . 0.0 111.787 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.58 -50.84 84.65 Favored Pre-proline 0 CA--C 1.544 0.725 0 CA-C-N 120.116 1.325 . . . . 0.0 113.393 -177.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -64.88 -29.24 58.46 Favored 'Trans proline' 0 C--N 1.35 0.645 0 CA-C-N 121.887 1.709 . . . . 0.0 112.179 176.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.5 t -66.11 -42.68 91.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 123.425 0.69 . . . . 0.0 109.327 177.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 85.3 mt -65.62 -36.1 82.73 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 118.715 -0.66 . . . . 0.0 110.432 174.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -65.86 -36.6 83.9 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 119.534 1.061 . . . . 0.0 111.511 175.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -64.94 -43.52 92.49 Favored 'General case' 0 CA--C 1.529 0.146 0 O-C-N 121.162 -0.962 . . . . 0.0 110.086 173.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 31.6 tp -64.58 -38.87 92.5 Favored 'General case' 0 CA--C 1.532 0.276 0 O-C-N 122.252 -0.28 . . . . 0.0 110.522 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -64.32 -43.61 94.15 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 124.164 0.985 . . . . 0.0 110.476 177.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -61.68 -29.07 69.85 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 121.482 -0.761 . . . . 0.0 111.796 174.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -89.88 -35.53 15.57 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.907 0.883 . . . . 0.0 112.698 -174.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 40.6 mtt -136.5 -0.24 2.43 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -169.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -70.19 42.28 0.5 Allowed Glycine 0 CA--C 1.535 1.306 0 C-N-CA 126.914 2.197 . . . . 0.0 115.856 -169.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -143.21 -43.6 0.29 Allowed 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 126.849 2.06 . . . . 0.0 108.789 168.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 58.6 mtmt -72.06 -20.63 61.64 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.73 0.812 . . . . 0.0 111.28 169.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.9 tp -133.32 153.21 51.78 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 128.584 2.753 . . . . 0.0 106.704 -177.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -118.61 154.87 31.94 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 168.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 21.7 mt -122.37 134.7 64.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 104.921 -2.252 . . . . 0.0 104.921 172.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 79.3 t -128.9 109.75 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 -177.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -70.42 138.95 51.67 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 169.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 13.2 tt -144.85 108.25 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 176.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 62.6 t0 -78.44 115.37 18.11 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 123.631 0.772 . . . . 0.0 109.012 -175.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 29.4 m -60.76 -24.85 33.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 123.0 0.52 . . . . 0.0 112.278 -176.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -72.59 -0.79 13.83 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.804 0.842 . . . . 0.0 112.292 179.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -131.07 7.36 4.65 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.189 1.396 . . . . 0.0 110.591 170.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 63.4 m-80 -142.41 44.94 1.64 Allowed 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.599 1.16 . . . . 0.0 110.318 -168.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.487 ' H ' ' NE2' ' A' ' 61' ' ' GLN . 0.4 OUTLIER -56.09 -47.6 77.73 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.266 1.027 . . . . 0.0 108.764 176.885 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 38.5 mp0 -67.17 -47.8 69.9 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 125.231 1.412 . . . . 0.0 109.411 -175.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.53 -47.57 72.48 Favored 'General case' 0 C--O 1.222 -0.356 0 C-N-CA 122.759 0.424 . . . . 0.0 110.168 -176.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.2 -44.03 96.5 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 119.004 0.82 . . . . 0.0 109.313 -179.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -58.1 -27.44 59.96 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 123.948 0.785 . . . . 0.0 112.923 174.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 31.1 ttmt -59.1 -26.21 64.48 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 118.615 1.208 . . . . 0.0 111.448 177.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -117.01 11.56 14.31 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.698 1.199 . . . . 0.0 111.097 179.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 69.82 22.73 77.02 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 124.265 0.936 . . . . 0.0 113.163 -178.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 97.9 t -93.06 135.04 28.9 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 179.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -155.35 28.0 0.4 Allowed 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.33 1.052 . . . . 0.0 109.686 168.104 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 22.8 m -139.06 152.66 47.73 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 126.407 1.883 . . . . 0.0 106.819 178.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -144.13 157.08 57.76 Favored Pre-proline 0 CA--C 1.542 0.641 0 CA-C-O 118.392 -0.813 . . . . 0.0 110.176 -169.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -67.54 137.97 40.35 Favored 'Cis proline' 0 C--N 1.349 0.59 0 CA-C-N 119.933 1.012 . . . . 0.0 109.84 -10.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 53.1 m -129.67 119.5 23.62 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 174.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 96.4 mt -96.61 133.71 40.76 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.6 mp -119.53 130.66 55.29 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 105.203 -2.147 . . . . 0.0 105.203 169.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 16.5 t -93.63 121.35 44.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 103.286 -2.857 . . . . 0.0 103.286 169.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.8 mp -112.23 160.68 17.38 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 170.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -142.28 129.85 21.41 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 169.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.9 t70 42.85 37.55 1.11 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.183 1.393 . . . . 0.0 113.62 175.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 109.81 -6.67 31.26 Favored Glycine 0 CA--C 1.528 0.863 0 CA-C-O 117.97 -1.461 . . . . 0.0 115.482 169.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -132.04 148.41 52.5 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 120.316 2.058 . . . . 0.0 110.901 -175.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.3 t -67.35 137.95 23.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 176.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 35.7 m -127.42 -18.68 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 125.451 1.5 . . . . 0.0 111.051 176.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.62 170.47 22.33 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 120.099 1.318 . . . . 0.0 110.977 171.258 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 99.4 m -147.51 150.63 34.92 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 125.587 1.555 . . . . 0.0 109.075 177.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 58.6 m -150.06 159.25 44.55 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.931 1.692 . . . . 0.0 108.791 171.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 34.9 t -133.17 145.1 34.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 179.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 85.44 177.18 50.55 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 123.709 0.671 . . . . 0.0 111.897 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -62.83 146.95 51.45 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.049 0.939 . . . . 0.0 110.354 177.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 68.0 mttt -143.78 143.17 22.32 Favored Pre-proline 0 CA--C 1.533 0.306 0 C-N-CA 124.989 1.316 . . . . 0.0 107.714 169.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -74.49 159.85 42.43 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 123.221 2.614 . . . . 0.0 110.691 177.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.9 tmpt? -61.02 -34.44 74.83 Favored 'General case' 0 C--O 1.225 -0.205 0 O-C-N 121.453 -0.779 . . . . 0.0 111.222 -175.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -62.5 -37.42 85.95 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.924 0.783 . . . . 0.0 111.561 178.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.18 -42.89 71.83 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 118.068 0.394 . . . . 0.0 110.442 174.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 91.1 mt -64.75 -41.6 95.78 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-O 119.263 -0.398 . . . . 0.0 110.622 -178.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.2 pp0? -70.25 -31.76 69.3 Favored 'General case' 0 CA--C 1.527 0.073 0 CA-C-N 118.83 0.741 . . . . 0.0 110.305 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -65.37 -49.59 68.73 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 175.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 59.2 tp -56.66 -43.43 80.37 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.945 0.898 . . . . 0.0 110.748 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 43.8 t -68.13 -49.18 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 CA-C-O 118.668 -0.682 . . . . 0.0 110.365 178.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.35 -26.1 68.32 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 120.005 1.275 . . . . 0.0 112.431 -175.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 39.8 mmtm -64.84 -17.05 63.92 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 118.029 -0.986 . . . . 0.0 113.073 171.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 92.0 m-70 -118.45 -12.49 9.83 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 119.777 1.171 . . . . 0.0 113.656 179.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 60.2 mt . . . . . 0 C--O 1.248 1.019 0 CA-C-N 120.464 1.484 . . . . 0.0 109.786 172.737 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.1 ttt . . . . . 0 N--CA 1.483 1.22 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -163.13 162.37 25.6 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 125.536 1.534 . . . . 0.0 108.768 178.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 83.7 mt -75.66 154.18 6.15 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 172.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 42.2 t -131.9 170.59 19.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 125.949 1.699 . . . . 0.0 106.917 -174.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 34.0 ttmt -141.93 147.62 37.34 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 176.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -150.78 173.51 14.12 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 123.725 0.81 . . . . 0.0 110.236 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 76.6 p -131.59 175.13 9.43 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.137 1.375 . . . . 0.0 107.298 172.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -51.78 -30.48 23.09 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 120.134 1.333 . . . . 0.0 112.886 -176.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 25.3 mp0 -65.32 -27.96 68.97 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.738 2.015 . . . . 0.0 113.353 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 36.8 p -133.11 -15.87 2.53 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 114.317 1.228 . . . . 0.0 114.317 -168.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -54.2 -34.7 61.21 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 125.402 1.481 . . . . 0.0 111.019 178.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.4 p -64.89 -49.36 70.79 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 123.589 0.756 . . . . 0.0 110.949 -179.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.78 -44.78 96.34 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 122.908 0.483 . . . . 0.0 109.791 177.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -66.11 -37.89 86.87 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 119.263 -0.399 . . . . 0.0 111.616 -176.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 28.1 p -78.82 -1.48 35.06 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 118.67 0.668 . . . . 0.0 112.473 -178.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 59.1 m -106.06 33.0 4.02 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.421 1.089 . . . . 0.0 111.761 -171.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -133.06 -0.22 3.38 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -177.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 167.21 -167.35 39.8 Favored Glycine 0 C--N 1.337 0.614 0 CA-C-N 119.413 1.006 . . . . 0.0 111.563 -174.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 68.9 t -73.77 125.9 33.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 104.601 -2.37 . . . . 0.0 104.601 166.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.3 t -129.86 120.93 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 -174.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -94.01 105.66 17.66 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 105.851 -1.907 . . . . 0.0 105.851 -179.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -94.9 102.55 14.4 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -177.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -82.4 95.25 7.6 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 123.862 0.865 . . . . 0.0 108.705 175.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 45.8 m-85 -75.53 116.72 16.55 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 169.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 7.5 p-90 -141.61 176.81 8.6 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 123.498 0.719 . . . . 0.0 111.498 -170.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -153.68 146.29 17.48 Favored Pre-proline 0 CA--C 1.538 0.509 0 C-N-CA 124.856 1.262 . . . . 0.0 107.717 168.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.92 -19.02 16.37 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.882 2.388 . . . . 0.0 113.264 -171.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -78.74 -7.13 57.46 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 118.689 0.677 . . . . 0.0 112.067 177.158 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 46.6 t -94.98 119.1 32.93 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -178.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -55.47 -58.35 14.34 Favored Glycine 0 CA--C 1.531 1.076 0 CA-C-O 118.56 -1.133 . . . . 0.0 111.779 176.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_exo -49.45 -34.7 33.96 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 123.665 2.91 . . . . 0.0 115.603 177.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 92.7 m -60.6 -44.16 96.58 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 119.78 1.173 . . . . 0.0 111.423 173.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 45.2 mtmt -72.27 -30.91 65.28 Favored 'General case' 0 CA--C 1.529 0.146 0 O-C-N 121.682 -0.636 . . . . 0.0 110.427 178.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 63.0 mtt -67.48 -40.98 85.3 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 118.766 0.712 . . . . 0.0 111.302 176.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.7 tt -78.54 -19.25 13.31 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-N 119.168 0.895 . . . . 0.0 111.415 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.18 -51.01 72.28 Favored Pre-proline 0 CA--C 1.546 0.823 0 CA-C-N 119.895 1.225 . . . . 0.0 114.011 -178.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -65.5 -28.56 53.62 Favored 'Trans proline' 0 C--N 1.351 0.663 0 CA-C-N 121.897 1.713 . . . . 0.0 112.44 175.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 6.6 t -67.33 -37.58 79.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 118.903 0.774 . . . . 0.0 109.542 175.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 96.0 mt -67.74 -34.64 77.24 Favored 'General case' 0 C--O 1.226 -0.136 0 O-C-N 121.493 -0.754 . . . . 0.0 110.685 172.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -64.13 -38.29 90.54 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 119.758 1.163 . . . . 0.0 111.229 172.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -65.94 -37.88 87.17 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 121.092 -1.005 . . . . 0.0 110.384 173.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 46.7 tp -66.6 -36.37 82.45 Favored 'General case' 0 C--O 1.227 -0.13 0 CA-C-N 118.56 0.618 . . . . 0.0 110.512 177.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -65.71 -41.5 92.24 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 118.953 0.797 . . . . 0.0 110.28 174.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -63.9 -29.72 70.87 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 121.796 -0.565 . . . . 0.0 112.13 174.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -87.47 -39.32 15.31 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.141 0.976 . . . . 0.0 112.215 -175.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 16.5 mmt -133.58 -1.27 3.13 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 124.527 1.131 . . . . 0.0 113.76 -167.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -62.1 -7.56 13.67 Favored Glycine 0 CA--C 1.535 1.297 0 CA-C-N 121.193 1.815 . . . . 0.0 114.419 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -79.57 -22.29 43.98 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.674 1.99 . . . . 0.0 112.11 173.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -130.4 -10.03 4.13 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 126.46 1.904 . . . . 0.0 111.465 -171.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -135.74 164.08 28.72 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 126.515 1.926 . . . . 0.0 108.306 -177.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -121.54 142.05 50.45 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 169.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 17.0 mt -105.71 137.78 34.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 105.139 -2.171 . . . . 0.0 105.139 170.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 90.2 t -127.38 114.49 36.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 105.785 -1.931 . . . . 0.0 105.785 175.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.65 141.23 44.63 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 169.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 11.8 tt -151.63 125.58 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 175.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -81.97 129.22 34.72 Favored 'General case' 0 N--CA 1.466 0.325 0 O-C-N 121.586 -0.696 . . . . 0.0 109.446 -178.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 15.4 m -67.81 -34.34 66.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -174.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -76.52 -34.58 58.57 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 119.055 0.843 . . . . 0.0 109.768 -174.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -73.04 -16.21 61.5 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.668 0.787 . . . . 0.0 111.958 172.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 62.7 m-80 -140.22 50.85 1.7 Allowed 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 119.312 0.96 . . . . 0.0 111.182 -168.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -57.2 -36.8 71.31 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.533 0.733 . . . . 0.0 109.68 178.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -64.02 -28.51 69.85 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 125.095 1.358 . . . . 0.0 112.466 -178.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.3 -45.65 8.1 Favored 'General case' 0 C--O 1.222 -0.346 0 CA-C-N 118.573 0.624 . . . . 0.0 109.991 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.53 -45.75 89.17 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 119.484 1.038 . . . . 0.0 110.073 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -62.74 -21.91 63.58 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 124.195 0.902 . . . . 0.0 112.571 175.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.5 ttmm -59.32 -22.07 60.71 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 118.52 1.16 . . . . 0.0 111.617 174.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -121.46 11.34 10.65 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.917 1.287 . . . . 0.0 110.728 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 68.19 27.32 73.77 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 124.147 0.88 . . . . 0.0 112.801 -177.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 65.7 t -100.8 135.71 35.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.54 28.5 0.44 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.546 1.138 . . . . 0.0 109.466 168.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 42.2 m -133.52 156.49 47.69 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 126.257 1.823 . . . . 0.0 107.262 175.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -145.8 159.15 48.02 Favored Pre-proline 0 CA--C 1.539 0.541 0 C-N-CA 124.243 1.017 . . . . 0.0 110.205 -169.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.5 140.05 50.77 Favored 'Cis proline' 0 C--N 1.349 0.583 0 CA-C-N 119.938 1.014 . . . . 0.0 109.923 -10.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 61.5 m -135.0 129.03 33.52 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 106.395 -1.706 . . . . 0.0 106.395 177.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 56.3 mt -108.72 104.07 13.28 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 105.903 -1.888 . . . . 0.0 105.903 -177.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -78.76 141.95 37.39 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 105.374 -2.084 . . . . 0.0 105.374 168.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.2 t -118.95 116.82 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 N-CA-C 103.378 -2.823 . . . . 0.0 103.378 174.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 8.1 mp -111.85 159.86 17.93 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 175.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -141.7 127.9 19.76 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 170.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.8 t70 43.74 38.61 2.09 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.062 1.345 . . . . 0.0 113.323 175.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 104.64 -4.78 43.21 Favored Glycine 0 CA--C 1.53 0.969 0 CA-C-O 117.962 -1.466 . . . . 0.0 115.169 169.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -130.92 150.42 52.09 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 120.269 2.034 . . . . 0.0 110.98 -176.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.2 p -66.08 140.15 20.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 C-N-CA 123.803 0.841 . . . . 0.0 109.476 177.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 28.4 m -127.16 -19.54 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 C-N-CA 125.479 1.512 . . . . 0.0 110.865 173.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.87 168.33 26.03 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 120.399 1.454 . . . . 0.0 111.382 169.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 60.8 m -143.63 136.04 27.03 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.023 1.729 . . . . 0.0 107.216 169.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 38.4 m -140.57 152.51 45.55 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.92 1.288 . . . . 0.0 108.436 -177.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 38.5 t -133.48 147.53 31.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 -171.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.02 174.35 49.54 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 124.25 0.929 . . . . 0.0 112.229 175.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -61.33 148.09 42.52 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 123.784 0.834 . . . . 0.0 110.744 179.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -152.11 142.2 14.87 Favored Pre-proline 0 CA--C 1.533 0.324 0 C-N-CA 125.922 1.689 . . . . 0.0 106.999 -178.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -74.4 156.77 45.69 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 122.44 2.093 . . . . 0.0 110.612 174.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.5 tmpt? -58.31 -36.43 73.34 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 123.636 0.774 . . . . 0.0 110.982 -179.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 23.7 tp10 -65.91 -36.71 84.15 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 118.506 0.594 . . . . 0.0 111.441 -174.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.02 -42.96 79.87 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 122.926 0.49 . . . . 0.0 110.681 174.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 91.3 mt -65.68 -43.98 87.64 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 119.096 -0.478 . . . . 0.0 110.123 -177.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.8 pp0? -68.21 -30.0 68.97 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 118.909 0.777 . . . . 0.0 110.543 179.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -65.99 -50.22 65.04 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 175.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 54.9 tp -56.92 -44.32 82.31 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.063 0.545 . . . . 0.0 110.648 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 42.7 t -63.36 -50.73 77.53 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 C-N-CA 123.461 0.704 . . . . 0.0 109.717 178.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -65.66 -26.19 67.69 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 119.386 0.994 . . . . 0.0 112.403 -175.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -67.22 -36.71 82.24 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 118.78 -0.629 . . . . 0.0 111.214 170.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 79.8 m-70 -80.64 -24.51 38.97 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 118.078 -0.963 . . . . 0.0 113.378 178.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 65.8 mt . . . . . 0 C--O 1.248 1.015 0 CA-C-N 119.707 1.14 . . . . 0.0 110.155 177.699 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.7 mmt . . . . . 0 N--CA 1.485 1.298 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -149.66 158.48 44.21 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 124.993 1.317 . . . . 0.0 108.563 174.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 84.5 mt -71.42 150.23 9.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 124.5 1.12 . . . . 0.0 108.15 178.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 23.3 t -105.85 160.69 5.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 125.573 1.549 . . . . 0.0 107.379 -175.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.41 140.48 52.65 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 176.294 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -136.98 172.24 13.31 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.041 0.937 . . . . 0.0 110.498 179.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.0 p -129.6 173.56 10.49 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 125.739 1.616 . . . . 0.0 107.861 178.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -52.34 -35.56 51.23 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 119.509 1.049 . . . . 0.0 111.721 174.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 5.4 mp0 -75.86 -31.25 59.21 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -177.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 32.6 p -110.83 -14.93 13.91 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 -169.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -51.0 -39.56 56.03 Favored 'General case' 0 C--N 1.334 -0.078 0 C-N-CA 124.573 1.149 . . . . 0.0 110.224 173.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.2 m -74.09 -23.19 59.3 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -174.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.88 -48.39 18.45 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 169.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -66.96 -36.39 82.1 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 122.807 0.443 . . . . 0.0 111.965 -170.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 42.9 p -82.85 7.8 14.21 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 112.527 0.565 . . . . 0.0 112.527 -176.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 40.8 m -121.68 34.57 5.14 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.596 0.758 . . . . 0.0 112.216 -169.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -135.39 1.75 2.92 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -176.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 169.0 -165.86 39.25 Favored Glycine 0 C--N 1.333 0.408 0 N-CA-C 110.409 -1.076 . . . . 0.0 110.409 -171.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 1.5 t -78.82 133.01 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 N-CA-C 104.324 -2.473 . . . . 0.0 104.324 168.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 23.8 t -139.63 146.15 25.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 -173.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 9.0 tt -122.55 135.87 54.74 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 105.807 -1.923 . . . . 0.0 105.807 169.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -129.67 121.3 26.7 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 -174.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -96.08 102.55 14.36 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 125.504 1.522 . . . . 0.0 108.585 -177.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -76.41 116.84 17.48 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 169.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 6.9 p-90 -145.88 178.82 7.89 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.619 0.767 . . . . 0.0 110.898 -169.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -158.51 150.28 17.08 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 125.606 1.562 . . . . 0.0 107.054 167.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.18 -18.72 20.7 Favored 'Trans proline' 0 CA--C 1.532 0.417 0 C-N-CA 122.754 2.303 . . . . 0.0 113.478 -170.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -79.39 -11.12 59.93 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 118.94 0.791 . . . . 0.0 112.483 176.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 45.8 t -85.53 119.26 25.68 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -57.01 -58.26 15.51 Favored Glycine 0 CA--C 1.531 1.093 0 CA-C-O 118.622 -1.099 . . . . 0.0 111.632 174.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -49.95 -36.14 42.95 Favored 'Trans proline' 0 CA--C 1.536 0.618 0 C-N-CA 123.571 2.848 . . . . 0.0 115.309 176.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 98.4 m -59.39 -46.06 89.73 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 119.87 1.214 . . . . 0.0 111.306 173.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 46.1 mtmt -70.35 -30.26 67.16 Favored 'General case' 0 N--CA 1.462 0.168 0 O-C-N 121.511 -0.743 . . . . 0.0 110.844 178.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 87.2 mtp -67.32 -43.08 82.5 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 118.922 0.783 . . . . 0.0 110.98 175.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 8.3 tt -78.84 -18.91 13.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-N 119.048 0.84 . . . . 0.0 111.378 -178.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.33 -52.44 59.28 Favored Pre-proline 0 CA--C 1.544 0.743 0 CA-C-O 117.5 -1.238 . . . . 0.0 113.986 -178.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.03 -30.35 56.53 Favored 'Trans proline' 0 C--N 1.349 0.58 0 CA-C-N 121.931 1.725 . . . . 0.0 112.103 177.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 6.3 t -64.82 -42.68 95.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 118.762 0.71 . . . . 0.0 109.085 176.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 61.1 mt -67.14 -34.97 78.71 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 118.603 -0.713 . . . . 0.0 110.981 176.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -65.59 -40.39 92.64 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 119.553 1.07 . . . . 0.0 111.004 174.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -63.95 -42.87 97.18 Favored 'General case' 0 CA--C 1.53 0.188 0 O-C-N 121.405 -0.809 . . . . 0.0 109.875 174.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 25.8 tp -62.8 -39.15 93.39 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 122.845 0.458 . . . . 0.0 110.794 178.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -66.83 -38.89 87.28 Favored 'General case' 0 C--N 1.333 -0.116 0 O-C-N 121.448 -0.782 . . . . 0.0 110.856 177.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -64.45 -23.06 67.15 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 121.86 -0.525 . . . . 0.0 111.895 173.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -96.88 -30.9 12.86 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.784 1.234 . . . . 0.0 112.46 -176.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 19.0 mmt -129.73 -9.31 4.49 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 117.825 -1.084 . . . . 0.0 113.606 -168.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -48.49 -30.53 8.42 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 125.955 1.74 . . . . 0.0 115.985 -169.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -79.31 -38.63 34.82 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.296 1.038 . . . . 0.0 111.495 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -85.23 -26.17 26.86 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 124.7 1.2 . . . . 0.0 110.801 -178.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -148.44 124.39 10.66 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 125.016 1.326 . . . . 0.0 108.807 -177.253 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -72.36 148.14 45.58 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 176.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 22.8 mt -122.07 133.58 67.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 172.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 9.2 t -127.01 153.11 35.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 124.689 1.196 . . . . 0.0 108.196 -173.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 65.4 mmtt -118.9 141.17 48.89 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 126.085 1.754 . . . . 0.0 107.975 177.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 14.9 tt -145.54 120.8 3.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-O 121.358 0.599 . . . . 0.0 109.538 172.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -80.9 110.47 16.46 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 123.911 0.885 . . . . 0.0 108.823 -179.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 24.0 m -64.47 -25.5 38.08 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-O 118.986 -0.53 . . . . 0.0 112.427 -174.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -70.98 -12.94 61.82 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 119.14 0.882 . . . . 0.0 111.68 -178.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -120.03 -5.28 10.04 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.239 1.416 . . . . 0.0 110.979 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 60.9 m-80 -146.06 36.66 1.03 Allowed 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.217 1.007 . . . . 0.0 110.551 -168.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.404 ' H ' ' NE2' ' A' ' 61' ' ' GLN . 1.2 pm0 -59.07 -25.34 63.67 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.973 0.909 . . . . 0.0 111.487 179.219 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 59.6 mp0 -60.13 -32.44 71.02 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.028 1.731 . . . . 0.0 111.29 175.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.39 -48.81 14.72 Favored 'General case' 0 C--O 1.223 -0.326 0 CA-C-N 118.38 0.536 . . . . 0.0 110.0 172.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.23 -45.99 89.04 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 118.798 0.726 . . . . 0.0 110.278 -171.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -61.92 -23.99 64.22 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 124.166 0.889 . . . . 0.0 112.821 176.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.6 ttmm -59.18 -28.13 66.34 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 118.612 1.206 . . . . 0.0 111.295 175.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -115.84 11.01 15.45 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.776 1.23 . . . . 0.0 111.033 178.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 70.36 18.3 75.08 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 124.603 1.096 . . . . 0.0 113.738 -178.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 98.8 t -84.12 134.23 27.43 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 176.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -155.45 32.2 0.37 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.413 1.085 . . . . 0.0 109.09 166.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 23.3 m -138.01 151.45 47.91 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 126.824 2.05 . . . . 0.0 106.245 176.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 28.2 pt -147.3 159.58 41.73 Favored Pre-proline 0 CA--C 1.542 0.669 0 C-N-CA 124.041 0.937 . . . . 0.0 109.472 -169.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -66.65 142.07 57.91 Favored 'Cis proline' 0 N--CA 1.458 -0.559 0 N-CA-C 109.529 -0.989 . . . . 0.0 109.529 -10.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 26.7 m -132.43 129.07 38.8 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 178.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 50.1 mt -112.05 109.53 19.33 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 -174.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.5 mp -87.51 151.75 22.77 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 106.171 -1.788 . . . . 0.0 106.171 167.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 15.7 t -123.78 132.12 71.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 N-CA-C 104.131 -2.544 . . . . 0.0 104.131 169.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.3 mp -132.99 160.01 38.36 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 125.918 1.687 . . . . 0.0 107.254 -175.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -147.2 127.52 13.94 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.1 t70 59.13 -19.26 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 128.052 2.541 . . . . 0.0 116.298 177.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 162.17 -0.91 0.06 OUTLIER Glycine 0 CA--C 1.532 1.102 0 CA-C-O 118.141 -1.366 . . . . 0.0 114.4 173.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -134.26 151.01 51.05 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 120.239 2.02 . . . . 0.0 110.45 -173.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 42.4 t -64.84 139.95 20.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 C-N-CA 124.238 1.015 . . . . 0.0 108.373 175.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 33.6 m -121.17 -21.97 3.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 125.208 1.403 . . . . 0.0 110.593 172.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -158.02 164.2 36.99 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 119.79 1.177 . . . . 0.0 111.584 174.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 69.7 m -144.1 138.45 28.25 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.777 1.631 . . . . 0.0 108.205 172.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 44.6 m -143.38 153.48 42.74 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.695 1.598 . . . . 0.0 108.594 -178.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 40.2 t -133.69 146.46 31.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -174.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.63 174.46 45.81 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 124.633 1.111 . . . . 0.0 112.443 173.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 61.3 t80 -62.66 143.91 56.85 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.597 0.759 . . . . 0.0 109.99 176.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 44.7 mttm -145.29 148.26 37.06 Favored Pre-proline 0 C--O 1.235 0.29 0 C-N-CA 125.226 1.41 . . . . 0.0 107.994 169.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -74.1 159.88 43.61 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 123.062 2.508 . . . . 0.0 110.626 176.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 11.0 ttpt -58.32 -38.54 77.32 Favored 'General case' 0 C--O 1.223 -0.293 0 O-C-N 121.825 -0.547 . . . . 0.0 111.021 -177.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -59.93 -39.27 84.91 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.416 0.686 . . . . 0.0 111.558 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.13 -42.02 73.13 Favored 'General case' 0 N--CA 1.452 -0.346 0 O-C-N 122.17 -0.331 . . . . 0.0 110.483 175.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 90.9 mt -67.83 -37.57 82.08 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 119.014 -0.517 . . . . 0.0 111.056 -178.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.8 pp0? -71.48 -29.62 65.04 Favored 'General case' 0 CA--C 1.526 0.036 0 CA-C-N 119.523 1.056 . . . . 0.0 110.297 177.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -65.46 -49.59 68.55 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 174.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 52.0 tp -54.35 -46.06 72.87 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.831 0.852 . . . . 0.0 110.635 177.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 25.2 t -63.26 -53.06 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.83 -25.4 67.89 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 119.021 0.828 . . . . 0.0 112.457 -174.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 61.3 mtpt -66.74 -23.04 66.04 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 118.024 -0.989 . . . . 0.0 112.552 172.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -110.46 -13.55 14.24 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 119.765 1.166 . . . . 0.0 113.384 -179.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 56.5 mt . . . . . 0 C--O 1.249 1.073 0 CA-C-N 119.871 1.214 . . . . 0.0 109.449 170.041 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 75.9 mtm . . . . . 0 N--CA 1.479 0.997 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -154.99 145.46 22.14 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.93 1.292 . . . . 0.0 107.563 169.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 89.3 mt -76.07 143.61 12.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 179.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 38.7 t -101.18 166.42 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 125.494 1.518 . . . . 0.0 107.581 -173.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.4 mppt? -128.63 143.37 50.93 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 106.079 -1.822 . . . . 0.0 106.079 177.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -144.79 169.72 17.48 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 118.341 0.518 . . . . 0.0 110.976 175.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.6 p -134.01 170.09 16.15 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 172.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -52.66 -25.59 11.31 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 119.98 1.264 . . . . 0.0 112.317 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 69.4 mm-40 -63.71 -33.07 74.84 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.474 1.51 . . . . 0.0 112.516 -179.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.6 m -140.29 -4.93 1.28 Allowed 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -171.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -50.39 -39.74 47.7 Favored 'General case' 0 N--CA 1.457 -0.081 0 C-N-CA 125.328 1.451 . . . . 0.0 110.665 173.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.9 m -66.9 -36.42 82.24 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 118.003 0.365 . . . . 0.0 111.618 -176.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.12 -46.59 70.46 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 174.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -64.07 -38.69 91.99 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 122.784 0.434 . . . . 0.0 111.431 -175.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 30.9 p -79.35 -0.37 32.34 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -176.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 64.8 m -109.28 34.48 3.73 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.456 1.102 . . . . 0.0 111.614 -173.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -132.11 -0.21 3.75 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 -178.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 165.43 -167.97 39.2 Favored Glycine 0 C--N 1.336 0.546 0 CA-C-N 119.16 0.891 . . . . 0.0 111.042 -174.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 94.3 t -71.17 132.42 33.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 N-CA-C 104.558 -2.386 . . . . 0.0 104.558 166.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.3 t -135.57 118.62 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 -176.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -87.93 124.39 33.64 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 105.372 -2.085 . . . . 0.0 105.372 172.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -117.12 105.53 12.36 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -81.86 99.99 9.35 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 175.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -76.14 116.71 17.1 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 168.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 7.0 p-90 -144.86 179.53 7.27 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.59 0.756 . . . . 0.0 111.415 -169.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -158.48 152.32 19.57 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 125.648 1.579 . . . . 0.0 107.197 167.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -76.83 -16.96 16.0 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.835 2.357 . . . . 0.0 113.467 -169.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -79.14 -11.65 59.98 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.898 0.772 . . . . 0.0 111.986 177.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 41.7 t -87.52 121.46 29.98 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 178.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -58.71 -56.16 26.8 Favored Glycine 0 CA--C 1.532 1.121 0 CA-C-O 118.76 -1.022 . . . . 0.0 111.936 175.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_exo -49.35 -39.51 43.87 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 123.496 2.797 . . . . 0.0 115.077 175.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 69.8 m -58.58 -34.33 70.96 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 119.125 0.875 . . . . 0.0 112.864 175.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 45.6 mtmt -81.29 -42.25 20.9 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 8.2 ptt? -70.64 -24.2 62.66 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 119.358 0.981 . . . . 0.0 112.532 -176.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 8.0 tt -77.16 -18.14 14.43 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-N 119.602 1.092 . . . . 0.0 111.574 173.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.05 -48.51 95.88 Favored Pre-proline 0 CA--C 1.539 0.521 0 CA-C-O 117.287 -1.34 . . . . 0.0 113.417 -177.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -63.28 -31.28 73.93 Favored 'Trans proline' 0 C--N 1.35 0.614 0 CA-C-N 121.938 1.728 . . . . 0.0 112.143 175.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 6.6 t -66.54 -41.13 87.97 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-N 119.249 0.931 . . . . 0.0 109.521 177.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 63.4 mt -66.63 -32.82 74.38 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-O 118.813 -0.613 . . . . 0.0 110.912 174.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -68.66 -35.81 77.73 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 119.669 1.122 . . . . 0.0 111.304 173.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 -64.92 -39.42 93.49 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 120.903 -1.123 . . . . 0.0 109.886 171.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 24.4 tp -66.57 -35.86 81.25 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 121.604 -0.685 . . . . 0.0 110.969 176.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -65.76 -38.56 89.41 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.739 0.815 . . . . 0.0 110.632 175.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -66.71 -38.34 86.52 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.783 -0.573 . . . . 0.0 111.03 173.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -74.48 -43.0 58.04 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.026 0.93 . . . . 0.0 111.764 -174.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 42.6 mtt -142.8 3.03 1.41 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 117.849 -1.072 . . . . 0.0 113.742 -168.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -74.49 50.9 2.15 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 126.056 1.788 . . . . 0.0 113.641 -172.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -154.29 -41.16 0.09 Allowed 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 129.697 3.199 . . . . 0.0 107.327 169.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 48.0 mtpt -64.12 -33.74 76.45 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.599 1.16 . . . . 0.0 110.529 169.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -131.36 165.3 23.77 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.839 1.656 . . . . 0.0 109.679 169.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -102.88 149.68 24.26 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 170.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 20.3 mt -117.84 136.43 55.04 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 N-CA-C 105.036 -2.209 . . . . 0.0 105.036 170.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 63.8 t -129.66 138.56 53.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 -178.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 60.0 mmtt -97.77 139.34 33.79 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.859 1.264 . . . . 0.0 108.219 169.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 12.6 tt -149.17 128.56 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 CA-C-O 121.306 0.574 . . . . 0.0 109.555 175.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -83.73 127.19 33.61 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.546 0.739 . . . . 0.0 110.269 -175.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 13.5 m -67.92 -26.95 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 -173.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -83.54 -41.01 18.41 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 119.903 1.229 . . . . 0.0 109.634 -175.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -70.62 -25.22 62.94 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.355 0.662 . . . . 0.0 111.08 174.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -127.42 43.8 3.05 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.748 1.219 . . . . 0.0 109.74 -172.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.15 -36.44 51.45 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 126.666 1.986 . . . . 0.0 111.285 175.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -65.48 -40.28 92.93 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 124.012 0.925 . . . . 0.0 111.483 176.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.59 -43.32 48.9 Favored 'General case' 0 C--O 1.222 -0.356 0 CA-C-N 119.406 1.003 . . . . 0.0 110.111 -178.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -61.62 -46.17 90.97 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 119.205 0.911 . . . . 0.0 109.719 176.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -60.74 -22.42 59.62 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 124.456 1.027 . . . . 0.0 113.069 175.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 7.7 ttmm -59.92 -20.38 57.05 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 118.629 1.215 . . . . 0.0 111.503 175.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -124.36 10.37 8.59 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.353 1.461 . . . . 0.0 110.627 178.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 64.9 22.85 68.89 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.542 1.067 . . . . 0.0 113.226 -174.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 61.1 t -88.74 153.6 3.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 118.331 1.065 . . . . 0.0 109.198 178.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -161.04 -22.83 0.06 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 127.5 2.32 . . . . 0.0 109.86 167.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.5 m -63.6 153.15 36.8 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 124.312 1.045 . . . . 0.0 109.721 171.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 28.2 pt -146.58 156.25 48.91 Favored Pre-proline 0 CA--C 1.542 0.637 0 C-N-CA 124.141 0.976 . . . . 0.0 109.617 -178.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -68.41 140.49 56.43 Favored 'Cis proline' 0 N--CA 1.457 -0.625 0 N-CA-C 109.011 -1.188 . . . . 0.0 109.011 -11.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 54.4 m -131.17 125.28 32.61 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 178.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 40.6 mt -104.26 104.14 14.0 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 -176.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -78.27 143.64 36.87 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 105.726 -1.953 . . . . 0.0 105.726 168.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.8 t -120.29 118.41 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 103.489 -2.782 . . . . 0.0 103.489 172.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 8.8 mp -114.6 160.12 19.66 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 175.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -143.12 128.15 18.51 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 170.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.8 t70 44.01 37.79 1.94 Allowed 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.102 1.361 . . . . 0.0 113.39 175.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 104.86 -4.48 42.22 Favored Glycine 0 CA--C 1.528 0.857 0 CA-C-O 118.083 -1.398 . . . . 0.0 115.247 169.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -129.82 149.58 51.5 Favored 'General case' 0 C--N 1.34 0.162 0 CA-C-N 120.19 1.995 . . . . 0.0 110.755 -177.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.9 p -66.19 140.77 18.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 C-N-CA 123.765 0.826 . . . . 0.0 109.312 177.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 35.5 m -127.14 -19.54 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 C-N-CA 125.481 1.512 . . . . 0.0 110.8 173.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.35 167.59 28.47 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 120.227 1.376 . . . . 0.0 111.392 169.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 78.0 m -143.71 134.0 24.54 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 126.253 1.821 . . . . 0.0 107.243 169.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 39.0 m -141.41 153.8 45.24 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 124.898 1.279 . . . . 0.0 108.666 -176.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.1 t -132.95 148.67 31.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -172.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.08 170.61 46.08 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 124.407 1.003 . . . . 0.0 112.468 172.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -65.34 133.38 51.27 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 123.475 0.71 . . . . 0.0 109.54 175.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -134.73 144.02 48.89 Favored Pre-proline 0 CA--C 1.534 0.342 0 C-N-CA 126.111 1.764 . . . . 0.0 106.626 176.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -72.12 158.89 51.27 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 122.754 2.303 . . . . 0.0 110.553 176.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 9.9 ttpt -57.42 -37.41 72.71 Favored 'General case' 0 C--O 1.223 -0.321 0 O-C-N 121.719 -0.613 . . . . 0.0 111.133 -177.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -61.05 -37.38 82.41 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 118.528 0.604 . . . . 0.0 111.728 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -72.15 -41.76 66.74 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 122.748 0.419 . . . . 0.0 110.604 175.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 81.2 mt -64.04 -43.36 95.78 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 119.317 -0.373 . . . . 0.0 110.295 -179.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.9 pp0? -70.16 -30.43 67.58 Favored 'General case' 0 C--O 1.228 -0.067 0 CA-C-N 118.835 0.743 . . . . 0.0 110.11 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -64.75 -49.41 70.91 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 175.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 60.2 tp -57.14 -45.73 83.32 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.553 0.741 . . . . 0.0 110.507 178.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 40.0 t -62.88 -49.05 85.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 CA-C-O 119.029 -0.51 . . . . 0.0 109.941 179.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.62 -25.89 68.16 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 119.414 1.006 . . . . 0.0 112.543 -175.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -66.2 -19.36 65.81 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 118.068 -0.968 . . . . 0.0 112.811 171.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -113.07 -16.41 12.63 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 119.877 1.217 . . . . 0.0 113.528 -178.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 70.7 mt . . . . . 0 C--O 1.248 1.019 0 CA-C-N 119.972 1.26 . . . . 0.0 109.713 172.531 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.7 ttt . . . . . 0 N--CA 1.48 1.068 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -164.51 172.82 12.8 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 126.853 2.061 . . . . 0.0 107.58 -174.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 78.0 mt -75.18 148.72 7.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 169.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.7 t -131.49 165.25 32.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 124.877 1.271 . . . . 0.0 107.902 -168.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -127.12 142.43 51.51 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 174.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -148.32 171.19 16.39 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 124.302 1.041 . . . . 0.0 108.807 169.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 70.4 p -133.84 178.37 7.0 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 171.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -45.95 -31.15 2.05 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.487 1.115 . . . . 0.0 113.31 176.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -58.87 -34.46 71.64 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.321 1.848 . . . . 0.0 112.998 179.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.2 m -145.5 -3.61 0.71 Allowed 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 -169.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -54.33 -36.01 63.32 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.305 1.042 . . . . 0.0 110.84 177.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.8 m -67.01 -34.54 77.95 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 122.884 0.474 . . . . 0.0 111.9 -179.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -70.14 -45.85 65.94 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 175.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -64.35 -37.91 89.17 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 119.47 -0.3 . . . . 0.0 111.443 -175.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 20.2 p -75.98 1.16 16.07 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -178.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 52.0 m -117.51 37.12 4.0 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.294 1.037 . . . . 0.0 111.913 -169.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -130.97 -2.17 4.08 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 163.17 -165.88 36.76 Favored Glycine 0 C--N 1.335 0.498 0 N-CA-C 110.149 -1.18 . . . . 0.0 110.149 -172.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 87.5 t -68.53 141.0 18.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 105.758 -1.941 . . . . 0.0 105.758 166.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 62.4 t -141.97 142.97 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 107.194 -1.409 . . . . 0.0 107.194 -178.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 56.6 tp -112.71 99.22 7.76 Favored 'General case' 0 CA--C 1.521 -0.158 0 N-CA-C 106.573 -1.639 . . . . 0.0 106.573 173.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.06 144.12 40.95 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 170.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -129.26 95.55 4.07 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 125.393 1.477 . . . . 0.0 107.263 178.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -75.31 116.41 16.0 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 173.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 12.1 p-90 -135.72 175.15 9.85 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 124.069 0.947 . . . . 0.0 110.17 -173.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -148.62 146.27 21.92 Favored Pre-proline 0 CA--C 1.533 0.314 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 169.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -74.0 -15.78 23.24 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.808 2.339 . . . . 0.0 113.863 -169.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -93.24 -6.09 48.43 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.812 0.845 . . . . 0.0 112.126 178.13 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 42.3 t -85.41 116.49 23.76 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 -178.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -55.75 -55.03 30.97 Favored Glycine 0 CA--C 1.532 1.15 0 CA-C-O 118.671 -1.072 . . . . 0.0 112.236 175.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -50.26 -36.34 46.55 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 123.254 2.636 . . . . 0.0 115.219 175.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 92.9 m -59.91 -40.28 88.26 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 119.937 1.244 . . . . 0.0 111.713 172.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 61.9 mttm -66.28 -38.9 88.85 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 121.475 -0.766 . . . . 0.0 110.01 175.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 98.5 mmm -67.45 -41.84 84.07 Favored 'General case' 0 N--CA 1.461 0.089 0 C-N-CA 122.84 0.456 . . . . 0.0 111.423 -177.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 8.7 tt -76.63 -20.97 14.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-N 118.511 0.596 . . . . 0.0 111.054 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -52.48 -51.22 74.92 Favored Pre-proline 0 CA--C 1.544 0.749 0 CA-C-N 119.646 1.112 . . . . 0.0 113.88 -175.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -67.24 -26.2 42.26 Favored 'Trans proline' 0 C--N 1.349 0.555 0 CA-C-N 121.925 1.723 . . . . 0.0 112.295 177.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.8 t -67.6 -37.95 79.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-N 119.307 0.958 . . . . 0.0 109.359 173.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 90.1 mt -67.13 -36.14 81.23 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-O 118.621 -0.704 . . . . 0.0 110.663 173.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -62.71 -42.91 99.89 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 119.472 1.033 . . . . 0.0 110.642 172.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -62.86 -37.18 85.82 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 121.307 -0.871 . . . . 0.0 110.651 176.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -65.6 -39.88 92.05 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 123.437 0.695 . . . . 0.0 109.897 176.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -63.7 -42.0 98.04 Favored 'General case' 0 C--N 1.332 -0.152 0 C-N-CA 123.948 0.899 . . . . 0.0 110.586 174.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 62.0 mm-40 -65.96 -28.31 68.81 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 121.361 -0.837 . . . . 0.0 111.536 176.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -86.73 -41.05 14.45 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.238 1.015 . . . . 0.0 112.154 -177.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 75.4 mmm -135.63 -2.81 2.39 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.368 1.067 . . . . 0.0 113.799 -167.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.47 44.0 0.74 Allowed Glycine 0 N--CA 1.471 0.98 0 C-N-CA 127.453 2.454 . . . . 0.0 115.166 -169.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -147.24 -37.49 0.21 Allowed 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 127.09 2.156 . . . . 0.0 108.621 169.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -63.06 -31.3 72.4 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.95 1.3 . . . . 0.0 110.108 168.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -138.29 166.71 23.5 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 126.553 1.941 . . . . 0.0 109.698 170.161 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 15.3 ptpt -109.26 155.39 21.18 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 167.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 15.5 mt -105.8 141.31 21.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 171.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 24.1 t -126.02 107.8 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 177.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 11.7 mmmm -73.75 137.12 43.76 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 173.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 15.6 tt -147.27 115.15 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 49.0 t0 -83.26 115.85 22.15 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.681 0.793 . . . . 0.0 109.031 -175.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 34.1 m -59.14 -26.72 34.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 123.048 0.539 . . . . 0.0 112.416 -176.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -72.05 -2.0 16.76 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.776 0.831 . . . . 0.0 112.493 -178.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -131.78 7.56 4.43 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.878 1.271 . . . . 0.0 110.706 172.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 67.4 m-80 -142.01 45.77 1.66 Allowed 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.117 0.967 . . . . 0.0 110.774 -168.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.504 ' H ' ' NE2' ' A' ' 61' ' ' GLN . 0.4 OUTLIER -57.38 -45.35 84.56 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.043 0.937 . . . . 0.0 108.768 175.647 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -69.46 -31.84 70.39 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.252 1.421 . . . . 0.0 111.598 -172.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -82.09 -49.55 10.06 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 118.411 0.55 . . . . 0.0 109.845 175.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.75 -45.08 91.45 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 119.152 0.887 . . . . 0.0 109.931 -173.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -61.92 -23.55 63.69 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 124.041 0.829 . . . . 0.0 112.778 175.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.5 ttmm -59.32 -27.19 65.67 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 118.798 1.299 . . . . 0.0 111.284 175.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -117.39 12.39 14.23 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.805 1.242 . . . . 0.0 110.932 179.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 69.51 18.66 73.88 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 124.598 1.094 . . . . 0.0 113.719 -179.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 86.0 t -84.35 131.57 33.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 176.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.89 27.25 0.48 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.436 1.094 . . . . 0.0 109.741 168.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 24.7 m -140.39 153.63 46.42 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 126.882 2.073 . . . . 0.0 106.515 177.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -146.59 159.88 43.11 Favored Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 124.159 0.983 . . . . 0.0 109.728 -169.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -66.93 136.93 33.55 Favored 'Cis proline' 0 N--CA 1.457 -0.628 0 CA-C-N 120.081 1.065 . . . . 0.0 109.501 -11.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 52.9 m -132.63 121.17 22.78 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 178.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 82.2 mt -99.34 132.14 44.87 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.4 mp -117.18 129.29 55.85 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 105.444 -2.058 . . . . 0.0 105.444 170.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.2 t -93.44 126.4 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 N-CA-C 103.39 -2.819 . . . . 0.0 103.39 169.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.6 mp -119.24 159.81 23.36 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 174.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -145.84 124.75 12.71 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 173.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.4 t70 44.51 40.15 3.73 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.475 1.51 . . . . 0.0 113.267 174.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 98.57 5.96 56.59 Favored Glycine 0 CA--C 1.527 0.813 0 CA-C-O 118.792 -1.004 . . . . 0.0 114.574 169.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 81.9 mm-40 -128.16 144.09 51.09 Favored 'General case' 0 CA--C 1.521 -0.142 0 CA-C-N 119.262 1.531 . . . . 0.0 108.949 177.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.7 t -68.26 136.47 26.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 169.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 22.9 m -120.15 -20.73 4.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 117.856 -1.068 . . . . 0.0 110.479 174.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.54 164.76 38.24 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 119.711 1.141 . . . . 0.0 111.634 173.379 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 95.8 m -145.3 137.74 25.91 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.546 1.538 . . . . 0.0 108.381 175.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 44.6 m -145.06 153.13 41.13 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.04 1.736 . . . . 0.0 108.176 -178.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 40.6 t -133.19 148.21 31.21 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -174.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.83 177.13 46.81 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 123.858 0.742 . . . . 0.0 112.375 176.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -58.99 147.73 33.34 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 124.491 1.116 . . . . 0.0 110.745 178.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -155.23 147.7 17.7 Favored Pre-proline 0 CA--C 1.533 0.311 0 C-N-CA 125.272 1.429 . . . . 0.0 107.686 169.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.85 157.87 47.11 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.668 2.245 . . . . 0.0 111.34 -177.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 4.7 ttpt -60.68 -34.97 75.13 Favored 'General case' 0 C--O 1.223 -0.312 0 C-N-CA 123.909 0.884 . . . . 0.0 111.673 -178.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -64.67 -42.58 95.27 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 119.425 1.011 . . . . 0.0 111.822 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.14 -43.03 75.2 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 122.828 0.451 . . . . 0.0 110.364 177.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 38.8 tp -67.81 -40.71 83.81 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 119.111 -0.471 . . . . 0.0 110.714 -177.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.5 pp0? -67.79 -32.15 72.51 Favored 'General case' 0 C--O 1.222 -0.393 0 CA-C-O 117.856 -1.068 . . . . 0.0 109.578 175.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -67.34 -43.66 80.98 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 119.436 1.016 . . . . 0.0 109.268 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 58.0 tp -57.05 -51.81 67.8 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.409 0.684 . . . . 0.0 109.681 175.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 28.7 t -58.54 -48.86 84.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 123.461 0.705 . . . . 0.0 110.481 178.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -57.44 -46.43 83.6 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 126.501 1.92 . . . . 0.0 110.699 -176.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -59.41 -34.27 72.25 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 118.656 -0.688 . . . . 0.0 112.368 174.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 79.8 m-70 -81.2 -18.12 47.27 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 82.3 mt . . . . . 0 C--O 1.249 1.064 0 CA-C-N 119.93 1.241 . . . . 0.0 110.185 178.653 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.6 mtt . . . . . 0 N--CA 1.484 1.267 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -159.22 143.74 15.45 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.786 1.635 . . . . 0.0 106.694 169.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 90.8 mt -77.84 147.01 7.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 178.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 38.8 t -110.45 165.18 6.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 -174.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.93 134.93 41.12 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 -179.333 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -146.66 170.9 16.0 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.106 0.412 . . . . 0.0 111.299 178.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 76.2 p -137.32 174.41 10.63 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.416 1.487 . . . . 0.0 108.111 179.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -47.34 -33.27 5.6 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 119.997 1.271 . . . . 0.0 113.11 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 26.8 mp0 -61.4 -33.71 74.14 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.677 1.591 . . . . 0.0 112.875 -179.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.5 m -142.82 -1.82 1.08 Allowed 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 -169.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -52.72 -41.45 63.96 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.078 0.951 . . . . 0.0 110.13 175.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.6 m -65.45 -27.67 68.68 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.558 0.743 . . . . 0.0 112.433 -178.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -78.49 -27.62 46.22 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.788 0.835 . . . . 0.0 111.088 176.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -81.6 -40.95 22.23 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.031 0.532 . . . . 0.0 111.137 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 39.2 p -74.84 -2.91 28.86 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -174.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.0 p -108.71 29.54 7.34 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.762 1.225 . . . . 0.0 112.883 -169.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -131.27 -0.34 4.07 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 113.588 0.958 . . . . 0.0 113.588 -175.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 166.15 -166.38 38.72 Favored Glycine 0 C--N 1.336 0.547 0 CA-C-N 119.21 0.913 . . . . 0.0 110.848 -174.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 98.3 t -72.4 132.14 33.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 104.829 -2.285 . . . . 0.0 104.829 166.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 39.0 t -135.75 118.1 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 -176.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 63.1 tp -88.73 97.91 11.4 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 173.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.37 149.37 36.96 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 169.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -133.36 98.24 4.18 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 175.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -73.97 114.95 12.87 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 172.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 7.8 p-90 -138.02 175.03 9.94 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 123.49 0.716 . . . . 0.0 110.754 -169.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -152.14 147.16 19.3 Favored Pre-proline 0 CA--C 1.535 0.399 0 C-N-CA 124.563 1.145 . . . . 0.0 107.934 169.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.45 -21.02 17.65 Favored 'Trans proline' 0 CA--C 1.532 0.397 0 C-N-CA 122.795 2.33 . . . . 0.0 113.348 -171.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -82.74 -8.2 59.6 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 118.685 0.675 . . . . 0.0 112.045 178.363 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 44.3 t -90.32 120.75 31.72 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 -179.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -57.03 -58.21 15.78 Favored Glycine 0 CA--C 1.531 1.057 0 CA-C-O 118.707 -1.051 . . . . 0.0 112.086 178.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -50.35 -35.07 43.14 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 123.519 2.812 . . . . 0.0 115.271 177.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 97.8 m -60.51 -33.13 72.19 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 119.451 1.023 . . . . 0.0 112.299 175.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 46.2 mtmt -85.04 -34.66 22.25 Favored 'General case' 0 C--N 1.333 -0.12 0 C-N-CA 123.043 0.537 . . . . 0.0 109.914 176.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 26.4 mmt -63.15 -34.96 78.74 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 119.137 0.88 . . . . 0.0 111.593 176.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.7 tt -81.19 -7.87 10.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-N 118.729 0.695 . . . . 0.0 111.667 178.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.44 -50.78 86.16 Favored Pre-proline 0 CA--C 1.541 0.618 0 O-C-N 120.635 -1.291 . . . . 0.0 112.494 178.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -64.07 -33.02 63.48 Favored 'Trans proline' 0 C--N 1.351 0.681 0 CA-C-N 121.844 1.694 . . . . 0.0 112.283 176.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 19.5 t -59.18 -47.76 89.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 119.1 0.864 . . . . 0.0 109.643 173.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 58.9 mt -65.87 -36.89 84.7 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 118.941 -0.552 . . . . 0.0 110.63 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -66.97 -37.6 84.54 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 119.013 0.824 . . . . 0.0 111.303 176.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -68.06 -39.23 83.04 Favored 'General case' 0 C--N 1.331 -0.2 0 O-C-N 121.091 -1.006 . . . . 0.0 110.377 174.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.48 -43.37 97.51 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 176.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -61.23 -42.25 98.28 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.839 0.856 . . . . 0.0 110.519 177.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -67.93 -13.44 62.17 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.703 0.801 . . . . 0.0 112.795 177.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -108.46 -32.09 7.55 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.226 1.01 . . . . 0.0 112.457 -178.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 19.5 mtt -140.2 2.25 1.88 Allowed 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 117.877 -1.059 . . . . 0.0 113.071 -169.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.3 44.63 0.74 Allowed Glycine 0 CA--C 1.532 1.136 0 C-N-CA 126.599 2.047 . . . . 0.0 114.561 -174.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -152.43 -40.3 0.11 Allowed 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 128.951 2.9 . . . . 0.0 107.615 171.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -63.21 -35.94 82.0 Favored 'General case' 0 C--N 1.343 0.319 0 C-N-CA 124.7 1.2 . . . . 0.0 110.451 169.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -133.99 165.29 25.38 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 125.925 1.69 . . . . 0.0 109.75 171.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -106.91 152.52 23.81 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.168 1.387 . . . . 0.0 107.758 170.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.2 mt -117.38 136.22 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 N-CA-C 105.582 -2.007 . . . . 0.0 105.582 171.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 58.1 t -131.65 114.51 25.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 -177.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 48.0 mmtt -74.26 144.56 44.59 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 169.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 13.4 tt -147.77 115.59 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 170.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 44.7 t0 -81.03 112.97 18.91 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.961 0.905 . . . . 0.0 109.224 -175.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 30.5 m -62.27 -21.87 27.86 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-O 118.425 -0.798 . . . . 0.0 113.02 -174.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -72.3 -6.53 43.82 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 120.012 1.278 . . . . 0.0 112.559 -178.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -126.35 4.21 6.99 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.344 1.058 . . . . 0.0 110.505 169.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -142.4 30.8 1.53 Allowed 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.389 1.076 . . . . 0.0 111.528 -168.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.407 ' CD ' ' H ' ' A' ' 61' ' ' GLN . 3.8 pm0 -55.44 -31.56 62.02 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 124.557 1.143 . . . . 0.0 110.435 169.676 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -65.08 -51.85 59.02 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 124.192 0.997 . . . . 0.0 110.173 176.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -67.17 -43.81 81.32 Favored 'General case' 0 C--O 1.222 -0.357 0 O-C-N 121.965 -0.46 . . . . 0.0 109.924 -178.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -61.63 -45.08 95.61 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 118.611 0.642 . . . . 0.0 109.596 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -59.86 -25.32 61.43 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 124.403 1.001 . . . . 0.0 112.903 175.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 8.5 ttmm -58.41 -23.37 57.1 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 118.621 1.21 . . . . 0.0 111.509 174.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -122.51 12.74 10.08 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.251 1.42 . . . . 0.0 110.894 178.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 70.88 17.45 75.32 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 124.552 1.073 . . . . 0.0 113.914 -179.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 95.4 t -85.55 137.16 21.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 176.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 6.6 tpt -153.49 25.14 0.52 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.092 0.957 . . . . 0.0 109.559 168.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 20.1 m -140.24 154.99 47.06 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 126.403 1.881 . . . . 0.0 107.297 -178.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -145.62 158.26 50.4 Favored Pre-proline 0 CA--C 1.542 0.663 0 C-N-CA 123.743 0.817 . . . . 0.0 110.376 -169.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.14 138.86 43.49 Favored 'Cis proline' 0 C--N 1.35 0.625 0 N-CA-C 109.512 -0.995 . . . . 0.0 109.512 -10.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 53.0 m -131.25 115.93 16.97 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 175.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 90.1 mt -89.86 136.39 33.07 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 176.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.0 mp -122.05 131.06 53.79 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 105.32 -2.104 . . . . 0.0 105.32 169.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 16.1 t -95.21 124.48 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 N-CA-C 103.062 -2.94 . . . . 0.0 103.062 168.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.9 mp -116.96 158.63 23.76 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 173.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 74.2 tttt -144.77 127.51 16.24 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 174.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 29.3 t70 46.83 33.47 2.19 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.248 1.419 . . . . 0.0 113.839 174.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 115.72 -7.97 19.71 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-O 118.096 -1.391 . . . . 0.0 115.082 168.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -133.2 146.09 51.18 Favored 'General case' 0 C--N 1.339 0.119 0 CA-C-N 120.071 1.935 . . . . 0.0 110.598 -174.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 5.8 p -65.48 137.34 25.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 172.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 34.9 m -123.58 -21.38 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 C-N-CA 125.338 1.455 . . . . 0.0 110.573 177.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -156.64 165.55 35.95 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.727 1.149 . . . . 0.0 110.999 174.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 98.9 m -143.74 149.41 37.08 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.761 1.624 . . . . 0.0 108.746 178.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 73.3 m -149.94 155.34 39.8 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.713 1.605 . . . . 0.0 108.306 171.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 40.8 t -132.93 144.93 35.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 -174.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.54 175.85 49.55 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 124.153 0.882 . . . . 0.0 111.716 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -62.47 149.3 43.12 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.428 0.691 . . . . 0.0 110.376 176.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 42.1 mttm -141.5 145.4 37.54 Favored Pre-proline 0 C--O 1.233 0.215 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 168.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -71.63 158.28 53.89 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 122.253 1.969 . . . . 0.0 109.879 172.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.2 tmpt? -62.67 -35.2 78.9 Favored 'General case' 0 N--CA 1.457 -0.117 0 O-C-N 121.686 -0.634 . . . . 0.0 111.601 -176.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -68.3 -35.07 77.27 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 119.125 0.875 . . . . 0.0 111.177 -177.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.9 -41.37 78.35 Favored 'General case' 0 N--CA 1.454 -0.233 0 O-C-N 121.86 -0.525 . . . . 0.0 110.498 171.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 45.7 tp -64.41 -40.18 95.27 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 119.34 -0.362 . . . . 0.0 110.694 -178.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.8 pp0? -70.97 -32.86 69.84 Favored 'General case' 0 C--O 1.226 -0.144 0 CA-C-N 118.994 0.815 . . . . 0.0 110.363 176.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -65.79 -37.17 85.56 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 118.63 0.65 . . . . 0.0 109.445 177.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 61.4 tp -63.33 -55.9 20.82 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.282 0.633 . . . . 0.0 110.055 171.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 25.2 t -61.53 -44.0 97.87 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 C-N-CA 123.384 0.673 . . . . 0.0 110.783 -172.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.78 -28.15 69.25 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 118.769 0.713 . . . . 0.0 112.326 -170.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 35.2 mtmm -73.37 -27.84 61.7 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 118.914 -0.565 . . . . 0.0 112.462 175.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -87.55 -20.57 26.26 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 118.365 -0.826 . . . . 0.0 112.456 -179.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 74.2 mt . . . . . 0 C--O 1.249 1.075 0 CA-C-N 119.192 0.905 . . . . 0.0 109.779 174.152 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.165 0 N-CA-C 110.266 -0.272 . . . . 0.0 110.266 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -157.84 148.22 20.63 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.162 0.985 . . . . 0.0 109.446 174.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 91.2 mt -75.49 154.54 6.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 125.094 1.357 . . . . 0.0 107.994 173.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 25.2 t -124.41 166.32 19.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 125.94 1.696 . . . . 0.0 106.503 -174.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 11.2 mtmt -134.94 146.96 49.63 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 174.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -144.95 170.93 15.19 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 123.32 0.648 . . . . 0.0 110.166 175.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 80.7 p -133.7 175.62 9.28 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 170.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -49.73 -29.67 8.03 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 119.257 0.935 . . . . 0.0 113.32 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -59.02 -34.25 71.67 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.769 2.027 . . . . 0.0 112.477 179.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.4 m -143.17 -2.42 1.0 Allowed 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 114.299 1.222 . . . . 0.0 114.299 -170.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -52.73 -38.82 61.39 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 124.027 0.931 . . . . 0.0 111.038 176.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.6 m -68.36 -39.01 81.98 Favored 'General case' 0 N--CA 1.453 -0.323 0 O-C-N 122.187 -0.321 . . . . 0.0 111.23 -177.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.12 -44.55 79.63 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 175.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 61.8 mm-40 -63.14 -42.29 99.46 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 122.939 0.495 . . . . 0.0 110.856 -177.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 22.4 p -75.7 3.02 10.54 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -177.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 58.2 m -111.8 36.17 3.4 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.758 1.223 . . . . 0.0 111.688 -173.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -128.69 -3.97 5.28 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -179.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 162.88 -164.02 35.64 Favored Glycine 0 C--N 1.336 0.549 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 -172.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 82.0 t -71.51 133.43 31.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 105.095 -2.187 . . . . 0.0 105.095 166.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 31.9 t -137.5 125.52 31.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 107.065 -1.458 . . . . 0.0 107.065 -177.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 63.6 tp -92.61 98.37 11.39 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 173.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.74 145.23 40.99 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 169.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -133.17 96.74 3.81 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 124.993 1.317 . . . . 0.0 107.712 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -75.98 115.29 15.53 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 173.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 6.7 p-90 -138.08 175.76 9.29 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 123.47 0.708 . . . . 0.0 110.453 -171.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -150.19 143.79 16.91 Favored Pre-proline 0 CA--C 1.534 0.351 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 169.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.88 -23.63 21.98 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.334 2.023 . . . . 0.0 113.34 -169.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -81.38 -8.39 59.73 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 118.629 0.65 . . . . 0.0 112.499 178.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 52.7 t -84.86 115.38 22.73 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -178.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -52.35 -56.16 18.69 Favored Glycine 0 CA--C 1.531 1.087 0 CA-C-O 118.685 -1.064 . . . . 0.0 112.231 176.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_exo -51.41 -35.38 54.51 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 123.1 2.533 . . . . 0.0 115.195 174.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 97.5 m -63.26 -40.24 96.86 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 119.85 1.205 . . . . 0.0 111.409 172.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -64.65 -39.74 94.23 Favored 'General case' 0 N--CA 1.465 0.288 0 O-C-N 121.364 -0.835 . . . . 0.0 110.2 173.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 62.2 mtt -65.62 -38.62 89.95 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 123.088 0.555 . . . . 0.0 111.277 -177.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.6 tt -80.43 -18.47 12.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-N 118.819 0.736 . . . . 0.0 111.56 -178.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -52.45 -49.96 82.67 Favored Pre-proline 0 CA--C 1.544 0.749 0 CA-C-N 119.821 1.191 . . . . 0.0 113.567 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -65.69 -30.7 50.49 Favored 'Trans proline' 0 C--N 1.352 0.745 0 CA-C-N 121.873 1.705 . . . . 0.0 112.422 176.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 28.3 t -61.96 -44.48 98.97 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 119.409 1.004 . . . . 0.0 108.98 174.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 92.9 mt -64.44 -38.19 90.14 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-O 118.832 -0.604 . . . . 0.0 110.541 177.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -64.67 -40.37 95.3 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.428 1.013 . . . . 0.0 111.555 175.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -69.61 -35.41 75.25 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 121.16 -0.962 . . . . 0.0 110.69 176.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 9.3 tp -66.89 -39.66 87.55 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.434 0.693 . . . . 0.0 110.381 176.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -64.16 -42.3 96.8 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 123.778 0.831 . . . . 0.0 110.052 176.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -61.8 -31.0 71.19 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 121.629 -0.669 . . . . 0.0 112.229 173.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -85.07 -40.21 17.07 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.792 0.837 . . . . 0.0 112.497 -176.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 38.9 mtt -138.2 4.45 2.46 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 114.025 1.121 . . . . 0.0 114.025 -167.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.38 38.85 0.58 Allowed Glycine 0 CA--C 1.534 1.229 0 C-N-CA 126.487 1.994 . . . . 0.0 115.788 -169.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -140.69 -43.45 0.4 Allowed 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 125.775 1.63 . . . . 0.0 109.421 169.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 52.0 pttt -69.93 -22.74 63.16 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 119.228 -0.415 . . . . 0.0 111.88 170.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -136.96 163.67 30.14 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 125.584 1.554 . . . . 0.0 107.287 165.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 57.2 pttt -124.98 159.94 30.08 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 123.536 0.735 . . . . 0.0 109.069 168.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 22.7 mt -111.87 137.67 43.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 105.503 -2.036 . . . . 0.0 105.503 -178.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 87.2 t -127.06 109.57 20.94 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.13 144.93 44.68 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 171.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 14.7 tt -148.42 117.62 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 173.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -81.2 116.41 21.08 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -176.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 31.0 m -61.78 -26.51 40.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-O 119.061 -0.495 . . . . 0.0 112.031 -177.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -73.4 0.85 11.04 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.917 0.887 . . . . 0.0 112.074 -179.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -130.82 0.75 4.33 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.872 1.269 . . . . 0.0 111.035 170.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -141.39 48.66 1.65 Allowed 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.503 1.121 . . . . 0.0 109.769 -168.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.539 ' H ' ' NE2' ' A' ' 61' ' ' GLN . 0.4 OUTLIER -54.14 -44.94 71.82 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.642 1.577 . . . . 0.0 108.803 177.535 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -64.09 -47.51 79.76 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 125.825 1.65 . . . . 0.0 109.884 -175.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.451 ' HA ' ' HE3' ' A' ' 66' ' ' LYS . 0.7 OUTLIER -69.44 -43.18 73.87 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-O 119.298 -0.382 . . . . 0.0 110.153 -176.006 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -61.76 -46.57 89.04 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 119.239 0.927 . . . . 0.0 109.615 176.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -58.22 -26.39 58.74 Favored Glycine 0 CA--C 1.532 1.094 0 C-N-CA 124.165 0.888 . . . . 0.0 113.053 175.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.451 ' HE3' ' HA ' ' A' ' 63' ' ' THR . 28.9 ttmt -57.95 -21.5 44.38 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.33 1.452 . . . . 0.0 111.937 177.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -127.6 13.17 6.97 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.86 1.264 . . . . 0.0 110.638 178.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 69.83 19.02 74.78 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 124.667 1.127 . . . . 0.0 113.664 -178.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 96.3 t -82.19 137.93 20.3 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 175.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -153.16 25.02 0.54 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.901 1.28 . . . . 0.0 109.499 168.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 20.4 m -139.51 154.82 47.77 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 126.412 1.885 . . . . 0.0 107.32 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -146.18 160.31 43.13 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 124.345 1.058 . . . . 0.0 109.544 -170.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -66.86 139.24 44.48 Favored 'Cis proline' 0 C--N 1.35 0.632 0 N-CA-C 109.285 -1.083 . . . . 0.0 109.285 -11.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 51.3 m -131.9 118.59 20.01 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 177.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 88.3 mt -96.3 134.27 39.64 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 106.63 -1.619 . . . . 0.0 106.63 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.9 mp -119.54 128.37 53.87 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 104.793 -2.299 . . . . 0.0 104.793 169.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 15.5 t -93.58 125.26 46.18 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 103.104 -2.924 . . . . 0.0 103.104 168.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.7 mp -118.36 159.38 23.52 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 173.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 75.9 tttt -144.22 124.23 13.58 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 174.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.7 t70 45.76 36.76 2.93 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.44 1.496 . . . . 0.0 113.423 175.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 107.45 -2.28 34.62 Favored Glycine 0 CA--C 1.527 0.806 0 CA-C-O 118.089 -1.395 . . . . 0.0 115.365 168.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -130.39 147.36 52.08 Favored 'General case' 0 C--N 1.339 0.126 0 CA-C-N 120.08 1.94 . . . . 0.0 110.246 -178.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 16.8 t -67.66 137.61 24.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 107.813 -1.181 . . . . 0.0 107.813 175.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 29.0 m -119.63 -20.26 4.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 124.827 1.251 . . . . 0.0 110.537 173.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -156.85 162.26 39.69 Favored 'General case' 0 C--N 1.346 0.417 0 CA-C-N 119.642 1.11 . . . . 0.0 111.242 173.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 87.0 m -143.49 137.92 28.86 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.645 1.578 . . . . 0.0 108.356 174.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 29.3 m -145.39 153.22 40.98 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.933 1.693 . . . . 0.0 108.44 -178.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 40.9 t -133.07 145.21 34.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -175.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.91 175.52 46.79 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 124.462 1.029 . . . . 0.0 111.844 178.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -62.29 148.5 44.77 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.727 0.811 . . . . 0.0 110.377 176.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 46.3 mttm -142.01 146.1 38.95 Favored Pre-proline 0 C--O 1.233 0.195 0 C-N-CA 124.93 1.292 . . . . 0.0 107.733 168.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -72.87 161.21 44.28 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 122.746 2.297 . . . . 0.0 110.266 173.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -56.16 -43.78 78.68 Favored 'General case' 0 C--O 1.223 -0.326 0 CA-C-O 118.626 -0.702 . . . . 0.0 110.683 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -65.65 -37.78 87.49 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 119.162 0.892 . . . . 0.0 111.458 -169.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.53 -43.97 71.93 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 122.904 0.481 . . . . 0.0 110.639 174.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 29.6 tp -67.15 -41.77 85.48 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 122.568 0.347 . . . . 0.0 110.76 -175.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.2 pp0? -70.55 -32.69 70.22 Favored 'General case' 0 N--CA 1.456 -0.138 0 O-C-N 121.798 -0.564 . . . . 0.0 109.866 177.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -63.43 -48.05 79.38 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 176.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 51.1 tp -60.17 -44.4 95.07 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 122.824 0.45 . . . . 0.0 110.696 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 26.3 t -58.06 -47.48 86.76 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 175.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.71 -25.09 67.79 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 119.078 0.854 . . . . 0.0 112.675 -177.284 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -66.02 -23.65 66.6 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 119.048 0.84 . . . . 0.0 112.479 169.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -107.85 -16.52 14.29 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 119.478 1.035 . . . . 0.0 113.242 -174.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 80.7 mt . . . . . 0 C--O 1.249 1.068 0 CA-C-N 119.484 1.038 . . . . 0.0 109.681 172.248 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.9 tmm? . . . . . 0 N--CA 1.478 0.945 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -156.08 144.56 20.07 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 169.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 91.8 mt -75.51 153.87 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 N-CA-C 107.3 -1.371 . . . . 0.0 107.3 174.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 36.7 t -120.03 170.68 9.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 -174.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 27.8 mtpt -137.31 149.84 47.34 Favored 'General case' 0 CA--C 1.518 -0.268 0 O-C-N 120.732 -1.23 . . . . 0.0 108.679 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -151.01 170.36 19.54 Favored 'General case' 0 C--N 1.331 -0.196 0 O-C-N 123.489 0.493 . . . . 0.0 111.66 176.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.3 p -136.51 174.11 10.97 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.863 1.665 . . . . 0.0 107.205 172.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -47.08 -33.3 4.83 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 119.917 1.235 . . . . 0.0 113.243 -179.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 26.9 mp0 -60.68 -31.45 70.71 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.075 1.75 . . . . 0.0 113.109 -179.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.3 m -140.41 -2.57 1.41 Allowed 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -170.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -54.79 -37.94 66.68 Favored 'General case' 0 CA--C 1.528 0.098 0 C-N-CA 124.191 0.997 . . . . 0.0 111.03 178.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.4 p -63.09 -50.53 70.18 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.653 0.781 . . . . 0.0 110.788 179.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.31 -44.44 92.57 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 122.972 0.509 . . . . 0.0 110.159 178.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -66.58 -37.76 85.6 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-O 119.2 -0.428 . . . . 0.0 111.403 -177.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 34.2 p -80.21 3.35 21.02 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 118.607 0.64 . . . . 0.0 112.451 -178.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 51.2 m -111.73 32.78 5.19 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.598 1.159 . . . . 0.0 112.346 -172.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -132.58 -0.44 3.55 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -177.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 165.92 -167.09 39.01 Favored Glycine 0 C--N 1.334 0.452 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 -174.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 97.4 t -71.91 133.3 32.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 104.56 -2.385 . . . . 0.0 104.56 166.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 38.6 t -136.49 121.77 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 -176.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 56.6 tp -96.45 98.0 9.89 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 173.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.2 156.16 33.87 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 169.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -139.38 100.04 3.89 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 125.382 1.473 . . . . 0.0 107.547 179.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -75.05 115.52 14.76 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 169.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 8.6 p-90 -137.0 174.72 10.31 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 123.554 0.742 . . . . 0.0 110.237 -174.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -153.96 148.02 18.96 Favored Pre-proline 0 CA--C 1.535 0.402 0 N-CA-C 107.753 -1.202 . . . . 0.0 107.753 169.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -73.52 -22.46 18.31 Favored 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 122.574 2.183 . . . . 0.0 113.22 -169.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -79.43 -5.55 54.94 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 118.623 0.647 . . . . 0.0 112.356 179.047 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 45.2 t -95.12 110.51 22.45 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 -175.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -51.03 -53.21 27.97 Favored Glycine 0 CA--C 1.533 1.215 0 CA-C-O 118.801 -0.999 . . . . 0.0 112.74 176.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_exo -52.34 -34.19 59.32 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 122.858 2.372 . . . . 0.0 114.846 174.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 80.9 m -67.39 -39.8 85.6 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 120.185 1.357 . . . . 0.0 111.146 172.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -59.88 -34.34 73.03 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 121.051 -1.031 . . . . 0.0 110.262 173.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 26.2 mmt -73.88 -37.12 64.83 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 123.043 0.537 . . . . 0.0 111.48 177.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.2 tp -70.68 -23.27 23.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 119.408 1.004 . . . . 0.0 110.935 179.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.81 -54.95 46.28 Favored Pre-proline 0 CA--C 1.543 0.701 0 CA-C-O 117.775 -1.107 . . . . 0.0 113.006 -177.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -66.55 -28.41 45.29 Favored 'Trans proline' 0 C--N 1.349 0.576 0 CA-C-N 121.703 1.644 . . . . 0.0 112.499 177.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 97.8 t -62.87 -43.61 99.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 119.607 1.094 . . . . 0.0 109.335 174.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 89.5 mt -69.28 -35.03 75.63 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-O 118.585 -0.722 . . . . 0.0 111.112 178.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -65.51 -41.23 93.39 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 119.526 1.057 . . . . 0.0 110.883 174.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -59.43 -45.23 92.13 Favored 'General case' 0 N--CA 1.455 -0.196 0 O-C-N 121.479 -0.763 . . . . 0.0 110.4 171.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.2 tp -64.36 -38.93 92.76 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 122.869 0.468 . . . . 0.0 110.698 -178.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -65.3 -41.78 93.72 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.524 0.73 . . . . 0.0 110.611 177.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -66.91 -36.3 81.94 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 122.067 -0.396 . . . . 0.0 111.252 176.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -73.96 -49.66 23.58 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.231 1.013 . . . . 0.0 111.013 -175.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 7.9 ptp -146.06 10.53 1.17 Allowed 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 -167.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.68 52.02 1.54 Allowed Glycine 0 CA--C 1.526 0.764 0 C-N-CA 126.53 2.014 . . . . 0.0 113.156 -178.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -148.66 -39.42 0.16 Allowed 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 128.229 2.612 . . . . 0.0 107.697 169.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 58.7 mtmt -65.95 -29.71 70.16 Favored 'General case' 0 C--N 1.345 0.375 0 C-N-CA 123.58 0.752 . . . . 0.0 110.68 168.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -131.96 162.65 30.18 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 125.138 1.375 . . . . 0.0 110.324 168.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -99.28 154.91 17.8 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.018 1.327 . . . . 0.0 107.538 169.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 12.8 mt -120.83 137.37 54.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 N-CA-C 105.704 -1.961 . . . . 0.0 105.704 170.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 84.6 t -133.61 114.1 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-N 119.048 0.84 . . . . 0.0 108.963 -174.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 56.7 mmtt -73.73 143.29 46.18 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 121.853 -0.529 . . . . 0.0 109.845 170.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 13.0 tt -151.35 149.68 13.86 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 N-CA-C 107.699 -1.222 . . . . 0.0 107.699 170.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -123.33 118.04 26.62 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 120.958 -1.089 . . . . 0.0 109.808 -169.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 30.5 m -55.13 -29.48 22.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 124.233 1.013 . . . . 0.0 113.027 -174.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -69.76 -9.09 53.24 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.874 0.869 . . . . 0.0 112.424 -175.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -132.07 6.05 4.22 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.838 1.255 . . . . 0.0 110.953 176.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 67.1 m-80 -141.21 46.7 1.72 Allowed 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.957 0.903 . . . . 0.0 110.679 -168.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.476 ' H ' ' NE2' ' A' ' 61' ' ' GLN . 0.5 OUTLIER -55.09 -43.94 74.45 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.908 0.883 . . . . 0.0 108.947 173.616 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -68.38 -31.73 71.31 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 125.48 1.512 . . . . 0.0 111.63 -171.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -84.68 -47.54 10.37 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 118.31 0.504 . . . . 0.0 109.918 176.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -64.22 -45.17 89.4 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 119.216 0.916 . . . . 0.0 109.904 -175.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -61.1 -24.97 63.77 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 124.009 0.814 . . . . 0.0 112.409 176.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.4 ttmm -58.99 -26.44 64.5 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 118.348 1.074 . . . . 0.0 111.533 176.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -114.83 10.47 16.48 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.606 1.162 . . . . 0.0 111.146 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 71.15 31.43 66.45 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 123.649 0.642 . . . . 0.0 112.418 -178.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 98.1 t -111.05 138.27 40.03 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 C-N-CA 125.073 1.349 . . . . 0.0 107.835 -178.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 8.6 tpt -153.97 30.75 0.45 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.034 0.934 . . . . 0.0 108.989 167.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 19.3 m -139.21 158.8 43.54 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 126.401 1.88 . . . . 0.0 107.671 -178.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -143.43 158.62 57.17 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 123.956 0.903 . . . . 0.0 110.013 -173.285 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -66.75 138.36 39.85 Favored 'Cis proline' 0 N--CA 1.457 -0.631 0 N-CA-C 108.786 -1.275 . . . . 0.0 108.786 -11.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 99.1 m -132.31 112.73 12.46 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 174.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 95.6 mt -83.46 141.77 31.43 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 175.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -128.8 127.27 41.63 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 104.133 -2.543 . . . . 0.0 104.133 -178.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.0 t -112.57 121.72 65.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 104.235 -2.506 . . . . 0.0 104.235 -176.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.2 mp -127.46 159.32 34.87 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 77.2 tttt -146.08 124.15 12.12 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 177.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.0 t70 45.16 35.94 1.91 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.438 1.495 . . . . 0.0 113.441 175.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 105.54 1.71 40.48 Favored Glycine 0 CA--C 1.527 0.794 0 CA-C-O 118.092 -1.393 . . . . 0.0 115.074 169.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -130.69 145.2 51.87 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 120.082 1.941 . . . . 0.0 109.921 179.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.7 p -69.0 140.67 18.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 C-N-CA 123.769 0.827 . . . . 0.0 109.19 174.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 35.5 m -128.02 -17.95 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 125.69 1.596 . . . . 0.0 110.681 178.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -160.1 167.28 28.14 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 120.389 1.45 . . . . 0.0 111.545 169.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 52.7 m -145.4 141.53 28.52 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.054 1.742 . . . . 0.0 107.549 169.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 14.7 m -145.84 146.55 31.18 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 124.215 1.006 . . . . 0.0 108.631 -178.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 39.8 t -127.41 148.8 32.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 -170.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.99 172.55 39.57 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 124.185 0.897 . . . . 0.0 111.589 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -61.22 153.75 25.31 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.225 0.61 . . . . 0.0 110.762 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -153.41 148.25 19.65 Favored Pre-proline 0 CA--C 1.533 0.301 0 C-N-CA 125.082 1.353 . . . . 0.0 107.677 169.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.51 162.41 41.47 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.644 2.23 . . . . 0.0 111.013 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -53.97 -43.8 70.23 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-O 118.574 -0.727 . . . . 0.0 110.952 177.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -63.59 -42.14 98.3 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 119.059 0.845 . . . . 0.0 111.369 -169.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.58 -41.71 88.11 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 123.096 0.558 . . . . 0.0 110.854 175.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 30.9 tp -68.1 -41.95 81.02 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 119.549 -0.262 . . . . 0.0 110.911 -176.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.7 pp0? -71.15 -30.81 66.92 Favored 'General case' 0 N--CA 1.457 -0.113 0 CA-C-N 118.512 0.596 . . . . 0.0 110.044 177.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -63.1 -50.03 72.12 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 174.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 66.9 tp -58.04 -46.54 85.19 Favored 'General case' 0 C--N 1.334 -0.09 0 C-N-CA 123.723 0.809 . . . . 0.0 110.31 -178.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 42.9 t -63.7 -49.08 83.73 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-O 118.561 -0.733 . . . . 0.0 109.783 179.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.05 -26.89 68.76 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 119.725 1.148 . . . . 0.0 112.268 -176.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -68.22 -26.83 65.91 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 118.323 -0.846 . . . . 0.0 112.384 171.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 77.0 m-70 -95.23 -19.84 19.7 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 119.571 1.078 . . . . 0.0 113.368 178.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 61.3 mt . . . . . 0 C--O 1.248 0.982 0 CA-C-N 119.781 1.173 . . . . 0.0 109.745 175.296 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.8 ttp . . . . . 0 N--CA 1.478 0.963 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -156.87 147.17 21.21 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.891 1.677 . . . . 0.0 106.539 169.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 90.5 mt -75.6 145.05 11.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 40.9 t -104.38 167.58 2.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 -174.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 5.9 mptt -137.13 138.51 40.37 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 -178.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -144.91 170.22 16.55 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.068 0.461 . . . . 0.0 111.656 -179.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 70.8 p -137.08 173.5 11.63 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.725 1.61 . . . . 0.0 107.48 177.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -49.75 -32.43 13.7 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 119.836 1.198 . . . . 0.0 112.979 -178.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 26.2 mp0 -63.82 -30.75 71.81 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.098 1.759 . . . . 0.0 112.778 -178.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.6 m -138.47 -4.93 1.61 Allowed 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 -169.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -54.92 -37.48 66.43 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 124.039 0.935 . . . . 0.0 110.821 177.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.3 p -62.94 -50.98 68.7 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 123.861 0.865 . . . . 0.0 110.835 178.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.22 -44.29 92.3 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.019 0.527 . . . . 0.0 110.081 178.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -66.03 -38.67 89.0 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-O 119.237 -0.411 . . . . 0.0 111.294 -177.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 28.8 p -78.62 1.41 22.79 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 118.528 0.604 . . . . 0.0 112.58 -179.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 50.4 m -110.29 32.61 5.02 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.57 1.148 . . . . 0.0 112.27 -172.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -132.17 -0.17 3.73 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -178.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 165.51 -167.69 39.1 Favored Glycine 0 C--N 1.336 0.54 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 -174.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 97.4 t -71.24 134.23 30.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 N-CA-C 104.687 -2.338 . . . . 0.0 104.687 166.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 40.4 t -136.8 120.85 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 -175.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 61.6 tp -95.35 96.91 9.45 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 173.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.24 157.76 32.28 Favored 'General case' 0 N--CA 1.444 -0.732 0 O-C-N 121.831 -0.543 . . . . 0.0 109.7 169.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -139.92 99.26 3.65 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 125.558 1.543 . . . . 0.0 107.436 178.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -73.96 117.14 15.4 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 169.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 8.2 p-90 -138.2 173.4 11.65 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 123.396 0.678 . . . . 0.0 110.883 -174.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -153.47 149.13 20.71 Favored Pre-proline 0 C--O 1.238 0.46 0 C-N-CA 126.416 1.886 . . . . 0.0 105.957 169.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -75.68 -21.97 14.11 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.695 2.263 . . . . 0.0 113.251 -169.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -78.32 -7.84 57.71 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 118.541 0.609 . . . . 0.0 112.521 -176.141 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 37.5 t -100.16 108.78 20.99 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 -178.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -46.47 -51.21 12.53 Favored Glycine 0 CA--C 1.533 1.215 0 CA-C-O 118.425 -1.208 . . . . 0.0 113.767 -178.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -49.81 -31.51 26.41 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 123.443 2.762 . . . . 0.0 115.885 176.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 61.6 m -62.5 -40.94 98.34 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 120.409 1.459 . . . . 0.0 110.782 173.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -67.88 -37.75 82.18 Favored 'General case' 0 N--CA 1.462 0.144 0 O-C-N 121.729 -0.607 . . . . 0.0 109.933 175.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 64.3 mtt -65.66 -40.5 92.5 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 118.202 0.455 . . . . 0.0 111.165 -178.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 10.1 tt -80.87 -19.03 11.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 118.666 0.667 . . . . 0.0 111.619 -177.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -52.35 -51.53 71.55 Favored Pre-proline 0 CA--C 1.543 0.686 0 CA-C-O 117.529 -1.224 . . . . 0.0 113.632 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.1 -30.45 55.87 Favored 'Trans proline' 0 C--N 1.351 0.683 0 CA-C-N 121.874 1.705 . . . . 0.0 112.037 177.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 14.0 t -63.6 -44.61 98.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 119.126 0.875 . . . . 0.0 109.157 176.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 78.5 mt -65.59 -36.38 83.58 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 118.917 -0.563 . . . . 0.0 110.731 177.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -66.05 -38.88 89.47 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 119.266 0.939 . . . . 0.0 111.203 175.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -67.38 -37.52 83.27 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 121.087 -1.008 . . . . 0.0 110.344 174.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 16.0 tp -66.34 -39.11 89.01 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.348 0.659 . . . . 0.0 110.551 177.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -65.1 -40.07 94.03 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.014 0.926 . . . . 0.0 110.708 175.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -66.84 -36.45 82.37 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.942 -0.474 . . . . 0.0 111.306 175.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -72.35 -53.47 12.25 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.921 0.889 . . . . 0.0 110.987 -178.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 11.6 ptp -144.44 15.63 1.64 Allowed 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 114.212 1.189 . . . . 0.0 114.212 -167.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.35 53.94 1.14 Allowed Glycine 0 CA--C 1.529 0.965 0 C-N-CA 126.124 1.821 . . . . 0.0 112.092 175.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -153.51 -40.93 0.1 Allowed 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 129.41 3.084 . . . . 0.0 107.281 172.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -63.95 -35.24 80.03 Favored 'General case' 0 C--N 1.343 0.311 0 C-N-CA 124.04 0.936 . . . . 0.0 110.176 168.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -131.04 165.34 23.43 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 125.34 1.456 . . . . 0.0 110.473 169.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -102.06 154.64 18.8 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 169.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.6 mt -120.58 137.45 54.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 170.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 66.7 t -134.02 115.94 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-N 119.2 0.909 . . . . 0.0 109.502 -175.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 65.7 mmtt -74.89 145.04 43.05 Favored 'General case' 0 C--O 1.235 0.303 0 O-C-N 121.233 -0.917 . . . . 0.0 109.783 169.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 12.4 tt -151.33 141.7 15.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 169.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -98.49 128.08 44.69 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 121.488 -0.757 . . . . 0.0 110.063 -173.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 15.9 m -67.99 -27.42 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 114.51 1.3 . . . . 0.0 114.51 -173.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -80.62 -41.32 24.09 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 120.072 1.305 . . . . 0.0 109.41 -175.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -71.75 -26.26 62.38 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.413 0.685 . . . . 0.0 111.18 175.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 -128.39 43.43 3.14 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.735 1.214 . . . . 0.0 109.864 -170.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.79 -39.67 62.55 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 126.697 1.999 . . . . 0.0 111.049 176.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -64.02 -46.02 86.33 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 123.615 0.766 . . . . 0.0 110.335 176.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.519 ' HA ' ' HE3' ' A' ' 66' ' ' LYS . 0.3 OUTLIER -69.89 -41.93 74.09 Favored 'General case' 0 C--O 1.222 -0.369 0 CA-C-N 118.69 0.677 . . . . 0.0 110.74 -175.979 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.77 -45.16 93.99 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 119.307 0.958 . . . . 0.0 109.273 176.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -57.53 -27.9 59.01 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 123.838 0.733 . . . . 0.0 112.778 174.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.519 ' HE3' ' HA ' ' A' ' 63' ' ' THR . 25.0 ttmt -59.51 -19.94 51.83 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.458 1.503 . . . . 0.0 111.96 178.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -125.3 12.41 8.19 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.659 1.184 . . . . 0.0 110.915 179.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 71.52 32.6 64.52 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 123.713 0.673 . . . . 0.0 112.722 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 90.8 t -111.18 139.05 36.96 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 C-N-CA 125.054 1.342 . . . . 0.0 108.003 -178.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 8.6 tpt -155.26 30.29 0.39 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.408 1.083 . . . . 0.0 108.989 167.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 18.2 m -136.96 158.96 43.27 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 126.181 1.792 . . . . 0.0 107.919 -177.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -144.8 155.57 56.01 Favored Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 123.354 0.662 . . . . 0.0 111.152 -170.293 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -69.73 140.14 58.67 Favored 'Cis proline' 0 N--CA 1.458 -0.599 0 N-CA-C 108.653 -1.326 . . . . 0.0 108.653 -11.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 96.3 m -130.68 113.11 13.76 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 176.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 94.4 mt -81.18 144.71 31.43 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 175.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.9 126.4 36.06 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 103.949 -2.611 . . . . 0.0 103.949 -179.036 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 5.2 t -109.52 122.33 63.96 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.42 0 N-CA-C 104.227 -2.509 . . . . 0.0 104.227 -179.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.4 mp -125.86 159.8 31.55 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 179.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -145.41 126.44 14.6 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 175.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.0 t70 44.41 35.65 1.39 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.368 1.467 . . . . 0.0 113.55 174.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 106.48 0.19 37.35 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-O 118.004 -1.442 . . . . 0.0 115.07 169.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -130.69 145.82 52.02 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-N 120.13 1.965 . . . . 0.0 110.216 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 10.0 p -70.03 140.98 17.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 C-N-CA 123.845 0.858 . . . . 0.0 109.435 174.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 32.5 m -129.94 -17.61 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 125.734 1.613 . . . . 0.0 110.788 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -160.29 168.56 25.05 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 120.422 1.465 . . . . 0.0 111.696 169.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 53.9 m -146.84 141.85 27.06 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.072 1.749 . . . . 0.0 108.023 170.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 18.7 m -146.16 152.86 39.94 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 124.77 1.228 . . . . 0.0 108.864 -177.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 32.8 t -130.15 148.85 33.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-N 119.155 0.888 . . . . 0.0 108.691 -171.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 80.62 179.72 53.0 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 124.098 0.856 . . . . 0.0 111.994 176.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -62.07 150.69 37.58 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.773 0.829 . . . . 0.0 110.759 177.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.41 147.74 29.17 Favored Pre-proline 0 CA--C 1.531 0.233 0 C-N-CA 124.893 1.277 . . . . 0.0 107.739 167.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -74.1 160.71 42.27 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 123.207 2.604 . . . . 0.0 110.452 174.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 75.3 tttt -55.18 -41.32 71.74 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 118.816 -0.612 . . . . 0.0 110.515 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -59.74 -41.7 91.54 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 118.516 0.598 . . . . 0.0 110.871 -174.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.14 -43.36 87.3 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.03 0.532 . . . . 0.0 110.792 176.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 61.1 mt -64.29 -45.88 86.06 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 119.141 -0.457 . . . . 0.0 109.945 -179.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 2.9 pp0? -71.12 -27.57 63.68 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.799 0.727 . . . . 0.0 110.676 -177.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -67.72 -50.16 58.89 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 173.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 60.9 tp -58.26 -47.47 83.48 Favored 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 123.235 0.614 . . . . 0.0 109.975 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 44.4 t -62.66 -46.94 95.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 CA-C-O 117.995 -1.002 . . . . 0.0 109.696 -179.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -60.24 -34.71 74.06 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 120.073 1.306 . . . . 0.0 111.315 -177.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 48.2 mmtm -71.07 -10.09 59.16 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 118.045 -0.978 . . . . 0.0 113.468 175.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -108.17 -17.03 14.13 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 119.982 1.264 . . . . 0.0 113.383 172.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 64.8 mt . . . . . 0 C--O 1.25 1.109 0 CA-C-N 120.239 1.381 . . . . 0.0 109.761 174.293 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.9 mmt . . . . . 0 N--CA 1.486 1.335 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.76 159.71 43.11 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 125.618 1.567 . . . . 0.0 108.405 175.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 79.5 mt -69.08 153.92 8.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 124.945 1.298 . . . . 0.0 108.562 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 31.5 t -114.34 167.56 7.0 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 125.939 1.696 . . . . 0.0 107.104 -174.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 9.2 mtmt -132.75 147.79 52.32 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 176.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -148.59 169.7 19.75 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.545 0.738 . . . . 0.0 110.426 176.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 77.8 p -135.53 174.94 10.06 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.562 1.145 . . . . 0.0 107.918 171.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -47.7 -31.03 4.29 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 119.964 1.256 . . . . 0.0 112.928 178.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -58.76 -33.33 70.17 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.374 1.87 . . . . 0.0 112.791 179.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.7 m -142.95 -3.09 0.99 Allowed 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 114.217 1.192 . . . . 0.0 114.217 -169.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -53.8 -37.45 63.53 Favored 'General case' 0 C--O 1.23 0.065 0 C-N-CA 124.435 1.094 . . . . 0.0 111.105 179.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.4 p -61.53 -53.63 53.8 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.808 0.843 . . . . 0.0 110.658 179.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.25 -43.76 88.01 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.018 0.527 . . . . 0.0 110.28 179.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -65.97 -35.51 80.79 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 119.081 -0.485 . . . . 0.0 111.746 -177.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 32.1 p -85.75 1.14 50.75 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -178.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 40.5 m -115.24 32.48 6.02 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -169.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -144.02 17.54 1.76 Allowed 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 177.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 172.6 -169.23 42.37 Favored Glycine 0 C--N 1.339 0.711 0 O-C-N 121.329 -0.857 . . . . 0.0 112.151 174.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 1.8 t -78.65 134.35 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 104.106 -2.553 . . . . 0.0 104.106 168.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 25.5 t -139.62 138.4 39.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 -172.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 42.6 tp -114.02 97.6 6.47 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 173.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.95 157.55 33.01 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 169.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -138.31 99.4 3.84 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 125.27 1.428 . . . . 0.0 107.259 177.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -72.5 115.66 12.03 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 169.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 9.3 p-90 -137.19 175.53 9.53 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.704 0.801 . . . . 0.0 110.373 -172.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -152.3 146.58 18.55 Favored Pre-proline 0 CA--C 1.535 0.399 0 C-N-CA 124.491 1.117 . . . . 0.0 107.994 169.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.25 -19.3 17.46 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.801 2.334 . . . . 0.0 113.299 -171.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -82.36 -7.47 59.63 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 121.537 -0.727 . . . . 0.0 111.961 177.566 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 48.6 t -92.07 120.76 32.99 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -57.0 -58.32 15.19 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-O 118.656 -1.08 . . . . 0.0 111.925 177.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -49.63 -36.33 40.5 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 123.653 2.902 . . . . 0.0 115.157 177.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 95.8 m -60.16 -36.66 78.07 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 119.429 1.013 . . . . 0.0 112.313 175.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 46.3 mtmt -80.48 -35.35 34.93 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-O 118.986 -0.53 . . . . 0.0 109.893 177.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 26.4 mmt -64.36 -39.23 93.47 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 118.967 0.803 . . . . 0.0 111.304 178.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 8.4 tt -76.46 -13.21 14.6 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 CA-C-N 118.824 0.738 . . . . 0.0 111.349 179.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -57.17 -52.22 75.79 Favored Pre-proline 0 CA--C 1.541 0.631 0 CA-C-O 117.515 -1.231 . . . . 0.0 113.21 -177.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.71 -28.86 60.06 Favored 'Trans proline' 0 C--N 1.351 0.685 0 CA-C-N 121.873 1.704 . . . . 0.0 112.418 176.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 10.5 t -65.08 -44.17 95.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 177.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 61.6 mt -68.12 -33.22 74.1 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 118.056 -0.973 . . . . 0.0 111.138 175.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -65.48 -43.76 89.23 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 120.036 1.289 . . . . 0.0 110.578 174.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -59.79 -42.57 93.69 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 118.77 0.714 . . . . 0.0 110.031 175.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 37.7 tp -65.0 -39.17 93.06 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 122.529 0.332 . . . . 0.0 110.903 178.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -64.43 -41.86 96.34 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 124.566 1.147 . . . . 0.0 110.477 178.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 65.0 mm-40 -65.73 -26.07 67.58 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.634 -0.666 . . . . 0.0 111.578 176.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -91.98 -31.08 15.75 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.749 1.22 . . . . 0.0 112.908 -177.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 19.3 mmt -126.07 -11.26 6.49 Favored 'General case' 0 C--O 1.226 -0.171 0 CA-C-O 117.697 -1.144 . . . . 0.0 113.483 -168.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -45.54 -35.14 5.37 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 126.287 1.899 . . . . 0.0 115.923 -170.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -76.06 -37.97 57.64 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.04 0.936 . . . . 0.0 111.519 -178.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 29.2 mtmt -83.79 -27.46 28.81 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 125.27 1.428 . . . . 0.0 110.444 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -151.14 122.18 7.68 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 124.542 1.137 . . . . 0.0 109.847 -170.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -74.28 151.92 39.77 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.911 0.885 . . . . 0.0 108.978 174.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.9 mt -122.46 134.02 66.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 N-CA-C 105.985 -1.858 . . . . 0.0 105.985 172.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 41.1 t -131.6 113.26 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -171.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 60.3 mmtt -74.2 143.17 45.3 Favored 'General case' 0 C--O 1.235 0.319 0 O-C-N 121.505 -0.747 . . . . 0.0 109.557 170.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 11.7 tt -150.13 121.38 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 173.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -86.86 116.85 25.21 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 121.393 -0.817 . . . . 0.0 109.384 -174.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 29.9 m -58.69 -28.02 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-N 118.674 0.67 . . . . 0.0 112.713 -176.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -71.99 -7.96 51.74 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 119.26 0.936 . . . . 0.0 112.059 -177.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -123.23 2.38 9.18 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.3 1.44 . . . . 0.0 110.513 173.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -146.54 36.45 0.98 Allowed 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 124.683 1.193 . . . . 0.0 111.026 -168.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.407 ' H ' ' NE2' ' A' ' 61' ' ' GLN . 1.6 pm0 -58.22 -30.41 66.46 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.333 0.653 . . . . 0.0 110.236 173.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 59.3 mp0 -62.16 -55.08 32.35 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.406 1.482 . . . . 0.0 109.685 174.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.86 -43.91 74.41 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 119.377 -0.344 . . . . 0.0 110.164 -174.44 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.83 -45.4 92.79 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 118.71 0.686 . . . . 0.0 109.583 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -59.6 -25.34 60.85 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.122 0.868 . . . . 0.0 112.748 175.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 9.9 ttmm -59.44 -23.54 62.77 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.575 1.187 . . . . 0.0 111.405 175.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -118.8 11.07 12.55 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.162 1.385 . . . . 0.0 110.984 178.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 68.62 20.53 74.03 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 124.23 0.919 . . . . 0.0 113.346 -176.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 91.0 t -90.52 133.67 31.65 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 177.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 7.2 tpt -154.7 30.73 0.42 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.778 0.831 . . . . 0.0 109.621 167.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 45.1 m -135.36 156.79 48.36 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 126.36 1.864 . . . . 0.0 106.834 172.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -145.16 158.27 52.07 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 123.935 0.894 . . . . 0.0 109.992 -170.309 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -67.7 136.78 35.11 Favored 'Cis proline' 0 C--N 1.349 0.591 0 CA-C-N 120.085 1.066 . . . . 0.0 109.784 -10.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 70.4 m -132.26 113.95 13.85 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 176.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 88.5 mt -82.39 145.5 29.85 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 175.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -129.61 124.7 34.38 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 104.263 -2.495 . . . . 0.0 104.263 179.387 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.5 t -106.69 124.34 62.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 N-CA-C 104.031 -2.581 . . . . 0.0 104.031 -178.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.7 mp -127.16 160.21 31.93 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.517 1.127 . . . . 0.0 108.102 178.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -148.18 128.03 13.48 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 174.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.0 t70 42.64 38.3 1.26 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.211 1.404 . . . . 0.0 113.276 179.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.72 6.67 60.62 Favored Glycine 0 CA--C 1.527 0.842 0 CA-C-O 118.777 -1.013 . . . . 0.0 114.726 171.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -121.82 143.05 49.63 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 119.333 1.567 . . . . 0.0 108.881 176.177 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 78.1 t -67.24 139.4 21.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 169.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.1 m -124.95 -21.55 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 CA-C-O 117.513 -1.232 . . . . 0.0 110.484 174.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -158.41 166.67 31.67 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 120.288 1.404 . . . . 0.0 111.846 174.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 72.4 m -144.24 139.5 28.71 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.89 1.676 . . . . 0.0 107.569 169.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 20.2 m -146.13 153.18 40.39 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.588 1.155 . . . . 0.0 109.035 -174.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 30.7 t -131.7 150.53 34.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 CA-C-N 119.04 0.836 . . . . 0.0 108.993 -170.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.8 169.17 45.16 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 124.693 1.139 . . . . 0.0 112.76 170.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -62.16 134.95 57.24 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 172.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 33.2 mttp -144.34 146.99 35.15 Favored Pre-proline 0 C--O 1.233 0.215 0 C-N-CA 125.364 1.466 . . . . 0.0 107.759 176.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -75.28 157.38 41.62 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 123.007 2.471 . . . . 0.0 110.96 -176.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.7 tmpt? -60.47 -33.67 72.91 Favored 'General case' 0 C--O 1.224 -0.266 0 O-C-N 121.698 -0.626 . . . . 0.0 111.241 -175.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -62.58 -37.16 85.13 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 118.967 0.803 . . . . 0.0 111.823 178.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -72.27 -40.63 67.47 Favored 'General case' 0 N--CA 1.452 -0.35 0 O-C-N 121.85 -0.531 . . . . 0.0 110.655 174.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 52.7 mt -65.89 -41.37 91.61 Favored 'General case' 0 N--CA 1.455 -0.201 0 O-C-N 122.057 -0.402 . . . . 0.0 110.253 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.7 pp0? -69.95 -30.17 67.48 Favored 'General case' 0 C--O 1.227 -0.081 0 CA-C-N 118.932 0.787 . . . . 0.0 110.272 178.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -63.86 -49.98 70.63 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 174.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 65.3 tp -57.63 -43.76 85.06 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.804 0.841 . . . . 0.0 110.726 178.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 24.7 t -61.94 -53.56 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 177.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.34 -26.16 68.35 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 119.082 0.856 . . . . 0.0 112.272 -175.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -67.3 -18.69 65.29 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 117.869 -1.062 . . . . 0.0 112.837 172.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -115.88 -13.0 11.35 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 119.929 1.241 . . . . 0.0 113.69 178.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 43.7 mt . . . . . 0 C--O 1.249 1.075 0 CA-C-N 120.284 1.402 . . . . 0.0 109.63 170.903 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.7 mtt . . . . . 0 N--CA 1.484 1.246 0 CA-C-O 121.175 0.512 . . . . 0.0 109.742 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -159.3 143.68 15.28 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 126.08 1.752 . . . . 0.0 106.489 168.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 88.3 mt -76.6 138.3 20.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 36.6 t -98.5 166.89 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 125.285 1.434 . . . . 0.0 107.504 -175.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 6.1 mptt -137.07 135.96 37.96 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 179.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -147.17 170.76 16.55 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 122.92 0.488 . . . . 0.0 110.9 -178.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.9 p -137.5 174.6 10.42 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.958 1.303 . . . . 0.0 108.047 177.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -45.99 -34.22 3.87 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.776 1.23 . . . . 0.0 113.17 179.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 26.8 mp0 -62.1 -31.81 72.31 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.901 1.681 . . . . 0.0 113.1 -178.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.5 m -139.98 -5.07 1.32 Allowed 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 -170.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -55.87 -35.61 66.67 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 124.097 0.959 . . . . 0.0 111.236 178.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.4 p -63.53 -48.6 76.85 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.895 0.878 . . . . 0.0 111.097 178.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.71 -44.5 96.5 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 122.938 0.495 . . . . 0.0 109.876 177.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -65.43 -38.41 89.8 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 119.39 -0.338 . . . . 0.0 111.502 -177.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 22.2 p -78.04 -0.16 26.86 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -178.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 60.0 m -108.65 32.87 4.54 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.466 1.106 . . . . 0.0 112.033 -171.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -132.54 -1.98 3.44 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -176.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 167.28 -166.36 39.2 Favored Glycine 0 C--N 1.337 0.593 0 CA-C-N 119.338 0.972 . . . . 0.0 110.854 -173.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 97.1 t -72.81 130.18 35.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 N-CA-C 104.554 -2.387 . . . . 0.0 104.554 166.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 38.1 t -134.82 116.85 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 -175.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 57.2 tp -84.57 139.6 31.99 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 169.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -133.1 113.61 12.94 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 -177.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -92.38 96.72 10.42 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 178.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -73.46 114.45 11.7 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 105.053 -2.202 . . . . 0.0 105.053 169.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 7.6 p-90 -138.03 175.9 9.17 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 123.499 0.72 . . . . 0.0 110.973 -169.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -152.47 145.15 17.16 Favored Pre-proline 0 CA--C 1.534 0.358 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 168.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -71.92 -23.26 22.28 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 122.421 2.081 . . . . 0.0 113.383 -169.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -80.91 -8.17 59.67 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 118.58 0.627 . . . . 0.0 112.653 179.617 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 49.1 t -91.62 110.58 21.9 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 -177.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -49.46 -53.92 18.47 Favored Glycine 0 CA--C 1.533 1.218 0 CA-C-O 118.693 -1.059 . . . . 0.0 113.085 179.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_exo -51.65 -32.58 45.43 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 123.223 2.615 . . . . 0.0 115.35 175.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 89.4 m -62.76 -35.46 79.88 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.908 1.231 . . . . 0.0 111.432 173.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -71.01 -41.04 71.42 Favored 'General case' 0 N--CA 1.463 0.191 0 O-C-N 121.642 -0.662 . . . . 0.0 109.626 173.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 26.5 mmt -64.42 -34.94 79.35 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 118.455 0.571 . . . . 0.0 111.75 -176.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 8.8 tt -82.19 -10.36 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-N 118.549 0.613 . . . . 0.0 111.707 178.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -57.04 -49.99 90.79 Favored Pre-proline 0 CA--C 1.543 0.692 0 CA-C-O 117.568 -1.206 . . . . 0.0 112.644 178.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -65.55 -31.46 50.61 Favored 'Trans proline' 0 C--N 1.351 0.687 0 CA-C-N 121.71 1.646 . . . . 0.0 112.476 176.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 23.1 t -59.48 -44.98 94.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 119.679 1.127 . . . . 0.0 109.638 172.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 75.8 mt -67.48 -36.71 81.66 Favored 'General case' 0 C--O 1.226 -0.184 0 CA-C-O 118.925 -0.56 . . . . 0.0 110.671 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -68.0 -37.7 81.76 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 119.369 0.986 . . . . 0.0 111.469 176.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -64.21 -37.08 86.17 Favored 'General case' 0 N--CA 1.456 -0.126 0 O-C-N 121.345 -0.847 . . . . 0.0 110.323 173.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 11.1 tp -72.48 -38.88 68.06 Favored 'General case' 0 N--CA 1.446 -0.633 0 O-C-N 121.816 -0.553 . . . . 0.0 110.556 178.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -65.21 -42.93 93.03 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.748 0.819 . . . . 0.0 110.147 -179.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -74.07 -13.55 60.86 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 -176.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 65.3 mt-10 -103.64 -33.6 8.92 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.52 1.128 . . . . 0.0 113.058 179.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 42.8 mtt -137.77 -0.39 2.13 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 117.997 -1.001 . . . . 0.0 113.027 -169.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.09 43.67 0.84 Allowed Glycine 0 CA--C 1.533 1.157 0 C-N-CA 126.766 2.127 . . . . 0.0 114.695 -172.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -149.0 -39.76 0.15 Allowed 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 128.443 2.697 . . . . 0.0 107.78 169.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -63.56 -34.76 78.51 Favored 'General case' 0 C--N 1.343 0.307 0 C-N-CA 124.623 1.169 . . . . 0.0 110.369 169.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -132.73 164.32 27.03 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 125.719 1.608 . . . . 0.0 109.622 168.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -103.16 151.43 22.61 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 169.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 17.4 mt -119.04 136.37 56.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 N-CA-C 105.301 -2.111 . . . . 0.0 105.301 170.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 45.7 t -128.48 135.04 63.5 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 107.524 -1.288 . . . . 0.0 107.524 -179.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 61.3 mmtt -92.31 142.63 27.25 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 169.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 17.5 tt -147.25 115.52 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-O 121.375 0.607 . . . . 0.0 109.382 171.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -82.27 112.8 19.6 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.827 0.851 . . . . 0.0 109.33 -175.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 32.9 m -59.85 -26.01 34.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-N 118.515 0.598 . . . . 0.0 112.539 -175.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -72.57 -1.59 16.59 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.571 0.749 . . . . 0.0 112.237 -178.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -131.57 6.77 4.43 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.418 1.487 . . . . 0.0 110.498 172.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 67.8 m-80 -143.31 46.44 1.52 Allowed 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.334 1.054 . . . . 0.0 110.645 -168.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.493 ' H ' ' NE2' ' A' ' 61' ' ' GLN . 0.4 OUTLIER -57.45 -44.02 84.45 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.92 0.888 . . . . 0.0 109.082 175.994 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -67.38 -29.9 69.55 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 125.612 1.565 . . . . 0.0 111.55 -173.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.07 -47.33 11.04 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 119.031 -0.509 . . . . 0.0 109.736 175.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.69 -45.89 90.69 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 119.572 1.078 . . . . 0.0 110.304 -176.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -61.81 -22.61 62.34 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 123.728 0.68 . . . . 0.0 112.721 176.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.7 ttmm -61.19 -25.62 67.16 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 118.532 1.166 . . . . 0.0 111.423 177.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -116.51 11.18 14.75 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.758 1.223 . . . . 0.0 110.703 179.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 67.6 26.36 73.72 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.145 0.879 . . . . 0.0 112.781 -176.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 89.3 t -99.1 154.25 4.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-N 118.18 0.99 . . . . 0.0 109.158 179.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -162.57 -24.0 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 127.252 2.221 . . . . 0.0 109.492 167.469 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 8.0 m -63.69 150.58 44.04 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 123.896 0.878 . . . . 0.0 109.112 170.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -145.22 155.9 54.35 Favored Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 124.256 1.022 . . . . 0.0 108.998 176.32 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.39 140.78 50.27 Favored 'Cis proline' 0 N--CA 1.456 -0.678 0 CA-C-N 119.916 1.006 . . . . 0.0 109.541 -10.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 54.4 m -131.93 121.51 24.11 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 176.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 52.7 mt -95.53 102.3 14.09 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 179.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -81.01 143.27 32.64 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 167.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.7 t -125.51 126.1 69.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 104.289 -2.485 . . . . 0.0 104.289 174.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.9 mp -126.79 160.77 29.92 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 124.994 1.318 . . . . 0.0 107.976 -178.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -144.89 125.89 14.51 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 175.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.0 t70 44.81 36.96 2.04 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.279 1.432 . . . . 0.0 113.469 175.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 105.68 -2.26 39.17 Favored Glycine 0 CA--C 1.528 0.885 0 CA-C-O 118.055 -1.414 . . . . 0.0 115.126 169.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -130.58 148.72 52.41 Favored 'General case' 0 C--N 1.338 0.099 0 CA-C-N 120.159 1.98 . . . . 0.0 110.516 -178.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 52.5 t -66.19 140.47 19.49 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 C-N-CA 124.053 0.941 . . . . 0.0 108.773 177.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 35.3 m -124.62 -18.39 3.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 125.398 1.479 . . . . 0.0 110.917 172.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.96 165.4 32.12 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 120.318 1.417 . . . . 0.0 111.429 169.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 56.3 m -144.05 133.05 22.77 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.892 1.677 . . . . 0.0 107.077 169.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 17.8 m -143.61 152.93 42.0 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.875 1.27 . . . . 0.0 108.481 -176.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 28.6 t -131.22 150.29 34.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-N 119.145 0.884 . . . . 0.0 108.794 -170.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.73 174.27 46.33 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 124.518 1.056 . . . . 0.0 112.173 176.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -59.58 152.12 22.88 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 123.623 0.769 . . . . 0.0 110.806 177.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -153.38 146.73 18.03 Favored Pre-proline 0 C--O 1.233 0.232 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 168.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.2 158.18 52.44 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.172 1.915 . . . . 0.0 110.332 177.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 4.8 ttpt -59.3 -33.95 71.71 Favored 'General case' 0 C--O 1.224 -0.288 0 C-N-CA 123.462 0.705 . . . . 0.0 111.551 179.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -64.51 -39.91 94.66 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 119.106 0.866 . . . . 0.0 111.946 -179.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.32 -41.2 70.18 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 122.735 0.414 . . . . 0.0 110.389 175.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 28.0 tp -66.75 -40.3 88.24 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 122.638 0.375 . . . . 0.0 110.744 -177.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.8 pp0? -69.43 -31.17 69.33 Favored 'General case' 0 C--O 1.227 -0.106 0 CA-C-N 118.821 0.737 . . . . 0.0 110.164 176.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -64.91 -47.72 76.73 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 176.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 63.6 tp -57.86 -46.67 84.49 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.354 0.662 . . . . 0.0 110.381 178.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 23.4 t -62.37 -49.27 84.61 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 CA-C-O 119.061 -0.495 . . . . 0.0 110.029 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.46 -26.96 68.67 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 119.171 0.896 . . . . 0.0 112.215 -175.557 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 61.6 mtpt -67.86 -29.76 68.97 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 118.597 -0.716 . . . . 0.0 112.041 171.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 86.1 m-70 -90.87 -21.35 21.46 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.259 0.936 . . . . 0.0 113.244 179.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 65.9 mt . . . . . 0 C--O 1.249 1.053 0 CA-C-N 119.569 1.077 . . . . 0.0 109.88 175.472 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.0 tpt . . . . . 0 N--CA 1.483 1.21 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.81 163.85 38.31 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 125.782 1.633 . . . . 0.0 108.359 176.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 79.8 mt -66.42 154.25 8.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 124.906 1.282 . . . . 0.0 107.783 177.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.6 t -119.48 167.53 12.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 125.348 1.459 . . . . 0.0 107.767 -168.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.7 tppp? -128.5 145.88 50.98 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 177.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -146.19 168.73 20.29 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 123.24 0.616 . . . . 0.0 110.332 171.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 72.0 p -135.44 173.57 11.57 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.584 1.553 . . . . 0.0 106.938 174.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -52.44 -30.5 29.92 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 119.701 1.137 . . . . 0.0 113.01 -176.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 26.0 mp0 -62.75 -30.73 71.66 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.097 1.759 . . . . 0.0 112.817 179.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.5 m -139.15 -3.78 1.55 Allowed 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -169.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 61.3 t80 -54.65 -37.79 66.12 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 123.938 0.895 . . . . 0.0 111.035 177.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.4 p -63.04 -50.5 70.42 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.671 0.788 . . . . 0.0 110.76 179.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.21 -44.87 92.26 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.017 0.527 . . . . 0.0 110.081 178.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -66.03 -37.89 87.0 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 119.348 -0.358 . . . . 0.0 111.445 -177.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 27.8 p -79.66 0.44 30.27 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 118.513 0.597 . . . . 0.0 112.549 -178.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.5 m -110.23 32.27 5.27 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.418 1.087 . . . . 0.0 112.312 -172.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 -131.81 2.22 4.04 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -177.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 167.34 -165.62 38.73 Favored Glycine 0 C--N 1.334 0.428 0 O-C-N 121.414 -0.804 . . . . 0.0 111.185 -176.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 1.9 t -76.66 134.86 27.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 104.275 -2.491 . . . . 0.0 104.275 168.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 30.2 t -138.34 141.57 37.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -172.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 58.9 tp -113.53 97.96 6.77 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 106.02 -1.844 . . . . 0.0 106.02 173.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.21 149.06 37.29 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 170.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -133.16 99.0 4.42 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 107.2 -1.408 . . . . 0.0 107.2 177.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -76.63 114.97 15.96 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 173.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 7.3 p-90 -138.84 175.89 9.17 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 123.401 0.68 . . . . 0.0 110.85 -169.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -151.61 146.66 19.05 Favored Pre-proline 0 CA--C 1.535 0.394 0 C-N-CA 124.53 1.132 . . . . 0.0 107.98 169.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.25 -17.85 18.68 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.962 2.441 . . . . 0.0 113.515 -169.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -84.81 -7.21 59.28 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 118.789 0.722 . . . . 0.0 112.088 177.439 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 54.1 t -87.82 117.08 26.41 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 -178.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -55.82 -55.72 27.52 Favored Glycine 0 CA--C 1.531 1.092 0 CA-C-O 118.691 -1.061 . . . . 0.0 112.201 175.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -51.15 -34.58 48.64 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 123.256 2.637 . . . . 0.0 115.434 176.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 97.7 m -60.92 -35.78 77.58 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 119.96 1.255 . . . . 0.0 111.672 173.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.1 mttm -70.14 -40.94 74.51 Favored 'General case' 0 N--CA 1.464 0.266 0 O-C-N 121.52 -0.737 . . . . 0.0 109.692 173.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 26.3 mmt -64.71 -38.17 90.07 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 118.231 0.469 . . . . 0.0 111.487 -176.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 10.8 tt -79.16 -15.97 13.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-N 118.394 0.543 . . . . 0.0 111.51 179.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.9 -48.97 94.46 Favored Pre-proline 0 CA--C 1.541 0.598 0 CA-C-O 117.472 -1.251 . . . . 0.0 113.597 -177.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.06 -27.73 49.67 Favored 'Trans proline' 0 C--N 1.35 0.632 0 CA-C-N 122.087 1.781 . . . . 0.0 112.461 176.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 6.0 t -66.42 -41.13 88.23 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-N 119.346 0.975 . . . . 0.0 109.059 174.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 66.0 mt -67.03 -34.28 77.37 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 118.745 -0.645 . . . . 0.0 110.961 175.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -69.45 -36.55 76.71 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 119.482 1.037 . . . . 0.0 111.496 174.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 44.0 mm-40 -61.17 -46.73 89.3 Favored 'General case' 0 CA--C 1.528 0.098 0 O-C-N 121.137 -0.977 . . . . 0.0 109.233 171.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -62.11 -35.96 80.3 Favored 'General case' 0 C--O 1.224 -0.255 0 C-N-CA 122.857 0.463 . . . . 0.0 111.557 177.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -65.28 -41.88 93.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 119.27 0.941 . . . . 0.0 110.427 176.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -68.01 -36.97 80.87 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 122.823 0.449 . . . . 0.0 111.634 178.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -93.35 -30.1 15.29 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.014 0.926 . . . . 0.0 112.426 -169.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 20.0 mmt -136.95 -3.41 2.02 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.39 1.476 . . . . 0.0 112.706 -169.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -52.12 -28.74 26.88 Favored Glycine 0 CA--C 1.538 1.469 0 CA-C-N 120.945 1.702 . . . . 0.0 113.277 177.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -73.67 -29.32 62.24 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.844 1.658 . . . . 0.0 111.434 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 55.3 mmtt -97.82 -25.97 14.86 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 125.444 1.498 . . . . 0.0 110.651 -177.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -150.58 126.11 10.2 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.095 0.958 . . . . 0.0 110.038 -167.357 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -73.76 152.49 40.34 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 175.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 17.6 mt -125.72 130.97 72.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 N-CA-C 105.645 -1.983 . . . . 0.0 105.645 175.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 22.0 t -132.07 113.66 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -170.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 48.2 mmtt -73.86 143.29 45.92 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 170.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 15.4 tt -149.02 125.34 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 169.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -80.28 128.57 33.69 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 22.5 m -70.02 -31.59 48.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 -173.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -77.6 -35.36 52.95 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 119.136 0.88 . . . . 0.0 109.755 -175.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -72.98 -15.9 61.53 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.861 0.864 . . . . 0.0 111.869 172.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 63.3 m-80 -139.77 51.97 1.72 Allowed 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 119.227 0.921 . . . . 0.0 111.044 -168.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -56.56 -38.66 72.22 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.791 0.836 . . . . 0.0 109.55 179.673 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -66.49 -27.74 68.02 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.946 1.298 . . . . 0.0 112.553 -177.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.42 -45.53 9.89 Favored 'General case' 0 C--O 1.222 -0.373 0 CA-C-N 118.809 0.731 . . . . 0.0 109.725 178.47 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.79 -46.9 85.85 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.271 0.941 . . . . 0.0 109.792 179.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -61.77 -22.37 61.95 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 124.48 1.038 . . . . 0.0 112.746 175.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.7 ttmm -57.84 -23.08 51.16 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 118.778 1.289 . . . . 0.0 111.852 174.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -125.76 13.58 8.01 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.688 1.195 . . . . 0.0 110.375 179.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 68.65 20.12 73.71 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 124.661 1.124 . . . . 0.0 113.689 -178.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 97.9 t -84.83 136.28 23.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 176.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -155.42 29.02 0.39 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.732 1.213 . . . . 0.0 109.258 167.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 20.8 m -138.15 154.41 49.17 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 126.678 1.991 . . . . 0.0 106.864 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -145.31 158.72 50.73 Favored Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 123.866 0.867 . . . . 0.0 110.143 -169.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -67.92 140.74 56.03 Favored 'Cis proline' 0 C--N 1.349 0.573 0 N-CA-C 109.168 -1.128 . . . . 0.0 109.168 -11.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 54.7 m -131.67 118.28 19.8 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 177.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 89.4 mt -93.54 137.98 32.28 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 178.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.0 mp -121.22 130.34 53.64 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 105.238 -2.134 . . . . 0.0 105.238 169.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.8 t -94.35 127.73 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 103.571 -2.751 . . . . 0.0 103.571 168.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.6 mp -125.33 160.42 29.37 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 125.198 1.399 . . . . 0.0 107.792 176.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -149.32 125.08 10.48 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.8 t70 44.88 34.98 1.34 Allowed 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.304 1.441 . . . . 0.0 113.714 177.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 109.71 -1.72 30.5 Favored Glycine 0 CA--C 1.527 0.785 0 CA-C-O 118.033 -1.426 . . . . 0.0 115.588 168.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -131.06 145.18 51.93 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 120.13 1.965 . . . . 0.0 110.288 -178.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.3 p -66.86 138.45 22.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 172.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 27.1 m -127.03 -16.47 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 125.68 1.592 . . . . 0.0 110.682 178.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.44 164.3 38.42 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 119.871 1.214 . . . . 0.0 110.902 169.18 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 93.9 m -146.37 137.83 24.61 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.461 1.505 . . . . 0.0 108.421 176.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 19.7 m -146.24 152.98 40.07 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.413 1.485 . . . . 0.0 108.691 -176.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 40.3 t -133.03 146.43 32.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 -173.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 85.49 178.62 50.51 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 124.451 1.024 . . . . 0.0 111.89 178.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -60.26 152.86 23.83 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.173 0.989 . . . . 0.0 110.575 174.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -141.42 148.2 49.65 Favored Pre-proline 0 C--O 1.234 0.257 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 168.282 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -71.56 158.59 53.38 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 122.381 2.054 . . . . 0.0 110.22 171.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -55.31 -45.97 76.28 Favored 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 123.397 0.679 . . . . 0.0 111.042 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -64.33 -42.04 96.49 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 118.345 0.521 . . . . 0.0 111.248 -169.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.0 -42.51 89.65 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 122.897 0.479 . . . . 0.0 110.878 175.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 43.3 tp -69.16 -41.01 77.8 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 119.233 -0.413 . . . . 0.0 110.744 -176.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.7 pp0? -70.8 -30.12 66.49 Favored 'General case' 0 C--N 1.337 0.058 0 CA-C-N 119.022 0.828 . . . . 0.0 110.303 176.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -64.07 -49.22 73.16 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 175.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 67.6 tp -57.65 -46.1 84.64 Favored 'General case' 0 CA--C 1.527 0.095 0 C-N-CA 123.869 0.867 . . . . 0.0 110.349 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 19.6 t -60.06 -53.45 48.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 177.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -63.35 -28.88 70.3 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 118.78 0.718 . . . . 0.0 112.395 -175.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -68.12 -32.13 72.2 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 118.475 -0.774 . . . . 0.0 111.958 173.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 58.0 m-70 -89.75 -16.73 29.66 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 119.326 0.966 . . . . 0.0 113.296 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 65.5 mt . . . . . 0 C--O 1.249 1.073 0 CA-C-N 119.737 1.153 . . . . 0.0 109.847 173.032 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.4 mmt . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 118.202 -0.904 . . . . 0.0 111.257 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 64.73 -178.38 0.17 Allowed 'General case' 0 C--O 1.238 0.481 0 C-N-CA 125.589 1.556 . . . . 0.0 113.332 177.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 21.2 mt -75.69 143.72 12.85 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 169.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 25.6 t -140.44 167.59 18.04 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 128.069 2.547 . . . . 0.0 105.678 -176.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.0 mtmt -125.62 144.36 50.62 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 173.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -144.8 170.1 16.77 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 122.913 0.485 . . . . 0.0 110.622 176.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 73.7 p -135.63 173.35 11.81 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 176.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -49.27 -32.38 10.75 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 119.669 1.122 . . . . 0.0 113.138 -177.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 25.3 mp0 -62.04 -31.58 71.99 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.408 1.883 . . . . 0.0 112.777 -179.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.3 m -139.92 -4.26 1.38 Allowed 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 -171.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -53.57 -37.59 63.07 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 124.305 1.042 . . . . 0.0 111.006 176.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.0 m -67.29 -38.83 85.66 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 122.49 0.316 . . . . 0.0 111.286 -178.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.18 -45.2 77.68 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 175.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -64.54 -37.12 86.46 Favored 'General case' 0 C--O 1.231 0.116 0 C-N-CA 122.64 0.376 . . . . 0.0 111.374 -175.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 19.9 p -77.28 -1.39 29.52 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 179.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 67.9 m -108.65 33.29 4.28 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.448 1.099 . . . . 0.0 111.933 -171.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -132.65 0.62 3.61 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -177.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 166.31 -165.55 38.31 Favored Glycine 0 C--N 1.336 0.535 0 CA-C-N 119.367 0.985 . . . . 0.0 111.424 -175.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 97.3 t -73.77 127.73 35.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 N-CA-C 104.6 -2.37 . . . . 0.0 104.6 166.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 39.2 t -133.72 122.64 43.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 -174.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 18.3 tp -87.8 139.22 30.75 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 105.84 -1.911 . . . . 0.0 105.84 168.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -125.01 113.67 18.1 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 -179.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -94.1 90.41 6.38 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 125.337 1.455 . . . . 0.0 108.391 -178.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -72.1 113.22 8.89 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 169.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 7.9 p-90 -138.79 176.42 8.71 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 123.561 0.744 . . . . 0.0 111.068 -169.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -151.84 146.6 18.85 Favored Pre-proline 0 CA--C 1.535 0.379 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 169.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.35 -20.17 16.45 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 122.744 2.296 . . . . 0.0 113.494 -171.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -81.95 -7.84 59.63 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 121.526 -0.734 . . . . 0.0 111.823 176.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 52.0 t -88.12 117.32 26.92 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -55.58 -57.92 16.4 Favored Glycine 0 CA--C 1.531 1.067 0 CA-C-O 118.572 -1.126 . . . . 0.0 111.598 173.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -49.89 -36.32 42.96 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 123.569 2.846 . . . . 0.0 115.434 177.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 98.0 m -60.02 -45.51 92.55 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 119.886 1.221 . . . . 0.0 111.418 173.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 46.5 mtmt -70.86 -30.58 67.02 Favored 'General case' 0 CA--C 1.53 0.174 0 O-C-N 121.465 -0.772 . . . . 0.0 110.639 178.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 86.5 mtp -68.37 -42.54 79.03 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 118.685 0.675 . . . . 0.0 111.226 176.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 7.4 tt -76.82 -21.45 14.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-N 119.1 0.863 . . . . 0.0 111.115 -178.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.17 -51.28 64.11 Favored Pre-proline 0 CA--C 1.546 0.823 0 CA-C-N 119.737 1.153 . . . . 0.0 113.915 -177.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.28 -30.5 54.23 Favored 'Trans proline' 0 C--N 1.349 0.59 0 CA-C-N 121.866 1.702 . . . . 0.0 112.364 176.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 6.8 t -65.49 -37.87 81.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-N 119.334 0.97 . . . . 0.0 109.521 174.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 82.6 mt -68.24 -33.41 74.33 Favored 'General case' 0 C--O 1.225 -0.213 0 CA-C-O 118.569 -0.729 . . . . 0.0 110.844 173.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -66.65 -36.13 81.81 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.836 1.198 . . . . 0.0 111.405 172.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 55.4 mm-40 -65.93 -39.05 90.17 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 120.808 -1.182 . . . . 0.0 110.149 172.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 46.9 tp -66.5 -36.66 83.27 Favored 'General case' 0 C--O 1.226 -0.144 0 O-C-N 121.648 -0.658 . . . . 0.0 110.731 175.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -66.29 -37.47 85.5 Favored 'General case' 0 N--CA 1.454 -0.238 0 O-C-N 121.586 -0.696 . . . . 0.0 111.096 176.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -64.36 -33.42 75.8 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.376 -0.828 . . . . 0.0 111.305 171.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -79.0 -39.16 34.83 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.301 1.04 . . . . 0.0 112.139 -177.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 21.2 mmt -133.5 -7.23 2.9 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 -166.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.97 -3.85 12.48 Favored Glycine 0 CA--C 1.531 1.079 0 CA-C-N 120.474 1.488 . . . . 0.0 115.142 -174.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -82.29 -27.5 32.3 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.518 1.527 . . . . 0.0 111.751 172.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -129.04 -1.77 5.19 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.837 1.655 . . . . 0.0 112.624 -172.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -139.38 155.87 47.37 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 126.828 2.051 . . . . 0.0 106.906 177.329 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -110.01 151.35 27.27 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 173.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 18.3 mt -119.72 136.7 56.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 105.064 -2.198 . . . . 0.0 105.064 170.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 99.5 t -126.24 115.14 41.43 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 -176.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 10.3 mmmm -75.19 140.88 43.59 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 171.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 16.6 tt -148.92 113.91 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 173.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 60.6 t0 -77.24 117.18 18.51 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 -178.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 30.6 m -62.88 -27.35 42.93 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -175.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -69.18 -28.87 66.79 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 119.331 0.969 . . . . 0.0 110.768 -178.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -93.62 -7.72 43.16 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.63 1.172 . . . . 0.0 111.073 177.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -141.38 47.12 1.7 Allowed 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 124.549 1.14 . . . . 0.0 109.929 -168.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.433 ' CD ' ' H ' ' A' ' 61' ' ' GLN . 1.4 mp0 -58.39 -40.9 83.6 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.315 1.046 . . . . 0.0 109.024 -177.294 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -63.21 -45.12 93.17 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.497 1.119 . . . . 0.0 110.399 179.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.469 ' HA ' ' HE3' ' A' ' 66' ' ' LYS . 0.8 OUTLIER -69.01 -43.77 74.14 Favored 'General case' 0 C--O 1.221 -0.433 0 CA-C-N 118.729 0.695 . . . . 0.0 110.362 -176.752 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.16 -45.68 92.31 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 119.166 0.894 . . . . 0.0 109.417 176.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -58.11 -26.37 58.44 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 124.232 0.92 . . . . 0.0 113.081 174.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.469 ' HE3' ' HA ' ' A' ' 63' ' ' THR . 27.4 ttmt -57.82 -21.54 42.84 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.459 1.504 . . . . 0.0 111.908 177.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -127.81 12.84 6.83 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.88 1.272 . . . . 0.0 110.532 179.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 68.95 20.18 74.34 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 124.558 1.075 . . . . 0.0 113.544 -177.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 85.2 t -85.35 137.08 21.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 176.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -157.66 28.9 0.28 Allowed 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.512 1.125 . . . . 0.0 109.523 167.043 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 44.1 m -135.08 154.06 51.81 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 126.317 1.847 . . . . 0.0 106.89 174.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -146.32 160.2 43.04 Favored Pre-proline 0 CA--C 1.543 0.688 0 C-N-CA 124.565 1.146 . . . . 0.0 109.273 -170.15 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -66.93 139.84 47.75 Favored 'Cis proline' 0 C--N 1.349 0.553 0 CA-C-N 120.161 1.093 . . . . 0.0 109.77 -10.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 41.5 m -132.99 133.79 43.61 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 178.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 78.6 mt -119.28 103.08 9.17 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 -172.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.7 mp -84.87 146.01 27.52 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 106.822 -1.548 . . . . 0.0 106.822 168.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.4 t -111.33 127.87 68.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 103.633 -2.728 . . . . 0.0 103.633 169.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.7 mp -127.0 158.62 36.44 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.308 1.443 . . . . 0.0 107.445 179.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -145.77 127.16 14.94 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 175.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.9 t70 44.3 37.44 1.98 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.389 1.476 . . . . 0.0 113.616 174.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.87 5.25 47.76 Favored Glycine 0 CA--C 1.527 0.783 0 CA-C-O 118.59 -1.117 . . . . 0.0 114.861 169.138 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 82.1 mm-40 -130.13 141.44 50.68 Favored 'General case' 0 CA--C 1.522 -0.105 0 CA-C-N 119.52 1.66 . . . . 0.0 109.133 178.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.5 p -69.25 137.42 24.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 169.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 25.3 m -125.21 -20.48 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 C-N-CA 124.989 1.316 . . . . 0.0 110.328 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.21 167.1 31.49 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 119.545 1.066 . . . . 0.0 111.454 175.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 80.7 m -148.43 141.05 24.47 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.55 1.54 . . . . 0.0 108.738 176.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 21.3 m -144.63 155.88 43.83 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.988 1.715 . . . . 0.0 108.309 177.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 39.5 t -133.81 149.72 30.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 -176.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.09 172.3 47.08 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 124.385 0.993 . . . . 0.0 112.449 172.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -63.92 131.19 46.93 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 123.59 0.756 . . . . 0.0 109.291 175.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -136.1 143.73 45.23 Favored Pre-proline 0 CA--C 1.534 0.35 0 C-N-CA 126.095 1.758 . . . . 0.0 107.035 179.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -74.68 156.83 44.43 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.691 2.26 . . . . 0.0 110.917 178.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.6 tmpt? -58.98 -36.24 74.54 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 123.449 0.699 . . . . 0.0 111.247 -177.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -67.52 -35.15 78.55 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 118.838 0.744 . . . . 0.0 111.269 -175.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.03 -42.61 72.73 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 122.886 0.474 . . . . 0.0 110.485 173.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 84.5 mt -67.05 -41.39 86.56 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-O 118.902 -0.57 . . . . 0.0 110.392 -178.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.0 pp0? -68.22 -30.8 69.95 Favored 'General case' 0 C--O 1.228 -0.075 0 CA-C-N 119.274 0.943 . . . . 0.0 110.247 177.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -65.41 -47.75 75.21 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 176.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 59.2 tp -58.47 -43.35 88.89 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.269 0.627 . . . . 0.0 110.652 178.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 39.6 t -61.22 -50.63 79.68 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 C-N-CA 123.103 0.561 . . . . 0.0 109.593 176.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -63.88 -26.89 68.81 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 118.975 0.807 . . . . 0.0 112.284 -175.346 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 62.1 mtpt -67.17 -18.55 65.32 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 118.056 -0.973 . . . . 0.0 112.997 171.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -114.34 -10.09 12.71 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 119.856 1.207 . . . . 0.0 113.658 -179.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 80.3 mt . . . . . 0 C--O 1.251 1.161 0 CA-C-N 120.032 1.287 . . . . 0.0 109.723 172.314 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.477 0.892 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -155.47 144.36 20.64 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 169.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 92.6 mt -75.93 144.29 12.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 177.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 40.5 t -105.33 166.48 3.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 -174.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 5.8 mptt -138.55 134.69 34.18 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 -178.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -143.45 170.7 15.3 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 122.935 0.494 . . . . 0.0 110.791 -179.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.1 p -135.29 171.71 14.05 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 178.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -49.5 -32.42 12.2 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 119.808 1.186 . . . . 0.0 113.021 -176.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 25.2 mp0 -63.48 -30.35 71.49 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.716 2.007 . . . . 0.0 112.923 -179.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.6 m -138.61 -6.7 1.5 Allowed 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 114.358 1.244 . . . . 0.0 114.358 -172.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -56.22 -34.83 66.69 Favored 'General case' 0 C--N 1.333 -0.122 0 C-N-CA 124.606 1.162 . . . . 0.0 111.11 178.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.4 p -62.75 -48.47 79.07 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 123.649 0.78 . . . . 0.0 111.062 178.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.33 -44.88 96.44 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 122.78 0.432 . . . . 0.0 109.862 177.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -65.14 -37.6 87.93 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 119.274 -0.393 . . . . 0.0 111.546 -176.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.3 p -78.93 0.25 28.16 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 118.595 0.634 . . . . 0.0 112.533 -179.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 48.8 m -112.03 34.43 4.24 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.406 1.082 . . . . 0.0 111.962 -171.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -131.78 -1.35 3.79 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -178.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 166.41 -167.09 39.27 Favored Glycine 0 C--N 1.335 0.518 0 CA-C-N 119.198 0.908 . . . . 0.0 110.872 -172.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 76.9 t -72.3 134.06 30.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 104.874 -2.269 . . . . 0.0 104.874 167.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 38.8 t -137.12 119.25 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 -176.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 60.5 tp -88.75 97.44 11.14 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 170.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.47 149.41 36.79 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 169.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -133.21 98.41 4.25 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 176.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -73.97 113.45 11.16 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 172.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 6.0 p-90 -136.26 175.89 9.19 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 123.721 0.808 . . . . 0.0 110.219 -169.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -149.89 144.98 18.22 Favored Pre-proline 0 CA--C 1.534 0.345 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 169.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.37 -21.91 22.38 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 122.438 2.092 . . . . 0.0 113.471 -170.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -83.84 -8.24 59.26 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 118.693 0.679 . . . . 0.0 112.228 178.609 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 53.7 t -85.15 117.63 24.22 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -178.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -54.58 -57.11 18.93 Favored Glycine 0 CA--C 1.532 1.154 0 CA-C-O 118.651 -1.083 . . . . 0.0 112.137 176.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -50.86 -35.87 50.57 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 123.18 2.586 . . . . 0.0 115.093 175.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 90.7 m -62.1 -37.05 83.6 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 119.676 1.126 . . . . 0.0 111.882 173.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -69.63 -42.07 74.79 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 118.804 0.729 . . . . 0.0 109.851 172.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 62.0 mtt -62.36 -38.01 87.9 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 122.948 0.499 . . . . 0.0 111.159 -175.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 10.9 tt -78.86 -16.04 13.54 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-N 118.569 0.622 . . . . 0.0 111.848 -178.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.03 -51.22 82.38 Favored Pre-proline 0 CA--C 1.544 0.728 0 CA-C-N 120.069 1.304 . . . . 0.0 113.57 -178.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -64.3 -30.31 63.69 Favored 'Trans proline' 0 C--N 1.351 0.672 0 CA-C-N 121.769 1.667 . . . . 0.0 111.872 176.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.4 t -64.82 -42.14 94.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-N 118.908 0.776 . . . . 0.0 109.56 176.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 66.2 mt -66.88 -32.98 74.59 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 118.347 -0.835 . . . . 0.0 110.734 175.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -68.29 -37.95 81.17 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 120.206 1.366 . . . . 0.0 111.49 173.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -64.62 -31.55 72.82 Favored 'General case' 0 C--N 1.334 -0.095 0 O-C-N 121.225 -0.922 . . . . 0.0 110.99 172.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 18.5 tp -76.82 -38.81 53.17 Favored 'General case' 0 N--CA 1.448 -0.56 0 O-C-N 121.82 -0.55 . . . . 0.0 110.857 174.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -64.73 -36.59 84.77 Favored 'General case' 0 C--O 1.23 0.068 0 C-N-CA 124.354 1.062 . . . . 0.0 110.654 -178.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -76.48 -22.03 55.05 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 121.894 -0.504 . . . . 0.0 111.977 -177.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 89.0 mt-10 -94.33 -34.7 12.71 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.462 1.105 . . . . 0.0 113.158 178.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 32.8 mtt -136.76 -4.55 1.99 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 118.046 -0.978 . . . . 0.0 113.263 -169.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -76.34 49.81 2.7 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 125.878 1.704 . . . . 0.0 113.11 -173.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -154.98 -40.69 0.09 Allowed 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 129.678 3.191 . . . . 0.0 106.915 171.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 57.3 mttp -61.62 -36.98 82.29 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.291 1.436 . . . . 0.0 109.817 168.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -134.02 165.5 24.9 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 126.545 1.938 . . . . 0.0 109.603 170.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -101.48 151.66 21.69 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.428 1.091 . . . . 0.0 108.135 171.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 18.7 mt -116.48 134.75 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 N-CA-C 105.118 -2.178 . . . . 0.0 105.118 170.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 87.2 t -132.43 117.57 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -176.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 55.6 mmtt -75.7 144.91 41.31 Favored 'General case' 0 C--O 1.235 0.303 0 O-C-N 121.695 -0.628 . . . . 0.0 109.663 169.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 15.3 tt -148.19 119.13 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 169.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 50.9 t0 -82.72 114.13 20.86 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.969 0.907 . . . . 0.0 109.924 -174.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 25.0 m -63.02 -22.89 31.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 -174.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -66.01 -30.54 71.1 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 119.016 0.826 . . . . 0.0 111.275 -175.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -99.66 -39.29 8.34 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 123.267 0.627 . . . . 0.0 109.73 173.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 -89.45 46.29 1.36 Allowed 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 124.268 1.027 . . . . 0.0 111.245 -169.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -56.11 -43.02 77.73 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 126.624 1.97 . . . . 0.0 108.816 179.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 30.7 mm-40 -67.5 -27.38 66.95 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 125.112 1.365 . . . . 0.0 112.306 -177.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.45 -46.01 9.49 Favored 'General case' 0 C--O 1.222 -0.392 0 CA-C-N 118.599 0.636 . . . . 0.0 109.687 179.519 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.87 -46.03 89.78 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 119.321 0.964 . . . . 0.0 109.624 179.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -60.65 -24.17 61.74 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 124.095 0.855 . . . . 0.0 112.862 175.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.2 ttmm -58.13 -23.49 55.28 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 118.573 1.187 . . . . 0.0 112.056 176.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -124.87 13.05 8.5 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.734 1.214 . . . . 0.0 110.487 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 68.96 19.61 73.83 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 124.538 1.066 . . . . 0.0 113.691 -178.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 96.5 t -84.28 135.63 24.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 176.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.18 28.22 0.46 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.586 1.154 . . . . 0.0 109.372 168.019 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 22.5 m -138.12 152.76 49.05 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 126.704 2.002 . . . . 0.0 106.77 178.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -145.72 160.09 45.31 Favored Pre-proline 0 CA--C 1.541 0.602 0 C-N-CA 124.058 0.943 . . . . 0.0 109.905 -169.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -66.94 139.52 46.19 Favored 'Cis proline' 0 C--N 1.349 0.601 0 N-CA-C 109.366 -1.051 . . . . 0.0 109.366 -11.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 51.9 m -132.0 117.74 18.8 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 177.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 95.4 mt -92.8 136.7 33.01 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 179.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.8 mp -121.09 130.92 53.96 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 105.061 -2.2 . . . . 0.0 105.061 169.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.5 t -93.56 124.24 45.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 103.196 -2.89 . . . . 0.0 103.196 168.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.9 mp -118.75 159.01 24.45 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 173.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 73.7 tttt -145.2 126.73 15.06 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 173.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.7 t70 44.33 38.62 2.58 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.395 1.478 . . . . 0.0 113.484 175.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 101.21 5.33 52.86 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-O 118.598 -1.112 . . . . 0.0 114.862 169.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 82.1 mm-40 -130.49 142.31 50.49 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 119.513 1.657 . . . . 0.0 109.142 178.051 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.2 p -68.54 138.32 22.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 169.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 33.0 m -126.75 -20.68 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 125.062 1.345 . . . . 0.0 110.478 179.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -153.08 166.9 31.01 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 119.73 1.15 . . . . 0.0 111.339 171.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 96.1 m -148.67 141.04 24.19 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.577 1.551 . . . . 0.0 108.732 177.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 16.0 m -147.68 156.62 42.96 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.565 1.546 . . . . 0.0 108.611 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 40.6 t -132.99 149.41 31.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -174.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.66 173.99 45.8 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 124.424 1.011 . . . . 0.0 112.299 176.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -59.02 150.74 23.89 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.165 0.986 . . . . 0.0 110.68 177.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -153.94 147.27 18.2 Favored Pre-proline 0 CA--C 1.532 0.279 0 C-N-CA 125.057 1.343 . . . . 0.0 107.514 169.199 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.3 159.28 47.27 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.761 2.307 . . . . 0.0 110.81 179.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 2.9 ttpp -57.44 -36.51 71.49 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.898 0.879 . . . . 0.0 111.51 -177.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -62.4 -36.2 81.59 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.471 0.578 . . . . 0.0 112.059 177.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.79 -40.6 69.11 Favored 'General case' 0 N--CA 1.453 -0.31 0 O-C-N 121.924 -0.485 . . . . 0.0 110.814 174.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 42.7 mt -64.18 -43.44 95.11 Favored 'General case' 0 N--CA 1.457 -0.08 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -179.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.0 pp0? -68.89 -31.66 70.74 Favored 'General case' 0 C--O 1.226 -0.149 0 CA-C-N 118.62 0.645 . . . . 0.0 110.258 178.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -64.23 -49.57 71.41 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 176.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 58.9 tp -57.16 -44.69 83.7 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.372 0.669 . . . . 0.0 110.476 178.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 37.3 t -65.42 -47.34 87.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 CA-C-O 118.946 -0.549 . . . . 0.0 110.638 179.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.29 -25.52 68.09 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 119.606 1.094 . . . . 0.0 112.341 -175.181 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -66.1 -16.42 63.93 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 117.897 -1.049 . . . . 0.0 113.167 171.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -121.64 -10.51 8.77 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 119.96 1.255 . . . . 0.0 113.822 -177.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 66.6 mt . . . . . 0 C--O 1.25 1.101 0 CA-C-N 120.114 1.325 . . . . 0.0 109.39 169.958 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.5 ttt . . . . . 0 N--CA 1.479 0.995 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -158.64 143.99 16.43 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 125.166 1.386 . . . . 0.0 107.837 168.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 81.8 mt -78.09 154.51 5.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 173.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 20.3 t -124.69 169.45 16.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 106.106 -1.812 . . . . 0.0 106.106 -172.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.82 153.25 49.65 Favored 'General case' 0 C--O 1.234 0.274 0 O-C-N 120.809 -1.182 . . . . 0.0 109.168 171.498 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -147.73 171.15 16.13 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 123.687 0.795 . . . . 0.0 110.047 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 72.9 p -134.62 173.22 11.9 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 175.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -51.69 -30.76 23.33 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 119.644 1.111 . . . . 0.0 112.977 -176.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 26.1 mp0 -62.13 -31.64 72.14 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.061 1.744 . . . . 0.0 112.728 179.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.4 m -139.61 -2.93 1.52 Allowed 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 114.475 1.287 . . . . 0.0 114.475 -169.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 58.2 t80 -53.63 -38.5 64.12 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 123.95 0.9 . . . . 0.0 110.773 176.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.4 m -66.37 -41.82 88.88 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 122.691 0.397 . . . . 0.0 111.205 -178.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.83 -45.26 86.91 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 176.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -65.3 -37.49 87.3 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 122.568 0.347 . . . . 0.0 111.247 -176.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.9 p -78.32 0.49 25.26 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 60.0 m -109.34 32.23 5.15 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.375 1.07 . . . . 0.0 112.302 -173.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -132.44 3.72 3.93 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -177.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 166.59 -166.68 39.12 Favored Glycine 0 C--N 1.335 0.498 0 O-C-N 121.339 -0.85 . . . . 0.0 111.162 -177.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.2 t -76.2 136.12 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 103.717 -2.698 . . . . 0.0 103.717 167.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 40.5 t -137.29 139.58 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 -172.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -117.73 97.2 5.72 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 105.331 -2.1 . . . . 0.0 105.331 176.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.56 154.83 28.49 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 172.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -135.7 98.95 4.05 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 125.718 1.607 . . . . 0.0 107.015 -179.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -73.87 116.39 14.43 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 169.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 9.1 p-90 -137.47 175.06 9.94 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.015 0.926 . . . . 0.0 110.759 -172.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -151.83 146.8 19.05 Favored Pre-proline 0 CA--C 1.538 0.485 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 169.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.25 -17.14 21.84 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.835 2.357 . . . . 0.0 113.625 -169.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -85.0 -6.49 59.33 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 118.715 0.689 . . . . 0.0 112.494 178.097 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 42.4 t -91.16 117.98 30.06 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 118.997 0.817 . . . . 0.0 109.066 -176.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -56.84 -54.02 39.78 Favored Glycine 0 CA--C 1.532 1.103 0 CA-C-O 118.812 -0.993 . . . . 0.0 112.414 176.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -50.53 -36.39 49.27 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 123.19 2.594 . . . . 0.0 115.272 174.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 98.6 m -60.6 -36.62 79.02 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 120.03 1.286 . . . . 0.0 111.831 173.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 59.9 mttm -69.8 -42.94 73.07 Favored 'General case' 0 N--CA 1.464 0.231 0 O-C-N 121.601 -0.687 . . . . 0.0 109.591 174.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 74.2 mtm -64.65 -35.01 79.65 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 118.987 -0.53 . . . . 0.0 111.771 -176.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 11.7 tt -80.94 -16.46 12.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-N 119.095 0.861 . . . . 0.0 111.811 179.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.53 -49.0 91.01 Favored Pre-proline 0 CA--C 1.543 0.709 0 CA-C-O 117.526 -1.226 . . . . 0.0 113.643 -179.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.52 -27.43 46.34 Favored 'Trans proline' 0 C--N 1.35 0.608 0 CA-C-N 122.048 1.767 . . . . 0.0 112.572 176.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.3 t -66.65 -40.41 86.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 119.226 0.921 . . . . 0.0 109.18 174.026 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 62.8 mt -66.94 -35.59 80.32 Favored 'General case' 0 CA--C 1.529 0.159 0 O-C-N 121.688 -0.632 . . . . 0.0 110.888 175.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -68.48 -36.2 78.62 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 119.269 0.941 . . . . 0.0 111.422 174.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -62.04 -43.17 99.42 Favored 'General case' 0 C--N 1.332 -0.158 0 O-C-N 121.122 -0.986 . . . . 0.0 109.903 171.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -65.26 -35.02 79.74 Favored 'General case' 0 N--CA 1.456 -0.171 0 O-C-N 121.93 -0.481 . . . . 0.0 111.509 176.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -65.7 -38.63 89.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 119.044 0.838 . . . . 0.0 110.357 175.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -68.91 -38.03 79.33 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 121.323 -0.861 . . . . 0.0 111.737 175.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -85.99 -36.16 19.96 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.258 1.023 . . . . 0.0 112.064 -171.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.431 ' SD ' ' HE2' ' A' ' 49' ' ' LYS . 19.0 mmt -135.57 -8.37 2.19 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.169 1.387 . . . . 0.0 112.626 -168.042 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.5 -21.41 54.32 Favored Glycine 0 CA--C 1.532 1.123 0 CA-C-N 120.321 1.419 . . . . 0.0 114.577 -171.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -76.79 -18.51 58.37 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.626 1.97 . . . . 0.0 112.134 -179.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.431 ' HE2' ' SD ' ' A' ' 46' ' ' MET . 14.8 pttm -134.02 -2.07 2.93 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 126.56 1.944 . . . . 0.0 112.239 -173.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -145.2 120.22 10.04 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 125.996 1.718 . . . . 0.0 107.424 174.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -73.07 150.99 41.86 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 176.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 16.9 mt -121.97 132.7 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 N-CA-C 105.892 -1.892 . . . . 0.0 105.892 173.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 48.0 t -132.15 111.75 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-N 118.687 0.676 . . . . 0.0 109.495 -170.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 61.2 mmtt -72.86 142.27 47.96 Favored 'General case' 0 C--O 1.234 0.288 0 O-C-N 121.551 -0.718 . . . . 0.0 109.49 171.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 11.9 tt -151.26 131.36 3.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 171.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -87.44 129.64 34.98 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 121.375 -0.828 . . . . 0.0 109.579 -177.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.0 m -66.31 -36.21 76.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 -174.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -75.0 -35.44 62.02 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 119.146 0.885 . . . . 0.0 109.762 -173.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -74.14 -15.67 61.02 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.699 0.799 . . . . 0.0 112.043 173.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 60.1 m-80 -141.11 49.61 1.65 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 119.523 1.056 . . . . 0.0 111.558 -167.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -56.82 -38.8 73.12 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.956 0.902 . . . . 0.0 109.478 179.563 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -65.87 -28.2 68.78 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 125.034 1.334 . . . . 0.0 112.572 -178.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.43 -44.23 10.89 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-N 118.673 0.67 . . . . 0.0 109.797 179.036 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.23 -46.58 86.3 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 119.017 0.826 . . . . 0.0 109.731 178.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -60.94 -24.17 62.4 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 124.166 0.889 . . . . 0.0 112.466 175.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.9 ttmm -58.52 -22.07 54.11 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.298 1.039 . . . . 0.0 111.966 175.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -122.19 12.03 10.22 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.659 1.184 . . . . 0.0 110.854 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 70.78 31.8 67.22 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 123.743 0.687 . . . . 0.0 112.573 -178.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 94.9 t -111.08 139.22 35.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 C-N-CA 124.962 1.305 . . . . 0.0 107.825 -178.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 9.1 tpt -155.23 30.09 0.39 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.372 1.069 . . . . 0.0 108.807 167.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 19.3 m -138.39 157.01 47.06 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 126.335 1.854 . . . . 0.0 107.456 -177.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -144.33 157.35 56.56 Favored Pre-proline 0 CA--C 1.54 0.569 0 CA-C-O 118.462 -0.78 . . . . 0.0 110.79 -169.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -66.81 139.76 46.91 Favored 'Cis proline' 0 N--CA 1.458 -0.575 0 N-CA-C 109.335 -1.064 . . . . 0.0 109.335 -11.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 85.0 m -133.6 116.07 15.44 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 174.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 72.7 mt -86.46 144.68 27.16 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 175.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -129.24 126.82 39.95 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 104.261 -2.496 . . . . 0.0 104.261 -178.068 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.1 t -111.33 123.52 67.26 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.414 0 N-CA-C 104.367 -2.457 . . . . 0.0 104.367 -175.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.0 mp -129.65 161.75 29.87 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 124.525 1.13 . . . . 0.0 108.236 -177.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 63.0 tttm -149.03 127.34 12.16 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 176.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.8 t70 43.39 35.27 0.87 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.428 1.491 . . . . 0.0 113.684 176.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 105.38 1.74 40.95 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-O 118.11 -1.383 . . . . 0.0 115.224 169.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -130.34 145.79 51.83 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 120.044 1.922 . . . . 0.0 110.089 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.6 p -69.37 141.45 17.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 C-N-CA 123.924 0.89 . . . . 0.0 109.306 174.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 35.6 m -129.42 -18.32 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 C-N-CA 125.709 1.604 . . . . 0.0 110.693 178.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -161.06 169.46 22.41 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 120.543 1.52 . . . . 0.0 111.669 170.149 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 54.5 m -145.82 144.65 30.4 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.07 1.748 . . . . 0.0 108.01 169.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 15.8 m -146.86 150.2 34.78 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 124.636 1.174 . . . . 0.0 108.83 -178.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 39.9 t -129.61 148.21 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -171.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.55 179.06 51.92 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 124.015 0.817 . . . . 0.0 111.708 178.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -62.43 151.58 36.73 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.539 0.736 . . . . 0.0 110.623 176.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.35 145.91 33.98 Favored Pre-proline 0 C--O 1.234 0.253 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 167.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -70.91 163.57 38.73 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.658 2.238 . . . . 0.0 110.173 173.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -54.78 -44.66 73.92 Favored 'General case' 0 C--O 1.224 -0.266 0 CA-C-O 118.585 -0.722 . . . . 0.0 110.694 179.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -63.81 -41.62 97.85 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 118.849 0.75 . . . . 0.0 111.319 -169.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.54 -42.71 82.25 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 123.22 0.608 . . . . 0.0 110.893 176.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 42.4 tp -69.37 -40.25 77.55 Favored 'General case' 0 N--CA 1.451 -0.416 0 O-C-N 122.124 -0.36 . . . . 0.0 110.808 -177.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.5 pp0? -71.71 -29.32 64.43 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 118.888 0.767 . . . . 0.0 110.062 176.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -64.04 -49.29 72.95 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 174.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 59.1 tp -57.33 -44.14 83.96 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 123.751 0.82 . . . . 0.0 110.515 178.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 11.1 t -62.19 -52.1 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 176.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.83 -25.15 67.78 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 119.095 0.861 . . . . 0.0 112.313 -175.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -67.74 -17.14 64.45 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 117.938 -1.03 . . . . 0.0 113.004 171.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -114.2 -15.07 12.25 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 120.017 1.281 . . . . 0.0 113.182 176.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 53.2 mt . . . . . 0 C--O 1.249 1.067 0 CA-C-N 119.403 1.001 . . . . 0.0 109.493 169.387 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 N--CA 1.478 0.941 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -155.11 144.6 21.25 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.73 1.212 . . . . 0.0 107.78 169.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 89.8 mt -78.2 146.16 8.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 177.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 39.0 t -107.05 167.19 3.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 -174.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 5.7 mptt -138.47 136.53 36.27 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 -177.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -144.84 169.75 17.45 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 123.035 0.534 . . . . 0.0 110.957 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 75.8 p -133.71 176.75 8.27 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.989 1.316 . . . . 0.0 108.162 177.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -51.05 -31.97 20.4 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 120.307 1.412 . . . . 0.0 112.773 -178.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 24.3 mp0 -67.93 -25.9 65.7 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.664 1.985 . . . . 0.0 112.792 -178.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 51.7 p -135.92 -17.56 1.64 Allowed 'General case' 0 C--O 1.234 0.241 0 N-CA-C 115.343 1.608 . . . . 0.0 115.343 -168.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -53.89 -34.81 60.56 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 124.909 1.283 . . . . 0.0 110.869 179.021 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.0 m -70.22 -37.91 75.13 Favored 'General case' 0 N--CA 1.453 -0.282 0 O-C-N 122.303 -0.248 . . . . 0.0 111.116 -176.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.15 -45.82 72.49 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 174.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -64.61 -37.39 87.39 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 119.283 -0.389 . . . . 0.0 111.468 -174.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.7 p -78.38 -0.11 27.81 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -178.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 62.1 m -111.38 33.76 4.5 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.228 1.011 . . . . 0.0 111.999 -170.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -132.21 -1.29 3.63 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 -177.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 166.67 -166.87 39.27 Favored Glycine 0 C--N 1.335 0.523 0 N-CA-C 110.686 -0.966 . . . . 0.0 110.686 -173.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 72.9 t -72.01 134.72 29.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 104.695 -2.335 . . . . 0.0 104.695 166.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.1 t -137.56 124.11 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 -176.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 61.6 tp -94.46 97.94 10.51 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 173.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.97 150.01 35.91 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 170.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -132.89 99.77 4.7 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 125.375 1.47 . . . . 0.0 107.262 175.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -76.95 114.57 15.89 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 172.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 9.1 p-90 -137.7 175.05 9.94 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 123.273 0.629 . . . . 0.0 110.689 -169.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -152.93 146.78 18.34 Favored Pre-proline 0 CA--C 1.535 0.397 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 168.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -73.49 -22.27 18.6 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.613 2.208 . . . . 0.0 113.187 -169.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -81.88 -7.21 59.59 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.398 0.679 . . . . 0.0 112.28 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 48.4 t -93.12 110.61 22.1 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 -177.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -50.09 -52.18 27.69 Favored Glycine 0 CA--C 1.533 1.205 0 CA-C-O 118.852 -0.971 . . . . 0.0 113.024 177.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_exo -51.3 -34.73 50.81 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 123.13 2.553 . . . . 0.0 115.366 173.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 93.6 m -62.53 -37.0 84.38 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 120.182 1.355 . . . . 0.0 111.428 173.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -69.05 -43.14 75.27 Favored 'General case' 0 N--CA 1.463 0.198 0 O-C-N 121.722 -0.611 . . . . 0.0 109.704 173.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 75.1 mtm -65.28 -33.65 76.49 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 118.439 0.563 . . . . 0.0 111.911 -176.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.4 tt -82.0 -15.44 12.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-N 119.152 0.887 . . . . 0.0 111.852 179.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.27 -48.94 93.02 Favored Pre-proline 0 CA--C 1.544 0.725 0 CA-C-O 117.593 -1.194 . . . . 0.0 113.331 179.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.07 -28.68 56.98 Favored 'Trans proline' 0 C--N 1.351 0.665 0 CA-C-N 121.88 1.707 . . . . 0.0 112.412 175.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 16.5 t -65.91 -40.19 86.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 119.569 1.077 . . . . 0.0 109.491 174.06 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 70.3 mt -67.51 -33.25 74.69 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-O 118.657 -0.687 . . . . 0.0 110.855 176.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -68.56 -36.0 78.18 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.443 1.02 . . . . 0.0 111.583 172.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 -61.9 -45.34 94.17 Favored 'General case' 0 C--O 1.227 -0.097 0 O-C-N 120.839 -1.163 . . . . 0.0 109.426 171.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -61.73 -36.22 80.33 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 118.523 0.601 . . . . 0.0 111.511 174.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -66.03 -37.51 86.06 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 118.919 0.781 . . . . 0.0 110.691 178.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -70.7 -45.81 64.28 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 122.993 0.517 . . . . 0.0 111.169 176.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -79.78 -33.2 40.78 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.469 1.107 . . . . 0.0 111.738 -169.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.413 ' HA ' ' HE3' ' A' ' 49' ' ' LYS . 22.2 mmt -139.95 -9.01 1.18 Allowed 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 117.808 -1.092 . . . . 0.0 113.842 -168.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -75.21 47.83 2.03 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 126.134 1.826 . . . . 0.0 114.569 -169.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -150.95 -39.75 0.13 Allowed 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 128.129 2.572 . . . . 0.0 107.584 169.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.413 ' HE3' ' HA ' ' A' ' 46' ' ' MET . 41.4 mtmt -65.22 -30.7 71.61 Favored 'General case' 0 C--N 1.342 0.28 0 C-N-CA 124.492 1.117 . . . . 0.0 110.651 169.041 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -134.25 164.37 27.54 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 125.486 1.514 . . . . 0.0 110.198 169.522 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -99.26 152.46 19.9 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 124.673 1.189 . . . . 0.0 108.182 172.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 19.0 mt -118.41 136.32 55.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 N-CA-C 105.488 -2.041 . . . . 0.0 105.488 172.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 79.1 t -133.17 117.76 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 119.054 0.843 . . . . 0.0 108.802 -176.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 55.1 mmtt -76.29 145.16 39.81 Favored 'General case' 0 C--O 1.234 0.284 0 O-C-N 121.672 -0.642 . . . . 0.0 109.859 169.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 16.0 tt -148.76 119.03 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 169.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -82.24 116.72 21.9 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -177.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 33.9 m -62.19 -25.83 38.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -174.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -66.1 -29.96 70.38 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 119.513 1.051 . . . . 0.0 110.949 -177.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -100.75 -3.27 30.42 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.298 1.039 . . . . 0.0 110.99 179.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 -141.65 43.48 1.73 Allowed 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.715 1.206 . . . . 0.0 109.942 -168.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.448 ' CD ' ' H ' ' A' ' 61' ' ' GLN . 1.0 OUTLIER -58.33 -41.5 84.71 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.804 1.242 . . . . 0.0 108.77 -177.937 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -64.5 -42.97 95.51 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.91 0.884 . . . . 0.0 110.509 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.498 ' HA ' ' HE3' ' A' ' 66' ' ' LYS . 0.5 OUTLIER -68.94 -44.04 73.86 Favored 'General case' 0 C--O 1.221 -0.397 0 CA-C-N 118.776 0.716 . . . . 0.0 110.255 -177.519 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.3 -45.1 94.77 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 119.094 0.861 . . . . 0.0 109.347 176.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -57.46 -27.53 58.41 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 124.077 0.846 . . . . 0.0 112.702 174.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.498 ' HE3' ' HA ' ' A' ' 63' ' ' THR . 25.7 ttmt -58.49 -21.22 51.06 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.656 1.582 . . . . 0.0 111.924 178.566 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -126.61 13.74 7.53 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.657 1.183 . . . . 0.0 110.687 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 71.71 32.56 64.05 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 123.775 0.702 . . . . 0.0 112.754 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 93.6 t -109.85 137.87 40.08 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 C-N-CA 124.806 1.243 . . . . 0.0 107.756 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 8.4 tpt -155.95 31.45 0.35 Allowed 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.355 1.062 . . . . 0.0 108.804 166.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 20.4 m -138.27 152.39 48.5 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 126.779 2.031 . . . . 0.0 106.643 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -146.11 159.08 47.14 Favored Pre-proline 0 CA--C 1.54 0.592 0 C-N-CA 123.95 0.9 . . . . 0.0 110.02 -169.417 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -67.17 138.94 43.95 Favored 'Cis proline' 0 C--N 1.349 0.59 0 CA-C-N 119.956 1.02 . . . . 0.0 109.691 -10.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 54.9 m -132.36 116.9 17.43 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 177.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 81.0 mt -92.45 137.13 32.63 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 177.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.6 mp -122.39 132.47 54.39 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 105.74 -1.948 . . . . 0.0 105.74 169.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 17.0 t -95.58 125.9 48.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 103.09 -2.929 . . . . 0.0 103.09 168.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.8 mp -120.72 159.18 25.91 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 125.422 1.489 . . . . 0.0 107.322 175.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -146.28 125.12 12.66 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 176.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.9 t70 45.81 35.66 2.39 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.311 1.444 . . . . 0.0 113.694 175.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 110.04 -2.53 30.02 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-O 118.055 -1.414 . . . . 0.0 115.484 168.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -131.57 144.43 51.08 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 120.081 1.941 . . . . 0.0 110.2 -178.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 5.3 p -65.72 137.16 25.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 171.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 34.3 m -121.12 -21.5 3.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 125.175 1.39 . . . . 0.0 110.433 176.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -157.31 162.73 39.14 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 119.701 1.137 . . . . 0.0 111.312 174.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 90.6 m -136.57 149.28 47.99 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.383 1.873 . . . . 0.0 108.416 175.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 30.4 m -147.35 152.81 38.82 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 126.267 1.827 . . . . 0.0 107.834 170.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 41.3 t -133.13 144.44 36.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 -175.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 80.22 179.83 52.86 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 123.907 0.765 . . . . 0.0 111.582 -179.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -62.97 147.7 49.78 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.683 0.793 . . . . 0.0 110.667 178.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 69.2 mttt -142.37 147.66 44.28 Favored Pre-proline 0 CA--C 1.531 0.233 0 C-N-CA 125.713 1.605 . . . . 0.0 106.898 168.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -73.2 159.44 47.27 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.581 2.187 . . . . 0.0 110.459 176.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 17.1 ptmt -55.55 -48.94 73.94 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 112.257 0.465 . . . . 0.0 112.257 -177.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -61.9 -39.29 91.46 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 123.59 0.756 . . . . 0.0 110.868 -169.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.64 -42.8 73.78 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 122.823 0.449 . . . . 0.0 110.855 176.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 46.5 tp -68.66 -38.42 80.39 Favored 'General case' 0 N--CA 1.451 -0.41 0 O-C-N 122.039 -0.413 . . . . 0.0 110.857 -178.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.4 pp0? -72.06 -29.47 64.17 Favored 'General case' 0 C--N 1.339 0.118 0 CA-C-N 119.174 0.897 . . . . 0.0 110.314 175.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -63.5 -48.85 75.89 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 174.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 59.3 tp -58.59 -44.97 90.0 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.191 0.596 . . . . 0.0 110.558 179.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.6 t -60.22 -51.43 73.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 C-N-CA 122.898 0.479 . . . . 0.0 109.74 177.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.37 -27.99 69.39 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 118.893 0.77 . . . . 0.0 112.121 -176.57 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -68.56 -25.87 65.12 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 118.303 -0.856 . . . . 0.0 112.345 172.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 75.5 m-70 -96.69 -16.98 20.63 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 119.68 1.127 . . . . 0.0 113.421 178.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 67.8 mt . . . . . 0 C--O 1.25 1.115 0 CA-C-N 119.813 1.188 . . . . 0.0 109.665 173.543 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mpt? . . . . . 0 N--CA 1.482 1.125 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -158.26 142.38 15.75 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.309 1.443 . . . . 0.0 107.374 168.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 86.7 mt -76.24 154.01 5.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 174.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 35.7 t -122.68 167.1 16.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 -175.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 6.1 mtmt -132.34 143.76 50.08 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 176.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -144.89 170.43 16.16 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 123.12 0.568 . . . . 0.0 110.246 175.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 77.4 p -134.62 173.61 11.48 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.915 1.286 . . . . 0.0 107.636 177.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -50.49 -30.65 13.33 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 119.271 0.941 . . . . 0.0 113.132 -177.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 26.9 mp0 -64.25 -32.23 73.74 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.13 1.772 . . . . 0.0 112.794 -179.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.2 m -140.02 -5.57 1.29 Allowed 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 -169.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -52.26 -38.8 59.22 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 124.355 1.062 . . . . 0.0 110.786 175.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.4 m -67.75 -36.15 80.01 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 122.675 0.39 . . . . 0.0 111.656 -176.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.92 -45.99 69.41 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 175.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -64.03 -35.23 80.03 Favored 'General case' 0 C--O 1.231 0.11 0 C-N-CA 123.06 0.544 . . . . 0.0 111.721 -174.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 22.3 p -82.44 2.09 34.33 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.611 0.764 . . . . 0.0 112.955 -178.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 48.7 m -118.07 35.61 4.67 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 118.891 0.769 . . . . 0.0 112.726 -169.224 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -145.89 14.3 1.34 Allowed 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 176.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 172.08 -168.54 41.64 Favored Glycine 0 C--N 1.34 0.771 0 O-C-N 121.17 -0.956 . . . . 0.0 111.698 176.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 61.0 t -74.81 133.74 30.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 N-CA-C 104.498 -2.408 . . . . 0.0 104.498 167.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 38.1 t -139.63 117.32 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 -174.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 64.4 tp -88.25 97.29 10.94 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 173.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.05 147.77 38.46 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 169.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -133.73 98.9 4.31 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 125.172 1.389 . . . . 0.0 107.539 176.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -75.81 114.88 14.91 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 105.893 -1.891 . . . . 0.0 105.893 173.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 9.2 p-90 -137.49 175.21 9.81 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.478 0.711 . . . . 0.0 110.81 -169.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -152.92 147.43 19.06 Favored Pre-proline 0 CA--C 1.537 0.446 0 C-N-CA 124.602 1.161 . . . . 0.0 107.897 169.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.3 -21.57 17.41 Favored 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 122.8 2.333 . . . . 0.0 113.423 -170.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -81.71 -9.3 59.68 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 118.665 0.666 . . . . 0.0 112.051 178.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 51.0 t -88.28 117.1 26.95 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -179.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -54.4 -57.65 16.34 Favored Glycine 0 CA--C 1.531 1.05 0 CA-C-O 118.565 -1.13 . . . . 0.0 111.888 176.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_exo -49.37 -35.44 35.49 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 123.703 2.935 . . . . 0.0 115.736 177.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 84.5 m -60.56 -37.85 82.61 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 119.941 1.246 . . . . 0.0 111.65 174.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 45.9 mtmt -79.88 -31.21 40.34 Favored 'General case' 0 CA--C 1.529 0.151 0 O-C-N 121.674 -0.641 . . . . 0.0 110.29 177.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 63.6 mtt -65.06 -38.86 92.21 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.994 0.816 . . . . 0.0 111.278 175.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 10.2 tt -80.95 -16.94 12.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 118.887 0.767 . . . . 0.0 111.632 -179.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -52.32 -49.8 83.14 Favored Pre-proline 0 CA--C 1.544 0.716 0 CA-C-O 117.506 -1.235 . . . . 0.0 113.777 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -64.98 -31.52 55.78 Favored 'Trans proline' 0 C--N 1.35 0.649 0 CA-C-N 121.92 1.722 . . . . 0.0 112.236 176.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 20.2 t -63.44 -43.61 98.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-N 119.106 0.866 . . . . 0.0 109.049 175.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 71.9 mt -65.17 -36.16 83.36 Favored 'General case' 0 C--O 1.227 -0.115 0 CA-C-O 118.849 -0.596 . . . . 0.0 110.954 177.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -65.94 -38.09 87.71 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 119.273 0.942 . . . . 0.0 111.279 174.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -68.2 -38.86 82.41 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 121.133 -0.98 . . . . 0.0 110.456 174.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.91 -42.26 99.73 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.001 0.92 . . . . 0.0 109.421 177.15 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -63.15 -45.01 93.9 Favored 'General case' 0 C--O 1.226 -0.132 0 C-N-CA 123.718 0.807 . . . . 0.0 110.449 176.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -61.69 -30.5 70.78 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 121.705 -0.622 . . . . 0.0 111.989 176.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -85.99 -40.01 16.28 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.893 0.877 . . . . 0.0 112.133 -175.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 17.8 mmt -135.68 1.11 2.78 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 -167.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.3 47.51 1.11 Allowed Glycine 0 CA--C 1.53 1.022 0 C-N-CA 127.224 2.345 . . . . 0.0 114.625 -169.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -149.71 -40.1 0.14 Allowed 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 128.552 2.741 . . . . 0.0 108.032 171.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -62.81 -38.8 92.14 Favored 'General case' 0 C--N 1.342 0.263 0 C-N-CA 124.633 1.173 . . . . 0.0 110.218 169.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -133.31 165.22 25.33 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.418 1.487 . . . . 0.0 110.294 173.264 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -104.81 155.11 19.19 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.726 1.61 . . . . 0.0 107.453 171.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 17.9 mt -117.52 135.78 56.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 N-CA-C 105.242 -2.132 . . . . 0.0 105.242 169.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 91.3 t -130.96 113.78 25.27 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -177.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 44.4 mmtt -73.78 144.25 45.69 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 169.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 15.2 tt -148.06 118.03 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 169.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -82.51 115.44 21.5 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 -176.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 27.8 m -62.49 -24.79 36.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 N-CA-C 112.519 0.562 . . . . 0.0 112.519 -175.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -70.48 -10.62 59.65 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 119.318 0.963 . . . . 0.0 112.083 -178.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -122.95 1.09 9.25 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.645 1.178 . . . . 0.0 110.889 175.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -145.65 36.88 1.08 Allowed 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.636 1.174 . . . . 0.0 110.128 -169.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -59.07 -29.25 67.19 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.579 0.752 . . . . 0.0 110.551 177.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 59.6 mp0 -59.97 -49.48 77.5 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.504 1.522 . . . . 0.0 110.041 173.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.63 -41.87 68.32 Favored 'General case' 0 C--O 1.222 -0.392 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 -175.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -61.14 -46.78 89.14 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 119.057 0.844 . . . . 0.0 109.775 176.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -59.19 -24.55 58.9 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 124.312 0.958 . . . . 0.0 112.856 175.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 8.9 ttmm -59.38 -20.82 57.77 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.764 1.225 . . . . 0.0 111.791 176.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -125.6 13.11 8.08 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.199 1.4 . . . . 0.0 110.473 177.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 68.52 21.63 74.59 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 124.554 1.074 . . . . 0.0 113.524 -177.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 87.3 t -89.34 154.39 3.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-N 118.308 1.054 . . . . 0.0 109.372 178.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -162.23 -24.01 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.898 2.079 . . . . 0.0 109.404 167.097 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 8.8 m -63.51 149.3 46.51 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 123.571 0.749 . . . . 0.0 109.114 169.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -144.31 155.46 57.77 Favored Pre-proline 0 CA--C 1.541 0.614 0 C-N-CA 124.176 0.99 . . . . 0.0 108.925 176.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -66.69 140.24 48.84 Favored 'Cis proline' 0 N--CA 1.457 -0.643 0 CA-C-N 120.003 1.037 . . . . 0.0 109.584 -10.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 52.7 m -131.63 117.81 19.19 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 175.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 93.1 mt -93.79 135.24 35.3 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 178.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.5 mp -122.9 129.45 51.64 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 104.713 -2.329 . . . . 0.0 104.713 169.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 48.1 t -94.84 120.94 44.96 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.416 0 N-CA-C 103.361 -2.829 . . . . 0.0 103.361 168.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.9 mp -108.41 159.26 16.81 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 169.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -146.34 123.91 11.78 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 106.738 -1.579 . . . . 0.0 106.738 175.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.0 t70 42.21 40.67 1.82 Allowed 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.032 1.333 . . . . 0.0 113.08 179.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.67 9.66 59.77 Favored Glycine 0 CA--C 1.529 0.962 0 CA-C-O 118.584 -1.12 . . . . 0.0 114.957 171.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -126.55 139.81 52.92 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 119.552 1.676 . . . . 0.0 108.472 177.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 18.5 t -68.01 134.28 30.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 106.711 -1.589 . . . . 0.0 106.711 169.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.6 m -124.89 -18.61 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 124.41 1.084 . . . . 0.0 110.898 177.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.22 165.17 36.55 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 119.619 1.1 . . . . 0.0 110.955 174.065 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 97.5 m -149.32 149.28 30.65 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.209 1.403 . . . . 0.0 109.108 177.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.9 m -149.87 156.25 41.46 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 126.018 1.727 . . . . 0.0 108.929 172.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.9 t -133.58 144.46 35.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 -179.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.1 -178.45 53.61 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 123.647 0.641 . . . . 0.0 111.567 -178.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -62.33 149.0 43.39 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.786 0.834 . . . . 0.0 110.678 177.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 25.3 mttp -142.32 142.11 23.0 Favored Pre-proline 0 C--O 1.234 0.248 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 168.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -72.5 162.93 40.04 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 122.646 2.23 . . . . 0.0 110.458 175.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -54.64 -46.2 73.92 Favored 'General case' 0 C--O 1.223 -0.295 0 C-N-CA 123.073 0.549 . . . . 0.0 110.82 -179.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -64.84 -41.13 95.97 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 118.356 0.525 . . . . 0.0 111.05 -169.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.28 -45.45 80.41 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 122.651 0.38 . . . . 0.0 110.539 176.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 46.5 tp -65.75 -42.42 90.93 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 123.037 0.535 . . . . 0.0 110.436 -176.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -68.37 -32.78 73.1 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 118.715 0.689 . . . . 0.0 109.818 178.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -67.64 -46.8 71.39 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 118.835 0.743 . . . . 0.0 109.446 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.0 tt -54.16 -42.75 69.95 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.385 1.074 . . . . 0.0 109.569 175.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 25.2 t -63.84 -50.67 76.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-O 117.499 -1.239 . . . . 0.0 110.548 175.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -56.12 -46.18 79.24 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 120.718 1.599 . . . . 0.0 110.279 -176.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -57.21 -15.0 4.84 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.228 1.011 . . . . 0.0 113.225 178.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 78.8 m-70 -121.09 -5.06 9.51 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 177.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 53.9 mt . . . . . 0 C--O 1.248 1.008 0 CA-C-N 120.106 1.321 . . . . 0.0 109.113 169.959 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.4 ttp . . . . . 0 N--CA 1.483 1.222 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -160.23 157.51 28.32 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.48 1.512 . . . . 0.0 108.261 175.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 77.3 mt -75.29 153.84 6.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 172.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.4 t -129.22 169.88 19.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 -173.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.26 153.46 50.34 Favored 'General case' 0 C--O 1.233 0.235 0 O-C-N 120.791 -1.193 . . . . 0.0 108.994 169.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -144.71 175.5 10.12 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 123.886 0.874 . . . . 0.0 109.939 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 70.6 p -133.13 177.36 7.73 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.798 1.239 . . . . 0.0 107.947 174.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -53.97 -25.94 23.33 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 119.547 1.067 . . . . 0.0 112.553 176.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 48.2 mm-40 -73.34 -25.17 60.5 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.091 1.356 . . . . 0.0 112.522 -178.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 33.2 p -135.15 -11.99 2.18 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 115.634 1.716 . . . . 0.0 115.634 -167.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -53.96 -35.79 62.17 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 124.194 0.998 . . . . 0.0 110.852 179.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.7 m -70.81 -34.92 72.24 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 122.686 0.394 . . . . 0.0 111.48 -177.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -72.94 -32.74 65.46 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 123.556 0.742 . . . . 0.0 110.625 176.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -79.05 -39.59 33.53 Favored 'General case' 0 N--CA 1.453 -0.319 0 O-C-N 122.003 -0.435 . . . . 0.0 111.505 -177.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 25.2 p -78.11 -0.64 28.97 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -174.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 28.7 p -110.46 30.94 6.33 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.269 1.028 . . . . 0.0 112.834 -169.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -131.48 -0.13 4.0 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 113.58 0.955 . . . . 0.0 113.58 -175.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 165.73 -166.29 38.46 Favored Glycine 0 C--N 1.336 0.559 0 CA-C-N 119.358 0.981 . . . . 0.0 110.886 -174.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 88.6 t -71.73 129.82 35.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 N-CA-C 105.212 -2.144 . . . . 0.0 105.212 166.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 25.4 t -133.11 116.66 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 -176.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 63.9 tp -88.21 96.83 10.7 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 174.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.06 148.54 37.9 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 170.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -133.51 96.76 3.78 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 125.031 1.332 . . . . 0.0 107.419 177.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -74.53 113.81 12.21 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 172.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 6.6 p-90 -137.63 176.72 8.45 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 123.435 0.694 . . . . 0.0 110.532 -169.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -155.72 147.75 17.36 Favored Pre-proline 0 C--O 1.237 0.446 0 C-N-CA 125.793 1.637 . . . . 0.0 106.731 169.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.94 -20.49 15.01 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.99 2.46 . . . . 0.0 113.3 -170.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -79.37 -7.59 58.47 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 118.528 0.604 . . . . 0.0 112.381 -179.616 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 44.0 t -95.56 122.25 38.1 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -178.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -56.87 -57.48 19.44 Favored Glycine 0 CA--C 1.531 1.046 0 CA-C-O 118.623 -1.098 . . . . 0.0 112.098 178.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_exo -48.37 -36.19 29.73 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 123.756 2.971 . . . . 0.0 115.8 177.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 79.8 m -59.6 -31.82 69.83 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 119.875 1.216 . . . . 0.0 112.504 175.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt -88.32 -33.88 17.85 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 123.445 0.698 . . . . 0.0 109.737 177.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 62.3 mtt -61.65 -37.07 82.68 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.935 0.789 . . . . 0.0 111.264 175.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 10.9 tt -80.08 -14.04 13.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-N 118.603 0.638 . . . . 0.0 111.928 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.97 -48.35 94.14 Favored Pre-proline 0 CA--C 1.543 0.685 0 CA-C-O 117.403 -1.284 . . . . 0.0 113.411 -178.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -65.03 -29.15 57.14 Favored 'Trans proline' 0 C--N 1.349 0.592 0 CA-C-N 121.996 1.749 . . . . 0.0 112.607 175.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 12.9 t -66.71 -40.45 86.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 119.343 0.974 . . . . 0.0 109.305 174.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 91.6 mt -66.72 -35.69 80.72 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-O 118.756 -0.64 . . . . 0.0 110.845 175.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -68.04 -36.06 79.28 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 119.481 1.037 . . . . 0.0 111.288 174.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 45.3 mm-40 -63.88 -43.91 94.62 Favored 'General case' 0 CA--C 1.529 0.151 0 O-C-N 121.05 -1.031 . . . . 0.0 109.958 171.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -63.3 -36.54 84.0 Favored 'General case' 0 C--O 1.226 -0.181 0 C-N-CA 123.129 0.572 . . . . 0.0 111.109 176.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -64.71 -42.7 95.07 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 118.636 0.653 . . . . 0.0 109.995 176.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -65.91 -33.39 75.72 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.708 -0.62 . . . . 0.0 112.377 175.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -89.27 -32.48 17.37 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.093 0.957 . . . . 0.0 112.274 -172.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.511 ' SD ' ' HE2' ' A' ' 49' ' ' LYS . 22.5 mmt -136.25 -11.54 1.92 Allowed 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.879 1.271 . . . . 0.0 112.663 -168.361 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.42 2.88 18.79 Favored Glycine 0 CA--C 1.53 0.988 0 CA-C-N 120.827 1.649 . . . . 0.0 114.545 -172.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -90.2 -17.15 28.06 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 127.126 2.17 . . . . 0.0 111.766 170.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.511 ' HE2' ' SD ' ' A' ' 46' ' ' MET . 14.9 pttm -138.94 6.4 2.41 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 127.072 2.149 . . . . 0.0 112.466 -174.244 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -145.85 163.96 33.41 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 129.144 2.978 . . . . 0.0 105.998 175.314 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -121.05 154.91 35.46 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 125.231 1.412 . . . . 0.0 107.359 173.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 15.7 mt -123.4 135.28 63.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 N-CA-C 105.179 -2.156 . . . . 0.0 105.179 174.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 88.3 t -132.1 111.19 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -174.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 38.6 mmtt -71.65 142.55 49.9 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 169.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 15.7 tt -148.64 119.78 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 170.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 50.7 t0 -80.26 115.88 20.05 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 123.561 0.745 . . . . 0.0 109.138 -177.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 28.6 m -60.95 -30.25 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-N 118.227 0.467 . . . . 0.0 111.889 -177.268 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -76.16 2.68 12.4 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.986 0.914 . . . . 0.0 112.024 -176.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -129.89 -4.13 4.59 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.69 1.596 . . . . 0.0 110.743 173.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -141.34 47.55 1.69 Allowed 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.287 1.035 . . . . 0.0 109.938 -168.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.503 ' H ' ' NE2' ' A' ' 61' ' ' GLN . 0.3 OUTLIER -52.47 -43.35 64.92 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.587 1.555 . . . . 0.0 109.427 177.958 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 33.3 mp0 -67.35 -27.97 67.57 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 126.206 1.802 . . . . 0.0 111.903 -174.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.41 ' HA ' ' HE2' ' A' ' 66' ' ' LYS . 0.2 OUTLIER -88.39 -46.2 9.36 Favored 'General case' 0 C--O 1.22 -0.481 0 CA-C-N 118.474 0.579 . . . . 0.0 109.614 178.722 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.8 -47.41 83.55 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.859 0.754 . . . . 0.0 109.683 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -61.46 -22.41 61.32 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 124.514 1.054 . . . . 0.0 112.846 175.108 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.41 ' HE2' ' HA ' ' A' ' 63' ' ' THR . 5.9 ttmm -57.61 -24.14 54.8 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 118.811 1.306 . . . . 0.0 111.771 174.669 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -125.4 14.74 8.27 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.851 1.26 . . . . 0.0 110.304 178.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 70.12 19.09 75.34 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 124.849 1.214 . . . . 0.0 114.038 -179.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 84.6 t -81.31 127.63 39.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 177.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 8.6 mmt -147.5 29.42 0.94 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.892 1.677 . . . . 0.0 108.735 169.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 17.0 m -142.85 152.18 41.88 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 126.681 1.993 . . . . 0.0 106.734 179.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -145.64 157.56 51.48 Favored Pre-proline 0 CA--C 1.54 0.576 0 C-N-CA 123.832 0.853 . . . . 0.0 109.914 -171.199 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -67.57 141.73 59.84 Favored 'Cis proline' 0 N--CA 1.459 -0.548 0 CA-C-N 119.852 0.983 . . . . 0.0 109.581 -10.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 55.2 m -131.78 116.4 17.22 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 176.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 93.3 mt -91.4 136.84 32.82 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 178.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.2 mp -120.68 130.84 54.27 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 105.098 -2.186 . . . . 0.0 105.098 169.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 25.5 t -93.72 121.09 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 103.016 -2.957 . . . . 0.0 103.016 169.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.8 mp -115.86 158.62 22.67 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 172.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -146.19 126.2 13.68 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 175.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.6 t70 44.75 38.31 2.75 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.263 1.425 . . . . 0.0 113.364 175.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.76 6.89 54.12 Favored Glycine 0 CA--C 1.53 0.982 0 CA-C-O 118.561 -1.133 . . . . 0.0 114.345 169.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -129.01 138.43 51.93 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 119.432 1.616 . . . . 0.0 108.764 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.7 p -68.96 135.91 27.43 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 168.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.4 m -125.3 -19.64 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 C-N-CA 124.543 1.137 . . . . 0.0 110.476 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.18 167.38 30.57 Favored 'General case' 0 C--N 1.344 0.369 0 CA-C-N 119.588 1.086 . . . . 0.0 111.182 174.146 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 97.4 m -147.22 149.32 32.68 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.571 1.548 . . . . 0.0 108.789 178.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 66.2 m -150.59 156.25 41.0 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.494 1.518 . . . . 0.0 108.691 172.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 40.6 t -132.59 144.46 36.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -177.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 83.84 179.4 51.98 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 124.007 0.813 . . . . 0.0 111.711 -179.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -61.89 150.59 37.05 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.845 0.858 . . . . 0.0 110.61 176.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 40.8 mttm -140.68 144.84 37.68 Favored Pre-proline 0 C--O 1.233 0.213 0 C-N-CA 125.007 1.323 . . . . 0.0 107.518 168.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -72.66 161.54 43.68 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.63 2.22 . . . . 0.0 110.327 173.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -55.16 -47.74 74.72 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 123.089 0.556 . . . . 0.0 110.957 -178.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -63.51 -43.6 96.73 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 118.218 0.463 . . . . 0.0 111.516 -168.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.46 -42.81 87.0 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.106 0.563 . . . . 0.0 110.954 178.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 42.7 tp -67.75 -42.46 81.76 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 110.27 -0.27 . . . . 0.0 110.27 -178.163 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.7 pp0? -69.48 -34.35 74.2 Favored 'General case' 0 N--CA 1.454 -0.273 0 O-C-N 121.567 -0.708 . . . . 0.0 109.605 177.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -60.14 -45.94 91.35 Favored 'General case' 0 C--N 1.339 0.115 0 CA-C-N 119.41 1.004 . . . . 0.0 108.532 176.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 61.0 tp -58.09 -39.9 79.78 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.558 0.743 . . . . 0.0 110.888 176.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 56.0 t -63.56 -48.93 84.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-O 118.498 -0.763 . . . . 0.0 110.517 175.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 24.4 m-80 -58.08 -40.8 81.99 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 120.239 1.381 . . . . 0.0 109.908 179.268 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -62.82 -13.83 38.28 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 117.904 -1.046 . . . . 0.0 113.13 -178.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 70.4 m-70 -124.28 -19.57 5.48 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.248 0.978 0 CA-C-N 120.302 1.41 . . . . 0.0 109.914 178.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.1 ttm . . . . . 0 N--CA 1.483 1.224 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -157.68 159.92 37.43 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.88 1.672 . . . . 0.0 107.916 173.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 81.8 mt -74.68 149.55 7.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 179.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 48.4 t -109.09 167.19 4.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 125.827 1.651 . . . . 0.0 106.915 -173.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 5.7 mptt -138.68 137.84 37.2 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 -176.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -149.01 171.76 15.85 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 122.973 0.509 . . . . 0.0 110.863 -179.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.5 p -136.63 173.23 11.93 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 125.598 1.559 . . . . 0.0 107.695 -176.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -50.55 -27.06 6.01 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.644 1.178 . . . . 0.0 112.634 176.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 49.0 mm-40 -65.18 -32.64 74.43 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 125.15 1.38 . . . . 0.0 112.104 -178.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.4 m -143.4 -5.48 0.84 Allowed 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 115.103 1.52 . . . . 0.0 115.103 -171.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -54.04 -35.47 62.0 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 119.48 1.036 . . . . 0.0 111.276 179.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.7 m -67.0 -41.64 86.36 Favored 'General case' 0 N--CA 1.452 -0.345 0 O-C-N 122.065 -0.397 . . . . 0.0 111.197 -178.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.62 -43.82 79.48 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 176.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -62.12 -38.49 89.13 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 123.503 0.721 . . . . 0.0 111.074 -176.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 25.9 p -81.55 3.53 24.64 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -178.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 50.4 m -120.46 36.79 4.45 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.384 1.074 . . . . 0.0 112.156 -169.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -142.5 12.48 1.93 Allowed 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 176.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 174.73 -166.59 38.44 Favored Glycine 0 C--N 1.339 0.709 0 O-C-N 121.191 -0.943 . . . . 0.0 111.629 179.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.1 t -80.09 125.11 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 103.281 -2.859 . . . . 0.0 103.281 167.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 22.9 t -136.8 118.73 19.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 -171.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 35.0 tp -87.93 147.49 25.04 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 168.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -135.34 154.06 51.64 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 176.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -134.48 98.9 4.2 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 -175.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -74.88 117.19 16.45 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 169.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 6.0 p-90 -145.72 179.53 7.38 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.441 0.697 . . . . 0.0 111.205 -170.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -159.96 151.78 16.79 Favored Pre-proline 0 CA--C 1.538 0.51 0 C-N-CA 125.896 1.678 . . . . 0.0 107.024 167.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -75.75 -18.46 17.15 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.851 2.367 . . . . 0.0 113.319 -169.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -80.01 -10.92 59.81 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 118.721 0.691 . . . . 0.0 112.044 178.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 50.9 t -88.74 119.19 29.0 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 178.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -56.23 -57.74 17.7 Favored Glycine 0 CA--C 1.531 1.049 0 CA-C-O 118.808 -0.995 . . . . 0.0 111.954 176.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -51.16 -32.9 41.91 Favored 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 123.375 2.717 . . . . 0.0 115.651 177.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 88.2 m -59.57 -42.5 92.6 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 119.905 1.229 . . . . 0.0 111.323 173.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 44.1 mtmt -74.12 -30.39 62.28 Favored 'General case' 0 CA--C 1.529 0.139 0 O-C-N 121.801 -0.562 . . . . 0.0 110.476 177.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 89.8 mtp -65.75 -40.54 92.19 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 119.001 0.819 . . . . 0.0 111.242 175.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 12.3 tt -80.97 -16.27 12.45 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-N 119.158 0.89 . . . . 0.0 111.603 -179.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.9 -50.17 75.91 Favored Pre-proline 0 CA--C 1.545 0.767 0 CA-C-O 117.494 -1.241 . . . . 0.0 114.003 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.68 -28.74 52.1 Favored 'Trans proline' 0 C--N 1.35 0.652 0 CA-C-N 122.044 1.766 . . . . 0.0 112.691 176.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 13.8 t -66.89 -40.56 86.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-N 119.027 0.831 . . . . 0.0 109.143 174.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 46.1 mt -66.88 -36.52 82.48 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 118.604 -0.712 . . . . 0.0 110.694 176.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -65.87 -40.5 91.68 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 119.279 0.945 . . . . 0.0 110.897 173.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 30.6 mm-40 -59.5 -42.21 91.64 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 119.068 0.849 . . . . 0.0 110.406 173.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.65 -36.2 83.03 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 123.263 0.625 . . . . 0.0 111.364 176.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -65.04 -45.44 85.42 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 123.633 0.773 . . . . 0.0 109.918 175.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 73.5 mm-40 -65.44 -27.69 68.7 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.923 -0.486 . . . . 0.0 111.95 178.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -92.12 -37.42 12.76 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.366 1.066 . . . . 0.0 112.193 -175.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 20.7 mmt -128.77 -9.67 4.98 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 124.241 1.017 . . . . 0.0 113.372 -167.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -50.06 -25.24 7.44 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 126.233 1.873 . . . . 0.0 115.351 -175.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -75.58 -28.29 58.89 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 124.829 1.252 . . . . 0.0 112.07 -176.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.63 -4.76 7.09 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 125.665 1.586 . . . . 0.0 112.984 -175.474 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -144.96 123.43 12.38 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 124.499 1.12 . . . . 0.0 108.095 172.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -80.39 154.81 27.47 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 176.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 29.4 mt -127.76 130.91 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 N-CA-C 105.516 -2.031 . . . . 0.0 105.516 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.9 t -129.53 116.84 40.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 118.485 0.584 . . . . 0.0 109.723 -171.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt -74.17 143.89 45.05 Favored 'General case' 0 C--O 1.236 0.347 0 O-C-N 121.477 -0.765 . . . . 0.0 109.558 170.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 10.6 tt -150.34 129.8 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 170.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -86.8 126.96 34.97 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 121.411 -0.806 . . . . 0.0 109.69 -176.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 12.4 m -67.72 -32.57 57.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -174.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -75.62 -35.39 60.52 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 119.31 0.959 . . . . 0.0 109.78 -175.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -78.57 -15.17 58.86 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.279 0.632 . . . . 0.0 111.901 175.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 48.5 m-80 -140.87 50.78 1.64 Allowed 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 119.194 0.906 . . . . 0.0 110.562 -168.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.425 ' CD ' ' H ' ' A' ' 61' ' ' GLN . 1.1 mp0 -58.69 -43.06 89.87 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.459 1.103 . . . . 0.0 109.49 -174.627 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -64.0 -41.48 97.46 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.327 1.051 . . . . 0.0 110.751 -176.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.05 -43.71 70.68 Favored 'General case' 0 C--O 1.222 -0.348 0 CA-C-N 118.633 0.651 . . . . 0.0 109.821 -177.574 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.27 -44.01 97.52 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 118.94 0.791 . . . . 0.0 109.461 176.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -57.46 -27.69 58.59 Favored Glycine 0 CA--C 1.534 1.233 0 C-N-CA 124.325 0.964 . . . . 0.0 112.635 174.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 24.8 ttmt -59.21 -21.64 59.8 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.983 1.313 . . . . 0.0 111.777 177.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -120.38 10.58 11.26 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.981 1.312 . . . . 0.0 111.009 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 70.21 32.14 68.95 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 123.694 0.664 . . . . 0.0 112.319 -177.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 86.7 t -110.88 134.67 52.43 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 C-N-CA 124.762 1.225 . . . . 0.0 107.92 -178.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 8.4 tpt -155.7 32.16 0.36 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.36 1.064 . . . . 0.0 108.976 167.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 20.2 m -137.47 155.91 48.76 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 126.787 2.035 . . . . 0.0 106.724 179.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 29.8 pt -145.7 157.63 51.15 Favored Pre-proline 0 CA--C 1.541 0.602 0 CA-C-O 118.716 -0.659 . . . . 0.0 111.069 -168.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -67.33 141.71 58.84 Favored 'Cis proline' 0 N--CA 1.458 -0.574 0 N-CA-C 109.022 -1.184 . . . . 0.0 109.022 -11.085 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 58.2 m -136.12 131.0 34.18 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 176.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -103.61 143.94 32.1 Favored 'General case' 0 N--CA 1.437 -1.123 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 -176.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -125.45 137.39 53.98 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 104.382 -2.451 . . . . 0.0 104.382 178.105 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 11.1 t -127.29 127.97 69.71 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.593 0 N-CA-C 105.036 -2.209 . . . . 0.0 105.036 177.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.8 mp -130.15 157.96 41.01 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 -177.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -142.58 121.77 13.0 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 175.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.2 t70 44.06 37.55 1.86 Allowed 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.689 1.196 . . . . 0.0 112.476 -172.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.2 -6.29 82.59 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-O 118.839 -0.978 . . . . 0.0 114.473 174.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -90.04 128.51 36.3 Favored 'General case' 0 CA--C 1.522 -0.113 0 CA-C-N 119.407 1.603 . . . . 0.0 106.874 175.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 71.0 t -63.99 134.56 28.77 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 168.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 32.9 m -122.94 -20.48 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 124.749 1.219 . . . . 0.0 110.547 176.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.63 161.41 41.6 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 119.999 1.272 . . . . 0.0 111.869 172.13 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 70.7 m -147.63 133.68 19.27 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.249 1.82 . . . . 0.0 106.913 169.02 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 16.9 m -146.13 152.4 39.22 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.018 0.927 . . . . 0.0 109.396 -172.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 42.6 t -129.13 148.94 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-N 119.431 1.014 . . . . 0.0 108.919 -170.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.27 175.38 50.03 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 124.536 1.065 . . . . 0.0 112.358 174.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -57.91 154.37 12.44 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.907 0.883 . . . . 0.0 110.594 176.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -152.28 144.36 16.57 Favored Pre-proline 0 CA--C 1.53 0.207 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 169.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_endo -71.64 163.39 39.13 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.582 2.188 . . . . 0.0 110.339 175.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -54.69 -46.25 74.08 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-O 118.855 -0.593 . . . . 0.0 110.636 -179.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -64.38 -40.24 95.44 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 118.451 0.569 . . . . 0.0 111.122 -169.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.57 -45.13 76.48 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 122.823 0.449 . . . . 0.0 110.688 177.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 50.9 tp -67.59 -40.99 84.77 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 122.899 0.479 . . . . 0.0 110.403 -176.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.8 pp0? -71.6 -31.26 66.72 Favored 'General case' 0 N--CA 1.457 -0.121 0 CA-C-N 118.614 0.643 . . . . 0.0 110.127 177.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 20.2 tp10 -65.41 -48.27 73.37 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 176.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 10.3 tt -57.1 -44.88 83.63 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.266 0.626 . . . . 0.0 110.374 178.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 4.8 t -60.55 -48.6 87.84 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 123.056 0.542 . . . . 0.0 110.392 176.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.4 -20.94 66.2 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 118.839 0.745 . . . . 0.0 112.843 -175.214 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 57.5 mmtt -60.62 -35.55 76.43 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 118.386 0.539 . . . . 0.0 111.1 169.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 94.2 m-70 -97.7 -22.49 16.41 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.647 0.779 . . . . 0.0 112.697 -172.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 70.7 mt . . . . . 0 C--O 1.247 0.959 0 CA-C-O 118.237 -0.887 . . . . 0.0 109.485 172.409 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 89.6 mt . . . . . 0 CA--C 1.536 0.428 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 35.8 t -100.81 165.99 2.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 125.691 1.596 . . . . 0.0 107.897 -174.236 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.31 141.65 50.58 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 177.106 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -151.73 168.09 26.15 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 122.979 0.511 . . . . 0.0 111.569 176.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 40.0 p -140.55 -176.45 4.64 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.981 2.113 . . . . 0.0 107.204 174.706 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -48.97 -32.63 9.46 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.687 1.195 . . . . 0.0 113.256 179.223 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 27.3 mp0 -61.13 -32.85 72.55 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 126.233 1.813 . . . . 0.0 112.5 -177.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 12.3 m -143.78 -6.57 0.77 Allowed 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 115.12 1.526 . . . . 0.0 115.12 -169.515 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -55.62 -36.1 66.59 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 119.856 1.207 . . . . 0.0 110.98 178.39 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.0 m -68.71 -38.86 80.56 Favored 'General case' 0 N--CA 1.453 -0.306 0 O-C-N 122.226 -0.296 . . . . 0.0 111.22 -178.192 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.61 -46.2 76.64 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 175.537 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -64.03 -38.51 91.33 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 122.995 0.518 . . . . 0.0 111.311 -175.059 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.409 ' HA ' HG21 ' A' ' 20' ' ' VAL . 29.4 p -79.12 0.73 26.97 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -177.734 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 59.9 m -112.23 33.16 5.04 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.171 0.988 . . . . 0.0 112.044 -171.355 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 59.3 mt-10 -132.1 -3.24 3.55 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 -176.488 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 167.45 -162.3 36.1 Favored Glycine 0 C--N 1.334 0.443 0 CA-C-N 119.346 0.976 . . . . 0.0 111.046 -172.521 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 40.3 t -74.27 127.56 36.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 N-CA-C 105.55 -2.019 . . . . 0.0 105.55 167.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.409 HG21 ' HA ' ' A' ' 15' ' ' THR . 24.8 t -137.18 115.13 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 -175.713 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 8.2 tt -88.01 147.01 25.2 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 168.579 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -132.56 153.35 51.07 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 177.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -132.92 99.12 4.49 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 -178.392 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -76.37 112.5 12.95 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 173.578 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 7.1 p-90 -139.36 174.75 10.19 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 123.132 0.573 . . . . 0.0 111.934 -168.733 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -153.67 147.42 18.53 Favored Pre-proline 0 CA--C 1.538 0.515 0 C-N-CA 125.276 1.43 . . . . 0.0 107.527 168.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.03 -20.57 14.77 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.807 2.338 . . . . 0.0 113.272 -170.192 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -78.83 -8.21 58.6 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 121.595 -0.691 . . . . 0.0 111.975 178.25 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 44.5 t -92.94 117.45 30.07 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -53.91 -58.1 13.86 Favored Glycine 0 CA--C 1.531 1.049 0 CA-C-O 118.727 -1.041 . . . . 0.0 112.152 177.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -51.19 -33.33 43.93 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 123.457 2.771 . . . . 0.0 115.607 178.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 90.6 m -60.31 -37.66 81.28 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 119.729 1.15 . . . . 0.0 111.668 174.356 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 43.2 mtmt -78.61 -33.54 47.33 Favored 'General case' 0 C--N 1.333 -0.118 0 O-C-N 121.764 -0.585 . . . . 0.0 109.98 177.127 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 26.5 mmt -65.32 -38.73 91.06 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 119.12 0.873 . . . . 0.0 111.439 177.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 12.0 tt -78.17 -14.86 14.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-N 118.877 0.762 . . . . 0.0 111.379 179.089 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.06 -49.88 89.63 Favored Pre-proline 0 CA--C 1.541 0.62 0 CA-C-O 117.437 -1.268 . . . . 0.0 113.545 -177.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -64.16 -28.49 64.84 Favored 'Trans proline' 0 C--N 1.351 0.662 0 CA-C-N 121.952 1.733 . . . . 0.0 112.401 176.027 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.2 t -68.37 -39.39 80.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 119.256 0.935 . . . . 0.0 109.457 176.54 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 48.4 mt -67.69 -34.88 77.77 Favored 'General case' 0 C--O 1.226 -0.15 0 O-C-N 121.517 -0.74 . . . . 0.0 110.636 174.595 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -68.29 -33.92 75.23 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 119.262 0.937 . . . . 0.0 111.44 173.666 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 50.2 mm-40 -62.32 -45.61 92.43 Favored 'General case' 0 N--CA 1.457 -0.094 0 O-C-N 120.922 -1.112 . . . . 0.0 109.583 170.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -63.86 -35.34 80.3 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 118.827 0.74 . . . . 0.0 111.668 176.123 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -66.35 -36.73 83.64 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 119.055 0.843 . . . . 0.0 111.035 177.121 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -69.8 -44.96 68.97 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 121.643 -0.661 . . . . 0.0 110.907 175.351 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -81.22 -33.6 32.77 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.983 0.913 . . . . 0.0 112.114 -169.575 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 52.2 mtt -140.62 -2.94 1.33 Allowed 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.541 1.136 . . . . 0.0 112.884 -169.256 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -75.14 47.55 1.97 Allowed Glycine 0 CA--C 1.528 0.885 0 C-N-CA 125.671 1.605 . . . . 0.0 113.517 -173.543 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -150.66 -40.71 0.13 Allowed 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 128.999 2.919 . . . . 0.0 107.176 169.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -63.55 -32.68 74.21 Favored 'General case' 0 C--N 1.343 0.314 0 C-N-CA 124.472 1.109 . . . . 0.0 110.546 168.632 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -135.67 160.95 36.93 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 125.719 1.608 . . . . 0.0 110.193 172.73 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -98.73 151.15 21.07 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.968 1.307 . . . . 0.0 107.879 171.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 15.7 mt -122.5 133.8 67.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 N-CA-C 105.839 -1.912 . . . . 0.0 105.839 174.11 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 8.0 t -128.4 116.12 40.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 C-N-CA 123.396 0.679 . . . . 0.0 109.556 -176.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 64.7 mmtt -75.14 140.41 43.35 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 168.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 8.3 tt -150.89 125.94 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.116 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -96.95 123.96 40.8 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 121.044 -1.035 . . . . 0.0 110.382 -168.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 23.3 m -61.67 -22.76 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -171.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -73.33 -28.83 62.29 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 120.052 1.296 . . . . 0.0 110.775 175.468 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -92.81 -33.98 14.05 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.446 1.099 . . . . 0.0 111.158 -171.481 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -112.59 33.76 4.76 Favored 'General case' 0 C--O 1.222 -0.344 0 C-N-CA 125.039 1.336 . . . . 0.0 109.914 -177.21 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.84 -39.89 54.54 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.542 1.137 . . . . 0.0 111.89 -175.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -65.23 -48.82 72.0 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.305 1.042 . . . . 0.0 111.656 174.083 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.34 -40.48 81.53 Favored 'General case' 0 C--O 1.223 -0.304 0 C-N-CA 123.906 0.882 . . . . 0.0 110.828 -175.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -61.97 -42.95 99.7 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.294 -0.879 . . . . 0.0 109.26 174.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -57.1 -27.42 57.33 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 123.963 0.792 . . . . 0.0 113.137 172.331 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 14.2 ttmm -60.84 -21.85 63.62 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 118.747 1.274 . . . . 0.0 111.451 176.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -120.06 9.8 11.28 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.206 1.403 . . . . 0.0 110.624 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 68.76 22.74 75.58 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 124.407 1.003 . . . . 0.0 113.33 -177.36 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 89.8 t -91.58 125.48 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 -179.099 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 5.9 mmt -148.63 26.85 0.92 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.714 1.605 . . . . 0.0 109.437 169.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 22.3 m -141.1 152.91 45.14 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 126.318 1.847 . . . . 0.0 107.167 -179.26 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -144.82 156.99 55.55 Favored Pre-proline 0 CA--C 1.54 0.583 0 C-N-CA 123.885 0.874 . . . . 0.0 110.262 -171.155 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -67.8 138.88 45.56 Favored 'Cis proline' 0 C--N 1.349 0.566 0 CA-C-N 119.788 0.96 . . . . 0.0 109.649 -10.46 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 54.5 m -130.16 118.08 20.89 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 174.601 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 61.1 mt -90.21 144.03 26.23 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 174.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.5 mp -124.65 155.91 38.39 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 169.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.462 HG11 ' CD2' ' A' ' 103' ' ' HIS . 94.1 t -126.67 130.46 71.63 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 N-CA-C 104.077 -2.564 . . . . 0.0 104.077 168.401 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.1 mp -127.13 156.23 42.09 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 126.234 1.814 . . . . 0.0 106.732 176.179 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 75.1 tttt -147.17 119.93 8.64 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 -177.241 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.7 t70 47.39 35.81 4.36 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.16 1.384 . . . . 0.0 113.588 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 108.88 -2.64 31.83 Favored Glycine 0 CA--C 1.527 0.781 0 CA-C-O 118.154 -1.359 . . . . 0.0 115.971 168.153 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -129.96 144.43 51.32 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 119.943 1.871 . . . . 0.0 110.208 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.7 p -66.79 138.1 23.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 C-N-CA 123.865 0.866 . . . . 0.0 108.765 173.133 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 35.7 m -129.12 -17.55 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 C-N-CA 125.346 1.459 . . . . 0.0 110.803 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.34 162.97 40.86 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 119.898 1.226 . . . . 0.0 111.559 172.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 85.1 m -151.08 142.12 23.06 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.118 1.767 . . . . 0.0 108.61 176.543 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 15.1 m -148.85 155.98 41.68 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.588 1.555 . . . . 0.0 108.869 -178.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 37.1 t -132.89 147.98 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 -174.45 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.75 175.47 49.39 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 124.426 1.012 . . . . 0.0 112.028 177.027 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -59.91 155.03 17.35 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.281 1.033 . . . . 0.0 110.566 174.274 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -141.44 145.65 38.79 Favored Pre-proline 0 C--O 1.233 0.235 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 168.003 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -71.89 160.43 47.81 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 122.62 2.213 . . . . 0.0 109.832 169.593 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -55.26 -47.52 75.34 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 118.742 -0.647 . . . . 0.0 111.116 -178.504 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -63.62 -43.5 96.68 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 118.555 0.616 . . . . 0.0 110.679 -170.064 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.98 -43.44 92.62 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 122.802 0.441 . . . . 0.0 110.743 176.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 45.2 tp -66.44 -42.36 87.75 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 119.307 -0.378 . . . . 0.0 110.346 -177.133 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.5 pp0? -72.62 -29.24 63.31 Favored 'General case' 0 C--N 1.337 0.064 0 CA-C-N 118.89 0.768 . . . . 0.0 110.505 179.345 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -65.89 -49.24 68.75 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 174.346 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 58.8 tp -55.58 -44.45 76.9 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.361 0.664 . . . . 0.0 110.454 178.32 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.434 ' HA ' ' NE2' ' A' ' 103' ' ' HIS . 48.5 t -68.53 -49.32 66.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 CA-C-O 119.538 -0.268 . . . . 0.0 110.52 -178.644 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -62.43 -27.18 68.92 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 119.143 0.883 . . . . 0.0 112.004 -173.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -65.15 -20.6 66.53 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 117.703 -1.141 . . . . 0.0 113.196 174.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' HIS . . . . . 0.462 ' CD2' HG11 ' A' ' 77' ' ' VAL . 8.1 p80 -116.55 2.37 13.04 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 120.32 1.418 . . . . 0.0 113.511 -179.287 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 80.8 mt . . . . . 0 C--O 1.248 1.012 0 CA-C-N 119.764 1.166 . . . . 0.0 108.144 170.225 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 93.7 mt . . . . . 0 CA--C 1.536 0.418 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 32.5 t -123.43 167.03 17.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 -173.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.5 mtmt -135.19 145.38 47.65 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 175.346 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -147.79 171.02 16.36 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.291 0.636 . . . . 0.0 110.083 176.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.414 HG22 HD21 ' A' ' 60' ' ' ASN . 81.3 p -133.79 178.33 7.03 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 171.245 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -47.25 -30.49 3.07 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 119.906 1.23 . . . . 0.0 113.187 176.44 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 12.0 mp0 -58.3 -34.38 70.49 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.691 1.596 . . . . 0.0 112.752 179.083 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 12.8 m -145.42 -2.83 0.75 Allowed 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 114.833 1.42 . . . . 0.0 114.833 -169.608 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -54.08 -36.82 63.56 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 119.186 0.903 . . . . 0.0 111.005 178.23 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.3 m -67.47 -38.67 84.78 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 122.472 0.309 . . . . 0.0 111.387 -178.462 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.42 -45.25 76.65 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 175.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -64.94 -37.55 88.0 Favored 'General case' 0 C--O 1.231 0.121 0 C-N-CA 122.451 0.3 . . . . 0.0 111.381 -176.059 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.527 ' HA ' HG21 ' A' ' 20' ' ' VAL . 22.4 p -76.48 -1.65 28.29 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 71.1 m -107.72 33.55 4.01 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.55 1.14 . . . . 0.0 111.977 -171.564 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -133.39 1.53 3.45 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -177.577 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 165.66 -165.67 38.08 Favored Glycine 0 C--N 1.336 0.563 0 CA-C-O 118.796 -1.002 . . . . 0.0 111.242 -176.375 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 88.9 t -73.87 134.25 29.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 N-CA-C 103.678 -2.712 . . . . 0.0 103.678 166.698 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.527 HG21 ' HA ' ' A' ' 15' ' ' THR . 39.4 t -134.65 117.57 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 -175.396 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 62.3 tp -87.85 97.33 10.86 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 173.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.59 146.41 40.41 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 170.403 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -133.93 94.52 3.28 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 124.818 1.247 . . . . 0.0 107.735 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -71.29 113.36 8.24 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 106.301 -1.741 . . . . 0.0 106.301 172.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 6.3 p-90 -138.26 175.12 9.85 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 123.333 0.653 . . . . 0.0 110.962 -169.414 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -152.16 146.26 18.34 Favored Pre-proline 0 CA--C 1.536 0.431 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 168.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.31 -17.99 18.44 Favored 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 122.833 2.356 . . . . 0.0 113.377 -171.311 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -82.29 -8.53 59.64 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 121.53 -0.731 . . . . 0.0 111.997 176.288 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 42.0 t -88.12 126.32 35.05 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -61.42 -59.6 9.63 Favored Glycine 0 CA--C 1.531 1.083 0 CA-C-O 118.491 -1.172 . . . . 0.0 111.661 177.528 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_exo -49.04 -37.87 38.51 Favored 'Trans proline' 0 CA--C 1.535 0.566 0 C-N-CA 123.683 2.922 . . . . 0.0 115.094 177.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 86.1 m -59.17 -34.16 71.79 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 119.244 0.929 . . . . 0.0 112.793 175.235 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -84.94 -34.89 22.39 Favored 'General case' 0 N--CA 1.461 0.093 0 CA-C-O 118.942 -0.552 . . . . 0.0 109.996 176.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 85.1 mtp -60.92 -38.56 86.22 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 118.853 0.752 . . . . 0.0 110.993 177.077 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.0 tt -78.77 -14.62 13.68 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-N 118.549 0.613 . . . . 0.0 111.787 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.58 -50.84 84.65 Favored Pre-proline 0 CA--C 1.544 0.725 0 CA-C-N 120.116 1.325 . . . . 0.0 113.393 -177.306 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -64.88 -29.24 58.46 Favored 'Trans proline' 0 C--N 1.35 0.645 0 CA-C-N 121.887 1.709 . . . . 0.0 112.179 176.403 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.5 t -66.11 -42.68 91.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 123.425 0.69 . . . . 0.0 109.327 177.063 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 85.3 mt -65.62 -36.1 82.73 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 118.715 -0.66 . . . . 0.0 110.432 174.301 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -65.86 -36.6 83.9 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 119.534 1.061 . . . . 0.0 111.511 175.551 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -64.94 -43.52 92.49 Favored 'General case' 0 CA--C 1.529 0.146 0 O-C-N 121.162 -0.962 . . . . 0.0 110.086 173.347 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 31.6 tp -64.58 -38.87 92.5 Favored 'General case' 0 CA--C 1.532 0.276 0 O-C-N 122.252 -0.28 . . . . 0.0 110.522 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -64.32 -43.61 94.15 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 124.164 0.985 . . . . 0.0 110.476 177.164 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -61.68 -29.07 69.85 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 121.482 -0.761 . . . . 0.0 111.796 174.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -89.88 -35.53 15.57 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.907 0.883 . . . . 0.0 112.698 -174.176 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 40.6 mtt -136.5 -0.24 2.43 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -169.235 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -70.19 42.28 0.5 Allowed Glycine 0 CA--C 1.535 1.306 0 C-N-CA 126.914 2.197 . . . . 0.0 115.856 -169.764 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -143.21 -43.6 0.29 Allowed 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 126.849 2.06 . . . . 0.0 108.789 168.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 58.6 mtmt -72.06 -20.63 61.64 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.73 0.812 . . . . 0.0 111.28 169.056 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.9 tp -133.32 153.21 51.78 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 128.584 2.753 . . . . 0.0 106.704 -177.09 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -118.61 154.87 31.94 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 168.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 21.7 mt -122.37 134.7 64.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 104.921 -2.252 . . . . 0.0 104.921 172.034 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 79.3 t -128.9 109.75 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 -177.522 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -70.42 138.95 51.67 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 169.061 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 13.2 tt -144.85 108.25 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 176.209 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 62.6 t0 -78.44 115.37 18.11 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 123.631 0.772 . . . . 0.0 109.012 -175.125 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 29.4 m -60.76 -24.85 33.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 123.0 0.52 . . . . 0.0 112.278 -176.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -72.59 -0.79 13.83 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.804 0.842 . . . . 0.0 112.292 179.205 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -131.07 7.36 4.65 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.189 1.396 . . . . 0.0 110.591 170.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.414 HD21 HG22 ' A' ' 7' ' ' THR . 63.4 m-80 -142.41 44.94 1.64 Allowed 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.599 1.16 . . . . 0.0 110.318 -168.586 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.498 ' NE2' ' H ' ' A' ' 61' ' ' GLN . 0.4 OUTLIER -56.09 -47.6 77.73 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.266 1.027 . . . . 0.0 108.764 176.885 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 38.5 mp0 -67.17 -47.8 69.9 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 125.231 1.412 . . . . 0.0 109.411 -175.027 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.53 -47.57 72.48 Favored 'General case' 0 C--O 1.222 -0.356 0 C-N-CA 122.759 0.424 . . . . 0.0 110.168 -176.695 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.2 -44.03 96.5 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 119.004 0.82 . . . . 0.0 109.313 -179.189 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -58.1 -27.44 59.96 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 123.948 0.785 . . . . 0.0 112.923 174.559 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 31.1 ttmt -59.1 -26.21 64.48 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 118.615 1.208 . . . . 0.0 111.448 177.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -117.01 11.56 14.31 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.698 1.199 . . . . 0.0 111.097 179.033 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 69.82 22.73 77.02 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 124.265 0.936 . . . . 0.0 113.163 -178.386 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 97.9 t -93.06 135.04 28.9 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 179.437 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -155.35 28.0 0.4 Allowed 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.33 1.052 . . . . 0.0 109.686 168.104 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 22.8 m -139.06 152.66 47.73 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 126.407 1.883 . . . . 0.0 106.819 178.349 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -144.13 157.08 57.76 Favored Pre-proline 0 CA--C 1.542 0.641 0 CA-C-O 118.392 -0.813 . . . . 0.0 110.176 -169.839 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -67.54 137.97 40.35 Favored 'Cis proline' 0 C--N 1.349 0.59 0 CA-C-N 119.933 1.012 . . . . 0.0 109.84 -10.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 53.1 m -129.67 119.5 23.62 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 174.194 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 96.4 mt -96.61 133.71 40.76 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.6 mp -119.53 130.66 55.29 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 105.203 -2.147 . . . . 0.0 105.203 169.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 16.5 t -93.63 121.35 44.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 103.286 -2.857 . . . . 0.0 103.286 169.582 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.8 mp -112.23 160.68 17.38 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 170.185 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -142.28 129.85 21.41 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 169.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.9 t70 42.85 37.55 1.11 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.183 1.393 . . . . 0.0 113.62 175.007 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 109.81 -6.67 31.26 Favored Glycine 0 CA--C 1.528 0.863 0 CA-C-O 117.97 -1.461 . . . . 0.0 115.482 169.154 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -132.04 148.41 52.5 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 120.316 2.058 . . . . 0.0 110.901 -175.343 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.3 t -67.35 137.95 23.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 176.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 35.7 m -127.42 -18.68 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 125.451 1.5 . . . . 0.0 111.051 176.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.62 170.47 22.33 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 120.099 1.318 . . . . 0.0 110.977 171.258 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 99.4 m -147.51 150.63 34.92 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 125.587 1.555 . . . . 0.0 109.075 177.253 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 58.6 m -150.06 159.25 44.55 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.931 1.692 . . . . 0.0 108.791 171.756 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 34.9 t -133.17 145.1 34.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 179.346 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 85.44 177.18 50.55 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 123.709 0.671 . . . . 0.0 111.897 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -62.83 146.95 51.45 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.049 0.939 . . . . 0.0 110.354 177.261 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 68.0 mttt -143.78 143.17 22.32 Favored Pre-proline 0 CA--C 1.533 0.306 0 C-N-CA 124.989 1.316 . . . . 0.0 107.714 169.227 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -74.49 159.85 42.43 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 123.221 2.614 . . . . 0.0 110.691 177.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.9 tmpt? -61.02 -34.44 74.83 Favored 'General case' 0 C--O 1.225 -0.205 0 O-C-N 121.453 -0.779 . . . . 0.0 111.222 -175.431 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -62.5 -37.42 85.95 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.924 0.783 . . . . 0.0 111.561 178.467 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.18 -42.89 71.83 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 118.068 0.394 . . . . 0.0 110.442 174.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 91.1 mt -64.75 -41.6 95.78 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-O 119.263 -0.398 . . . . 0.0 110.622 -178.144 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.2 pp0? -70.25 -31.76 69.3 Favored 'General case' 0 CA--C 1.527 0.073 0 CA-C-N 118.83 0.741 . . . . 0.0 110.305 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -65.37 -49.59 68.73 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 175.141 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 59.2 tp -56.66 -43.43 80.37 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.945 0.898 . . . . 0.0 110.748 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 43.8 t -68.13 -49.18 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 CA-C-O 118.668 -0.682 . . . . 0.0 110.365 178.289 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.35 -26.1 68.32 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 120.005 1.275 . . . . 0.0 112.431 -175.471 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 39.8 mmtm -64.84 -17.05 63.92 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 118.029 -0.986 . . . . 0.0 113.073 171.184 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 92.0 m-70 -118.45 -12.49 9.83 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 119.777 1.171 . . . . 0.0 113.656 179.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 60.2 mt . . . . . 0 C--O 1.248 1.019 0 CA-C-N 120.464 1.484 . . . . 0.0 109.786 172.737 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 83.7 mt . . . . . 0 CA--C 1.541 0.62 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 42.2 t -131.9 170.59 19.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 125.949 1.699 . . . . 0.0 106.917 -174.354 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 34.0 ttmt -141.93 147.62 37.34 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 176.348 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -150.78 173.51 14.12 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 123.725 0.81 . . . . 0.0 110.236 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 76.6 p -131.59 175.13 9.43 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.137 1.375 . . . . 0.0 107.298 172.383 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -51.78 -30.48 23.09 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 120.134 1.333 . . . . 0.0 112.886 -176.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 25.3 mp0 -65.32 -27.96 68.97 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.738 2.015 . . . . 0.0 113.353 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 36.8 p -133.11 -15.87 2.53 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 114.317 1.228 . . . . 0.0 114.317 -168.748 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -54.2 -34.7 61.21 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 125.402 1.481 . . . . 0.0 111.019 178.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.4 p -64.89 -49.36 70.79 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 123.589 0.756 . . . . 0.0 110.949 -179.188 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.78 -44.78 96.34 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 122.908 0.483 . . . . 0.0 109.791 177.109 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -66.11 -37.89 86.87 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 119.263 -0.399 . . . . 0.0 111.616 -176.144 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.507 ' HA ' HG21 ' A' ' 20' ' ' VAL . 28.1 p -78.82 -1.48 35.06 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 118.67 0.668 . . . . 0.0 112.473 -178.415 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 59.1 m -106.06 33.0 4.02 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.421 1.089 . . . . 0.0 111.761 -171.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -133.06 -0.22 3.38 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -177.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 167.21 -167.35 39.8 Favored Glycine 0 C--N 1.337 0.614 0 CA-C-N 119.413 1.006 . . . . 0.0 111.563 -174.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 68.9 t -73.77 125.9 33.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 104.601 -2.37 . . . . 0.0 104.601 166.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.507 HG21 ' HA ' ' A' ' 15' ' ' THR . 35.3 t -129.86 120.93 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 -174.074 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -94.01 105.66 17.66 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 105.851 -1.907 . . . . 0.0 105.851 -179.499 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -94.9 102.55 14.4 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -177.551 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -82.4 95.25 7.6 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 123.862 0.865 . . . . 0.0 108.705 175.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 45.8 m-85 -75.53 116.72 16.55 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 169.325 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 7.5 p-90 -141.61 176.81 8.6 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 123.498 0.719 . . . . 0.0 111.498 -170.439 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -153.68 146.29 17.48 Favored Pre-proline 0 CA--C 1.538 0.509 0 C-N-CA 124.856 1.262 . . . . 0.0 107.717 168.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.92 -19.02 16.37 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.882 2.388 . . . . 0.0 113.264 -171.06 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -78.74 -7.13 57.46 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 118.689 0.677 . . . . 0.0 112.067 177.158 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 46.6 t -94.98 119.1 32.93 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -178.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -55.47 -58.35 14.34 Favored Glycine 0 CA--C 1.531 1.076 0 CA-C-O 118.56 -1.133 . . . . 0.0 111.779 176.487 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_exo -49.45 -34.7 33.96 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 123.665 2.91 . . . . 0.0 115.603 177.396 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 92.7 m -60.6 -44.16 96.58 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 119.78 1.173 . . . . 0.0 111.423 173.544 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 45.2 mtmt -72.27 -30.91 65.28 Favored 'General case' 0 CA--C 1.529 0.146 0 O-C-N 121.682 -0.636 . . . . 0.0 110.427 178.095 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 63.0 mtt -67.48 -40.98 85.3 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 118.766 0.712 . . . . 0.0 111.302 176.35 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.7 tt -78.54 -19.25 13.31 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-N 119.168 0.895 . . . . 0.0 111.415 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.18 -51.01 72.28 Favored Pre-proline 0 CA--C 1.546 0.823 0 CA-C-N 119.895 1.225 . . . . 0.0 114.011 -178.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -65.5 -28.56 53.62 Favored 'Trans proline' 0 C--N 1.351 0.663 0 CA-C-N 121.897 1.713 . . . . 0.0 112.44 175.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 6.6 t -67.33 -37.58 79.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 118.903 0.774 . . . . 0.0 109.542 175.069 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 96.0 mt -67.74 -34.64 77.24 Favored 'General case' 0 C--O 1.226 -0.136 0 O-C-N 121.493 -0.754 . . . . 0.0 110.685 172.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -64.13 -38.29 90.54 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 119.758 1.163 . . . . 0.0 111.229 172.045 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -65.94 -37.88 87.17 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 121.092 -1.005 . . . . 0.0 110.384 173.079 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 46.7 tp -66.6 -36.37 82.45 Favored 'General case' 0 C--O 1.227 -0.13 0 CA-C-N 118.56 0.618 . . . . 0.0 110.512 177.267 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -65.71 -41.5 92.24 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 118.953 0.797 . . . . 0.0 110.28 174.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -63.9 -29.72 70.87 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 121.796 -0.565 . . . . 0.0 112.13 174.337 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -87.47 -39.32 15.31 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.141 0.976 . . . . 0.0 112.215 -175.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 16.5 mmt -133.58 -1.27 3.13 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 124.527 1.131 . . . . 0.0 113.76 -167.359 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -62.1 -7.56 13.67 Favored Glycine 0 CA--C 1.535 1.297 0 CA-C-N 121.193 1.815 . . . . 0.0 114.419 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -79.57 -22.29 43.98 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.674 1.99 . . . . 0.0 112.11 173.029 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -130.4 -10.03 4.13 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 126.46 1.904 . . . . 0.0 111.465 -171.07 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -135.74 164.08 28.72 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 126.515 1.926 . . . . 0.0 108.306 -177.716 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -121.54 142.05 50.45 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 169.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 17.0 mt -105.71 137.78 34.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 105.139 -2.171 . . . . 0.0 105.139 170.212 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 90.2 t -127.38 114.49 36.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 105.785 -1.931 . . . . 0.0 105.785 175.397 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.65 141.23 44.63 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 169.646 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 11.8 tt -151.63 125.58 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 175.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -81.97 129.22 34.72 Favored 'General case' 0 N--CA 1.466 0.325 0 O-C-N 121.586 -0.696 . . . . 0.0 109.446 -178.459 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 15.4 m -67.81 -34.34 66.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -174.473 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -76.52 -34.58 58.57 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 119.055 0.843 . . . . 0.0 109.768 -174.328 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -73.04 -16.21 61.5 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.668 0.787 . . . . 0.0 111.958 172.489 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 62.7 m-80 -140.22 50.85 1.7 Allowed 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 119.312 0.96 . . . . 0.0 111.182 -168.315 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -57.2 -36.8 71.31 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.533 0.733 . . . . 0.0 109.68 178.65 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -64.02 -28.51 69.85 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 125.095 1.358 . . . . 0.0 112.466 -178.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.418 ' HA ' ' HE2' ' A' ' 66' ' ' LYS . 0.2 OUTLIER -92.3 -45.65 8.1 Favored 'General case' 0 C--O 1.222 -0.346 0 CA-C-N 118.573 0.624 . . . . 0.0 109.991 179.542 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.53 -45.75 89.17 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 119.484 1.038 . . . . 0.0 110.073 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -62.74 -21.91 63.58 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 124.195 0.902 . . . . 0.0 112.571 175.514 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.418 ' HE2' ' HA ' ' A' ' 63' ' ' THR . 5.5 ttmm -59.32 -22.07 60.71 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 118.52 1.16 . . . . 0.0 111.617 174.774 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -121.46 11.34 10.65 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.917 1.287 . . . . 0.0 110.728 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 68.19 27.32 73.77 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 124.147 0.88 . . . . 0.0 112.801 -177.295 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 65.7 t -100.8 135.71 35.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.54 28.5 0.44 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.546 1.138 . . . . 0.0 109.466 168.386 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 42.2 m -133.52 156.49 47.69 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 126.257 1.823 . . . . 0.0 107.262 175.556 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -145.8 159.15 48.02 Favored Pre-proline 0 CA--C 1.539 0.541 0 C-N-CA 124.243 1.017 . . . . 0.0 110.205 -169.557 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.5 140.05 50.77 Favored 'Cis proline' 0 C--N 1.349 0.583 0 CA-C-N 119.938 1.014 . . . . 0.0 109.923 -10.492 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 61.5 m -135.0 129.03 33.52 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 106.395 -1.706 . . . . 0.0 106.395 177.506 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 56.3 mt -108.72 104.07 13.28 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 105.903 -1.888 . . . . 0.0 105.903 -177.127 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -78.76 141.95 37.39 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 105.374 -2.084 . . . . 0.0 105.374 168.496 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.2 t -118.95 116.82 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 N-CA-C 103.378 -2.823 . . . . 0.0 103.378 174.119 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 8.1 mp -111.85 159.86 17.93 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 175.023 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -141.7 127.9 19.76 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 170.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.8 t70 43.74 38.61 2.09 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.062 1.345 . . . . 0.0 113.323 175.529 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 104.64 -4.78 43.21 Favored Glycine 0 CA--C 1.53 0.969 0 CA-C-O 117.962 -1.466 . . . . 0.0 115.169 169.351 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -130.92 150.42 52.09 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 120.269 2.034 . . . . 0.0 110.98 -176.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.2 p -66.08 140.15 20.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 C-N-CA 123.803 0.841 . . . . 0.0 109.476 177.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 28.4 m -127.16 -19.54 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 C-N-CA 125.479 1.512 . . . . 0.0 110.865 173.653 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.87 168.33 26.03 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 120.399 1.454 . . . . 0.0 111.382 169.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 60.8 m -143.63 136.04 27.03 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.023 1.729 . . . . 0.0 107.216 169.479 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 38.4 m -140.57 152.51 45.55 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.92 1.288 . . . . 0.0 108.436 -177.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 38.5 t -133.48 147.53 31.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 -171.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.02 174.35 49.54 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 124.25 0.929 . . . . 0.0 112.229 175.556 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -61.33 148.09 42.52 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 123.784 0.834 . . . . 0.0 110.744 179.121 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -152.11 142.2 14.87 Favored Pre-proline 0 CA--C 1.533 0.324 0 C-N-CA 125.922 1.689 . . . . 0.0 106.999 -178.356 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -74.4 156.77 45.69 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 122.44 2.093 . . . . 0.0 110.612 174.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.5 tmpt? -58.31 -36.43 73.34 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 123.636 0.774 . . . . 0.0 110.982 -179.115 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 23.7 tp10 -65.91 -36.71 84.15 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 118.506 0.594 . . . . 0.0 111.441 -174.594 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.02 -42.96 79.87 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 122.926 0.49 . . . . 0.0 110.681 174.234 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 91.3 mt -65.68 -43.98 87.64 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 119.096 -0.478 . . . . 0.0 110.123 -177.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.8 pp0? -68.21 -30.0 68.97 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 118.909 0.777 . . . . 0.0 110.543 179.025 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -65.99 -50.22 65.04 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 175.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 54.9 tp -56.92 -44.32 82.31 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.063 0.545 . . . . 0.0 110.648 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 42.7 t -63.36 -50.73 77.53 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 C-N-CA 123.461 0.704 . . . . 0.0 109.717 178.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -65.66 -26.19 67.69 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 119.386 0.994 . . . . 0.0 112.403 -175.783 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -67.22 -36.71 82.24 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 118.78 -0.629 . . . . 0.0 111.214 170.386 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 79.8 m-70 -80.64 -24.51 38.97 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 118.078 -0.963 . . . . 0.0 113.378 178.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 65.8 mt . . . . . 0 C--O 1.248 1.015 0 CA-C-N 119.707 1.14 . . . . 0.0 110.155 177.699 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 84.5 mt . . . . . 0 CA--C 1.534 0.353 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 23.3 t -105.85 160.69 5.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 125.573 1.549 . . . . 0.0 107.379 -175.128 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.41 140.48 52.65 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 176.294 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -136.98 172.24 13.31 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.041 0.937 . . . . 0.0 110.498 179.054 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.0 p -129.6 173.56 10.49 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 125.739 1.616 . . . . 0.0 107.861 178.116 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -52.34 -35.56 51.23 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 119.509 1.049 . . . . 0.0 111.721 174.023 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 5.4 mp0 -75.86 -31.25 59.21 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -177.491 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 32.6 p -110.83 -14.93 13.91 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 -169.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -51.0 -39.56 56.03 Favored 'General case' 0 C--N 1.334 -0.078 0 C-N-CA 124.573 1.149 . . . . 0.0 110.224 173.372 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.2 m -74.09 -23.19 59.3 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -174.643 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.88 -48.39 18.45 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 169.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -66.96 -36.39 82.1 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 122.807 0.443 . . . . 0.0 111.965 -170.669 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 42.9 p -82.85 7.8 14.21 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 112.527 0.565 . . . . 0.0 112.527 -176.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 40.8 m -121.68 34.57 5.14 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.596 0.758 . . . . 0.0 112.216 -169.117 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -135.39 1.75 2.92 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -176.248 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 169.0 -165.86 39.25 Favored Glycine 0 C--N 1.333 0.408 0 N-CA-C 110.409 -1.076 . . . . 0.0 110.409 -171.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.435 HG22 ' HE3' ' A' ' 79' ' ' LYS . 1.5 t -78.82 133.01 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 N-CA-C 104.324 -2.473 . . . . 0.0 104.324 168.408 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 23.8 t -139.63 146.15 25.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 -173.452 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 9.0 tt -122.55 135.87 54.74 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 105.807 -1.923 . . . . 0.0 105.807 169.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -129.67 121.3 26.7 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 -174.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -96.08 102.55 14.36 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 125.504 1.522 . . . . 0.0 108.585 -177.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -76.41 116.84 17.48 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 169.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 6.9 p-90 -145.88 178.82 7.89 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.619 0.767 . . . . 0.0 110.898 -169.685 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -158.51 150.28 17.08 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 125.606 1.562 . . . . 0.0 107.054 167.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.18 -18.72 20.7 Favored 'Trans proline' 0 CA--C 1.532 0.417 0 C-N-CA 122.754 2.303 . . . . 0.0 113.478 -170.028 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -79.39 -11.12 59.93 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 118.94 0.791 . . . . 0.0 112.483 176.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 45.8 t -85.53 119.26 25.68 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -57.01 -58.26 15.51 Favored Glycine 0 CA--C 1.531 1.093 0 CA-C-O 118.622 -1.099 . . . . 0.0 111.632 174.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -49.95 -36.14 42.95 Favored 'Trans proline' 0 CA--C 1.536 0.618 0 C-N-CA 123.571 2.848 . . . . 0.0 115.309 176.631 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 98.4 m -59.39 -46.06 89.73 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 119.87 1.214 . . . . 0.0 111.306 173.002 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 46.1 mtmt -70.35 -30.26 67.16 Favored 'General case' 0 N--CA 1.462 0.168 0 O-C-N 121.511 -0.743 . . . . 0.0 110.844 178.251 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 87.2 mtp -67.32 -43.08 82.5 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 118.922 0.783 . . . . 0.0 110.98 175.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 8.3 tt -78.84 -18.91 13.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-N 119.048 0.84 . . . . 0.0 111.378 -178.584 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.33 -52.44 59.28 Favored Pre-proline 0 CA--C 1.544 0.743 0 CA-C-O 117.5 -1.238 . . . . 0.0 113.986 -178.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.03 -30.35 56.53 Favored 'Trans proline' 0 C--N 1.349 0.58 0 CA-C-N 121.931 1.725 . . . . 0.0 112.103 177.256 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 6.3 t -64.82 -42.68 95.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 118.762 0.71 . . . . 0.0 109.085 176.711 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 61.1 mt -67.14 -34.97 78.71 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 118.603 -0.713 . . . . 0.0 110.981 176.237 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -65.59 -40.39 92.64 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 119.553 1.07 . . . . 0.0 111.004 174.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -63.95 -42.87 97.18 Favored 'General case' 0 CA--C 1.53 0.188 0 O-C-N 121.405 -0.809 . . . . 0.0 109.875 174.025 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 25.8 tp -62.8 -39.15 93.39 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 122.845 0.458 . . . . 0.0 110.794 178.066 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -66.83 -38.89 87.28 Favored 'General case' 0 C--N 1.333 -0.116 0 O-C-N 121.448 -0.782 . . . . 0.0 110.856 177.711 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -64.45 -23.06 67.15 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 121.86 -0.525 . . . . 0.0 111.895 173.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -96.88 -30.9 12.86 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.784 1.234 . . . . 0.0 112.46 -176.242 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 19.0 mmt -129.73 -9.31 4.49 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 117.825 -1.084 . . . . 0.0 113.606 -168.43 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -48.49 -30.53 8.42 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 125.955 1.74 . . . . 0.0 115.985 -169.677 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -79.31 -38.63 34.82 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.296 1.038 . . . . 0.0 111.495 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -85.23 -26.17 26.86 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 124.7 1.2 . . . . 0.0 110.801 -178.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -148.44 124.39 10.66 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 125.016 1.326 . . . . 0.0 108.807 -177.253 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -72.36 148.14 45.58 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 176.174 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 22.8 mt -122.07 133.58 67.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 172.655 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 9.2 t -127.01 153.11 35.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 124.689 1.196 . . . . 0.0 108.196 -173.337 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 65.4 mmtt -118.9 141.17 48.89 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 126.085 1.754 . . . . 0.0 107.975 177.116 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 14.9 tt -145.54 120.8 3.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-O 121.358 0.599 . . . . 0.0 109.538 172.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -80.9 110.47 16.46 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 123.911 0.885 . . . . 0.0 108.823 -179.263 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 24.0 m -64.47 -25.5 38.08 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-O 118.986 -0.53 . . . . 0.0 112.427 -174.806 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -70.98 -12.94 61.82 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 119.14 0.882 . . . . 0.0 111.68 -178.33 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -120.03 -5.28 10.04 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.239 1.416 . . . . 0.0 110.979 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 60.9 m-80 -146.06 36.66 1.03 Allowed 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.217 1.007 . . . . 0.0 110.551 -168.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.2 pm0 -59.07 -25.34 63.67 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.973 0.909 . . . . 0.0 111.487 179.219 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 59.6 mp0 -60.13 -32.44 71.02 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.028 1.731 . . . . 0.0 111.29 175.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.39 -48.81 14.72 Favored 'General case' 0 C--O 1.223 -0.326 0 CA-C-N 118.38 0.536 . . . . 0.0 110.0 172.328 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.23 -45.99 89.04 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 118.798 0.726 . . . . 0.0 110.278 -171.082 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -61.92 -23.99 64.22 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 124.166 0.889 . . . . 0.0 112.821 176.128 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.6 ttmm -59.18 -28.13 66.34 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 118.612 1.206 . . . . 0.0 111.295 175.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -115.84 11.01 15.45 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.776 1.23 . . . . 0.0 111.033 178.539 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 70.36 18.3 75.08 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 124.603 1.096 . . . . 0.0 113.738 -178.458 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 98.8 t -84.12 134.23 27.43 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 176.792 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -155.45 32.2 0.37 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.413 1.085 . . . . 0.0 109.09 166.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 23.3 m -138.01 151.45 47.91 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 126.824 2.05 . . . . 0.0 106.245 176.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 28.2 pt -147.3 159.58 41.73 Favored Pre-proline 0 CA--C 1.542 0.669 0 C-N-CA 124.041 0.937 . . . . 0.0 109.472 -169.551 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -66.65 142.07 57.91 Favored 'Cis proline' 0 N--CA 1.458 -0.559 0 N-CA-C 109.529 -0.989 . . . . 0.0 109.529 -10.712 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 26.7 m -132.43 129.07 38.8 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 178.539 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 50.1 mt -112.05 109.53 19.33 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 -174.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.5 mp -87.51 151.75 22.77 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 106.171 -1.788 . . . . 0.0 106.171 167.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 15.7 t -123.78 132.12 71.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 N-CA-C 104.131 -2.544 . . . . 0.0 104.131 169.363 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.3 mp -132.99 160.01 38.36 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 125.918 1.687 . . . . 0.0 107.254 -175.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.435 ' HE3' HG22 ' A' ' 19' ' ' VAL . 77.1 tttt -147.2 127.52 13.94 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.596 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.1 t70 59.13 -19.26 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 128.052 2.541 . . . . 0.0 116.298 177.138 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 162.17 -0.91 0.06 OUTLIER Glycine 0 CA--C 1.532 1.102 0 CA-C-O 118.141 -1.366 . . . . 0.0 114.4 173.584 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -134.26 151.01 51.05 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 120.239 2.02 . . . . 0.0 110.45 -173.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 42.4 t -64.84 139.95 20.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 C-N-CA 124.238 1.015 . . . . 0.0 108.373 175.306 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 33.6 m -121.17 -21.97 3.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 125.208 1.403 . . . . 0.0 110.593 172.451 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -158.02 164.2 36.99 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 119.79 1.177 . . . . 0.0 111.584 174.771 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 69.7 m -144.1 138.45 28.25 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.777 1.631 . . . . 0.0 108.205 172.518 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 44.6 m -143.38 153.48 42.74 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.695 1.598 . . . . 0.0 108.594 -178.299 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 40.2 t -133.69 146.46 31.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -174.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.63 174.46 45.81 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 124.633 1.111 . . . . 0.0 112.443 173.679 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 61.3 t80 -62.66 143.91 56.85 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.597 0.759 . . . . 0.0 109.99 176.245 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 44.7 mttm -145.29 148.26 37.06 Favored Pre-proline 0 C--O 1.235 0.29 0 C-N-CA 125.226 1.41 . . . . 0.0 107.994 169.635 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -74.1 159.88 43.61 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 123.062 2.508 . . . . 0.0 110.626 176.039 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 11.0 ttpt -58.32 -38.54 77.32 Favored 'General case' 0 C--O 1.223 -0.293 0 O-C-N 121.825 -0.547 . . . . 0.0 111.021 -177.328 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -59.93 -39.27 84.91 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.416 0.686 . . . . 0.0 111.558 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.13 -42.02 73.13 Favored 'General case' 0 N--CA 1.452 -0.346 0 O-C-N 122.17 -0.331 . . . . 0.0 110.483 175.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 90.9 mt -67.83 -37.57 82.08 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 119.014 -0.517 . . . . 0.0 111.056 -178.105 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.8 pp0? -71.48 -29.62 65.04 Favored 'General case' 0 CA--C 1.526 0.036 0 CA-C-N 119.523 1.056 . . . . 0.0 110.297 177.486 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -65.46 -49.59 68.55 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 174.01 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 52.0 tp -54.35 -46.06 72.87 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.831 0.852 . . . . 0.0 110.635 177.238 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 25.2 t -63.26 -53.06 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.83 -25.4 67.89 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 119.021 0.828 . . . . 0.0 112.457 -174.122 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 61.3 mtpt -66.74 -23.04 66.04 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 118.024 -0.989 . . . . 0.0 112.552 172.156 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -110.46 -13.55 14.24 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 119.765 1.166 . . . . 0.0 113.384 -179.382 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 56.5 mt . . . . . 0 C--O 1.249 1.073 0 CA-C-N 119.871 1.214 . . . . 0.0 109.449 170.041 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 89.3 mt . . . . . 0 C--O 1.236 0.347 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 38.7 t -101.18 166.42 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 125.494 1.518 . . . . 0.0 107.581 -173.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.4 mppt? -128.63 143.37 50.93 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 106.079 -1.822 . . . . 0.0 106.079 177.005 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -144.79 169.72 17.48 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 118.341 0.518 . . . . 0.0 110.976 175.062 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.6 p -134.01 170.09 16.15 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 172.128 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -52.66 -25.59 11.31 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 119.98 1.264 . . . . 0.0 112.317 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 69.4 mm-40 -63.71 -33.07 74.84 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.474 1.51 . . . . 0.0 112.516 -179.184 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.6 m -140.29 -4.93 1.28 Allowed 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -171.246 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -50.39 -39.74 47.7 Favored 'General case' 0 N--CA 1.457 -0.081 0 C-N-CA 125.328 1.451 . . . . 0.0 110.665 173.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.9 m -66.9 -36.42 82.24 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 118.003 0.365 . . . . 0.0 111.618 -176.162 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.12 -46.59 70.46 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 174.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -64.07 -38.69 91.99 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 122.784 0.434 . . . . 0.0 111.431 -175.369 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.551 ' HA ' HG21 ' A' ' 20' ' ' VAL . 30.9 p -79.35 -0.37 32.34 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -176.736 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 64.8 m -109.28 34.48 3.73 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.456 1.102 . . . . 0.0 111.614 -173.259 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -132.11 -0.21 3.75 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 -178.319 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 165.43 -167.97 39.2 Favored Glycine 0 C--N 1.336 0.546 0 CA-C-N 119.16 0.891 . . . . 0.0 111.042 -174.089 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 94.3 t -71.17 132.42 33.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 N-CA-C 104.558 -2.386 . . . . 0.0 104.558 166.165 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.551 HG21 ' HA ' ' A' ' 15' ' ' THR . 27.3 t -135.57 118.62 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 -176.65 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -87.93 124.39 33.64 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 105.372 -2.085 . . . . 0.0 105.372 172.736 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -117.12 105.53 12.36 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -81.86 99.99 9.35 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 175.08 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -76.14 116.71 17.1 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 168.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 7.0 p-90 -144.86 179.53 7.27 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.59 0.756 . . . . 0.0 111.415 -169.029 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -158.48 152.32 19.57 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 125.648 1.579 . . . . 0.0 107.197 167.343 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -76.83 -16.96 16.0 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.835 2.357 . . . . 0.0 113.467 -169.749 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -79.14 -11.65 59.98 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.898 0.772 . . . . 0.0 111.986 177.843 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 41.7 t -87.52 121.46 29.98 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 178.06 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -58.71 -56.16 26.8 Favored Glycine 0 CA--C 1.532 1.121 0 CA-C-O 118.76 -1.022 . . . . 0.0 111.936 175.47 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_exo -49.35 -39.51 43.87 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 123.496 2.797 . . . . 0.0 115.077 175.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 69.8 m -58.58 -34.33 70.96 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 119.125 0.875 . . . . 0.0 112.864 175.434 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 45.6 mtmt -81.29 -42.25 20.9 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.17 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 8.2 ptt? -70.64 -24.2 62.66 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 119.358 0.981 . . . . 0.0 112.532 -176.181 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 8.0 tt -77.16 -18.14 14.43 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-N 119.602 1.092 . . . . 0.0 111.574 173.237 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.05 -48.51 95.88 Favored Pre-proline 0 CA--C 1.539 0.521 0 CA-C-O 117.287 -1.34 . . . . 0.0 113.417 -177.425 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -63.28 -31.28 73.93 Favored 'Trans proline' 0 C--N 1.35 0.614 0 CA-C-N 121.938 1.728 . . . . 0.0 112.143 175.744 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 6.6 t -66.54 -41.13 87.97 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-N 119.249 0.931 . . . . 0.0 109.521 177.143 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 63.4 mt -66.63 -32.82 74.38 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-O 118.813 -0.613 . . . . 0.0 110.912 174.622 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -68.66 -35.81 77.73 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 119.669 1.122 . . . . 0.0 111.304 173.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 -64.92 -39.42 93.49 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 120.903 -1.123 . . . . 0.0 109.886 171.628 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 24.4 tp -66.57 -35.86 81.25 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 121.604 -0.685 . . . . 0.0 110.969 176.252 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -65.76 -38.56 89.41 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.739 0.815 . . . . 0.0 110.632 175.806 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -66.71 -38.34 86.52 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.783 -0.573 . . . . 0.0 111.03 173.151 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -74.48 -43.0 58.04 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.026 0.93 . . . . 0.0 111.764 -174.536 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 42.6 mtt -142.8 3.03 1.41 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 117.849 -1.072 . . . . 0.0 113.742 -168.486 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -74.49 50.9 2.15 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 126.056 1.788 . . . . 0.0 113.641 -172.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -154.29 -41.16 0.09 Allowed 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 129.697 3.199 . . . . 0.0 107.327 169.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 48.0 mtpt -64.12 -33.74 76.45 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.599 1.16 . . . . 0.0 110.529 169.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -131.36 165.3 23.77 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.839 1.656 . . . . 0.0 109.679 169.302 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -102.88 149.68 24.26 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 170.374 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 20.3 mt -117.84 136.43 55.04 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 N-CA-C 105.036 -2.209 . . . . 0.0 105.036 170.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 63.8 t -129.66 138.56 53.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 -178.155 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 60.0 mmtt -97.77 139.34 33.79 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.859 1.264 . . . . 0.0 108.219 169.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 12.6 tt -149.17 128.56 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 CA-C-O 121.306 0.574 . . . . 0.0 109.555 175.524 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -83.73 127.19 33.61 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.546 0.739 . . . . 0.0 110.269 -175.183 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 13.5 m -67.92 -26.95 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 -173.762 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -83.54 -41.01 18.41 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 119.903 1.229 . . . . 0.0 109.634 -175.289 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -70.62 -25.22 62.94 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.355 0.662 . . . . 0.0 111.08 174.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -127.42 43.8 3.05 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.748 1.219 . . . . 0.0 109.74 -172.17 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.15 -36.44 51.45 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 126.666 1.986 . . . . 0.0 111.285 175.557 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -65.48 -40.28 92.93 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 124.012 0.925 . . . . 0.0 111.483 176.263 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.59 -43.32 48.9 Favored 'General case' 0 C--O 1.222 -0.356 0 CA-C-N 119.406 1.003 . . . . 0.0 110.111 -178.84 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -61.62 -46.17 90.97 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 119.205 0.911 . . . . 0.0 109.719 176.215 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -60.74 -22.42 59.62 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 124.456 1.027 . . . . 0.0 113.069 175.169 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 7.7 ttmm -59.92 -20.38 57.05 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 118.629 1.215 . . . . 0.0 111.503 175.662 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -124.36 10.37 8.59 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.353 1.461 . . . . 0.0 110.627 178.454 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 64.9 22.85 68.89 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.542 1.067 . . . . 0.0 113.226 -174.076 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 61.1 t -88.74 153.6 3.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 118.331 1.065 . . . . 0.0 109.198 178.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -161.04 -22.83 0.06 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 127.5 2.32 . . . . 0.0 109.86 167.506 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.5 m -63.6 153.15 36.8 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 124.312 1.045 . . . . 0.0 109.721 171.465 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 28.2 pt -146.58 156.25 48.91 Favored Pre-proline 0 CA--C 1.542 0.637 0 C-N-CA 124.141 0.976 . . . . 0.0 109.617 -178.227 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -68.41 140.49 56.43 Favored 'Cis proline' 0 N--CA 1.457 -0.625 0 N-CA-C 109.011 -1.188 . . . . 0.0 109.011 -11.664 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 54.4 m -131.17 125.28 32.61 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 178.594 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 40.6 mt -104.26 104.14 14.0 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 -176.013 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -78.27 143.64 36.87 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 105.726 -1.953 . . . . 0.0 105.726 168.638 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.8 t -120.29 118.41 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 103.489 -2.782 . . . . 0.0 103.489 172.626 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 8.8 mp -114.6 160.12 19.66 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 175.647 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -143.12 128.15 18.51 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 170.447 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.8 t70 44.01 37.79 1.94 Allowed 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.102 1.361 . . . . 0.0 113.39 175.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 104.86 -4.48 42.22 Favored Glycine 0 CA--C 1.528 0.857 0 CA-C-O 118.083 -1.398 . . . . 0.0 115.247 169.258 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -129.82 149.58 51.5 Favored 'General case' 0 C--N 1.34 0.162 0 CA-C-N 120.19 1.995 . . . . 0.0 110.755 -177.101 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.9 p -66.19 140.77 18.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 C-N-CA 123.765 0.826 . . . . 0.0 109.312 177.503 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 35.5 m -127.14 -19.54 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 C-N-CA 125.481 1.512 . . . . 0.0 110.8 173.746 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.35 167.59 28.47 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 120.227 1.376 . . . . 0.0 111.392 169.617 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 78.0 m -143.71 134.0 24.54 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 126.253 1.821 . . . . 0.0 107.243 169.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 39.0 m -141.41 153.8 45.24 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 124.898 1.279 . . . . 0.0 108.666 -176.62 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.1 t -132.95 148.67 31.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -172.433 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.08 170.61 46.08 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 124.407 1.003 . . . . 0.0 112.468 172.084 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -65.34 133.38 51.27 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 123.475 0.71 . . . . 0.0 109.54 175.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -134.73 144.02 48.89 Favored Pre-proline 0 CA--C 1.534 0.342 0 C-N-CA 126.111 1.764 . . . . 0.0 106.626 176.046 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -72.12 158.89 51.27 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 122.754 2.303 . . . . 0.0 110.553 176.729 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 9.9 ttpt -57.42 -37.41 72.71 Favored 'General case' 0 C--O 1.223 -0.321 0 O-C-N 121.719 -0.613 . . . . 0.0 111.133 -177.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -61.05 -37.38 82.41 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 118.528 0.604 . . . . 0.0 111.728 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -72.15 -41.76 66.74 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 122.748 0.419 . . . . 0.0 110.604 175.233 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 81.2 mt -64.04 -43.36 95.78 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 119.317 -0.373 . . . . 0.0 110.295 -179.496 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.9 pp0? -70.16 -30.43 67.58 Favored 'General case' 0 C--O 1.228 -0.067 0 CA-C-N 118.835 0.743 . . . . 0.0 110.11 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -64.75 -49.41 70.91 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 175.408 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 60.2 tp -57.14 -45.73 83.32 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.553 0.741 . . . . 0.0 110.507 178.638 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 40.0 t -62.88 -49.05 85.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 CA-C-O 119.029 -0.51 . . . . 0.0 109.941 179.187 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.62 -25.89 68.16 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 119.414 1.006 . . . . 0.0 112.543 -175.516 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -66.2 -19.36 65.81 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 118.068 -0.968 . . . . 0.0 112.811 171.036 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -113.07 -16.41 12.63 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 119.877 1.217 . . . . 0.0 113.528 -178.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 70.7 mt . . . . . 0 C--O 1.248 1.019 0 CA-C-N 119.972 1.26 . . . . 0.0 109.713 172.531 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 78.0 mt . . . . . 0 CA--C 1.538 0.485 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.7 t -131.49 165.25 32.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 124.877 1.271 . . . . 0.0 107.902 -168.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -127.12 142.43 51.51 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 174.088 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -148.32 171.19 16.39 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 124.302 1.041 . . . . 0.0 108.807 169.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 70.4 p -133.84 178.37 7.0 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 171.243 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -45.95 -31.15 2.05 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.487 1.115 . . . . 0.0 113.31 176.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 11.9 mp0 -58.87 -34.46 71.64 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.321 1.848 . . . . 0.0 112.998 179.182 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.2 m -145.5 -3.61 0.71 Allowed 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 -169.429 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -54.33 -36.01 63.32 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.305 1.042 . . . . 0.0 110.84 177.191 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.8 m -67.01 -34.54 77.95 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 122.884 0.474 . . . . 0.0 111.9 -179.088 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -70.14 -45.85 65.94 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 175.358 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -64.35 -37.91 89.17 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 119.47 -0.3 . . . . 0.0 111.443 -175.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.505 ' HA ' HG21 ' A' ' 20' ' ' VAL . 20.2 p -75.98 1.16 16.07 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -178.856 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 52.0 m -117.51 37.12 4.0 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.294 1.037 . . . . 0.0 111.913 -169.613 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -130.97 -2.17 4.08 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 163.17 -165.88 36.76 Favored Glycine 0 C--N 1.335 0.498 0 N-CA-C 110.149 -1.18 . . . . 0.0 110.149 -172.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 87.5 t -68.53 141.0 18.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 105.758 -1.941 . . . . 0.0 105.758 166.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.505 HG21 ' HA ' ' A' ' 15' ' ' THR . 62.4 t -141.97 142.97 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 107.194 -1.409 . . . . 0.0 107.194 -178.205 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 56.6 tp -112.71 99.22 7.76 Favored 'General case' 0 CA--C 1.521 -0.158 0 N-CA-C 106.573 -1.639 . . . . 0.0 106.573 173.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.06 144.12 40.95 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 170.058 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -129.26 95.55 4.07 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 125.393 1.477 . . . . 0.0 107.263 178.227 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -75.31 116.41 16.0 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 173.119 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 12.1 p-90 -135.72 175.15 9.85 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 124.069 0.947 . . . . 0.0 110.17 -173.492 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -148.62 146.27 21.92 Favored Pre-proline 0 CA--C 1.533 0.314 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 169.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -74.0 -15.78 23.24 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.808 2.339 . . . . 0.0 113.863 -169.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -93.24 -6.09 48.43 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.812 0.845 . . . . 0.0 112.126 178.13 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 42.3 t -85.41 116.49 23.76 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 -178.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -55.75 -55.03 30.97 Favored Glycine 0 CA--C 1.532 1.15 0 CA-C-O 118.671 -1.072 . . . . 0.0 112.236 175.551 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -50.26 -36.34 46.55 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 123.254 2.636 . . . . 0.0 115.219 175.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 92.9 m -59.91 -40.28 88.26 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 119.937 1.244 . . . . 0.0 111.713 172.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 61.9 mttm -66.28 -38.9 88.85 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 121.475 -0.766 . . . . 0.0 110.01 175.562 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 98.5 mmm -67.45 -41.84 84.07 Favored 'General case' 0 N--CA 1.461 0.089 0 C-N-CA 122.84 0.456 . . . . 0.0 111.423 -177.483 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 8.7 tt -76.63 -20.97 14.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-N 118.511 0.596 . . . . 0.0 111.054 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -52.48 -51.22 74.92 Favored Pre-proline 0 CA--C 1.544 0.749 0 CA-C-N 119.646 1.112 . . . . 0.0 113.88 -175.055 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -67.24 -26.2 42.26 Favored 'Trans proline' 0 C--N 1.349 0.555 0 CA-C-N 121.925 1.723 . . . . 0.0 112.295 177.277 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.8 t -67.6 -37.95 79.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-N 119.307 0.958 . . . . 0.0 109.359 173.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 90.1 mt -67.13 -36.14 81.23 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-O 118.621 -0.704 . . . . 0.0 110.663 173.286 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -62.71 -42.91 99.89 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 119.472 1.033 . . . . 0.0 110.642 172.05 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -62.86 -37.18 85.82 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 121.307 -0.871 . . . . 0.0 110.651 176.378 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -65.6 -39.88 92.05 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 123.437 0.695 . . . . 0.0 109.897 176.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -63.7 -42.0 98.04 Favored 'General case' 0 C--N 1.332 -0.152 0 C-N-CA 123.948 0.899 . . . . 0.0 110.586 174.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 62.0 mm-40 -65.96 -28.31 68.81 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 121.361 -0.837 . . . . 0.0 111.536 176.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -86.73 -41.05 14.45 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.238 1.015 . . . . 0.0 112.154 -177.594 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 75.4 mmm -135.63 -2.81 2.39 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.368 1.067 . . . . 0.0 113.799 -167.035 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.47 44.0 0.74 Allowed Glycine 0 N--CA 1.471 0.98 0 C-N-CA 127.453 2.454 . . . . 0.0 115.166 -169.296 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -147.24 -37.49 0.21 Allowed 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 127.09 2.156 . . . . 0.0 108.621 169.072 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -63.06 -31.3 72.4 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.95 1.3 . . . . 0.0 110.108 168.662 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -138.29 166.71 23.5 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 126.553 1.941 . . . . 0.0 109.698 170.161 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 15.3 ptpt -109.26 155.39 21.18 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 167.379 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 15.5 mt -105.8 141.31 21.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 171.29 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 24.1 t -126.02 107.8 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 177.179 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 11.7 mmmm -73.75 137.12 43.76 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 173.23 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 15.6 tt -147.27 115.15 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.436 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 49.0 t0 -83.26 115.85 22.15 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.681 0.793 . . . . 0.0 109.031 -175.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 34.1 m -59.14 -26.72 34.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 123.048 0.539 . . . . 0.0 112.416 -176.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -72.05 -2.0 16.76 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.776 0.831 . . . . 0.0 112.493 -178.156 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -131.78 7.56 4.43 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.878 1.271 . . . . 0.0 110.706 172.111 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 67.4 m-80 -142.01 45.77 1.66 Allowed 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.117 0.967 . . . . 0.0 110.774 -168.369 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.547 ' NE2' ' H ' ' A' ' 61' ' ' GLN . 0.4 OUTLIER -57.38 -45.35 84.56 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.043 0.937 . . . . 0.0 108.768 175.647 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -69.46 -31.84 70.39 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.252 1.421 . . . . 0.0 111.598 -172.457 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -82.09 -49.55 10.06 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 118.411 0.55 . . . . 0.0 109.845 175.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.75 -45.08 91.45 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 119.152 0.887 . . . . 0.0 109.931 -173.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -61.92 -23.55 63.69 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 124.041 0.829 . . . . 0.0 112.778 175.5 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.5 ttmm -59.32 -27.19 65.67 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 118.798 1.299 . . . . 0.0 111.284 175.592 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -117.39 12.39 14.23 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.805 1.242 . . . . 0.0 110.932 179.135 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 69.51 18.66 73.88 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 124.598 1.094 . . . . 0.0 113.719 -179.193 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 86.0 t -84.35 131.57 33.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 176.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.89 27.25 0.48 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.436 1.094 . . . . 0.0 109.741 168.347 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 24.7 m -140.39 153.63 46.42 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 126.882 2.073 . . . . 0.0 106.515 177.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -146.59 159.88 43.11 Favored Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 124.159 0.983 . . . . 0.0 109.728 -169.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -66.93 136.93 33.55 Favored 'Cis proline' 0 N--CA 1.457 -0.628 0 CA-C-N 120.081 1.065 . . . . 0.0 109.501 -11.153 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 52.9 m -132.63 121.17 22.78 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 178.598 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 82.2 mt -99.34 132.14 44.87 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.4 mp -117.18 129.29 55.85 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 105.444 -2.058 . . . . 0.0 105.444 170.216 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.2 t -93.44 126.4 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 N-CA-C 103.39 -2.819 . . . . 0.0 103.39 169.136 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.6 mp -119.24 159.81 23.36 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 174.264 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -145.84 124.75 12.71 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 173.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.4 t70 44.51 40.15 3.73 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.475 1.51 . . . . 0.0 113.267 174.652 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 98.57 5.96 56.59 Favored Glycine 0 CA--C 1.527 0.813 0 CA-C-O 118.792 -1.004 . . . . 0.0 114.574 169.73 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 81.9 mm-40 -128.16 144.09 51.09 Favored 'General case' 0 CA--C 1.521 -0.142 0 CA-C-N 119.262 1.531 . . . . 0.0 108.949 177.377 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.7 t -68.26 136.47 26.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 169.23 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 22.9 m -120.15 -20.73 4.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 117.856 -1.068 . . . . 0.0 110.479 174.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.54 164.76 38.24 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 119.711 1.141 . . . . 0.0 111.634 173.379 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 95.8 m -145.3 137.74 25.91 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.546 1.538 . . . . 0.0 108.381 175.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 44.6 m -145.06 153.13 41.13 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.04 1.736 . . . . 0.0 108.176 -178.231 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 40.6 t -133.19 148.21 31.21 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -174.769 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.83 177.13 46.81 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 123.858 0.742 . . . . 0.0 112.375 176.658 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -58.99 147.73 33.34 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 124.491 1.116 . . . . 0.0 110.745 178.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -155.23 147.7 17.7 Favored Pre-proline 0 CA--C 1.533 0.311 0 C-N-CA 125.272 1.429 . . . . 0.0 107.686 169.308 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.85 157.87 47.11 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.668 2.245 . . . . 0.0 111.34 -177.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 4.7 ttpt -60.68 -34.97 75.13 Favored 'General case' 0 C--O 1.223 -0.312 0 C-N-CA 123.909 0.884 . . . . 0.0 111.673 -178.304 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -64.67 -42.58 95.27 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 119.425 1.011 . . . . 0.0 111.822 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.14 -43.03 75.2 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 122.828 0.451 . . . . 0.0 110.364 177.614 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 38.8 tp -67.81 -40.71 83.81 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 119.111 -0.471 . . . . 0.0 110.714 -177.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.5 pp0? -67.79 -32.15 72.51 Favored 'General case' 0 C--O 1.222 -0.393 0 CA-C-O 117.856 -1.068 . . . . 0.0 109.578 175.75 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -67.34 -43.66 80.98 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 119.436 1.016 . . . . 0.0 109.268 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 58.0 tp -57.05 -51.81 67.8 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.409 0.684 . . . . 0.0 109.681 175.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 28.7 t -58.54 -48.86 84.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 123.461 0.705 . . . . 0.0 110.481 178.199 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -57.44 -46.43 83.6 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 126.501 1.92 . . . . 0.0 110.699 -176.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -59.41 -34.27 72.25 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 118.656 -0.688 . . . . 0.0 112.368 174.007 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 79.8 m-70 -81.2 -18.12 47.27 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 82.3 mt . . . . . 0 C--O 1.249 1.064 0 CA-C-N 119.93 1.241 . . . . 0.0 110.185 178.653 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 90.8 mt . . . . . 0 CA--C 1.535 0.39 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 38.8 t -110.45 165.18 6.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 -174.451 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.93 134.93 41.12 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 -179.333 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -146.66 170.9 16.0 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.106 0.412 . . . . 0.0 111.299 178.204 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 76.2 p -137.32 174.41 10.63 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.416 1.487 . . . . 0.0 108.111 179.321 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -47.34 -33.27 5.6 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 119.997 1.271 . . . . 0.0 113.11 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 26.8 mp0 -61.4 -33.71 74.14 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.677 1.591 . . . . 0.0 112.875 -179.255 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.5 m -142.82 -1.82 1.08 Allowed 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 -169.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -52.72 -41.45 63.96 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.078 0.951 . . . . 0.0 110.13 175.043 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.6 m -65.45 -27.67 68.68 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.558 0.743 . . . . 0.0 112.433 -178.267 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -78.49 -27.62 46.22 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.788 0.835 . . . . 0.0 111.088 176.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -81.6 -40.95 22.23 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.031 0.532 . . . . 0.0 111.137 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.527 ' HA ' HG21 ' A' ' 20' ' ' VAL . 39.2 p -74.84 -2.91 28.86 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -174.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.0 p -108.71 29.54 7.34 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.762 1.225 . . . . 0.0 112.883 -169.191 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -131.27 -0.34 4.07 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 113.588 0.958 . . . . 0.0 113.588 -175.621 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 166.15 -166.38 38.72 Favored Glycine 0 C--N 1.336 0.547 0 CA-C-N 119.21 0.913 . . . . 0.0 110.848 -174.043 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 98.3 t -72.4 132.14 33.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 104.829 -2.285 . . . . 0.0 104.829 166.697 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.527 HG21 ' HA ' ' A' ' 15' ' ' THR . 39.0 t -135.75 118.1 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 -176.062 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 63.1 tp -88.73 97.91 11.4 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 173.557 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.37 149.37 36.96 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 169.443 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -133.36 98.24 4.18 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 175.327 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -73.97 114.95 12.87 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 172.169 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 7.8 p-90 -138.02 175.03 9.94 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 123.49 0.716 . . . . 0.0 110.754 -169.572 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -152.14 147.16 19.3 Favored Pre-proline 0 CA--C 1.535 0.399 0 C-N-CA 124.563 1.145 . . . . 0.0 107.934 169.195 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.45 -21.02 17.65 Favored 'Trans proline' 0 CA--C 1.532 0.397 0 C-N-CA 122.795 2.33 . . . . 0.0 113.348 -171.087 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -82.74 -8.2 59.6 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 118.685 0.675 . . . . 0.0 112.045 178.363 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 44.3 t -90.32 120.75 31.72 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 -179.433 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -57.03 -58.21 15.78 Favored Glycine 0 CA--C 1.531 1.057 0 CA-C-O 118.707 -1.051 . . . . 0.0 112.086 178.477 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -50.35 -35.07 43.14 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 123.519 2.812 . . . . 0.0 115.271 177.622 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 97.8 m -60.51 -33.13 72.19 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 119.451 1.023 . . . . 0.0 112.299 175.088 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 46.2 mtmt -85.04 -34.66 22.25 Favored 'General case' 0 C--N 1.333 -0.12 0 C-N-CA 123.043 0.537 . . . . 0.0 109.914 176.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 26.4 mmt -63.15 -34.96 78.74 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 119.137 0.88 . . . . 0.0 111.593 176.572 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.7 tt -81.19 -7.87 10.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-N 118.729 0.695 . . . . 0.0 111.667 178.061 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.44 -50.78 86.16 Favored Pre-proline 0 CA--C 1.541 0.618 0 O-C-N 120.635 -1.291 . . . . 0.0 112.494 178.383 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -64.07 -33.02 63.48 Favored 'Trans proline' 0 C--N 1.351 0.681 0 CA-C-N 121.844 1.694 . . . . 0.0 112.283 176.261 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 19.5 t -59.18 -47.76 89.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 119.1 0.864 . . . . 0.0 109.643 173.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 58.9 mt -65.87 -36.89 84.7 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 118.941 -0.552 . . . . 0.0 110.63 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -66.97 -37.6 84.54 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 119.013 0.824 . . . . 0.0 111.303 176.647 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -68.06 -39.23 83.04 Favored 'General case' 0 C--N 1.331 -0.2 0 O-C-N 121.091 -1.006 . . . . 0.0 110.377 174.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.48 -43.37 97.51 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 176.318 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -61.23 -42.25 98.28 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.839 0.856 . . . . 0.0 110.519 177.581 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -67.93 -13.44 62.17 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.703 0.801 . . . . 0.0 112.795 177.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -108.46 -32.09 7.55 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.226 1.01 . . . . 0.0 112.457 -178.182 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 19.5 mtt -140.2 2.25 1.88 Allowed 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 117.877 -1.059 . . . . 0.0 113.071 -169.417 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.3 44.63 0.74 Allowed Glycine 0 CA--C 1.532 1.136 0 C-N-CA 126.599 2.047 . . . . 0.0 114.561 -174.029 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -152.43 -40.3 0.11 Allowed 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 128.951 2.9 . . . . 0.0 107.615 171.325 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -63.21 -35.94 82.0 Favored 'General case' 0 C--N 1.343 0.319 0 C-N-CA 124.7 1.2 . . . . 0.0 110.451 169.407 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -133.99 165.29 25.38 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 125.925 1.69 . . . . 0.0 109.75 171.644 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -106.91 152.52 23.81 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.168 1.387 . . . . 0.0 107.758 170.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.2 mt -117.38 136.22 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 N-CA-C 105.582 -2.007 . . . . 0.0 105.582 171.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 58.1 t -131.65 114.51 25.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 -177.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 48.0 mmtt -74.26 144.56 44.59 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 169.497 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 13.4 tt -147.77 115.59 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 170.701 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 44.7 t0 -81.03 112.97 18.91 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.961 0.905 . . . . 0.0 109.224 -175.721 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 30.5 m -62.27 -21.87 27.86 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-O 118.425 -0.798 . . . . 0.0 113.02 -174.148 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -72.3 -6.53 43.82 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 120.012 1.278 . . . . 0.0 112.559 -178.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -126.35 4.21 6.99 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.344 1.058 . . . . 0.0 110.505 169.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -142.4 30.8 1.53 Allowed 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.389 1.076 . . . . 0.0 111.528 -168.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.424 ' CD ' ' H ' ' A' ' 61' ' ' GLN . 3.8 pm0 -55.44 -31.56 62.02 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 124.557 1.143 . . . . 0.0 110.435 169.676 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -65.08 -51.85 59.02 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 124.192 0.997 . . . . 0.0 110.173 176.293 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -67.17 -43.81 81.32 Favored 'General case' 0 C--O 1.222 -0.357 0 O-C-N 121.965 -0.46 . . . . 0.0 109.924 -178.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -61.63 -45.08 95.61 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 118.611 0.642 . . . . 0.0 109.596 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -59.86 -25.32 61.43 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 124.403 1.001 . . . . 0.0 112.903 175.453 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 8.5 ttmm -58.41 -23.37 57.1 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 118.621 1.21 . . . . 0.0 111.509 174.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -122.51 12.74 10.08 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.251 1.42 . . . . 0.0 110.894 178.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 70.88 17.45 75.32 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 124.552 1.073 . . . . 0.0 113.914 -179.255 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 95.4 t -85.55 137.16 21.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 176.297 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 6.6 tpt -153.49 25.14 0.52 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.092 0.957 . . . . 0.0 109.559 168.139 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 20.1 m -140.24 154.99 47.06 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 126.403 1.881 . . . . 0.0 107.297 -178.344 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -145.62 158.26 50.4 Favored Pre-proline 0 CA--C 1.542 0.663 0 C-N-CA 123.743 0.817 . . . . 0.0 110.376 -169.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.14 138.86 43.49 Favored 'Cis proline' 0 C--N 1.35 0.625 0 N-CA-C 109.512 -0.995 . . . . 0.0 109.512 -10.543 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 53.0 m -131.25 115.93 16.97 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 175.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 90.1 mt -89.86 136.39 33.07 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 176.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.0 mp -122.05 131.06 53.79 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 105.32 -2.104 . . . . 0.0 105.32 169.77 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 16.1 t -95.21 124.48 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 N-CA-C 103.062 -2.94 . . . . 0.0 103.062 168.322 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.9 mp -116.96 158.63 23.76 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 173.249 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 74.2 tttt -144.77 127.51 16.24 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 174.333 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 29.3 t70 46.83 33.47 2.19 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.248 1.419 . . . . 0.0 113.839 174.227 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 115.72 -7.97 19.71 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-O 118.096 -1.391 . . . . 0.0 115.082 168.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -133.2 146.09 51.18 Favored 'General case' 0 C--N 1.339 0.119 0 CA-C-N 120.071 1.935 . . . . 0.0 110.598 -174.201 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 5.8 p -65.48 137.34 25.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 172.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 34.9 m -123.58 -21.38 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 C-N-CA 125.338 1.455 . . . . 0.0 110.573 177.457 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -156.64 165.55 35.95 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.727 1.149 . . . . 0.0 110.999 174.704 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 98.9 m -143.74 149.41 37.08 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.761 1.624 . . . . 0.0 108.746 178.467 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 73.3 m -149.94 155.34 39.8 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.713 1.605 . . . . 0.0 108.306 171.48 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 40.8 t -132.93 144.93 35.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 -174.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.54 175.85 49.55 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 124.153 0.882 . . . . 0.0 111.716 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -62.47 149.3 43.12 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.428 0.691 . . . . 0.0 110.376 176.421 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 42.1 mttm -141.5 145.4 37.54 Favored Pre-proline 0 C--O 1.233 0.215 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 168.722 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -71.63 158.28 53.89 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 122.253 1.969 . . . . 0.0 109.879 172.112 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.2 tmpt? -62.67 -35.2 78.9 Favored 'General case' 0 N--CA 1.457 -0.117 0 O-C-N 121.686 -0.634 . . . . 0.0 111.601 -176.17 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -68.3 -35.07 77.27 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 119.125 0.875 . . . . 0.0 111.177 -177.194 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.9 -41.37 78.35 Favored 'General case' 0 N--CA 1.454 -0.233 0 O-C-N 121.86 -0.525 . . . . 0.0 110.498 171.667 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 45.7 tp -64.41 -40.18 95.27 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 119.34 -0.362 . . . . 0.0 110.694 -178.506 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.8 pp0? -70.97 -32.86 69.84 Favored 'General case' 0 C--O 1.226 -0.144 0 CA-C-N 118.994 0.815 . . . . 0.0 110.363 176.523 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -65.79 -37.17 85.56 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 118.63 0.65 . . . . 0.0 109.445 177.356 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 61.4 tp -63.33 -55.9 20.82 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.282 0.633 . . . . 0.0 110.055 171.566 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 25.2 t -61.53 -44.0 97.87 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 C-N-CA 123.384 0.673 . . . . 0.0 110.783 -172.141 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.78 -28.15 69.25 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 118.769 0.713 . . . . 0.0 112.326 -170.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 35.2 mtmm -73.37 -27.84 61.7 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 118.914 -0.565 . . . . 0.0 112.462 175.499 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -87.55 -20.57 26.26 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 118.365 -0.826 . . . . 0.0 112.456 -179.494 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 74.2 mt . . . . . 0 C--O 1.249 1.075 0 CA-C-N 119.192 0.905 . . . . 0.0 109.779 174.152 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 91.2 mt . . . . . 0 CA--C 1.538 0.492 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 25.2 t -124.41 166.32 19.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 125.94 1.696 . . . . 0.0 106.503 -174.401 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 11.2 mtmt -134.94 146.96 49.63 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 174.546 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -144.95 170.93 15.19 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 123.32 0.648 . . . . 0.0 110.166 175.567 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 80.7 p -133.7 175.62 9.28 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 170.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -49.73 -29.67 8.03 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 119.257 0.935 . . . . 0.0 113.32 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 11.9 mp0 -59.02 -34.25 71.67 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.769 2.027 . . . . 0.0 112.477 179.408 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.4 m -143.17 -2.42 1.0 Allowed 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 114.299 1.222 . . . . 0.0 114.299 -170.003 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -52.73 -38.82 61.39 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 124.027 0.931 . . . . 0.0 111.038 176.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.6 m -68.36 -39.01 81.98 Favored 'General case' 0 N--CA 1.453 -0.323 0 O-C-N 122.187 -0.321 . . . . 0.0 111.23 -177.139 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.12 -44.55 79.63 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 175.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 61.8 mm-40 -63.14 -42.29 99.46 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 122.939 0.495 . . . . 0.0 110.856 -177.514 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 22.4 p -75.7 3.02 10.54 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -177.16 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 58.2 m -111.8 36.17 3.4 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.758 1.223 . . . . 0.0 111.688 -173.065 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -128.69 -3.97 5.28 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -179.23 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 162.88 -164.02 35.64 Favored Glycine 0 C--N 1.336 0.549 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 -172.204 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 82.0 t -71.51 133.43 31.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 105.095 -2.187 . . . . 0.0 105.095 166.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 31.9 t -137.5 125.52 31.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 107.065 -1.458 . . . . 0.0 107.065 -177.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 63.6 tp -92.61 98.37 11.39 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 173.592 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.74 145.23 40.99 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 169.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -133.17 96.74 3.81 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 124.993 1.317 . . . . 0.0 107.712 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -75.98 115.29 15.53 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 173.507 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 6.7 p-90 -138.08 175.76 9.29 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 123.47 0.708 . . . . 0.0 110.453 -171.077 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -150.19 143.79 16.91 Favored Pre-proline 0 CA--C 1.534 0.351 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 169.063 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.88 -23.63 21.98 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.334 2.023 . . . . 0.0 113.34 -169.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -81.38 -8.39 59.73 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 118.629 0.65 . . . . 0.0 112.499 178.791 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 52.7 t -84.86 115.38 22.73 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -178.44 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -52.35 -56.16 18.69 Favored Glycine 0 CA--C 1.531 1.087 0 CA-C-O 118.685 -1.064 . . . . 0.0 112.231 176.354 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_exo -51.41 -35.38 54.51 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 123.1 2.533 . . . . 0.0 115.195 174.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 97.5 m -63.26 -40.24 96.86 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 119.85 1.205 . . . . 0.0 111.409 172.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -64.65 -39.74 94.23 Favored 'General case' 0 N--CA 1.465 0.288 0 O-C-N 121.364 -0.835 . . . . 0.0 110.2 173.327 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 62.2 mtt -65.62 -38.62 89.95 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 123.088 0.555 . . . . 0.0 111.277 -177.409 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.6 tt -80.43 -18.47 12.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-N 118.819 0.736 . . . . 0.0 111.56 -178.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -52.45 -49.96 82.67 Favored Pre-proline 0 CA--C 1.544 0.749 0 CA-C-N 119.821 1.191 . . . . 0.0 113.567 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -65.69 -30.7 50.49 Favored 'Trans proline' 0 C--N 1.352 0.745 0 CA-C-N 121.873 1.705 . . . . 0.0 112.422 176.359 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 28.3 t -61.96 -44.48 98.97 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 119.409 1.004 . . . . 0.0 108.98 174.099 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 92.9 mt -64.44 -38.19 90.14 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-O 118.832 -0.604 . . . . 0.0 110.541 177.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -64.67 -40.37 95.3 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.428 1.013 . . . . 0.0 111.555 175.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -69.61 -35.41 75.25 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 121.16 -0.962 . . . . 0.0 110.69 176.733 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 9.3 tp -66.89 -39.66 87.55 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.434 0.693 . . . . 0.0 110.381 176.066 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -64.16 -42.3 96.8 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 123.778 0.831 . . . . 0.0 110.052 176.286 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -61.8 -31.0 71.19 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 121.629 -0.669 . . . . 0.0 112.229 173.641 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -85.07 -40.21 17.07 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.792 0.837 . . . . 0.0 112.497 -176.045 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 38.9 mtt -138.2 4.45 2.46 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 114.025 1.121 . . . . 0.0 114.025 -167.591 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.38 38.85 0.58 Allowed Glycine 0 CA--C 1.534 1.229 0 C-N-CA 126.487 1.994 . . . . 0.0 115.788 -169.403 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -140.69 -43.45 0.4 Allowed 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 125.775 1.63 . . . . 0.0 109.421 169.423 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 52.0 pttt -69.93 -22.74 63.16 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 119.228 -0.415 . . . . 0.0 111.88 170.174 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -136.96 163.67 30.14 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 125.584 1.554 . . . . 0.0 107.287 165.784 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 57.2 pttt -124.98 159.94 30.08 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 123.536 0.735 . . . . 0.0 109.069 168.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 22.7 mt -111.87 137.67 43.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 105.503 -2.036 . . . . 0.0 105.503 -178.679 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 87.2 t -127.06 109.57 20.94 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.13 144.93 44.68 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 171.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 14.7 tt -148.42 117.62 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 173.43 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -81.2 116.41 21.08 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -176.577 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 31.0 m -61.78 -26.51 40.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-O 119.061 -0.495 . . . . 0.0 112.031 -177.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -73.4 0.85 11.04 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.917 0.887 . . . . 0.0 112.074 -179.367 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -130.82 0.75 4.33 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.872 1.269 . . . . 0.0 111.035 170.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -141.39 48.66 1.65 Allowed 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.503 1.121 . . . . 0.0 109.769 -168.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.547 ' NE2' ' H ' ' A' ' 61' ' ' GLN . 0.4 OUTLIER -54.14 -44.94 71.82 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.642 1.577 . . . . 0.0 108.803 177.535 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -64.09 -47.51 79.76 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 125.825 1.65 . . . . 0.0 109.884 -175.644 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.459 ' HA ' ' HE3' ' A' ' 66' ' ' LYS . 0.7 OUTLIER -69.44 -43.18 73.87 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-O 119.298 -0.382 . . . . 0.0 110.153 -176.006 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -61.76 -46.57 89.04 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 119.239 0.927 . . . . 0.0 109.615 176.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -58.22 -26.39 58.74 Favored Glycine 0 CA--C 1.532 1.094 0 C-N-CA 124.165 0.888 . . . . 0.0 113.053 175.187 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.459 ' HE3' ' HA ' ' A' ' 63' ' ' THR . 28.9 ttmt -57.95 -21.5 44.38 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.33 1.452 . . . . 0.0 111.937 177.5 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -127.6 13.17 6.97 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.86 1.264 . . . . 0.0 110.638 178.469 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 69.83 19.02 74.78 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 124.667 1.127 . . . . 0.0 113.664 -178.13 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 96.3 t -82.19 137.93 20.3 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 175.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -153.16 25.02 0.54 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.901 1.28 . . . . 0.0 109.499 168.581 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 20.4 m -139.51 154.82 47.77 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 126.412 1.885 . . . . 0.0 107.32 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -146.18 160.31 43.13 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 124.345 1.058 . . . . 0.0 109.544 -170.579 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -66.86 139.24 44.48 Favored 'Cis proline' 0 C--N 1.35 0.632 0 N-CA-C 109.285 -1.083 . . . . 0.0 109.285 -11.112 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 51.3 m -131.9 118.59 20.01 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 177.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 88.3 mt -96.3 134.27 39.64 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 106.63 -1.619 . . . . 0.0 106.63 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.9 mp -119.54 128.37 53.87 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 104.793 -2.299 . . . . 0.0 104.793 169.394 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 15.5 t -93.58 125.26 46.18 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 103.104 -2.924 . . . . 0.0 103.104 168.623 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.7 mp -118.36 159.38 23.52 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 173.515 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 75.9 tttt -144.22 124.23 13.58 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 174.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.7 t70 45.76 36.76 2.93 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.44 1.496 . . . . 0.0 113.423 175.093 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 107.45 -2.28 34.62 Favored Glycine 0 CA--C 1.527 0.806 0 CA-C-O 118.089 -1.395 . . . . 0.0 115.365 168.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -130.39 147.36 52.08 Favored 'General case' 0 C--N 1.339 0.126 0 CA-C-N 120.08 1.94 . . . . 0.0 110.246 -178.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 16.8 t -67.66 137.61 24.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 107.813 -1.181 . . . . 0.0 107.813 175.172 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 29.0 m -119.63 -20.26 4.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 124.827 1.251 . . . . 0.0 110.537 173.456 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -156.85 162.26 39.69 Favored 'General case' 0 C--N 1.346 0.417 0 CA-C-N 119.642 1.11 . . . . 0.0 111.242 173.351 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 87.0 m -143.49 137.92 28.86 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.645 1.578 . . . . 0.0 108.356 174.334 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 29.3 m -145.39 153.22 40.98 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.933 1.693 . . . . 0.0 108.44 -178.165 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 40.9 t -133.07 145.21 34.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -175.629 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.91 175.52 46.79 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 124.462 1.029 . . . . 0.0 111.844 178.407 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -62.29 148.5 44.77 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.727 0.811 . . . . 0.0 110.377 176.056 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 46.3 mttm -142.01 146.1 38.95 Favored Pre-proline 0 C--O 1.233 0.195 0 C-N-CA 124.93 1.292 . . . . 0.0 107.733 168.629 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -72.87 161.21 44.28 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 122.746 2.297 . . . . 0.0 110.266 173.707 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -56.16 -43.78 78.68 Favored 'General case' 0 C--O 1.223 -0.326 0 CA-C-O 118.626 -0.702 . . . . 0.0 110.683 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -65.65 -37.78 87.49 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 119.162 0.892 . . . . 0.0 111.458 -169.773 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.53 -43.97 71.93 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 122.904 0.481 . . . . 0.0 110.639 174.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 29.6 tp -67.15 -41.77 85.48 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 122.568 0.347 . . . . 0.0 110.76 -175.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.2 pp0? -70.55 -32.69 70.22 Favored 'General case' 0 N--CA 1.456 -0.138 0 O-C-N 121.798 -0.564 . . . . 0.0 109.866 177.773 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -63.43 -48.05 79.38 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 176.232 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 51.1 tp -60.17 -44.4 95.07 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 122.824 0.45 . . . . 0.0 110.696 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 26.3 t -58.06 -47.48 86.76 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 175.378 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.71 -25.09 67.79 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 119.078 0.854 . . . . 0.0 112.675 -177.284 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -66.02 -23.65 66.6 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 119.048 0.84 . . . . 0.0 112.479 169.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -107.85 -16.52 14.29 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 119.478 1.035 . . . . 0.0 113.242 -174.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 80.7 mt . . . . . 0 C--O 1.249 1.068 0 CA-C-N 119.484 1.038 . . . . 0.0 109.681 172.248 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 91.8 mt . . . . . 0 CA--C 1.539 0.551 0 N-CA-C 107.3 -1.371 . . . . 0.0 107.3 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 36.7 t -120.03 170.68 9.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 -174.015 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 27.8 mtpt -137.31 149.84 47.34 Favored 'General case' 0 CA--C 1.518 -0.268 0 O-C-N 120.732 -1.23 . . . . 0.0 108.679 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -151.01 170.36 19.54 Favored 'General case' 0 C--N 1.331 -0.196 0 O-C-N 123.489 0.493 . . . . 0.0 111.66 176.142 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.3 p -136.51 174.11 10.97 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.863 1.665 . . . . 0.0 107.205 172.163 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -47.08 -33.3 4.83 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 119.917 1.235 . . . . 0.0 113.243 -179.429 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 26.9 mp0 -60.68 -31.45 70.71 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.075 1.75 . . . . 0.0 113.109 -179.469 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.3 m -140.41 -2.57 1.41 Allowed 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -170.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -54.79 -37.94 66.68 Favored 'General case' 0 CA--C 1.528 0.098 0 C-N-CA 124.191 0.997 . . . . 0.0 111.03 178.411 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.4 p -63.09 -50.53 70.18 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.653 0.781 . . . . 0.0 110.788 179.346 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.31 -44.44 92.57 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 122.972 0.509 . . . . 0.0 110.159 178.572 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -66.58 -37.76 85.6 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-O 119.2 -0.428 . . . . 0.0 111.403 -177.528 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.517 ' HA ' HG21 ' A' ' 20' ' ' VAL . 34.2 p -80.21 3.35 21.02 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 118.607 0.64 . . . . 0.0 112.451 -178.514 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 51.2 m -111.73 32.78 5.19 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.598 1.159 . . . . 0.0 112.346 -172.78 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -132.58 -0.44 3.55 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -177.243 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 165.92 -167.09 39.01 Favored Glycine 0 C--N 1.334 0.452 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 -174.199 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 97.4 t -71.91 133.3 32.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 104.56 -2.385 . . . . 0.0 104.56 166.108 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.517 HG21 ' HA ' ' A' ' 15' ' ' THR . 38.6 t -136.49 121.77 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 -176.307 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 56.6 tp -96.45 98.0 9.89 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 173.633 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.2 156.16 33.87 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 169.493 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -139.38 100.04 3.89 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 125.382 1.473 . . . . 0.0 107.547 179.124 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -75.05 115.52 14.76 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 169.232 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 8.6 p-90 -137.0 174.72 10.31 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 123.554 0.742 . . . . 0.0 110.237 -174.089 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -153.96 148.02 18.96 Favored Pre-proline 0 CA--C 1.535 0.402 0 N-CA-C 107.753 -1.202 . . . . 0.0 107.753 169.362 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -73.52 -22.46 18.31 Favored 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 122.574 2.183 . . . . 0.0 113.22 -169.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -79.43 -5.55 54.94 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 118.623 0.647 . . . . 0.0 112.356 179.047 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 45.2 t -95.12 110.51 22.45 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 -175.747 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -51.03 -53.21 27.97 Favored Glycine 0 CA--C 1.533 1.215 0 CA-C-O 118.801 -0.999 . . . . 0.0 112.74 176.1 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_exo -52.34 -34.19 59.32 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 122.858 2.372 . . . . 0.0 114.846 174.379 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 80.9 m -67.39 -39.8 85.6 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 120.185 1.357 . . . . 0.0 111.146 172.296 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -59.88 -34.34 73.03 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 121.051 -1.031 . . . . 0.0 110.262 173.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 26.2 mmt -73.88 -37.12 64.83 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 123.043 0.537 . . . . 0.0 111.48 177.366 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.2 tp -70.68 -23.27 23.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 119.408 1.004 . . . . 0.0 110.935 179.068 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.81 -54.95 46.28 Favored Pre-proline 0 CA--C 1.543 0.701 0 CA-C-O 117.775 -1.107 . . . . 0.0 113.006 -177.456 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -66.55 -28.41 45.29 Favored 'Trans proline' 0 C--N 1.349 0.576 0 CA-C-N 121.703 1.644 . . . . 0.0 112.499 177.35 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 97.8 t -62.87 -43.61 99.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 119.607 1.094 . . . . 0.0 109.335 174.133 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 89.5 mt -69.28 -35.03 75.63 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-O 118.585 -0.722 . . . . 0.0 111.112 178.159 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -65.51 -41.23 93.39 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 119.526 1.057 . . . . 0.0 110.883 174.546 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -59.43 -45.23 92.13 Favored 'General case' 0 N--CA 1.455 -0.196 0 O-C-N 121.479 -0.763 . . . . 0.0 110.4 171.386 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.2 tp -64.36 -38.93 92.76 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 122.869 0.468 . . . . 0.0 110.698 -178.142 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -65.3 -41.78 93.72 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.524 0.73 . . . . 0.0 110.611 177.121 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -66.91 -36.3 81.94 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 122.067 -0.396 . . . . 0.0 111.252 176.671 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -73.96 -49.66 23.58 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.231 1.013 . . . . 0.0 111.013 -175.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 7.9 ptp -146.06 10.53 1.17 Allowed 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 -167.776 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.68 52.02 1.54 Allowed Glycine 0 CA--C 1.526 0.764 0 C-N-CA 126.53 2.014 . . . . 0.0 113.156 -178.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -148.66 -39.42 0.16 Allowed 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 128.229 2.612 . . . . 0.0 107.697 169.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 58.7 mtmt -65.95 -29.71 70.16 Favored 'General case' 0 C--N 1.345 0.375 0 C-N-CA 123.58 0.752 . . . . 0.0 110.68 168.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -131.96 162.65 30.18 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 125.138 1.375 . . . . 0.0 110.324 168.812 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -99.28 154.91 17.8 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.018 1.327 . . . . 0.0 107.538 169.3 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 12.8 mt -120.83 137.37 54.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 N-CA-C 105.704 -1.961 . . . . 0.0 105.704 170.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 84.6 t -133.61 114.1 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-N 119.048 0.84 . . . . 0.0 108.963 -174.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 56.7 mmtt -73.73 143.29 46.18 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 121.853 -0.529 . . . . 0.0 109.845 170.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 13.0 tt -151.35 149.68 13.86 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 N-CA-C 107.699 -1.222 . . . . 0.0 107.699 170.408 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -123.33 118.04 26.62 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 120.958 -1.089 . . . . 0.0 109.808 -169.595 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 30.5 m -55.13 -29.48 22.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 124.233 1.013 . . . . 0.0 113.027 -174.538 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -69.76 -9.09 53.24 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.874 0.869 . . . . 0.0 112.424 -175.491 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -132.07 6.05 4.22 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.838 1.255 . . . . 0.0 110.953 176.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 67.1 m-80 -141.21 46.7 1.72 Allowed 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.957 0.903 . . . . 0.0 110.679 -168.599 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.515 ' NE2' ' H ' ' A' ' 61' ' ' GLN . 0.5 OUTLIER -55.09 -43.94 74.45 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.908 0.883 . . . . 0.0 108.947 173.616 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -68.38 -31.73 71.31 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 125.48 1.512 . . . . 0.0 111.63 -171.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -84.68 -47.54 10.37 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 118.31 0.504 . . . . 0.0 109.918 176.579 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -64.22 -45.17 89.4 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 119.216 0.916 . . . . 0.0 109.904 -175.081 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -61.1 -24.97 63.77 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 124.009 0.814 . . . . 0.0 112.409 176.194 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.4 ttmm -58.99 -26.44 64.5 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 118.348 1.074 . . . . 0.0 111.533 176.009 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -114.83 10.47 16.48 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.606 1.162 . . . . 0.0 111.146 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 71.15 31.43 66.45 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 123.649 0.642 . . . . 0.0 112.418 -178.173 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 98.1 t -111.05 138.27 40.03 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 C-N-CA 125.073 1.349 . . . . 0.0 107.835 -178.383 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 8.6 tpt -153.97 30.75 0.45 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.034 0.934 . . . . 0.0 108.989 167.273 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 19.3 m -139.21 158.8 43.54 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 126.401 1.88 . . . . 0.0 107.671 -178.315 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -143.43 158.62 57.17 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 123.956 0.903 . . . . 0.0 110.013 -173.285 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -66.75 138.36 39.85 Favored 'Cis proline' 0 N--CA 1.457 -0.631 0 N-CA-C 108.786 -1.275 . . . . 0.0 108.786 -11.276 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 99.1 m -132.31 112.73 12.46 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 174.414 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 95.6 mt -83.46 141.77 31.43 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 175.421 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -128.8 127.27 41.63 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 104.133 -2.543 . . . . 0.0 104.133 -178.607 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.0 t -112.57 121.72 65.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 104.235 -2.506 . . . . 0.0 104.235 -176.66 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.2 mp -127.46 159.32 34.87 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 77.2 tttt -146.08 124.15 12.12 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 177.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.0 t70 45.16 35.94 1.91 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.438 1.495 . . . . 0.0 113.441 175.112 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 105.54 1.71 40.48 Favored Glycine 0 CA--C 1.527 0.794 0 CA-C-O 118.092 -1.393 . . . . 0.0 115.074 169.339 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -130.69 145.2 51.87 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 120.082 1.941 . . . . 0.0 109.921 179.068 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.7 p -69.0 140.67 18.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 C-N-CA 123.769 0.827 . . . . 0.0 109.19 174.01 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 35.5 m -128.02 -17.95 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 125.69 1.596 . . . . 0.0 110.681 178.506 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -160.1 167.28 28.14 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 120.389 1.45 . . . . 0.0 111.545 169.773 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 52.7 m -145.4 141.53 28.52 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.054 1.742 . . . . 0.0 107.549 169.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 14.7 m -145.84 146.55 31.18 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 124.215 1.006 . . . . 0.0 108.631 -178.094 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 39.8 t -127.41 148.8 32.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 -170.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.99 172.55 39.57 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 124.185 0.897 . . . . 0.0 111.589 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -61.22 153.75 25.31 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.225 0.61 . . . . 0.0 110.762 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -153.41 148.25 19.65 Favored Pre-proline 0 CA--C 1.533 0.301 0 C-N-CA 125.082 1.353 . . . . 0.0 107.677 169.772 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.51 162.41 41.47 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.644 2.23 . . . . 0.0 111.013 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -53.97 -43.8 70.23 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-O 118.574 -0.727 . . . . 0.0 110.952 177.245 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -63.59 -42.14 98.3 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 119.059 0.845 . . . . 0.0 111.369 -169.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.58 -41.71 88.11 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 123.096 0.558 . . . . 0.0 110.854 175.425 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 30.9 tp -68.1 -41.95 81.02 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 119.549 -0.262 . . . . 0.0 110.911 -176.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.7 pp0? -71.15 -30.81 66.92 Favored 'General case' 0 N--CA 1.457 -0.113 0 CA-C-N 118.512 0.596 . . . . 0.0 110.044 177.557 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -63.1 -50.03 72.12 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 174.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 66.9 tp -58.04 -46.54 85.19 Favored 'General case' 0 C--N 1.334 -0.09 0 C-N-CA 123.723 0.809 . . . . 0.0 110.31 -178.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 42.9 t -63.7 -49.08 83.73 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-O 118.561 -0.733 . . . . 0.0 109.783 179.272 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.05 -26.89 68.76 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 119.725 1.148 . . . . 0.0 112.268 -176.551 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -68.22 -26.83 65.91 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 118.323 -0.846 . . . . 0.0 112.384 171.019 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 77.0 m-70 -95.23 -19.84 19.7 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 119.571 1.078 . . . . 0.0 113.368 178.143 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 61.3 mt . . . . . 0 C--O 1.248 0.982 0 CA-C-N 119.781 1.173 . . . . 0.0 109.745 175.296 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 90.5 mt . . . . . 0 C--O 1.236 0.384 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 40.9 t -104.38 167.58 2.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 -174.546 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 5.9 mptt -137.13 138.51 40.37 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 -178.366 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -144.91 170.22 16.55 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.068 0.461 . . . . 0.0 111.656 -179.446 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 70.8 p -137.08 173.5 11.63 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.725 1.61 . . . . 0.0 107.48 177.458 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -49.75 -32.43 13.7 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 119.836 1.198 . . . . 0.0 112.979 -178.2 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 26.2 mp0 -63.82 -30.75 71.81 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.098 1.759 . . . . 0.0 112.778 -178.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.6 m -138.47 -4.93 1.61 Allowed 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 -169.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -54.92 -37.48 66.43 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 124.039 0.935 . . . . 0.0 110.821 177.398 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.3 p -62.94 -50.98 68.7 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 123.861 0.865 . . . . 0.0 110.835 178.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.22 -44.29 92.3 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.019 0.527 . . . . 0.0 110.081 178.487 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -66.03 -38.67 89.0 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-O 119.237 -0.411 . . . . 0.0 111.294 -177.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.551 ' HA ' HG21 ' A' ' 20' ' ' VAL . 28.8 p -78.62 1.41 22.79 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 118.528 0.604 . . . . 0.0 112.58 -179.08 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 50.4 m -110.29 32.61 5.02 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.57 1.148 . . . . 0.0 112.27 -172.368 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -132.17 -0.17 3.73 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -178.194 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 165.51 -167.69 39.1 Favored Glycine 0 C--N 1.336 0.54 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 -174.523 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 97.4 t -71.24 134.23 30.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 N-CA-C 104.687 -2.338 . . . . 0.0 104.687 166.21 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.551 HG21 ' HA ' ' A' ' 15' ' ' THR . 40.4 t -136.8 120.85 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 -175.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 61.6 tp -95.35 96.91 9.45 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 173.444 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.24 157.76 32.28 Favored 'General case' 0 N--CA 1.444 -0.732 0 O-C-N 121.831 -0.543 . . . . 0.0 109.7 169.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -139.92 99.26 3.65 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 125.558 1.543 . . . . 0.0 107.436 178.399 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -73.96 117.14 15.4 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 169.535 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 8.2 p-90 -138.2 173.4 11.65 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 123.396 0.678 . . . . 0.0 110.883 -174.363 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -153.47 149.13 20.71 Favored Pre-proline 0 C--O 1.238 0.46 0 C-N-CA 126.416 1.886 . . . . 0.0 105.957 169.007 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -75.68 -21.97 14.11 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.695 2.263 . . . . 0.0 113.251 -169.237 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -78.32 -7.84 57.71 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 118.541 0.609 . . . . 0.0 112.521 -176.141 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 37.5 t -100.16 108.78 20.99 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 -178.437 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -46.47 -51.21 12.53 Favored Glycine 0 CA--C 1.533 1.215 0 CA-C-O 118.425 -1.208 . . . . 0.0 113.767 -178.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -49.81 -31.51 26.41 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 123.443 2.762 . . . . 0.0 115.885 176.107 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 61.6 m -62.5 -40.94 98.34 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 120.409 1.459 . . . . 0.0 110.782 173.561 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -67.88 -37.75 82.18 Favored 'General case' 0 N--CA 1.462 0.144 0 O-C-N 121.729 -0.607 . . . . 0.0 109.933 175.536 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 64.3 mtt -65.66 -40.5 92.5 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 118.202 0.455 . . . . 0.0 111.165 -178.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 10.1 tt -80.87 -19.03 11.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 118.666 0.667 . . . . 0.0 111.619 -177.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -52.35 -51.53 71.55 Favored Pre-proline 0 CA--C 1.543 0.686 0 CA-C-O 117.529 -1.224 . . . . 0.0 113.632 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.1 -30.45 55.87 Favored 'Trans proline' 0 C--N 1.351 0.683 0 CA-C-N 121.874 1.705 . . . . 0.0 112.037 177.274 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 14.0 t -63.6 -44.61 98.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 119.126 0.875 . . . . 0.0 109.157 176.034 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 78.5 mt -65.59 -36.38 83.58 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 118.917 -0.563 . . . . 0.0 110.731 177.346 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -66.05 -38.88 89.47 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 119.266 0.939 . . . . 0.0 111.203 175.3 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -67.38 -37.52 83.27 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 121.087 -1.008 . . . . 0.0 110.344 174.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 16.0 tp -66.34 -39.11 89.01 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.348 0.659 . . . . 0.0 110.551 177.038 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -65.1 -40.07 94.03 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.014 0.926 . . . . 0.0 110.708 175.665 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -66.84 -36.45 82.37 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.942 -0.474 . . . . 0.0 111.306 175.702 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -72.35 -53.47 12.25 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.921 0.889 . . . . 0.0 110.987 -178.357 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 11.6 ptp -144.44 15.63 1.64 Allowed 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 114.212 1.189 . . . . 0.0 114.212 -167.126 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.35 53.94 1.14 Allowed Glycine 0 CA--C 1.529 0.965 0 C-N-CA 126.124 1.821 . . . . 0.0 112.092 175.612 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -153.51 -40.93 0.1 Allowed 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 129.41 3.084 . . . . 0.0 107.281 172.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -63.95 -35.24 80.03 Favored 'General case' 0 C--N 1.343 0.311 0 C-N-CA 124.04 0.936 . . . . 0.0 110.176 168.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -131.04 165.34 23.43 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 125.34 1.456 . . . . 0.0 110.473 169.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -102.06 154.64 18.8 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 169.229 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.6 mt -120.58 137.45 54.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 170.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 66.7 t -134.02 115.94 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-N 119.2 0.909 . . . . 0.0 109.502 -175.157 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 65.7 mmtt -74.89 145.04 43.05 Favored 'General case' 0 C--O 1.235 0.303 0 O-C-N 121.233 -0.917 . . . . 0.0 109.783 169.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 12.4 tt -151.33 141.7 15.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 169.715 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -98.49 128.08 44.69 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 121.488 -0.757 . . . . 0.0 110.063 -173.315 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 15.9 m -67.99 -27.42 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 114.51 1.3 . . . . 0.0 114.51 -173.036 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -80.62 -41.32 24.09 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 120.072 1.305 . . . . 0.0 109.41 -175.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -71.75 -26.26 62.38 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.413 0.685 . . . . 0.0 111.18 175.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 -128.39 43.43 3.14 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.735 1.214 . . . . 0.0 109.864 -170.408 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.79 -39.67 62.55 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 126.697 1.999 . . . . 0.0 111.049 176.721 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -64.02 -46.02 86.33 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 123.615 0.766 . . . . 0.0 110.335 176.316 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.539 ' HA ' ' HE3' ' A' ' 66' ' ' LYS . 0.3 OUTLIER -69.89 -41.93 74.09 Favored 'General case' 0 C--O 1.222 -0.369 0 CA-C-N 118.69 0.677 . . . . 0.0 110.74 -175.979 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.77 -45.16 93.99 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 119.307 0.958 . . . . 0.0 109.273 176.066 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -57.53 -27.9 59.01 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 123.838 0.733 . . . . 0.0 112.778 174.589 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.539 ' HE3' ' HA ' ' A' ' 63' ' ' THR . 25.0 ttmt -59.51 -19.94 51.83 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.458 1.503 . . . . 0.0 111.96 178.55 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -125.3 12.41 8.19 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.659 1.184 . . . . 0.0 110.915 179.288 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 71.52 32.6 64.52 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 123.713 0.673 . . . . 0.0 112.722 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 90.8 t -111.18 139.05 36.96 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 C-N-CA 125.054 1.342 . . . . 0.0 108.003 -178.554 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 8.6 tpt -155.26 30.29 0.39 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.408 1.083 . . . . 0.0 108.989 167.524 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 18.2 m -136.96 158.96 43.27 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 126.181 1.792 . . . . 0.0 107.919 -177.466 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -144.8 155.57 56.01 Favored Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 123.354 0.662 . . . . 0.0 111.152 -170.293 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -69.73 140.14 58.67 Favored 'Cis proline' 0 N--CA 1.458 -0.599 0 N-CA-C 108.653 -1.326 . . . . 0.0 108.653 -11.731 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 96.3 m -130.68 113.11 13.76 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 176.195 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 94.4 mt -81.18 144.71 31.43 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 175.028 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.9 126.4 36.06 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 103.949 -2.611 . . . . 0.0 103.949 -179.036 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 5.2 t -109.52 122.33 63.96 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.42 0 N-CA-C 104.227 -2.509 . . . . 0.0 104.227 -179.067 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.4 mp -125.86 159.8 31.55 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 179.218 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -145.41 126.44 14.6 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 175.703 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.0 t70 44.41 35.65 1.39 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.368 1.467 . . . . 0.0 113.55 174.401 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 106.48 0.19 37.35 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-O 118.004 -1.442 . . . . 0.0 115.07 169.414 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -130.69 145.82 52.02 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-N 120.13 1.965 . . . . 0.0 110.216 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 10.0 p -70.03 140.98 17.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 C-N-CA 123.845 0.858 . . . . 0.0 109.435 174.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 32.5 m -129.94 -17.61 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 125.734 1.613 . . . . 0.0 110.788 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -160.29 168.56 25.05 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 120.422 1.465 . . . . 0.0 111.696 169.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 53.9 m -146.84 141.85 27.06 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.072 1.749 . . . . 0.0 108.023 170.663 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 18.7 m -146.16 152.86 39.94 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 124.77 1.228 . . . . 0.0 108.864 -177.513 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 32.8 t -130.15 148.85 33.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-N 119.155 0.888 . . . . 0.0 108.691 -171.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 80.62 179.72 53.0 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 124.098 0.856 . . . . 0.0 111.994 176.545 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -62.07 150.69 37.58 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.773 0.829 . . . . 0.0 110.759 177.393 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.41 147.74 29.17 Favored Pre-proline 0 CA--C 1.531 0.233 0 C-N-CA 124.893 1.277 . . . . 0.0 107.739 167.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -74.1 160.71 42.27 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 123.207 2.604 . . . . 0.0 110.452 174.486 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 75.3 tttt -55.18 -41.32 71.74 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 118.816 -0.612 . . . . 0.0 110.515 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -59.74 -41.7 91.54 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 118.516 0.598 . . . . 0.0 110.871 -174.273 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.14 -43.36 87.3 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.03 0.532 . . . . 0.0 110.792 176.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 61.1 mt -64.29 -45.88 86.06 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 119.141 -0.457 . . . . 0.0 109.945 -179.158 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 2.9 pp0? -71.12 -27.57 63.68 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.799 0.727 . . . . 0.0 110.676 -177.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -67.72 -50.16 58.89 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 173.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 60.9 tp -58.26 -47.47 83.48 Favored 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 123.235 0.614 . . . . 0.0 109.975 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 44.4 t -62.66 -46.94 95.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 CA-C-O 117.995 -1.002 . . . . 0.0 109.696 -179.448 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -60.24 -34.71 74.06 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 120.073 1.306 . . . . 0.0 111.315 -177.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 48.2 mmtm -71.07 -10.09 59.16 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 118.045 -0.978 . . . . 0.0 113.468 175.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -108.17 -17.03 14.13 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 119.982 1.264 . . . . 0.0 113.383 172.032 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 64.8 mt . . . . . 0 C--O 1.25 1.109 0 CA-C-N 120.239 1.381 . . . . 0.0 109.761 174.293 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 79.5 mt . . . . . 0 CA--C 1.539 0.551 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 31.5 t -114.34 167.56 7.0 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 125.939 1.696 . . . . 0.0 107.104 -174.813 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 9.2 mtmt -132.75 147.79 52.32 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 176.745 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -148.59 169.7 19.75 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.545 0.738 . . . . 0.0 110.426 176.197 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 77.8 p -135.53 174.94 10.06 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.562 1.145 . . . . 0.0 107.918 171.115 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -47.7 -31.03 4.29 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 119.964 1.256 . . . . 0.0 112.928 178.15 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 12.9 mp0 -58.76 -33.33 70.17 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.374 1.87 . . . . 0.0 112.791 179.37 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.7 m -142.95 -3.09 0.99 Allowed 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 114.217 1.192 . . . . 0.0 114.217 -169.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -53.8 -37.45 63.53 Favored 'General case' 0 C--O 1.23 0.065 0 C-N-CA 124.435 1.094 . . . . 0.0 111.105 179.407 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.4 p -61.53 -53.63 53.8 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.808 0.843 . . . . 0.0 110.658 179.282 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.25 -43.76 88.01 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.018 0.527 . . . . 0.0 110.28 179.15 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -65.97 -35.51 80.79 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 119.081 -0.485 . . . . 0.0 111.746 -177.619 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.537 ' HA ' HG21 ' A' ' 20' ' ' VAL . 32.1 p -85.75 1.14 50.75 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -178.16 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 40.5 m -115.24 32.48 6.02 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -169.73 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -144.02 17.54 1.76 Allowed 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 177.299 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 172.6 -169.23 42.37 Favored Glycine 0 C--N 1.339 0.711 0 O-C-N 121.329 -0.857 . . . . 0.0 112.151 174.548 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 1.8 t -78.65 134.35 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 104.106 -2.553 . . . . 0.0 104.106 168.436 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.537 HG21 ' HA ' ' A' ' 15' ' ' THR . 25.5 t -139.62 138.4 39.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 -172.836 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 42.6 tp -114.02 97.6 6.47 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 173.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.95 157.55 33.01 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 169.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -138.31 99.4 3.84 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 125.27 1.428 . . . . 0.0 107.259 177.316 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -72.5 115.66 12.03 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 169.661 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 9.3 p-90 -137.19 175.53 9.53 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.704 0.801 . . . . 0.0 110.373 -172.047 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -152.3 146.58 18.55 Favored Pre-proline 0 CA--C 1.535 0.399 0 C-N-CA 124.491 1.117 . . . . 0.0 107.994 169.227 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.25 -19.3 17.46 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.801 2.334 . . . . 0.0 113.299 -171.31 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -82.36 -7.47 59.63 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 121.537 -0.727 . . . . 0.0 111.961 177.566 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 48.6 t -92.07 120.76 32.99 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -57.0 -58.32 15.19 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-O 118.656 -1.08 . . . . 0.0 111.925 177.626 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -49.63 -36.33 40.5 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 123.653 2.902 . . . . 0.0 115.157 177.424 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 95.8 m -60.16 -36.66 78.07 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 119.429 1.013 . . . . 0.0 112.313 175.029 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 46.3 mtmt -80.48 -35.35 34.93 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-O 118.986 -0.53 . . . . 0.0 109.893 177.351 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 26.4 mmt -64.36 -39.23 93.47 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 118.967 0.803 . . . . 0.0 111.304 178.063 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 8.4 tt -76.46 -13.21 14.6 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 CA-C-N 118.824 0.738 . . . . 0.0 111.349 179.308 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -57.17 -52.22 75.79 Favored Pre-proline 0 CA--C 1.541 0.631 0 CA-C-O 117.515 -1.231 . . . . 0.0 113.21 -177.104 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.71 -28.86 60.06 Favored 'Trans proline' 0 C--N 1.351 0.685 0 CA-C-N 121.873 1.704 . . . . 0.0 112.418 176.448 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 10.5 t -65.08 -44.17 95.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 177.021 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 61.6 mt -68.12 -33.22 74.1 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 118.056 -0.973 . . . . 0.0 111.138 175.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -65.48 -43.76 89.23 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 120.036 1.289 . . . . 0.0 110.578 174.457 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -59.79 -42.57 93.69 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 118.77 0.714 . . . . 0.0 110.031 175.427 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 37.7 tp -65.0 -39.17 93.06 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 122.529 0.332 . . . . 0.0 110.903 178.24 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -64.43 -41.86 96.34 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 124.566 1.147 . . . . 0.0 110.477 178.301 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 65.0 mm-40 -65.73 -26.07 67.58 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.634 -0.666 . . . . 0.0 111.578 176.216 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -91.98 -31.08 15.75 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.749 1.22 . . . . 0.0 112.908 -177.155 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.4 ' HA ' ' HE3' ' A' ' 49' ' ' LYS . 19.3 mmt -126.07 -11.26 6.49 Favored 'General case' 0 C--O 1.226 -0.171 0 CA-C-O 117.697 -1.144 . . . . 0.0 113.483 -168.624 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -45.54 -35.14 5.37 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 126.287 1.899 . . . . 0.0 115.923 -170.024 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -76.06 -37.97 57.64 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.04 0.936 . . . . 0.0 111.519 -178.599 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.4 ' HE3' ' HA ' ' A' ' 46' ' ' MET . 29.2 mtmt -83.79 -27.46 28.81 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 125.27 1.428 . . . . 0.0 110.444 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -151.14 122.18 7.68 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 124.542 1.137 . . . . 0.0 109.847 -170.444 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -74.28 151.92 39.77 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.911 0.885 . . . . 0.0 108.978 174.521 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.9 mt -122.46 134.02 66.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 N-CA-C 105.985 -1.858 . . . . 0.0 105.985 172.16 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 41.1 t -131.6 113.26 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -171.196 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 60.3 mmtt -74.2 143.17 45.3 Favored 'General case' 0 C--O 1.235 0.319 0 O-C-N 121.505 -0.747 . . . . 0.0 109.557 170.759 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 11.7 tt -150.13 121.38 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 173.062 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -86.86 116.85 25.21 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 121.393 -0.817 . . . . 0.0 109.384 -174.036 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 29.9 m -58.69 -28.02 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-N 118.674 0.67 . . . . 0.0 112.713 -176.823 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -71.99 -7.96 51.74 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 119.26 0.936 . . . . 0.0 112.059 -177.457 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -123.23 2.38 9.18 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.3 1.44 . . . . 0.0 110.513 173.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -146.54 36.45 0.98 Allowed 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 124.683 1.193 . . . . 0.0 111.026 -168.654 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.6 pm0 -58.22 -30.41 66.46 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.333 0.653 . . . . 0.0 110.236 173.83 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 59.3 mp0 -62.16 -55.08 32.35 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.406 1.482 . . . . 0.0 109.685 174.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.86 -43.91 74.41 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 119.377 -0.344 . . . . 0.0 110.164 -174.44 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.83 -45.4 92.79 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 118.71 0.686 . . . . 0.0 109.583 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -59.6 -25.34 60.85 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.122 0.868 . . . . 0.0 112.748 175.279 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 9.9 ttmm -59.44 -23.54 62.77 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.575 1.187 . . . . 0.0 111.405 175.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -118.8 11.07 12.55 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.162 1.385 . . . . 0.0 110.984 178.744 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 68.62 20.53 74.03 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 124.23 0.919 . . . . 0.0 113.346 -176.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 91.0 t -90.52 133.67 31.65 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 177.413 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 7.2 tpt -154.7 30.73 0.42 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.778 0.831 . . . . 0.0 109.621 167.171 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 45.1 m -135.36 156.79 48.36 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 126.36 1.864 . . . . 0.0 106.834 172.803 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -145.16 158.27 52.07 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 123.935 0.894 . . . . 0.0 109.992 -170.309 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -67.7 136.78 35.11 Favored 'Cis proline' 0 C--N 1.349 0.591 0 CA-C-N 120.085 1.066 . . . . 0.0 109.784 -10.299 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 70.4 m -132.26 113.95 13.85 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 176.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 88.5 mt -82.39 145.5 29.85 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 175.84 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -129.61 124.7 34.38 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 104.263 -2.495 . . . . 0.0 104.263 179.387 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.5 t -106.69 124.34 62.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 N-CA-C 104.031 -2.581 . . . . 0.0 104.031 -178.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.7 mp -127.16 160.21 31.93 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.517 1.127 . . . . 0.0 108.102 178.412 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -148.18 128.03 13.48 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 174.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.0 t70 42.64 38.3 1.26 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.211 1.404 . . . . 0.0 113.276 179.231 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.72 6.67 60.62 Favored Glycine 0 CA--C 1.527 0.842 0 CA-C-O 118.777 -1.013 . . . . 0.0 114.726 171.175 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -121.82 143.05 49.63 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 119.333 1.567 . . . . 0.0 108.881 176.177 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 78.1 t -67.24 139.4 21.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 169.236 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.1 m -124.95 -21.55 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 CA-C-O 117.513 -1.232 . . . . 0.0 110.484 174.258 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -158.41 166.67 31.67 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 120.288 1.404 . . . . 0.0 111.846 174.0 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 72.4 m -144.24 139.5 28.71 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.89 1.676 . . . . 0.0 107.569 169.651 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 20.2 m -146.13 153.18 40.39 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.588 1.155 . . . . 0.0 109.035 -174.768 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 30.7 t -131.7 150.53 34.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 CA-C-N 119.04 0.836 . . . . 0.0 108.993 -170.778 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.8 169.17 45.16 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 124.693 1.139 . . . . 0.0 112.76 170.01 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -62.16 134.95 57.24 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 172.118 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 33.2 mttp -144.34 146.99 35.15 Favored Pre-proline 0 C--O 1.233 0.215 0 C-N-CA 125.364 1.466 . . . . 0.0 107.759 176.483 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -75.28 157.38 41.62 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 123.007 2.471 . . . . 0.0 110.96 -176.034 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.7 tmpt? -60.47 -33.67 72.91 Favored 'General case' 0 C--O 1.224 -0.266 0 O-C-N 121.698 -0.626 . . . . 0.0 111.241 -175.258 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -62.58 -37.16 85.13 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 118.967 0.803 . . . . 0.0 111.823 178.196 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -72.27 -40.63 67.47 Favored 'General case' 0 N--CA 1.452 -0.35 0 O-C-N 121.85 -0.531 . . . . 0.0 110.655 174.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 52.7 mt -65.89 -41.37 91.61 Favored 'General case' 0 N--CA 1.455 -0.201 0 O-C-N 122.057 -0.402 . . . . 0.0 110.253 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.7 pp0? -69.95 -30.17 67.48 Favored 'General case' 0 C--O 1.227 -0.081 0 CA-C-N 118.932 0.787 . . . . 0.0 110.272 178.001 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -63.86 -49.98 70.63 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 174.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 65.3 tp -57.63 -43.76 85.06 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.804 0.841 . . . . 0.0 110.726 178.806 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 24.7 t -61.94 -53.56 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 177.543 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.34 -26.16 68.35 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 119.082 0.856 . . . . 0.0 112.272 -175.55 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -67.3 -18.69 65.29 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 117.869 -1.062 . . . . 0.0 112.837 172.113 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -115.88 -13.0 11.35 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 119.929 1.241 . . . . 0.0 113.69 178.763 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 43.7 mt . . . . . 0 C--O 1.249 1.075 0 CA-C-N 120.284 1.402 . . . . 0.0 109.63 170.903 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 88.3 mt . . . . . 0 C--O 1.236 0.378 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 36.6 t -98.5 166.89 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 125.285 1.434 . . . . 0.0 107.504 -175.172 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 6.1 mptt -137.07 135.96 37.96 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 179.421 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -147.17 170.76 16.55 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 122.92 0.488 . . . . 0.0 110.9 -178.844 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.9 p -137.5 174.6 10.42 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.958 1.303 . . . . 0.0 108.047 177.448 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -45.99 -34.22 3.87 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.776 1.23 . . . . 0.0 113.17 179.343 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 26.8 mp0 -62.1 -31.81 72.31 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.901 1.681 . . . . 0.0 113.1 -178.729 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.5 m -139.98 -5.07 1.32 Allowed 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 -170.131 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -55.87 -35.61 66.67 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 124.097 0.959 . . . . 0.0 111.236 178.397 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.4 p -63.53 -48.6 76.85 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.895 0.878 . . . . 0.0 111.097 178.42 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.71 -44.5 96.5 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 122.938 0.495 . . . . 0.0 109.876 177.795 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -65.43 -38.41 89.8 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 119.39 -0.338 . . . . 0.0 111.502 -177.287 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.493 ' HA ' HG21 ' A' ' 20' ' ' VAL . 22.2 p -78.04 -0.16 26.86 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -178.869 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 60.0 m -108.65 32.87 4.54 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.466 1.106 . . . . 0.0 112.033 -171.239 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -132.54 -1.98 3.44 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -176.576 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 167.28 -166.36 39.2 Favored Glycine 0 C--N 1.337 0.593 0 CA-C-N 119.338 0.972 . . . . 0.0 110.854 -173.604 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 97.1 t -72.81 130.18 35.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 N-CA-C 104.554 -2.387 . . . . 0.0 104.554 166.354 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.493 HG21 ' HA ' ' A' ' 15' ' ' THR . 38.1 t -134.82 116.85 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 -175.263 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 57.2 tp -84.57 139.6 31.99 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 169.257 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -133.1 113.61 12.94 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 -177.364 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -92.38 96.72 10.42 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 178.468 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -73.46 114.45 11.7 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 105.053 -2.202 . . . . 0.0 105.053 169.097 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 7.6 p-90 -138.03 175.9 9.17 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 123.499 0.72 . . . . 0.0 110.973 -169.021 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -152.47 145.15 17.16 Favored Pre-proline 0 CA--C 1.534 0.358 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 168.685 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -71.92 -23.26 22.28 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 122.421 2.081 . . . . 0.0 113.383 -169.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -80.91 -8.17 59.67 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 118.58 0.627 . . . . 0.0 112.653 179.617 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 49.1 t -91.62 110.58 21.9 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 -177.65 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -49.46 -53.92 18.47 Favored Glycine 0 CA--C 1.533 1.218 0 CA-C-O 118.693 -1.059 . . . . 0.0 113.085 179.118 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_exo -51.65 -32.58 45.43 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 123.223 2.615 . . . . 0.0 115.35 175.709 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 89.4 m -62.76 -35.46 79.88 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.908 1.231 . . . . 0.0 111.432 173.618 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -71.01 -41.04 71.42 Favored 'General case' 0 N--CA 1.463 0.191 0 O-C-N 121.642 -0.662 . . . . 0.0 109.626 173.087 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 26.5 mmt -64.42 -34.94 79.35 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 118.455 0.571 . . . . 0.0 111.75 -176.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 8.8 tt -82.19 -10.36 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-N 118.549 0.613 . . . . 0.0 111.707 178.852 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -57.04 -49.99 90.79 Favored Pre-proline 0 CA--C 1.543 0.692 0 CA-C-O 117.568 -1.206 . . . . 0.0 112.644 178.565 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -65.55 -31.46 50.61 Favored 'Trans proline' 0 C--N 1.351 0.687 0 CA-C-N 121.71 1.646 . . . . 0.0 112.476 176.754 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 23.1 t -59.48 -44.98 94.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 119.679 1.127 . . . . 0.0 109.638 172.82 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 75.8 mt -67.48 -36.71 81.66 Favored 'General case' 0 C--O 1.226 -0.184 0 CA-C-O 118.925 -0.56 . . . . 0.0 110.671 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -68.0 -37.7 81.76 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 119.369 0.986 . . . . 0.0 111.469 176.077 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -64.21 -37.08 86.17 Favored 'General case' 0 N--CA 1.456 -0.126 0 O-C-N 121.345 -0.847 . . . . 0.0 110.323 173.182 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 11.1 tp -72.48 -38.88 68.06 Favored 'General case' 0 N--CA 1.446 -0.633 0 O-C-N 121.816 -0.553 . . . . 0.0 110.556 178.55 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -65.21 -42.93 93.03 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.748 0.819 . . . . 0.0 110.147 -179.125 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -74.07 -13.55 60.86 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 -176.579 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 65.3 mt-10 -103.64 -33.6 8.92 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.52 1.128 . . . . 0.0 113.058 179.402 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 42.8 mtt -137.77 -0.39 2.13 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 117.997 -1.001 . . . . 0.0 113.027 -169.649 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.09 43.67 0.84 Allowed Glycine 0 CA--C 1.533 1.157 0 C-N-CA 126.766 2.127 . . . . 0.0 114.695 -172.621 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -149.0 -39.76 0.15 Allowed 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 128.443 2.697 . . . . 0.0 107.78 169.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -63.56 -34.76 78.51 Favored 'General case' 0 C--N 1.343 0.307 0 C-N-CA 124.623 1.169 . . . . 0.0 110.369 169.438 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -132.73 164.32 27.03 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 125.719 1.608 . . . . 0.0 109.622 168.779 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -103.16 151.43 22.61 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 169.858 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 17.4 mt -119.04 136.37 56.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 N-CA-C 105.301 -2.111 . . . . 0.0 105.301 170.012 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 45.7 t -128.48 135.04 63.5 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 107.524 -1.288 . . . . 0.0 107.524 -179.463 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 61.3 mmtt -92.31 142.63 27.25 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 169.14 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 17.5 tt -147.25 115.52 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-O 121.375 0.607 . . . . 0.0 109.382 171.303 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -82.27 112.8 19.6 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.827 0.851 . . . . 0.0 109.33 -175.832 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 32.9 m -59.85 -26.01 34.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-N 118.515 0.598 . . . . 0.0 112.539 -175.501 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -72.57 -1.59 16.59 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.571 0.749 . . . . 0.0 112.237 -178.688 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -131.57 6.77 4.43 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.418 1.487 . . . . 0.0 110.498 172.253 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 67.8 m-80 -143.31 46.44 1.52 Allowed 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.334 1.054 . . . . 0.0 110.645 -168.183 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.406 ' CD ' ' H ' ' A' ' 61' ' ' GLN . 16.2 mp0 -57.45 -44.02 84.45 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.92 0.888 . . . . 0.0 109.082 175.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -67.38 -29.9 69.55 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 125.612 1.565 . . . . 0.0 111.55 -173.564 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.07 -47.33 11.04 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 119.031 -0.509 . . . . 0.0 109.736 175.886 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.69 -45.89 90.69 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 119.572 1.078 . . . . 0.0 110.304 -176.107 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -61.81 -22.61 62.34 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 123.728 0.68 . . . . 0.0 112.721 176.104 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.7 ttmm -61.19 -25.62 67.16 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 118.532 1.166 . . . . 0.0 111.423 177.126 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -116.51 11.18 14.75 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.758 1.223 . . . . 0.0 110.703 179.297 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 67.6 26.36 73.72 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.145 0.879 . . . . 0.0 112.781 -176.641 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 89.3 t -99.1 154.25 4.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-N 118.18 0.99 . . . . 0.0 109.158 179.397 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -162.57 -24.0 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 127.252 2.221 . . . . 0.0 109.492 167.469 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 8.0 m -63.69 150.58 44.04 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 123.896 0.878 . . . . 0.0 109.112 170.444 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -145.22 155.9 54.35 Favored Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 124.256 1.022 . . . . 0.0 108.998 176.32 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.39 140.78 50.27 Favored 'Cis proline' 0 N--CA 1.456 -0.678 0 CA-C-N 119.916 1.006 . . . . 0.0 109.541 -10.396 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 54.4 m -131.93 121.51 24.11 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 176.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 52.7 mt -95.53 102.3 14.09 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 179.23 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -81.01 143.27 32.64 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 167.819 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.7 t -125.51 126.1 69.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 104.289 -2.485 . . . . 0.0 104.289 174.117 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.9 mp -126.79 160.77 29.92 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 124.994 1.318 . . . . 0.0 107.976 -178.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -144.89 125.89 14.51 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 175.03 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.0 t70 44.81 36.96 2.04 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.279 1.432 . . . . 0.0 113.469 175.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 105.68 -2.26 39.17 Favored Glycine 0 CA--C 1.528 0.885 0 CA-C-O 118.055 -1.414 . . . . 0.0 115.126 169.18 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -130.58 148.72 52.41 Favored 'General case' 0 C--N 1.338 0.099 0 CA-C-N 120.159 1.98 . . . . 0.0 110.516 -178.195 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 52.5 t -66.19 140.47 19.49 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 C-N-CA 124.053 0.941 . . . . 0.0 108.773 177.55 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 35.3 m -124.62 -18.39 3.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 125.398 1.479 . . . . 0.0 110.917 172.811 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.96 165.4 32.12 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 120.318 1.417 . . . . 0.0 111.429 169.655 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 56.3 m -144.05 133.05 22.77 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.892 1.677 . . . . 0.0 107.077 169.295 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 17.8 m -143.61 152.93 42.0 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.875 1.27 . . . . 0.0 108.481 -176.037 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 28.6 t -131.22 150.29 34.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-N 119.145 0.884 . . . . 0.0 108.794 -170.287 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.73 174.27 46.33 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 124.518 1.056 . . . . 0.0 112.173 176.47 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -59.58 152.12 22.88 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 123.623 0.769 . . . . 0.0 110.806 177.834 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -153.38 146.73 18.03 Favored Pre-proline 0 C--O 1.233 0.232 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 168.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.2 158.18 52.44 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.172 1.915 . . . . 0.0 110.332 177.687 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 4.8 ttpt -59.3 -33.95 71.71 Favored 'General case' 0 C--O 1.224 -0.288 0 C-N-CA 123.462 0.705 . . . . 0.0 111.551 179.507 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -64.51 -39.91 94.66 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 119.106 0.866 . . . . 0.0 111.946 -179.491 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.32 -41.2 70.18 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 122.735 0.414 . . . . 0.0 110.389 175.214 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 28.0 tp -66.75 -40.3 88.24 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 122.638 0.375 . . . . 0.0 110.744 -177.697 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.8 pp0? -69.43 -31.17 69.33 Favored 'General case' 0 C--O 1.227 -0.106 0 CA-C-N 118.821 0.737 . . . . 0.0 110.164 176.468 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -64.91 -47.72 76.73 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 176.627 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 63.6 tp -57.86 -46.67 84.49 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.354 0.662 . . . . 0.0 110.381 178.126 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 23.4 t -62.37 -49.27 84.61 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 CA-C-O 119.061 -0.495 . . . . 0.0 110.029 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.46 -26.96 68.67 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 119.171 0.896 . . . . 0.0 112.215 -175.557 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 61.6 mtpt -67.86 -29.76 68.97 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 118.597 -0.716 . . . . 0.0 112.041 171.293 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 86.1 m-70 -90.87 -21.35 21.46 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.259 0.936 . . . . 0.0 113.244 179.672 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 65.9 mt . . . . . 0 C--O 1.249 1.053 0 CA-C-N 119.569 1.077 . . . . 0.0 109.88 175.472 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 79.8 mt . . . . . 0 CA--C 1.54 0.593 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.6 t -119.48 167.53 12.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 125.348 1.459 . . . . 0.0 107.767 -168.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.7 tppp? -128.5 145.88 50.98 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 177.667 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -146.19 168.73 20.29 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 123.24 0.616 . . . . 0.0 110.332 171.156 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 72.0 p -135.44 173.57 11.57 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.584 1.553 . . . . 0.0 106.938 174.526 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -52.44 -30.5 29.92 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 119.701 1.137 . . . . 0.0 113.01 -176.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 26.0 mp0 -62.75 -30.73 71.66 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.097 1.759 . . . . 0.0 112.817 179.634 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.5 m -139.15 -3.78 1.55 Allowed 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -169.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 61.3 t80 -54.65 -37.79 66.12 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 123.938 0.895 . . . . 0.0 111.035 177.669 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.4 p -63.04 -50.5 70.42 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.671 0.788 . . . . 0.0 110.76 179.107 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.21 -44.87 92.26 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.017 0.527 . . . . 0.0 110.081 178.25 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -66.03 -37.89 87.0 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 119.348 -0.358 . . . . 0.0 111.445 -177.19 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.481 ' HA ' HG21 ' A' ' 20' ' ' VAL . 27.8 p -79.66 0.44 30.27 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 118.513 0.597 . . . . 0.0 112.549 -178.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.5 m -110.23 32.27 5.27 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.418 1.087 . . . . 0.0 112.312 -172.119 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 -131.81 2.22 4.04 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -177.595 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 167.34 -165.62 38.73 Favored Glycine 0 C--N 1.334 0.428 0 O-C-N 121.414 -0.804 . . . . 0.0 111.185 -176.194 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 1.9 t -76.66 134.86 27.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 104.275 -2.491 . . . . 0.0 104.275 168.081 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.481 HG21 ' HA ' ' A' ' 15' ' ' THR . 30.2 t -138.34 141.57 37.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -172.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 58.9 tp -113.53 97.96 6.77 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 106.02 -1.844 . . . . 0.0 106.02 173.812 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.21 149.06 37.29 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 170.511 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -133.16 99.0 4.42 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 107.2 -1.408 . . . . 0.0 107.2 177.12 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -76.63 114.97 15.96 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 173.3 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 7.3 p-90 -138.84 175.89 9.17 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 123.401 0.68 . . . . 0.0 110.85 -169.866 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -151.61 146.66 19.05 Favored Pre-proline 0 CA--C 1.535 0.394 0 C-N-CA 124.53 1.132 . . . . 0.0 107.98 169.251 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.25 -17.85 18.68 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.962 2.441 . . . . 0.0 113.515 -169.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -84.81 -7.21 59.28 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 118.789 0.722 . . . . 0.0 112.088 177.439 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 54.1 t -87.82 117.08 26.41 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 -178.407 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -55.82 -55.72 27.52 Favored Glycine 0 CA--C 1.531 1.092 0 CA-C-O 118.691 -1.061 . . . . 0.0 112.201 175.33 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -51.15 -34.58 48.64 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 123.256 2.637 . . . . 0.0 115.434 176.539 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 97.7 m -60.92 -35.78 77.58 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 119.96 1.255 . . . . 0.0 111.672 173.097 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.1 mttm -70.14 -40.94 74.51 Favored 'General case' 0 N--CA 1.464 0.266 0 O-C-N 121.52 -0.737 . . . . 0.0 109.692 173.61 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 26.3 mmt -64.71 -38.17 90.07 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 118.231 0.469 . . . . 0.0 111.487 -176.386 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 10.8 tt -79.16 -15.97 13.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-N 118.394 0.543 . . . . 0.0 111.51 179.042 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.9 -48.97 94.46 Favored Pre-proline 0 CA--C 1.541 0.598 0 CA-C-O 117.472 -1.251 . . . . 0.0 113.597 -177.434 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.06 -27.73 49.67 Favored 'Trans proline' 0 C--N 1.35 0.632 0 CA-C-N 122.087 1.781 . . . . 0.0 112.461 176.818 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 6.0 t -66.42 -41.13 88.23 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-N 119.346 0.975 . . . . 0.0 109.059 174.309 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 66.0 mt -67.03 -34.28 77.37 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 118.745 -0.645 . . . . 0.0 110.961 175.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -69.45 -36.55 76.71 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 119.482 1.037 . . . . 0.0 111.496 174.576 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 44.0 mm-40 -61.17 -46.73 89.3 Favored 'General case' 0 CA--C 1.528 0.098 0 O-C-N 121.137 -0.977 . . . . 0.0 109.233 171.152 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -62.11 -35.96 80.3 Favored 'General case' 0 C--O 1.224 -0.255 0 C-N-CA 122.857 0.463 . . . . 0.0 111.557 177.198 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -65.28 -41.88 93.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 119.27 0.941 . . . . 0.0 110.427 176.607 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -68.01 -36.97 80.87 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 122.823 0.449 . . . . 0.0 111.634 178.294 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -93.35 -30.1 15.29 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.014 0.926 . . . . 0.0 112.426 -169.588 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 20.0 mmt -136.95 -3.41 2.02 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.39 1.476 . . . . 0.0 112.706 -169.254 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -52.12 -28.74 26.88 Favored Glycine 0 CA--C 1.538 1.469 0 CA-C-N 120.945 1.702 . . . . 0.0 113.277 177.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -73.67 -29.32 62.24 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.844 1.658 . . . . 0.0 111.434 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 55.3 mmtt -97.82 -25.97 14.86 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 125.444 1.498 . . . . 0.0 110.651 -177.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -150.58 126.11 10.2 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.095 0.958 . . . . 0.0 110.038 -167.357 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -73.76 152.49 40.34 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 175.82 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 17.6 mt -125.72 130.97 72.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 N-CA-C 105.645 -1.983 . . . . 0.0 105.645 175.684 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 22.0 t -132.07 113.66 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -170.831 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 48.2 mmtt -73.86 143.29 45.92 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 170.694 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 15.4 tt -149.02 125.34 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 169.681 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -80.28 128.57 33.69 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 22.5 m -70.02 -31.59 48.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 -173.206 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -77.6 -35.36 52.95 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 119.136 0.88 . . . . 0.0 109.755 -175.143 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -72.98 -15.9 61.53 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.861 0.864 . . . . 0.0 111.869 172.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 63.3 m-80 -139.77 51.97 1.72 Allowed 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 119.227 0.921 . . . . 0.0 111.044 -168.518 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.413 ' CD ' ' H ' ' A' ' 61' ' ' GLN . 0.7 OUTLIER -56.56 -38.66 72.22 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.791 0.836 . . . . 0.0 109.55 179.673 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -66.49 -27.74 68.02 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.946 1.298 . . . . 0.0 112.553 -177.648 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.425 ' HA ' ' HE2' ' A' ' 66' ' ' LYS . 0.2 OUTLIER -88.42 -45.53 9.89 Favored 'General case' 0 C--O 1.222 -0.373 0 CA-C-N 118.809 0.731 . . . . 0.0 109.725 178.47 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.79 -46.9 85.85 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.271 0.941 . . . . 0.0 109.792 179.284 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -61.77 -22.37 61.95 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 124.48 1.038 . . . . 0.0 112.746 175.46 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.425 ' HE2' ' HA ' ' A' ' 63' ' ' THR . 5.7 ttmm -57.84 -23.08 51.16 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 118.778 1.289 . . . . 0.0 111.852 174.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -125.76 13.58 8.01 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.688 1.195 . . . . 0.0 110.375 179.387 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 68.65 20.12 73.71 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 124.661 1.124 . . . . 0.0 113.689 -178.144 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 97.9 t -84.83 136.28 23.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 176.597 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -155.42 29.02 0.39 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.732 1.213 . . . . 0.0 109.258 167.667 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 20.8 m -138.15 154.41 49.17 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 126.678 1.991 . . . . 0.0 106.864 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -145.31 158.72 50.73 Favored Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 123.866 0.867 . . . . 0.0 110.143 -169.703 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -67.92 140.74 56.03 Favored 'Cis proline' 0 C--N 1.349 0.573 0 N-CA-C 109.168 -1.128 . . . . 0.0 109.168 -11.269 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 54.7 m -131.67 118.28 19.8 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 177.086 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 89.4 mt -93.54 137.98 32.28 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 178.266 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.0 mp -121.22 130.34 53.64 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 105.238 -2.134 . . . . 0.0 105.238 169.318 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.8 t -94.35 127.73 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 103.571 -2.751 . . . . 0.0 103.571 168.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.6 mp -125.33 160.42 29.37 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 125.198 1.399 . . . . 0.0 107.792 176.671 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -149.32 125.08 10.48 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.172 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.8 t70 44.88 34.98 1.34 Allowed 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.304 1.441 . . . . 0.0 113.714 177.058 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 109.71 -1.72 30.5 Favored Glycine 0 CA--C 1.527 0.785 0 CA-C-O 118.033 -1.426 . . . . 0.0 115.588 168.695 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -131.06 145.18 51.93 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 120.13 1.965 . . . . 0.0 110.288 -178.67 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.3 p -66.86 138.45 22.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 172.738 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 27.1 m -127.03 -16.47 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 125.68 1.592 . . . . 0.0 110.682 178.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.44 164.3 38.42 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 119.871 1.214 . . . . 0.0 110.902 169.18 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 93.9 m -146.37 137.83 24.61 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.461 1.505 . . . . 0.0 108.421 176.051 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 19.7 m -146.24 152.98 40.07 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.413 1.485 . . . . 0.0 108.691 -176.817 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 40.3 t -133.03 146.43 32.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 -173.632 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 85.49 178.62 50.51 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 124.451 1.024 . . . . 0.0 111.89 178.413 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -60.26 152.86 23.83 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.173 0.989 . . . . 0.0 110.575 174.727 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -141.42 148.2 49.65 Favored Pre-proline 0 C--O 1.234 0.257 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 168.282 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -71.56 158.59 53.38 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 122.381 2.054 . . . . 0.0 110.22 171.572 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -55.31 -45.97 76.28 Favored 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 123.397 0.679 . . . . 0.0 111.042 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -64.33 -42.04 96.49 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 118.345 0.521 . . . . 0.0 111.248 -169.402 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.0 -42.51 89.65 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 122.897 0.479 . . . . 0.0 110.878 175.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 43.3 tp -69.16 -41.01 77.8 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 119.233 -0.413 . . . . 0.0 110.744 -176.1 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.7 pp0? -70.8 -30.12 66.49 Favored 'General case' 0 C--N 1.337 0.058 0 CA-C-N 119.022 0.828 . . . . 0.0 110.303 176.011 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -64.07 -49.22 73.16 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 175.515 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 67.6 tp -57.65 -46.1 84.64 Favored 'General case' 0 CA--C 1.527 0.095 0 C-N-CA 123.869 0.867 . . . . 0.0 110.349 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 19.6 t -60.06 -53.45 48.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 177.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -63.35 -28.88 70.3 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 118.78 0.718 . . . . 0.0 112.395 -175.803 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -68.12 -32.13 72.2 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 118.475 -0.774 . . . . 0.0 111.958 173.26 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 58.0 m-70 -89.75 -16.73 29.66 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 119.326 0.966 . . . . 0.0 113.296 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 65.5 mt . . . . . 0 C--O 1.249 1.073 0 CA-C-N 119.737 1.153 . . . . 0.0 109.847 173.032 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 21.2 mt . . . . . 0 CA--C 1.539 0.532 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 25.6 t -140.44 167.59 18.04 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 128.069 2.547 . . . . 0.0 105.678 -176.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.0 mtmt -125.62 144.36 50.62 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 173.374 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -144.8 170.1 16.77 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 122.913 0.485 . . . . 0.0 110.622 176.289 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 73.7 p -135.63 173.35 11.81 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 176.291 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -49.27 -32.38 10.75 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 119.669 1.122 . . . . 0.0 113.138 -177.235 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 25.3 mp0 -62.04 -31.58 71.99 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.408 1.883 . . . . 0.0 112.777 -179.206 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.3 m -139.92 -4.26 1.38 Allowed 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 -171.843 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -53.57 -37.59 63.07 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 124.305 1.042 . . . . 0.0 111.006 176.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.0 m -67.29 -38.83 85.66 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 122.49 0.316 . . . . 0.0 111.286 -178.132 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.18 -45.2 77.68 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 175.562 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -64.54 -37.12 86.46 Favored 'General case' 0 C--O 1.231 0.116 0 C-N-CA 122.64 0.376 . . . . 0.0 111.374 -175.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.443 ' HA ' HG21 ' A' ' 20' ' ' VAL . 19.9 p -77.28 -1.39 29.52 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 179.532 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 67.9 m -108.65 33.29 4.28 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.448 1.099 . . . . 0.0 111.933 -171.872 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -132.65 0.62 3.61 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -177.703 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 166.31 -165.55 38.31 Favored Glycine 0 C--N 1.336 0.535 0 CA-C-N 119.367 0.985 . . . . 0.0 111.424 -175.666 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 97.3 t -73.77 127.73 35.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 N-CA-C 104.6 -2.37 . . . . 0.0 104.6 166.808 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.443 HG21 ' HA ' ' A' ' 15' ' ' THR . 39.2 t -133.72 122.64 43.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 -174.657 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 18.3 tp -87.8 139.22 30.75 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 105.84 -1.911 . . . . 0.0 105.84 168.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -125.01 113.67 18.1 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 -179.032 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -94.1 90.41 6.38 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 125.337 1.455 . . . . 0.0 108.391 -178.18 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -72.1 113.22 8.89 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 169.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 7.9 p-90 -138.79 176.42 8.71 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 123.561 0.744 . . . . 0.0 111.068 -169.774 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -151.84 146.6 18.85 Favored Pre-proline 0 CA--C 1.535 0.379 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 169.185 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.35 -20.17 16.45 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 122.744 2.296 . . . . 0.0 113.494 -171.648 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -81.95 -7.84 59.63 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 121.526 -0.734 . . . . 0.0 111.823 176.777 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 52.0 t -88.12 117.32 26.92 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -55.58 -57.92 16.4 Favored Glycine 0 CA--C 1.531 1.067 0 CA-C-O 118.572 -1.126 . . . . 0.0 111.598 173.581 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -49.89 -36.32 42.96 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 123.569 2.846 . . . . 0.0 115.434 177.453 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 98.0 m -60.02 -45.51 92.55 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 119.886 1.221 . . . . 0.0 111.418 173.253 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 46.5 mtmt -70.86 -30.58 67.02 Favored 'General case' 0 CA--C 1.53 0.174 0 O-C-N 121.465 -0.772 . . . . 0.0 110.639 178.666 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 86.5 mtp -68.37 -42.54 79.03 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 118.685 0.675 . . . . 0.0 111.226 176.238 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 7.4 tt -76.82 -21.45 14.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-N 119.1 0.863 . . . . 0.0 111.115 -178.725 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.17 -51.28 64.11 Favored Pre-proline 0 CA--C 1.546 0.823 0 CA-C-N 119.737 1.153 . . . . 0.0 113.915 -177.592 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.28 -30.5 54.23 Favored 'Trans proline' 0 C--N 1.349 0.59 0 CA-C-N 121.866 1.702 . . . . 0.0 112.364 176.124 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 6.8 t -65.49 -37.87 81.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-N 119.334 0.97 . . . . 0.0 109.521 174.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 82.6 mt -68.24 -33.41 74.33 Favored 'General case' 0 C--O 1.225 -0.213 0 CA-C-O 118.569 -0.729 . . . . 0.0 110.844 173.602 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -66.65 -36.13 81.81 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.836 1.198 . . . . 0.0 111.405 172.429 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 55.4 mm-40 -65.93 -39.05 90.17 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 120.808 -1.182 . . . . 0.0 110.149 172.72 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 46.9 tp -66.5 -36.66 83.27 Favored 'General case' 0 C--O 1.226 -0.144 0 O-C-N 121.648 -0.658 . . . . 0.0 110.731 175.779 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -66.29 -37.47 85.5 Favored 'General case' 0 N--CA 1.454 -0.238 0 O-C-N 121.586 -0.696 . . . . 0.0 111.096 176.472 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -64.36 -33.42 75.8 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.376 -0.828 . . . . 0.0 111.305 171.372 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -79.0 -39.16 34.83 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.301 1.04 . . . . 0.0 112.139 -177.264 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 21.2 mmt -133.5 -7.23 2.9 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 -166.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.97 -3.85 12.48 Favored Glycine 0 CA--C 1.531 1.079 0 CA-C-N 120.474 1.488 . . . . 0.0 115.142 -174.18 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -82.29 -27.5 32.3 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.518 1.527 . . . . 0.0 111.751 172.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -129.04 -1.77 5.19 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.837 1.655 . . . . 0.0 112.624 -172.35 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -139.38 155.87 47.37 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 126.828 2.051 . . . . 0.0 106.906 177.329 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -110.01 151.35 27.27 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 173.204 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 18.3 mt -119.72 136.7 56.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 105.064 -2.198 . . . . 0.0 105.064 170.129 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 99.5 t -126.24 115.14 41.43 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 -176.213 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 10.3 mmmm -75.19 140.88 43.59 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 171.062 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 16.6 tt -148.92 113.91 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 173.08 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 60.6 t0 -77.24 117.18 18.51 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 -178.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 30.6 m -62.88 -27.35 42.93 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -175.547 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -69.18 -28.87 66.79 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 119.331 0.969 . . . . 0.0 110.768 -178.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -93.62 -7.72 43.16 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.63 1.172 . . . . 0.0 111.073 177.586 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -141.38 47.12 1.7 Allowed 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 124.549 1.14 . . . . 0.0 109.929 -168.289 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.485 ' CD ' ' H ' ' A' ' 61' ' ' GLN . 1.4 mp0 -58.39 -40.9 83.6 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.315 1.046 . . . . 0.0 109.024 -177.294 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -63.21 -45.12 93.17 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.497 1.119 . . . . 0.0 110.399 179.709 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.477 ' HA ' ' HE3' ' A' ' 66' ' ' LYS . 0.8 OUTLIER -69.01 -43.77 74.14 Favored 'General case' 0 C--O 1.221 -0.433 0 CA-C-N 118.729 0.695 . . . . 0.0 110.362 -176.752 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.16 -45.68 92.31 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 119.166 0.894 . . . . 0.0 109.417 176.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -58.11 -26.37 58.44 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 124.232 0.92 . . . . 0.0 113.081 174.821 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.477 ' HE3' ' HA ' ' A' ' 63' ' ' THR . 27.4 ttmt -57.82 -21.54 42.84 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.459 1.504 . . . . 0.0 111.908 177.742 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -127.81 12.84 6.83 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.88 1.272 . . . . 0.0 110.532 179.61 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 68.95 20.18 74.34 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 124.558 1.075 . . . . 0.0 113.544 -177.732 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 85.2 t -85.35 137.08 21.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 176.473 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -157.66 28.9 0.28 Allowed 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.512 1.125 . . . . 0.0 109.523 167.043 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 44.1 m -135.08 154.06 51.81 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 126.317 1.847 . . . . 0.0 106.89 174.267 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -146.32 160.2 43.04 Favored Pre-proline 0 CA--C 1.543 0.688 0 C-N-CA 124.565 1.146 . . . . 0.0 109.273 -170.15 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -66.93 139.84 47.75 Favored 'Cis proline' 0 C--N 1.349 0.553 0 CA-C-N 120.161 1.093 . . . . 0.0 109.77 -10.552 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 41.5 m -132.99 133.79 43.61 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 178.665 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 78.6 mt -119.28 103.08 9.17 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 -172.118 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.7 mp -84.87 146.01 27.52 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 106.822 -1.548 . . . . 0.0 106.822 168.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.4 t -111.33 127.87 68.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 103.633 -2.728 . . . . 0.0 103.633 169.282 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.7 mp -127.0 158.62 36.44 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.308 1.443 . . . . 0.0 107.445 179.542 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -145.77 127.16 14.94 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 175.027 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.9 t70 44.3 37.44 1.98 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.389 1.476 . . . . 0.0 113.616 174.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.87 5.25 47.76 Favored Glycine 0 CA--C 1.527 0.783 0 CA-C-O 118.59 -1.117 . . . . 0.0 114.861 169.138 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 82.1 mm-40 -130.13 141.44 50.68 Favored 'General case' 0 CA--C 1.522 -0.105 0 CA-C-N 119.52 1.66 . . . . 0.0 109.133 178.004 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.5 p -69.25 137.42 24.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 169.369 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 25.3 m -125.21 -20.48 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 C-N-CA 124.989 1.316 . . . . 0.0 110.328 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.21 167.1 31.49 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 119.545 1.066 . . . . 0.0 111.454 175.685 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 80.7 m -148.43 141.05 24.47 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.55 1.54 . . . . 0.0 108.738 176.537 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 21.3 m -144.63 155.88 43.83 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.988 1.715 . . . . 0.0 108.309 177.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 39.5 t -133.81 149.72 30.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 -176.591 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.09 172.3 47.08 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 124.385 0.993 . . . . 0.0 112.449 172.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -63.92 131.19 46.93 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 123.59 0.756 . . . . 0.0 109.291 175.685 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -136.1 143.73 45.23 Favored Pre-proline 0 CA--C 1.534 0.35 0 C-N-CA 126.095 1.758 . . . . 0.0 107.035 179.24 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -74.68 156.83 44.43 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.691 2.26 . . . . 0.0 110.917 178.5 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.6 tmpt? -58.98 -36.24 74.54 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 123.449 0.699 . . . . 0.0 111.247 -177.698 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -67.52 -35.15 78.55 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 118.838 0.744 . . . . 0.0 111.269 -175.459 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.03 -42.61 72.73 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 122.886 0.474 . . . . 0.0 110.485 173.774 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 84.5 mt -67.05 -41.39 86.56 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-O 118.902 -0.57 . . . . 0.0 110.392 -178.017 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.0 pp0? -68.22 -30.8 69.95 Favored 'General case' 0 C--O 1.228 -0.075 0 CA-C-N 119.274 0.943 . . . . 0.0 110.247 177.378 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -65.41 -47.75 75.21 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 176.073 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 59.2 tp -58.47 -43.35 88.89 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.269 0.627 . . . . 0.0 110.652 178.016 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 39.6 t -61.22 -50.63 79.68 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 C-N-CA 123.103 0.561 . . . . 0.0 109.593 176.685 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -63.88 -26.89 68.81 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 118.975 0.807 . . . . 0.0 112.284 -175.346 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 62.1 mtpt -67.17 -18.55 65.32 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 118.056 -0.973 . . . . 0.0 112.997 171.653 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -114.34 -10.09 12.71 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 119.856 1.207 . . . . 0.0 113.658 -179.368 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 80.3 mt . . . . . 0 C--O 1.251 1.161 0 CA-C-N 120.032 1.287 . . . . 0.0 109.723 172.314 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 92.6 mt . . . . . 0 C--O 1.236 0.345 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 40.5 t -105.33 166.48 3.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 -174.523 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 5.8 mptt -138.55 134.69 34.18 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 -178.415 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -143.45 170.7 15.3 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 122.935 0.494 . . . . 0.0 110.791 -179.617 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.1 p -135.29 171.71 14.05 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 178.417 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -49.5 -32.42 12.2 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 119.808 1.186 . . . . 0.0 113.021 -176.694 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 25.2 mp0 -63.48 -30.35 71.49 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.716 2.007 . . . . 0.0 112.923 -179.035 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.6 m -138.61 -6.7 1.5 Allowed 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 114.358 1.244 . . . . 0.0 114.358 -172.561 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -56.22 -34.83 66.69 Favored 'General case' 0 C--N 1.333 -0.122 0 C-N-CA 124.606 1.162 . . . . 0.0 111.11 178.155 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.4 p -62.75 -48.47 79.07 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 123.649 0.78 . . . . 0.0 111.062 178.156 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.33 -44.88 96.44 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 122.78 0.432 . . . . 0.0 109.862 177.083 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -65.14 -37.6 87.93 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 119.274 -0.393 . . . . 0.0 111.546 -176.756 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.51 ' HA ' HG21 ' A' ' 20' ' ' VAL . 23.3 p -78.93 0.25 28.16 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 118.595 0.634 . . . . 0.0 112.533 -179.146 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 48.8 m -112.03 34.43 4.24 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.406 1.082 . . . . 0.0 111.962 -171.15 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -131.78 -1.35 3.79 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -178.611 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 166.41 -167.09 39.27 Favored Glycine 0 C--N 1.335 0.518 0 CA-C-N 119.198 0.908 . . . . 0.0 110.872 -172.823 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 76.9 t -72.3 134.06 30.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 104.874 -2.269 . . . . 0.0 104.874 167.015 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.51 HG21 ' HA ' ' A' ' 15' ' ' THR . 38.8 t -137.12 119.25 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 -176.288 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 60.5 tp -88.75 97.44 11.14 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 170.907 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.47 149.41 36.79 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 169.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -133.21 98.41 4.25 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 176.491 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -73.97 113.45 11.16 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 172.588 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 6.0 p-90 -136.26 175.89 9.19 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 123.721 0.808 . . . . 0.0 110.219 -169.46 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -149.89 144.98 18.22 Favored Pre-proline 0 CA--C 1.534 0.345 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 169.21 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.37 -21.91 22.38 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 122.438 2.092 . . . . 0.0 113.471 -170.035 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -83.84 -8.24 59.26 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 118.693 0.679 . . . . 0.0 112.228 178.609 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 53.7 t -85.15 117.63 24.22 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -178.581 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -54.58 -57.11 18.93 Favored Glycine 0 CA--C 1.532 1.154 0 CA-C-O 118.651 -1.083 . . . . 0.0 112.137 176.541 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -50.86 -35.87 50.57 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 123.18 2.586 . . . . 0.0 115.093 175.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 90.7 m -62.1 -37.05 83.6 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 119.676 1.126 . . . . 0.0 111.882 173.753 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -69.63 -42.07 74.79 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 118.804 0.729 . . . . 0.0 109.851 172.6 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 62.0 mtt -62.36 -38.01 87.9 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 122.948 0.499 . . . . 0.0 111.159 -175.891 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 10.9 tt -78.86 -16.04 13.54 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-N 118.569 0.622 . . . . 0.0 111.848 -178.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.03 -51.22 82.38 Favored Pre-proline 0 CA--C 1.544 0.728 0 CA-C-N 120.069 1.304 . . . . 0.0 113.57 -178.605 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -64.3 -30.31 63.69 Favored 'Trans proline' 0 C--N 1.351 0.672 0 CA-C-N 121.769 1.667 . . . . 0.0 111.872 176.484 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.4 t -64.82 -42.14 94.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-N 118.908 0.776 . . . . 0.0 109.56 176.014 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 66.2 mt -66.88 -32.98 74.59 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 118.347 -0.835 . . . . 0.0 110.734 175.694 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -68.29 -37.95 81.17 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 120.206 1.366 . . . . 0.0 111.49 173.209 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -64.62 -31.55 72.82 Favored 'General case' 0 C--N 1.334 -0.095 0 O-C-N 121.225 -0.922 . . . . 0.0 110.99 172.763 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 18.5 tp -76.82 -38.81 53.17 Favored 'General case' 0 N--CA 1.448 -0.56 0 O-C-N 121.82 -0.55 . . . . 0.0 110.857 174.626 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -64.73 -36.59 84.77 Favored 'General case' 0 C--O 1.23 0.068 0 C-N-CA 124.354 1.062 . . . . 0.0 110.654 -178.544 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -76.48 -22.03 55.05 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 121.894 -0.504 . . . . 0.0 111.977 -177.195 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 89.0 mt-10 -94.33 -34.7 12.71 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.462 1.105 . . . . 0.0 113.158 178.036 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 32.8 mtt -136.76 -4.55 1.99 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 118.046 -0.978 . . . . 0.0 113.263 -169.493 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -76.34 49.81 2.7 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 125.878 1.704 . . . . 0.0 113.11 -173.722 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -154.98 -40.69 0.09 Allowed 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 129.678 3.191 . . . . 0.0 106.915 171.769 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 57.3 mttp -61.62 -36.98 82.29 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.291 1.436 . . . . 0.0 109.817 168.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -134.02 165.5 24.9 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 126.545 1.938 . . . . 0.0 109.603 170.741 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -101.48 151.66 21.69 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.428 1.091 . . . . 0.0 108.135 171.301 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 18.7 mt -116.48 134.75 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 N-CA-C 105.118 -2.178 . . . . 0.0 105.118 170.131 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 87.2 t -132.43 117.57 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -176.393 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 55.6 mmtt -75.7 144.91 41.31 Favored 'General case' 0 C--O 1.235 0.303 0 O-C-N 121.695 -0.628 . . . . 0.0 109.663 169.724 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 15.3 tt -148.19 119.13 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 169.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 50.9 t0 -82.72 114.13 20.86 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.969 0.907 . . . . 0.0 109.924 -174.553 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 25.0 m -63.02 -22.89 31.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 -174.236 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -66.01 -30.54 71.1 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 119.016 0.826 . . . . 0.0 111.275 -175.017 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -99.66 -39.29 8.34 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 123.267 0.627 . . . . 0.0 109.73 173.621 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 -89.45 46.29 1.36 Allowed 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 124.268 1.027 . . . . 0.0 111.245 -169.582 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -56.11 -43.02 77.73 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 126.624 1.97 . . . . 0.0 108.816 179.608 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 30.7 mm-40 -67.5 -27.38 66.95 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 125.112 1.365 . . . . 0.0 112.306 -177.659 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.414 ' HA ' ' HE2' ' A' ' 66' ' ' LYS . 0.2 OUTLIER -88.45 -46.01 9.49 Favored 'General case' 0 C--O 1.222 -0.392 0 CA-C-N 118.599 0.636 . . . . 0.0 109.687 179.519 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.87 -46.03 89.78 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 119.321 0.964 . . . . 0.0 109.624 179.259 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -60.65 -24.17 61.74 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 124.095 0.855 . . . . 0.0 112.862 175.248 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.414 ' HE2' ' HA ' ' A' ' 63' ' ' THR . 5.2 ttmm -58.13 -23.49 55.28 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 118.573 1.187 . . . . 0.0 112.056 176.041 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -124.87 13.05 8.5 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.734 1.214 . . . . 0.0 110.487 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 68.96 19.61 73.83 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 124.538 1.066 . . . . 0.0 113.691 -178.146 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 96.5 t -84.28 135.63 24.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 176.288 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.18 28.22 0.46 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.586 1.154 . . . . 0.0 109.372 168.019 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 22.5 m -138.12 152.76 49.05 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 126.704 2.002 . . . . 0.0 106.77 178.434 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -145.72 160.09 45.31 Favored Pre-proline 0 CA--C 1.541 0.602 0 C-N-CA 124.058 0.943 . . . . 0.0 109.905 -169.687 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -66.94 139.52 46.19 Favored 'Cis proline' 0 C--N 1.349 0.601 0 N-CA-C 109.366 -1.051 . . . . 0.0 109.366 -11.098 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 51.9 m -132.0 117.74 18.8 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 177.701 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 95.4 mt -92.8 136.7 33.01 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 179.396 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.8 mp -121.09 130.92 53.96 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 105.061 -2.2 . . . . 0.0 105.061 169.468 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.5 t -93.56 124.24 45.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 103.196 -2.89 . . . . 0.0 103.196 168.629 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.9 mp -118.75 159.01 24.45 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 173.028 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 73.7 tttt -145.2 126.73 15.06 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 173.557 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.7 t70 44.33 38.62 2.58 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.395 1.478 . . . . 0.0 113.484 175.348 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 101.21 5.33 52.86 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-O 118.598 -1.112 . . . . 0.0 114.862 169.161 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 82.1 mm-40 -130.49 142.31 50.49 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 119.513 1.657 . . . . 0.0 109.142 178.051 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.2 p -68.54 138.32 22.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 169.561 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 33.0 m -126.75 -20.68 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 125.062 1.345 . . . . 0.0 110.478 179.351 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -153.08 166.9 31.01 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 119.73 1.15 . . . . 0.0 111.339 171.011 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 96.1 m -148.67 141.04 24.19 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.577 1.551 . . . . 0.0 108.732 177.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 16.0 m -147.68 156.62 42.96 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.565 1.546 . . . . 0.0 108.611 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 40.6 t -132.99 149.41 31.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -174.715 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.66 173.99 45.8 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 124.424 1.011 . . . . 0.0 112.299 176.222 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -59.02 150.74 23.89 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.165 0.986 . . . . 0.0 110.68 177.507 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -153.94 147.27 18.2 Favored Pre-proline 0 CA--C 1.532 0.279 0 C-N-CA 125.057 1.343 . . . . 0.0 107.514 169.199 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.3 159.28 47.27 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.761 2.307 . . . . 0.0 110.81 179.389 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 2.9 ttpp -57.44 -36.51 71.49 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.898 0.879 . . . . 0.0 111.51 -177.071 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -62.4 -36.2 81.59 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.471 0.578 . . . . 0.0 112.059 177.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.79 -40.6 69.11 Favored 'General case' 0 N--CA 1.453 -0.31 0 O-C-N 121.924 -0.485 . . . . 0.0 110.814 174.058 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 42.7 mt -64.18 -43.44 95.11 Favored 'General case' 0 N--CA 1.457 -0.08 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -179.65 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.0 pp0? -68.89 -31.66 70.74 Favored 'General case' 0 C--O 1.226 -0.149 0 CA-C-N 118.62 0.645 . . . . 0.0 110.258 178.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -64.23 -49.57 71.41 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 176.737 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 58.9 tp -57.16 -44.69 83.7 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.372 0.669 . . . . 0.0 110.476 178.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 37.3 t -65.42 -47.34 87.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 CA-C-O 118.946 -0.549 . . . . 0.0 110.638 179.5 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.29 -25.52 68.09 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 119.606 1.094 . . . . 0.0 112.341 -175.181 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -66.1 -16.42 63.93 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 117.897 -1.049 . . . . 0.0 113.167 171.196 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -121.64 -10.51 8.77 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 119.96 1.255 . . . . 0.0 113.822 -177.136 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 66.6 mt . . . . . 0 C--O 1.25 1.101 0 CA-C-N 120.114 1.325 . . . . 0.0 109.39 169.958 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 81.8 mt . . . . . 0 CA--C 1.538 0.503 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 20.3 t -124.69 169.45 16.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 106.106 -1.812 . . . . 0.0 106.106 -172.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.82 153.25 49.65 Favored 'General case' 0 C--O 1.234 0.274 0 O-C-N 120.809 -1.182 . . . . 0.0 109.168 171.498 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -147.73 171.15 16.13 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 123.687 0.795 . . . . 0.0 110.047 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 72.9 p -134.62 173.22 11.9 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 175.82 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -51.69 -30.76 23.33 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 119.644 1.111 . . . . 0.0 112.977 -176.866 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 26.1 mp0 -62.13 -31.64 72.14 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.061 1.744 . . . . 0.0 112.728 179.497 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.4 m -139.61 -2.93 1.52 Allowed 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 114.475 1.287 . . . . 0.0 114.475 -169.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 58.2 t80 -53.63 -38.5 64.12 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 123.95 0.9 . . . . 0.0 110.773 176.586 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.4 m -66.37 -41.82 88.88 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 122.691 0.397 . . . . 0.0 111.205 -178.612 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.83 -45.26 86.91 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 176.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -65.3 -37.49 87.3 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 122.568 0.347 . . . . 0.0 111.247 -176.482 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.53 ' HA ' HG21 ' A' ' 20' ' ' VAL . 23.9 p -78.32 0.49 25.26 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 60.0 m -109.34 32.23 5.15 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.375 1.07 . . . . 0.0 112.302 -173.231 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -132.44 3.72 3.93 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -177.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 166.59 -166.68 39.12 Favored Glycine 0 C--N 1.335 0.498 0 O-C-N 121.339 -0.85 . . . . 0.0 111.162 -177.499 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.2 t -76.2 136.12 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 103.717 -2.698 . . . . 0.0 103.717 167.684 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.53 HG21 ' HA ' ' A' ' 15' ' ' THR . 40.5 t -137.29 139.58 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 -172.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -117.73 97.2 5.72 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 105.331 -2.1 . . . . 0.0 105.331 176.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.56 154.83 28.49 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 172.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -135.7 98.95 4.05 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 125.718 1.607 . . . . 0.0 107.015 -179.718 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -73.87 116.39 14.43 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 169.58 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 9.1 p-90 -137.47 175.06 9.94 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.015 0.926 . . . . 0.0 110.759 -172.428 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -151.83 146.8 19.05 Favored Pre-proline 0 CA--C 1.538 0.485 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 169.256 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.25 -17.14 21.84 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.835 2.357 . . . . 0.0 113.625 -169.606 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -85.0 -6.49 59.33 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 118.715 0.689 . . . . 0.0 112.494 178.097 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 42.4 t -91.16 117.98 30.06 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 118.997 0.817 . . . . 0.0 109.066 -176.423 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -56.84 -54.02 39.78 Favored Glycine 0 CA--C 1.532 1.103 0 CA-C-O 118.812 -0.993 . . . . 0.0 112.414 176.139 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -50.53 -36.39 49.27 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 123.19 2.594 . . . . 0.0 115.272 174.64 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 98.6 m -60.6 -36.62 79.02 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 120.03 1.286 . . . . 0.0 111.831 173.2 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 59.9 mttm -69.8 -42.94 73.07 Favored 'General case' 0 N--CA 1.464 0.231 0 O-C-N 121.601 -0.687 . . . . 0.0 109.591 174.067 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 74.2 mtm -64.65 -35.01 79.65 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 118.987 -0.53 . . . . 0.0 111.771 -176.576 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 11.7 tt -80.94 -16.46 12.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-N 119.095 0.861 . . . . 0.0 111.811 179.197 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.53 -49.0 91.01 Favored Pre-proline 0 CA--C 1.543 0.709 0 CA-C-O 117.526 -1.226 . . . . 0.0 113.643 -179.378 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.52 -27.43 46.34 Favored 'Trans proline' 0 C--N 1.35 0.608 0 CA-C-N 122.048 1.767 . . . . 0.0 112.572 176.731 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.3 t -66.65 -40.41 86.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 119.226 0.921 . . . . 0.0 109.18 174.026 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 62.8 mt -66.94 -35.59 80.32 Favored 'General case' 0 CA--C 1.529 0.159 0 O-C-N 121.688 -0.632 . . . . 0.0 110.888 175.787 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -68.48 -36.2 78.62 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 119.269 0.941 . . . . 0.0 111.422 174.237 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -62.04 -43.17 99.42 Favored 'General case' 0 C--N 1.332 -0.158 0 O-C-N 121.122 -0.986 . . . . 0.0 109.903 171.306 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -65.26 -35.02 79.74 Favored 'General case' 0 N--CA 1.456 -0.171 0 O-C-N 121.93 -0.481 . . . . 0.0 111.509 176.698 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -65.7 -38.63 89.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 119.044 0.838 . . . . 0.0 110.357 175.155 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -68.91 -38.03 79.33 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 121.323 -0.861 . . . . 0.0 111.737 175.588 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -85.99 -36.16 19.96 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.258 1.023 . . . . 0.0 112.064 -171.396 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.441 ' SD ' ' HE2' ' A' ' 49' ' ' LYS . 19.0 mmt -135.57 -8.37 2.19 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.169 1.387 . . . . 0.0 112.626 -168.042 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.5 -21.41 54.32 Favored Glycine 0 CA--C 1.532 1.123 0 CA-C-N 120.321 1.419 . . . . 0.0 114.577 -171.409 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -76.79 -18.51 58.37 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.626 1.97 . . . . 0.0 112.134 -179.679 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.441 ' HE2' ' SD ' ' A' ' 46' ' ' MET . 14.8 pttm -134.02 -2.07 2.93 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 126.56 1.944 . . . . 0.0 112.239 -173.839 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -145.2 120.22 10.04 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 125.996 1.718 . . . . 0.0 107.424 174.865 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -73.07 150.99 41.86 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 176.086 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 16.9 mt -121.97 132.7 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 N-CA-C 105.892 -1.892 . . . . 0.0 105.892 173.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 48.0 t -132.15 111.75 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-N 118.687 0.676 . . . . 0.0 109.495 -170.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 61.2 mmtt -72.86 142.27 47.96 Favored 'General case' 0 C--O 1.234 0.288 0 O-C-N 121.551 -0.718 . . . . 0.0 109.49 171.024 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 11.9 tt -151.26 131.36 3.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 171.189 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -87.44 129.64 34.98 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 121.375 -0.828 . . . . 0.0 109.579 -177.816 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.0 m -66.31 -36.21 76.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 -174.526 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -75.0 -35.44 62.02 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 119.146 0.885 . . . . 0.0 109.762 -173.385 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -74.14 -15.67 61.02 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.699 0.799 . . . . 0.0 112.043 173.325 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 60.1 m-80 -141.11 49.61 1.65 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 119.523 1.056 . . . . 0.0 111.558 -167.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.413 ' CD ' ' H ' ' A' ' 61' ' ' GLN . 0.1 OUTLIER -56.82 -38.8 73.12 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.956 0.902 . . . . 0.0 109.478 179.563 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -65.87 -28.2 68.78 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 125.034 1.334 . . . . 0.0 112.572 -178.299 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.416 ' HA ' ' HE2' ' A' ' 66' ' ' LYS . 0.2 OUTLIER -88.43 -44.23 10.89 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-N 118.673 0.67 . . . . 0.0 109.797 179.036 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.23 -46.58 86.3 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 119.017 0.826 . . . . 0.0 109.731 178.616 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -60.94 -24.17 62.4 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 124.166 0.889 . . . . 0.0 112.466 175.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.416 ' HE2' ' HA ' ' A' ' 63' ' ' THR . 4.9 ttmm -58.52 -22.07 54.11 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.298 1.039 . . . . 0.0 111.966 175.161 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -122.19 12.03 10.22 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.659 1.184 . . . . 0.0 110.854 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 70.78 31.8 67.22 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 123.743 0.687 . . . . 0.0 112.573 -178.314 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 94.9 t -111.08 139.22 35.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 C-N-CA 124.962 1.305 . . . . 0.0 107.825 -178.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 9.1 tpt -155.23 30.09 0.39 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.372 1.069 . . . . 0.0 108.807 167.296 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 19.3 m -138.39 157.01 47.06 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 126.335 1.854 . . . . 0.0 107.456 -177.716 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -144.33 157.35 56.56 Favored Pre-proline 0 CA--C 1.54 0.569 0 CA-C-O 118.462 -0.78 . . . . 0.0 110.79 -169.775 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -66.81 139.76 46.91 Favored 'Cis proline' 0 N--CA 1.458 -0.575 0 N-CA-C 109.335 -1.064 . . . . 0.0 109.335 -11.261 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 85.0 m -133.6 116.07 15.44 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 174.242 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 72.7 mt -86.46 144.68 27.16 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 175.759 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -129.24 126.82 39.95 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 104.261 -2.496 . . . . 0.0 104.261 -178.068 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.1 t -111.33 123.52 67.26 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.414 0 N-CA-C 104.367 -2.457 . . . . 0.0 104.367 -175.796 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.0 mp -129.65 161.75 29.87 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 124.525 1.13 . . . . 0.0 108.236 -177.718 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 63.0 tttm -149.03 127.34 12.16 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 176.044 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.8 t70 43.39 35.27 0.87 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.428 1.491 . . . . 0.0 113.684 176.334 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 105.38 1.74 40.95 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-O 118.11 -1.383 . . . . 0.0 115.224 169.407 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -130.34 145.79 51.83 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 120.044 1.922 . . . . 0.0 110.089 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.6 p -69.37 141.45 17.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 C-N-CA 123.924 0.89 . . . . 0.0 109.306 174.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 35.6 m -129.42 -18.32 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 C-N-CA 125.709 1.604 . . . . 0.0 110.693 178.788 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -161.06 169.46 22.41 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 120.543 1.52 . . . . 0.0 111.669 170.149 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 54.5 m -145.82 144.65 30.4 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.07 1.748 . . . . 0.0 108.01 169.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 15.8 m -146.86 150.2 34.78 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 124.636 1.174 . . . . 0.0 108.83 -178.714 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 39.9 t -129.61 148.21 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -171.341 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.55 179.06 51.92 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 124.015 0.817 . . . . 0.0 111.708 178.768 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -62.43 151.58 36.73 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.539 0.736 . . . . 0.0 110.623 176.618 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.35 145.91 33.98 Favored Pre-proline 0 C--O 1.234 0.253 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 167.733 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -70.91 163.57 38.73 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.658 2.238 . . . . 0.0 110.173 173.196 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -54.78 -44.66 73.92 Favored 'General case' 0 C--O 1.224 -0.266 0 CA-C-O 118.585 -0.722 . . . . 0.0 110.694 179.12 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -63.81 -41.62 97.85 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 118.849 0.75 . . . . 0.0 111.319 -169.772 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.54 -42.71 82.25 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 123.22 0.608 . . . . 0.0 110.893 176.709 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 42.4 tp -69.37 -40.25 77.55 Favored 'General case' 0 N--CA 1.451 -0.416 0 O-C-N 122.124 -0.36 . . . . 0.0 110.808 -177.112 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.5 pp0? -71.71 -29.32 64.43 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 118.888 0.767 . . . . 0.0 110.062 176.855 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -64.04 -49.29 72.95 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 174.402 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 59.1 tp -57.33 -44.14 83.96 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 123.751 0.82 . . . . 0.0 110.515 178.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 11.1 t -62.19 -52.1 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 176.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.83 -25.15 67.78 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 119.095 0.861 . . . . 0.0 112.313 -175.688 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -67.74 -17.14 64.45 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 117.938 -1.03 . . . . 0.0 113.004 171.588 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -114.2 -15.07 12.25 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 120.017 1.281 . . . . 0.0 113.182 176.86 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 53.2 mt . . . . . 0 C--O 1.249 1.067 0 CA-C-N 119.403 1.001 . . . . 0.0 109.493 169.387 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 89.8 mt . . . . . 0 C--O 1.236 0.392 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 39.0 t -107.05 167.19 3.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 -174.777 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 5.7 mptt -138.47 136.53 36.27 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 -177.66 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -144.84 169.75 17.45 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 123.035 0.534 . . . . 0.0 110.957 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 75.8 p -133.71 176.75 8.27 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.989 1.316 . . . . 0.0 108.162 177.684 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -51.05 -31.97 20.4 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 120.307 1.412 . . . . 0.0 112.773 -178.11 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 24.3 mp0 -67.93 -25.9 65.7 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.664 1.985 . . . . 0.0 112.792 -178.419 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 51.7 p -135.92 -17.56 1.64 Allowed 'General case' 0 C--O 1.234 0.241 0 N-CA-C 115.343 1.608 . . . . 0.0 115.343 -168.661 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -53.89 -34.81 60.56 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 124.909 1.283 . . . . 0.0 110.869 179.021 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.0 m -70.22 -37.91 75.13 Favored 'General case' 0 N--CA 1.453 -0.282 0 O-C-N 122.303 -0.248 . . . . 0.0 111.116 -176.587 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.15 -45.82 72.49 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 174.391 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -64.61 -37.39 87.39 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 119.283 -0.389 . . . . 0.0 111.468 -174.541 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.509 ' HA ' HG21 ' A' ' 20' ' ' VAL . 24.7 p -78.38 -0.11 27.81 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -178.911 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 62.1 m -111.38 33.76 4.5 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.228 1.011 . . . . 0.0 111.999 -170.657 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -132.21 -1.29 3.63 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 -177.73 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 166.67 -166.87 39.27 Favored Glycine 0 C--N 1.335 0.523 0 N-CA-C 110.686 -0.966 . . . . 0.0 110.686 -173.259 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 72.9 t -72.01 134.72 29.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 104.695 -2.335 . . . . 0.0 104.695 166.615 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.509 HG21 ' HA ' ' A' ' 15' ' ' THR . 35.1 t -137.56 124.11 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 -176.87 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 61.6 tp -94.46 97.94 10.51 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 173.586 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.97 150.01 35.91 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 170.487 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -132.89 99.77 4.7 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 125.375 1.47 . . . . 0.0 107.262 175.141 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -76.95 114.57 15.89 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 172.503 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 9.1 p-90 -137.7 175.05 9.94 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 123.273 0.629 . . . . 0.0 110.689 -169.84 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -152.93 146.78 18.34 Favored Pre-proline 0 CA--C 1.535 0.397 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 168.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -73.49 -22.27 18.6 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.613 2.208 . . . . 0.0 113.187 -169.863 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -81.88 -7.21 59.59 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.398 0.679 . . . . 0.0 112.28 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 48.4 t -93.12 110.61 22.1 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 -177.679 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -50.09 -52.18 27.69 Favored Glycine 0 CA--C 1.533 1.205 0 CA-C-O 118.852 -0.971 . . . . 0.0 113.024 177.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_exo -51.3 -34.73 50.81 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 123.13 2.553 . . . . 0.0 115.366 173.808 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 93.6 m -62.53 -37.0 84.38 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 120.182 1.355 . . . . 0.0 111.428 173.475 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -69.05 -43.14 75.27 Favored 'General case' 0 N--CA 1.463 0.198 0 O-C-N 121.722 -0.611 . . . . 0.0 109.704 173.57 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 75.1 mtm -65.28 -33.65 76.49 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 118.439 0.563 . . . . 0.0 111.911 -176.504 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.4 tt -82.0 -15.44 12.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-N 119.152 0.887 . . . . 0.0 111.852 179.335 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.27 -48.94 93.02 Favored Pre-proline 0 CA--C 1.544 0.725 0 CA-C-O 117.593 -1.194 . . . . 0.0 113.331 179.168 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.07 -28.68 56.98 Favored 'Trans proline' 0 C--N 1.351 0.665 0 CA-C-N 121.88 1.707 . . . . 0.0 112.412 175.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 16.5 t -65.91 -40.19 86.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 119.569 1.077 . . . . 0.0 109.491 174.06 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 70.3 mt -67.51 -33.25 74.69 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-O 118.657 -0.687 . . . . 0.0 110.855 176.09 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -68.56 -36.0 78.18 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.443 1.02 . . . . 0.0 111.583 172.193 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 -61.9 -45.34 94.17 Favored 'General case' 0 C--O 1.227 -0.097 0 O-C-N 120.839 -1.163 . . . . 0.0 109.426 171.512 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -61.73 -36.22 80.33 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 118.523 0.601 . . . . 0.0 111.511 174.832 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -66.03 -37.51 86.06 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 118.919 0.781 . . . . 0.0 110.691 178.559 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -70.7 -45.81 64.28 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 122.993 0.517 . . . . 0.0 111.169 176.178 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -79.78 -33.2 40.78 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.469 1.107 . . . . 0.0 111.738 -169.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.42 ' HA ' ' HE3' ' A' ' 49' ' ' LYS . 22.2 mmt -139.95 -9.01 1.18 Allowed 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 117.808 -1.092 . . . . 0.0 113.842 -168.918 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -75.21 47.83 2.03 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 126.134 1.826 . . . . 0.0 114.569 -169.794 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -150.95 -39.75 0.13 Allowed 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 128.129 2.572 . . . . 0.0 107.584 169.13 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.42 ' HE3' ' HA ' ' A' ' 46' ' ' MET . 41.4 mtmt -65.22 -30.7 71.61 Favored 'General case' 0 C--N 1.342 0.28 0 C-N-CA 124.492 1.117 . . . . 0.0 110.651 169.041 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -134.25 164.37 27.54 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 125.486 1.514 . . . . 0.0 110.198 169.522 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -99.26 152.46 19.9 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 124.673 1.189 . . . . 0.0 108.182 172.673 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 19.0 mt -118.41 136.32 55.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 N-CA-C 105.488 -2.041 . . . . 0.0 105.488 172.067 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 79.1 t -133.17 117.76 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 119.054 0.843 . . . . 0.0 108.802 -176.121 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 55.1 mmtt -76.29 145.16 39.81 Favored 'General case' 0 C--O 1.234 0.284 0 O-C-N 121.672 -0.642 . . . . 0.0 109.859 169.723 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 16.0 tt -148.76 119.03 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 169.419 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -82.24 116.72 21.9 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -177.558 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 33.9 m -62.19 -25.83 38.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -174.366 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -66.1 -29.96 70.38 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 119.513 1.051 . . . . 0.0 110.949 -177.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -100.75 -3.27 30.42 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.298 1.039 . . . . 0.0 110.99 179.784 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 -141.65 43.48 1.73 Allowed 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.715 1.206 . . . . 0.0 109.942 -168.67 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.5 ' CD ' ' H ' ' A' ' 61' ' ' GLN . 1.0 OUTLIER -58.33 -41.5 84.71 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.804 1.242 . . . . 0.0 108.77 -177.937 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -64.5 -42.97 95.51 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.91 0.884 . . . . 0.0 110.509 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.518 ' HA ' ' HE3' ' A' ' 66' ' ' LYS . 0.5 OUTLIER -68.94 -44.04 73.86 Favored 'General case' 0 C--O 1.221 -0.397 0 CA-C-N 118.776 0.716 . . . . 0.0 110.255 -177.519 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.3 -45.1 94.77 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 119.094 0.861 . . . . 0.0 109.347 176.86 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -57.46 -27.53 58.41 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 124.077 0.846 . . . . 0.0 112.702 174.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.518 ' HE3' ' HA ' ' A' ' 63' ' ' THR . 25.7 ttmt -58.49 -21.22 51.06 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.656 1.582 . . . . 0.0 111.924 178.566 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -126.61 13.74 7.53 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.657 1.183 . . . . 0.0 110.687 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 71.71 32.56 64.05 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 123.775 0.702 . . . . 0.0 112.754 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 93.6 t -109.85 137.87 40.08 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 C-N-CA 124.806 1.243 . . . . 0.0 107.756 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 8.4 tpt -155.95 31.45 0.35 Allowed 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.355 1.062 . . . . 0.0 108.804 166.365 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 20.4 m -138.27 152.39 48.5 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 126.779 2.031 . . . . 0.0 106.643 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -146.11 159.08 47.14 Favored Pre-proline 0 CA--C 1.54 0.592 0 C-N-CA 123.95 0.9 . . . . 0.0 110.02 -169.417 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -67.17 138.94 43.95 Favored 'Cis proline' 0 C--N 1.349 0.59 0 CA-C-N 119.956 1.02 . . . . 0.0 109.691 -10.266 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 54.9 m -132.36 116.9 17.43 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 177.07 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 81.0 mt -92.45 137.13 32.63 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 177.842 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.6 mp -122.39 132.47 54.39 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 105.74 -1.948 . . . . 0.0 105.74 169.876 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 17.0 t -95.58 125.9 48.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 103.09 -2.929 . . . . 0.0 103.09 168.208 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.8 mp -120.72 159.18 25.91 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 125.422 1.489 . . . . 0.0 107.322 175.225 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -146.28 125.12 12.66 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 176.359 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.9 t70 45.81 35.66 2.39 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.311 1.444 . . . . 0.0 113.694 175.348 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 110.04 -2.53 30.02 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-O 118.055 -1.414 . . . . 0.0 115.484 168.622 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -131.57 144.43 51.08 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 120.081 1.941 . . . . 0.0 110.2 -178.622 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 5.3 p -65.72 137.16 25.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 171.582 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 34.3 m -121.12 -21.5 3.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 125.175 1.39 . . . . 0.0 110.433 176.794 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -157.31 162.73 39.14 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 119.701 1.137 . . . . 0.0 111.312 174.503 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 90.6 m -136.57 149.28 47.99 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.383 1.873 . . . . 0.0 108.416 175.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 30.4 m -147.35 152.81 38.82 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 126.267 1.827 . . . . 0.0 107.834 170.7 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 41.3 t -133.13 144.44 36.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 -175.285 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 80.22 179.83 52.86 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 123.907 0.765 . . . . 0.0 111.582 -179.084 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -62.97 147.7 49.78 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.683 0.793 . . . . 0.0 110.667 178.056 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 69.2 mttt -142.37 147.66 44.28 Favored Pre-proline 0 CA--C 1.531 0.233 0 C-N-CA 125.713 1.605 . . . . 0.0 106.898 168.767 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -73.2 159.44 47.27 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.581 2.187 . . . . 0.0 110.459 176.069 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 17.1 ptmt -55.55 -48.94 73.94 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 112.257 0.465 . . . . 0.0 112.257 -177.289 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -61.9 -39.29 91.46 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 123.59 0.756 . . . . 0.0 110.868 -169.391 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.64 -42.8 73.78 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 122.823 0.449 . . . . 0.0 110.855 176.341 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 46.5 tp -68.66 -38.42 80.39 Favored 'General case' 0 N--CA 1.451 -0.41 0 O-C-N 122.039 -0.413 . . . . 0.0 110.857 -178.152 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.4 pp0? -72.06 -29.47 64.17 Favored 'General case' 0 C--N 1.339 0.118 0 CA-C-N 119.174 0.897 . . . . 0.0 110.314 175.543 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -63.5 -48.85 75.89 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 174.461 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 59.3 tp -58.59 -44.97 90.0 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.191 0.596 . . . . 0.0 110.558 179.062 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.6 t -60.22 -51.43 73.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 C-N-CA 122.898 0.479 . . . . 0.0 109.74 177.623 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.37 -27.99 69.39 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 118.893 0.77 . . . . 0.0 112.121 -176.57 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -68.56 -25.87 65.12 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 118.303 -0.856 . . . . 0.0 112.345 172.211 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 75.5 m-70 -96.69 -16.98 20.63 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 119.68 1.127 . . . . 0.0 113.421 178.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 67.8 mt . . . . . 0 C--O 1.25 1.115 0 CA-C-N 119.813 1.188 . . . . 0.0 109.665 173.543 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 86.7 mt . . . . . 0 CA--C 1.537 0.477 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 35.7 t -122.68 167.1 16.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 -175.29 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 6.1 mtmt -132.34 143.76 50.08 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 176.286 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -144.89 170.43 16.16 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 123.12 0.568 . . . . 0.0 110.246 175.251 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 77.4 p -134.62 173.61 11.48 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.915 1.286 . . . . 0.0 107.636 177.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -50.49 -30.65 13.33 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 119.271 0.941 . . . . 0.0 113.132 -177.566 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 26.9 mp0 -64.25 -32.23 73.74 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.13 1.772 . . . . 0.0 112.794 -179.343 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.2 m -140.02 -5.57 1.29 Allowed 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 -169.779 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -52.26 -38.8 59.22 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 124.355 1.062 . . . . 0.0 110.786 175.447 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.4 m -67.75 -36.15 80.01 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 122.675 0.39 . . . . 0.0 111.656 -176.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.92 -45.99 69.41 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 175.178 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -64.03 -35.23 80.03 Favored 'General case' 0 C--O 1.231 0.11 0 C-N-CA 123.06 0.544 . . . . 0.0 111.721 -174.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.492 ' HA ' HG21 ' A' ' 20' ' ' VAL . 22.3 p -82.44 2.09 34.33 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.611 0.764 . . . . 0.0 112.955 -178.538 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 48.7 m -118.07 35.61 4.67 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 118.891 0.769 . . . . 0.0 112.726 -169.224 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -145.89 14.3 1.34 Allowed 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 176.545 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 172.08 -168.54 41.64 Favored Glycine 0 C--N 1.34 0.771 0 O-C-N 121.17 -0.956 . . . . 0.0 111.698 176.635 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 61.0 t -74.81 133.74 30.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 N-CA-C 104.498 -2.408 . . . . 0.0 104.498 167.272 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.492 HG21 ' HA ' ' A' ' 15' ' ' THR . 38.1 t -139.63 117.32 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 -174.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 64.4 tp -88.25 97.29 10.94 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 173.798 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.05 147.77 38.46 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 169.827 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -133.73 98.9 4.31 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 125.172 1.389 . . . . 0.0 107.539 176.527 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -75.81 114.88 14.91 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 105.893 -1.891 . . . . 0.0 105.893 173.08 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 9.2 p-90 -137.49 175.21 9.81 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.478 0.711 . . . . 0.0 110.81 -169.895 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -152.92 147.43 19.06 Favored Pre-proline 0 CA--C 1.537 0.446 0 C-N-CA 124.602 1.161 . . . . 0.0 107.897 169.094 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.3 -21.57 17.41 Favored 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 122.8 2.333 . . . . 0.0 113.423 -170.645 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -81.71 -9.3 59.68 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 118.665 0.666 . . . . 0.0 112.051 178.411 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 51.0 t -88.28 117.1 26.95 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -179.395 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -54.4 -57.65 16.34 Favored Glycine 0 CA--C 1.531 1.05 0 CA-C-O 118.565 -1.13 . . . . 0.0 111.888 176.315 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_exo -49.37 -35.44 35.49 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 123.703 2.935 . . . . 0.0 115.736 177.206 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 84.5 m -60.56 -37.85 82.61 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 119.941 1.246 . . . . 0.0 111.65 174.41 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 45.9 mtmt -79.88 -31.21 40.34 Favored 'General case' 0 CA--C 1.529 0.151 0 O-C-N 121.674 -0.641 . . . . 0.0 110.29 177.826 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 63.6 mtt -65.06 -38.86 92.21 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.994 0.816 . . . . 0.0 111.278 175.247 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 10.2 tt -80.95 -16.94 12.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 118.887 0.767 . . . . 0.0 111.632 -179.735 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -52.32 -49.8 83.14 Favored Pre-proline 0 CA--C 1.544 0.716 0 CA-C-O 117.506 -1.235 . . . . 0.0 113.777 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -64.98 -31.52 55.78 Favored 'Trans proline' 0 C--N 1.35 0.649 0 CA-C-N 121.92 1.722 . . . . 0.0 112.236 176.327 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 20.2 t -63.44 -43.61 98.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-N 119.106 0.866 . . . . 0.0 109.049 175.184 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 71.9 mt -65.17 -36.16 83.36 Favored 'General case' 0 C--O 1.227 -0.115 0 CA-C-O 118.849 -0.596 . . . . 0.0 110.954 177.399 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -65.94 -38.09 87.71 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 119.273 0.942 . . . . 0.0 111.279 174.77 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -68.2 -38.86 82.41 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 121.133 -0.98 . . . . 0.0 110.456 174.452 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.91 -42.26 99.73 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.001 0.92 . . . . 0.0 109.421 177.15 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -63.15 -45.01 93.9 Favored 'General case' 0 C--O 1.226 -0.132 0 C-N-CA 123.718 0.807 . . . . 0.0 110.449 176.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -61.69 -30.5 70.78 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 121.705 -0.622 . . . . 0.0 111.989 176.05 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -85.99 -40.01 16.28 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.893 0.877 . . . . 0.0 112.133 -175.449 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 17.8 mmt -135.68 1.11 2.78 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 -167.191 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.3 47.51 1.11 Allowed Glycine 0 CA--C 1.53 1.022 0 C-N-CA 127.224 2.345 . . . . 0.0 114.625 -169.604 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -149.71 -40.1 0.14 Allowed 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 128.552 2.741 . . . . 0.0 108.032 171.157 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -62.81 -38.8 92.14 Favored 'General case' 0 C--N 1.342 0.263 0 C-N-CA 124.633 1.173 . . . . 0.0 110.218 169.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -133.31 165.22 25.33 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.418 1.487 . . . . 0.0 110.294 173.264 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -104.81 155.11 19.19 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.726 1.61 . . . . 0.0 107.453 171.779 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 17.9 mt -117.52 135.78 56.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 N-CA-C 105.242 -2.132 . . . . 0.0 105.242 169.494 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 91.3 t -130.96 113.78 25.27 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -177.037 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 44.4 mmtt -73.78 144.25 45.69 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 169.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 15.2 tt -148.06 118.03 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 169.699 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -82.51 115.44 21.5 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 -176.592 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 27.8 m -62.49 -24.79 36.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 N-CA-C 112.519 0.562 . . . . 0.0 112.519 -175.684 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -70.48 -10.62 59.65 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 119.318 0.963 . . . . 0.0 112.083 -178.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -122.95 1.09 9.25 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.645 1.178 . . . . 0.0 110.889 175.628 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -145.65 36.88 1.08 Allowed 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.636 1.174 . . . . 0.0 110.128 -169.649 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -59.07 -29.25 67.19 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.579 0.752 . . . . 0.0 110.551 177.625 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 59.6 mp0 -59.97 -49.48 77.5 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.504 1.522 . . . . 0.0 110.041 173.764 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.63 -41.87 68.32 Favored 'General case' 0 C--O 1.222 -0.392 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 -175.8 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -61.14 -46.78 89.14 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 119.057 0.844 . . . . 0.0 109.775 176.674 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -59.19 -24.55 58.9 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 124.312 0.958 . . . . 0.0 112.856 175.461 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 8.9 ttmm -59.38 -20.82 57.77 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.764 1.225 . . . . 0.0 111.791 176.412 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -125.6 13.11 8.08 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.199 1.4 . . . . 0.0 110.473 177.806 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 68.52 21.63 74.59 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 124.554 1.074 . . . . 0.0 113.524 -177.076 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 87.3 t -89.34 154.39 3.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-N 118.308 1.054 . . . . 0.0 109.372 178.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -162.23 -24.01 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.898 2.079 . . . . 0.0 109.404 167.097 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 8.8 m -63.51 149.3 46.51 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 123.571 0.749 . . . . 0.0 109.114 169.792 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -144.31 155.46 57.77 Favored Pre-proline 0 CA--C 1.541 0.614 0 C-N-CA 124.176 0.99 . . . . 0.0 108.925 176.739 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -66.69 140.24 48.84 Favored 'Cis proline' 0 N--CA 1.457 -0.643 0 CA-C-N 120.003 1.037 . . . . 0.0 109.584 -10.239 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 52.7 m -131.63 117.81 19.19 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 175.584 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 93.1 mt -93.79 135.24 35.3 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 178.701 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.5 mp -122.9 129.45 51.64 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 104.713 -2.329 . . . . 0.0 104.713 169.234 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 48.1 t -94.84 120.94 44.96 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.416 0 N-CA-C 103.361 -2.829 . . . . 0.0 103.361 168.373 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.9 mp -108.41 159.26 16.81 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 169.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -146.34 123.91 11.78 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 106.738 -1.579 . . . . 0.0 106.738 175.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.0 t70 42.21 40.67 1.82 Allowed 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.032 1.333 . . . . 0.0 113.08 179.582 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.67 9.66 59.77 Favored Glycine 0 CA--C 1.529 0.962 0 CA-C-O 118.584 -1.12 . . . . 0.0 114.957 171.175 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -126.55 139.81 52.92 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 119.552 1.676 . . . . 0.0 108.472 177.137 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 18.5 t -68.01 134.28 30.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 106.711 -1.589 . . . . 0.0 106.711 169.068 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.6 m -124.89 -18.61 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 124.41 1.084 . . . . 0.0 110.898 177.453 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.22 165.17 36.55 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 119.619 1.1 . . . . 0.0 110.955 174.065 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 97.5 m -149.32 149.28 30.65 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.209 1.403 . . . . 0.0 109.108 177.617 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.9 m -149.87 156.25 41.46 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 126.018 1.727 . . . . 0.0 108.929 172.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.9 t -133.58 144.46 35.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 -179.287 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.1 -178.45 53.61 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 123.647 0.641 . . . . 0.0 111.567 -178.561 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -62.33 149.0 43.39 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.786 0.834 . . . . 0.0 110.678 177.824 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 25.3 mttp -142.32 142.11 23.0 Favored Pre-proline 0 C--O 1.234 0.248 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 168.106 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -72.5 162.93 40.04 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 122.646 2.23 . . . . 0.0 110.458 175.749 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -54.64 -46.2 73.92 Favored 'General case' 0 C--O 1.223 -0.295 0 C-N-CA 123.073 0.549 . . . . 0.0 110.82 -179.552 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -64.84 -41.13 95.97 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 118.356 0.525 . . . . 0.0 111.05 -169.594 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.28 -45.45 80.41 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 122.651 0.38 . . . . 0.0 110.539 176.339 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 46.5 tp -65.75 -42.42 90.93 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 123.037 0.535 . . . . 0.0 110.436 -176.005 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -68.37 -32.78 73.1 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 118.715 0.689 . . . . 0.0 109.818 178.406 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -67.64 -46.8 71.39 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 118.835 0.743 . . . . 0.0 109.446 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.0 tt -54.16 -42.75 69.95 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.385 1.074 . . . . 0.0 109.569 175.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 25.2 t -63.84 -50.67 76.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-O 117.499 -1.239 . . . . 0.0 110.548 175.233 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -56.12 -46.18 79.24 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 120.718 1.599 . . . . 0.0 110.279 -176.813 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -57.21 -15.0 4.84 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.228 1.011 . . . . 0.0 113.225 178.739 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 78.8 m-70 -121.09 -5.06 9.51 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 177.623 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 53.9 mt . . . . . 0 C--O 1.248 1.008 0 CA-C-N 120.106 1.321 . . . . 0.0 109.113 169.959 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 77.3 mt . . . . . 0 CA--C 1.54 0.564 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.4 t -129.22 169.88 19.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 -173.383 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.26 153.46 50.34 Favored 'General case' 0 C--O 1.233 0.235 0 O-C-N 120.791 -1.193 . . . . 0.0 108.994 169.851 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -144.71 175.5 10.12 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 123.886 0.874 . . . . 0.0 109.939 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 70.6 p -133.13 177.36 7.73 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.798 1.239 . . . . 0.0 107.947 174.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -53.97 -25.94 23.33 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 119.547 1.067 . . . . 0.0 112.553 176.644 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 48.2 mm-40 -73.34 -25.17 60.5 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.091 1.356 . . . . 0.0 112.522 -178.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 33.2 p -135.15 -11.99 2.18 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 115.634 1.716 . . . . 0.0 115.634 -167.677 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -53.96 -35.79 62.17 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 124.194 0.998 . . . . 0.0 110.852 179.392 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.7 m -70.81 -34.92 72.24 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 122.686 0.394 . . . . 0.0 111.48 -177.373 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -72.94 -32.74 65.46 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 123.556 0.742 . . . . 0.0 110.625 176.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -79.05 -39.59 33.53 Favored 'General case' 0 N--CA 1.453 -0.319 0 O-C-N 122.003 -0.435 . . . . 0.0 111.505 -177.813 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.495 ' HA ' HG21 ' A' ' 20' ' ' VAL . 25.2 p -78.11 -0.64 28.97 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -174.026 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 28.7 p -110.46 30.94 6.33 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.269 1.028 . . . . 0.0 112.834 -169.339 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -131.48 -0.13 4.0 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 113.58 0.955 . . . . 0.0 113.58 -175.463 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 165.73 -166.29 38.46 Favored Glycine 0 C--N 1.336 0.559 0 CA-C-N 119.358 0.981 . . . . 0.0 110.886 -174.485 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 88.6 t -71.73 129.82 35.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 N-CA-C 105.212 -2.144 . . . . 0.0 105.212 166.86 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.495 HG21 ' HA ' ' A' ' 15' ' ' THR . 25.4 t -133.11 116.66 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 -176.516 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 63.9 tp -88.21 96.83 10.7 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 174.112 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.06 148.54 37.9 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 170.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -133.51 96.76 3.78 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 125.031 1.332 . . . . 0.0 107.419 177.36 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -74.53 113.81 12.21 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 172.828 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 6.6 p-90 -137.63 176.72 8.45 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 123.435 0.694 . . . . 0.0 110.532 -169.841 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -155.72 147.75 17.36 Favored Pre-proline 0 C--O 1.237 0.446 0 C-N-CA 125.793 1.637 . . . . 0.0 106.731 169.384 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.94 -20.49 15.01 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.99 2.46 . . . . 0.0 113.3 -170.232 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -79.37 -7.59 58.47 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 118.528 0.604 . . . . 0.0 112.381 -179.616 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 44.0 t -95.56 122.25 38.1 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -178.341 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -56.87 -57.48 19.44 Favored Glycine 0 CA--C 1.531 1.046 0 CA-C-O 118.623 -1.098 . . . . 0.0 112.098 178.115 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_exo -48.37 -36.19 29.73 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 123.756 2.971 . . . . 0.0 115.8 177.768 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 79.8 m -59.6 -31.82 69.83 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 119.875 1.216 . . . . 0.0 112.504 175.346 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt -88.32 -33.88 17.85 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 123.445 0.698 . . . . 0.0 109.737 177.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 62.3 mtt -61.65 -37.07 82.68 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.935 0.789 . . . . 0.0 111.264 175.661 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 10.9 tt -80.08 -14.04 13.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-N 118.603 0.638 . . . . 0.0 111.928 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.97 -48.35 94.14 Favored Pre-proline 0 CA--C 1.543 0.685 0 CA-C-O 117.403 -1.284 . . . . 0.0 113.411 -178.316 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -65.03 -29.15 57.14 Favored 'Trans proline' 0 C--N 1.349 0.592 0 CA-C-N 121.996 1.749 . . . . 0.0 112.607 175.714 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 12.9 t -66.71 -40.45 86.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 119.343 0.974 . . . . 0.0 109.305 174.557 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 91.6 mt -66.72 -35.69 80.72 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-O 118.756 -0.64 . . . . 0.0 110.845 175.863 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -68.04 -36.06 79.28 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 119.481 1.037 . . . . 0.0 111.288 174.501 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 45.3 mm-40 -63.88 -43.91 94.62 Favored 'General case' 0 CA--C 1.529 0.151 0 O-C-N 121.05 -1.031 . . . . 0.0 109.958 171.805 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -63.3 -36.54 84.0 Favored 'General case' 0 C--O 1.226 -0.181 0 C-N-CA 123.129 0.572 . . . . 0.0 111.109 176.785 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -64.71 -42.7 95.07 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 118.636 0.653 . . . . 0.0 109.995 176.112 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -65.91 -33.39 75.72 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.708 -0.62 . . . . 0.0 112.377 175.663 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -89.27 -32.48 17.37 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.093 0.957 . . . . 0.0 112.274 -172.129 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.525 ' SD ' ' HE2' ' A' ' 49' ' ' LYS . 22.5 mmt -136.25 -11.54 1.92 Allowed 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.879 1.271 . . . . 0.0 112.663 -168.361 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.42 2.88 18.79 Favored Glycine 0 CA--C 1.53 0.988 0 CA-C-N 120.827 1.649 . . . . 0.0 114.545 -172.327 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -90.2 -17.15 28.06 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 127.126 2.17 . . . . 0.0 111.766 170.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.525 ' HE2' ' SD ' ' A' ' 46' ' ' MET . 14.9 pttm -138.94 6.4 2.41 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 127.072 2.149 . . . . 0.0 112.466 -174.244 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -145.85 163.96 33.41 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 129.144 2.978 . . . . 0.0 105.998 175.314 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -121.05 154.91 35.46 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 125.231 1.412 . . . . 0.0 107.359 173.091 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 15.7 mt -123.4 135.28 63.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 N-CA-C 105.179 -2.156 . . . . 0.0 105.179 174.339 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 88.3 t -132.1 111.19 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -174.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 38.6 mmtt -71.65 142.55 49.9 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 169.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 15.7 tt -148.64 119.78 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 170.521 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 50.7 t0 -80.26 115.88 20.05 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 123.561 0.745 . . . . 0.0 109.138 -177.243 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 28.6 m -60.95 -30.25 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-N 118.227 0.467 . . . . 0.0 111.889 -177.268 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -76.16 2.68 12.4 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.986 0.914 . . . . 0.0 112.024 -176.091 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -129.89 -4.13 4.59 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.69 1.596 . . . . 0.0 110.743 173.478 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -141.34 47.55 1.69 Allowed 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.287 1.035 . . . . 0.0 109.938 -168.384 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.509 ' NE2' ' H ' ' A' ' 61' ' ' GLN . 0.3 OUTLIER -52.47 -43.35 64.92 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.587 1.555 . . . . 0.0 109.427 177.958 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 33.3 mp0 -67.35 -27.97 67.57 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 126.206 1.802 . . . . 0.0 111.903 -174.829 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.439 ' HA ' ' HE2' ' A' ' 66' ' ' LYS . 0.2 OUTLIER -88.39 -46.2 9.36 Favored 'General case' 0 C--O 1.22 -0.481 0 CA-C-N 118.474 0.579 . . . . 0.0 109.614 178.722 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.8 -47.41 83.55 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.859 0.754 . . . . 0.0 109.683 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -61.46 -22.41 61.32 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 124.514 1.054 . . . . 0.0 112.846 175.108 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.439 ' HE2' ' HA ' ' A' ' 63' ' ' THR . 5.9 ttmm -57.61 -24.14 54.8 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 118.811 1.306 . . . . 0.0 111.771 174.669 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -125.4 14.74 8.27 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.851 1.26 . . . . 0.0 110.304 178.778 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 70.12 19.09 75.34 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 124.849 1.214 . . . . 0.0 114.038 -179.723 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 84.6 t -81.31 127.63 39.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 177.642 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 8.6 mmt -147.5 29.42 0.94 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.892 1.677 . . . . 0.0 108.735 169.341 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 17.0 m -142.85 152.18 41.88 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 126.681 1.993 . . . . 0.0 106.734 179.129 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -145.64 157.56 51.48 Favored Pre-proline 0 CA--C 1.54 0.576 0 C-N-CA 123.832 0.853 . . . . 0.0 109.914 -171.199 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -67.57 141.73 59.84 Favored 'Cis proline' 0 N--CA 1.459 -0.548 0 CA-C-N 119.852 0.983 . . . . 0.0 109.581 -10.235 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 55.2 m -131.78 116.4 17.22 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 176.25 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 93.3 mt -91.4 136.84 32.82 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 178.016 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.2 mp -120.68 130.84 54.27 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 105.098 -2.186 . . . . 0.0 105.098 169.133 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 25.5 t -93.72 121.09 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 103.016 -2.957 . . . . 0.0 103.016 169.429 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.8 mp -115.86 158.62 22.67 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 172.038 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -146.19 126.2 13.68 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 175.203 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.6 t70 44.75 38.31 2.75 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.263 1.425 . . . . 0.0 113.364 175.499 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.76 6.89 54.12 Favored Glycine 0 CA--C 1.53 0.982 0 CA-C-O 118.561 -1.133 . . . . 0.0 114.345 169.827 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -129.01 138.43 51.93 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 119.432 1.616 . . . . 0.0 108.764 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.7 p -68.96 135.91 27.43 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 168.023 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.4 m -125.3 -19.64 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 C-N-CA 124.543 1.137 . . . . 0.0 110.476 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.18 167.38 30.57 Favored 'General case' 0 C--N 1.344 0.369 0 CA-C-N 119.588 1.086 . . . . 0.0 111.182 174.146 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 97.4 m -147.22 149.32 32.68 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.571 1.548 . . . . 0.0 108.789 178.573 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 66.2 m -150.59 156.25 41.0 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.494 1.518 . . . . 0.0 108.691 172.422 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 40.6 t -132.59 144.46 36.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -177.289 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 83.84 179.4 51.98 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 124.007 0.813 . . . . 0.0 111.711 -179.18 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -61.89 150.59 37.05 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.845 0.858 . . . . 0.0 110.61 176.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 40.8 mttm -140.68 144.84 37.68 Favored Pre-proline 0 C--O 1.233 0.213 0 C-N-CA 125.007 1.323 . . . . 0.0 107.518 168.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -72.66 161.54 43.68 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.63 2.22 . . . . 0.0 110.327 173.349 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -55.16 -47.74 74.72 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 123.089 0.556 . . . . 0.0 110.957 -178.69 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -63.51 -43.6 96.73 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 118.218 0.463 . . . . 0.0 111.516 -168.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.46 -42.81 87.0 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.106 0.563 . . . . 0.0 110.954 178.328 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 42.7 tp -67.75 -42.46 81.76 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 110.27 -0.27 . . . . 0.0 110.27 -178.163 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.7 pp0? -69.48 -34.35 74.2 Favored 'General case' 0 N--CA 1.454 -0.273 0 O-C-N 121.567 -0.708 . . . . 0.0 109.605 177.698 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -60.14 -45.94 91.35 Favored 'General case' 0 C--N 1.339 0.115 0 CA-C-N 119.41 1.004 . . . . 0.0 108.532 176.297 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 61.0 tp -58.09 -39.9 79.78 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.558 0.743 . . . . 0.0 110.888 176.199 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 56.0 t -63.56 -48.93 84.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-O 118.498 -0.763 . . . . 0.0 110.517 175.081 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 24.4 m-80 -58.08 -40.8 81.99 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 120.239 1.381 . . . . 0.0 109.908 179.268 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -62.82 -13.83 38.28 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 117.904 -1.046 . . . . 0.0 113.13 -178.749 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 70.4 m-70 -124.28 -19.57 5.48 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.248 0.978 0 CA-C-N 120.302 1.41 . . . . 0.0 109.914 178.331 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 81.8 mt . . . . . 0 CA--C 1.535 0.382 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 48.4 t -109.09 167.19 4.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 125.827 1.651 . . . . 0.0 106.915 -173.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 5.7 mptt -138.68 137.84 37.2 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 -176.257 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -149.01 171.76 15.85 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 122.973 0.509 . . . . 0.0 110.863 -179.641 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.5 p -136.63 173.23 11.93 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 125.598 1.559 . . . . 0.0 107.695 -176.192 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -50.55 -27.06 6.01 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.644 1.178 . . . . 0.0 112.634 176.626 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 49.0 mm-40 -65.18 -32.64 74.43 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 125.15 1.38 . . . . 0.0 112.104 -178.684 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.4 m -143.4 -5.48 0.84 Allowed 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 115.103 1.52 . . . . 0.0 115.103 -171.169 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -54.04 -35.47 62.0 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 119.48 1.036 . . . . 0.0 111.276 179.306 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.7 m -67.0 -41.64 86.36 Favored 'General case' 0 N--CA 1.452 -0.345 0 O-C-N 122.065 -0.397 . . . . 0.0 111.197 -178.737 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.62 -43.82 79.48 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 176.329 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -62.12 -38.49 89.13 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 123.503 0.721 . . . . 0.0 111.074 -176.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 25.9 p -81.55 3.53 24.64 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -178.299 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 50.4 m -120.46 36.79 4.45 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.384 1.074 . . . . 0.0 112.156 -169.649 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -142.5 12.48 1.93 Allowed 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 176.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 174.73 -166.59 38.44 Favored Glycine 0 C--N 1.339 0.709 0 O-C-N 121.191 -0.943 . . . . 0.0 111.629 179.078 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.1 t -80.09 125.11 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 103.281 -2.859 . . . . 0.0 103.281 167.59 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 22.9 t -136.8 118.73 19.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 -171.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 35.0 tp -87.93 147.49 25.04 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 168.159 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -135.34 154.06 51.64 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 176.387 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -134.48 98.9 4.2 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 -175.711 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -74.88 117.19 16.45 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 169.626 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 6.0 p-90 -145.72 179.53 7.38 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.441 0.697 . . . . 0.0 111.205 -170.278 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -159.96 151.78 16.79 Favored Pre-proline 0 CA--C 1.538 0.51 0 C-N-CA 125.896 1.678 . . . . 0.0 107.024 167.261 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -75.75 -18.46 17.15 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.851 2.367 . . . . 0.0 113.319 -169.781 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -80.01 -10.92 59.81 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 118.721 0.691 . . . . 0.0 112.044 178.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 50.9 t -88.74 119.19 29.0 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 178.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -56.23 -57.74 17.7 Favored Glycine 0 CA--C 1.531 1.049 0 CA-C-O 118.808 -0.995 . . . . 0.0 111.954 176.807 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -51.16 -32.9 41.91 Favored 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 123.375 2.717 . . . . 0.0 115.651 177.742 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 88.2 m -59.57 -42.5 92.6 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 119.905 1.229 . . . . 0.0 111.323 173.153 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 44.1 mtmt -74.12 -30.39 62.28 Favored 'General case' 0 CA--C 1.529 0.139 0 O-C-N 121.801 -0.562 . . . . 0.0 110.476 177.659 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 89.8 mtp -65.75 -40.54 92.19 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 119.001 0.819 . . . . 0.0 111.242 175.703 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 12.3 tt -80.97 -16.27 12.45 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-N 119.158 0.89 . . . . 0.0 111.603 -179.654 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.9 -50.17 75.91 Favored Pre-proline 0 CA--C 1.545 0.767 0 CA-C-O 117.494 -1.241 . . . . 0.0 114.003 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.68 -28.74 52.1 Favored 'Trans proline' 0 C--N 1.35 0.652 0 CA-C-N 122.044 1.766 . . . . 0.0 112.691 176.543 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 13.8 t -66.89 -40.56 86.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-N 119.027 0.831 . . . . 0.0 109.143 174.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 46.1 mt -66.88 -36.52 82.48 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 118.604 -0.712 . . . . 0.0 110.694 176.439 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -65.87 -40.5 91.68 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 119.279 0.945 . . . . 0.0 110.897 173.56 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 30.6 mm-40 -59.5 -42.21 91.64 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 119.068 0.849 . . . . 0.0 110.406 173.102 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.65 -36.2 83.03 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 123.263 0.625 . . . . 0.0 111.364 176.904 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -65.04 -45.44 85.42 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 123.633 0.773 . . . . 0.0 109.918 175.0 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 73.5 mm-40 -65.44 -27.69 68.7 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.923 -0.486 . . . . 0.0 111.95 178.334 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -92.12 -37.42 12.76 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.366 1.066 . . . . 0.0 112.193 -175.388 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.401 ' SD ' ' HE2' ' A' ' 49' ' ' LYS . 20.7 mmt -128.77 -9.67 4.98 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 124.241 1.017 . . . . 0.0 113.372 -167.595 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -50.06 -25.24 7.44 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 126.233 1.873 . . . . 0.0 115.351 -175.093 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -75.58 -28.29 58.89 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 124.829 1.252 . . . . 0.0 112.07 -176.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.401 ' HE2' ' SD ' ' A' ' 46' ' ' MET . 0.0 OUTLIER -125.63 -4.76 7.09 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 125.665 1.586 . . . . 0.0 112.984 -175.474 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -144.96 123.43 12.38 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 124.499 1.12 . . . . 0.0 108.095 172.911 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -80.39 154.81 27.47 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 176.667 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 29.4 mt -127.76 130.91 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 N-CA-C 105.516 -2.031 . . . . 0.0 105.516 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.9 t -129.53 116.84 40.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 118.485 0.584 . . . . 0.0 109.723 -171.326 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt -74.17 143.89 45.05 Favored 'General case' 0 C--O 1.236 0.347 0 O-C-N 121.477 -0.765 . . . . 0.0 109.558 170.184 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 10.6 tt -150.34 129.8 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 170.349 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -86.8 126.96 34.97 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 121.411 -0.806 . . . . 0.0 109.69 -176.233 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 12.4 m -67.72 -32.57 57.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -174.343 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -75.62 -35.39 60.52 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 119.31 0.959 . . . . 0.0 109.78 -175.108 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -78.57 -15.17 58.86 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.279 0.632 . . . . 0.0 111.901 175.248 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 48.5 m-80 -140.87 50.78 1.64 Allowed 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 119.194 0.906 . . . . 0.0 110.562 -168.788 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.477 ' CD ' ' H ' ' A' ' 61' ' ' GLN . 1.1 mp0 -58.69 -43.06 89.87 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.459 1.103 . . . . 0.0 109.49 -174.627 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -64.0 -41.48 97.46 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.327 1.051 . . . . 0.0 110.751 -176.166 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.05 -43.71 70.68 Favored 'General case' 0 C--O 1.222 -0.348 0 CA-C-N 118.633 0.651 . . . . 0.0 109.821 -177.574 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.27 -44.01 97.52 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 118.94 0.791 . . . . 0.0 109.461 176.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -57.46 -27.69 58.59 Favored Glycine 0 CA--C 1.534 1.233 0 C-N-CA 124.325 0.964 . . . . 0.0 112.635 174.318 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 24.8 ttmt -59.21 -21.64 59.8 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.983 1.313 . . . . 0.0 111.777 177.323 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -120.38 10.58 11.26 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.981 1.312 . . . . 0.0 111.009 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 70.21 32.14 68.95 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 123.694 0.664 . . . . 0.0 112.319 -177.392 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 86.7 t -110.88 134.67 52.43 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 C-N-CA 124.762 1.225 . . . . 0.0 107.92 -178.067 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 8.4 tpt -155.7 32.16 0.36 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.36 1.064 . . . . 0.0 108.976 167.278 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 20.2 m -137.47 155.91 48.76 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 126.787 2.035 . . . . 0.0 106.724 179.046 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 29.8 pt -145.7 157.63 51.15 Favored Pre-proline 0 CA--C 1.541 0.602 0 CA-C-O 118.716 -0.659 . . . . 0.0 111.069 -168.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -67.33 141.71 58.84 Favored 'Cis proline' 0 N--CA 1.458 -0.574 0 N-CA-C 109.022 -1.184 . . . . 0.0 109.022 -11.085 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 58.2 m -136.12 131.0 34.18 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 176.168 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -103.61 143.94 32.1 Favored 'General case' 0 N--CA 1.437 -1.123 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 -176.73 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -125.45 137.39 53.98 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 104.382 -2.451 . . . . 0.0 104.382 178.105 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 11.1 t -127.29 127.97 69.71 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.593 0 N-CA-C 105.036 -2.209 . . . . 0.0 105.036 177.73 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.8 mp -130.15 157.96 41.01 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 -177.77 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -142.58 121.77 13.0 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 175.265 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.2 t70 44.06 37.55 1.86 Allowed 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.689 1.196 . . . . 0.0 112.476 -172.516 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.2 -6.29 82.59 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-O 118.839 -0.978 . . . . 0.0 114.473 174.158 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -90.04 128.51 36.3 Favored 'General case' 0 CA--C 1.522 -0.113 0 CA-C-N 119.407 1.603 . . . . 0.0 106.874 175.206 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 71.0 t -63.99 134.56 28.77 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 168.587 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 32.9 m -122.94 -20.48 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 124.749 1.219 . . . . 0.0 110.547 176.693 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.63 161.41 41.6 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 119.999 1.272 . . . . 0.0 111.869 172.13 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 70.7 m -147.63 133.68 19.27 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.249 1.82 . . . . 0.0 106.913 169.02 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 16.9 m -146.13 152.4 39.22 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.018 0.927 . . . . 0.0 109.396 -172.051 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 42.6 t -129.13 148.94 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-N 119.431 1.014 . . . . 0.0 108.919 -170.485 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.27 175.38 50.03 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 124.536 1.065 . . . . 0.0 112.358 174.292 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -57.91 154.37 12.44 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.907 0.883 . . . . 0.0 110.594 176.388 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -152.28 144.36 16.57 Favored Pre-proline 0 CA--C 1.53 0.207 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 169.804 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_endo -71.64 163.39 39.13 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.582 2.188 . . . . 0.0 110.339 175.771 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -54.69 -46.25 74.08 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-O 118.855 -0.593 . . . . 0.0 110.636 -179.455 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -64.38 -40.24 95.44 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 118.451 0.569 . . . . 0.0 111.122 -169.542 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.57 -45.13 76.48 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 122.823 0.449 . . . . 0.0 110.688 177.103 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 50.9 tp -67.59 -40.99 84.77 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 122.899 0.479 . . . . 0.0 110.403 -176.195 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.8 pp0? -71.6 -31.26 66.72 Favored 'General case' 0 N--CA 1.457 -0.121 0 CA-C-N 118.614 0.643 . . . . 0.0 110.127 177.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 20.2 tp10 -65.41 -48.27 73.37 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 176.667 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 10.3 tt -57.1 -44.88 83.63 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.266 0.626 . . . . 0.0 110.374 178.572 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 4.8 t -60.55 -48.6 87.84 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 123.056 0.542 . . . . 0.0 110.392 176.771 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.4 -20.94 66.2 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 118.839 0.745 . . . . 0.0 112.843 -175.214 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 57.5 mmtt -60.62 -35.55 76.43 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 118.386 0.539 . . . . 0.0 111.1 169.059 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 94.2 m-70 -97.7 -22.49 16.41 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.647 0.779 . . . . 0.0 112.697 -172.168 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 70.7 mt . . . . . 0 C--O 1.247 0.959 0 CA-C-O 118.237 -0.887 . . . . 0.0 109.485 172.409 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.9 mmt . . . . . 0 N--CA 1.48 1.037 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -153.75 144.11 22.3 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 169.244 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 89.6 mt -77.39 146.89 7.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 35.8 t -100.81 165.99 2.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 125.691 1.596 . . . . 0.0 107.897 -174.236 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.31 141.65 50.58 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 177.106 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -151.73 168.09 26.15 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 122.979 0.511 . . . . 0.0 111.569 176.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 40.0 p -140.55 -176.45 4.64 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.981 2.113 . . . . 0.0 107.204 174.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -48.97 -32.63 9.46 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.687 1.195 . . . . 0.0 113.256 179.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 27.3 mp0 -61.13 -32.85 72.55 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 126.233 1.813 . . . . 0.0 112.5 -177.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 12.3 m -143.78 -6.57 0.77 Allowed 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 115.12 1.526 . . . . 0.0 115.12 -169.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -55.62 -36.1 66.59 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 119.856 1.207 . . . . 0.0 110.98 178.39 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.0 m -68.71 -38.86 80.56 Favored 'General case' 0 N--CA 1.453 -0.306 0 O-C-N 122.226 -0.296 . . . . 0.0 111.22 -178.192 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.61 -46.2 76.64 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 175.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -64.03 -38.51 91.33 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 122.995 0.518 . . . . 0.0 111.311 -175.059 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.409 ' HA ' HG21 ' A' ' 20' ' ' VAL . 29.4 p -79.12 0.73 26.97 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -177.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 59.9 m -112.23 33.16 5.04 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.171 0.988 . . . . 0.0 112.044 -171.355 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 59.3 mt-10 -132.1 -3.24 3.55 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 -176.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 167.45 -162.3 36.1 Favored Glycine 0 C--N 1.334 0.443 0 CA-C-N 119.346 0.976 . . . . 0.0 111.046 -172.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 40.3 t -74.27 127.56 36.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 N-CA-C 105.55 -2.019 . . . . 0.0 105.55 167.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.409 HG21 ' HA ' ' A' ' 15' ' ' THR . 24.8 t -137.18 115.13 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 -175.713 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 8.2 tt -88.01 147.01 25.2 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 168.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -132.56 153.35 51.07 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 177.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -132.92 99.12 4.49 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 -178.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -76.37 112.5 12.95 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 173.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 7.1 p-90 -139.36 174.75 10.19 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 123.132 0.573 . . . . 0.0 111.934 -168.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -153.67 147.42 18.53 Favored Pre-proline 0 CA--C 1.538 0.515 0 C-N-CA 125.276 1.43 . . . . 0.0 107.527 168.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.03 -20.57 14.77 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.807 2.338 . . . . 0.0 113.272 -170.192 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -78.83 -8.21 58.6 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 121.595 -0.691 . . . . 0.0 111.975 178.25 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 44.5 t -92.94 117.45 30.07 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -53.91 -58.1 13.86 Favored Glycine 0 CA--C 1.531 1.049 0 CA-C-O 118.727 -1.041 . . . . 0.0 112.152 177.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -51.19 -33.33 43.93 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 123.457 2.771 . . . . 0.0 115.607 178.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 90.6 m -60.31 -37.66 81.28 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 119.729 1.15 . . . . 0.0 111.668 174.356 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 43.2 mtmt -78.61 -33.54 47.33 Favored 'General case' 0 C--N 1.333 -0.118 0 O-C-N 121.764 -0.585 . . . . 0.0 109.98 177.127 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 26.5 mmt -65.32 -38.73 91.06 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 119.12 0.873 . . . . 0.0 111.439 177.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 12.0 tt -78.17 -14.86 14.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-N 118.877 0.762 . . . . 0.0 111.379 179.089 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.06 -49.88 89.63 Favored Pre-proline 0 CA--C 1.541 0.62 0 CA-C-O 117.437 -1.268 . . . . 0.0 113.545 -177.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -64.16 -28.49 64.84 Favored 'Trans proline' 0 C--N 1.351 0.662 0 CA-C-N 121.952 1.733 . . . . 0.0 112.401 176.027 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.2 t -68.37 -39.39 80.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 119.256 0.935 . . . . 0.0 109.457 176.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 48.4 mt -67.69 -34.88 77.77 Favored 'General case' 0 C--O 1.226 -0.15 0 O-C-N 121.517 -0.74 . . . . 0.0 110.636 174.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -68.29 -33.92 75.23 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 119.262 0.937 . . . . 0.0 111.44 173.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 50.2 mm-40 -62.32 -45.61 92.43 Favored 'General case' 0 N--CA 1.457 -0.094 0 O-C-N 120.922 -1.112 . . . . 0.0 109.583 170.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -63.86 -35.34 80.3 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 118.827 0.74 . . . . 0.0 111.668 176.123 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -66.35 -36.73 83.64 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 119.055 0.843 . . . . 0.0 111.035 177.121 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -69.8 -44.96 68.97 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 121.643 -0.661 . . . . 0.0 110.907 175.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -81.22 -33.6 32.77 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.983 0.913 . . . . 0.0 112.114 -169.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 52.2 mtt -140.62 -2.94 1.33 Allowed 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.541 1.136 . . . . 0.0 112.884 -169.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -75.14 47.55 1.97 Allowed Glycine 0 CA--C 1.528 0.885 0 C-N-CA 125.671 1.605 . . . . 0.0 113.517 -173.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -150.66 -40.71 0.13 Allowed 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 128.999 2.919 . . . . 0.0 107.176 169.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -63.55 -32.68 74.21 Favored 'General case' 0 C--N 1.343 0.314 0 C-N-CA 124.472 1.109 . . . . 0.0 110.546 168.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -135.67 160.95 36.93 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 125.719 1.608 . . . . 0.0 110.193 172.73 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -98.73 151.15 21.07 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.968 1.307 . . . . 0.0 107.879 171.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 15.7 mt -122.5 133.8 67.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 N-CA-C 105.839 -1.912 . . . . 0.0 105.839 174.11 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 8.0 t -128.4 116.12 40.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 C-N-CA 123.396 0.679 . . . . 0.0 109.556 -176.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 64.7 mmtt -75.14 140.41 43.35 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 168.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 8.3 tt -150.89 125.94 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.116 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -96.95 123.96 40.8 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 121.044 -1.035 . . . . 0.0 110.382 -168.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 23.3 m -61.67 -22.76 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -171.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -73.33 -28.83 62.29 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 120.052 1.296 . . . . 0.0 110.775 175.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -92.81 -33.98 14.05 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.446 1.099 . . . . 0.0 111.158 -171.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -112.59 33.76 4.76 Favored 'General case' 0 C--O 1.222 -0.344 0 C-N-CA 125.039 1.336 . . . . 0.0 109.914 -177.21 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.84 -39.89 54.54 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.542 1.137 . . . . 0.0 111.89 -175.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -65.23 -48.82 72.0 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.305 1.042 . . . . 0.0 111.656 174.083 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.34 -40.48 81.53 Favored 'General case' 0 C--O 1.223 -0.304 0 C-N-CA 123.906 0.882 . . . . 0.0 110.828 -175.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -61.97 -42.95 99.7 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.294 -0.879 . . . . 0.0 109.26 174.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -57.1 -27.42 57.33 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 123.963 0.792 . . . . 0.0 113.137 172.331 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 14.2 ttmm -60.84 -21.85 63.62 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 118.747 1.274 . . . . 0.0 111.451 176.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -120.06 9.8 11.28 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.206 1.403 . . . . 0.0 110.624 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 68.76 22.74 75.58 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 124.407 1.003 . . . . 0.0 113.33 -177.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 89.8 t -91.58 125.48 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 -179.099 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 5.9 mmt -148.63 26.85 0.92 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.714 1.605 . . . . 0.0 109.437 169.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 22.3 m -141.1 152.91 45.14 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 126.318 1.847 . . . . 0.0 107.167 -179.26 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -144.82 156.99 55.55 Favored Pre-proline 0 CA--C 1.54 0.583 0 C-N-CA 123.885 0.874 . . . . 0.0 110.262 -171.155 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -67.8 138.88 45.56 Favored 'Cis proline' 0 C--N 1.349 0.566 0 CA-C-N 119.788 0.96 . . . . 0.0 109.649 -10.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 54.5 m -130.16 118.08 20.89 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 174.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 61.1 mt -90.21 144.03 26.23 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 174.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.5 mp -124.65 155.91 38.39 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 169.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.462 HG11 ' CD2' ' A' ' 103' ' ' HIS . 94.1 t -126.67 130.46 71.63 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 N-CA-C 104.077 -2.564 . . . . 0.0 104.077 168.401 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.1 mp -127.13 156.23 42.09 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 126.234 1.814 . . . . 0.0 106.732 176.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 75.1 tttt -147.17 119.93 8.64 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 -177.241 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.7 t70 47.39 35.81 4.36 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.16 1.384 . . . . 0.0 113.588 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 108.88 -2.64 31.83 Favored Glycine 0 CA--C 1.527 0.781 0 CA-C-O 118.154 -1.359 . . . . 0.0 115.971 168.153 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -129.96 144.43 51.32 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 119.943 1.871 . . . . 0.0 110.208 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.7 p -66.79 138.1 23.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 C-N-CA 123.865 0.866 . . . . 0.0 108.765 173.133 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 35.7 m -129.12 -17.55 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 C-N-CA 125.346 1.459 . . . . 0.0 110.803 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.34 162.97 40.86 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 119.898 1.226 . . . . 0.0 111.559 172.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 85.1 m -151.08 142.12 23.06 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.118 1.767 . . . . 0.0 108.61 176.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 15.1 m -148.85 155.98 41.68 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.588 1.555 . . . . 0.0 108.869 -178.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 37.1 t -132.89 147.98 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 -174.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.75 175.47 49.39 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 124.426 1.012 . . . . 0.0 112.028 177.027 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -59.91 155.03 17.35 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.281 1.033 . . . . 0.0 110.566 174.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -141.44 145.65 38.79 Favored Pre-proline 0 C--O 1.233 0.235 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 168.003 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -71.89 160.43 47.81 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 122.62 2.213 . . . . 0.0 109.832 169.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -55.26 -47.52 75.34 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 118.742 -0.647 . . . . 0.0 111.116 -178.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -63.62 -43.5 96.68 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 118.555 0.616 . . . . 0.0 110.679 -170.064 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.98 -43.44 92.62 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 122.802 0.441 . . . . 0.0 110.743 176.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 45.2 tp -66.44 -42.36 87.75 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 119.307 -0.378 . . . . 0.0 110.346 -177.133 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.5 pp0? -72.62 -29.24 63.31 Favored 'General case' 0 C--N 1.337 0.064 0 CA-C-N 118.89 0.768 . . . . 0.0 110.505 179.345 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -65.89 -49.24 68.75 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 174.346 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 58.8 tp -55.58 -44.45 76.9 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.361 0.664 . . . . 0.0 110.454 178.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.434 ' HA ' ' NE2' ' A' ' 103' ' ' HIS . 48.5 t -68.53 -49.32 66.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 CA-C-O 119.538 -0.268 . . . . 0.0 110.52 -178.644 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -62.43 -27.18 68.92 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 119.143 0.883 . . . . 0.0 112.004 -173.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -65.15 -20.6 66.53 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 117.703 -1.141 . . . . 0.0 113.196 174.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.462 ' CD2' HG11 ' A' ' 77' ' ' VAL . 8.1 p80 -116.55 2.37 13.04 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 120.32 1.418 . . . . 0.0 113.511 -179.287 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 80.8 mt . . . . . 0 C--O 1.248 1.012 0 CA-C-N 119.764 1.166 . . . . 0.0 108.144 170.225 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.3 mpp? . . . . . 0 N--CA 1.482 1.17 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -157.8 144.08 17.59 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 125.263 1.425 . . . . 0.0 107.294 168.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 93.7 mt -75.34 153.67 6.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 174.257 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 32.5 t -123.43 167.03 17.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 -173.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.5 mtmt -135.19 145.38 47.65 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 175.346 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -147.79 171.02 16.36 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.291 0.636 . . . . 0.0 110.083 176.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.414 HG22 HD21 ' A' ' 60' ' ' ASN . 81.3 p -133.79 178.33 7.03 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 171.245 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -47.25 -30.49 3.07 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 119.906 1.23 . . . . 0.0 113.187 176.44 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 12.0 mp0 -58.3 -34.38 70.49 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.691 1.596 . . . . 0.0 112.752 179.083 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 12.8 m -145.42 -2.83 0.75 Allowed 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 114.833 1.42 . . . . 0.0 114.833 -169.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -54.08 -36.82 63.56 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 119.186 0.903 . . . . 0.0 111.005 178.23 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.3 m -67.47 -38.67 84.78 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 122.472 0.309 . . . . 0.0 111.387 -178.462 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.42 -45.25 76.65 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 175.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -64.94 -37.55 88.0 Favored 'General case' 0 C--O 1.231 0.121 0 C-N-CA 122.451 0.3 . . . . 0.0 111.381 -176.059 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.527 ' HA ' HG21 ' A' ' 20' ' ' VAL . 22.4 p -76.48 -1.65 28.29 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 71.1 m -107.72 33.55 4.01 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.55 1.14 . . . . 0.0 111.977 -171.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -133.39 1.53 3.45 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -177.577 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 165.66 -165.67 38.08 Favored Glycine 0 C--N 1.336 0.563 0 CA-C-O 118.796 -1.002 . . . . 0.0 111.242 -176.375 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 88.9 t -73.87 134.25 29.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 N-CA-C 103.678 -2.712 . . . . 0.0 103.678 166.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.527 HG21 ' HA ' ' A' ' 15' ' ' THR . 39.4 t -134.65 117.57 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 -175.396 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 62.3 tp -87.85 97.33 10.86 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 173.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.59 146.41 40.41 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 170.403 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -133.93 94.52 3.28 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 124.818 1.247 . . . . 0.0 107.735 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -71.29 113.36 8.24 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 106.301 -1.741 . . . . 0.0 106.301 172.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 6.3 p-90 -138.26 175.12 9.85 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 123.333 0.653 . . . . 0.0 110.962 -169.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -152.16 146.26 18.34 Favored Pre-proline 0 CA--C 1.536 0.431 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 168.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.31 -17.99 18.44 Favored 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 122.833 2.356 . . . . 0.0 113.377 -171.311 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -82.29 -8.53 59.64 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 121.53 -0.731 . . . . 0.0 111.997 176.288 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 42.0 t -88.12 126.32 35.05 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -61.42 -59.6 9.63 Favored Glycine 0 CA--C 1.531 1.083 0 CA-C-O 118.491 -1.172 . . . . 0.0 111.661 177.528 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_exo -49.04 -37.87 38.51 Favored 'Trans proline' 0 CA--C 1.535 0.566 0 C-N-CA 123.683 2.922 . . . . 0.0 115.094 177.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 86.1 m -59.17 -34.16 71.79 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 119.244 0.929 . . . . 0.0 112.793 175.235 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -84.94 -34.89 22.39 Favored 'General case' 0 N--CA 1.461 0.093 0 CA-C-O 118.942 -0.552 . . . . 0.0 109.996 176.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 85.1 mtp -60.92 -38.56 86.22 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 118.853 0.752 . . . . 0.0 110.993 177.077 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.0 tt -78.77 -14.62 13.68 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-N 118.549 0.613 . . . . 0.0 111.787 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.58 -50.84 84.65 Favored Pre-proline 0 CA--C 1.544 0.725 0 CA-C-N 120.116 1.325 . . . . 0.0 113.393 -177.306 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -64.88 -29.24 58.46 Favored 'Trans proline' 0 C--N 1.35 0.645 0 CA-C-N 121.887 1.709 . . . . 0.0 112.179 176.403 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.5 t -66.11 -42.68 91.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 123.425 0.69 . . . . 0.0 109.327 177.063 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 85.3 mt -65.62 -36.1 82.73 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 118.715 -0.66 . . . . 0.0 110.432 174.301 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -65.86 -36.6 83.9 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 119.534 1.061 . . . . 0.0 111.511 175.551 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -64.94 -43.52 92.49 Favored 'General case' 0 CA--C 1.529 0.146 0 O-C-N 121.162 -0.962 . . . . 0.0 110.086 173.347 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 31.6 tp -64.58 -38.87 92.5 Favored 'General case' 0 CA--C 1.532 0.276 0 O-C-N 122.252 -0.28 . . . . 0.0 110.522 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -64.32 -43.61 94.15 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 124.164 0.985 . . . . 0.0 110.476 177.164 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -61.68 -29.07 69.85 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 121.482 -0.761 . . . . 0.0 111.796 174.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -89.88 -35.53 15.57 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.907 0.883 . . . . 0.0 112.698 -174.176 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 40.6 mtt -136.5 -0.24 2.43 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -169.235 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -70.19 42.28 0.5 Allowed Glycine 0 CA--C 1.535 1.306 0 C-N-CA 126.914 2.197 . . . . 0.0 115.856 -169.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -143.21 -43.6 0.29 Allowed 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 126.849 2.06 . . . . 0.0 108.789 168.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 58.6 mtmt -72.06 -20.63 61.64 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.73 0.812 . . . . 0.0 111.28 169.056 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.9 tp -133.32 153.21 51.78 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 128.584 2.753 . . . . 0.0 106.704 -177.09 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -118.61 154.87 31.94 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 168.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 21.7 mt -122.37 134.7 64.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 104.921 -2.252 . . . . 0.0 104.921 172.034 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 79.3 t -128.9 109.75 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 -177.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -70.42 138.95 51.67 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 169.061 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 13.2 tt -144.85 108.25 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 176.209 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 62.6 t0 -78.44 115.37 18.11 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 123.631 0.772 . . . . 0.0 109.012 -175.125 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 29.4 m -60.76 -24.85 33.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 123.0 0.52 . . . . 0.0 112.278 -176.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -72.59 -0.79 13.83 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.804 0.842 . . . . 0.0 112.292 179.205 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -131.07 7.36 4.65 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.189 1.396 . . . . 0.0 110.591 170.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.414 HD21 HG22 ' A' ' 7' ' ' THR . 63.4 m-80 -142.41 44.94 1.64 Allowed 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.599 1.16 . . . . 0.0 110.318 -168.586 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.498 ' NE2' ' H ' ' A' ' 61' ' ' GLN . 0.4 OUTLIER -56.09 -47.6 77.73 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.266 1.027 . . . . 0.0 108.764 176.885 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 38.5 mp0 -67.17 -47.8 69.9 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 125.231 1.412 . . . . 0.0 109.411 -175.027 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.53 -47.57 72.48 Favored 'General case' 0 C--O 1.222 -0.356 0 C-N-CA 122.759 0.424 . . . . 0.0 110.168 -176.695 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.2 -44.03 96.5 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 119.004 0.82 . . . . 0.0 109.313 -179.189 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -58.1 -27.44 59.96 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 123.948 0.785 . . . . 0.0 112.923 174.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 31.1 ttmt -59.1 -26.21 64.48 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 118.615 1.208 . . . . 0.0 111.448 177.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -117.01 11.56 14.31 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.698 1.199 . . . . 0.0 111.097 179.033 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 69.82 22.73 77.02 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 124.265 0.936 . . . . 0.0 113.163 -178.386 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 97.9 t -93.06 135.04 28.9 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 179.437 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -155.35 28.0 0.4 Allowed 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.33 1.052 . . . . 0.0 109.686 168.104 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 22.8 m -139.06 152.66 47.73 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 126.407 1.883 . . . . 0.0 106.819 178.349 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -144.13 157.08 57.76 Favored Pre-proline 0 CA--C 1.542 0.641 0 CA-C-O 118.392 -0.813 . . . . 0.0 110.176 -169.839 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -67.54 137.97 40.35 Favored 'Cis proline' 0 C--N 1.349 0.59 0 CA-C-N 119.933 1.012 . . . . 0.0 109.84 -10.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 53.1 m -129.67 119.5 23.62 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 174.194 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 96.4 mt -96.61 133.71 40.76 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.6 mp -119.53 130.66 55.29 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 105.203 -2.147 . . . . 0.0 105.203 169.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 16.5 t -93.63 121.35 44.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 103.286 -2.857 . . . . 0.0 103.286 169.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.8 mp -112.23 160.68 17.38 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 170.185 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -142.28 129.85 21.41 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 169.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.9 t70 42.85 37.55 1.11 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.183 1.393 . . . . 0.0 113.62 175.007 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 109.81 -6.67 31.26 Favored Glycine 0 CA--C 1.528 0.863 0 CA-C-O 117.97 -1.461 . . . . 0.0 115.482 169.154 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -132.04 148.41 52.5 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 120.316 2.058 . . . . 0.0 110.901 -175.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.3 t -67.35 137.95 23.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 176.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 35.7 m -127.42 -18.68 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 125.451 1.5 . . . . 0.0 111.051 176.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.62 170.47 22.33 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 120.099 1.318 . . . . 0.0 110.977 171.258 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 99.4 m -147.51 150.63 34.92 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 125.587 1.555 . . . . 0.0 109.075 177.253 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 58.6 m -150.06 159.25 44.55 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.931 1.692 . . . . 0.0 108.791 171.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 34.9 t -133.17 145.1 34.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 179.346 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 85.44 177.18 50.55 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 123.709 0.671 . . . . 0.0 111.897 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -62.83 146.95 51.45 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.049 0.939 . . . . 0.0 110.354 177.261 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 68.0 mttt -143.78 143.17 22.32 Favored Pre-proline 0 CA--C 1.533 0.306 0 C-N-CA 124.989 1.316 . . . . 0.0 107.714 169.227 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -74.49 159.85 42.43 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 123.221 2.614 . . . . 0.0 110.691 177.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.9 tmpt? -61.02 -34.44 74.83 Favored 'General case' 0 C--O 1.225 -0.205 0 O-C-N 121.453 -0.779 . . . . 0.0 111.222 -175.431 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -62.5 -37.42 85.95 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.924 0.783 . . . . 0.0 111.561 178.467 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.18 -42.89 71.83 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 118.068 0.394 . . . . 0.0 110.442 174.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 91.1 mt -64.75 -41.6 95.78 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-O 119.263 -0.398 . . . . 0.0 110.622 -178.144 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.2 pp0? -70.25 -31.76 69.3 Favored 'General case' 0 CA--C 1.527 0.073 0 CA-C-N 118.83 0.741 . . . . 0.0 110.305 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -65.37 -49.59 68.73 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 175.141 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 59.2 tp -56.66 -43.43 80.37 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.945 0.898 . . . . 0.0 110.748 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 43.8 t -68.13 -49.18 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 CA-C-O 118.668 -0.682 . . . . 0.0 110.365 178.289 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.35 -26.1 68.32 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 120.005 1.275 . . . . 0.0 112.431 -175.471 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 39.8 mmtm -64.84 -17.05 63.92 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 118.029 -0.986 . . . . 0.0 113.073 171.184 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 92.0 m-70 -118.45 -12.49 9.83 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 119.777 1.171 . . . . 0.0 113.656 179.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 60.2 mt . . . . . 0 C--O 1.248 1.019 0 CA-C-N 120.464 1.484 . . . . 0.0 109.786 172.737 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.1 ttt . . . . . 0 N--CA 1.483 1.22 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -163.13 162.37 25.6 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 125.536 1.534 . . . . 0.0 108.768 178.281 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 83.7 mt -75.66 154.18 6.15 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 172.186 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 42.2 t -131.9 170.59 19.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 125.949 1.699 . . . . 0.0 106.917 -174.354 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 34.0 ttmt -141.93 147.62 37.34 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 176.348 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -150.78 173.51 14.12 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 123.725 0.81 . . . . 0.0 110.236 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 76.6 p -131.59 175.13 9.43 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.137 1.375 . . . . 0.0 107.298 172.383 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -51.78 -30.48 23.09 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 120.134 1.333 . . . . 0.0 112.886 -176.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 25.3 mp0 -65.32 -27.96 68.97 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.738 2.015 . . . . 0.0 113.353 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 36.8 p -133.11 -15.87 2.53 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 114.317 1.228 . . . . 0.0 114.317 -168.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -54.2 -34.7 61.21 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 125.402 1.481 . . . . 0.0 111.019 178.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.4 p -64.89 -49.36 70.79 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 123.589 0.756 . . . . 0.0 110.949 -179.188 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.78 -44.78 96.34 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 122.908 0.483 . . . . 0.0 109.791 177.109 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -66.11 -37.89 86.87 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 119.263 -0.399 . . . . 0.0 111.616 -176.144 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.507 ' HA ' HG21 ' A' ' 20' ' ' VAL . 28.1 p -78.82 -1.48 35.06 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 118.67 0.668 . . . . 0.0 112.473 -178.415 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 59.1 m -106.06 33.0 4.02 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.421 1.089 . . . . 0.0 111.761 -171.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -133.06 -0.22 3.38 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -177.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 167.21 -167.35 39.8 Favored Glycine 0 C--N 1.337 0.614 0 CA-C-N 119.413 1.006 . . . . 0.0 111.563 -174.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 68.9 t -73.77 125.9 33.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 104.601 -2.37 . . . . 0.0 104.601 166.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.507 HG21 ' HA ' ' A' ' 15' ' ' THR . 35.3 t -129.86 120.93 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 -174.074 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -94.01 105.66 17.66 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 105.851 -1.907 . . . . 0.0 105.851 -179.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -94.9 102.55 14.4 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -177.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -82.4 95.25 7.6 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 123.862 0.865 . . . . 0.0 108.705 175.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 45.8 m-85 -75.53 116.72 16.55 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 169.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 7.5 p-90 -141.61 176.81 8.6 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 123.498 0.719 . . . . 0.0 111.498 -170.439 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -153.68 146.29 17.48 Favored Pre-proline 0 CA--C 1.538 0.509 0 C-N-CA 124.856 1.262 . . . . 0.0 107.717 168.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.92 -19.02 16.37 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.882 2.388 . . . . 0.0 113.264 -171.06 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -78.74 -7.13 57.46 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 118.689 0.677 . . . . 0.0 112.067 177.158 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 46.6 t -94.98 119.1 32.93 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -178.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -55.47 -58.35 14.34 Favored Glycine 0 CA--C 1.531 1.076 0 CA-C-O 118.56 -1.133 . . . . 0.0 111.779 176.487 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_exo -49.45 -34.7 33.96 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 123.665 2.91 . . . . 0.0 115.603 177.396 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 92.7 m -60.6 -44.16 96.58 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 119.78 1.173 . . . . 0.0 111.423 173.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 45.2 mtmt -72.27 -30.91 65.28 Favored 'General case' 0 CA--C 1.529 0.146 0 O-C-N 121.682 -0.636 . . . . 0.0 110.427 178.095 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 63.0 mtt -67.48 -40.98 85.3 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 118.766 0.712 . . . . 0.0 111.302 176.35 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.7 tt -78.54 -19.25 13.31 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-N 119.168 0.895 . . . . 0.0 111.415 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.18 -51.01 72.28 Favored Pre-proline 0 CA--C 1.546 0.823 0 CA-C-N 119.895 1.225 . . . . 0.0 114.011 -178.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -65.5 -28.56 53.62 Favored 'Trans proline' 0 C--N 1.351 0.663 0 CA-C-N 121.897 1.713 . . . . 0.0 112.44 175.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 6.6 t -67.33 -37.58 79.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 118.903 0.774 . . . . 0.0 109.542 175.069 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 96.0 mt -67.74 -34.64 77.24 Favored 'General case' 0 C--O 1.226 -0.136 0 O-C-N 121.493 -0.754 . . . . 0.0 110.685 172.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -64.13 -38.29 90.54 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 119.758 1.163 . . . . 0.0 111.229 172.045 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -65.94 -37.88 87.17 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 121.092 -1.005 . . . . 0.0 110.384 173.079 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 46.7 tp -66.6 -36.37 82.45 Favored 'General case' 0 C--O 1.227 -0.13 0 CA-C-N 118.56 0.618 . . . . 0.0 110.512 177.267 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -65.71 -41.5 92.24 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 118.953 0.797 . . . . 0.0 110.28 174.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -63.9 -29.72 70.87 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 121.796 -0.565 . . . . 0.0 112.13 174.337 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -87.47 -39.32 15.31 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.141 0.976 . . . . 0.0 112.215 -175.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 16.5 mmt -133.58 -1.27 3.13 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 124.527 1.131 . . . . 0.0 113.76 -167.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -62.1 -7.56 13.67 Favored Glycine 0 CA--C 1.535 1.297 0 CA-C-N 121.193 1.815 . . . . 0.0 114.419 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -79.57 -22.29 43.98 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.674 1.99 . . . . 0.0 112.11 173.029 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -130.4 -10.03 4.13 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 126.46 1.904 . . . . 0.0 111.465 -171.07 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -135.74 164.08 28.72 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 126.515 1.926 . . . . 0.0 108.306 -177.716 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -121.54 142.05 50.45 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 169.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 17.0 mt -105.71 137.78 34.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 105.139 -2.171 . . . . 0.0 105.139 170.212 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 90.2 t -127.38 114.49 36.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 105.785 -1.931 . . . . 0.0 105.785 175.397 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.65 141.23 44.63 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 169.646 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 11.8 tt -151.63 125.58 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 175.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -81.97 129.22 34.72 Favored 'General case' 0 N--CA 1.466 0.325 0 O-C-N 121.586 -0.696 . . . . 0.0 109.446 -178.459 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 15.4 m -67.81 -34.34 66.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -174.473 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -76.52 -34.58 58.57 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 119.055 0.843 . . . . 0.0 109.768 -174.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -73.04 -16.21 61.5 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.668 0.787 . . . . 0.0 111.958 172.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 62.7 m-80 -140.22 50.85 1.7 Allowed 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 119.312 0.96 . . . . 0.0 111.182 -168.315 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -57.2 -36.8 71.31 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.533 0.733 . . . . 0.0 109.68 178.65 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -64.02 -28.51 69.85 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 125.095 1.358 . . . . 0.0 112.466 -178.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.418 ' HA ' ' HE2' ' A' ' 66' ' ' LYS . 0.2 OUTLIER -92.3 -45.65 8.1 Favored 'General case' 0 C--O 1.222 -0.346 0 CA-C-N 118.573 0.624 . . . . 0.0 109.991 179.542 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.53 -45.75 89.17 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 119.484 1.038 . . . . 0.0 110.073 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -62.74 -21.91 63.58 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 124.195 0.902 . . . . 0.0 112.571 175.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.418 ' HE2' ' HA ' ' A' ' 63' ' ' THR . 5.5 ttmm -59.32 -22.07 60.71 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 118.52 1.16 . . . . 0.0 111.617 174.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -121.46 11.34 10.65 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.917 1.287 . . . . 0.0 110.728 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 68.19 27.32 73.77 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 124.147 0.88 . . . . 0.0 112.801 -177.295 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 65.7 t -100.8 135.71 35.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.54 28.5 0.44 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.546 1.138 . . . . 0.0 109.466 168.386 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 42.2 m -133.52 156.49 47.69 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 126.257 1.823 . . . . 0.0 107.262 175.556 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -145.8 159.15 48.02 Favored Pre-proline 0 CA--C 1.539 0.541 0 C-N-CA 124.243 1.017 . . . . 0.0 110.205 -169.557 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.5 140.05 50.77 Favored 'Cis proline' 0 C--N 1.349 0.583 0 CA-C-N 119.938 1.014 . . . . 0.0 109.923 -10.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 61.5 m -135.0 129.03 33.52 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 106.395 -1.706 . . . . 0.0 106.395 177.506 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 56.3 mt -108.72 104.07 13.28 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 105.903 -1.888 . . . . 0.0 105.903 -177.127 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -78.76 141.95 37.39 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 105.374 -2.084 . . . . 0.0 105.374 168.496 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.2 t -118.95 116.82 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 N-CA-C 103.378 -2.823 . . . . 0.0 103.378 174.119 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 8.1 mp -111.85 159.86 17.93 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 175.023 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -141.7 127.9 19.76 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 170.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.8 t70 43.74 38.61 2.09 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.062 1.345 . . . . 0.0 113.323 175.529 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 104.64 -4.78 43.21 Favored Glycine 0 CA--C 1.53 0.969 0 CA-C-O 117.962 -1.466 . . . . 0.0 115.169 169.351 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -130.92 150.42 52.09 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 120.269 2.034 . . . . 0.0 110.98 -176.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.2 p -66.08 140.15 20.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 C-N-CA 123.803 0.841 . . . . 0.0 109.476 177.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 28.4 m -127.16 -19.54 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 C-N-CA 125.479 1.512 . . . . 0.0 110.865 173.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.87 168.33 26.03 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 120.399 1.454 . . . . 0.0 111.382 169.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 60.8 m -143.63 136.04 27.03 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.023 1.729 . . . . 0.0 107.216 169.479 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 38.4 m -140.57 152.51 45.55 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.92 1.288 . . . . 0.0 108.436 -177.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 38.5 t -133.48 147.53 31.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 -171.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.02 174.35 49.54 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 124.25 0.929 . . . . 0.0 112.229 175.556 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -61.33 148.09 42.52 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 123.784 0.834 . . . . 0.0 110.744 179.121 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -152.11 142.2 14.87 Favored Pre-proline 0 CA--C 1.533 0.324 0 C-N-CA 125.922 1.689 . . . . 0.0 106.999 -178.356 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -74.4 156.77 45.69 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 122.44 2.093 . . . . 0.0 110.612 174.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.5 tmpt? -58.31 -36.43 73.34 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 123.636 0.774 . . . . 0.0 110.982 -179.115 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 23.7 tp10 -65.91 -36.71 84.15 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 118.506 0.594 . . . . 0.0 111.441 -174.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.02 -42.96 79.87 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 122.926 0.49 . . . . 0.0 110.681 174.234 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 91.3 mt -65.68 -43.98 87.64 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 119.096 -0.478 . . . . 0.0 110.123 -177.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.8 pp0? -68.21 -30.0 68.97 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 118.909 0.777 . . . . 0.0 110.543 179.025 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -65.99 -50.22 65.04 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 175.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 54.9 tp -56.92 -44.32 82.31 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.063 0.545 . . . . 0.0 110.648 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 42.7 t -63.36 -50.73 77.53 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 C-N-CA 123.461 0.704 . . . . 0.0 109.717 178.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -65.66 -26.19 67.69 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 119.386 0.994 . . . . 0.0 112.403 -175.783 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -67.22 -36.71 82.24 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 118.78 -0.629 . . . . 0.0 111.214 170.386 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 79.8 m-70 -80.64 -24.51 38.97 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 118.078 -0.963 . . . . 0.0 113.378 178.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 65.8 mt . . . . . 0 C--O 1.248 1.015 0 CA-C-N 119.707 1.14 . . . . 0.0 110.155 177.699 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.7 mmt . . . . . 0 N--CA 1.485 1.298 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -149.66 158.48 44.21 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 124.993 1.317 . . . . 0.0 108.563 174.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 84.5 mt -71.42 150.23 9.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 124.5 1.12 . . . . 0.0 108.15 178.263 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 23.3 t -105.85 160.69 5.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 125.573 1.549 . . . . 0.0 107.379 -175.128 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.41 140.48 52.65 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 176.294 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -136.98 172.24 13.31 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.041 0.937 . . . . 0.0 110.498 179.054 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.0 p -129.6 173.56 10.49 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 125.739 1.616 . . . . 0.0 107.861 178.116 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -52.34 -35.56 51.23 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 119.509 1.049 . . . . 0.0 111.721 174.023 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 5.4 mp0 -75.86 -31.25 59.21 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -177.491 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 32.6 p -110.83 -14.93 13.91 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 -169.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -51.0 -39.56 56.03 Favored 'General case' 0 C--N 1.334 -0.078 0 C-N-CA 124.573 1.149 . . . . 0.0 110.224 173.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.2 m -74.09 -23.19 59.3 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -174.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.88 -48.39 18.45 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 169.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -66.96 -36.39 82.1 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 122.807 0.443 . . . . 0.0 111.965 -170.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 42.9 p -82.85 7.8 14.21 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 112.527 0.565 . . . . 0.0 112.527 -176.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 40.8 m -121.68 34.57 5.14 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.596 0.758 . . . . 0.0 112.216 -169.117 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -135.39 1.75 2.92 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -176.248 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 169.0 -165.86 39.25 Favored Glycine 0 C--N 1.333 0.408 0 N-CA-C 110.409 -1.076 . . . . 0.0 110.409 -171.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.435 HG22 ' HE3' ' A' ' 79' ' ' LYS . 1.5 t -78.82 133.01 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 N-CA-C 104.324 -2.473 . . . . 0.0 104.324 168.408 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 23.8 t -139.63 146.15 25.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 -173.452 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 9.0 tt -122.55 135.87 54.74 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 105.807 -1.923 . . . . 0.0 105.807 169.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -129.67 121.3 26.7 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 -174.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -96.08 102.55 14.36 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 125.504 1.522 . . . . 0.0 108.585 -177.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -76.41 116.84 17.48 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 169.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 6.9 p-90 -145.88 178.82 7.89 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.619 0.767 . . . . 0.0 110.898 -169.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -158.51 150.28 17.08 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 125.606 1.562 . . . . 0.0 107.054 167.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.18 -18.72 20.7 Favored 'Trans proline' 0 CA--C 1.532 0.417 0 C-N-CA 122.754 2.303 . . . . 0.0 113.478 -170.028 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -79.39 -11.12 59.93 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 118.94 0.791 . . . . 0.0 112.483 176.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 45.8 t -85.53 119.26 25.68 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -57.01 -58.26 15.51 Favored Glycine 0 CA--C 1.531 1.093 0 CA-C-O 118.622 -1.099 . . . . 0.0 111.632 174.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -49.95 -36.14 42.95 Favored 'Trans proline' 0 CA--C 1.536 0.618 0 C-N-CA 123.571 2.848 . . . . 0.0 115.309 176.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 98.4 m -59.39 -46.06 89.73 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 119.87 1.214 . . . . 0.0 111.306 173.002 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 46.1 mtmt -70.35 -30.26 67.16 Favored 'General case' 0 N--CA 1.462 0.168 0 O-C-N 121.511 -0.743 . . . . 0.0 110.844 178.251 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 87.2 mtp -67.32 -43.08 82.5 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 118.922 0.783 . . . . 0.0 110.98 175.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 8.3 tt -78.84 -18.91 13.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-N 119.048 0.84 . . . . 0.0 111.378 -178.584 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.33 -52.44 59.28 Favored Pre-proline 0 CA--C 1.544 0.743 0 CA-C-O 117.5 -1.238 . . . . 0.0 113.986 -178.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.03 -30.35 56.53 Favored 'Trans proline' 0 C--N 1.349 0.58 0 CA-C-N 121.931 1.725 . . . . 0.0 112.103 177.256 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 6.3 t -64.82 -42.68 95.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 118.762 0.71 . . . . 0.0 109.085 176.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 61.1 mt -67.14 -34.97 78.71 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 118.603 -0.713 . . . . 0.0 110.981 176.237 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -65.59 -40.39 92.64 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 119.553 1.07 . . . . 0.0 111.004 174.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -63.95 -42.87 97.18 Favored 'General case' 0 CA--C 1.53 0.188 0 O-C-N 121.405 -0.809 . . . . 0.0 109.875 174.025 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 25.8 tp -62.8 -39.15 93.39 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 122.845 0.458 . . . . 0.0 110.794 178.066 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -66.83 -38.89 87.28 Favored 'General case' 0 C--N 1.333 -0.116 0 O-C-N 121.448 -0.782 . . . . 0.0 110.856 177.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -64.45 -23.06 67.15 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 121.86 -0.525 . . . . 0.0 111.895 173.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -96.88 -30.9 12.86 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.784 1.234 . . . . 0.0 112.46 -176.242 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 19.0 mmt -129.73 -9.31 4.49 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 117.825 -1.084 . . . . 0.0 113.606 -168.43 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -48.49 -30.53 8.42 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 125.955 1.74 . . . . 0.0 115.985 -169.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -79.31 -38.63 34.82 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.296 1.038 . . . . 0.0 111.495 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -85.23 -26.17 26.86 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 124.7 1.2 . . . . 0.0 110.801 -178.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -148.44 124.39 10.66 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 125.016 1.326 . . . . 0.0 108.807 -177.253 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -72.36 148.14 45.58 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 176.174 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 22.8 mt -122.07 133.58 67.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 172.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 9.2 t -127.01 153.11 35.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 124.689 1.196 . . . . 0.0 108.196 -173.337 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 65.4 mmtt -118.9 141.17 48.89 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 126.085 1.754 . . . . 0.0 107.975 177.116 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 14.9 tt -145.54 120.8 3.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-O 121.358 0.599 . . . . 0.0 109.538 172.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -80.9 110.47 16.46 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 123.911 0.885 . . . . 0.0 108.823 -179.263 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 24.0 m -64.47 -25.5 38.08 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-O 118.986 -0.53 . . . . 0.0 112.427 -174.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -70.98 -12.94 61.82 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 119.14 0.882 . . . . 0.0 111.68 -178.33 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -120.03 -5.28 10.04 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.239 1.416 . . . . 0.0 110.979 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 60.9 m-80 -146.06 36.66 1.03 Allowed 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.217 1.007 . . . . 0.0 110.551 -168.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.2 pm0 -59.07 -25.34 63.67 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.973 0.909 . . . . 0.0 111.487 179.219 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 59.6 mp0 -60.13 -32.44 71.02 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.028 1.731 . . . . 0.0 111.29 175.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.39 -48.81 14.72 Favored 'General case' 0 C--O 1.223 -0.326 0 CA-C-N 118.38 0.536 . . . . 0.0 110.0 172.328 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.23 -45.99 89.04 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 118.798 0.726 . . . . 0.0 110.278 -171.082 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -61.92 -23.99 64.22 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 124.166 0.889 . . . . 0.0 112.821 176.128 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.6 ttmm -59.18 -28.13 66.34 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 118.612 1.206 . . . . 0.0 111.295 175.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -115.84 11.01 15.45 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.776 1.23 . . . . 0.0 111.033 178.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 70.36 18.3 75.08 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 124.603 1.096 . . . . 0.0 113.738 -178.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 98.8 t -84.12 134.23 27.43 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 176.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -155.45 32.2 0.37 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.413 1.085 . . . . 0.0 109.09 166.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 23.3 m -138.01 151.45 47.91 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 126.824 2.05 . . . . 0.0 106.245 176.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 28.2 pt -147.3 159.58 41.73 Favored Pre-proline 0 CA--C 1.542 0.669 0 C-N-CA 124.041 0.937 . . . . 0.0 109.472 -169.551 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -66.65 142.07 57.91 Favored 'Cis proline' 0 N--CA 1.458 -0.559 0 N-CA-C 109.529 -0.989 . . . . 0.0 109.529 -10.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 26.7 m -132.43 129.07 38.8 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 178.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 50.1 mt -112.05 109.53 19.33 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 -174.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.5 mp -87.51 151.75 22.77 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 106.171 -1.788 . . . . 0.0 106.171 167.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 15.7 t -123.78 132.12 71.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 N-CA-C 104.131 -2.544 . . . . 0.0 104.131 169.363 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.3 mp -132.99 160.01 38.36 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 125.918 1.687 . . . . 0.0 107.254 -175.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.435 ' HE3' HG22 ' A' ' 19' ' ' VAL . 77.1 tttt -147.2 127.52 13.94 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.596 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.1 t70 59.13 -19.26 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 128.052 2.541 . . . . 0.0 116.298 177.138 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 162.17 -0.91 0.06 OUTLIER Glycine 0 CA--C 1.532 1.102 0 CA-C-O 118.141 -1.366 . . . . 0.0 114.4 173.584 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -134.26 151.01 51.05 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 120.239 2.02 . . . . 0.0 110.45 -173.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 42.4 t -64.84 139.95 20.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 C-N-CA 124.238 1.015 . . . . 0.0 108.373 175.306 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 33.6 m -121.17 -21.97 3.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 125.208 1.403 . . . . 0.0 110.593 172.451 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -158.02 164.2 36.99 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 119.79 1.177 . . . . 0.0 111.584 174.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 69.7 m -144.1 138.45 28.25 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.777 1.631 . . . . 0.0 108.205 172.518 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 44.6 m -143.38 153.48 42.74 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.695 1.598 . . . . 0.0 108.594 -178.299 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 40.2 t -133.69 146.46 31.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -174.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.63 174.46 45.81 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 124.633 1.111 . . . . 0.0 112.443 173.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 61.3 t80 -62.66 143.91 56.85 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.597 0.759 . . . . 0.0 109.99 176.245 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 44.7 mttm -145.29 148.26 37.06 Favored Pre-proline 0 C--O 1.235 0.29 0 C-N-CA 125.226 1.41 . . . . 0.0 107.994 169.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -74.1 159.88 43.61 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 123.062 2.508 . . . . 0.0 110.626 176.039 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 11.0 ttpt -58.32 -38.54 77.32 Favored 'General case' 0 C--O 1.223 -0.293 0 O-C-N 121.825 -0.547 . . . . 0.0 111.021 -177.328 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -59.93 -39.27 84.91 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.416 0.686 . . . . 0.0 111.558 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.13 -42.02 73.13 Favored 'General case' 0 N--CA 1.452 -0.346 0 O-C-N 122.17 -0.331 . . . . 0.0 110.483 175.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 90.9 mt -67.83 -37.57 82.08 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 119.014 -0.517 . . . . 0.0 111.056 -178.105 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.8 pp0? -71.48 -29.62 65.04 Favored 'General case' 0 CA--C 1.526 0.036 0 CA-C-N 119.523 1.056 . . . . 0.0 110.297 177.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -65.46 -49.59 68.55 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 174.01 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 52.0 tp -54.35 -46.06 72.87 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.831 0.852 . . . . 0.0 110.635 177.238 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 25.2 t -63.26 -53.06 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.83 -25.4 67.89 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 119.021 0.828 . . . . 0.0 112.457 -174.122 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 61.3 mtpt -66.74 -23.04 66.04 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 118.024 -0.989 . . . . 0.0 112.552 172.156 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -110.46 -13.55 14.24 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 119.765 1.166 . . . . 0.0 113.384 -179.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 56.5 mt . . . . . 0 C--O 1.249 1.073 0 CA-C-N 119.871 1.214 . . . . 0.0 109.449 170.041 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 75.9 mtm . . . . . 0 N--CA 1.479 0.997 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -154.99 145.46 22.14 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.93 1.292 . . . . 0.0 107.563 169.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 89.3 mt -76.07 143.61 12.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 179.597 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 38.7 t -101.18 166.42 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 125.494 1.518 . . . . 0.0 107.581 -173.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.4 mppt? -128.63 143.37 50.93 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 106.079 -1.822 . . . . 0.0 106.079 177.005 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -144.79 169.72 17.48 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 118.341 0.518 . . . . 0.0 110.976 175.062 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.6 p -134.01 170.09 16.15 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 172.128 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -52.66 -25.59 11.31 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 119.98 1.264 . . . . 0.0 112.317 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 69.4 mm-40 -63.71 -33.07 74.84 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.474 1.51 . . . . 0.0 112.516 -179.184 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.6 m -140.29 -4.93 1.28 Allowed 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -171.246 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -50.39 -39.74 47.7 Favored 'General case' 0 N--CA 1.457 -0.081 0 C-N-CA 125.328 1.451 . . . . 0.0 110.665 173.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.9 m -66.9 -36.42 82.24 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 118.003 0.365 . . . . 0.0 111.618 -176.162 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.12 -46.59 70.46 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 174.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -64.07 -38.69 91.99 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 122.784 0.434 . . . . 0.0 111.431 -175.369 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.551 ' HA ' HG21 ' A' ' 20' ' ' VAL . 30.9 p -79.35 -0.37 32.34 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -176.736 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 64.8 m -109.28 34.48 3.73 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.456 1.102 . . . . 0.0 111.614 -173.259 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -132.11 -0.21 3.75 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 -178.319 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 165.43 -167.97 39.2 Favored Glycine 0 C--N 1.336 0.546 0 CA-C-N 119.16 0.891 . . . . 0.0 111.042 -174.089 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 94.3 t -71.17 132.42 33.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 N-CA-C 104.558 -2.386 . . . . 0.0 104.558 166.165 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.551 HG21 ' HA ' ' A' ' 15' ' ' THR . 27.3 t -135.57 118.62 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 -176.65 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -87.93 124.39 33.64 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 105.372 -2.085 . . . . 0.0 105.372 172.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -117.12 105.53 12.36 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -81.86 99.99 9.35 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 175.08 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -76.14 116.71 17.1 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 168.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 7.0 p-90 -144.86 179.53 7.27 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.59 0.756 . . . . 0.0 111.415 -169.029 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -158.48 152.32 19.57 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 125.648 1.579 . . . . 0.0 107.197 167.343 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -76.83 -16.96 16.0 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.835 2.357 . . . . 0.0 113.467 -169.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -79.14 -11.65 59.98 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.898 0.772 . . . . 0.0 111.986 177.843 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 41.7 t -87.52 121.46 29.98 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 178.06 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -58.71 -56.16 26.8 Favored Glycine 0 CA--C 1.532 1.121 0 CA-C-O 118.76 -1.022 . . . . 0.0 111.936 175.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_exo -49.35 -39.51 43.87 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 123.496 2.797 . . . . 0.0 115.077 175.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 69.8 m -58.58 -34.33 70.96 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 119.125 0.875 . . . . 0.0 112.864 175.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 45.6 mtmt -81.29 -42.25 20.9 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 8.2 ptt? -70.64 -24.2 62.66 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 119.358 0.981 . . . . 0.0 112.532 -176.181 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 8.0 tt -77.16 -18.14 14.43 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-N 119.602 1.092 . . . . 0.0 111.574 173.237 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.05 -48.51 95.88 Favored Pre-proline 0 CA--C 1.539 0.521 0 CA-C-O 117.287 -1.34 . . . . 0.0 113.417 -177.425 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -63.28 -31.28 73.93 Favored 'Trans proline' 0 C--N 1.35 0.614 0 CA-C-N 121.938 1.728 . . . . 0.0 112.143 175.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 6.6 t -66.54 -41.13 87.97 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-N 119.249 0.931 . . . . 0.0 109.521 177.143 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 63.4 mt -66.63 -32.82 74.38 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-O 118.813 -0.613 . . . . 0.0 110.912 174.622 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -68.66 -35.81 77.73 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 119.669 1.122 . . . . 0.0 111.304 173.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 -64.92 -39.42 93.49 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 120.903 -1.123 . . . . 0.0 109.886 171.628 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 24.4 tp -66.57 -35.86 81.25 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 121.604 -0.685 . . . . 0.0 110.969 176.252 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -65.76 -38.56 89.41 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.739 0.815 . . . . 0.0 110.632 175.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -66.71 -38.34 86.52 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.783 -0.573 . . . . 0.0 111.03 173.151 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -74.48 -43.0 58.04 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.026 0.93 . . . . 0.0 111.764 -174.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 42.6 mtt -142.8 3.03 1.41 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 117.849 -1.072 . . . . 0.0 113.742 -168.486 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -74.49 50.9 2.15 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 126.056 1.788 . . . . 0.0 113.641 -172.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -154.29 -41.16 0.09 Allowed 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 129.697 3.199 . . . . 0.0 107.327 169.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 48.0 mtpt -64.12 -33.74 76.45 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.599 1.16 . . . . 0.0 110.529 169.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -131.36 165.3 23.77 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.839 1.656 . . . . 0.0 109.679 169.302 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -102.88 149.68 24.26 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 170.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 20.3 mt -117.84 136.43 55.04 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 N-CA-C 105.036 -2.209 . . . . 0.0 105.036 170.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 63.8 t -129.66 138.56 53.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 -178.155 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 60.0 mmtt -97.77 139.34 33.79 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.859 1.264 . . . . 0.0 108.219 169.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 12.6 tt -149.17 128.56 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 CA-C-O 121.306 0.574 . . . . 0.0 109.555 175.524 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -83.73 127.19 33.61 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.546 0.739 . . . . 0.0 110.269 -175.183 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 13.5 m -67.92 -26.95 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 -173.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -83.54 -41.01 18.41 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 119.903 1.229 . . . . 0.0 109.634 -175.289 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -70.62 -25.22 62.94 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.355 0.662 . . . . 0.0 111.08 174.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -127.42 43.8 3.05 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.748 1.219 . . . . 0.0 109.74 -172.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.15 -36.44 51.45 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 126.666 1.986 . . . . 0.0 111.285 175.557 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -65.48 -40.28 92.93 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 124.012 0.925 . . . . 0.0 111.483 176.263 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.59 -43.32 48.9 Favored 'General case' 0 C--O 1.222 -0.356 0 CA-C-N 119.406 1.003 . . . . 0.0 110.111 -178.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -61.62 -46.17 90.97 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 119.205 0.911 . . . . 0.0 109.719 176.215 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -60.74 -22.42 59.62 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 124.456 1.027 . . . . 0.0 113.069 175.169 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 7.7 ttmm -59.92 -20.38 57.05 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 118.629 1.215 . . . . 0.0 111.503 175.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -124.36 10.37 8.59 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.353 1.461 . . . . 0.0 110.627 178.454 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 64.9 22.85 68.89 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.542 1.067 . . . . 0.0 113.226 -174.076 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 61.1 t -88.74 153.6 3.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 118.331 1.065 . . . . 0.0 109.198 178.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -161.04 -22.83 0.06 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 127.5 2.32 . . . . 0.0 109.86 167.506 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.5 m -63.6 153.15 36.8 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 124.312 1.045 . . . . 0.0 109.721 171.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 28.2 pt -146.58 156.25 48.91 Favored Pre-proline 0 CA--C 1.542 0.637 0 C-N-CA 124.141 0.976 . . . . 0.0 109.617 -178.227 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -68.41 140.49 56.43 Favored 'Cis proline' 0 N--CA 1.457 -0.625 0 N-CA-C 109.011 -1.188 . . . . 0.0 109.011 -11.664 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 54.4 m -131.17 125.28 32.61 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 178.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 40.6 mt -104.26 104.14 14.0 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 -176.013 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -78.27 143.64 36.87 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 105.726 -1.953 . . . . 0.0 105.726 168.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.8 t -120.29 118.41 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 103.489 -2.782 . . . . 0.0 103.489 172.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 8.8 mp -114.6 160.12 19.66 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 175.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -143.12 128.15 18.51 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 170.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.8 t70 44.01 37.79 1.94 Allowed 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.102 1.361 . . . . 0.0 113.39 175.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 104.86 -4.48 42.22 Favored Glycine 0 CA--C 1.528 0.857 0 CA-C-O 118.083 -1.398 . . . . 0.0 115.247 169.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -129.82 149.58 51.5 Favored 'General case' 0 C--N 1.34 0.162 0 CA-C-N 120.19 1.995 . . . . 0.0 110.755 -177.101 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.9 p -66.19 140.77 18.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 C-N-CA 123.765 0.826 . . . . 0.0 109.312 177.503 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 35.5 m -127.14 -19.54 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 C-N-CA 125.481 1.512 . . . . 0.0 110.8 173.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.35 167.59 28.47 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 120.227 1.376 . . . . 0.0 111.392 169.617 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 78.0 m -143.71 134.0 24.54 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 126.253 1.821 . . . . 0.0 107.243 169.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 39.0 m -141.41 153.8 45.24 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 124.898 1.279 . . . . 0.0 108.666 -176.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.1 t -132.95 148.67 31.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -172.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.08 170.61 46.08 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 124.407 1.003 . . . . 0.0 112.468 172.084 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -65.34 133.38 51.27 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 123.475 0.71 . . . . 0.0 109.54 175.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -134.73 144.02 48.89 Favored Pre-proline 0 CA--C 1.534 0.342 0 C-N-CA 126.111 1.764 . . . . 0.0 106.626 176.046 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -72.12 158.89 51.27 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 122.754 2.303 . . . . 0.0 110.553 176.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 9.9 ttpt -57.42 -37.41 72.71 Favored 'General case' 0 C--O 1.223 -0.321 0 O-C-N 121.719 -0.613 . . . . 0.0 111.133 -177.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -61.05 -37.38 82.41 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 118.528 0.604 . . . . 0.0 111.728 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -72.15 -41.76 66.74 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 122.748 0.419 . . . . 0.0 110.604 175.233 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 81.2 mt -64.04 -43.36 95.78 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 119.317 -0.373 . . . . 0.0 110.295 -179.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.9 pp0? -70.16 -30.43 67.58 Favored 'General case' 0 C--O 1.228 -0.067 0 CA-C-N 118.835 0.743 . . . . 0.0 110.11 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -64.75 -49.41 70.91 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 175.408 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 60.2 tp -57.14 -45.73 83.32 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.553 0.741 . . . . 0.0 110.507 178.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 40.0 t -62.88 -49.05 85.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 CA-C-O 119.029 -0.51 . . . . 0.0 109.941 179.187 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.62 -25.89 68.16 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 119.414 1.006 . . . . 0.0 112.543 -175.516 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -66.2 -19.36 65.81 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 118.068 -0.968 . . . . 0.0 112.811 171.036 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -113.07 -16.41 12.63 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 119.877 1.217 . . . . 0.0 113.528 -178.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 70.7 mt . . . . . 0 C--O 1.248 1.019 0 CA-C-N 119.972 1.26 . . . . 0.0 109.713 172.531 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.7 ttt . . . . . 0 N--CA 1.48 1.068 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -164.51 172.82 12.8 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 126.853 2.061 . . . . 0.0 107.58 -174.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 78.0 mt -75.18 148.72 7.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 169.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.7 t -131.49 165.25 32.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 124.877 1.271 . . . . 0.0 107.902 -168.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -127.12 142.43 51.51 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 174.088 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -148.32 171.19 16.39 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 124.302 1.041 . . . . 0.0 108.807 169.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 70.4 p -133.84 178.37 7.0 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 171.243 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -45.95 -31.15 2.05 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.487 1.115 . . . . 0.0 113.31 176.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 11.9 mp0 -58.87 -34.46 71.64 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.321 1.848 . . . . 0.0 112.998 179.182 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.2 m -145.5 -3.61 0.71 Allowed 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 -169.429 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -54.33 -36.01 63.32 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.305 1.042 . . . . 0.0 110.84 177.191 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.8 m -67.01 -34.54 77.95 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 122.884 0.474 . . . . 0.0 111.9 -179.088 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -70.14 -45.85 65.94 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 175.358 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -64.35 -37.91 89.17 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 119.47 -0.3 . . . . 0.0 111.443 -175.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.505 ' HA ' HG21 ' A' ' 20' ' ' VAL . 20.2 p -75.98 1.16 16.07 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -178.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 52.0 m -117.51 37.12 4.0 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.294 1.037 . . . . 0.0 111.913 -169.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -130.97 -2.17 4.08 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 163.17 -165.88 36.76 Favored Glycine 0 C--N 1.335 0.498 0 N-CA-C 110.149 -1.18 . . . . 0.0 110.149 -172.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 87.5 t -68.53 141.0 18.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 105.758 -1.941 . . . . 0.0 105.758 166.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.505 HG21 ' HA ' ' A' ' 15' ' ' THR . 62.4 t -141.97 142.97 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 107.194 -1.409 . . . . 0.0 107.194 -178.205 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 56.6 tp -112.71 99.22 7.76 Favored 'General case' 0 CA--C 1.521 -0.158 0 N-CA-C 106.573 -1.639 . . . . 0.0 106.573 173.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.06 144.12 40.95 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 170.058 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -129.26 95.55 4.07 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 125.393 1.477 . . . . 0.0 107.263 178.227 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -75.31 116.41 16.0 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 173.119 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 12.1 p-90 -135.72 175.15 9.85 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 124.069 0.947 . . . . 0.0 110.17 -173.492 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -148.62 146.27 21.92 Favored Pre-proline 0 CA--C 1.533 0.314 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 169.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -74.0 -15.78 23.24 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.808 2.339 . . . . 0.0 113.863 -169.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -93.24 -6.09 48.43 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.812 0.845 . . . . 0.0 112.126 178.13 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 42.3 t -85.41 116.49 23.76 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 -178.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -55.75 -55.03 30.97 Favored Glycine 0 CA--C 1.532 1.15 0 CA-C-O 118.671 -1.072 . . . . 0.0 112.236 175.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -50.26 -36.34 46.55 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 123.254 2.636 . . . . 0.0 115.219 175.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 92.9 m -59.91 -40.28 88.26 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 119.937 1.244 . . . . 0.0 111.713 172.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 61.9 mttm -66.28 -38.9 88.85 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 121.475 -0.766 . . . . 0.0 110.01 175.562 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 98.5 mmm -67.45 -41.84 84.07 Favored 'General case' 0 N--CA 1.461 0.089 0 C-N-CA 122.84 0.456 . . . . 0.0 111.423 -177.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 8.7 tt -76.63 -20.97 14.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-N 118.511 0.596 . . . . 0.0 111.054 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -52.48 -51.22 74.92 Favored Pre-proline 0 CA--C 1.544 0.749 0 CA-C-N 119.646 1.112 . . . . 0.0 113.88 -175.055 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -67.24 -26.2 42.26 Favored 'Trans proline' 0 C--N 1.349 0.555 0 CA-C-N 121.925 1.723 . . . . 0.0 112.295 177.277 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.8 t -67.6 -37.95 79.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-N 119.307 0.958 . . . . 0.0 109.359 173.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 90.1 mt -67.13 -36.14 81.23 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-O 118.621 -0.704 . . . . 0.0 110.663 173.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -62.71 -42.91 99.89 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 119.472 1.033 . . . . 0.0 110.642 172.05 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -62.86 -37.18 85.82 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 121.307 -0.871 . . . . 0.0 110.651 176.378 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -65.6 -39.88 92.05 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 123.437 0.695 . . . . 0.0 109.897 176.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -63.7 -42.0 98.04 Favored 'General case' 0 C--N 1.332 -0.152 0 C-N-CA 123.948 0.899 . . . . 0.0 110.586 174.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 62.0 mm-40 -65.96 -28.31 68.81 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 121.361 -0.837 . . . . 0.0 111.536 176.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -86.73 -41.05 14.45 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.238 1.015 . . . . 0.0 112.154 -177.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 75.4 mmm -135.63 -2.81 2.39 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.368 1.067 . . . . 0.0 113.799 -167.035 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.47 44.0 0.74 Allowed Glycine 0 N--CA 1.471 0.98 0 C-N-CA 127.453 2.454 . . . . 0.0 115.166 -169.296 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -147.24 -37.49 0.21 Allowed 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 127.09 2.156 . . . . 0.0 108.621 169.072 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -63.06 -31.3 72.4 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.95 1.3 . . . . 0.0 110.108 168.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -138.29 166.71 23.5 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 126.553 1.941 . . . . 0.0 109.698 170.161 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 15.3 ptpt -109.26 155.39 21.18 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 167.379 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 15.5 mt -105.8 141.31 21.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 171.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 24.1 t -126.02 107.8 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 177.179 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 11.7 mmmm -73.75 137.12 43.76 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 173.23 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 15.6 tt -147.27 115.15 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.436 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 49.0 t0 -83.26 115.85 22.15 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.681 0.793 . . . . 0.0 109.031 -175.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 34.1 m -59.14 -26.72 34.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 123.048 0.539 . . . . 0.0 112.416 -176.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -72.05 -2.0 16.76 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.776 0.831 . . . . 0.0 112.493 -178.156 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -131.78 7.56 4.43 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.878 1.271 . . . . 0.0 110.706 172.111 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 67.4 m-80 -142.01 45.77 1.66 Allowed 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.117 0.967 . . . . 0.0 110.774 -168.369 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.547 ' NE2' ' H ' ' A' ' 61' ' ' GLN . 0.4 OUTLIER -57.38 -45.35 84.56 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.043 0.937 . . . . 0.0 108.768 175.647 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -69.46 -31.84 70.39 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.252 1.421 . . . . 0.0 111.598 -172.457 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -82.09 -49.55 10.06 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 118.411 0.55 . . . . 0.0 109.845 175.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.75 -45.08 91.45 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 119.152 0.887 . . . . 0.0 109.931 -173.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -61.92 -23.55 63.69 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 124.041 0.829 . . . . 0.0 112.778 175.5 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.5 ttmm -59.32 -27.19 65.67 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 118.798 1.299 . . . . 0.0 111.284 175.592 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -117.39 12.39 14.23 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.805 1.242 . . . . 0.0 110.932 179.135 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 69.51 18.66 73.88 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 124.598 1.094 . . . . 0.0 113.719 -179.193 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 86.0 t -84.35 131.57 33.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 176.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.89 27.25 0.48 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.436 1.094 . . . . 0.0 109.741 168.347 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 24.7 m -140.39 153.63 46.42 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 126.882 2.073 . . . . 0.0 106.515 177.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -146.59 159.88 43.11 Favored Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 124.159 0.983 . . . . 0.0 109.728 -169.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -66.93 136.93 33.55 Favored 'Cis proline' 0 N--CA 1.457 -0.628 0 CA-C-N 120.081 1.065 . . . . 0.0 109.501 -11.153 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 52.9 m -132.63 121.17 22.78 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 178.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 82.2 mt -99.34 132.14 44.87 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.4 mp -117.18 129.29 55.85 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 105.444 -2.058 . . . . 0.0 105.444 170.216 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.2 t -93.44 126.4 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 N-CA-C 103.39 -2.819 . . . . 0.0 103.39 169.136 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.6 mp -119.24 159.81 23.36 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 174.264 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -145.84 124.75 12.71 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 173.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.4 t70 44.51 40.15 3.73 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.475 1.51 . . . . 0.0 113.267 174.652 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 98.57 5.96 56.59 Favored Glycine 0 CA--C 1.527 0.813 0 CA-C-O 118.792 -1.004 . . . . 0.0 114.574 169.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 81.9 mm-40 -128.16 144.09 51.09 Favored 'General case' 0 CA--C 1.521 -0.142 0 CA-C-N 119.262 1.531 . . . . 0.0 108.949 177.377 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.7 t -68.26 136.47 26.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 169.23 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 22.9 m -120.15 -20.73 4.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 117.856 -1.068 . . . . 0.0 110.479 174.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.54 164.76 38.24 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 119.711 1.141 . . . . 0.0 111.634 173.379 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 95.8 m -145.3 137.74 25.91 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.546 1.538 . . . . 0.0 108.381 175.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 44.6 m -145.06 153.13 41.13 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.04 1.736 . . . . 0.0 108.176 -178.231 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 40.6 t -133.19 148.21 31.21 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -174.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.83 177.13 46.81 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 123.858 0.742 . . . . 0.0 112.375 176.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -58.99 147.73 33.34 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 124.491 1.116 . . . . 0.0 110.745 178.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -155.23 147.7 17.7 Favored Pre-proline 0 CA--C 1.533 0.311 0 C-N-CA 125.272 1.429 . . . . 0.0 107.686 169.308 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.85 157.87 47.11 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.668 2.245 . . . . 0.0 111.34 -177.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 4.7 ttpt -60.68 -34.97 75.13 Favored 'General case' 0 C--O 1.223 -0.312 0 C-N-CA 123.909 0.884 . . . . 0.0 111.673 -178.304 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -64.67 -42.58 95.27 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 119.425 1.011 . . . . 0.0 111.822 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.14 -43.03 75.2 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 122.828 0.451 . . . . 0.0 110.364 177.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 38.8 tp -67.81 -40.71 83.81 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 119.111 -0.471 . . . . 0.0 110.714 -177.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.5 pp0? -67.79 -32.15 72.51 Favored 'General case' 0 C--O 1.222 -0.393 0 CA-C-O 117.856 -1.068 . . . . 0.0 109.578 175.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -67.34 -43.66 80.98 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 119.436 1.016 . . . . 0.0 109.268 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 58.0 tp -57.05 -51.81 67.8 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.409 0.684 . . . . 0.0 109.681 175.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 28.7 t -58.54 -48.86 84.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 123.461 0.705 . . . . 0.0 110.481 178.199 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -57.44 -46.43 83.6 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 126.501 1.92 . . . . 0.0 110.699 -176.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -59.41 -34.27 72.25 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 118.656 -0.688 . . . . 0.0 112.368 174.007 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 79.8 m-70 -81.2 -18.12 47.27 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 82.3 mt . . . . . 0 C--O 1.249 1.064 0 CA-C-N 119.93 1.241 . . . . 0.0 110.185 178.653 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.6 mtt . . . . . 0 N--CA 1.484 1.267 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -159.22 143.74 15.45 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.786 1.635 . . . . 0.0 106.694 169.061 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 90.8 mt -77.84 147.01 7.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 178.179 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 38.8 t -110.45 165.18 6.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 -174.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.93 134.93 41.12 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 -179.333 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -146.66 170.9 16.0 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.106 0.412 . . . . 0.0 111.299 178.204 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 76.2 p -137.32 174.41 10.63 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.416 1.487 . . . . 0.0 108.111 179.321 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -47.34 -33.27 5.6 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 119.997 1.271 . . . . 0.0 113.11 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 26.8 mp0 -61.4 -33.71 74.14 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.677 1.591 . . . . 0.0 112.875 -179.255 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.5 m -142.82 -1.82 1.08 Allowed 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 -169.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -52.72 -41.45 63.96 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.078 0.951 . . . . 0.0 110.13 175.043 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.6 m -65.45 -27.67 68.68 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.558 0.743 . . . . 0.0 112.433 -178.267 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -78.49 -27.62 46.22 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.788 0.835 . . . . 0.0 111.088 176.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -81.6 -40.95 22.23 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.031 0.532 . . . . 0.0 111.137 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.527 ' HA ' HG21 ' A' ' 20' ' ' VAL . 39.2 p -74.84 -2.91 28.86 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -174.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.0 p -108.71 29.54 7.34 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.762 1.225 . . . . 0.0 112.883 -169.191 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -131.27 -0.34 4.07 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 113.588 0.958 . . . . 0.0 113.588 -175.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 166.15 -166.38 38.72 Favored Glycine 0 C--N 1.336 0.547 0 CA-C-N 119.21 0.913 . . . . 0.0 110.848 -174.043 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 98.3 t -72.4 132.14 33.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 104.829 -2.285 . . . . 0.0 104.829 166.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.527 HG21 ' HA ' ' A' ' 15' ' ' THR . 39.0 t -135.75 118.1 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 -176.062 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 63.1 tp -88.73 97.91 11.4 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 173.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.37 149.37 36.96 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 169.443 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -133.36 98.24 4.18 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 175.327 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -73.97 114.95 12.87 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 172.169 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 7.8 p-90 -138.02 175.03 9.94 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 123.49 0.716 . . . . 0.0 110.754 -169.572 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -152.14 147.16 19.3 Favored Pre-proline 0 CA--C 1.535 0.399 0 C-N-CA 124.563 1.145 . . . . 0.0 107.934 169.195 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.45 -21.02 17.65 Favored 'Trans proline' 0 CA--C 1.532 0.397 0 C-N-CA 122.795 2.33 . . . . 0.0 113.348 -171.087 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -82.74 -8.2 59.6 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 118.685 0.675 . . . . 0.0 112.045 178.363 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 44.3 t -90.32 120.75 31.72 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 -179.433 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -57.03 -58.21 15.78 Favored Glycine 0 CA--C 1.531 1.057 0 CA-C-O 118.707 -1.051 . . . . 0.0 112.086 178.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -50.35 -35.07 43.14 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 123.519 2.812 . . . . 0.0 115.271 177.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 97.8 m -60.51 -33.13 72.19 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 119.451 1.023 . . . . 0.0 112.299 175.088 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 46.2 mtmt -85.04 -34.66 22.25 Favored 'General case' 0 C--N 1.333 -0.12 0 C-N-CA 123.043 0.537 . . . . 0.0 109.914 176.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 26.4 mmt -63.15 -34.96 78.74 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 119.137 0.88 . . . . 0.0 111.593 176.572 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.7 tt -81.19 -7.87 10.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-N 118.729 0.695 . . . . 0.0 111.667 178.061 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.44 -50.78 86.16 Favored Pre-proline 0 CA--C 1.541 0.618 0 O-C-N 120.635 -1.291 . . . . 0.0 112.494 178.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -64.07 -33.02 63.48 Favored 'Trans proline' 0 C--N 1.351 0.681 0 CA-C-N 121.844 1.694 . . . . 0.0 112.283 176.261 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 19.5 t -59.18 -47.76 89.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 119.1 0.864 . . . . 0.0 109.643 173.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 58.9 mt -65.87 -36.89 84.7 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 118.941 -0.552 . . . . 0.0 110.63 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -66.97 -37.6 84.54 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 119.013 0.824 . . . . 0.0 111.303 176.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -68.06 -39.23 83.04 Favored 'General case' 0 C--N 1.331 -0.2 0 O-C-N 121.091 -1.006 . . . . 0.0 110.377 174.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.48 -43.37 97.51 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 176.318 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -61.23 -42.25 98.28 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.839 0.856 . . . . 0.0 110.519 177.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -67.93 -13.44 62.17 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.703 0.801 . . . . 0.0 112.795 177.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -108.46 -32.09 7.55 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.226 1.01 . . . . 0.0 112.457 -178.182 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 19.5 mtt -140.2 2.25 1.88 Allowed 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 117.877 -1.059 . . . . 0.0 113.071 -169.417 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.3 44.63 0.74 Allowed Glycine 0 CA--C 1.532 1.136 0 C-N-CA 126.599 2.047 . . . . 0.0 114.561 -174.029 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -152.43 -40.3 0.11 Allowed 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 128.951 2.9 . . . . 0.0 107.615 171.325 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -63.21 -35.94 82.0 Favored 'General case' 0 C--N 1.343 0.319 0 C-N-CA 124.7 1.2 . . . . 0.0 110.451 169.407 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -133.99 165.29 25.38 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 125.925 1.69 . . . . 0.0 109.75 171.644 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -106.91 152.52 23.81 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.168 1.387 . . . . 0.0 107.758 170.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.2 mt -117.38 136.22 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 N-CA-C 105.582 -2.007 . . . . 0.0 105.582 171.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 58.1 t -131.65 114.51 25.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 -177.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 48.0 mmtt -74.26 144.56 44.59 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 169.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 13.4 tt -147.77 115.59 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 170.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 44.7 t0 -81.03 112.97 18.91 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.961 0.905 . . . . 0.0 109.224 -175.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 30.5 m -62.27 -21.87 27.86 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-O 118.425 -0.798 . . . . 0.0 113.02 -174.148 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -72.3 -6.53 43.82 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 120.012 1.278 . . . . 0.0 112.559 -178.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -126.35 4.21 6.99 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.344 1.058 . . . . 0.0 110.505 169.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -142.4 30.8 1.53 Allowed 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.389 1.076 . . . . 0.0 111.528 -168.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.424 ' CD ' ' H ' ' A' ' 61' ' ' GLN . 3.8 pm0 -55.44 -31.56 62.02 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 124.557 1.143 . . . . 0.0 110.435 169.676 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -65.08 -51.85 59.02 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 124.192 0.997 . . . . 0.0 110.173 176.293 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -67.17 -43.81 81.32 Favored 'General case' 0 C--O 1.222 -0.357 0 O-C-N 121.965 -0.46 . . . . 0.0 109.924 -178.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -61.63 -45.08 95.61 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 118.611 0.642 . . . . 0.0 109.596 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -59.86 -25.32 61.43 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 124.403 1.001 . . . . 0.0 112.903 175.453 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 8.5 ttmm -58.41 -23.37 57.1 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 118.621 1.21 . . . . 0.0 111.509 174.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -122.51 12.74 10.08 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.251 1.42 . . . . 0.0 110.894 178.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 70.88 17.45 75.32 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 124.552 1.073 . . . . 0.0 113.914 -179.255 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 95.4 t -85.55 137.16 21.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 176.297 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 6.6 tpt -153.49 25.14 0.52 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.092 0.957 . . . . 0.0 109.559 168.139 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 20.1 m -140.24 154.99 47.06 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 126.403 1.881 . . . . 0.0 107.297 -178.344 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -145.62 158.26 50.4 Favored Pre-proline 0 CA--C 1.542 0.663 0 C-N-CA 123.743 0.817 . . . . 0.0 110.376 -169.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.14 138.86 43.49 Favored 'Cis proline' 0 C--N 1.35 0.625 0 N-CA-C 109.512 -0.995 . . . . 0.0 109.512 -10.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 53.0 m -131.25 115.93 16.97 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 175.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 90.1 mt -89.86 136.39 33.07 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 176.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.0 mp -122.05 131.06 53.79 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 105.32 -2.104 . . . . 0.0 105.32 169.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 16.1 t -95.21 124.48 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 N-CA-C 103.062 -2.94 . . . . 0.0 103.062 168.322 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.9 mp -116.96 158.63 23.76 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 173.249 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 74.2 tttt -144.77 127.51 16.24 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 174.333 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 29.3 t70 46.83 33.47 2.19 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.248 1.419 . . . . 0.0 113.839 174.227 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 115.72 -7.97 19.71 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-O 118.096 -1.391 . . . . 0.0 115.082 168.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -133.2 146.09 51.18 Favored 'General case' 0 C--N 1.339 0.119 0 CA-C-N 120.071 1.935 . . . . 0.0 110.598 -174.201 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 5.8 p -65.48 137.34 25.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 172.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 34.9 m -123.58 -21.38 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 C-N-CA 125.338 1.455 . . . . 0.0 110.573 177.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -156.64 165.55 35.95 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.727 1.149 . . . . 0.0 110.999 174.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 98.9 m -143.74 149.41 37.08 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.761 1.624 . . . . 0.0 108.746 178.467 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 73.3 m -149.94 155.34 39.8 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.713 1.605 . . . . 0.0 108.306 171.48 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 40.8 t -132.93 144.93 35.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 -174.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.54 175.85 49.55 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 124.153 0.882 . . . . 0.0 111.716 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -62.47 149.3 43.12 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.428 0.691 . . . . 0.0 110.376 176.421 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 42.1 mttm -141.5 145.4 37.54 Favored Pre-proline 0 C--O 1.233 0.215 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 168.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -71.63 158.28 53.89 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 122.253 1.969 . . . . 0.0 109.879 172.112 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.2 tmpt? -62.67 -35.2 78.9 Favored 'General case' 0 N--CA 1.457 -0.117 0 O-C-N 121.686 -0.634 . . . . 0.0 111.601 -176.17 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -68.3 -35.07 77.27 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 119.125 0.875 . . . . 0.0 111.177 -177.194 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.9 -41.37 78.35 Favored 'General case' 0 N--CA 1.454 -0.233 0 O-C-N 121.86 -0.525 . . . . 0.0 110.498 171.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 45.7 tp -64.41 -40.18 95.27 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 119.34 -0.362 . . . . 0.0 110.694 -178.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.8 pp0? -70.97 -32.86 69.84 Favored 'General case' 0 C--O 1.226 -0.144 0 CA-C-N 118.994 0.815 . . . . 0.0 110.363 176.523 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -65.79 -37.17 85.56 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 118.63 0.65 . . . . 0.0 109.445 177.356 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 61.4 tp -63.33 -55.9 20.82 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.282 0.633 . . . . 0.0 110.055 171.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 25.2 t -61.53 -44.0 97.87 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 C-N-CA 123.384 0.673 . . . . 0.0 110.783 -172.141 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.78 -28.15 69.25 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 118.769 0.713 . . . . 0.0 112.326 -170.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 35.2 mtmm -73.37 -27.84 61.7 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 118.914 -0.565 . . . . 0.0 112.462 175.499 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -87.55 -20.57 26.26 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 118.365 -0.826 . . . . 0.0 112.456 -179.494 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 74.2 mt . . . . . 0 C--O 1.249 1.075 0 CA-C-N 119.192 0.905 . . . . 0.0 109.779 174.152 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.165 0 N-CA-C 110.266 -0.272 . . . . 0.0 110.266 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -157.84 148.22 20.63 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.162 0.985 . . . . 0.0 109.446 174.261 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 91.2 mt -75.49 154.54 6.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 125.094 1.357 . . . . 0.0 107.994 173.229 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 25.2 t -124.41 166.32 19.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 125.94 1.696 . . . . 0.0 106.503 -174.401 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 11.2 mtmt -134.94 146.96 49.63 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 174.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -144.95 170.93 15.19 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 123.32 0.648 . . . . 0.0 110.166 175.567 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 80.7 p -133.7 175.62 9.28 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 170.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -49.73 -29.67 8.03 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 119.257 0.935 . . . . 0.0 113.32 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 11.9 mp0 -59.02 -34.25 71.67 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.769 2.027 . . . . 0.0 112.477 179.408 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.4 m -143.17 -2.42 1.0 Allowed 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 114.299 1.222 . . . . 0.0 114.299 -170.003 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -52.73 -38.82 61.39 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 124.027 0.931 . . . . 0.0 111.038 176.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.6 m -68.36 -39.01 81.98 Favored 'General case' 0 N--CA 1.453 -0.323 0 O-C-N 122.187 -0.321 . . . . 0.0 111.23 -177.139 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.12 -44.55 79.63 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 175.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 61.8 mm-40 -63.14 -42.29 99.46 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 122.939 0.495 . . . . 0.0 110.856 -177.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 22.4 p -75.7 3.02 10.54 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -177.16 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 58.2 m -111.8 36.17 3.4 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.758 1.223 . . . . 0.0 111.688 -173.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -128.69 -3.97 5.28 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -179.23 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 162.88 -164.02 35.64 Favored Glycine 0 C--N 1.336 0.549 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 -172.204 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 82.0 t -71.51 133.43 31.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 105.095 -2.187 . . . . 0.0 105.095 166.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 31.9 t -137.5 125.52 31.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 107.065 -1.458 . . . . 0.0 107.065 -177.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 63.6 tp -92.61 98.37 11.39 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 173.592 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.74 145.23 40.99 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 169.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -133.17 96.74 3.81 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 124.993 1.317 . . . . 0.0 107.712 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -75.98 115.29 15.53 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 173.507 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 6.7 p-90 -138.08 175.76 9.29 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 123.47 0.708 . . . . 0.0 110.453 -171.077 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -150.19 143.79 16.91 Favored Pre-proline 0 CA--C 1.534 0.351 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 169.063 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.88 -23.63 21.98 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.334 2.023 . . . . 0.0 113.34 -169.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -81.38 -8.39 59.73 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 118.629 0.65 . . . . 0.0 112.499 178.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 52.7 t -84.86 115.38 22.73 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -178.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -52.35 -56.16 18.69 Favored Glycine 0 CA--C 1.531 1.087 0 CA-C-O 118.685 -1.064 . . . . 0.0 112.231 176.354 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_exo -51.41 -35.38 54.51 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 123.1 2.533 . . . . 0.0 115.195 174.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 97.5 m -63.26 -40.24 96.86 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 119.85 1.205 . . . . 0.0 111.409 172.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -64.65 -39.74 94.23 Favored 'General case' 0 N--CA 1.465 0.288 0 O-C-N 121.364 -0.835 . . . . 0.0 110.2 173.327 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 62.2 mtt -65.62 -38.62 89.95 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 123.088 0.555 . . . . 0.0 111.277 -177.409 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.6 tt -80.43 -18.47 12.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-N 118.819 0.736 . . . . 0.0 111.56 -178.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -52.45 -49.96 82.67 Favored Pre-proline 0 CA--C 1.544 0.749 0 CA-C-N 119.821 1.191 . . . . 0.0 113.567 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -65.69 -30.7 50.49 Favored 'Trans proline' 0 C--N 1.352 0.745 0 CA-C-N 121.873 1.705 . . . . 0.0 112.422 176.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 28.3 t -61.96 -44.48 98.97 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 119.409 1.004 . . . . 0.0 108.98 174.099 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 92.9 mt -64.44 -38.19 90.14 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-O 118.832 -0.604 . . . . 0.0 110.541 177.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -64.67 -40.37 95.3 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.428 1.013 . . . . 0.0 111.555 175.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -69.61 -35.41 75.25 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 121.16 -0.962 . . . . 0.0 110.69 176.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 9.3 tp -66.89 -39.66 87.55 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.434 0.693 . . . . 0.0 110.381 176.066 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -64.16 -42.3 96.8 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 123.778 0.831 . . . . 0.0 110.052 176.286 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -61.8 -31.0 71.19 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 121.629 -0.669 . . . . 0.0 112.229 173.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -85.07 -40.21 17.07 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.792 0.837 . . . . 0.0 112.497 -176.045 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 38.9 mtt -138.2 4.45 2.46 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 114.025 1.121 . . . . 0.0 114.025 -167.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.38 38.85 0.58 Allowed Glycine 0 CA--C 1.534 1.229 0 C-N-CA 126.487 1.994 . . . . 0.0 115.788 -169.403 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -140.69 -43.45 0.4 Allowed 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 125.775 1.63 . . . . 0.0 109.421 169.423 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 52.0 pttt -69.93 -22.74 63.16 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 119.228 -0.415 . . . . 0.0 111.88 170.174 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -136.96 163.67 30.14 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 125.584 1.554 . . . . 0.0 107.287 165.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 57.2 pttt -124.98 159.94 30.08 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 123.536 0.735 . . . . 0.0 109.069 168.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 22.7 mt -111.87 137.67 43.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 105.503 -2.036 . . . . 0.0 105.503 -178.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 87.2 t -127.06 109.57 20.94 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.13 144.93 44.68 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 171.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 14.7 tt -148.42 117.62 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 173.43 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -81.2 116.41 21.08 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -176.577 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 31.0 m -61.78 -26.51 40.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-O 119.061 -0.495 . . . . 0.0 112.031 -177.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -73.4 0.85 11.04 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.917 0.887 . . . . 0.0 112.074 -179.367 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -130.82 0.75 4.33 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.872 1.269 . . . . 0.0 111.035 170.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -141.39 48.66 1.65 Allowed 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.503 1.121 . . . . 0.0 109.769 -168.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.547 ' NE2' ' H ' ' A' ' 61' ' ' GLN . 0.4 OUTLIER -54.14 -44.94 71.82 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.642 1.577 . . . . 0.0 108.803 177.535 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -64.09 -47.51 79.76 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 125.825 1.65 . . . . 0.0 109.884 -175.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.459 ' HA ' ' HE3' ' A' ' 66' ' ' LYS . 0.7 OUTLIER -69.44 -43.18 73.87 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-O 119.298 -0.382 . . . . 0.0 110.153 -176.006 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -61.76 -46.57 89.04 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 119.239 0.927 . . . . 0.0 109.615 176.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -58.22 -26.39 58.74 Favored Glycine 0 CA--C 1.532 1.094 0 C-N-CA 124.165 0.888 . . . . 0.0 113.053 175.187 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.459 ' HE3' ' HA ' ' A' ' 63' ' ' THR . 28.9 ttmt -57.95 -21.5 44.38 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.33 1.452 . . . . 0.0 111.937 177.5 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -127.6 13.17 6.97 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.86 1.264 . . . . 0.0 110.638 178.469 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 69.83 19.02 74.78 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 124.667 1.127 . . . . 0.0 113.664 -178.13 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 96.3 t -82.19 137.93 20.3 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 175.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -153.16 25.02 0.54 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.901 1.28 . . . . 0.0 109.499 168.581 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 20.4 m -139.51 154.82 47.77 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 126.412 1.885 . . . . 0.0 107.32 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -146.18 160.31 43.13 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 124.345 1.058 . . . . 0.0 109.544 -170.579 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -66.86 139.24 44.48 Favored 'Cis proline' 0 C--N 1.35 0.632 0 N-CA-C 109.285 -1.083 . . . . 0.0 109.285 -11.112 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 51.3 m -131.9 118.59 20.01 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 177.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 88.3 mt -96.3 134.27 39.64 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 106.63 -1.619 . . . . 0.0 106.63 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.9 mp -119.54 128.37 53.87 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 104.793 -2.299 . . . . 0.0 104.793 169.394 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 15.5 t -93.58 125.26 46.18 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 103.104 -2.924 . . . . 0.0 103.104 168.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.7 mp -118.36 159.38 23.52 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 173.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 75.9 tttt -144.22 124.23 13.58 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 174.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.7 t70 45.76 36.76 2.93 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.44 1.496 . . . . 0.0 113.423 175.093 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 107.45 -2.28 34.62 Favored Glycine 0 CA--C 1.527 0.806 0 CA-C-O 118.089 -1.395 . . . . 0.0 115.365 168.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -130.39 147.36 52.08 Favored 'General case' 0 C--N 1.339 0.126 0 CA-C-N 120.08 1.94 . . . . 0.0 110.246 -178.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 16.8 t -67.66 137.61 24.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 107.813 -1.181 . . . . 0.0 107.813 175.172 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 29.0 m -119.63 -20.26 4.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 124.827 1.251 . . . . 0.0 110.537 173.456 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -156.85 162.26 39.69 Favored 'General case' 0 C--N 1.346 0.417 0 CA-C-N 119.642 1.11 . . . . 0.0 111.242 173.351 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 87.0 m -143.49 137.92 28.86 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.645 1.578 . . . . 0.0 108.356 174.334 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 29.3 m -145.39 153.22 40.98 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.933 1.693 . . . . 0.0 108.44 -178.165 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 40.9 t -133.07 145.21 34.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -175.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.91 175.52 46.79 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 124.462 1.029 . . . . 0.0 111.844 178.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -62.29 148.5 44.77 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.727 0.811 . . . . 0.0 110.377 176.056 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 46.3 mttm -142.01 146.1 38.95 Favored Pre-proline 0 C--O 1.233 0.195 0 C-N-CA 124.93 1.292 . . . . 0.0 107.733 168.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -72.87 161.21 44.28 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 122.746 2.297 . . . . 0.0 110.266 173.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -56.16 -43.78 78.68 Favored 'General case' 0 C--O 1.223 -0.326 0 CA-C-O 118.626 -0.702 . . . . 0.0 110.683 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -65.65 -37.78 87.49 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 119.162 0.892 . . . . 0.0 111.458 -169.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.53 -43.97 71.93 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 122.904 0.481 . . . . 0.0 110.639 174.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 29.6 tp -67.15 -41.77 85.48 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 122.568 0.347 . . . . 0.0 110.76 -175.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.2 pp0? -70.55 -32.69 70.22 Favored 'General case' 0 N--CA 1.456 -0.138 0 O-C-N 121.798 -0.564 . . . . 0.0 109.866 177.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -63.43 -48.05 79.38 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 176.232 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 51.1 tp -60.17 -44.4 95.07 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 122.824 0.45 . . . . 0.0 110.696 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 26.3 t -58.06 -47.48 86.76 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 175.378 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.71 -25.09 67.79 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 119.078 0.854 . . . . 0.0 112.675 -177.284 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -66.02 -23.65 66.6 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 119.048 0.84 . . . . 0.0 112.479 169.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -107.85 -16.52 14.29 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 119.478 1.035 . . . . 0.0 113.242 -174.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 80.7 mt . . . . . 0 C--O 1.249 1.068 0 CA-C-N 119.484 1.038 . . . . 0.0 109.681 172.248 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.9 tmm? . . . . . 0 N--CA 1.478 0.945 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -156.08 144.56 20.07 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 169.41 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 91.8 mt -75.51 153.87 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 N-CA-C 107.3 -1.371 . . . . 0.0 107.3 174.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 36.7 t -120.03 170.68 9.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 -174.015 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 27.8 mtpt -137.31 149.84 47.34 Favored 'General case' 0 CA--C 1.518 -0.268 0 O-C-N 120.732 -1.23 . . . . 0.0 108.679 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -151.01 170.36 19.54 Favored 'General case' 0 C--N 1.331 -0.196 0 O-C-N 123.489 0.493 . . . . 0.0 111.66 176.142 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.3 p -136.51 174.11 10.97 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.863 1.665 . . . . 0.0 107.205 172.163 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -47.08 -33.3 4.83 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 119.917 1.235 . . . . 0.0 113.243 -179.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 26.9 mp0 -60.68 -31.45 70.71 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.075 1.75 . . . . 0.0 113.109 -179.469 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.3 m -140.41 -2.57 1.41 Allowed 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -170.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -54.79 -37.94 66.68 Favored 'General case' 0 CA--C 1.528 0.098 0 C-N-CA 124.191 0.997 . . . . 0.0 111.03 178.411 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.4 p -63.09 -50.53 70.18 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.653 0.781 . . . . 0.0 110.788 179.346 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.31 -44.44 92.57 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 122.972 0.509 . . . . 0.0 110.159 178.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -66.58 -37.76 85.6 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-O 119.2 -0.428 . . . . 0.0 111.403 -177.528 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.517 ' HA ' HG21 ' A' ' 20' ' ' VAL . 34.2 p -80.21 3.35 21.02 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 118.607 0.64 . . . . 0.0 112.451 -178.514 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 51.2 m -111.73 32.78 5.19 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.598 1.159 . . . . 0.0 112.346 -172.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -132.58 -0.44 3.55 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -177.243 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 165.92 -167.09 39.01 Favored Glycine 0 C--N 1.334 0.452 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 -174.199 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 97.4 t -71.91 133.3 32.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 104.56 -2.385 . . . . 0.0 104.56 166.108 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.517 HG21 ' HA ' ' A' ' 15' ' ' THR . 38.6 t -136.49 121.77 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 -176.307 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 56.6 tp -96.45 98.0 9.89 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 173.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.2 156.16 33.87 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 169.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -139.38 100.04 3.89 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 125.382 1.473 . . . . 0.0 107.547 179.124 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -75.05 115.52 14.76 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 169.232 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 8.6 p-90 -137.0 174.72 10.31 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 123.554 0.742 . . . . 0.0 110.237 -174.089 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -153.96 148.02 18.96 Favored Pre-proline 0 CA--C 1.535 0.402 0 N-CA-C 107.753 -1.202 . . . . 0.0 107.753 169.362 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -73.52 -22.46 18.31 Favored 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 122.574 2.183 . . . . 0.0 113.22 -169.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -79.43 -5.55 54.94 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 118.623 0.647 . . . . 0.0 112.356 179.047 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 45.2 t -95.12 110.51 22.45 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 -175.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -51.03 -53.21 27.97 Favored Glycine 0 CA--C 1.533 1.215 0 CA-C-O 118.801 -0.999 . . . . 0.0 112.74 176.1 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_exo -52.34 -34.19 59.32 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 122.858 2.372 . . . . 0.0 114.846 174.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 80.9 m -67.39 -39.8 85.6 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 120.185 1.357 . . . . 0.0 111.146 172.296 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -59.88 -34.34 73.03 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 121.051 -1.031 . . . . 0.0 110.262 173.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 26.2 mmt -73.88 -37.12 64.83 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 123.043 0.537 . . . . 0.0 111.48 177.366 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.2 tp -70.68 -23.27 23.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 119.408 1.004 . . . . 0.0 110.935 179.068 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.81 -54.95 46.28 Favored Pre-proline 0 CA--C 1.543 0.701 0 CA-C-O 117.775 -1.107 . . . . 0.0 113.006 -177.456 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -66.55 -28.41 45.29 Favored 'Trans proline' 0 C--N 1.349 0.576 0 CA-C-N 121.703 1.644 . . . . 0.0 112.499 177.35 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 97.8 t -62.87 -43.61 99.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 119.607 1.094 . . . . 0.0 109.335 174.133 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 89.5 mt -69.28 -35.03 75.63 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-O 118.585 -0.722 . . . . 0.0 111.112 178.159 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -65.51 -41.23 93.39 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 119.526 1.057 . . . . 0.0 110.883 174.546 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -59.43 -45.23 92.13 Favored 'General case' 0 N--CA 1.455 -0.196 0 O-C-N 121.479 -0.763 . . . . 0.0 110.4 171.386 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.2 tp -64.36 -38.93 92.76 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 122.869 0.468 . . . . 0.0 110.698 -178.142 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -65.3 -41.78 93.72 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.524 0.73 . . . . 0.0 110.611 177.121 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -66.91 -36.3 81.94 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 122.067 -0.396 . . . . 0.0 111.252 176.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -73.96 -49.66 23.58 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.231 1.013 . . . . 0.0 111.013 -175.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 7.9 ptp -146.06 10.53 1.17 Allowed 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 -167.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.68 52.02 1.54 Allowed Glycine 0 CA--C 1.526 0.764 0 C-N-CA 126.53 2.014 . . . . 0.0 113.156 -178.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -148.66 -39.42 0.16 Allowed 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 128.229 2.612 . . . . 0.0 107.697 169.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 58.7 mtmt -65.95 -29.71 70.16 Favored 'General case' 0 C--N 1.345 0.375 0 C-N-CA 123.58 0.752 . . . . 0.0 110.68 168.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -131.96 162.65 30.18 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 125.138 1.375 . . . . 0.0 110.324 168.812 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -99.28 154.91 17.8 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.018 1.327 . . . . 0.0 107.538 169.3 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 12.8 mt -120.83 137.37 54.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 N-CA-C 105.704 -1.961 . . . . 0.0 105.704 170.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 84.6 t -133.61 114.1 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-N 119.048 0.84 . . . . 0.0 108.963 -174.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 56.7 mmtt -73.73 143.29 46.18 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 121.853 -0.529 . . . . 0.0 109.845 170.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 13.0 tt -151.35 149.68 13.86 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 N-CA-C 107.699 -1.222 . . . . 0.0 107.699 170.408 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -123.33 118.04 26.62 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 120.958 -1.089 . . . . 0.0 109.808 -169.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 30.5 m -55.13 -29.48 22.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 124.233 1.013 . . . . 0.0 113.027 -174.538 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -69.76 -9.09 53.24 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.874 0.869 . . . . 0.0 112.424 -175.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -132.07 6.05 4.22 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.838 1.255 . . . . 0.0 110.953 176.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 67.1 m-80 -141.21 46.7 1.72 Allowed 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.957 0.903 . . . . 0.0 110.679 -168.599 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.515 ' NE2' ' H ' ' A' ' 61' ' ' GLN . 0.5 OUTLIER -55.09 -43.94 74.45 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.908 0.883 . . . . 0.0 108.947 173.616 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -68.38 -31.73 71.31 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 125.48 1.512 . . . . 0.0 111.63 -171.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -84.68 -47.54 10.37 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 118.31 0.504 . . . . 0.0 109.918 176.579 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -64.22 -45.17 89.4 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 119.216 0.916 . . . . 0.0 109.904 -175.081 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -61.1 -24.97 63.77 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 124.009 0.814 . . . . 0.0 112.409 176.194 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.4 ttmm -58.99 -26.44 64.5 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 118.348 1.074 . . . . 0.0 111.533 176.009 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -114.83 10.47 16.48 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.606 1.162 . . . . 0.0 111.146 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 71.15 31.43 66.45 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 123.649 0.642 . . . . 0.0 112.418 -178.173 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 98.1 t -111.05 138.27 40.03 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 C-N-CA 125.073 1.349 . . . . 0.0 107.835 -178.383 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 8.6 tpt -153.97 30.75 0.45 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.034 0.934 . . . . 0.0 108.989 167.273 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 19.3 m -139.21 158.8 43.54 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 126.401 1.88 . . . . 0.0 107.671 -178.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -143.43 158.62 57.17 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 123.956 0.903 . . . . 0.0 110.013 -173.285 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -66.75 138.36 39.85 Favored 'Cis proline' 0 N--CA 1.457 -0.631 0 N-CA-C 108.786 -1.275 . . . . 0.0 108.786 -11.276 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 99.1 m -132.31 112.73 12.46 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 174.414 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 95.6 mt -83.46 141.77 31.43 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 175.421 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -128.8 127.27 41.63 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 104.133 -2.543 . . . . 0.0 104.133 -178.607 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.0 t -112.57 121.72 65.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 104.235 -2.506 . . . . 0.0 104.235 -176.66 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.2 mp -127.46 159.32 34.87 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 77.2 tttt -146.08 124.15 12.12 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 177.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.0 t70 45.16 35.94 1.91 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.438 1.495 . . . . 0.0 113.441 175.112 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 105.54 1.71 40.48 Favored Glycine 0 CA--C 1.527 0.794 0 CA-C-O 118.092 -1.393 . . . . 0.0 115.074 169.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -130.69 145.2 51.87 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 120.082 1.941 . . . . 0.0 109.921 179.068 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.7 p -69.0 140.67 18.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 C-N-CA 123.769 0.827 . . . . 0.0 109.19 174.01 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 35.5 m -128.02 -17.95 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 125.69 1.596 . . . . 0.0 110.681 178.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -160.1 167.28 28.14 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 120.389 1.45 . . . . 0.0 111.545 169.773 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 52.7 m -145.4 141.53 28.52 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.054 1.742 . . . . 0.0 107.549 169.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 14.7 m -145.84 146.55 31.18 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 124.215 1.006 . . . . 0.0 108.631 -178.094 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 39.8 t -127.41 148.8 32.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 -170.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.99 172.55 39.57 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 124.185 0.897 . . . . 0.0 111.589 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -61.22 153.75 25.31 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.225 0.61 . . . . 0.0 110.762 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -153.41 148.25 19.65 Favored Pre-proline 0 CA--C 1.533 0.301 0 C-N-CA 125.082 1.353 . . . . 0.0 107.677 169.772 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.51 162.41 41.47 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.644 2.23 . . . . 0.0 111.013 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -53.97 -43.8 70.23 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-O 118.574 -0.727 . . . . 0.0 110.952 177.245 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -63.59 -42.14 98.3 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 119.059 0.845 . . . . 0.0 111.369 -169.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.58 -41.71 88.11 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 123.096 0.558 . . . . 0.0 110.854 175.425 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 30.9 tp -68.1 -41.95 81.02 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 119.549 -0.262 . . . . 0.0 110.911 -176.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.7 pp0? -71.15 -30.81 66.92 Favored 'General case' 0 N--CA 1.457 -0.113 0 CA-C-N 118.512 0.596 . . . . 0.0 110.044 177.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -63.1 -50.03 72.12 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 174.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 66.9 tp -58.04 -46.54 85.19 Favored 'General case' 0 C--N 1.334 -0.09 0 C-N-CA 123.723 0.809 . . . . 0.0 110.31 -178.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 42.9 t -63.7 -49.08 83.73 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-O 118.561 -0.733 . . . . 0.0 109.783 179.272 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.05 -26.89 68.76 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 119.725 1.148 . . . . 0.0 112.268 -176.551 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -68.22 -26.83 65.91 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 118.323 -0.846 . . . . 0.0 112.384 171.019 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 77.0 m-70 -95.23 -19.84 19.7 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 119.571 1.078 . . . . 0.0 113.368 178.143 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 61.3 mt . . . . . 0 C--O 1.248 0.982 0 CA-C-N 119.781 1.173 . . . . 0.0 109.745 175.296 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.8 ttp . . . . . 0 N--CA 1.478 0.963 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -156.87 147.17 21.21 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.891 1.677 . . . . 0.0 106.539 169.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 90.5 mt -75.6 145.05 11.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 40.9 t -104.38 167.58 2.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 -174.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 5.9 mptt -137.13 138.51 40.37 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 -178.366 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -144.91 170.22 16.55 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.068 0.461 . . . . 0.0 111.656 -179.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 70.8 p -137.08 173.5 11.63 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.725 1.61 . . . . 0.0 107.48 177.458 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -49.75 -32.43 13.7 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 119.836 1.198 . . . . 0.0 112.979 -178.2 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 26.2 mp0 -63.82 -30.75 71.81 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.098 1.759 . . . . 0.0 112.778 -178.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.6 m -138.47 -4.93 1.61 Allowed 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 -169.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -54.92 -37.48 66.43 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 124.039 0.935 . . . . 0.0 110.821 177.398 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.3 p -62.94 -50.98 68.7 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 123.861 0.865 . . . . 0.0 110.835 178.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.22 -44.29 92.3 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.019 0.527 . . . . 0.0 110.081 178.487 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -66.03 -38.67 89.0 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-O 119.237 -0.411 . . . . 0.0 111.294 -177.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.551 ' HA ' HG21 ' A' ' 20' ' ' VAL . 28.8 p -78.62 1.41 22.79 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 118.528 0.604 . . . . 0.0 112.58 -179.08 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 50.4 m -110.29 32.61 5.02 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.57 1.148 . . . . 0.0 112.27 -172.368 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -132.17 -0.17 3.73 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -178.194 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 165.51 -167.69 39.1 Favored Glycine 0 C--N 1.336 0.54 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 -174.523 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 97.4 t -71.24 134.23 30.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 N-CA-C 104.687 -2.338 . . . . 0.0 104.687 166.21 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.551 HG21 ' HA ' ' A' ' 15' ' ' THR . 40.4 t -136.8 120.85 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 -175.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 61.6 tp -95.35 96.91 9.45 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 173.444 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.24 157.76 32.28 Favored 'General case' 0 N--CA 1.444 -0.732 0 O-C-N 121.831 -0.543 . . . . 0.0 109.7 169.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -139.92 99.26 3.65 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 125.558 1.543 . . . . 0.0 107.436 178.399 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -73.96 117.14 15.4 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 169.535 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 8.2 p-90 -138.2 173.4 11.65 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 123.396 0.678 . . . . 0.0 110.883 -174.363 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -153.47 149.13 20.71 Favored Pre-proline 0 C--O 1.238 0.46 0 C-N-CA 126.416 1.886 . . . . 0.0 105.957 169.007 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -75.68 -21.97 14.11 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.695 2.263 . . . . 0.0 113.251 -169.237 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -78.32 -7.84 57.71 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 118.541 0.609 . . . . 0.0 112.521 -176.141 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 37.5 t -100.16 108.78 20.99 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 -178.437 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -46.47 -51.21 12.53 Favored Glycine 0 CA--C 1.533 1.215 0 CA-C-O 118.425 -1.208 . . . . 0.0 113.767 -178.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -49.81 -31.51 26.41 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 123.443 2.762 . . . . 0.0 115.885 176.107 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 61.6 m -62.5 -40.94 98.34 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 120.409 1.459 . . . . 0.0 110.782 173.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -67.88 -37.75 82.18 Favored 'General case' 0 N--CA 1.462 0.144 0 O-C-N 121.729 -0.607 . . . . 0.0 109.933 175.536 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 64.3 mtt -65.66 -40.5 92.5 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 118.202 0.455 . . . . 0.0 111.165 -178.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 10.1 tt -80.87 -19.03 11.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 118.666 0.667 . . . . 0.0 111.619 -177.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -52.35 -51.53 71.55 Favored Pre-proline 0 CA--C 1.543 0.686 0 CA-C-O 117.529 -1.224 . . . . 0.0 113.632 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.1 -30.45 55.87 Favored 'Trans proline' 0 C--N 1.351 0.683 0 CA-C-N 121.874 1.705 . . . . 0.0 112.037 177.274 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 14.0 t -63.6 -44.61 98.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 119.126 0.875 . . . . 0.0 109.157 176.034 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 78.5 mt -65.59 -36.38 83.58 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 118.917 -0.563 . . . . 0.0 110.731 177.346 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -66.05 -38.88 89.47 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 119.266 0.939 . . . . 0.0 111.203 175.3 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -67.38 -37.52 83.27 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 121.087 -1.008 . . . . 0.0 110.344 174.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 16.0 tp -66.34 -39.11 89.01 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.348 0.659 . . . . 0.0 110.551 177.038 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -65.1 -40.07 94.03 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.014 0.926 . . . . 0.0 110.708 175.665 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -66.84 -36.45 82.37 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.942 -0.474 . . . . 0.0 111.306 175.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -72.35 -53.47 12.25 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.921 0.889 . . . . 0.0 110.987 -178.357 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 11.6 ptp -144.44 15.63 1.64 Allowed 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 114.212 1.189 . . . . 0.0 114.212 -167.126 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.35 53.94 1.14 Allowed Glycine 0 CA--C 1.529 0.965 0 C-N-CA 126.124 1.821 . . . . 0.0 112.092 175.612 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -153.51 -40.93 0.1 Allowed 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 129.41 3.084 . . . . 0.0 107.281 172.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -63.95 -35.24 80.03 Favored 'General case' 0 C--N 1.343 0.311 0 C-N-CA 124.04 0.936 . . . . 0.0 110.176 168.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -131.04 165.34 23.43 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 125.34 1.456 . . . . 0.0 110.473 169.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -102.06 154.64 18.8 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 169.229 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.6 mt -120.58 137.45 54.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 170.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 66.7 t -134.02 115.94 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-N 119.2 0.909 . . . . 0.0 109.502 -175.157 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 65.7 mmtt -74.89 145.04 43.05 Favored 'General case' 0 C--O 1.235 0.303 0 O-C-N 121.233 -0.917 . . . . 0.0 109.783 169.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 12.4 tt -151.33 141.7 15.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 169.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -98.49 128.08 44.69 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 121.488 -0.757 . . . . 0.0 110.063 -173.315 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 15.9 m -67.99 -27.42 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 114.51 1.3 . . . . 0.0 114.51 -173.036 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -80.62 -41.32 24.09 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 120.072 1.305 . . . . 0.0 109.41 -175.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -71.75 -26.26 62.38 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.413 0.685 . . . . 0.0 111.18 175.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 -128.39 43.43 3.14 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.735 1.214 . . . . 0.0 109.864 -170.408 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.79 -39.67 62.55 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 126.697 1.999 . . . . 0.0 111.049 176.721 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -64.02 -46.02 86.33 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 123.615 0.766 . . . . 0.0 110.335 176.316 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.539 ' HA ' ' HE3' ' A' ' 66' ' ' LYS . 0.3 OUTLIER -69.89 -41.93 74.09 Favored 'General case' 0 C--O 1.222 -0.369 0 CA-C-N 118.69 0.677 . . . . 0.0 110.74 -175.979 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.77 -45.16 93.99 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 119.307 0.958 . . . . 0.0 109.273 176.066 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -57.53 -27.9 59.01 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 123.838 0.733 . . . . 0.0 112.778 174.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.539 ' HE3' ' HA ' ' A' ' 63' ' ' THR . 25.0 ttmt -59.51 -19.94 51.83 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.458 1.503 . . . . 0.0 111.96 178.55 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -125.3 12.41 8.19 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.659 1.184 . . . . 0.0 110.915 179.288 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 71.52 32.6 64.52 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 123.713 0.673 . . . . 0.0 112.722 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 90.8 t -111.18 139.05 36.96 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 C-N-CA 125.054 1.342 . . . . 0.0 108.003 -178.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 8.6 tpt -155.26 30.29 0.39 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.408 1.083 . . . . 0.0 108.989 167.524 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 18.2 m -136.96 158.96 43.27 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 126.181 1.792 . . . . 0.0 107.919 -177.466 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -144.8 155.57 56.01 Favored Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 123.354 0.662 . . . . 0.0 111.152 -170.293 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -69.73 140.14 58.67 Favored 'Cis proline' 0 N--CA 1.458 -0.599 0 N-CA-C 108.653 -1.326 . . . . 0.0 108.653 -11.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 96.3 m -130.68 113.11 13.76 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 176.195 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 94.4 mt -81.18 144.71 31.43 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 175.028 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.9 126.4 36.06 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 103.949 -2.611 . . . . 0.0 103.949 -179.036 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 5.2 t -109.52 122.33 63.96 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.42 0 N-CA-C 104.227 -2.509 . . . . 0.0 104.227 -179.067 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.4 mp -125.86 159.8 31.55 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 179.218 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -145.41 126.44 14.6 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 175.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.0 t70 44.41 35.65 1.39 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.368 1.467 . . . . 0.0 113.55 174.401 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 106.48 0.19 37.35 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-O 118.004 -1.442 . . . . 0.0 115.07 169.414 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -130.69 145.82 52.02 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-N 120.13 1.965 . . . . 0.0 110.216 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 10.0 p -70.03 140.98 17.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 C-N-CA 123.845 0.858 . . . . 0.0 109.435 174.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 32.5 m -129.94 -17.61 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 125.734 1.613 . . . . 0.0 110.788 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -160.29 168.56 25.05 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 120.422 1.465 . . . . 0.0 111.696 169.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 53.9 m -146.84 141.85 27.06 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.072 1.749 . . . . 0.0 108.023 170.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 18.7 m -146.16 152.86 39.94 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 124.77 1.228 . . . . 0.0 108.864 -177.513 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 32.8 t -130.15 148.85 33.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-N 119.155 0.888 . . . . 0.0 108.691 -171.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 80.62 179.72 53.0 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 124.098 0.856 . . . . 0.0 111.994 176.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -62.07 150.69 37.58 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.773 0.829 . . . . 0.0 110.759 177.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.41 147.74 29.17 Favored Pre-proline 0 CA--C 1.531 0.233 0 C-N-CA 124.893 1.277 . . . . 0.0 107.739 167.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -74.1 160.71 42.27 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 123.207 2.604 . . . . 0.0 110.452 174.486 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 75.3 tttt -55.18 -41.32 71.74 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 118.816 -0.612 . . . . 0.0 110.515 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -59.74 -41.7 91.54 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 118.516 0.598 . . . . 0.0 110.871 -174.273 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.14 -43.36 87.3 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.03 0.532 . . . . 0.0 110.792 176.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 61.1 mt -64.29 -45.88 86.06 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 119.141 -0.457 . . . . 0.0 109.945 -179.158 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 2.9 pp0? -71.12 -27.57 63.68 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.799 0.727 . . . . 0.0 110.676 -177.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -67.72 -50.16 58.89 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 173.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 60.9 tp -58.26 -47.47 83.48 Favored 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 123.235 0.614 . . . . 0.0 109.975 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 44.4 t -62.66 -46.94 95.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 CA-C-O 117.995 -1.002 . . . . 0.0 109.696 -179.448 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -60.24 -34.71 74.06 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 120.073 1.306 . . . . 0.0 111.315 -177.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 48.2 mmtm -71.07 -10.09 59.16 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 118.045 -0.978 . . . . 0.0 113.468 175.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -108.17 -17.03 14.13 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 119.982 1.264 . . . . 0.0 113.383 172.032 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 64.8 mt . . . . . 0 C--O 1.25 1.109 0 CA-C-N 120.239 1.381 . . . . 0.0 109.761 174.293 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.9 mmt . . . . . 0 N--CA 1.486 1.335 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.76 159.71 43.11 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 125.618 1.567 . . . . 0.0 108.405 175.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 79.5 mt -69.08 153.92 8.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 124.945 1.298 . . . . 0.0 108.562 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 31.5 t -114.34 167.56 7.0 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 125.939 1.696 . . . . 0.0 107.104 -174.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 9.2 mtmt -132.75 147.79 52.32 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 176.745 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -148.59 169.7 19.75 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.545 0.738 . . . . 0.0 110.426 176.197 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 77.8 p -135.53 174.94 10.06 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.562 1.145 . . . . 0.0 107.918 171.115 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -47.7 -31.03 4.29 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 119.964 1.256 . . . . 0.0 112.928 178.15 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 12.9 mp0 -58.76 -33.33 70.17 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.374 1.87 . . . . 0.0 112.791 179.37 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.7 m -142.95 -3.09 0.99 Allowed 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 114.217 1.192 . . . . 0.0 114.217 -169.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -53.8 -37.45 63.53 Favored 'General case' 0 C--O 1.23 0.065 0 C-N-CA 124.435 1.094 . . . . 0.0 111.105 179.407 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.4 p -61.53 -53.63 53.8 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.808 0.843 . . . . 0.0 110.658 179.282 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.25 -43.76 88.01 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.018 0.527 . . . . 0.0 110.28 179.15 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -65.97 -35.51 80.79 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 119.081 -0.485 . . . . 0.0 111.746 -177.619 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.537 ' HA ' HG21 ' A' ' 20' ' ' VAL . 32.1 p -85.75 1.14 50.75 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -178.16 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 40.5 m -115.24 32.48 6.02 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -169.73 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -144.02 17.54 1.76 Allowed 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 177.299 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 172.6 -169.23 42.37 Favored Glycine 0 C--N 1.339 0.711 0 O-C-N 121.329 -0.857 . . . . 0.0 112.151 174.548 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 1.8 t -78.65 134.35 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 104.106 -2.553 . . . . 0.0 104.106 168.436 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.537 HG21 ' HA ' ' A' ' 15' ' ' THR . 25.5 t -139.62 138.4 39.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 -172.836 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 42.6 tp -114.02 97.6 6.47 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 173.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.95 157.55 33.01 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 169.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -138.31 99.4 3.84 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 125.27 1.428 . . . . 0.0 107.259 177.316 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -72.5 115.66 12.03 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 169.661 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 9.3 p-90 -137.19 175.53 9.53 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.704 0.801 . . . . 0.0 110.373 -172.047 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -152.3 146.58 18.55 Favored Pre-proline 0 CA--C 1.535 0.399 0 C-N-CA 124.491 1.117 . . . . 0.0 107.994 169.227 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.25 -19.3 17.46 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.801 2.334 . . . . 0.0 113.299 -171.31 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -82.36 -7.47 59.63 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 121.537 -0.727 . . . . 0.0 111.961 177.566 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 48.6 t -92.07 120.76 32.99 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -57.0 -58.32 15.19 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-O 118.656 -1.08 . . . . 0.0 111.925 177.626 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -49.63 -36.33 40.5 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 123.653 2.902 . . . . 0.0 115.157 177.424 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 95.8 m -60.16 -36.66 78.07 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 119.429 1.013 . . . . 0.0 112.313 175.029 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 46.3 mtmt -80.48 -35.35 34.93 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-O 118.986 -0.53 . . . . 0.0 109.893 177.351 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 26.4 mmt -64.36 -39.23 93.47 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 118.967 0.803 . . . . 0.0 111.304 178.063 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 8.4 tt -76.46 -13.21 14.6 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 CA-C-N 118.824 0.738 . . . . 0.0 111.349 179.308 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -57.17 -52.22 75.79 Favored Pre-proline 0 CA--C 1.541 0.631 0 CA-C-O 117.515 -1.231 . . . . 0.0 113.21 -177.104 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.71 -28.86 60.06 Favored 'Trans proline' 0 C--N 1.351 0.685 0 CA-C-N 121.873 1.704 . . . . 0.0 112.418 176.448 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 10.5 t -65.08 -44.17 95.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 177.021 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 61.6 mt -68.12 -33.22 74.1 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 118.056 -0.973 . . . . 0.0 111.138 175.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -65.48 -43.76 89.23 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 120.036 1.289 . . . . 0.0 110.578 174.457 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -59.79 -42.57 93.69 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 118.77 0.714 . . . . 0.0 110.031 175.427 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 37.7 tp -65.0 -39.17 93.06 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 122.529 0.332 . . . . 0.0 110.903 178.24 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -64.43 -41.86 96.34 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 124.566 1.147 . . . . 0.0 110.477 178.301 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 65.0 mm-40 -65.73 -26.07 67.58 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.634 -0.666 . . . . 0.0 111.578 176.216 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -91.98 -31.08 15.75 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.749 1.22 . . . . 0.0 112.908 -177.155 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.4 ' HA ' ' HE3' ' A' ' 49' ' ' LYS . 19.3 mmt -126.07 -11.26 6.49 Favored 'General case' 0 C--O 1.226 -0.171 0 CA-C-O 117.697 -1.144 . . . . 0.0 113.483 -168.624 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -45.54 -35.14 5.37 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 126.287 1.899 . . . . 0.0 115.923 -170.024 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -76.06 -37.97 57.64 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.04 0.936 . . . . 0.0 111.519 -178.599 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.4 ' HE3' ' HA ' ' A' ' 46' ' ' MET . 29.2 mtmt -83.79 -27.46 28.81 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 125.27 1.428 . . . . 0.0 110.444 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -151.14 122.18 7.68 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 124.542 1.137 . . . . 0.0 109.847 -170.444 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -74.28 151.92 39.77 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.911 0.885 . . . . 0.0 108.978 174.521 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.9 mt -122.46 134.02 66.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 N-CA-C 105.985 -1.858 . . . . 0.0 105.985 172.16 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 41.1 t -131.6 113.26 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -171.196 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 60.3 mmtt -74.2 143.17 45.3 Favored 'General case' 0 C--O 1.235 0.319 0 O-C-N 121.505 -0.747 . . . . 0.0 109.557 170.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 11.7 tt -150.13 121.38 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 173.062 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -86.86 116.85 25.21 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 121.393 -0.817 . . . . 0.0 109.384 -174.036 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 29.9 m -58.69 -28.02 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-N 118.674 0.67 . . . . 0.0 112.713 -176.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -71.99 -7.96 51.74 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 119.26 0.936 . . . . 0.0 112.059 -177.457 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -123.23 2.38 9.18 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.3 1.44 . . . . 0.0 110.513 173.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -146.54 36.45 0.98 Allowed 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 124.683 1.193 . . . . 0.0 111.026 -168.654 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.6 pm0 -58.22 -30.41 66.46 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.333 0.653 . . . . 0.0 110.236 173.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 59.3 mp0 -62.16 -55.08 32.35 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.406 1.482 . . . . 0.0 109.685 174.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.86 -43.91 74.41 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 119.377 -0.344 . . . . 0.0 110.164 -174.44 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.83 -45.4 92.79 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 118.71 0.686 . . . . 0.0 109.583 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -59.6 -25.34 60.85 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.122 0.868 . . . . 0.0 112.748 175.279 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 9.9 ttmm -59.44 -23.54 62.77 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.575 1.187 . . . . 0.0 111.405 175.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -118.8 11.07 12.55 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.162 1.385 . . . . 0.0 110.984 178.744 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 68.62 20.53 74.03 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 124.23 0.919 . . . . 0.0 113.346 -176.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 91.0 t -90.52 133.67 31.65 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 177.413 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 7.2 tpt -154.7 30.73 0.42 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.778 0.831 . . . . 0.0 109.621 167.171 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 45.1 m -135.36 156.79 48.36 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 126.36 1.864 . . . . 0.0 106.834 172.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -145.16 158.27 52.07 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 123.935 0.894 . . . . 0.0 109.992 -170.309 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -67.7 136.78 35.11 Favored 'Cis proline' 0 C--N 1.349 0.591 0 CA-C-N 120.085 1.066 . . . . 0.0 109.784 -10.299 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 70.4 m -132.26 113.95 13.85 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 176.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 88.5 mt -82.39 145.5 29.85 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 175.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -129.61 124.7 34.38 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 104.263 -2.495 . . . . 0.0 104.263 179.387 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.5 t -106.69 124.34 62.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 N-CA-C 104.031 -2.581 . . . . 0.0 104.031 -178.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.7 mp -127.16 160.21 31.93 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.517 1.127 . . . . 0.0 108.102 178.412 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -148.18 128.03 13.48 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 174.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.0 t70 42.64 38.3 1.26 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.211 1.404 . . . . 0.0 113.276 179.231 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.72 6.67 60.62 Favored Glycine 0 CA--C 1.527 0.842 0 CA-C-O 118.777 -1.013 . . . . 0.0 114.726 171.175 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -121.82 143.05 49.63 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 119.333 1.567 . . . . 0.0 108.881 176.177 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 78.1 t -67.24 139.4 21.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 169.236 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.1 m -124.95 -21.55 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 CA-C-O 117.513 -1.232 . . . . 0.0 110.484 174.258 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -158.41 166.67 31.67 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 120.288 1.404 . . . . 0.0 111.846 174.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 72.4 m -144.24 139.5 28.71 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.89 1.676 . . . . 0.0 107.569 169.651 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 20.2 m -146.13 153.18 40.39 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.588 1.155 . . . . 0.0 109.035 -174.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 30.7 t -131.7 150.53 34.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 CA-C-N 119.04 0.836 . . . . 0.0 108.993 -170.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.8 169.17 45.16 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 124.693 1.139 . . . . 0.0 112.76 170.01 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -62.16 134.95 57.24 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 172.118 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 33.2 mttp -144.34 146.99 35.15 Favored Pre-proline 0 C--O 1.233 0.215 0 C-N-CA 125.364 1.466 . . . . 0.0 107.759 176.483 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -75.28 157.38 41.62 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 123.007 2.471 . . . . 0.0 110.96 -176.034 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.7 tmpt? -60.47 -33.67 72.91 Favored 'General case' 0 C--O 1.224 -0.266 0 O-C-N 121.698 -0.626 . . . . 0.0 111.241 -175.258 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -62.58 -37.16 85.13 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 118.967 0.803 . . . . 0.0 111.823 178.196 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -72.27 -40.63 67.47 Favored 'General case' 0 N--CA 1.452 -0.35 0 O-C-N 121.85 -0.531 . . . . 0.0 110.655 174.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 52.7 mt -65.89 -41.37 91.61 Favored 'General case' 0 N--CA 1.455 -0.201 0 O-C-N 122.057 -0.402 . . . . 0.0 110.253 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.7 pp0? -69.95 -30.17 67.48 Favored 'General case' 0 C--O 1.227 -0.081 0 CA-C-N 118.932 0.787 . . . . 0.0 110.272 178.001 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -63.86 -49.98 70.63 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 174.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 65.3 tp -57.63 -43.76 85.06 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.804 0.841 . . . . 0.0 110.726 178.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 24.7 t -61.94 -53.56 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 177.543 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.34 -26.16 68.35 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 119.082 0.856 . . . . 0.0 112.272 -175.55 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -67.3 -18.69 65.29 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 117.869 -1.062 . . . . 0.0 112.837 172.113 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -115.88 -13.0 11.35 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 119.929 1.241 . . . . 0.0 113.69 178.763 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 43.7 mt . . . . . 0 C--O 1.249 1.075 0 CA-C-N 120.284 1.402 . . . . 0.0 109.63 170.903 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.7 mtt . . . . . 0 N--CA 1.484 1.246 0 CA-C-O 121.175 0.512 . . . . 0.0 109.742 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -159.3 143.68 15.28 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 126.08 1.752 . . . . 0.0 106.489 168.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 88.3 mt -76.6 138.3 20.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 36.6 t -98.5 166.89 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 125.285 1.434 . . . . 0.0 107.504 -175.172 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 6.1 mptt -137.07 135.96 37.96 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 179.421 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -147.17 170.76 16.55 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 122.92 0.488 . . . . 0.0 110.9 -178.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.9 p -137.5 174.6 10.42 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.958 1.303 . . . . 0.0 108.047 177.448 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -45.99 -34.22 3.87 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.776 1.23 . . . . 0.0 113.17 179.343 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 26.8 mp0 -62.1 -31.81 72.31 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.901 1.681 . . . . 0.0 113.1 -178.729 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.5 m -139.98 -5.07 1.32 Allowed 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 -170.131 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -55.87 -35.61 66.67 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 124.097 0.959 . . . . 0.0 111.236 178.397 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.4 p -63.53 -48.6 76.85 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.895 0.878 . . . . 0.0 111.097 178.42 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.71 -44.5 96.5 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 122.938 0.495 . . . . 0.0 109.876 177.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -65.43 -38.41 89.8 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 119.39 -0.338 . . . . 0.0 111.502 -177.287 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.493 ' HA ' HG21 ' A' ' 20' ' ' VAL . 22.2 p -78.04 -0.16 26.86 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -178.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 60.0 m -108.65 32.87 4.54 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.466 1.106 . . . . 0.0 112.033 -171.239 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -132.54 -1.98 3.44 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -176.576 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 167.28 -166.36 39.2 Favored Glycine 0 C--N 1.337 0.593 0 CA-C-N 119.338 0.972 . . . . 0.0 110.854 -173.604 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 97.1 t -72.81 130.18 35.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 N-CA-C 104.554 -2.387 . . . . 0.0 104.554 166.354 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.493 HG21 ' HA ' ' A' ' 15' ' ' THR . 38.1 t -134.82 116.85 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 -175.263 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 57.2 tp -84.57 139.6 31.99 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 169.257 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -133.1 113.61 12.94 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 -177.364 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -92.38 96.72 10.42 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 178.468 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -73.46 114.45 11.7 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 105.053 -2.202 . . . . 0.0 105.053 169.097 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 7.6 p-90 -138.03 175.9 9.17 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 123.499 0.72 . . . . 0.0 110.973 -169.021 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -152.47 145.15 17.16 Favored Pre-proline 0 CA--C 1.534 0.358 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 168.685 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -71.92 -23.26 22.28 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 122.421 2.081 . . . . 0.0 113.383 -169.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -80.91 -8.17 59.67 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 118.58 0.627 . . . . 0.0 112.653 179.617 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 49.1 t -91.62 110.58 21.9 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 -177.65 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -49.46 -53.92 18.47 Favored Glycine 0 CA--C 1.533 1.218 0 CA-C-O 118.693 -1.059 . . . . 0.0 113.085 179.118 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_exo -51.65 -32.58 45.43 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 123.223 2.615 . . . . 0.0 115.35 175.709 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 89.4 m -62.76 -35.46 79.88 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.908 1.231 . . . . 0.0 111.432 173.618 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -71.01 -41.04 71.42 Favored 'General case' 0 N--CA 1.463 0.191 0 O-C-N 121.642 -0.662 . . . . 0.0 109.626 173.087 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 26.5 mmt -64.42 -34.94 79.35 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 118.455 0.571 . . . . 0.0 111.75 -176.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 8.8 tt -82.19 -10.36 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-N 118.549 0.613 . . . . 0.0 111.707 178.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -57.04 -49.99 90.79 Favored Pre-proline 0 CA--C 1.543 0.692 0 CA-C-O 117.568 -1.206 . . . . 0.0 112.644 178.565 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -65.55 -31.46 50.61 Favored 'Trans proline' 0 C--N 1.351 0.687 0 CA-C-N 121.71 1.646 . . . . 0.0 112.476 176.754 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 23.1 t -59.48 -44.98 94.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 119.679 1.127 . . . . 0.0 109.638 172.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 75.8 mt -67.48 -36.71 81.66 Favored 'General case' 0 C--O 1.226 -0.184 0 CA-C-O 118.925 -0.56 . . . . 0.0 110.671 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -68.0 -37.7 81.76 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 119.369 0.986 . . . . 0.0 111.469 176.077 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -64.21 -37.08 86.17 Favored 'General case' 0 N--CA 1.456 -0.126 0 O-C-N 121.345 -0.847 . . . . 0.0 110.323 173.182 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 11.1 tp -72.48 -38.88 68.06 Favored 'General case' 0 N--CA 1.446 -0.633 0 O-C-N 121.816 -0.553 . . . . 0.0 110.556 178.55 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -65.21 -42.93 93.03 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.748 0.819 . . . . 0.0 110.147 -179.125 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -74.07 -13.55 60.86 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 -176.579 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 65.3 mt-10 -103.64 -33.6 8.92 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.52 1.128 . . . . 0.0 113.058 179.402 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 42.8 mtt -137.77 -0.39 2.13 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 117.997 -1.001 . . . . 0.0 113.027 -169.649 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.09 43.67 0.84 Allowed Glycine 0 CA--C 1.533 1.157 0 C-N-CA 126.766 2.127 . . . . 0.0 114.695 -172.621 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -149.0 -39.76 0.15 Allowed 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 128.443 2.697 . . . . 0.0 107.78 169.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -63.56 -34.76 78.51 Favored 'General case' 0 C--N 1.343 0.307 0 C-N-CA 124.623 1.169 . . . . 0.0 110.369 169.438 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -132.73 164.32 27.03 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 125.719 1.608 . . . . 0.0 109.622 168.779 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -103.16 151.43 22.61 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 169.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 17.4 mt -119.04 136.37 56.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 N-CA-C 105.301 -2.111 . . . . 0.0 105.301 170.012 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 45.7 t -128.48 135.04 63.5 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 107.524 -1.288 . . . . 0.0 107.524 -179.463 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 61.3 mmtt -92.31 142.63 27.25 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 169.14 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 17.5 tt -147.25 115.52 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-O 121.375 0.607 . . . . 0.0 109.382 171.303 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -82.27 112.8 19.6 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.827 0.851 . . . . 0.0 109.33 -175.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 32.9 m -59.85 -26.01 34.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-N 118.515 0.598 . . . . 0.0 112.539 -175.501 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -72.57 -1.59 16.59 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.571 0.749 . . . . 0.0 112.237 -178.688 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -131.57 6.77 4.43 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.418 1.487 . . . . 0.0 110.498 172.253 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 67.8 m-80 -143.31 46.44 1.52 Allowed 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.334 1.054 . . . . 0.0 110.645 -168.183 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.406 ' CD ' ' H ' ' A' ' 61' ' ' GLN . 16.2 mp0 -57.45 -44.02 84.45 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.92 0.888 . . . . 0.0 109.082 175.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -67.38 -29.9 69.55 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 125.612 1.565 . . . . 0.0 111.55 -173.564 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.07 -47.33 11.04 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 119.031 -0.509 . . . . 0.0 109.736 175.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.69 -45.89 90.69 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 119.572 1.078 . . . . 0.0 110.304 -176.107 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -61.81 -22.61 62.34 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 123.728 0.68 . . . . 0.0 112.721 176.104 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.7 ttmm -61.19 -25.62 67.16 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 118.532 1.166 . . . . 0.0 111.423 177.126 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -116.51 11.18 14.75 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.758 1.223 . . . . 0.0 110.703 179.297 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 67.6 26.36 73.72 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.145 0.879 . . . . 0.0 112.781 -176.641 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 89.3 t -99.1 154.25 4.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-N 118.18 0.99 . . . . 0.0 109.158 179.397 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -162.57 -24.0 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 127.252 2.221 . . . . 0.0 109.492 167.469 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 8.0 m -63.69 150.58 44.04 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 123.896 0.878 . . . . 0.0 109.112 170.444 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -145.22 155.9 54.35 Favored Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 124.256 1.022 . . . . 0.0 108.998 176.32 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.39 140.78 50.27 Favored 'Cis proline' 0 N--CA 1.456 -0.678 0 CA-C-N 119.916 1.006 . . . . 0.0 109.541 -10.396 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 54.4 m -131.93 121.51 24.11 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 176.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 52.7 mt -95.53 102.3 14.09 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 179.23 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -81.01 143.27 32.64 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 167.819 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.7 t -125.51 126.1 69.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 104.289 -2.485 . . . . 0.0 104.289 174.117 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.9 mp -126.79 160.77 29.92 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 124.994 1.318 . . . . 0.0 107.976 -178.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -144.89 125.89 14.51 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 175.03 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.0 t70 44.81 36.96 2.04 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.279 1.432 . . . . 0.0 113.469 175.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 105.68 -2.26 39.17 Favored Glycine 0 CA--C 1.528 0.885 0 CA-C-O 118.055 -1.414 . . . . 0.0 115.126 169.18 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -130.58 148.72 52.41 Favored 'General case' 0 C--N 1.338 0.099 0 CA-C-N 120.159 1.98 . . . . 0.0 110.516 -178.195 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 52.5 t -66.19 140.47 19.49 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 C-N-CA 124.053 0.941 . . . . 0.0 108.773 177.55 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 35.3 m -124.62 -18.39 3.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 125.398 1.479 . . . . 0.0 110.917 172.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.96 165.4 32.12 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 120.318 1.417 . . . . 0.0 111.429 169.655 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 56.3 m -144.05 133.05 22.77 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.892 1.677 . . . . 0.0 107.077 169.295 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 17.8 m -143.61 152.93 42.0 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.875 1.27 . . . . 0.0 108.481 -176.037 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 28.6 t -131.22 150.29 34.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-N 119.145 0.884 . . . . 0.0 108.794 -170.287 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.73 174.27 46.33 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 124.518 1.056 . . . . 0.0 112.173 176.47 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -59.58 152.12 22.88 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 123.623 0.769 . . . . 0.0 110.806 177.834 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -153.38 146.73 18.03 Favored Pre-proline 0 C--O 1.233 0.232 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 168.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.2 158.18 52.44 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.172 1.915 . . . . 0.0 110.332 177.687 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 4.8 ttpt -59.3 -33.95 71.71 Favored 'General case' 0 C--O 1.224 -0.288 0 C-N-CA 123.462 0.705 . . . . 0.0 111.551 179.507 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -64.51 -39.91 94.66 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 119.106 0.866 . . . . 0.0 111.946 -179.491 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.32 -41.2 70.18 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 122.735 0.414 . . . . 0.0 110.389 175.214 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 28.0 tp -66.75 -40.3 88.24 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 122.638 0.375 . . . . 0.0 110.744 -177.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.8 pp0? -69.43 -31.17 69.33 Favored 'General case' 0 C--O 1.227 -0.106 0 CA-C-N 118.821 0.737 . . . . 0.0 110.164 176.468 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -64.91 -47.72 76.73 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 176.627 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 63.6 tp -57.86 -46.67 84.49 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.354 0.662 . . . . 0.0 110.381 178.126 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 23.4 t -62.37 -49.27 84.61 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 CA-C-O 119.061 -0.495 . . . . 0.0 110.029 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.46 -26.96 68.67 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 119.171 0.896 . . . . 0.0 112.215 -175.557 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 61.6 mtpt -67.86 -29.76 68.97 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 118.597 -0.716 . . . . 0.0 112.041 171.293 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 86.1 m-70 -90.87 -21.35 21.46 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.259 0.936 . . . . 0.0 113.244 179.672 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 65.9 mt . . . . . 0 C--O 1.249 1.053 0 CA-C-N 119.569 1.077 . . . . 0.0 109.88 175.472 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.0 tpt . . . . . 0 N--CA 1.483 1.21 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.81 163.85 38.31 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 125.782 1.633 . . . . 0.0 108.359 176.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 79.8 mt -66.42 154.25 8.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 124.906 1.282 . . . . 0.0 107.783 177.449 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.6 t -119.48 167.53 12.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 125.348 1.459 . . . . 0.0 107.767 -168.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.7 tppp? -128.5 145.88 50.98 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 177.667 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -146.19 168.73 20.29 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 123.24 0.616 . . . . 0.0 110.332 171.156 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 72.0 p -135.44 173.57 11.57 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.584 1.553 . . . . 0.0 106.938 174.526 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -52.44 -30.5 29.92 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 119.701 1.137 . . . . 0.0 113.01 -176.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 26.0 mp0 -62.75 -30.73 71.66 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.097 1.759 . . . . 0.0 112.817 179.634 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.5 m -139.15 -3.78 1.55 Allowed 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -169.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 61.3 t80 -54.65 -37.79 66.12 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 123.938 0.895 . . . . 0.0 111.035 177.669 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.4 p -63.04 -50.5 70.42 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.671 0.788 . . . . 0.0 110.76 179.107 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.21 -44.87 92.26 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.017 0.527 . . . . 0.0 110.081 178.25 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -66.03 -37.89 87.0 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 119.348 -0.358 . . . . 0.0 111.445 -177.19 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.481 ' HA ' HG21 ' A' ' 20' ' ' VAL . 27.8 p -79.66 0.44 30.27 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 118.513 0.597 . . . . 0.0 112.549 -178.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.5 m -110.23 32.27 5.27 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.418 1.087 . . . . 0.0 112.312 -172.119 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 -131.81 2.22 4.04 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -177.595 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 167.34 -165.62 38.73 Favored Glycine 0 C--N 1.334 0.428 0 O-C-N 121.414 -0.804 . . . . 0.0 111.185 -176.194 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 1.9 t -76.66 134.86 27.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 104.275 -2.491 . . . . 0.0 104.275 168.081 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.481 HG21 ' HA ' ' A' ' 15' ' ' THR . 30.2 t -138.34 141.57 37.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -172.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 58.9 tp -113.53 97.96 6.77 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 106.02 -1.844 . . . . 0.0 106.02 173.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.21 149.06 37.29 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 170.511 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -133.16 99.0 4.42 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 107.2 -1.408 . . . . 0.0 107.2 177.12 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -76.63 114.97 15.96 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 173.3 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 7.3 p-90 -138.84 175.89 9.17 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 123.401 0.68 . . . . 0.0 110.85 -169.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -151.61 146.66 19.05 Favored Pre-proline 0 CA--C 1.535 0.394 0 C-N-CA 124.53 1.132 . . . . 0.0 107.98 169.251 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.25 -17.85 18.68 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.962 2.441 . . . . 0.0 113.515 -169.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -84.81 -7.21 59.28 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 118.789 0.722 . . . . 0.0 112.088 177.439 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 54.1 t -87.82 117.08 26.41 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 -178.407 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -55.82 -55.72 27.52 Favored Glycine 0 CA--C 1.531 1.092 0 CA-C-O 118.691 -1.061 . . . . 0.0 112.201 175.33 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -51.15 -34.58 48.64 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 123.256 2.637 . . . . 0.0 115.434 176.539 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 97.7 m -60.92 -35.78 77.58 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 119.96 1.255 . . . . 0.0 111.672 173.097 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.1 mttm -70.14 -40.94 74.51 Favored 'General case' 0 N--CA 1.464 0.266 0 O-C-N 121.52 -0.737 . . . . 0.0 109.692 173.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 26.3 mmt -64.71 -38.17 90.07 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 118.231 0.469 . . . . 0.0 111.487 -176.386 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 10.8 tt -79.16 -15.97 13.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-N 118.394 0.543 . . . . 0.0 111.51 179.042 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.9 -48.97 94.46 Favored Pre-proline 0 CA--C 1.541 0.598 0 CA-C-O 117.472 -1.251 . . . . 0.0 113.597 -177.434 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.06 -27.73 49.67 Favored 'Trans proline' 0 C--N 1.35 0.632 0 CA-C-N 122.087 1.781 . . . . 0.0 112.461 176.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 6.0 t -66.42 -41.13 88.23 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-N 119.346 0.975 . . . . 0.0 109.059 174.309 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 66.0 mt -67.03 -34.28 77.37 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 118.745 -0.645 . . . . 0.0 110.961 175.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -69.45 -36.55 76.71 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 119.482 1.037 . . . . 0.0 111.496 174.576 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 44.0 mm-40 -61.17 -46.73 89.3 Favored 'General case' 0 CA--C 1.528 0.098 0 O-C-N 121.137 -0.977 . . . . 0.0 109.233 171.152 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -62.11 -35.96 80.3 Favored 'General case' 0 C--O 1.224 -0.255 0 C-N-CA 122.857 0.463 . . . . 0.0 111.557 177.198 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -65.28 -41.88 93.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 119.27 0.941 . . . . 0.0 110.427 176.607 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -68.01 -36.97 80.87 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 122.823 0.449 . . . . 0.0 111.634 178.294 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -93.35 -30.1 15.29 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.014 0.926 . . . . 0.0 112.426 -169.588 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 20.0 mmt -136.95 -3.41 2.02 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.39 1.476 . . . . 0.0 112.706 -169.254 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -52.12 -28.74 26.88 Favored Glycine 0 CA--C 1.538 1.469 0 CA-C-N 120.945 1.702 . . . . 0.0 113.277 177.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -73.67 -29.32 62.24 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.844 1.658 . . . . 0.0 111.434 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 55.3 mmtt -97.82 -25.97 14.86 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 125.444 1.498 . . . . 0.0 110.651 -177.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -150.58 126.11 10.2 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.095 0.958 . . . . 0.0 110.038 -167.357 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -73.76 152.49 40.34 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 175.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 17.6 mt -125.72 130.97 72.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 N-CA-C 105.645 -1.983 . . . . 0.0 105.645 175.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 22.0 t -132.07 113.66 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -170.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 48.2 mmtt -73.86 143.29 45.92 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 170.694 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 15.4 tt -149.02 125.34 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 169.681 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -80.28 128.57 33.69 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 22.5 m -70.02 -31.59 48.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 -173.206 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -77.6 -35.36 52.95 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 119.136 0.88 . . . . 0.0 109.755 -175.143 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -72.98 -15.9 61.53 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.861 0.864 . . . . 0.0 111.869 172.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 63.3 m-80 -139.77 51.97 1.72 Allowed 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 119.227 0.921 . . . . 0.0 111.044 -168.518 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.413 ' CD ' ' H ' ' A' ' 61' ' ' GLN . 0.7 OUTLIER -56.56 -38.66 72.22 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.791 0.836 . . . . 0.0 109.55 179.673 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -66.49 -27.74 68.02 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.946 1.298 . . . . 0.0 112.553 -177.648 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.425 ' HA ' ' HE2' ' A' ' 66' ' ' LYS . 0.2 OUTLIER -88.42 -45.53 9.89 Favored 'General case' 0 C--O 1.222 -0.373 0 CA-C-N 118.809 0.731 . . . . 0.0 109.725 178.47 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.79 -46.9 85.85 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.271 0.941 . . . . 0.0 109.792 179.284 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -61.77 -22.37 61.95 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 124.48 1.038 . . . . 0.0 112.746 175.46 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.425 ' HE2' ' HA ' ' A' ' 63' ' ' THR . 5.7 ttmm -57.84 -23.08 51.16 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 118.778 1.289 . . . . 0.0 111.852 174.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -125.76 13.58 8.01 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.688 1.195 . . . . 0.0 110.375 179.387 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 68.65 20.12 73.71 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 124.661 1.124 . . . . 0.0 113.689 -178.144 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 97.9 t -84.83 136.28 23.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 176.597 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -155.42 29.02 0.39 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.732 1.213 . . . . 0.0 109.258 167.667 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 20.8 m -138.15 154.41 49.17 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 126.678 1.991 . . . . 0.0 106.864 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -145.31 158.72 50.73 Favored Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 123.866 0.867 . . . . 0.0 110.143 -169.703 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -67.92 140.74 56.03 Favored 'Cis proline' 0 C--N 1.349 0.573 0 N-CA-C 109.168 -1.128 . . . . 0.0 109.168 -11.269 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 54.7 m -131.67 118.28 19.8 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 177.086 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 89.4 mt -93.54 137.98 32.28 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 178.266 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.0 mp -121.22 130.34 53.64 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 105.238 -2.134 . . . . 0.0 105.238 169.318 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.8 t -94.35 127.73 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 103.571 -2.751 . . . . 0.0 103.571 168.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.6 mp -125.33 160.42 29.37 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 125.198 1.399 . . . . 0.0 107.792 176.671 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -149.32 125.08 10.48 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.172 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.8 t70 44.88 34.98 1.34 Allowed 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.304 1.441 . . . . 0.0 113.714 177.058 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 109.71 -1.72 30.5 Favored Glycine 0 CA--C 1.527 0.785 0 CA-C-O 118.033 -1.426 . . . . 0.0 115.588 168.695 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -131.06 145.18 51.93 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 120.13 1.965 . . . . 0.0 110.288 -178.67 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.3 p -66.86 138.45 22.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 172.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 27.1 m -127.03 -16.47 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 125.68 1.592 . . . . 0.0 110.682 178.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.44 164.3 38.42 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 119.871 1.214 . . . . 0.0 110.902 169.18 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 93.9 m -146.37 137.83 24.61 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.461 1.505 . . . . 0.0 108.421 176.051 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 19.7 m -146.24 152.98 40.07 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.413 1.485 . . . . 0.0 108.691 -176.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 40.3 t -133.03 146.43 32.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 -173.632 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 85.49 178.62 50.51 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 124.451 1.024 . . . . 0.0 111.89 178.413 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -60.26 152.86 23.83 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.173 0.989 . . . . 0.0 110.575 174.727 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -141.42 148.2 49.65 Favored Pre-proline 0 C--O 1.234 0.257 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 168.282 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -71.56 158.59 53.38 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 122.381 2.054 . . . . 0.0 110.22 171.572 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -55.31 -45.97 76.28 Favored 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 123.397 0.679 . . . . 0.0 111.042 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -64.33 -42.04 96.49 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 118.345 0.521 . . . . 0.0 111.248 -169.402 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.0 -42.51 89.65 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 122.897 0.479 . . . . 0.0 110.878 175.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 43.3 tp -69.16 -41.01 77.8 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 119.233 -0.413 . . . . 0.0 110.744 -176.1 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.7 pp0? -70.8 -30.12 66.49 Favored 'General case' 0 C--N 1.337 0.058 0 CA-C-N 119.022 0.828 . . . . 0.0 110.303 176.011 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -64.07 -49.22 73.16 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 175.515 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 67.6 tp -57.65 -46.1 84.64 Favored 'General case' 0 CA--C 1.527 0.095 0 C-N-CA 123.869 0.867 . . . . 0.0 110.349 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 19.6 t -60.06 -53.45 48.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 177.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -63.35 -28.88 70.3 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 118.78 0.718 . . . . 0.0 112.395 -175.803 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -68.12 -32.13 72.2 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 118.475 -0.774 . . . . 0.0 111.958 173.26 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 58.0 m-70 -89.75 -16.73 29.66 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 119.326 0.966 . . . . 0.0 113.296 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 65.5 mt . . . . . 0 C--O 1.249 1.073 0 CA-C-N 119.737 1.153 . . . . 0.0 109.847 173.032 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.4 mmt . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 118.202 -0.904 . . . . 0.0 111.257 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 64.73 -178.38 0.17 Allowed 'General case' 0 C--O 1.238 0.481 0 C-N-CA 125.589 1.556 . . . . 0.0 113.332 177.555 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 21.2 mt -75.69 143.72 12.85 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 169.627 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 25.6 t -140.44 167.59 18.04 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 128.069 2.547 . . . . 0.0 105.678 -176.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.0 mtmt -125.62 144.36 50.62 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 173.374 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -144.8 170.1 16.77 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 122.913 0.485 . . . . 0.0 110.622 176.289 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 73.7 p -135.63 173.35 11.81 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 176.291 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -49.27 -32.38 10.75 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 119.669 1.122 . . . . 0.0 113.138 -177.235 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 25.3 mp0 -62.04 -31.58 71.99 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.408 1.883 . . . . 0.0 112.777 -179.206 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.3 m -139.92 -4.26 1.38 Allowed 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 -171.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -53.57 -37.59 63.07 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 124.305 1.042 . . . . 0.0 111.006 176.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.0 m -67.29 -38.83 85.66 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 122.49 0.316 . . . . 0.0 111.286 -178.132 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.18 -45.2 77.68 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 175.562 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -64.54 -37.12 86.46 Favored 'General case' 0 C--O 1.231 0.116 0 C-N-CA 122.64 0.376 . . . . 0.0 111.374 -175.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.443 ' HA ' HG21 ' A' ' 20' ' ' VAL . 19.9 p -77.28 -1.39 29.52 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 179.532 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 67.9 m -108.65 33.29 4.28 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.448 1.099 . . . . 0.0 111.933 -171.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -132.65 0.62 3.61 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -177.703 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 166.31 -165.55 38.31 Favored Glycine 0 C--N 1.336 0.535 0 CA-C-N 119.367 0.985 . . . . 0.0 111.424 -175.666 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 97.3 t -73.77 127.73 35.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 N-CA-C 104.6 -2.37 . . . . 0.0 104.6 166.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.443 HG21 ' HA ' ' A' ' 15' ' ' THR . 39.2 t -133.72 122.64 43.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 -174.657 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 18.3 tp -87.8 139.22 30.75 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 105.84 -1.911 . . . . 0.0 105.84 168.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -125.01 113.67 18.1 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 -179.032 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -94.1 90.41 6.38 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 125.337 1.455 . . . . 0.0 108.391 -178.18 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -72.1 113.22 8.89 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 169.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 7.9 p-90 -138.79 176.42 8.71 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 123.561 0.744 . . . . 0.0 111.068 -169.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -151.84 146.6 18.85 Favored Pre-proline 0 CA--C 1.535 0.379 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 169.185 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.35 -20.17 16.45 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 122.744 2.296 . . . . 0.0 113.494 -171.648 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -81.95 -7.84 59.63 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 121.526 -0.734 . . . . 0.0 111.823 176.777 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 52.0 t -88.12 117.32 26.92 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -55.58 -57.92 16.4 Favored Glycine 0 CA--C 1.531 1.067 0 CA-C-O 118.572 -1.126 . . . . 0.0 111.598 173.581 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -49.89 -36.32 42.96 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 123.569 2.846 . . . . 0.0 115.434 177.453 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 98.0 m -60.02 -45.51 92.55 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 119.886 1.221 . . . . 0.0 111.418 173.253 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 46.5 mtmt -70.86 -30.58 67.02 Favored 'General case' 0 CA--C 1.53 0.174 0 O-C-N 121.465 -0.772 . . . . 0.0 110.639 178.666 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 86.5 mtp -68.37 -42.54 79.03 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 118.685 0.675 . . . . 0.0 111.226 176.238 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 7.4 tt -76.82 -21.45 14.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-N 119.1 0.863 . . . . 0.0 111.115 -178.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.17 -51.28 64.11 Favored Pre-proline 0 CA--C 1.546 0.823 0 CA-C-N 119.737 1.153 . . . . 0.0 113.915 -177.592 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.28 -30.5 54.23 Favored 'Trans proline' 0 C--N 1.349 0.59 0 CA-C-N 121.866 1.702 . . . . 0.0 112.364 176.124 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 6.8 t -65.49 -37.87 81.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-N 119.334 0.97 . . . . 0.0 109.521 174.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 82.6 mt -68.24 -33.41 74.33 Favored 'General case' 0 C--O 1.225 -0.213 0 CA-C-O 118.569 -0.729 . . . . 0.0 110.844 173.602 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -66.65 -36.13 81.81 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.836 1.198 . . . . 0.0 111.405 172.429 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 55.4 mm-40 -65.93 -39.05 90.17 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 120.808 -1.182 . . . . 0.0 110.149 172.72 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 46.9 tp -66.5 -36.66 83.27 Favored 'General case' 0 C--O 1.226 -0.144 0 O-C-N 121.648 -0.658 . . . . 0.0 110.731 175.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -66.29 -37.47 85.5 Favored 'General case' 0 N--CA 1.454 -0.238 0 O-C-N 121.586 -0.696 . . . . 0.0 111.096 176.472 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -64.36 -33.42 75.8 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.376 -0.828 . . . . 0.0 111.305 171.372 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -79.0 -39.16 34.83 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.301 1.04 . . . . 0.0 112.139 -177.264 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 21.2 mmt -133.5 -7.23 2.9 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 -166.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.97 -3.85 12.48 Favored Glycine 0 CA--C 1.531 1.079 0 CA-C-N 120.474 1.488 . . . . 0.0 115.142 -174.18 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -82.29 -27.5 32.3 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.518 1.527 . . . . 0.0 111.751 172.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -129.04 -1.77 5.19 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.837 1.655 . . . . 0.0 112.624 -172.35 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -139.38 155.87 47.37 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 126.828 2.051 . . . . 0.0 106.906 177.329 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -110.01 151.35 27.27 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 173.204 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 18.3 mt -119.72 136.7 56.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 105.064 -2.198 . . . . 0.0 105.064 170.129 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 99.5 t -126.24 115.14 41.43 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 -176.213 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 10.3 mmmm -75.19 140.88 43.59 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 171.062 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 16.6 tt -148.92 113.91 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 173.08 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 60.6 t0 -77.24 117.18 18.51 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 -178.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 30.6 m -62.88 -27.35 42.93 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -175.547 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -69.18 -28.87 66.79 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 119.331 0.969 . . . . 0.0 110.768 -178.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -93.62 -7.72 43.16 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.63 1.172 . . . . 0.0 111.073 177.586 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -141.38 47.12 1.7 Allowed 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 124.549 1.14 . . . . 0.0 109.929 -168.289 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.485 ' CD ' ' H ' ' A' ' 61' ' ' GLN . 1.4 mp0 -58.39 -40.9 83.6 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.315 1.046 . . . . 0.0 109.024 -177.294 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -63.21 -45.12 93.17 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.497 1.119 . . . . 0.0 110.399 179.709 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.477 ' HA ' ' HE3' ' A' ' 66' ' ' LYS . 0.8 OUTLIER -69.01 -43.77 74.14 Favored 'General case' 0 C--O 1.221 -0.433 0 CA-C-N 118.729 0.695 . . . . 0.0 110.362 -176.752 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.16 -45.68 92.31 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 119.166 0.894 . . . . 0.0 109.417 176.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -58.11 -26.37 58.44 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 124.232 0.92 . . . . 0.0 113.081 174.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.477 ' HE3' ' HA ' ' A' ' 63' ' ' THR . 27.4 ttmt -57.82 -21.54 42.84 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.459 1.504 . . . . 0.0 111.908 177.742 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -127.81 12.84 6.83 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.88 1.272 . . . . 0.0 110.532 179.61 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 68.95 20.18 74.34 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 124.558 1.075 . . . . 0.0 113.544 -177.732 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 85.2 t -85.35 137.08 21.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 176.473 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -157.66 28.9 0.28 Allowed 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.512 1.125 . . . . 0.0 109.523 167.043 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 44.1 m -135.08 154.06 51.81 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 126.317 1.847 . . . . 0.0 106.89 174.267 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -146.32 160.2 43.04 Favored Pre-proline 0 CA--C 1.543 0.688 0 C-N-CA 124.565 1.146 . . . . 0.0 109.273 -170.15 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -66.93 139.84 47.75 Favored 'Cis proline' 0 C--N 1.349 0.553 0 CA-C-N 120.161 1.093 . . . . 0.0 109.77 -10.552 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 41.5 m -132.99 133.79 43.61 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 178.665 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 78.6 mt -119.28 103.08 9.17 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 -172.118 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.7 mp -84.87 146.01 27.52 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 106.822 -1.548 . . . . 0.0 106.822 168.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.4 t -111.33 127.87 68.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 103.633 -2.728 . . . . 0.0 103.633 169.282 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.7 mp -127.0 158.62 36.44 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.308 1.443 . . . . 0.0 107.445 179.542 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -145.77 127.16 14.94 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 175.027 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.9 t70 44.3 37.44 1.98 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.389 1.476 . . . . 0.0 113.616 174.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.87 5.25 47.76 Favored Glycine 0 CA--C 1.527 0.783 0 CA-C-O 118.59 -1.117 . . . . 0.0 114.861 169.138 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 82.1 mm-40 -130.13 141.44 50.68 Favored 'General case' 0 CA--C 1.522 -0.105 0 CA-C-N 119.52 1.66 . . . . 0.0 109.133 178.004 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.5 p -69.25 137.42 24.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 169.369 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 25.3 m -125.21 -20.48 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 C-N-CA 124.989 1.316 . . . . 0.0 110.328 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.21 167.1 31.49 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 119.545 1.066 . . . . 0.0 111.454 175.685 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 80.7 m -148.43 141.05 24.47 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.55 1.54 . . . . 0.0 108.738 176.537 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 21.3 m -144.63 155.88 43.83 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.988 1.715 . . . . 0.0 108.309 177.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 39.5 t -133.81 149.72 30.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 -176.591 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.09 172.3 47.08 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 124.385 0.993 . . . . 0.0 112.449 172.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -63.92 131.19 46.93 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 123.59 0.756 . . . . 0.0 109.291 175.685 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -136.1 143.73 45.23 Favored Pre-proline 0 CA--C 1.534 0.35 0 C-N-CA 126.095 1.758 . . . . 0.0 107.035 179.24 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -74.68 156.83 44.43 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.691 2.26 . . . . 0.0 110.917 178.5 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.6 tmpt? -58.98 -36.24 74.54 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 123.449 0.699 . . . . 0.0 111.247 -177.698 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -67.52 -35.15 78.55 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 118.838 0.744 . . . . 0.0 111.269 -175.459 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.03 -42.61 72.73 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 122.886 0.474 . . . . 0.0 110.485 173.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 84.5 mt -67.05 -41.39 86.56 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-O 118.902 -0.57 . . . . 0.0 110.392 -178.017 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.0 pp0? -68.22 -30.8 69.95 Favored 'General case' 0 C--O 1.228 -0.075 0 CA-C-N 119.274 0.943 . . . . 0.0 110.247 177.378 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -65.41 -47.75 75.21 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 176.073 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 59.2 tp -58.47 -43.35 88.89 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.269 0.627 . . . . 0.0 110.652 178.016 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 39.6 t -61.22 -50.63 79.68 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 C-N-CA 123.103 0.561 . . . . 0.0 109.593 176.685 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -63.88 -26.89 68.81 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 118.975 0.807 . . . . 0.0 112.284 -175.346 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 62.1 mtpt -67.17 -18.55 65.32 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 118.056 -0.973 . . . . 0.0 112.997 171.653 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -114.34 -10.09 12.71 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 119.856 1.207 . . . . 0.0 113.658 -179.368 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 80.3 mt . . . . . 0 C--O 1.251 1.161 0 CA-C-N 120.032 1.287 . . . . 0.0 109.723 172.314 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.477 0.892 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -155.47 144.36 20.64 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 169.39 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 92.6 mt -75.93 144.29 12.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 177.629 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 40.5 t -105.33 166.48 3.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 -174.523 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 5.8 mptt -138.55 134.69 34.18 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 -178.415 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -143.45 170.7 15.3 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 122.935 0.494 . . . . 0.0 110.791 -179.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.1 p -135.29 171.71 14.05 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 178.417 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -49.5 -32.42 12.2 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 119.808 1.186 . . . . 0.0 113.021 -176.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 25.2 mp0 -63.48 -30.35 71.49 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.716 2.007 . . . . 0.0 112.923 -179.035 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.6 m -138.61 -6.7 1.5 Allowed 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 114.358 1.244 . . . . 0.0 114.358 -172.561 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -56.22 -34.83 66.69 Favored 'General case' 0 C--N 1.333 -0.122 0 C-N-CA 124.606 1.162 . . . . 0.0 111.11 178.155 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.4 p -62.75 -48.47 79.07 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 123.649 0.78 . . . . 0.0 111.062 178.156 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.33 -44.88 96.44 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 122.78 0.432 . . . . 0.0 109.862 177.083 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -65.14 -37.6 87.93 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 119.274 -0.393 . . . . 0.0 111.546 -176.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.51 ' HA ' HG21 ' A' ' 20' ' ' VAL . 23.3 p -78.93 0.25 28.16 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 118.595 0.634 . . . . 0.0 112.533 -179.146 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 48.8 m -112.03 34.43 4.24 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.406 1.082 . . . . 0.0 111.962 -171.15 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -131.78 -1.35 3.79 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -178.611 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 166.41 -167.09 39.27 Favored Glycine 0 C--N 1.335 0.518 0 CA-C-N 119.198 0.908 . . . . 0.0 110.872 -172.823 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 76.9 t -72.3 134.06 30.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 104.874 -2.269 . . . . 0.0 104.874 167.015 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.51 HG21 ' HA ' ' A' ' 15' ' ' THR . 38.8 t -137.12 119.25 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 -176.288 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 60.5 tp -88.75 97.44 11.14 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 170.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.47 149.41 36.79 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 169.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -133.21 98.41 4.25 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 176.491 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -73.97 113.45 11.16 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 172.588 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 6.0 p-90 -136.26 175.89 9.19 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 123.721 0.808 . . . . 0.0 110.219 -169.46 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -149.89 144.98 18.22 Favored Pre-proline 0 CA--C 1.534 0.345 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 169.21 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.37 -21.91 22.38 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 122.438 2.092 . . . . 0.0 113.471 -170.035 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -83.84 -8.24 59.26 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 118.693 0.679 . . . . 0.0 112.228 178.609 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 53.7 t -85.15 117.63 24.22 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -178.581 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -54.58 -57.11 18.93 Favored Glycine 0 CA--C 1.532 1.154 0 CA-C-O 118.651 -1.083 . . . . 0.0 112.137 176.541 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -50.86 -35.87 50.57 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 123.18 2.586 . . . . 0.0 115.093 175.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 90.7 m -62.1 -37.05 83.6 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 119.676 1.126 . . . . 0.0 111.882 173.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -69.63 -42.07 74.79 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 118.804 0.729 . . . . 0.0 109.851 172.6 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 62.0 mtt -62.36 -38.01 87.9 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 122.948 0.499 . . . . 0.0 111.159 -175.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 10.9 tt -78.86 -16.04 13.54 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-N 118.569 0.622 . . . . 0.0 111.848 -178.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.03 -51.22 82.38 Favored Pre-proline 0 CA--C 1.544 0.728 0 CA-C-N 120.069 1.304 . . . . 0.0 113.57 -178.605 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -64.3 -30.31 63.69 Favored 'Trans proline' 0 C--N 1.351 0.672 0 CA-C-N 121.769 1.667 . . . . 0.0 111.872 176.484 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.4 t -64.82 -42.14 94.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-N 118.908 0.776 . . . . 0.0 109.56 176.014 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 66.2 mt -66.88 -32.98 74.59 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 118.347 -0.835 . . . . 0.0 110.734 175.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -68.29 -37.95 81.17 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 120.206 1.366 . . . . 0.0 111.49 173.209 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -64.62 -31.55 72.82 Favored 'General case' 0 C--N 1.334 -0.095 0 O-C-N 121.225 -0.922 . . . . 0.0 110.99 172.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 18.5 tp -76.82 -38.81 53.17 Favored 'General case' 0 N--CA 1.448 -0.56 0 O-C-N 121.82 -0.55 . . . . 0.0 110.857 174.626 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -64.73 -36.59 84.77 Favored 'General case' 0 C--O 1.23 0.068 0 C-N-CA 124.354 1.062 . . . . 0.0 110.654 -178.544 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -76.48 -22.03 55.05 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 121.894 -0.504 . . . . 0.0 111.977 -177.195 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 89.0 mt-10 -94.33 -34.7 12.71 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.462 1.105 . . . . 0.0 113.158 178.036 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 32.8 mtt -136.76 -4.55 1.99 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 118.046 -0.978 . . . . 0.0 113.263 -169.493 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -76.34 49.81 2.7 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 125.878 1.704 . . . . 0.0 113.11 -173.722 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -154.98 -40.69 0.09 Allowed 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 129.678 3.191 . . . . 0.0 106.915 171.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 57.3 mttp -61.62 -36.98 82.29 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.291 1.436 . . . . 0.0 109.817 168.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -134.02 165.5 24.9 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 126.545 1.938 . . . . 0.0 109.603 170.741 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -101.48 151.66 21.69 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.428 1.091 . . . . 0.0 108.135 171.301 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 18.7 mt -116.48 134.75 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 N-CA-C 105.118 -2.178 . . . . 0.0 105.118 170.131 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 87.2 t -132.43 117.57 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -176.393 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 55.6 mmtt -75.7 144.91 41.31 Favored 'General case' 0 C--O 1.235 0.303 0 O-C-N 121.695 -0.628 . . . . 0.0 109.663 169.724 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 15.3 tt -148.19 119.13 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 169.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 50.9 t0 -82.72 114.13 20.86 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.969 0.907 . . . . 0.0 109.924 -174.553 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 25.0 m -63.02 -22.89 31.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 -174.236 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -66.01 -30.54 71.1 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 119.016 0.826 . . . . 0.0 111.275 -175.017 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -99.66 -39.29 8.34 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 123.267 0.627 . . . . 0.0 109.73 173.621 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 -89.45 46.29 1.36 Allowed 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 124.268 1.027 . . . . 0.0 111.245 -169.582 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -56.11 -43.02 77.73 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 126.624 1.97 . . . . 0.0 108.816 179.608 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 30.7 mm-40 -67.5 -27.38 66.95 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 125.112 1.365 . . . . 0.0 112.306 -177.659 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.414 ' HA ' ' HE2' ' A' ' 66' ' ' LYS . 0.2 OUTLIER -88.45 -46.01 9.49 Favored 'General case' 0 C--O 1.222 -0.392 0 CA-C-N 118.599 0.636 . . . . 0.0 109.687 179.519 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.87 -46.03 89.78 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 119.321 0.964 . . . . 0.0 109.624 179.259 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -60.65 -24.17 61.74 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 124.095 0.855 . . . . 0.0 112.862 175.248 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.414 ' HE2' ' HA ' ' A' ' 63' ' ' THR . 5.2 ttmm -58.13 -23.49 55.28 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 118.573 1.187 . . . . 0.0 112.056 176.041 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -124.87 13.05 8.5 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.734 1.214 . . . . 0.0 110.487 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 68.96 19.61 73.83 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 124.538 1.066 . . . . 0.0 113.691 -178.146 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 96.5 t -84.28 135.63 24.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 176.288 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.18 28.22 0.46 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.586 1.154 . . . . 0.0 109.372 168.019 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 22.5 m -138.12 152.76 49.05 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 126.704 2.002 . . . . 0.0 106.77 178.434 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -145.72 160.09 45.31 Favored Pre-proline 0 CA--C 1.541 0.602 0 C-N-CA 124.058 0.943 . . . . 0.0 109.905 -169.687 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -66.94 139.52 46.19 Favored 'Cis proline' 0 C--N 1.349 0.601 0 N-CA-C 109.366 -1.051 . . . . 0.0 109.366 -11.098 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 51.9 m -132.0 117.74 18.8 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 177.701 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 95.4 mt -92.8 136.7 33.01 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 179.396 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.8 mp -121.09 130.92 53.96 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 105.061 -2.2 . . . . 0.0 105.061 169.468 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.5 t -93.56 124.24 45.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 103.196 -2.89 . . . . 0.0 103.196 168.629 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.9 mp -118.75 159.01 24.45 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 173.028 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 73.7 tttt -145.2 126.73 15.06 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 173.557 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.7 t70 44.33 38.62 2.58 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.395 1.478 . . . . 0.0 113.484 175.348 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 101.21 5.33 52.86 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-O 118.598 -1.112 . . . . 0.0 114.862 169.161 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 82.1 mm-40 -130.49 142.31 50.49 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 119.513 1.657 . . . . 0.0 109.142 178.051 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.2 p -68.54 138.32 22.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 169.561 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 33.0 m -126.75 -20.68 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 125.062 1.345 . . . . 0.0 110.478 179.351 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -153.08 166.9 31.01 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 119.73 1.15 . . . . 0.0 111.339 171.011 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 96.1 m -148.67 141.04 24.19 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.577 1.551 . . . . 0.0 108.732 177.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 16.0 m -147.68 156.62 42.96 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.565 1.546 . . . . 0.0 108.611 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 40.6 t -132.99 149.41 31.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -174.715 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.66 173.99 45.8 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 124.424 1.011 . . . . 0.0 112.299 176.222 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -59.02 150.74 23.89 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.165 0.986 . . . . 0.0 110.68 177.507 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -153.94 147.27 18.2 Favored Pre-proline 0 CA--C 1.532 0.279 0 C-N-CA 125.057 1.343 . . . . 0.0 107.514 169.199 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.3 159.28 47.27 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.761 2.307 . . . . 0.0 110.81 179.389 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 2.9 ttpp -57.44 -36.51 71.49 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.898 0.879 . . . . 0.0 111.51 -177.071 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -62.4 -36.2 81.59 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.471 0.578 . . . . 0.0 112.059 177.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.79 -40.6 69.11 Favored 'General case' 0 N--CA 1.453 -0.31 0 O-C-N 121.924 -0.485 . . . . 0.0 110.814 174.058 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 42.7 mt -64.18 -43.44 95.11 Favored 'General case' 0 N--CA 1.457 -0.08 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -179.65 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.0 pp0? -68.89 -31.66 70.74 Favored 'General case' 0 C--O 1.226 -0.149 0 CA-C-N 118.62 0.645 . . . . 0.0 110.258 178.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -64.23 -49.57 71.41 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 176.737 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 58.9 tp -57.16 -44.69 83.7 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.372 0.669 . . . . 0.0 110.476 178.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 37.3 t -65.42 -47.34 87.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 CA-C-O 118.946 -0.549 . . . . 0.0 110.638 179.5 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.29 -25.52 68.09 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 119.606 1.094 . . . . 0.0 112.341 -175.181 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -66.1 -16.42 63.93 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 117.897 -1.049 . . . . 0.0 113.167 171.196 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -121.64 -10.51 8.77 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 119.96 1.255 . . . . 0.0 113.822 -177.136 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 66.6 mt . . . . . 0 C--O 1.25 1.101 0 CA-C-N 120.114 1.325 . . . . 0.0 109.39 169.958 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.5 ttt . . . . . 0 N--CA 1.479 0.995 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -158.64 143.99 16.43 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 125.166 1.386 . . . . 0.0 107.837 168.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 81.8 mt -78.09 154.51 5.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 173.283 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 20.3 t -124.69 169.45 16.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 106.106 -1.812 . . . . 0.0 106.106 -172.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.82 153.25 49.65 Favored 'General case' 0 C--O 1.234 0.274 0 O-C-N 120.809 -1.182 . . . . 0.0 109.168 171.498 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -147.73 171.15 16.13 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 123.687 0.795 . . . . 0.0 110.047 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 72.9 p -134.62 173.22 11.9 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 175.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -51.69 -30.76 23.33 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 119.644 1.111 . . . . 0.0 112.977 -176.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 26.1 mp0 -62.13 -31.64 72.14 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.061 1.744 . . . . 0.0 112.728 179.497 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.4 m -139.61 -2.93 1.52 Allowed 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 114.475 1.287 . . . . 0.0 114.475 -169.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 58.2 t80 -53.63 -38.5 64.12 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 123.95 0.9 . . . . 0.0 110.773 176.586 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.4 m -66.37 -41.82 88.88 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 122.691 0.397 . . . . 0.0 111.205 -178.612 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.83 -45.26 86.91 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 176.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -65.3 -37.49 87.3 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 122.568 0.347 . . . . 0.0 111.247 -176.482 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.53 ' HA ' HG21 ' A' ' 20' ' ' VAL . 23.9 p -78.32 0.49 25.26 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 60.0 m -109.34 32.23 5.15 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.375 1.07 . . . . 0.0 112.302 -173.231 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -132.44 3.72 3.93 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -177.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 166.59 -166.68 39.12 Favored Glycine 0 C--N 1.335 0.498 0 O-C-N 121.339 -0.85 . . . . 0.0 111.162 -177.499 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.2 t -76.2 136.12 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 103.717 -2.698 . . . . 0.0 103.717 167.684 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.53 HG21 ' HA ' ' A' ' 15' ' ' THR . 40.5 t -137.29 139.58 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 -172.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -117.73 97.2 5.72 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 105.331 -2.1 . . . . 0.0 105.331 176.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.56 154.83 28.49 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 172.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -135.7 98.95 4.05 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 125.718 1.607 . . . . 0.0 107.015 -179.718 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -73.87 116.39 14.43 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 169.58 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 9.1 p-90 -137.47 175.06 9.94 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.015 0.926 . . . . 0.0 110.759 -172.428 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -151.83 146.8 19.05 Favored Pre-proline 0 CA--C 1.538 0.485 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 169.256 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.25 -17.14 21.84 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.835 2.357 . . . . 0.0 113.625 -169.606 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -85.0 -6.49 59.33 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 118.715 0.689 . . . . 0.0 112.494 178.097 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 42.4 t -91.16 117.98 30.06 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 118.997 0.817 . . . . 0.0 109.066 -176.423 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -56.84 -54.02 39.78 Favored Glycine 0 CA--C 1.532 1.103 0 CA-C-O 118.812 -0.993 . . . . 0.0 112.414 176.139 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -50.53 -36.39 49.27 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 123.19 2.594 . . . . 0.0 115.272 174.64 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 98.6 m -60.6 -36.62 79.02 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 120.03 1.286 . . . . 0.0 111.831 173.2 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 59.9 mttm -69.8 -42.94 73.07 Favored 'General case' 0 N--CA 1.464 0.231 0 O-C-N 121.601 -0.687 . . . . 0.0 109.591 174.067 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 74.2 mtm -64.65 -35.01 79.65 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 118.987 -0.53 . . . . 0.0 111.771 -176.576 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 11.7 tt -80.94 -16.46 12.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-N 119.095 0.861 . . . . 0.0 111.811 179.197 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.53 -49.0 91.01 Favored Pre-proline 0 CA--C 1.543 0.709 0 CA-C-O 117.526 -1.226 . . . . 0.0 113.643 -179.378 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.52 -27.43 46.34 Favored 'Trans proline' 0 C--N 1.35 0.608 0 CA-C-N 122.048 1.767 . . . . 0.0 112.572 176.731 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.3 t -66.65 -40.41 86.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 119.226 0.921 . . . . 0.0 109.18 174.026 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 62.8 mt -66.94 -35.59 80.32 Favored 'General case' 0 CA--C 1.529 0.159 0 O-C-N 121.688 -0.632 . . . . 0.0 110.888 175.787 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -68.48 -36.2 78.62 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 119.269 0.941 . . . . 0.0 111.422 174.237 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -62.04 -43.17 99.42 Favored 'General case' 0 C--N 1.332 -0.158 0 O-C-N 121.122 -0.986 . . . . 0.0 109.903 171.306 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -65.26 -35.02 79.74 Favored 'General case' 0 N--CA 1.456 -0.171 0 O-C-N 121.93 -0.481 . . . . 0.0 111.509 176.698 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -65.7 -38.63 89.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 119.044 0.838 . . . . 0.0 110.357 175.155 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -68.91 -38.03 79.33 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 121.323 -0.861 . . . . 0.0 111.737 175.588 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -85.99 -36.16 19.96 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.258 1.023 . . . . 0.0 112.064 -171.396 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.441 ' SD ' ' HE2' ' A' ' 49' ' ' LYS . 19.0 mmt -135.57 -8.37 2.19 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.169 1.387 . . . . 0.0 112.626 -168.042 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.5 -21.41 54.32 Favored Glycine 0 CA--C 1.532 1.123 0 CA-C-N 120.321 1.419 . . . . 0.0 114.577 -171.409 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -76.79 -18.51 58.37 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.626 1.97 . . . . 0.0 112.134 -179.679 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.441 ' HE2' ' SD ' ' A' ' 46' ' ' MET . 14.8 pttm -134.02 -2.07 2.93 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 126.56 1.944 . . . . 0.0 112.239 -173.839 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -145.2 120.22 10.04 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 125.996 1.718 . . . . 0.0 107.424 174.865 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -73.07 150.99 41.86 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 176.086 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 16.9 mt -121.97 132.7 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 N-CA-C 105.892 -1.892 . . . . 0.0 105.892 173.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 48.0 t -132.15 111.75 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-N 118.687 0.676 . . . . 0.0 109.495 -170.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 61.2 mmtt -72.86 142.27 47.96 Favored 'General case' 0 C--O 1.234 0.288 0 O-C-N 121.551 -0.718 . . . . 0.0 109.49 171.024 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 11.9 tt -151.26 131.36 3.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 171.189 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -87.44 129.64 34.98 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 121.375 -0.828 . . . . 0.0 109.579 -177.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.0 m -66.31 -36.21 76.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 -174.526 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -75.0 -35.44 62.02 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 119.146 0.885 . . . . 0.0 109.762 -173.385 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -74.14 -15.67 61.02 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.699 0.799 . . . . 0.0 112.043 173.325 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 60.1 m-80 -141.11 49.61 1.65 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 119.523 1.056 . . . . 0.0 111.558 -167.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.413 ' CD ' ' H ' ' A' ' 61' ' ' GLN . 0.1 OUTLIER -56.82 -38.8 73.12 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.956 0.902 . . . . 0.0 109.478 179.563 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -65.87 -28.2 68.78 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 125.034 1.334 . . . . 0.0 112.572 -178.299 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.416 ' HA ' ' HE2' ' A' ' 66' ' ' LYS . 0.2 OUTLIER -88.43 -44.23 10.89 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-N 118.673 0.67 . . . . 0.0 109.797 179.036 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.23 -46.58 86.3 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 119.017 0.826 . . . . 0.0 109.731 178.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -60.94 -24.17 62.4 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 124.166 0.889 . . . . 0.0 112.466 175.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.416 ' HE2' ' HA ' ' A' ' 63' ' ' THR . 4.9 ttmm -58.52 -22.07 54.11 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.298 1.039 . . . . 0.0 111.966 175.161 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -122.19 12.03 10.22 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.659 1.184 . . . . 0.0 110.854 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 70.78 31.8 67.22 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 123.743 0.687 . . . . 0.0 112.573 -178.314 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 94.9 t -111.08 139.22 35.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 C-N-CA 124.962 1.305 . . . . 0.0 107.825 -178.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 9.1 tpt -155.23 30.09 0.39 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.372 1.069 . . . . 0.0 108.807 167.296 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 19.3 m -138.39 157.01 47.06 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 126.335 1.854 . . . . 0.0 107.456 -177.716 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -144.33 157.35 56.56 Favored Pre-proline 0 CA--C 1.54 0.569 0 CA-C-O 118.462 -0.78 . . . . 0.0 110.79 -169.775 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -66.81 139.76 46.91 Favored 'Cis proline' 0 N--CA 1.458 -0.575 0 N-CA-C 109.335 -1.064 . . . . 0.0 109.335 -11.261 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 85.0 m -133.6 116.07 15.44 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 174.242 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 72.7 mt -86.46 144.68 27.16 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 175.759 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -129.24 126.82 39.95 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 104.261 -2.496 . . . . 0.0 104.261 -178.068 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.1 t -111.33 123.52 67.26 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.414 0 N-CA-C 104.367 -2.457 . . . . 0.0 104.367 -175.796 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.0 mp -129.65 161.75 29.87 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 124.525 1.13 . . . . 0.0 108.236 -177.718 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 63.0 tttm -149.03 127.34 12.16 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 176.044 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.8 t70 43.39 35.27 0.87 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.428 1.491 . . . . 0.0 113.684 176.334 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 105.38 1.74 40.95 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-O 118.11 -1.383 . . . . 0.0 115.224 169.407 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -130.34 145.79 51.83 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 120.044 1.922 . . . . 0.0 110.089 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.6 p -69.37 141.45 17.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 C-N-CA 123.924 0.89 . . . . 0.0 109.306 174.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 35.6 m -129.42 -18.32 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 C-N-CA 125.709 1.604 . . . . 0.0 110.693 178.788 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -161.06 169.46 22.41 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 120.543 1.52 . . . . 0.0 111.669 170.149 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 54.5 m -145.82 144.65 30.4 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.07 1.748 . . . . 0.0 108.01 169.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 15.8 m -146.86 150.2 34.78 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 124.636 1.174 . . . . 0.0 108.83 -178.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 39.9 t -129.61 148.21 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -171.341 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.55 179.06 51.92 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 124.015 0.817 . . . . 0.0 111.708 178.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -62.43 151.58 36.73 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.539 0.736 . . . . 0.0 110.623 176.618 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.35 145.91 33.98 Favored Pre-proline 0 C--O 1.234 0.253 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 167.733 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -70.91 163.57 38.73 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.658 2.238 . . . . 0.0 110.173 173.196 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -54.78 -44.66 73.92 Favored 'General case' 0 C--O 1.224 -0.266 0 CA-C-O 118.585 -0.722 . . . . 0.0 110.694 179.12 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -63.81 -41.62 97.85 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 118.849 0.75 . . . . 0.0 111.319 -169.772 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.54 -42.71 82.25 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 123.22 0.608 . . . . 0.0 110.893 176.709 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 42.4 tp -69.37 -40.25 77.55 Favored 'General case' 0 N--CA 1.451 -0.416 0 O-C-N 122.124 -0.36 . . . . 0.0 110.808 -177.112 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.5 pp0? -71.71 -29.32 64.43 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 118.888 0.767 . . . . 0.0 110.062 176.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -64.04 -49.29 72.95 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 174.402 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 59.1 tp -57.33 -44.14 83.96 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 123.751 0.82 . . . . 0.0 110.515 178.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 11.1 t -62.19 -52.1 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 176.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.83 -25.15 67.78 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 119.095 0.861 . . . . 0.0 112.313 -175.688 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -67.74 -17.14 64.45 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 117.938 -1.03 . . . . 0.0 113.004 171.588 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -114.2 -15.07 12.25 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 120.017 1.281 . . . . 0.0 113.182 176.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 53.2 mt . . . . . 0 C--O 1.249 1.067 0 CA-C-N 119.403 1.001 . . . . 0.0 109.493 169.387 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 N--CA 1.478 0.941 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -155.11 144.6 21.25 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.73 1.212 . . . . 0.0 107.78 169.606 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 89.8 mt -78.2 146.16 8.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 177.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 39.0 t -107.05 167.19 3.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 -174.777 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 5.7 mptt -138.47 136.53 36.27 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 -177.66 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -144.84 169.75 17.45 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 123.035 0.534 . . . . 0.0 110.957 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 75.8 p -133.71 176.75 8.27 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.989 1.316 . . . . 0.0 108.162 177.684 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -51.05 -31.97 20.4 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 120.307 1.412 . . . . 0.0 112.773 -178.11 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 24.3 mp0 -67.93 -25.9 65.7 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.664 1.985 . . . . 0.0 112.792 -178.419 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 51.7 p -135.92 -17.56 1.64 Allowed 'General case' 0 C--O 1.234 0.241 0 N-CA-C 115.343 1.608 . . . . 0.0 115.343 -168.661 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -53.89 -34.81 60.56 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 124.909 1.283 . . . . 0.0 110.869 179.021 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.0 m -70.22 -37.91 75.13 Favored 'General case' 0 N--CA 1.453 -0.282 0 O-C-N 122.303 -0.248 . . . . 0.0 111.116 -176.587 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.15 -45.82 72.49 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 174.391 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -64.61 -37.39 87.39 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 119.283 -0.389 . . . . 0.0 111.468 -174.541 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.509 ' HA ' HG21 ' A' ' 20' ' ' VAL . 24.7 p -78.38 -0.11 27.81 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -178.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 62.1 m -111.38 33.76 4.5 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.228 1.011 . . . . 0.0 111.999 -170.657 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -132.21 -1.29 3.63 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 -177.73 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 166.67 -166.87 39.27 Favored Glycine 0 C--N 1.335 0.523 0 N-CA-C 110.686 -0.966 . . . . 0.0 110.686 -173.259 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 72.9 t -72.01 134.72 29.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 104.695 -2.335 . . . . 0.0 104.695 166.615 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.509 HG21 ' HA ' ' A' ' 15' ' ' THR . 35.1 t -137.56 124.11 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 -176.87 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 61.6 tp -94.46 97.94 10.51 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 173.586 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.97 150.01 35.91 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 170.487 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -132.89 99.77 4.7 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 125.375 1.47 . . . . 0.0 107.262 175.141 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -76.95 114.57 15.89 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 172.503 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 9.1 p-90 -137.7 175.05 9.94 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 123.273 0.629 . . . . 0.0 110.689 -169.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -152.93 146.78 18.34 Favored Pre-proline 0 CA--C 1.535 0.397 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 168.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -73.49 -22.27 18.6 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.613 2.208 . . . . 0.0 113.187 -169.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -81.88 -7.21 59.59 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.398 0.679 . . . . 0.0 112.28 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 48.4 t -93.12 110.61 22.1 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 -177.679 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -50.09 -52.18 27.69 Favored Glycine 0 CA--C 1.533 1.205 0 CA-C-O 118.852 -0.971 . . . . 0.0 113.024 177.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_exo -51.3 -34.73 50.81 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 123.13 2.553 . . . . 0.0 115.366 173.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 93.6 m -62.53 -37.0 84.38 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 120.182 1.355 . . . . 0.0 111.428 173.475 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -69.05 -43.14 75.27 Favored 'General case' 0 N--CA 1.463 0.198 0 O-C-N 121.722 -0.611 . . . . 0.0 109.704 173.57 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 75.1 mtm -65.28 -33.65 76.49 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 118.439 0.563 . . . . 0.0 111.911 -176.504 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.4 tt -82.0 -15.44 12.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-N 119.152 0.887 . . . . 0.0 111.852 179.335 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.27 -48.94 93.02 Favored Pre-proline 0 CA--C 1.544 0.725 0 CA-C-O 117.593 -1.194 . . . . 0.0 113.331 179.168 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.07 -28.68 56.98 Favored 'Trans proline' 0 C--N 1.351 0.665 0 CA-C-N 121.88 1.707 . . . . 0.0 112.412 175.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 16.5 t -65.91 -40.19 86.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 119.569 1.077 . . . . 0.0 109.491 174.06 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 70.3 mt -67.51 -33.25 74.69 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-O 118.657 -0.687 . . . . 0.0 110.855 176.09 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -68.56 -36.0 78.18 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.443 1.02 . . . . 0.0 111.583 172.193 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 -61.9 -45.34 94.17 Favored 'General case' 0 C--O 1.227 -0.097 0 O-C-N 120.839 -1.163 . . . . 0.0 109.426 171.512 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -61.73 -36.22 80.33 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 118.523 0.601 . . . . 0.0 111.511 174.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -66.03 -37.51 86.06 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 118.919 0.781 . . . . 0.0 110.691 178.559 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -70.7 -45.81 64.28 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 122.993 0.517 . . . . 0.0 111.169 176.178 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -79.78 -33.2 40.78 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.469 1.107 . . . . 0.0 111.738 -169.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.42 ' HA ' ' HE3' ' A' ' 49' ' ' LYS . 22.2 mmt -139.95 -9.01 1.18 Allowed 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 117.808 -1.092 . . . . 0.0 113.842 -168.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -75.21 47.83 2.03 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 126.134 1.826 . . . . 0.0 114.569 -169.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -150.95 -39.75 0.13 Allowed 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 128.129 2.572 . . . . 0.0 107.584 169.13 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.42 ' HE3' ' HA ' ' A' ' 46' ' ' MET . 41.4 mtmt -65.22 -30.7 71.61 Favored 'General case' 0 C--N 1.342 0.28 0 C-N-CA 124.492 1.117 . . . . 0.0 110.651 169.041 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -134.25 164.37 27.54 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 125.486 1.514 . . . . 0.0 110.198 169.522 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -99.26 152.46 19.9 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 124.673 1.189 . . . . 0.0 108.182 172.673 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 19.0 mt -118.41 136.32 55.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 N-CA-C 105.488 -2.041 . . . . 0.0 105.488 172.067 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 79.1 t -133.17 117.76 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 119.054 0.843 . . . . 0.0 108.802 -176.121 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 55.1 mmtt -76.29 145.16 39.81 Favored 'General case' 0 C--O 1.234 0.284 0 O-C-N 121.672 -0.642 . . . . 0.0 109.859 169.723 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 16.0 tt -148.76 119.03 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 169.419 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -82.24 116.72 21.9 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -177.558 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 33.9 m -62.19 -25.83 38.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -174.366 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -66.1 -29.96 70.38 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 119.513 1.051 . . . . 0.0 110.949 -177.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -100.75 -3.27 30.42 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.298 1.039 . . . . 0.0 110.99 179.784 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 -141.65 43.48 1.73 Allowed 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.715 1.206 . . . . 0.0 109.942 -168.67 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.5 ' CD ' ' H ' ' A' ' 61' ' ' GLN . 1.0 OUTLIER -58.33 -41.5 84.71 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.804 1.242 . . . . 0.0 108.77 -177.937 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -64.5 -42.97 95.51 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.91 0.884 . . . . 0.0 110.509 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.518 ' HA ' ' HE3' ' A' ' 66' ' ' LYS . 0.5 OUTLIER -68.94 -44.04 73.86 Favored 'General case' 0 C--O 1.221 -0.397 0 CA-C-N 118.776 0.716 . . . . 0.0 110.255 -177.519 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.3 -45.1 94.77 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 119.094 0.861 . . . . 0.0 109.347 176.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -57.46 -27.53 58.41 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 124.077 0.846 . . . . 0.0 112.702 174.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.518 ' HE3' ' HA ' ' A' ' 63' ' ' THR . 25.7 ttmt -58.49 -21.22 51.06 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.656 1.582 . . . . 0.0 111.924 178.566 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -126.61 13.74 7.53 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.657 1.183 . . . . 0.0 110.687 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 71.71 32.56 64.05 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 123.775 0.702 . . . . 0.0 112.754 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 93.6 t -109.85 137.87 40.08 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 C-N-CA 124.806 1.243 . . . . 0.0 107.756 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 8.4 tpt -155.95 31.45 0.35 Allowed 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.355 1.062 . . . . 0.0 108.804 166.365 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 20.4 m -138.27 152.39 48.5 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 126.779 2.031 . . . . 0.0 106.643 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -146.11 159.08 47.14 Favored Pre-proline 0 CA--C 1.54 0.592 0 C-N-CA 123.95 0.9 . . . . 0.0 110.02 -169.417 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -67.17 138.94 43.95 Favored 'Cis proline' 0 C--N 1.349 0.59 0 CA-C-N 119.956 1.02 . . . . 0.0 109.691 -10.266 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 54.9 m -132.36 116.9 17.43 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 177.07 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 81.0 mt -92.45 137.13 32.63 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 177.842 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.6 mp -122.39 132.47 54.39 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 105.74 -1.948 . . . . 0.0 105.74 169.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 17.0 t -95.58 125.9 48.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 103.09 -2.929 . . . . 0.0 103.09 168.208 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.8 mp -120.72 159.18 25.91 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 125.422 1.489 . . . . 0.0 107.322 175.225 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -146.28 125.12 12.66 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 176.359 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.9 t70 45.81 35.66 2.39 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.311 1.444 . . . . 0.0 113.694 175.348 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 110.04 -2.53 30.02 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-O 118.055 -1.414 . . . . 0.0 115.484 168.622 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -131.57 144.43 51.08 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 120.081 1.941 . . . . 0.0 110.2 -178.622 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 5.3 p -65.72 137.16 25.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 171.582 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 34.3 m -121.12 -21.5 3.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 125.175 1.39 . . . . 0.0 110.433 176.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -157.31 162.73 39.14 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 119.701 1.137 . . . . 0.0 111.312 174.503 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 90.6 m -136.57 149.28 47.99 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.383 1.873 . . . . 0.0 108.416 175.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 30.4 m -147.35 152.81 38.82 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 126.267 1.827 . . . . 0.0 107.834 170.7 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 41.3 t -133.13 144.44 36.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 -175.285 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 80.22 179.83 52.86 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 123.907 0.765 . . . . 0.0 111.582 -179.084 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -62.97 147.7 49.78 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.683 0.793 . . . . 0.0 110.667 178.056 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 69.2 mttt -142.37 147.66 44.28 Favored Pre-proline 0 CA--C 1.531 0.233 0 C-N-CA 125.713 1.605 . . . . 0.0 106.898 168.767 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -73.2 159.44 47.27 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.581 2.187 . . . . 0.0 110.459 176.069 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 17.1 ptmt -55.55 -48.94 73.94 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 112.257 0.465 . . . . 0.0 112.257 -177.289 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -61.9 -39.29 91.46 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 123.59 0.756 . . . . 0.0 110.868 -169.391 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.64 -42.8 73.78 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 122.823 0.449 . . . . 0.0 110.855 176.341 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 46.5 tp -68.66 -38.42 80.39 Favored 'General case' 0 N--CA 1.451 -0.41 0 O-C-N 122.039 -0.413 . . . . 0.0 110.857 -178.152 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.4 pp0? -72.06 -29.47 64.17 Favored 'General case' 0 C--N 1.339 0.118 0 CA-C-N 119.174 0.897 . . . . 0.0 110.314 175.543 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -63.5 -48.85 75.89 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 174.461 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 59.3 tp -58.59 -44.97 90.0 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.191 0.596 . . . . 0.0 110.558 179.062 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.6 t -60.22 -51.43 73.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 C-N-CA 122.898 0.479 . . . . 0.0 109.74 177.623 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.37 -27.99 69.39 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 118.893 0.77 . . . . 0.0 112.121 -176.57 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -68.56 -25.87 65.12 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 118.303 -0.856 . . . . 0.0 112.345 172.211 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 75.5 m-70 -96.69 -16.98 20.63 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 119.68 1.127 . . . . 0.0 113.421 178.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 67.8 mt . . . . . 0 C--O 1.25 1.115 0 CA-C-N 119.813 1.188 . . . . 0.0 109.665 173.543 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mpt? . . . . . 0 N--CA 1.482 1.125 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -158.26 142.38 15.75 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.309 1.443 . . . . 0.0 107.374 168.655 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 86.7 mt -76.24 154.01 5.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 174.666 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 35.7 t -122.68 167.1 16.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 -175.29 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 6.1 mtmt -132.34 143.76 50.08 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 176.286 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -144.89 170.43 16.16 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 123.12 0.568 . . . . 0.0 110.246 175.251 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 77.4 p -134.62 173.61 11.48 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.915 1.286 . . . . 0.0 107.636 177.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -50.49 -30.65 13.33 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 119.271 0.941 . . . . 0.0 113.132 -177.566 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 26.9 mp0 -64.25 -32.23 73.74 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.13 1.772 . . . . 0.0 112.794 -179.343 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.2 m -140.02 -5.57 1.29 Allowed 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 -169.779 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -52.26 -38.8 59.22 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 124.355 1.062 . . . . 0.0 110.786 175.447 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.4 m -67.75 -36.15 80.01 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 122.675 0.39 . . . . 0.0 111.656 -176.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.92 -45.99 69.41 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 175.178 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -64.03 -35.23 80.03 Favored 'General case' 0 C--O 1.231 0.11 0 C-N-CA 123.06 0.544 . . . . 0.0 111.721 -174.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.492 ' HA ' HG21 ' A' ' 20' ' ' VAL . 22.3 p -82.44 2.09 34.33 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.611 0.764 . . . . 0.0 112.955 -178.538 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 48.7 m -118.07 35.61 4.67 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 118.891 0.769 . . . . 0.0 112.726 -169.224 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -145.89 14.3 1.34 Allowed 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 176.545 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 172.08 -168.54 41.64 Favored Glycine 0 C--N 1.34 0.771 0 O-C-N 121.17 -0.956 . . . . 0.0 111.698 176.635 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 61.0 t -74.81 133.74 30.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 N-CA-C 104.498 -2.408 . . . . 0.0 104.498 167.272 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.492 HG21 ' HA ' ' A' ' 15' ' ' THR . 38.1 t -139.63 117.32 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 -174.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 64.4 tp -88.25 97.29 10.94 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 173.798 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.05 147.77 38.46 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 169.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -133.73 98.9 4.31 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 125.172 1.389 . . . . 0.0 107.539 176.527 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -75.81 114.88 14.91 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 105.893 -1.891 . . . . 0.0 105.893 173.08 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 9.2 p-90 -137.49 175.21 9.81 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.478 0.711 . . . . 0.0 110.81 -169.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -152.92 147.43 19.06 Favored Pre-proline 0 CA--C 1.537 0.446 0 C-N-CA 124.602 1.161 . . . . 0.0 107.897 169.094 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.3 -21.57 17.41 Favored 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 122.8 2.333 . . . . 0.0 113.423 -170.645 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -81.71 -9.3 59.68 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 118.665 0.666 . . . . 0.0 112.051 178.411 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 51.0 t -88.28 117.1 26.95 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -179.395 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -54.4 -57.65 16.34 Favored Glycine 0 CA--C 1.531 1.05 0 CA-C-O 118.565 -1.13 . . . . 0.0 111.888 176.315 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_exo -49.37 -35.44 35.49 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 123.703 2.935 . . . . 0.0 115.736 177.206 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 84.5 m -60.56 -37.85 82.61 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 119.941 1.246 . . . . 0.0 111.65 174.41 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 45.9 mtmt -79.88 -31.21 40.34 Favored 'General case' 0 CA--C 1.529 0.151 0 O-C-N 121.674 -0.641 . . . . 0.0 110.29 177.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 63.6 mtt -65.06 -38.86 92.21 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.994 0.816 . . . . 0.0 111.278 175.247 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 10.2 tt -80.95 -16.94 12.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 118.887 0.767 . . . . 0.0 111.632 -179.735 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -52.32 -49.8 83.14 Favored Pre-proline 0 CA--C 1.544 0.716 0 CA-C-O 117.506 -1.235 . . . . 0.0 113.777 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -64.98 -31.52 55.78 Favored 'Trans proline' 0 C--N 1.35 0.649 0 CA-C-N 121.92 1.722 . . . . 0.0 112.236 176.327 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 20.2 t -63.44 -43.61 98.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-N 119.106 0.866 . . . . 0.0 109.049 175.184 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 71.9 mt -65.17 -36.16 83.36 Favored 'General case' 0 C--O 1.227 -0.115 0 CA-C-O 118.849 -0.596 . . . . 0.0 110.954 177.399 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -65.94 -38.09 87.71 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 119.273 0.942 . . . . 0.0 111.279 174.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -68.2 -38.86 82.41 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 121.133 -0.98 . . . . 0.0 110.456 174.452 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.91 -42.26 99.73 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.001 0.92 . . . . 0.0 109.421 177.15 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -63.15 -45.01 93.9 Favored 'General case' 0 C--O 1.226 -0.132 0 C-N-CA 123.718 0.807 . . . . 0.0 110.449 176.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -61.69 -30.5 70.78 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 121.705 -0.622 . . . . 0.0 111.989 176.05 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -85.99 -40.01 16.28 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.893 0.877 . . . . 0.0 112.133 -175.449 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 17.8 mmt -135.68 1.11 2.78 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 -167.191 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.3 47.51 1.11 Allowed Glycine 0 CA--C 1.53 1.022 0 C-N-CA 127.224 2.345 . . . . 0.0 114.625 -169.604 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -149.71 -40.1 0.14 Allowed 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 128.552 2.741 . . . . 0.0 108.032 171.157 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -62.81 -38.8 92.14 Favored 'General case' 0 C--N 1.342 0.263 0 C-N-CA 124.633 1.173 . . . . 0.0 110.218 169.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -133.31 165.22 25.33 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.418 1.487 . . . . 0.0 110.294 173.264 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -104.81 155.11 19.19 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.726 1.61 . . . . 0.0 107.453 171.779 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 17.9 mt -117.52 135.78 56.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 N-CA-C 105.242 -2.132 . . . . 0.0 105.242 169.494 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 91.3 t -130.96 113.78 25.27 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -177.037 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 44.4 mmtt -73.78 144.25 45.69 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 169.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 15.2 tt -148.06 118.03 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 169.699 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -82.51 115.44 21.5 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 -176.592 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 27.8 m -62.49 -24.79 36.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 N-CA-C 112.519 0.562 . . . . 0.0 112.519 -175.684 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -70.48 -10.62 59.65 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 119.318 0.963 . . . . 0.0 112.083 -178.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -122.95 1.09 9.25 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.645 1.178 . . . . 0.0 110.889 175.628 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -145.65 36.88 1.08 Allowed 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.636 1.174 . . . . 0.0 110.128 -169.649 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -59.07 -29.25 67.19 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.579 0.752 . . . . 0.0 110.551 177.625 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 59.6 mp0 -59.97 -49.48 77.5 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.504 1.522 . . . . 0.0 110.041 173.764 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.63 -41.87 68.32 Favored 'General case' 0 C--O 1.222 -0.392 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 -175.8 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -61.14 -46.78 89.14 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 119.057 0.844 . . . . 0.0 109.775 176.674 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -59.19 -24.55 58.9 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 124.312 0.958 . . . . 0.0 112.856 175.461 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 8.9 ttmm -59.38 -20.82 57.77 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.764 1.225 . . . . 0.0 111.791 176.412 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -125.6 13.11 8.08 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.199 1.4 . . . . 0.0 110.473 177.806 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 68.52 21.63 74.59 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 124.554 1.074 . . . . 0.0 113.524 -177.076 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 87.3 t -89.34 154.39 3.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-N 118.308 1.054 . . . . 0.0 109.372 178.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -162.23 -24.01 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.898 2.079 . . . . 0.0 109.404 167.097 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 8.8 m -63.51 149.3 46.51 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 123.571 0.749 . . . . 0.0 109.114 169.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -144.31 155.46 57.77 Favored Pre-proline 0 CA--C 1.541 0.614 0 C-N-CA 124.176 0.99 . . . . 0.0 108.925 176.739 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -66.69 140.24 48.84 Favored 'Cis proline' 0 N--CA 1.457 -0.643 0 CA-C-N 120.003 1.037 . . . . 0.0 109.584 -10.239 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 52.7 m -131.63 117.81 19.19 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 175.584 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 93.1 mt -93.79 135.24 35.3 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 178.701 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.5 mp -122.9 129.45 51.64 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 104.713 -2.329 . . . . 0.0 104.713 169.234 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 48.1 t -94.84 120.94 44.96 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.416 0 N-CA-C 103.361 -2.829 . . . . 0.0 103.361 168.373 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.9 mp -108.41 159.26 16.81 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 169.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -146.34 123.91 11.78 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 106.738 -1.579 . . . . 0.0 106.738 175.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.0 t70 42.21 40.67 1.82 Allowed 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.032 1.333 . . . . 0.0 113.08 179.582 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.67 9.66 59.77 Favored Glycine 0 CA--C 1.529 0.962 0 CA-C-O 118.584 -1.12 . . . . 0.0 114.957 171.175 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -126.55 139.81 52.92 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 119.552 1.676 . . . . 0.0 108.472 177.137 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 18.5 t -68.01 134.28 30.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 106.711 -1.589 . . . . 0.0 106.711 169.068 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.6 m -124.89 -18.61 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 124.41 1.084 . . . . 0.0 110.898 177.453 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.22 165.17 36.55 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 119.619 1.1 . . . . 0.0 110.955 174.065 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 97.5 m -149.32 149.28 30.65 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.209 1.403 . . . . 0.0 109.108 177.617 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.9 m -149.87 156.25 41.46 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 126.018 1.727 . . . . 0.0 108.929 172.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.9 t -133.58 144.46 35.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 -179.287 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.1 -178.45 53.61 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 123.647 0.641 . . . . 0.0 111.567 -178.561 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -62.33 149.0 43.39 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.786 0.834 . . . . 0.0 110.678 177.824 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 25.3 mttp -142.32 142.11 23.0 Favored Pre-proline 0 C--O 1.234 0.248 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 168.106 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -72.5 162.93 40.04 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 122.646 2.23 . . . . 0.0 110.458 175.749 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -54.64 -46.2 73.92 Favored 'General case' 0 C--O 1.223 -0.295 0 C-N-CA 123.073 0.549 . . . . 0.0 110.82 -179.552 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -64.84 -41.13 95.97 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 118.356 0.525 . . . . 0.0 111.05 -169.594 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.28 -45.45 80.41 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 122.651 0.38 . . . . 0.0 110.539 176.339 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 46.5 tp -65.75 -42.42 90.93 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 123.037 0.535 . . . . 0.0 110.436 -176.005 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -68.37 -32.78 73.1 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 118.715 0.689 . . . . 0.0 109.818 178.406 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -67.64 -46.8 71.39 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 118.835 0.743 . . . . 0.0 109.446 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.0 tt -54.16 -42.75 69.95 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.385 1.074 . . . . 0.0 109.569 175.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 25.2 t -63.84 -50.67 76.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-O 117.499 -1.239 . . . . 0.0 110.548 175.233 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -56.12 -46.18 79.24 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 120.718 1.599 . . . . 0.0 110.279 -176.813 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -57.21 -15.0 4.84 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.228 1.011 . . . . 0.0 113.225 178.739 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 78.8 m-70 -121.09 -5.06 9.51 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 177.623 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 53.9 mt . . . . . 0 C--O 1.248 1.008 0 CA-C-N 120.106 1.321 . . . . 0.0 109.113 169.959 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.4 ttp . . . . . 0 N--CA 1.483 1.222 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -160.23 157.51 28.32 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.48 1.512 . . . . 0.0 108.261 175.138 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 77.3 mt -75.29 153.84 6.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 172.695 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.4 t -129.22 169.88 19.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 -173.383 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.26 153.46 50.34 Favored 'General case' 0 C--O 1.233 0.235 0 O-C-N 120.791 -1.193 . . . . 0.0 108.994 169.851 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -144.71 175.5 10.12 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 123.886 0.874 . . . . 0.0 109.939 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 70.6 p -133.13 177.36 7.73 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.798 1.239 . . . . 0.0 107.947 174.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -53.97 -25.94 23.33 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 119.547 1.067 . . . . 0.0 112.553 176.644 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 48.2 mm-40 -73.34 -25.17 60.5 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.091 1.356 . . . . 0.0 112.522 -178.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 33.2 p -135.15 -11.99 2.18 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 115.634 1.716 . . . . 0.0 115.634 -167.677 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -53.96 -35.79 62.17 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 124.194 0.998 . . . . 0.0 110.852 179.392 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.7 m -70.81 -34.92 72.24 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 122.686 0.394 . . . . 0.0 111.48 -177.373 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -72.94 -32.74 65.46 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 123.556 0.742 . . . . 0.0 110.625 176.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -79.05 -39.59 33.53 Favored 'General case' 0 N--CA 1.453 -0.319 0 O-C-N 122.003 -0.435 . . . . 0.0 111.505 -177.813 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.495 ' HA ' HG21 ' A' ' 20' ' ' VAL . 25.2 p -78.11 -0.64 28.97 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -174.026 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 28.7 p -110.46 30.94 6.33 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.269 1.028 . . . . 0.0 112.834 -169.339 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -131.48 -0.13 4.0 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 113.58 0.955 . . . . 0.0 113.58 -175.463 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 165.73 -166.29 38.46 Favored Glycine 0 C--N 1.336 0.559 0 CA-C-N 119.358 0.981 . . . . 0.0 110.886 -174.485 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 88.6 t -71.73 129.82 35.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 N-CA-C 105.212 -2.144 . . . . 0.0 105.212 166.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.495 HG21 ' HA ' ' A' ' 15' ' ' THR . 25.4 t -133.11 116.66 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 -176.516 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 63.9 tp -88.21 96.83 10.7 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 174.112 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.06 148.54 37.9 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 170.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -133.51 96.76 3.78 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 125.031 1.332 . . . . 0.0 107.419 177.36 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -74.53 113.81 12.21 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 172.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 6.6 p-90 -137.63 176.72 8.45 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 123.435 0.694 . . . . 0.0 110.532 -169.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -155.72 147.75 17.36 Favored Pre-proline 0 C--O 1.237 0.446 0 C-N-CA 125.793 1.637 . . . . 0.0 106.731 169.384 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.94 -20.49 15.01 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.99 2.46 . . . . 0.0 113.3 -170.232 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -79.37 -7.59 58.47 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 118.528 0.604 . . . . 0.0 112.381 -179.616 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 44.0 t -95.56 122.25 38.1 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -178.341 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -56.87 -57.48 19.44 Favored Glycine 0 CA--C 1.531 1.046 0 CA-C-O 118.623 -1.098 . . . . 0.0 112.098 178.115 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_exo -48.37 -36.19 29.73 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 123.756 2.971 . . . . 0.0 115.8 177.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 79.8 m -59.6 -31.82 69.83 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 119.875 1.216 . . . . 0.0 112.504 175.346 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt -88.32 -33.88 17.85 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 123.445 0.698 . . . . 0.0 109.737 177.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 62.3 mtt -61.65 -37.07 82.68 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.935 0.789 . . . . 0.0 111.264 175.661 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 10.9 tt -80.08 -14.04 13.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-N 118.603 0.638 . . . . 0.0 111.928 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.97 -48.35 94.14 Favored Pre-proline 0 CA--C 1.543 0.685 0 CA-C-O 117.403 -1.284 . . . . 0.0 113.411 -178.316 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -65.03 -29.15 57.14 Favored 'Trans proline' 0 C--N 1.349 0.592 0 CA-C-N 121.996 1.749 . . . . 0.0 112.607 175.714 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 12.9 t -66.71 -40.45 86.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 119.343 0.974 . . . . 0.0 109.305 174.557 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 91.6 mt -66.72 -35.69 80.72 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-O 118.756 -0.64 . . . . 0.0 110.845 175.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -68.04 -36.06 79.28 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 119.481 1.037 . . . . 0.0 111.288 174.501 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 45.3 mm-40 -63.88 -43.91 94.62 Favored 'General case' 0 CA--C 1.529 0.151 0 O-C-N 121.05 -1.031 . . . . 0.0 109.958 171.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -63.3 -36.54 84.0 Favored 'General case' 0 C--O 1.226 -0.181 0 C-N-CA 123.129 0.572 . . . . 0.0 111.109 176.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -64.71 -42.7 95.07 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 118.636 0.653 . . . . 0.0 109.995 176.112 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -65.91 -33.39 75.72 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.708 -0.62 . . . . 0.0 112.377 175.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -89.27 -32.48 17.37 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.093 0.957 . . . . 0.0 112.274 -172.129 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.525 ' SD ' ' HE2' ' A' ' 49' ' ' LYS . 22.5 mmt -136.25 -11.54 1.92 Allowed 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.879 1.271 . . . . 0.0 112.663 -168.361 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.42 2.88 18.79 Favored Glycine 0 CA--C 1.53 0.988 0 CA-C-N 120.827 1.649 . . . . 0.0 114.545 -172.327 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -90.2 -17.15 28.06 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 127.126 2.17 . . . . 0.0 111.766 170.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.525 ' HE2' ' SD ' ' A' ' 46' ' ' MET . 14.9 pttm -138.94 6.4 2.41 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 127.072 2.149 . . . . 0.0 112.466 -174.244 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -145.85 163.96 33.41 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 129.144 2.978 . . . . 0.0 105.998 175.314 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -121.05 154.91 35.46 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 125.231 1.412 . . . . 0.0 107.359 173.091 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 15.7 mt -123.4 135.28 63.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 N-CA-C 105.179 -2.156 . . . . 0.0 105.179 174.339 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 88.3 t -132.1 111.19 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -174.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 38.6 mmtt -71.65 142.55 49.9 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 169.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 15.7 tt -148.64 119.78 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 170.521 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 50.7 t0 -80.26 115.88 20.05 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 123.561 0.745 . . . . 0.0 109.138 -177.243 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 28.6 m -60.95 -30.25 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-N 118.227 0.467 . . . . 0.0 111.889 -177.268 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -76.16 2.68 12.4 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.986 0.914 . . . . 0.0 112.024 -176.091 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -129.89 -4.13 4.59 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.69 1.596 . . . . 0.0 110.743 173.478 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -141.34 47.55 1.69 Allowed 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.287 1.035 . . . . 0.0 109.938 -168.384 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.509 ' NE2' ' H ' ' A' ' 61' ' ' GLN . 0.3 OUTLIER -52.47 -43.35 64.92 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.587 1.555 . . . . 0.0 109.427 177.958 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 33.3 mp0 -67.35 -27.97 67.57 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 126.206 1.802 . . . . 0.0 111.903 -174.829 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.439 ' HA ' ' HE2' ' A' ' 66' ' ' LYS . 0.2 OUTLIER -88.39 -46.2 9.36 Favored 'General case' 0 C--O 1.22 -0.481 0 CA-C-N 118.474 0.579 . . . . 0.0 109.614 178.722 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.8 -47.41 83.55 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.859 0.754 . . . . 0.0 109.683 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -61.46 -22.41 61.32 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 124.514 1.054 . . . . 0.0 112.846 175.108 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.439 ' HE2' ' HA ' ' A' ' 63' ' ' THR . 5.9 ttmm -57.61 -24.14 54.8 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 118.811 1.306 . . . . 0.0 111.771 174.669 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -125.4 14.74 8.27 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.851 1.26 . . . . 0.0 110.304 178.778 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 70.12 19.09 75.34 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 124.849 1.214 . . . . 0.0 114.038 -179.723 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 84.6 t -81.31 127.63 39.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 177.642 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 8.6 mmt -147.5 29.42 0.94 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.892 1.677 . . . . 0.0 108.735 169.341 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 17.0 m -142.85 152.18 41.88 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 126.681 1.993 . . . . 0.0 106.734 179.129 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -145.64 157.56 51.48 Favored Pre-proline 0 CA--C 1.54 0.576 0 C-N-CA 123.832 0.853 . . . . 0.0 109.914 -171.199 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -67.57 141.73 59.84 Favored 'Cis proline' 0 N--CA 1.459 -0.548 0 CA-C-N 119.852 0.983 . . . . 0.0 109.581 -10.235 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 55.2 m -131.78 116.4 17.22 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 176.25 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 93.3 mt -91.4 136.84 32.82 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 178.016 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.2 mp -120.68 130.84 54.27 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 105.098 -2.186 . . . . 0.0 105.098 169.133 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 25.5 t -93.72 121.09 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 103.016 -2.957 . . . . 0.0 103.016 169.429 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.8 mp -115.86 158.62 22.67 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 172.038 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -146.19 126.2 13.68 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 175.203 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.6 t70 44.75 38.31 2.75 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.263 1.425 . . . . 0.0 113.364 175.499 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.76 6.89 54.12 Favored Glycine 0 CA--C 1.53 0.982 0 CA-C-O 118.561 -1.133 . . . . 0.0 114.345 169.827 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -129.01 138.43 51.93 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 119.432 1.616 . . . . 0.0 108.764 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.7 p -68.96 135.91 27.43 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 168.023 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.4 m -125.3 -19.64 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 C-N-CA 124.543 1.137 . . . . 0.0 110.476 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.18 167.38 30.57 Favored 'General case' 0 C--N 1.344 0.369 0 CA-C-N 119.588 1.086 . . . . 0.0 111.182 174.146 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 97.4 m -147.22 149.32 32.68 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.571 1.548 . . . . 0.0 108.789 178.573 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 66.2 m -150.59 156.25 41.0 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.494 1.518 . . . . 0.0 108.691 172.422 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 40.6 t -132.59 144.46 36.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -177.289 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 83.84 179.4 51.98 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 124.007 0.813 . . . . 0.0 111.711 -179.18 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -61.89 150.59 37.05 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.845 0.858 . . . . 0.0 110.61 176.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 40.8 mttm -140.68 144.84 37.68 Favored Pre-proline 0 C--O 1.233 0.213 0 C-N-CA 125.007 1.323 . . . . 0.0 107.518 168.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -72.66 161.54 43.68 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.63 2.22 . . . . 0.0 110.327 173.349 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -55.16 -47.74 74.72 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 123.089 0.556 . . . . 0.0 110.957 -178.69 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -63.51 -43.6 96.73 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 118.218 0.463 . . . . 0.0 111.516 -168.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.46 -42.81 87.0 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.106 0.563 . . . . 0.0 110.954 178.328 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 42.7 tp -67.75 -42.46 81.76 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 110.27 -0.27 . . . . 0.0 110.27 -178.163 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.7 pp0? -69.48 -34.35 74.2 Favored 'General case' 0 N--CA 1.454 -0.273 0 O-C-N 121.567 -0.708 . . . . 0.0 109.605 177.698 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -60.14 -45.94 91.35 Favored 'General case' 0 C--N 1.339 0.115 0 CA-C-N 119.41 1.004 . . . . 0.0 108.532 176.297 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 61.0 tp -58.09 -39.9 79.78 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.558 0.743 . . . . 0.0 110.888 176.199 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 56.0 t -63.56 -48.93 84.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-O 118.498 -0.763 . . . . 0.0 110.517 175.081 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 24.4 m-80 -58.08 -40.8 81.99 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 120.239 1.381 . . . . 0.0 109.908 179.268 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -62.82 -13.83 38.28 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 117.904 -1.046 . . . . 0.0 113.13 -178.749 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 70.4 m-70 -124.28 -19.57 5.48 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.248 0.978 0 CA-C-N 120.302 1.41 . . . . 0.0 109.914 178.331 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.1 ttm . . . . . 0 N--CA 1.483 1.224 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -157.68 159.92 37.43 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.88 1.672 . . . . 0.0 107.916 173.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 81.8 mt -74.68 149.55 7.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 179.017 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 48.4 t -109.09 167.19 4.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 125.827 1.651 . . . . 0.0 106.915 -173.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 5.7 mptt -138.68 137.84 37.2 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 -176.257 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -149.01 171.76 15.85 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 122.973 0.509 . . . . 0.0 110.863 -179.641 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.5 p -136.63 173.23 11.93 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 125.598 1.559 . . . . 0.0 107.695 -176.192 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -50.55 -27.06 6.01 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.644 1.178 . . . . 0.0 112.634 176.626 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 49.0 mm-40 -65.18 -32.64 74.43 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 125.15 1.38 . . . . 0.0 112.104 -178.684 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.4 m -143.4 -5.48 0.84 Allowed 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 115.103 1.52 . . . . 0.0 115.103 -171.169 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -54.04 -35.47 62.0 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 119.48 1.036 . . . . 0.0 111.276 179.306 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.7 m -67.0 -41.64 86.36 Favored 'General case' 0 N--CA 1.452 -0.345 0 O-C-N 122.065 -0.397 . . . . 0.0 111.197 -178.737 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.62 -43.82 79.48 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 176.329 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -62.12 -38.49 89.13 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 123.503 0.721 . . . . 0.0 111.074 -176.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 25.9 p -81.55 3.53 24.64 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -178.299 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 50.4 m -120.46 36.79 4.45 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.384 1.074 . . . . 0.0 112.156 -169.649 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -142.5 12.48 1.93 Allowed 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 176.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 174.73 -166.59 38.44 Favored Glycine 0 C--N 1.339 0.709 0 O-C-N 121.191 -0.943 . . . . 0.0 111.629 179.078 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.1 t -80.09 125.11 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 103.281 -2.859 . . . . 0.0 103.281 167.59 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 22.9 t -136.8 118.73 19.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 -171.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 35.0 tp -87.93 147.49 25.04 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 168.159 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -135.34 154.06 51.64 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 176.387 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -134.48 98.9 4.2 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 -175.711 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -74.88 117.19 16.45 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 169.626 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 6.0 p-90 -145.72 179.53 7.38 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.441 0.697 . . . . 0.0 111.205 -170.278 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -159.96 151.78 16.79 Favored Pre-proline 0 CA--C 1.538 0.51 0 C-N-CA 125.896 1.678 . . . . 0.0 107.024 167.261 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -75.75 -18.46 17.15 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.851 2.367 . . . . 0.0 113.319 -169.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -80.01 -10.92 59.81 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 118.721 0.691 . . . . 0.0 112.044 178.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 50.9 t -88.74 119.19 29.0 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 178.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -56.23 -57.74 17.7 Favored Glycine 0 CA--C 1.531 1.049 0 CA-C-O 118.808 -0.995 . . . . 0.0 111.954 176.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -51.16 -32.9 41.91 Favored 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 123.375 2.717 . . . . 0.0 115.651 177.742 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 88.2 m -59.57 -42.5 92.6 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 119.905 1.229 . . . . 0.0 111.323 173.153 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 44.1 mtmt -74.12 -30.39 62.28 Favored 'General case' 0 CA--C 1.529 0.139 0 O-C-N 121.801 -0.562 . . . . 0.0 110.476 177.659 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 89.8 mtp -65.75 -40.54 92.19 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 119.001 0.819 . . . . 0.0 111.242 175.703 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 12.3 tt -80.97 -16.27 12.45 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-N 119.158 0.89 . . . . 0.0 111.603 -179.654 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.9 -50.17 75.91 Favored Pre-proline 0 CA--C 1.545 0.767 0 CA-C-O 117.494 -1.241 . . . . 0.0 114.003 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.68 -28.74 52.1 Favored 'Trans proline' 0 C--N 1.35 0.652 0 CA-C-N 122.044 1.766 . . . . 0.0 112.691 176.543 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 13.8 t -66.89 -40.56 86.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-N 119.027 0.831 . . . . 0.0 109.143 174.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 46.1 mt -66.88 -36.52 82.48 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 118.604 -0.712 . . . . 0.0 110.694 176.439 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -65.87 -40.5 91.68 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 119.279 0.945 . . . . 0.0 110.897 173.56 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 30.6 mm-40 -59.5 -42.21 91.64 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 119.068 0.849 . . . . 0.0 110.406 173.102 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.65 -36.2 83.03 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 123.263 0.625 . . . . 0.0 111.364 176.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -65.04 -45.44 85.42 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 123.633 0.773 . . . . 0.0 109.918 175.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 73.5 mm-40 -65.44 -27.69 68.7 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.923 -0.486 . . . . 0.0 111.95 178.334 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -92.12 -37.42 12.76 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.366 1.066 . . . . 0.0 112.193 -175.388 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.401 ' SD ' ' HE2' ' A' ' 49' ' ' LYS . 20.7 mmt -128.77 -9.67 4.98 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 124.241 1.017 . . . . 0.0 113.372 -167.595 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -50.06 -25.24 7.44 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 126.233 1.873 . . . . 0.0 115.351 -175.093 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -75.58 -28.29 58.89 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 124.829 1.252 . . . . 0.0 112.07 -176.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.401 ' HE2' ' SD ' ' A' ' 46' ' ' MET . 0.0 OUTLIER -125.63 -4.76 7.09 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 125.665 1.586 . . . . 0.0 112.984 -175.474 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -144.96 123.43 12.38 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 124.499 1.12 . . . . 0.0 108.095 172.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -80.39 154.81 27.47 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 176.667 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 29.4 mt -127.76 130.91 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 N-CA-C 105.516 -2.031 . . . . 0.0 105.516 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.9 t -129.53 116.84 40.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 118.485 0.584 . . . . 0.0 109.723 -171.326 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt -74.17 143.89 45.05 Favored 'General case' 0 C--O 1.236 0.347 0 O-C-N 121.477 -0.765 . . . . 0.0 109.558 170.184 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 10.6 tt -150.34 129.8 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 170.349 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -86.8 126.96 34.97 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 121.411 -0.806 . . . . 0.0 109.69 -176.233 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 12.4 m -67.72 -32.57 57.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -174.343 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -75.62 -35.39 60.52 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 119.31 0.959 . . . . 0.0 109.78 -175.108 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -78.57 -15.17 58.86 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.279 0.632 . . . . 0.0 111.901 175.248 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 48.5 m-80 -140.87 50.78 1.64 Allowed 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 119.194 0.906 . . . . 0.0 110.562 -168.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.477 ' CD ' ' H ' ' A' ' 61' ' ' GLN . 1.1 mp0 -58.69 -43.06 89.87 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.459 1.103 . . . . 0.0 109.49 -174.627 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -64.0 -41.48 97.46 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.327 1.051 . . . . 0.0 110.751 -176.166 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.05 -43.71 70.68 Favored 'General case' 0 C--O 1.222 -0.348 0 CA-C-N 118.633 0.651 . . . . 0.0 109.821 -177.574 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.27 -44.01 97.52 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 118.94 0.791 . . . . 0.0 109.461 176.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -57.46 -27.69 58.59 Favored Glycine 0 CA--C 1.534 1.233 0 C-N-CA 124.325 0.964 . . . . 0.0 112.635 174.318 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 24.8 ttmt -59.21 -21.64 59.8 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.983 1.313 . . . . 0.0 111.777 177.323 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -120.38 10.58 11.26 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.981 1.312 . . . . 0.0 111.009 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 70.21 32.14 68.95 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 123.694 0.664 . . . . 0.0 112.319 -177.392 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 86.7 t -110.88 134.67 52.43 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 C-N-CA 124.762 1.225 . . . . 0.0 107.92 -178.067 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 8.4 tpt -155.7 32.16 0.36 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.36 1.064 . . . . 0.0 108.976 167.278 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 20.2 m -137.47 155.91 48.76 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 126.787 2.035 . . . . 0.0 106.724 179.046 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 29.8 pt -145.7 157.63 51.15 Favored Pre-proline 0 CA--C 1.541 0.602 0 CA-C-O 118.716 -0.659 . . . . 0.0 111.069 -168.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -67.33 141.71 58.84 Favored 'Cis proline' 0 N--CA 1.458 -0.574 0 N-CA-C 109.022 -1.184 . . . . 0.0 109.022 -11.085 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 58.2 m -136.12 131.0 34.18 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 176.168 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -103.61 143.94 32.1 Favored 'General case' 0 N--CA 1.437 -1.123 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 -176.73 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -125.45 137.39 53.98 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 104.382 -2.451 . . . . 0.0 104.382 178.105 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 11.1 t -127.29 127.97 69.71 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.593 0 N-CA-C 105.036 -2.209 . . . . 0.0 105.036 177.73 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.8 mp -130.15 157.96 41.01 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 -177.77 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -142.58 121.77 13.0 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 175.265 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.2 t70 44.06 37.55 1.86 Allowed 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.689 1.196 . . . . 0.0 112.476 -172.516 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.2 -6.29 82.59 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-O 118.839 -0.978 . . . . 0.0 114.473 174.158 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -90.04 128.51 36.3 Favored 'General case' 0 CA--C 1.522 -0.113 0 CA-C-N 119.407 1.603 . . . . 0.0 106.874 175.206 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 71.0 t -63.99 134.56 28.77 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 168.587 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 32.9 m -122.94 -20.48 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 124.749 1.219 . . . . 0.0 110.547 176.693 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.63 161.41 41.6 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 119.999 1.272 . . . . 0.0 111.869 172.13 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 70.7 m -147.63 133.68 19.27 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.249 1.82 . . . . 0.0 106.913 169.02 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 16.9 m -146.13 152.4 39.22 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.018 0.927 . . . . 0.0 109.396 -172.051 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 42.6 t -129.13 148.94 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-N 119.431 1.014 . . . . 0.0 108.919 -170.485 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.27 175.38 50.03 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 124.536 1.065 . . . . 0.0 112.358 174.292 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -57.91 154.37 12.44 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.907 0.883 . . . . 0.0 110.594 176.388 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -152.28 144.36 16.57 Favored Pre-proline 0 CA--C 1.53 0.207 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 169.804 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_endo -71.64 163.39 39.13 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.582 2.188 . . . . 0.0 110.339 175.771 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -54.69 -46.25 74.08 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-O 118.855 -0.593 . . . . 0.0 110.636 -179.455 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -64.38 -40.24 95.44 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 118.451 0.569 . . . . 0.0 111.122 -169.542 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.57 -45.13 76.48 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 122.823 0.449 . . . . 0.0 110.688 177.103 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 50.9 tp -67.59 -40.99 84.77 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 122.899 0.479 . . . . 0.0 110.403 -176.195 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.8 pp0? -71.6 -31.26 66.72 Favored 'General case' 0 N--CA 1.457 -0.121 0 CA-C-N 118.614 0.643 . . . . 0.0 110.127 177.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 20.2 tp10 -65.41 -48.27 73.37 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 176.667 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 10.3 tt -57.1 -44.88 83.63 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.266 0.626 . . . . 0.0 110.374 178.572 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 4.8 t -60.55 -48.6 87.84 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 123.056 0.542 . . . . 0.0 110.392 176.771 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.4 -20.94 66.2 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 118.839 0.745 . . . . 0.0 112.843 -175.214 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 57.5 mmtt -60.62 -35.55 76.43 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 118.386 0.539 . . . . 0.0 111.1 169.059 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 94.2 m-70 -97.7 -22.49 16.41 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.647 0.779 . . . . 0.0 112.697 -172.168 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 70.7 mt . . . . . 0 C--O 1.247 0.959 0 CA-C-O 118.237 -0.887 . . . . 0.0 109.485 172.409 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 89.6 mt . . . . . 0 CA--C 1.536 0.428 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 35.8 t -100.81 165.99 2.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 125.691 1.596 . . . . 0.0 107.897 -174.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.31 141.65 50.58 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 177.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -151.73 168.09 26.15 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 122.979 0.511 . . . . 0.0 111.569 176.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 40.0 p -140.55 -176.45 4.64 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.981 2.113 . . . . 0.0 107.204 174.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -48.97 -32.63 9.46 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.687 1.195 . . . . 0.0 113.256 179.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 27.3 mp0 -61.13 -32.85 72.55 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 126.233 1.813 . . . . 0.0 112.5 -177.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 12.3 m -143.78 -6.57 0.77 Allowed 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 115.12 1.526 . . . . 0.0 115.12 -169.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -55.62 -36.1 66.59 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 119.856 1.207 . . . . 0.0 110.98 178.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.0 m -68.71 -38.86 80.56 Favored 'General case' 0 N--CA 1.453 -0.306 0 O-C-N 122.226 -0.296 . . . . 0.0 111.22 -178.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.61 -46.2 76.64 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 175.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -64.03 -38.51 91.33 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 122.995 0.518 . . . . 0.0 111.311 -175.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.409 ' HA ' HG21 ' A' ' 20' ' ' VAL . 29.4 p -79.12 0.73 26.97 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -177.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 59.9 m -112.23 33.16 5.04 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.171 0.988 . . . . 0.0 112.044 -171.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 59.3 mt-10 -132.1 -3.24 3.55 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 -176.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 167.45 -162.3 36.1 Favored Glycine 0 C--N 1.334 0.443 0 CA-C-N 119.346 0.976 . . . . 0.0 111.046 -172.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 40.3 t -74.27 127.56 36.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 N-CA-C 105.55 -2.019 . . . . 0.0 105.55 167.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.409 HG21 ' HA ' ' A' ' 15' ' ' THR . 24.8 t -137.18 115.13 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 -175.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 8.2 tt -88.01 147.01 25.2 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 168.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -132.56 153.35 51.07 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 177.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -132.92 99.12 4.49 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 -178.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -76.37 112.5 12.95 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 173.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 7.1 p-90 -139.36 174.75 10.19 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 123.132 0.573 . . . . 0.0 111.934 -168.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -153.67 147.42 18.53 Favored Pre-proline 0 CA--C 1.538 0.515 0 C-N-CA 125.276 1.43 . . . . 0.0 107.527 168.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.03 -20.57 14.77 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.807 2.338 . . . . 0.0 113.272 -170.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -78.83 -8.21 58.6 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 121.595 -0.691 . . . . 0.0 111.975 178.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 44.5 t -92.94 117.45 30.07 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -53.91 -58.1 13.86 Favored Glycine 0 CA--C 1.531 1.049 0 CA-C-O 118.727 -1.041 . . . . 0.0 112.152 177.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -51.19 -33.33 43.93 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 123.457 2.771 . . . . 0.0 115.607 178.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 90.6 m -60.31 -37.66 81.28 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 119.729 1.15 . . . . 0.0 111.668 174.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 43.2 mtmt -78.61 -33.54 47.33 Favored 'General case' 0 C--N 1.333 -0.118 0 O-C-N 121.764 -0.585 . . . . 0.0 109.98 177.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 26.5 mmt -65.32 -38.73 91.06 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 119.12 0.873 . . . . 0.0 111.439 177.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 12.0 tt -78.17 -14.86 14.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-N 118.877 0.762 . . . . 0.0 111.379 179.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.06 -49.88 89.63 Favored Pre-proline 0 CA--C 1.541 0.62 0 CA-C-O 117.437 -1.268 . . . . 0.0 113.545 -177.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -64.16 -28.49 64.84 Favored 'Trans proline' 0 C--N 1.351 0.662 0 CA-C-N 121.952 1.733 . . . . 0.0 112.401 176.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.2 t -68.37 -39.39 80.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 119.256 0.935 . . . . 0.0 109.457 176.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 48.4 mt -67.69 -34.88 77.77 Favored 'General case' 0 C--O 1.226 -0.15 0 O-C-N 121.517 -0.74 . . . . 0.0 110.636 174.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -68.29 -33.92 75.23 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 119.262 0.937 . . . . 0.0 111.44 173.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 50.2 mm-40 -62.32 -45.61 92.43 Favored 'General case' 0 N--CA 1.457 -0.094 0 O-C-N 120.922 -1.112 . . . . 0.0 109.583 170.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -63.86 -35.34 80.3 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 118.827 0.74 . . . . 0.0 111.668 176.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -66.35 -36.73 83.64 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 119.055 0.843 . . . . 0.0 111.035 177.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -69.8 -44.96 68.97 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 121.643 -0.661 . . . . 0.0 110.907 175.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -81.22 -33.6 32.77 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.983 0.913 . . . . 0.0 112.114 -169.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 52.2 mtt -140.62 -2.94 1.33 Allowed 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.541 1.136 . . . . 0.0 112.884 -169.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -75.14 47.55 1.97 Allowed Glycine 0 CA--C 1.528 0.885 0 C-N-CA 125.671 1.605 . . . . 0.0 113.517 -173.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -150.66 -40.71 0.13 Allowed 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 128.999 2.919 . . . . 0.0 107.176 169.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -63.55 -32.68 74.21 Favored 'General case' 0 C--N 1.343 0.314 0 C-N-CA 124.472 1.109 . . . . 0.0 110.546 168.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -135.67 160.95 36.93 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 125.719 1.608 . . . . 0.0 110.193 172.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -98.73 151.15 21.07 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.968 1.307 . . . . 0.0 107.879 171.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 15.7 mt -122.5 133.8 67.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 N-CA-C 105.839 -1.912 . . . . 0.0 105.839 174.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 8.0 t -128.4 116.12 40.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 C-N-CA 123.396 0.679 . . . . 0.0 109.556 -176.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 64.7 mmtt -75.14 140.41 43.35 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 168.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 8.3 tt -150.89 125.94 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -96.95 123.96 40.8 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 121.044 -1.035 . . . . 0.0 110.382 -168.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 23.3 m -61.67 -22.76 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -171.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -73.33 -28.83 62.29 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 120.052 1.296 . . . . 0.0 110.775 175.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -92.81 -33.98 14.05 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.446 1.099 . . . . 0.0 111.158 -171.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -112.59 33.76 4.76 Favored 'General case' 0 C--O 1.222 -0.344 0 C-N-CA 125.039 1.336 . . . . 0.0 109.914 -177.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.84 -39.89 54.54 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.542 1.137 . . . . 0.0 111.89 -175.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -65.23 -48.82 72.0 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.305 1.042 . . . . 0.0 111.656 174.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.34 -40.48 81.53 Favored 'General case' 0 C--O 1.223 -0.304 0 C-N-CA 123.906 0.882 . . . . 0.0 110.828 -175.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -61.97 -42.95 99.7 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.294 -0.879 . . . . 0.0 109.26 174.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -57.1 -27.42 57.33 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 123.963 0.792 . . . . 0.0 113.137 172.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 14.2 ttmm -60.84 -21.85 63.62 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 118.747 1.274 . . . . 0.0 111.451 176.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -120.06 9.8 11.28 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.206 1.403 . . . . 0.0 110.624 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 68.76 22.74 75.58 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 124.407 1.003 . . . . 0.0 113.33 -177.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 89.8 t -91.58 125.48 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 -179.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 5.9 mmt -148.63 26.85 0.92 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.714 1.605 . . . . 0.0 109.437 169.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 22.3 m -141.1 152.91 45.14 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 126.318 1.847 . . . . 0.0 107.167 -179.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -144.82 156.99 55.55 Favored Pre-proline 0 CA--C 1.54 0.583 0 C-N-CA 123.885 0.874 . . . . 0.0 110.262 -171.155 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -67.8 138.88 45.56 Favored 'Cis proline' 0 C--N 1.349 0.566 0 CA-C-N 119.788 0.96 . . . . 0.0 109.649 -10.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 54.5 m -130.16 118.08 20.89 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 174.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 61.1 mt -90.21 144.03 26.23 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 174.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.5 mp -124.65 155.91 38.39 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 169.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.462 HG11 ' CD2' ' A' ' 103' ' ' HIS . 94.1 t -126.67 130.46 71.63 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 N-CA-C 104.077 -2.564 . . . . 0.0 104.077 168.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.1 mp -127.13 156.23 42.09 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 126.234 1.814 . . . . 0.0 106.732 176.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 75.1 tttt -147.17 119.93 8.64 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 -177.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.7 t70 47.39 35.81 4.36 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.16 1.384 . . . . 0.0 113.588 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 108.88 -2.64 31.83 Favored Glycine 0 CA--C 1.527 0.781 0 CA-C-O 118.154 -1.359 . . . . 0.0 115.971 168.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -129.96 144.43 51.32 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 119.943 1.871 . . . . 0.0 110.208 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.7 p -66.79 138.1 23.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 C-N-CA 123.865 0.866 . . . . 0.0 108.765 173.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 35.7 m -129.12 -17.55 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 C-N-CA 125.346 1.459 . . . . 0.0 110.803 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.34 162.97 40.86 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 119.898 1.226 . . . . 0.0 111.559 172.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 85.1 m -151.08 142.12 23.06 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.118 1.767 . . . . 0.0 108.61 176.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 15.1 m -148.85 155.98 41.68 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.588 1.555 . . . . 0.0 108.869 -178.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 37.1 t -132.89 147.98 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 -174.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.75 175.47 49.39 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 124.426 1.012 . . . . 0.0 112.028 177.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -59.91 155.03 17.35 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.281 1.033 . . . . 0.0 110.566 174.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -141.44 145.65 38.79 Favored Pre-proline 0 C--O 1.233 0.235 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 168.003 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -71.89 160.43 47.81 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 122.62 2.213 . . . . 0.0 109.832 169.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -55.26 -47.52 75.34 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 118.742 -0.647 . . . . 0.0 111.116 -178.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -63.62 -43.5 96.68 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 118.555 0.616 . . . . 0.0 110.679 -170.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.98 -43.44 92.62 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 122.802 0.441 . . . . 0.0 110.743 176.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 45.2 tp -66.44 -42.36 87.75 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 119.307 -0.378 . . . . 0.0 110.346 -177.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.5 pp0? -72.62 -29.24 63.31 Favored 'General case' 0 C--N 1.337 0.064 0 CA-C-N 118.89 0.768 . . . . 0.0 110.505 179.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -65.89 -49.24 68.75 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 174.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 58.8 tp -55.58 -44.45 76.9 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.361 0.664 . . . . 0.0 110.454 178.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.434 ' HA ' ' NE2' ' A' ' 103' ' ' HIS . 48.5 t -68.53 -49.32 66.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 CA-C-O 119.538 -0.268 . . . . 0.0 110.52 -178.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -62.43 -27.18 68.92 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 119.143 0.883 . . . . 0.0 112.004 -173.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -65.15 -20.6 66.53 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 117.703 -1.141 . . . . 0.0 113.196 174.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . 0.462 ' CD2' HG11 ' A' ' 77' ' ' VAL . 8.1 p80 -116.55 2.37 13.04 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 120.32 1.418 . . . . 0.0 113.511 -179.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 80.8 mt . . . . . 0 C--O 1.248 1.012 0 CA-C-N 119.764 1.166 . . . . 0.0 108.144 170.225 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 93.7 mt . . . . . 0 CA--C 1.536 0.418 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 32.5 t -123.43 167.03 17.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 -173.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.5 mtmt -135.19 145.38 47.65 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 175.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -147.79 171.02 16.36 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.291 0.636 . . . . 0.0 110.083 176.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.414 HG22 HD21 ' A' ' 60' ' ' ASN . 81.3 p -133.79 178.33 7.03 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 171.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -47.25 -30.49 3.07 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 119.906 1.23 . . . . 0.0 113.187 176.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -58.3 -34.38 70.49 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.691 1.596 . . . . 0.0 112.752 179.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 12.8 m -145.42 -2.83 0.75 Allowed 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 114.833 1.42 . . . . 0.0 114.833 -169.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -54.08 -36.82 63.56 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 119.186 0.903 . . . . 0.0 111.005 178.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.3 m -67.47 -38.67 84.78 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 122.472 0.309 . . . . 0.0 111.387 -178.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.42 -45.25 76.65 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 175.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -64.94 -37.55 88.0 Favored 'General case' 0 C--O 1.231 0.121 0 C-N-CA 122.451 0.3 . . . . 0.0 111.381 -176.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.527 ' HA ' HG21 ' A' ' 20' ' ' VAL . 22.4 p -76.48 -1.65 28.29 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 71.1 m -107.72 33.55 4.01 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.55 1.14 . . . . 0.0 111.977 -171.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -133.39 1.53 3.45 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -177.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 165.66 -165.67 38.08 Favored Glycine 0 C--N 1.336 0.563 0 CA-C-O 118.796 -1.002 . . . . 0.0 111.242 -176.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 88.9 t -73.87 134.25 29.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 N-CA-C 103.678 -2.712 . . . . 0.0 103.678 166.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.527 HG21 ' HA ' ' A' ' 15' ' ' THR . 39.4 t -134.65 117.57 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 -175.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 62.3 tp -87.85 97.33 10.86 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 173.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.59 146.41 40.41 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 170.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -133.93 94.52 3.28 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 124.818 1.247 . . . . 0.0 107.735 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -71.29 113.36 8.24 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 106.301 -1.741 . . . . 0.0 106.301 172.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 6.3 p-90 -138.26 175.12 9.85 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 123.333 0.653 . . . . 0.0 110.962 -169.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -152.16 146.26 18.34 Favored Pre-proline 0 CA--C 1.536 0.431 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 168.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.31 -17.99 18.44 Favored 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 122.833 2.356 . . . . 0.0 113.377 -171.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -82.29 -8.53 59.64 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 121.53 -0.731 . . . . 0.0 111.997 176.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 42.0 t -88.12 126.32 35.05 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -61.42 -59.6 9.63 Favored Glycine 0 CA--C 1.531 1.083 0 CA-C-O 118.491 -1.172 . . . . 0.0 111.661 177.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_exo -49.04 -37.87 38.51 Favored 'Trans proline' 0 CA--C 1.535 0.566 0 C-N-CA 123.683 2.922 . . . . 0.0 115.094 177.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 86.1 m -59.17 -34.16 71.79 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 119.244 0.929 . . . . 0.0 112.793 175.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -84.94 -34.89 22.39 Favored 'General case' 0 N--CA 1.461 0.093 0 CA-C-O 118.942 -0.552 . . . . 0.0 109.996 176.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 85.1 mtp -60.92 -38.56 86.22 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 118.853 0.752 . . . . 0.0 110.993 177.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.0 tt -78.77 -14.62 13.68 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-N 118.549 0.613 . . . . 0.0 111.787 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.58 -50.84 84.65 Favored Pre-proline 0 CA--C 1.544 0.725 0 CA-C-N 120.116 1.325 . . . . 0.0 113.393 -177.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -64.88 -29.24 58.46 Favored 'Trans proline' 0 C--N 1.35 0.645 0 CA-C-N 121.887 1.709 . . . . 0.0 112.179 176.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.5 t -66.11 -42.68 91.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 123.425 0.69 . . . . 0.0 109.327 177.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 85.3 mt -65.62 -36.1 82.73 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 118.715 -0.66 . . . . 0.0 110.432 174.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -65.86 -36.6 83.9 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 119.534 1.061 . . . . 0.0 111.511 175.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -64.94 -43.52 92.49 Favored 'General case' 0 CA--C 1.529 0.146 0 O-C-N 121.162 -0.962 . . . . 0.0 110.086 173.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 31.6 tp -64.58 -38.87 92.5 Favored 'General case' 0 CA--C 1.532 0.276 0 O-C-N 122.252 -0.28 . . . . 0.0 110.522 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -64.32 -43.61 94.15 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 124.164 0.985 . . . . 0.0 110.476 177.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -61.68 -29.07 69.85 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 121.482 -0.761 . . . . 0.0 111.796 174.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -89.88 -35.53 15.57 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.907 0.883 . . . . 0.0 112.698 -174.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 40.6 mtt -136.5 -0.24 2.43 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -169.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -70.19 42.28 0.5 Allowed Glycine 0 CA--C 1.535 1.306 0 C-N-CA 126.914 2.197 . . . . 0.0 115.856 -169.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -143.21 -43.6 0.29 Allowed 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 126.849 2.06 . . . . 0.0 108.789 168.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 58.6 mtmt -72.06 -20.63 61.64 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.73 0.812 . . . . 0.0 111.28 169.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.9 tp -133.32 153.21 51.78 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 128.584 2.753 . . . . 0.0 106.704 -177.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -118.61 154.87 31.94 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 168.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 21.7 mt -122.37 134.7 64.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 104.921 -2.252 . . . . 0.0 104.921 172.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 79.3 t -128.9 109.75 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 -177.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -70.42 138.95 51.67 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 169.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 13.2 tt -144.85 108.25 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 176.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 62.6 t0 -78.44 115.37 18.11 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 123.631 0.772 . . . . 0.0 109.012 -175.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 29.4 m -60.76 -24.85 33.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 123.0 0.52 . . . . 0.0 112.278 -176.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -72.59 -0.79 13.83 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.804 0.842 . . . . 0.0 112.292 179.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -131.07 7.36 4.65 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.189 1.396 . . . . 0.0 110.591 170.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.414 HD21 HG22 ' A' ' 7' ' ' THR . 63.4 m-80 -142.41 44.94 1.64 Allowed 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.599 1.16 . . . . 0.0 110.318 -168.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.498 ' NE2' ' H ' ' A' ' 61' ' ' GLN . 0.4 OUTLIER -56.09 -47.6 77.73 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.266 1.027 . . . . 0.0 108.764 176.885 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 38.5 mp0 -67.17 -47.8 69.9 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 125.231 1.412 . . . . 0.0 109.411 -175.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.53 -47.57 72.48 Favored 'General case' 0 C--O 1.222 -0.356 0 C-N-CA 122.759 0.424 . . . . 0.0 110.168 -176.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.2 -44.03 96.5 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 119.004 0.82 . . . . 0.0 109.313 -179.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -58.1 -27.44 59.96 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 123.948 0.785 . . . . 0.0 112.923 174.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 31.1 ttmt -59.1 -26.21 64.48 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 118.615 1.208 . . . . 0.0 111.448 177.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -117.01 11.56 14.31 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.698 1.199 . . . . 0.0 111.097 179.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 69.82 22.73 77.02 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 124.265 0.936 . . . . 0.0 113.163 -178.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 97.9 t -93.06 135.04 28.9 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 179.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -155.35 28.0 0.4 Allowed 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.33 1.052 . . . . 0.0 109.686 168.104 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 22.8 m -139.06 152.66 47.73 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 126.407 1.883 . . . . 0.0 106.819 178.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -144.13 157.08 57.76 Favored Pre-proline 0 CA--C 1.542 0.641 0 CA-C-O 118.392 -0.813 . . . . 0.0 110.176 -169.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -67.54 137.97 40.35 Favored 'Cis proline' 0 C--N 1.349 0.59 0 CA-C-N 119.933 1.012 . . . . 0.0 109.84 -10.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 53.1 m -129.67 119.5 23.62 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 174.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 96.4 mt -96.61 133.71 40.76 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.6 mp -119.53 130.66 55.29 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 105.203 -2.147 . . . . 0.0 105.203 169.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 16.5 t -93.63 121.35 44.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 103.286 -2.857 . . . . 0.0 103.286 169.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.8 mp -112.23 160.68 17.38 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 170.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -142.28 129.85 21.41 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 169.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.9 t70 42.85 37.55 1.11 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.183 1.393 . . . . 0.0 113.62 175.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 109.81 -6.67 31.26 Favored Glycine 0 CA--C 1.528 0.863 0 CA-C-O 117.97 -1.461 . . . . 0.0 115.482 169.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -132.04 148.41 52.5 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 120.316 2.058 . . . . 0.0 110.901 -175.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.3 t -67.35 137.95 23.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 176.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 35.7 m -127.42 -18.68 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 125.451 1.5 . . . . 0.0 111.051 176.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.62 170.47 22.33 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 120.099 1.318 . . . . 0.0 110.977 171.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 99.4 m -147.51 150.63 34.92 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 125.587 1.555 . . . . 0.0 109.075 177.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 58.6 m -150.06 159.25 44.55 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.931 1.692 . . . . 0.0 108.791 171.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 34.9 t -133.17 145.1 34.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 179.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 85.44 177.18 50.55 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 123.709 0.671 . . . . 0.0 111.897 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -62.83 146.95 51.45 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.049 0.939 . . . . 0.0 110.354 177.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 68.0 mttt -143.78 143.17 22.32 Favored Pre-proline 0 CA--C 1.533 0.306 0 C-N-CA 124.989 1.316 . . . . 0.0 107.714 169.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -74.49 159.85 42.43 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 123.221 2.614 . . . . 0.0 110.691 177.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.9 tmpt? -61.02 -34.44 74.83 Favored 'General case' 0 C--O 1.225 -0.205 0 O-C-N 121.453 -0.779 . . . . 0.0 111.222 -175.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -62.5 -37.42 85.95 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.924 0.783 . . . . 0.0 111.561 178.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.18 -42.89 71.83 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 118.068 0.394 . . . . 0.0 110.442 174.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 91.1 mt -64.75 -41.6 95.78 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-O 119.263 -0.398 . . . . 0.0 110.622 -178.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.2 pp0? -70.25 -31.76 69.3 Favored 'General case' 0 CA--C 1.527 0.073 0 CA-C-N 118.83 0.741 . . . . 0.0 110.305 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -65.37 -49.59 68.73 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 175.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 59.2 tp -56.66 -43.43 80.37 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.945 0.898 . . . . 0.0 110.748 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 43.8 t -68.13 -49.18 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 CA-C-O 118.668 -0.682 . . . . 0.0 110.365 178.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.35 -26.1 68.32 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 120.005 1.275 . . . . 0.0 112.431 -175.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 39.8 mmtm -64.84 -17.05 63.92 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 118.029 -0.986 . . . . 0.0 113.073 171.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 92.0 m-70 -118.45 -12.49 9.83 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 119.777 1.171 . . . . 0.0 113.656 179.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 60.2 mt . . . . . 0 C--O 1.248 1.019 0 CA-C-N 120.464 1.484 . . . . 0.0 109.786 172.737 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 83.7 mt . . . . . 0 CA--C 1.541 0.62 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 42.2 t -131.9 170.59 19.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 125.949 1.699 . . . . 0.0 106.917 -174.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 34.0 ttmt -141.93 147.62 37.34 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 176.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -150.78 173.51 14.12 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 123.725 0.81 . . . . 0.0 110.236 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 76.6 p -131.59 175.13 9.43 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.137 1.375 . . . . 0.0 107.298 172.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -51.78 -30.48 23.09 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 120.134 1.333 . . . . 0.0 112.886 -176.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 25.3 mp0 -65.32 -27.96 68.97 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.738 2.015 . . . . 0.0 113.353 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 36.8 p -133.11 -15.87 2.53 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 114.317 1.228 . . . . 0.0 114.317 -168.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -54.2 -34.7 61.21 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 125.402 1.481 . . . . 0.0 111.019 178.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.4 p -64.89 -49.36 70.79 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 123.589 0.756 . . . . 0.0 110.949 -179.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.78 -44.78 96.34 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 122.908 0.483 . . . . 0.0 109.791 177.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -66.11 -37.89 86.87 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 119.263 -0.399 . . . . 0.0 111.616 -176.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.507 ' HA ' HG21 ' A' ' 20' ' ' VAL . 28.1 p -78.82 -1.48 35.06 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 118.67 0.668 . . . . 0.0 112.473 -178.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 59.1 m -106.06 33.0 4.02 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.421 1.089 . . . . 0.0 111.761 -171.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -133.06 -0.22 3.38 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -177.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 167.21 -167.35 39.8 Favored Glycine 0 C--N 1.337 0.614 0 CA-C-N 119.413 1.006 . . . . 0.0 111.563 -174.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 68.9 t -73.77 125.9 33.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 104.601 -2.37 . . . . 0.0 104.601 166.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.507 HG21 ' HA ' ' A' ' 15' ' ' THR . 35.3 t -129.86 120.93 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 -174.074 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -94.01 105.66 17.66 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 105.851 -1.907 . . . . 0.0 105.851 -179.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -94.9 102.55 14.4 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -177.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -82.4 95.25 7.6 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 123.862 0.865 . . . . 0.0 108.705 175.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 45.8 m-85 -75.53 116.72 16.55 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 169.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 7.5 p-90 -141.61 176.81 8.6 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 123.498 0.719 . . . . 0.0 111.498 -170.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -153.68 146.29 17.48 Favored Pre-proline 0 CA--C 1.538 0.509 0 C-N-CA 124.856 1.262 . . . . 0.0 107.717 168.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.92 -19.02 16.37 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.882 2.388 . . . . 0.0 113.264 -171.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -78.74 -7.13 57.46 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 118.689 0.677 . . . . 0.0 112.067 177.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 46.6 t -94.98 119.1 32.93 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -178.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -55.47 -58.35 14.34 Favored Glycine 0 CA--C 1.531 1.076 0 CA-C-O 118.56 -1.133 . . . . 0.0 111.779 176.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_exo -49.45 -34.7 33.96 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 123.665 2.91 . . . . 0.0 115.603 177.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 92.7 m -60.6 -44.16 96.58 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 119.78 1.173 . . . . 0.0 111.423 173.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 45.2 mtmt -72.27 -30.91 65.28 Favored 'General case' 0 CA--C 1.529 0.146 0 O-C-N 121.682 -0.636 . . . . 0.0 110.427 178.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 63.0 mtt -67.48 -40.98 85.3 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 118.766 0.712 . . . . 0.0 111.302 176.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.7 tt -78.54 -19.25 13.31 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-N 119.168 0.895 . . . . 0.0 111.415 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.18 -51.01 72.28 Favored Pre-proline 0 CA--C 1.546 0.823 0 CA-C-N 119.895 1.225 . . . . 0.0 114.011 -178.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -65.5 -28.56 53.62 Favored 'Trans proline' 0 C--N 1.351 0.663 0 CA-C-N 121.897 1.713 . . . . 0.0 112.44 175.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 6.6 t -67.33 -37.58 79.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 118.903 0.774 . . . . 0.0 109.542 175.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 96.0 mt -67.74 -34.64 77.24 Favored 'General case' 0 C--O 1.226 -0.136 0 O-C-N 121.493 -0.754 . . . . 0.0 110.685 172.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -64.13 -38.29 90.54 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 119.758 1.163 . . . . 0.0 111.229 172.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -65.94 -37.88 87.17 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 121.092 -1.005 . . . . 0.0 110.384 173.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 46.7 tp -66.6 -36.37 82.45 Favored 'General case' 0 C--O 1.227 -0.13 0 CA-C-N 118.56 0.618 . . . . 0.0 110.512 177.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -65.71 -41.5 92.24 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 118.953 0.797 . . . . 0.0 110.28 174.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -63.9 -29.72 70.87 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 121.796 -0.565 . . . . 0.0 112.13 174.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -87.47 -39.32 15.31 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.141 0.976 . . . . 0.0 112.215 -175.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 16.5 mmt -133.58 -1.27 3.13 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 124.527 1.131 . . . . 0.0 113.76 -167.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -62.1 -7.56 13.67 Favored Glycine 0 CA--C 1.535 1.297 0 CA-C-N 121.193 1.815 . . . . 0.0 114.419 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -79.57 -22.29 43.98 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.674 1.99 . . . . 0.0 112.11 173.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -130.4 -10.03 4.13 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 126.46 1.904 . . . . 0.0 111.465 -171.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -135.74 164.08 28.72 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 126.515 1.926 . . . . 0.0 108.306 -177.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -121.54 142.05 50.45 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 169.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 17.0 mt -105.71 137.78 34.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 105.139 -2.171 . . . . 0.0 105.139 170.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 90.2 t -127.38 114.49 36.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 105.785 -1.931 . . . . 0.0 105.785 175.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.65 141.23 44.63 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 169.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 11.8 tt -151.63 125.58 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 175.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -81.97 129.22 34.72 Favored 'General case' 0 N--CA 1.466 0.325 0 O-C-N 121.586 -0.696 . . . . 0.0 109.446 -178.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 15.4 m -67.81 -34.34 66.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -174.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -76.52 -34.58 58.57 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 119.055 0.843 . . . . 0.0 109.768 -174.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -73.04 -16.21 61.5 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.668 0.787 . . . . 0.0 111.958 172.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 62.7 m-80 -140.22 50.85 1.7 Allowed 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 119.312 0.96 . . . . 0.0 111.182 -168.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -57.2 -36.8 71.31 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.533 0.733 . . . . 0.0 109.68 178.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -64.02 -28.51 69.85 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 125.095 1.358 . . . . 0.0 112.466 -178.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.418 ' HA ' ' HE2' ' A' ' 66' ' ' LYS . 0.2 OUTLIER -92.3 -45.65 8.1 Favored 'General case' 0 C--O 1.222 -0.346 0 CA-C-N 118.573 0.624 . . . . 0.0 109.991 179.542 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.53 -45.75 89.17 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 119.484 1.038 . . . . 0.0 110.073 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -62.74 -21.91 63.58 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 124.195 0.902 . . . . 0.0 112.571 175.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.418 ' HE2' ' HA ' ' A' ' 63' ' ' THR . 5.5 ttmm -59.32 -22.07 60.71 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 118.52 1.16 . . . . 0.0 111.617 174.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -121.46 11.34 10.65 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.917 1.287 . . . . 0.0 110.728 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 68.19 27.32 73.77 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 124.147 0.88 . . . . 0.0 112.801 -177.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 65.7 t -100.8 135.71 35.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.54 28.5 0.44 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.546 1.138 . . . . 0.0 109.466 168.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 42.2 m -133.52 156.49 47.69 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 126.257 1.823 . . . . 0.0 107.262 175.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -145.8 159.15 48.02 Favored Pre-proline 0 CA--C 1.539 0.541 0 C-N-CA 124.243 1.017 . . . . 0.0 110.205 -169.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.5 140.05 50.77 Favored 'Cis proline' 0 C--N 1.349 0.583 0 CA-C-N 119.938 1.014 . . . . 0.0 109.923 -10.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 61.5 m -135.0 129.03 33.52 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 106.395 -1.706 . . . . 0.0 106.395 177.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 56.3 mt -108.72 104.07 13.28 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 105.903 -1.888 . . . . 0.0 105.903 -177.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -78.76 141.95 37.39 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 105.374 -2.084 . . . . 0.0 105.374 168.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.2 t -118.95 116.82 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 N-CA-C 103.378 -2.823 . . . . 0.0 103.378 174.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 8.1 mp -111.85 159.86 17.93 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 175.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -141.7 127.9 19.76 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 170.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.8 t70 43.74 38.61 2.09 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.062 1.345 . . . . 0.0 113.323 175.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 104.64 -4.78 43.21 Favored Glycine 0 CA--C 1.53 0.969 0 CA-C-O 117.962 -1.466 . . . . 0.0 115.169 169.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -130.92 150.42 52.09 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 120.269 2.034 . . . . 0.0 110.98 -176.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.2 p -66.08 140.15 20.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 C-N-CA 123.803 0.841 . . . . 0.0 109.476 177.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 28.4 m -127.16 -19.54 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 C-N-CA 125.479 1.512 . . . . 0.0 110.865 173.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.87 168.33 26.03 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 120.399 1.454 . . . . 0.0 111.382 169.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 60.8 m -143.63 136.04 27.03 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.023 1.729 . . . . 0.0 107.216 169.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 38.4 m -140.57 152.51 45.55 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.92 1.288 . . . . 0.0 108.436 -177.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 38.5 t -133.48 147.53 31.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 -171.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.02 174.35 49.54 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 124.25 0.929 . . . . 0.0 112.229 175.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -61.33 148.09 42.52 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 123.784 0.834 . . . . 0.0 110.744 179.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -152.11 142.2 14.87 Favored Pre-proline 0 CA--C 1.533 0.324 0 C-N-CA 125.922 1.689 . . . . 0.0 106.999 -178.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -74.4 156.77 45.69 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 122.44 2.093 . . . . 0.0 110.612 174.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.5 tmpt? -58.31 -36.43 73.34 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 123.636 0.774 . . . . 0.0 110.982 -179.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 23.7 tp10 -65.91 -36.71 84.15 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 118.506 0.594 . . . . 0.0 111.441 -174.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.02 -42.96 79.87 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 122.926 0.49 . . . . 0.0 110.681 174.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 91.3 mt -65.68 -43.98 87.64 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 119.096 -0.478 . . . . 0.0 110.123 -177.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.8 pp0? -68.21 -30.0 68.97 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 118.909 0.777 . . . . 0.0 110.543 179.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -65.99 -50.22 65.04 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 175.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 54.9 tp -56.92 -44.32 82.31 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.063 0.545 . . . . 0.0 110.648 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 42.7 t -63.36 -50.73 77.53 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 C-N-CA 123.461 0.704 . . . . 0.0 109.717 178.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -65.66 -26.19 67.69 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 119.386 0.994 . . . . 0.0 112.403 -175.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -67.22 -36.71 82.24 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 118.78 -0.629 . . . . 0.0 111.214 170.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 79.8 m-70 -80.64 -24.51 38.97 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 118.078 -0.963 . . . . 0.0 113.378 178.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 65.8 mt . . . . . 0 C--O 1.248 1.015 0 CA-C-N 119.707 1.14 . . . . 0.0 110.155 177.699 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 84.5 mt . . . . . 0 CA--C 1.534 0.353 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 23.3 t -105.85 160.69 5.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 125.573 1.549 . . . . 0.0 107.379 -175.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.41 140.48 52.65 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 176.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -136.98 172.24 13.31 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.041 0.937 . . . . 0.0 110.498 179.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.0 p -129.6 173.56 10.49 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 125.739 1.616 . . . . 0.0 107.861 178.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -52.34 -35.56 51.23 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 119.509 1.049 . . . . 0.0 111.721 174.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 5.4 mp0 -75.86 -31.25 59.21 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -177.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 32.6 p -110.83 -14.93 13.91 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 -169.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -51.0 -39.56 56.03 Favored 'General case' 0 C--N 1.334 -0.078 0 C-N-CA 124.573 1.149 . . . . 0.0 110.224 173.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.2 m -74.09 -23.19 59.3 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -174.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.88 -48.39 18.45 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 169.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -66.96 -36.39 82.1 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 122.807 0.443 . . . . 0.0 111.965 -170.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 42.9 p -82.85 7.8 14.21 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 112.527 0.565 . . . . 0.0 112.527 -176.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 40.8 m -121.68 34.57 5.14 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.596 0.758 . . . . 0.0 112.216 -169.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -135.39 1.75 2.92 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -176.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 169.0 -165.86 39.25 Favored Glycine 0 C--N 1.333 0.408 0 N-CA-C 110.409 -1.076 . . . . 0.0 110.409 -171.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.435 HG22 ' HE3' ' A' ' 79' ' ' LYS . 1.5 t -78.82 133.01 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 N-CA-C 104.324 -2.473 . . . . 0.0 104.324 168.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 23.8 t -139.63 146.15 25.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 -173.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 9.0 tt -122.55 135.87 54.74 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 105.807 -1.923 . . . . 0.0 105.807 169.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -129.67 121.3 26.7 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 -174.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -96.08 102.55 14.36 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 125.504 1.522 . . . . 0.0 108.585 -177.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -76.41 116.84 17.48 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 169.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 6.9 p-90 -145.88 178.82 7.89 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.619 0.767 . . . . 0.0 110.898 -169.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -158.51 150.28 17.08 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 125.606 1.562 . . . . 0.0 107.054 167.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.18 -18.72 20.7 Favored 'Trans proline' 0 CA--C 1.532 0.417 0 C-N-CA 122.754 2.303 . . . . 0.0 113.478 -170.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -79.39 -11.12 59.93 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 118.94 0.791 . . . . 0.0 112.483 176.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 45.8 t -85.53 119.26 25.68 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -57.01 -58.26 15.51 Favored Glycine 0 CA--C 1.531 1.093 0 CA-C-O 118.622 -1.099 . . . . 0.0 111.632 174.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -49.95 -36.14 42.95 Favored 'Trans proline' 0 CA--C 1.536 0.618 0 C-N-CA 123.571 2.848 . . . . 0.0 115.309 176.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 98.4 m -59.39 -46.06 89.73 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 119.87 1.214 . . . . 0.0 111.306 173.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 46.1 mtmt -70.35 -30.26 67.16 Favored 'General case' 0 N--CA 1.462 0.168 0 O-C-N 121.511 -0.743 . . . . 0.0 110.844 178.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 87.2 mtp -67.32 -43.08 82.5 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 118.922 0.783 . . . . 0.0 110.98 175.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 8.3 tt -78.84 -18.91 13.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-N 119.048 0.84 . . . . 0.0 111.378 -178.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.33 -52.44 59.28 Favored Pre-proline 0 CA--C 1.544 0.743 0 CA-C-O 117.5 -1.238 . . . . 0.0 113.986 -178.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.03 -30.35 56.53 Favored 'Trans proline' 0 C--N 1.349 0.58 0 CA-C-N 121.931 1.725 . . . . 0.0 112.103 177.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 6.3 t -64.82 -42.68 95.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 118.762 0.71 . . . . 0.0 109.085 176.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 61.1 mt -67.14 -34.97 78.71 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 118.603 -0.713 . . . . 0.0 110.981 176.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -65.59 -40.39 92.64 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 119.553 1.07 . . . . 0.0 111.004 174.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -63.95 -42.87 97.18 Favored 'General case' 0 CA--C 1.53 0.188 0 O-C-N 121.405 -0.809 . . . . 0.0 109.875 174.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 25.8 tp -62.8 -39.15 93.39 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 122.845 0.458 . . . . 0.0 110.794 178.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -66.83 -38.89 87.28 Favored 'General case' 0 C--N 1.333 -0.116 0 O-C-N 121.448 -0.782 . . . . 0.0 110.856 177.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -64.45 -23.06 67.15 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 121.86 -0.525 . . . . 0.0 111.895 173.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -96.88 -30.9 12.86 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.784 1.234 . . . . 0.0 112.46 -176.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 19.0 mmt -129.73 -9.31 4.49 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 117.825 -1.084 . . . . 0.0 113.606 -168.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -48.49 -30.53 8.42 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 125.955 1.74 . . . . 0.0 115.985 -169.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -79.31 -38.63 34.82 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.296 1.038 . . . . 0.0 111.495 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -85.23 -26.17 26.86 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 124.7 1.2 . . . . 0.0 110.801 -178.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -148.44 124.39 10.66 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 125.016 1.326 . . . . 0.0 108.807 -177.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -72.36 148.14 45.58 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 176.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 22.8 mt -122.07 133.58 67.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 172.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 9.2 t -127.01 153.11 35.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 124.689 1.196 . . . . 0.0 108.196 -173.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 65.4 mmtt -118.9 141.17 48.89 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 126.085 1.754 . . . . 0.0 107.975 177.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 14.9 tt -145.54 120.8 3.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-O 121.358 0.599 . . . . 0.0 109.538 172.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -80.9 110.47 16.46 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 123.911 0.885 . . . . 0.0 108.823 -179.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 24.0 m -64.47 -25.5 38.08 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-O 118.986 -0.53 . . . . 0.0 112.427 -174.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -70.98 -12.94 61.82 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 119.14 0.882 . . . . 0.0 111.68 -178.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -120.03 -5.28 10.04 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.239 1.416 . . . . 0.0 110.979 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 60.9 m-80 -146.06 36.66 1.03 Allowed 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.217 1.007 . . . . 0.0 110.551 -168.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.2 pm0 -59.07 -25.34 63.67 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.973 0.909 . . . . 0.0 111.487 179.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 59.6 mp0 -60.13 -32.44 71.02 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.028 1.731 . . . . 0.0 111.29 175.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.39 -48.81 14.72 Favored 'General case' 0 C--O 1.223 -0.326 0 CA-C-N 118.38 0.536 . . . . 0.0 110.0 172.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.23 -45.99 89.04 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 118.798 0.726 . . . . 0.0 110.278 -171.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -61.92 -23.99 64.22 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 124.166 0.889 . . . . 0.0 112.821 176.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.6 ttmm -59.18 -28.13 66.34 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 118.612 1.206 . . . . 0.0 111.295 175.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -115.84 11.01 15.45 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.776 1.23 . . . . 0.0 111.033 178.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 70.36 18.3 75.08 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 124.603 1.096 . . . . 0.0 113.738 -178.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 98.8 t -84.12 134.23 27.43 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 176.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -155.45 32.2 0.37 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.413 1.085 . . . . 0.0 109.09 166.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 23.3 m -138.01 151.45 47.91 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 126.824 2.05 . . . . 0.0 106.245 176.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 28.2 pt -147.3 159.58 41.73 Favored Pre-proline 0 CA--C 1.542 0.669 0 C-N-CA 124.041 0.937 . . . . 0.0 109.472 -169.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -66.65 142.07 57.91 Favored 'Cis proline' 0 N--CA 1.458 -0.559 0 N-CA-C 109.529 -0.989 . . . . 0.0 109.529 -10.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 26.7 m -132.43 129.07 38.8 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 178.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 50.1 mt -112.05 109.53 19.33 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 -174.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.5 mp -87.51 151.75 22.77 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 106.171 -1.788 . . . . 0.0 106.171 167.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 15.7 t -123.78 132.12 71.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 N-CA-C 104.131 -2.544 . . . . 0.0 104.131 169.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.3 mp -132.99 160.01 38.36 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 125.918 1.687 . . . . 0.0 107.254 -175.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.435 ' HE3' HG22 ' A' ' 19' ' ' VAL . 77.1 tttt -147.2 127.52 13.94 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.1 t70 59.13 -19.26 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 128.052 2.541 . . . . 0.0 116.298 177.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 162.17 -0.91 0.06 OUTLIER Glycine 0 CA--C 1.532 1.102 0 CA-C-O 118.141 -1.366 . . . . 0.0 114.4 173.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -134.26 151.01 51.05 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 120.239 2.02 . . . . 0.0 110.45 -173.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 42.4 t -64.84 139.95 20.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 C-N-CA 124.238 1.015 . . . . 0.0 108.373 175.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 33.6 m -121.17 -21.97 3.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 125.208 1.403 . . . . 0.0 110.593 172.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -158.02 164.2 36.99 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 119.79 1.177 . . . . 0.0 111.584 174.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 69.7 m -144.1 138.45 28.25 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.777 1.631 . . . . 0.0 108.205 172.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 44.6 m -143.38 153.48 42.74 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.695 1.598 . . . . 0.0 108.594 -178.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 40.2 t -133.69 146.46 31.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -174.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.63 174.46 45.81 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 124.633 1.111 . . . . 0.0 112.443 173.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 61.3 t80 -62.66 143.91 56.85 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.597 0.759 . . . . 0.0 109.99 176.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 44.7 mttm -145.29 148.26 37.06 Favored Pre-proline 0 C--O 1.235 0.29 0 C-N-CA 125.226 1.41 . . . . 0.0 107.994 169.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -74.1 159.88 43.61 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 123.062 2.508 . . . . 0.0 110.626 176.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 11.0 ttpt -58.32 -38.54 77.32 Favored 'General case' 0 C--O 1.223 -0.293 0 O-C-N 121.825 -0.547 . . . . 0.0 111.021 -177.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -59.93 -39.27 84.91 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.416 0.686 . . . . 0.0 111.558 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.13 -42.02 73.13 Favored 'General case' 0 N--CA 1.452 -0.346 0 O-C-N 122.17 -0.331 . . . . 0.0 110.483 175.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 90.9 mt -67.83 -37.57 82.08 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 119.014 -0.517 . . . . 0.0 111.056 -178.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.8 pp0? -71.48 -29.62 65.04 Favored 'General case' 0 CA--C 1.526 0.036 0 CA-C-N 119.523 1.056 . . . . 0.0 110.297 177.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -65.46 -49.59 68.55 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 174.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 52.0 tp -54.35 -46.06 72.87 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.831 0.852 . . . . 0.0 110.635 177.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 25.2 t -63.26 -53.06 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.83 -25.4 67.89 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 119.021 0.828 . . . . 0.0 112.457 -174.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 61.3 mtpt -66.74 -23.04 66.04 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 118.024 -0.989 . . . . 0.0 112.552 172.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -110.46 -13.55 14.24 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 119.765 1.166 . . . . 0.0 113.384 -179.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 56.5 mt . . . . . 0 C--O 1.249 1.073 0 CA-C-N 119.871 1.214 . . . . 0.0 109.449 170.041 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 89.3 mt . . . . . 0 C--O 1.236 0.347 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 38.7 t -101.18 166.42 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 125.494 1.518 . . . . 0.0 107.581 -173.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.4 mppt? -128.63 143.37 50.93 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 106.079 -1.822 . . . . 0.0 106.079 177.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -144.79 169.72 17.48 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 118.341 0.518 . . . . 0.0 110.976 175.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.6 p -134.01 170.09 16.15 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 172.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -52.66 -25.59 11.31 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 119.98 1.264 . . . . 0.0 112.317 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 69.4 mm-40 -63.71 -33.07 74.84 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.474 1.51 . . . . 0.0 112.516 -179.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.6 m -140.29 -4.93 1.28 Allowed 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -171.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -50.39 -39.74 47.7 Favored 'General case' 0 N--CA 1.457 -0.081 0 C-N-CA 125.328 1.451 . . . . 0.0 110.665 173.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.9 m -66.9 -36.42 82.24 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 118.003 0.365 . . . . 0.0 111.618 -176.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.12 -46.59 70.46 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 174.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -64.07 -38.69 91.99 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 122.784 0.434 . . . . 0.0 111.431 -175.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.551 ' HA ' HG21 ' A' ' 20' ' ' VAL . 30.9 p -79.35 -0.37 32.34 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -176.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 64.8 m -109.28 34.48 3.73 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.456 1.102 . . . . 0.0 111.614 -173.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -132.11 -0.21 3.75 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 -178.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 165.43 -167.97 39.2 Favored Glycine 0 C--N 1.336 0.546 0 CA-C-N 119.16 0.891 . . . . 0.0 111.042 -174.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 94.3 t -71.17 132.42 33.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 N-CA-C 104.558 -2.386 . . . . 0.0 104.558 166.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.551 HG21 ' HA ' ' A' ' 15' ' ' THR . 27.3 t -135.57 118.62 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 -176.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -87.93 124.39 33.64 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 105.372 -2.085 . . . . 0.0 105.372 172.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -117.12 105.53 12.36 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -81.86 99.99 9.35 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 175.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -76.14 116.71 17.1 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 168.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 7.0 p-90 -144.86 179.53 7.27 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.59 0.756 . . . . 0.0 111.415 -169.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -158.48 152.32 19.57 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 125.648 1.579 . . . . 0.0 107.197 167.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -76.83 -16.96 16.0 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.835 2.357 . . . . 0.0 113.467 -169.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -79.14 -11.65 59.98 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.898 0.772 . . . . 0.0 111.986 177.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 41.7 t -87.52 121.46 29.98 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 178.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -58.71 -56.16 26.8 Favored Glycine 0 CA--C 1.532 1.121 0 CA-C-O 118.76 -1.022 . . . . 0.0 111.936 175.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_exo -49.35 -39.51 43.87 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 123.496 2.797 . . . . 0.0 115.077 175.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 69.8 m -58.58 -34.33 70.96 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 119.125 0.875 . . . . 0.0 112.864 175.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 45.6 mtmt -81.29 -42.25 20.9 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 8.2 ptt? -70.64 -24.2 62.66 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 119.358 0.981 . . . . 0.0 112.532 -176.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 8.0 tt -77.16 -18.14 14.43 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-N 119.602 1.092 . . . . 0.0 111.574 173.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.05 -48.51 95.88 Favored Pre-proline 0 CA--C 1.539 0.521 0 CA-C-O 117.287 -1.34 . . . . 0.0 113.417 -177.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -63.28 -31.28 73.93 Favored 'Trans proline' 0 C--N 1.35 0.614 0 CA-C-N 121.938 1.728 . . . . 0.0 112.143 175.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 6.6 t -66.54 -41.13 87.97 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-N 119.249 0.931 . . . . 0.0 109.521 177.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 63.4 mt -66.63 -32.82 74.38 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-O 118.813 -0.613 . . . . 0.0 110.912 174.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -68.66 -35.81 77.73 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 119.669 1.122 . . . . 0.0 111.304 173.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 -64.92 -39.42 93.49 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 120.903 -1.123 . . . . 0.0 109.886 171.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 24.4 tp -66.57 -35.86 81.25 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 121.604 -0.685 . . . . 0.0 110.969 176.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -65.76 -38.56 89.41 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.739 0.815 . . . . 0.0 110.632 175.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -66.71 -38.34 86.52 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.783 -0.573 . . . . 0.0 111.03 173.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -74.48 -43.0 58.04 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.026 0.93 . . . . 0.0 111.764 -174.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 42.6 mtt -142.8 3.03 1.41 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 117.849 -1.072 . . . . 0.0 113.742 -168.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -74.49 50.9 2.15 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 126.056 1.788 . . . . 0.0 113.641 -172.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -154.29 -41.16 0.09 Allowed 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 129.697 3.199 . . . . 0.0 107.327 169.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 48.0 mtpt -64.12 -33.74 76.45 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.599 1.16 . . . . 0.0 110.529 169.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -131.36 165.3 23.77 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.839 1.656 . . . . 0.0 109.679 169.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -102.88 149.68 24.26 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 170.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 20.3 mt -117.84 136.43 55.04 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 N-CA-C 105.036 -2.209 . . . . 0.0 105.036 170.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 63.8 t -129.66 138.56 53.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 -178.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 60.0 mmtt -97.77 139.34 33.79 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.859 1.264 . . . . 0.0 108.219 169.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 12.6 tt -149.17 128.56 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 CA-C-O 121.306 0.574 . . . . 0.0 109.555 175.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -83.73 127.19 33.61 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.546 0.739 . . . . 0.0 110.269 -175.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 13.5 m -67.92 -26.95 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 -173.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -83.54 -41.01 18.41 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 119.903 1.229 . . . . 0.0 109.634 -175.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -70.62 -25.22 62.94 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.355 0.662 . . . . 0.0 111.08 174.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -127.42 43.8 3.05 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.748 1.219 . . . . 0.0 109.74 -172.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.15 -36.44 51.45 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 126.666 1.986 . . . . 0.0 111.285 175.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -65.48 -40.28 92.93 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 124.012 0.925 . . . . 0.0 111.483 176.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.59 -43.32 48.9 Favored 'General case' 0 C--O 1.222 -0.356 0 CA-C-N 119.406 1.003 . . . . 0.0 110.111 -178.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -61.62 -46.17 90.97 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 119.205 0.911 . . . . 0.0 109.719 176.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -60.74 -22.42 59.62 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 124.456 1.027 . . . . 0.0 113.069 175.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 7.7 ttmm -59.92 -20.38 57.05 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 118.629 1.215 . . . . 0.0 111.503 175.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -124.36 10.37 8.59 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.353 1.461 . . . . 0.0 110.627 178.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 64.9 22.85 68.89 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.542 1.067 . . . . 0.0 113.226 -174.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 61.1 t -88.74 153.6 3.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 118.331 1.065 . . . . 0.0 109.198 178.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -161.04 -22.83 0.06 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 127.5 2.32 . . . . 0.0 109.86 167.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.5 m -63.6 153.15 36.8 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 124.312 1.045 . . . . 0.0 109.721 171.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 28.2 pt -146.58 156.25 48.91 Favored Pre-proline 0 CA--C 1.542 0.637 0 C-N-CA 124.141 0.976 . . . . 0.0 109.617 -178.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -68.41 140.49 56.43 Favored 'Cis proline' 0 N--CA 1.457 -0.625 0 N-CA-C 109.011 -1.188 . . . . 0.0 109.011 -11.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 54.4 m -131.17 125.28 32.61 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 178.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 40.6 mt -104.26 104.14 14.0 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 -176.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -78.27 143.64 36.87 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 105.726 -1.953 . . . . 0.0 105.726 168.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.8 t -120.29 118.41 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 103.489 -2.782 . . . . 0.0 103.489 172.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 8.8 mp -114.6 160.12 19.66 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 175.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -143.12 128.15 18.51 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 170.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.8 t70 44.01 37.79 1.94 Allowed 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.102 1.361 . . . . 0.0 113.39 175.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 104.86 -4.48 42.22 Favored Glycine 0 CA--C 1.528 0.857 0 CA-C-O 118.083 -1.398 . . . . 0.0 115.247 169.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -129.82 149.58 51.5 Favored 'General case' 0 C--N 1.34 0.162 0 CA-C-N 120.19 1.995 . . . . 0.0 110.755 -177.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.9 p -66.19 140.77 18.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 C-N-CA 123.765 0.826 . . . . 0.0 109.312 177.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 35.5 m -127.14 -19.54 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 C-N-CA 125.481 1.512 . . . . 0.0 110.8 173.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.35 167.59 28.47 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 120.227 1.376 . . . . 0.0 111.392 169.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 78.0 m -143.71 134.0 24.54 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 126.253 1.821 . . . . 0.0 107.243 169.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 39.0 m -141.41 153.8 45.24 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 124.898 1.279 . . . . 0.0 108.666 -176.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.1 t -132.95 148.67 31.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -172.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.08 170.61 46.08 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 124.407 1.003 . . . . 0.0 112.468 172.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -65.34 133.38 51.27 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 123.475 0.71 . . . . 0.0 109.54 175.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -134.73 144.02 48.89 Favored Pre-proline 0 CA--C 1.534 0.342 0 C-N-CA 126.111 1.764 . . . . 0.0 106.626 176.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -72.12 158.89 51.27 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 122.754 2.303 . . . . 0.0 110.553 176.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 9.9 ttpt -57.42 -37.41 72.71 Favored 'General case' 0 C--O 1.223 -0.321 0 O-C-N 121.719 -0.613 . . . . 0.0 111.133 -177.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -61.05 -37.38 82.41 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 118.528 0.604 . . . . 0.0 111.728 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -72.15 -41.76 66.74 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 122.748 0.419 . . . . 0.0 110.604 175.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 81.2 mt -64.04 -43.36 95.78 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 119.317 -0.373 . . . . 0.0 110.295 -179.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.9 pp0? -70.16 -30.43 67.58 Favored 'General case' 0 C--O 1.228 -0.067 0 CA-C-N 118.835 0.743 . . . . 0.0 110.11 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -64.75 -49.41 70.91 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 175.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 60.2 tp -57.14 -45.73 83.32 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.553 0.741 . . . . 0.0 110.507 178.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 40.0 t -62.88 -49.05 85.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 CA-C-O 119.029 -0.51 . . . . 0.0 109.941 179.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.62 -25.89 68.16 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 119.414 1.006 . . . . 0.0 112.543 -175.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -66.2 -19.36 65.81 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 118.068 -0.968 . . . . 0.0 112.811 171.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -113.07 -16.41 12.63 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 119.877 1.217 . . . . 0.0 113.528 -178.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 70.7 mt . . . . . 0 C--O 1.248 1.019 0 CA-C-N 119.972 1.26 . . . . 0.0 109.713 172.531 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 78.0 mt . . . . . 0 CA--C 1.538 0.485 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.7 t -131.49 165.25 32.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 124.877 1.271 . . . . 0.0 107.902 -168.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -127.12 142.43 51.51 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 174.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -148.32 171.19 16.39 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 124.302 1.041 . . . . 0.0 108.807 169.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 70.4 p -133.84 178.37 7.0 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 171.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -45.95 -31.15 2.05 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.487 1.115 . . . . 0.0 113.31 176.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -58.87 -34.46 71.64 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.321 1.848 . . . . 0.0 112.998 179.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.2 m -145.5 -3.61 0.71 Allowed 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 -169.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -54.33 -36.01 63.32 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.305 1.042 . . . . 0.0 110.84 177.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.8 m -67.01 -34.54 77.95 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 122.884 0.474 . . . . 0.0 111.9 -179.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -70.14 -45.85 65.94 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 175.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -64.35 -37.91 89.17 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 119.47 -0.3 . . . . 0.0 111.443 -175.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.505 ' HA ' HG21 ' A' ' 20' ' ' VAL . 20.2 p -75.98 1.16 16.07 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -178.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 52.0 m -117.51 37.12 4.0 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.294 1.037 . . . . 0.0 111.913 -169.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -130.97 -2.17 4.08 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 163.17 -165.88 36.76 Favored Glycine 0 C--N 1.335 0.498 0 N-CA-C 110.149 -1.18 . . . . 0.0 110.149 -172.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 87.5 t -68.53 141.0 18.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 105.758 -1.941 . . . . 0.0 105.758 166.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.505 HG21 ' HA ' ' A' ' 15' ' ' THR . 62.4 t -141.97 142.97 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 107.194 -1.409 . . . . 0.0 107.194 -178.205 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 56.6 tp -112.71 99.22 7.76 Favored 'General case' 0 CA--C 1.521 -0.158 0 N-CA-C 106.573 -1.639 . . . . 0.0 106.573 173.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.06 144.12 40.95 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 170.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -129.26 95.55 4.07 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 125.393 1.477 . . . . 0.0 107.263 178.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -75.31 116.41 16.0 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 173.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 12.1 p-90 -135.72 175.15 9.85 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 124.069 0.947 . . . . 0.0 110.17 -173.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -148.62 146.27 21.92 Favored Pre-proline 0 CA--C 1.533 0.314 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 169.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -74.0 -15.78 23.24 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.808 2.339 . . . . 0.0 113.863 -169.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -93.24 -6.09 48.43 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.812 0.845 . . . . 0.0 112.126 178.13 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 42.3 t -85.41 116.49 23.76 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 -178.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -55.75 -55.03 30.97 Favored Glycine 0 CA--C 1.532 1.15 0 CA-C-O 118.671 -1.072 . . . . 0.0 112.236 175.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -50.26 -36.34 46.55 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 123.254 2.636 . . . . 0.0 115.219 175.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 92.9 m -59.91 -40.28 88.26 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 119.937 1.244 . . . . 0.0 111.713 172.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 61.9 mttm -66.28 -38.9 88.85 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 121.475 -0.766 . . . . 0.0 110.01 175.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 98.5 mmm -67.45 -41.84 84.07 Favored 'General case' 0 N--CA 1.461 0.089 0 C-N-CA 122.84 0.456 . . . . 0.0 111.423 -177.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 8.7 tt -76.63 -20.97 14.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-N 118.511 0.596 . . . . 0.0 111.054 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -52.48 -51.22 74.92 Favored Pre-proline 0 CA--C 1.544 0.749 0 CA-C-N 119.646 1.112 . . . . 0.0 113.88 -175.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -67.24 -26.2 42.26 Favored 'Trans proline' 0 C--N 1.349 0.555 0 CA-C-N 121.925 1.723 . . . . 0.0 112.295 177.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.8 t -67.6 -37.95 79.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-N 119.307 0.958 . . . . 0.0 109.359 173.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 90.1 mt -67.13 -36.14 81.23 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-O 118.621 -0.704 . . . . 0.0 110.663 173.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -62.71 -42.91 99.89 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 119.472 1.033 . . . . 0.0 110.642 172.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -62.86 -37.18 85.82 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 121.307 -0.871 . . . . 0.0 110.651 176.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -65.6 -39.88 92.05 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 123.437 0.695 . . . . 0.0 109.897 176.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -63.7 -42.0 98.04 Favored 'General case' 0 C--N 1.332 -0.152 0 C-N-CA 123.948 0.899 . . . . 0.0 110.586 174.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 62.0 mm-40 -65.96 -28.31 68.81 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 121.361 -0.837 . . . . 0.0 111.536 176.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -86.73 -41.05 14.45 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.238 1.015 . . . . 0.0 112.154 -177.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 75.4 mmm -135.63 -2.81 2.39 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.368 1.067 . . . . 0.0 113.799 -167.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.47 44.0 0.74 Allowed Glycine 0 N--CA 1.471 0.98 0 C-N-CA 127.453 2.454 . . . . 0.0 115.166 -169.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -147.24 -37.49 0.21 Allowed 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 127.09 2.156 . . . . 0.0 108.621 169.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -63.06 -31.3 72.4 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.95 1.3 . . . . 0.0 110.108 168.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -138.29 166.71 23.5 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 126.553 1.941 . . . . 0.0 109.698 170.161 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 15.3 ptpt -109.26 155.39 21.18 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 167.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 15.5 mt -105.8 141.31 21.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 171.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 24.1 t -126.02 107.8 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 177.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 11.7 mmmm -73.75 137.12 43.76 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 173.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 15.6 tt -147.27 115.15 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 49.0 t0 -83.26 115.85 22.15 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.681 0.793 . . . . 0.0 109.031 -175.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 34.1 m -59.14 -26.72 34.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 123.048 0.539 . . . . 0.0 112.416 -176.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -72.05 -2.0 16.76 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.776 0.831 . . . . 0.0 112.493 -178.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -131.78 7.56 4.43 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.878 1.271 . . . . 0.0 110.706 172.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 67.4 m-80 -142.01 45.77 1.66 Allowed 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.117 0.967 . . . . 0.0 110.774 -168.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.547 ' NE2' ' H ' ' A' ' 61' ' ' GLN . 0.4 OUTLIER -57.38 -45.35 84.56 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.043 0.937 . . . . 0.0 108.768 175.647 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -69.46 -31.84 70.39 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.252 1.421 . . . . 0.0 111.598 -172.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -82.09 -49.55 10.06 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 118.411 0.55 . . . . 0.0 109.845 175.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.75 -45.08 91.45 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 119.152 0.887 . . . . 0.0 109.931 -173.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -61.92 -23.55 63.69 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 124.041 0.829 . . . . 0.0 112.778 175.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.5 ttmm -59.32 -27.19 65.67 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 118.798 1.299 . . . . 0.0 111.284 175.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -117.39 12.39 14.23 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.805 1.242 . . . . 0.0 110.932 179.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 69.51 18.66 73.88 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 124.598 1.094 . . . . 0.0 113.719 -179.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 86.0 t -84.35 131.57 33.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 176.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.89 27.25 0.48 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.436 1.094 . . . . 0.0 109.741 168.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 24.7 m -140.39 153.63 46.42 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 126.882 2.073 . . . . 0.0 106.515 177.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -146.59 159.88 43.11 Favored Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 124.159 0.983 . . . . 0.0 109.728 -169.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -66.93 136.93 33.55 Favored 'Cis proline' 0 N--CA 1.457 -0.628 0 CA-C-N 120.081 1.065 . . . . 0.0 109.501 -11.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 52.9 m -132.63 121.17 22.78 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 178.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 82.2 mt -99.34 132.14 44.87 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.4 mp -117.18 129.29 55.85 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 105.444 -2.058 . . . . 0.0 105.444 170.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.2 t -93.44 126.4 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 N-CA-C 103.39 -2.819 . . . . 0.0 103.39 169.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.6 mp -119.24 159.81 23.36 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 174.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -145.84 124.75 12.71 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 173.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.4 t70 44.51 40.15 3.73 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.475 1.51 . . . . 0.0 113.267 174.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 98.57 5.96 56.59 Favored Glycine 0 CA--C 1.527 0.813 0 CA-C-O 118.792 -1.004 . . . . 0.0 114.574 169.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 81.9 mm-40 -128.16 144.09 51.09 Favored 'General case' 0 CA--C 1.521 -0.142 0 CA-C-N 119.262 1.531 . . . . 0.0 108.949 177.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.7 t -68.26 136.47 26.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 169.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 22.9 m -120.15 -20.73 4.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 117.856 -1.068 . . . . 0.0 110.479 174.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.54 164.76 38.24 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 119.711 1.141 . . . . 0.0 111.634 173.379 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 95.8 m -145.3 137.74 25.91 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.546 1.538 . . . . 0.0 108.381 175.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 44.6 m -145.06 153.13 41.13 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.04 1.736 . . . . 0.0 108.176 -178.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 40.6 t -133.19 148.21 31.21 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -174.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.83 177.13 46.81 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 123.858 0.742 . . . . 0.0 112.375 176.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -58.99 147.73 33.34 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 124.491 1.116 . . . . 0.0 110.745 178.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -155.23 147.7 17.7 Favored Pre-proline 0 CA--C 1.533 0.311 0 C-N-CA 125.272 1.429 . . . . 0.0 107.686 169.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.85 157.87 47.11 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.668 2.245 . . . . 0.0 111.34 -177.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 4.7 ttpt -60.68 -34.97 75.13 Favored 'General case' 0 C--O 1.223 -0.312 0 C-N-CA 123.909 0.884 . . . . 0.0 111.673 -178.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -64.67 -42.58 95.27 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 119.425 1.011 . . . . 0.0 111.822 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.14 -43.03 75.2 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 122.828 0.451 . . . . 0.0 110.364 177.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 38.8 tp -67.81 -40.71 83.81 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 119.111 -0.471 . . . . 0.0 110.714 -177.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.5 pp0? -67.79 -32.15 72.51 Favored 'General case' 0 C--O 1.222 -0.393 0 CA-C-O 117.856 -1.068 . . . . 0.0 109.578 175.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -67.34 -43.66 80.98 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 119.436 1.016 . . . . 0.0 109.268 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 58.0 tp -57.05 -51.81 67.8 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.409 0.684 . . . . 0.0 109.681 175.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 28.7 t -58.54 -48.86 84.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 123.461 0.705 . . . . 0.0 110.481 178.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -57.44 -46.43 83.6 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 126.501 1.92 . . . . 0.0 110.699 -176.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -59.41 -34.27 72.25 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 118.656 -0.688 . . . . 0.0 112.368 174.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 79.8 m-70 -81.2 -18.12 47.27 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 82.3 mt . . . . . 0 C--O 1.249 1.064 0 CA-C-N 119.93 1.241 . . . . 0.0 110.185 178.653 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 90.8 mt . . . . . 0 CA--C 1.535 0.39 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 38.8 t -110.45 165.18 6.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 -174.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.93 134.93 41.12 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 -179.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -146.66 170.9 16.0 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.106 0.412 . . . . 0.0 111.299 178.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 76.2 p -137.32 174.41 10.63 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.416 1.487 . . . . 0.0 108.111 179.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -47.34 -33.27 5.6 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 119.997 1.271 . . . . 0.0 113.11 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 26.8 mp0 -61.4 -33.71 74.14 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.677 1.591 . . . . 0.0 112.875 -179.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.5 m -142.82 -1.82 1.08 Allowed 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 -169.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -52.72 -41.45 63.96 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.078 0.951 . . . . 0.0 110.13 175.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.6 m -65.45 -27.67 68.68 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.558 0.743 . . . . 0.0 112.433 -178.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -78.49 -27.62 46.22 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.788 0.835 . . . . 0.0 111.088 176.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -81.6 -40.95 22.23 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.031 0.532 . . . . 0.0 111.137 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.527 ' HA ' HG21 ' A' ' 20' ' ' VAL . 39.2 p -74.84 -2.91 28.86 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -174.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.0 p -108.71 29.54 7.34 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.762 1.225 . . . . 0.0 112.883 -169.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -131.27 -0.34 4.07 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 113.588 0.958 . . . . 0.0 113.588 -175.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 166.15 -166.38 38.72 Favored Glycine 0 C--N 1.336 0.547 0 CA-C-N 119.21 0.913 . . . . 0.0 110.848 -174.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 98.3 t -72.4 132.14 33.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 104.829 -2.285 . . . . 0.0 104.829 166.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.527 HG21 ' HA ' ' A' ' 15' ' ' THR . 39.0 t -135.75 118.1 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 -176.062 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 63.1 tp -88.73 97.91 11.4 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 173.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.37 149.37 36.96 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 169.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -133.36 98.24 4.18 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 175.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -73.97 114.95 12.87 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 172.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 7.8 p-90 -138.02 175.03 9.94 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 123.49 0.716 . . . . 0.0 110.754 -169.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -152.14 147.16 19.3 Favored Pre-proline 0 CA--C 1.535 0.399 0 C-N-CA 124.563 1.145 . . . . 0.0 107.934 169.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.45 -21.02 17.65 Favored 'Trans proline' 0 CA--C 1.532 0.397 0 C-N-CA 122.795 2.33 . . . . 0.0 113.348 -171.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -82.74 -8.2 59.6 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 118.685 0.675 . . . . 0.0 112.045 178.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 44.3 t -90.32 120.75 31.72 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 -179.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -57.03 -58.21 15.78 Favored Glycine 0 CA--C 1.531 1.057 0 CA-C-O 118.707 -1.051 . . . . 0.0 112.086 178.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -50.35 -35.07 43.14 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 123.519 2.812 . . . . 0.0 115.271 177.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 97.8 m -60.51 -33.13 72.19 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 119.451 1.023 . . . . 0.0 112.299 175.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 46.2 mtmt -85.04 -34.66 22.25 Favored 'General case' 0 C--N 1.333 -0.12 0 C-N-CA 123.043 0.537 . . . . 0.0 109.914 176.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 26.4 mmt -63.15 -34.96 78.74 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 119.137 0.88 . . . . 0.0 111.593 176.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.7 tt -81.19 -7.87 10.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-N 118.729 0.695 . . . . 0.0 111.667 178.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.44 -50.78 86.16 Favored Pre-proline 0 CA--C 1.541 0.618 0 O-C-N 120.635 -1.291 . . . . 0.0 112.494 178.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -64.07 -33.02 63.48 Favored 'Trans proline' 0 C--N 1.351 0.681 0 CA-C-N 121.844 1.694 . . . . 0.0 112.283 176.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 19.5 t -59.18 -47.76 89.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 119.1 0.864 . . . . 0.0 109.643 173.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 58.9 mt -65.87 -36.89 84.7 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 118.941 -0.552 . . . . 0.0 110.63 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -66.97 -37.6 84.54 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 119.013 0.824 . . . . 0.0 111.303 176.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -68.06 -39.23 83.04 Favored 'General case' 0 C--N 1.331 -0.2 0 O-C-N 121.091 -1.006 . . . . 0.0 110.377 174.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.48 -43.37 97.51 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 176.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -61.23 -42.25 98.28 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.839 0.856 . . . . 0.0 110.519 177.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -67.93 -13.44 62.17 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.703 0.801 . . . . 0.0 112.795 177.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -108.46 -32.09 7.55 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.226 1.01 . . . . 0.0 112.457 -178.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 19.5 mtt -140.2 2.25 1.88 Allowed 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 117.877 -1.059 . . . . 0.0 113.071 -169.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.3 44.63 0.74 Allowed Glycine 0 CA--C 1.532 1.136 0 C-N-CA 126.599 2.047 . . . . 0.0 114.561 -174.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -152.43 -40.3 0.11 Allowed 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 128.951 2.9 . . . . 0.0 107.615 171.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -63.21 -35.94 82.0 Favored 'General case' 0 C--N 1.343 0.319 0 C-N-CA 124.7 1.2 . . . . 0.0 110.451 169.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -133.99 165.29 25.38 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 125.925 1.69 . . . . 0.0 109.75 171.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -106.91 152.52 23.81 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.168 1.387 . . . . 0.0 107.758 170.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.2 mt -117.38 136.22 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 N-CA-C 105.582 -2.007 . . . . 0.0 105.582 171.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 58.1 t -131.65 114.51 25.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 -177.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 48.0 mmtt -74.26 144.56 44.59 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 169.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 13.4 tt -147.77 115.59 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 170.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 44.7 t0 -81.03 112.97 18.91 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.961 0.905 . . . . 0.0 109.224 -175.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 30.5 m -62.27 -21.87 27.86 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-O 118.425 -0.798 . . . . 0.0 113.02 -174.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -72.3 -6.53 43.82 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 120.012 1.278 . . . . 0.0 112.559 -178.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -126.35 4.21 6.99 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.344 1.058 . . . . 0.0 110.505 169.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -142.4 30.8 1.53 Allowed 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.389 1.076 . . . . 0.0 111.528 -168.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.424 ' CD ' ' H ' ' A' ' 61' ' ' GLN . 3.8 pm0 -55.44 -31.56 62.02 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 124.557 1.143 . . . . 0.0 110.435 169.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -65.08 -51.85 59.02 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 124.192 0.997 . . . . 0.0 110.173 176.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -67.17 -43.81 81.32 Favored 'General case' 0 C--O 1.222 -0.357 0 O-C-N 121.965 -0.46 . . . . 0.0 109.924 -178.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -61.63 -45.08 95.61 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 118.611 0.642 . . . . 0.0 109.596 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -59.86 -25.32 61.43 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 124.403 1.001 . . . . 0.0 112.903 175.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 8.5 ttmm -58.41 -23.37 57.1 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 118.621 1.21 . . . . 0.0 111.509 174.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -122.51 12.74 10.08 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.251 1.42 . . . . 0.0 110.894 178.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 70.88 17.45 75.32 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 124.552 1.073 . . . . 0.0 113.914 -179.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 95.4 t -85.55 137.16 21.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 176.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 6.6 tpt -153.49 25.14 0.52 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.092 0.957 . . . . 0.0 109.559 168.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 20.1 m -140.24 154.99 47.06 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 126.403 1.881 . . . . 0.0 107.297 -178.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -145.62 158.26 50.4 Favored Pre-proline 0 CA--C 1.542 0.663 0 C-N-CA 123.743 0.817 . . . . 0.0 110.376 -169.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.14 138.86 43.49 Favored 'Cis proline' 0 C--N 1.35 0.625 0 N-CA-C 109.512 -0.995 . . . . 0.0 109.512 -10.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 53.0 m -131.25 115.93 16.97 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 175.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 90.1 mt -89.86 136.39 33.07 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 176.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.0 mp -122.05 131.06 53.79 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 105.32 -2.104 . . . . 0.0 105.32 169.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 16.1 t -95.21 124.48 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 N-CA-C 103.062 -2.94 . . . . 0.0 103.062 168.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.9 mp -116.96 158.63 23.76 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 173.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 74.2 tttt -144.77 127.51 16.24 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 174.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 29.3 t70 46.83 33.47 2.19 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.248 1.419 . . . . 0.0 113.839 174.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 115.72 -7.97 19.71 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-O 118.096 -1.391 . . . . 0.0 115.082 168.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -133.2 146.09 51.18 Favored 'General case' 0 C--N 1.339 0.119 0 CA-C-N 120.071 1.935 . . . . 0.0 110.598 -174.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 5.8 p -65.48 137.34 25.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 172.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 34.9 m -123.58 -21.38 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 C-N-CA 125.338 1.455 . . . . 0.0 110.573 177.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -156.64 165.55 35.95 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.727 1.149 . . . . 0.0 110.999 174.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 98.9 m -143.74 149.41 37.08 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.761 1.624 . . . . 0.0 108.746 178.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 73.3 m -149.94 155.34 39.8 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.713 1.605 . . . . 0.0 108.306 171.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 40.8 t -132.93 144.93 35.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 -174.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.54 175.85 49.55 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 124.153 0.882 . . . . 0.0 111.716 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -62.47 149.3 43.12 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.428 0.691 . . . . 0.0 110.376 176.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 42.1 mttm -141.5 145.4 37.54 Favored Pre-proline 0 C--O 1.233 0.215 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 168.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -71.63 158.28 53.89 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 122.253 1.969 . . . . 0.0 109.879 172.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.2 tmpt? -62.67 -35.2 78.9 Favored 'General case' 0 N--CA 1.457 -0.117 0 O-C-N 121.686 -0.634 . . . . 0.0 111.601 -176.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -68.3 -35.07 77.27 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 119.125 0.875 . . . . 0.0 111.177 -177.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.9 -41.37 78.35 Favored 'General case' 0 N--CA 1.454 -0.233 0 O-C-N 121.86 -0.525 . . . . 0.0 110.498 171.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 45.7 tp -64.41 -40.18 95.27 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 119.34 -0.362 . . . . 0.0 110.694 -178.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.8 pp0? -70.97 -32.86 69.84 Favored 'General case' 0 C--O 1.226 -0.144 0 CA-C-N 118.994 0.815 . . . . 0.0 110.363 176.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -65.79 -37.17 85.56 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 118.63 0.65 . . . . 0.0 109.445 177.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 61.4 tp -63.33 -55.9 20.82 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.282 0.633 . . . . 0.0 110.055 171.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 25.2 t -61.53 -44.0 97.87 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 C-N-CA 123.384 0.673 . . . . 0.0 110.783 -172.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.78 -28.15 69.25 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 118.769 0.713 . . . . 0.0 112.326 -170.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 35.2 mtmm -73.37 -27.84 61.7 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 118.914 -0.565 . . . . 0.0 112.462 175.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -87.55 -20.57 26.26 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 118.365 -0.826 . . . . 0.0 112.456 -179.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 74.2 mt . . . . . 0 C--O 1.249 1.075 0 CA-C-N 119.192 0.905 . . . . 0.0 109.779 174.152 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 91.2 mt . . . . . 0 CA--C 1.538 0.492 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 25.2 t -124.41 166.32 19.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 125.94 1.696 . . . . 0.0 106.503 -174.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 11.2 mtmt -134.94 146.96 49.63 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 174.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -144.95 170.93 15.19 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 123.32 0.648 . . . . 0.0 110.166 175.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 80.7 p -133.7 175.62 9.28 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 170.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -49.73 -29.67 8.03 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 119.257 0.935 . . . . 0.0 113.32 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -59.02 -34.25 71.67 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.769 2.027 . . . . 0.0 112.477 179.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.4 m -143.17 -2.42 1.0 Allowed 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 114.299 1.222 . . . . 0.0 114.299 -170.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -52.73 -38.82 61.39 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 124.027 0.931 . . . . 0.0 111.038 176.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.6 m -68.36 -39.01 81.98 Favored 'General case' 0 N--CA 1.453 -0.323 0 O-C-N 122.187 -0.321 . . . . 0.0 111.23 -177.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.12 -44.55 79.63 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 175.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 61.8 mm-40 -63.14 -42.29 99.46 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 122.939 0.495 . . . . 0.0 110.856 -177.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 22.4 p -75.7 3.02 10.54 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -177.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 58.2 m -111.8 36.17 3.4 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.758 1.223 . . . . 0.0 111.688 -173.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -128.69 -3.97 5.28 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -179.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 162.88 -164.02 35.64 Favored Glycine 0 C--N 1.336 0.549 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 -172.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 82.0 t -71.51 133.43 31.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 105.095 -2.187 . . . . 0.0 105.095 166.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 31.9 t -137.5 125.52 31.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 107.065 -1.458 . . . . 0.0 107.065 -177.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 63.6 tp -92.61 98.37 11.39 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 173.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.74 145.23 40.99 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 169.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -133.17 96.74 3.81 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 124.993 1.317 . . . . 0.0 107.712 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -75.98 115.29 15.53 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 173.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 6.7 p-90 -138.08 175.76 9.29 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 123.47 0.708 . . . . 0.0 110.453 -171.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -150.19 143.79 16.91 Favored Pre-proline 0 CA--C 1.534 0.351 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 169.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.88 -23.63 21.98 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.334 2.023 . . . . 0.0 113.34 -169.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -81.38 -8.39 59.73 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 118.629 0.65 . . . . 0.0 112.499 178.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 52.7 t -84.86 115.38 22.73 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -178.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -52.35 -56.16 18.69 Favored Glycine 0 CA--C 1.531 1.087 0 CA-C-O 118.685 -1.064 . . . . 0.0 112.231 176.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_exo -51.41 -35.38 54.51 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 123.1 2.533 . . . . 0.0 115.195 174.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 97.5 m -63.26 -40.24 96.86 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 119.85 1.205 . . . . 0.0 111.409 172.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -64.65 -39.74 94.23 Favored 'General case' 0 N--CA 1.465 0.288 0 O-C-N 121.364 -0.835 . . . . 0.0 110.2 173.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 62.2 mtt -65.62 -38.62 89.95 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 123.088 0.555 . . . . 0.0 111.277 -177.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.6 tt -80.43 -18.47 12.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-N 118.819 0.736 . . . . 0.0 111.56 -178.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -52.45 -49.96 82.67 Favored Pre-proline 0 CA--C 1.544 0.749 0 CA-C-N 119.821 1.191 . . . . 0.0 113.567 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -65.69 -30.7 50.49 Favored 'Trans proline' 0 C--N 1.352 0.745 0 CA-C-N 121.873 1.705 . . . . 0.0 112.422 176.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 28.3 t -61.96 -44.48 98.97 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 119.409 1.004 . . . . 0.0 108.98 174.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 92.9 mt -64.44 -38.19 90.14 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-O 118.832 -0.604 . . . . 0.0 110.541 177.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -64.67 -40.37 95.3 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.428 1.013 . . . . 0.0 111.555 175.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -69.61 -35.41 75.25 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 121.16 -0.962 . . . . 0.0 110.69 176.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 9.3 tp -66.89 -39.66 87.55 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.434 0.693 . . . . 0.0 110.381 176.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -64.16 -42.3 96.8 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 123.778 0.831 . . . . 0.0 110.052 176.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -61.8 -31.0 71.19 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 121.629 -0.669 . . . . 0.0 112.229 173.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -85.07 -40.21 17.07 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.792 0.837 . . . . 0.0 112.497 -176.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 38.9 mtt -138.2 4.45 2.46 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 114.025 1.121 . . . . 0.0 114.025 -167.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.38 38.85 0.58 Allowed Glycine 0 CA--C 1.534 1.229 0 C-N-CA 126.487 1.994 . . . . 0.0 115.788 -169.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -140.69 -43.45 0.4 Allowed 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 125.775 1.63 . . . . 0.0 109.421 169.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 52.0 pttt -69.93 -22.74 63.16 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 119.228 -0.415 . . . . 0.0 111.88 170.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -136.96 163.67 30.14 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 125.584 1.554 . . . . 0.0 107.287 165.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 57.2 pttt -124.98 159.94 30.08 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 123.536 0.735 . . . . 0.0 109.069 168.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 22.7 mt -111.87 137.67 43.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 105.503 -2.036 . . . . 0.0 105.503 -178.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 87.2 t -127.06 109.57 20.94 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.13 144.93 44.68 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 171.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 14.7 tt -148.42 117.62 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 173.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -81.2 116.41 21.08 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -176.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 31.0 m -61.78 -26.51 40.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-O 119.061 -0.495 . . . . 0.0 112.031 -177.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -73.4 0.85 11.04 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.917 0.887 . . . . 0.0 112.074 -179.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -130.82 0.75 4.33 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.872 1.269 . . . . 0.0 111.035 170.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -141.39 48.66 1.65 Allowed 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.503 1.121 . . . . 0.0 109.769 -168.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.547 ' NE2' ' H ' ' A' ' 61' ' ' GLN . 0.4 OUTLIER -54.14 -44.94 71.82 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.642 1.577 . . . . 0.0 108.803 177.535 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -64.09 -47.51 79.76 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 125.825 1.65 . . . . 0.0 109.884 -175.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.459 ' HA ' ' HE3' ' A' ' 66' ' ' LYS . 0.7 OUTLIER -69.44 -43.18 73.87 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-O 119.298 -0.382 . . . . 0.0 110.153 -176.006 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -61.76 -46.57 89.04 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 119.239 0.927 . . . . 0.0 109.615 176.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -58.22 -26.39 58.74 Favored Glycine 0 CA--C 1.532 1.094 0 C-N-CA 124.165 0.888 . . . . 0.0 113.053 175.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.459 ' HE3' ' HA ' ' A' ' 63' ' ' THR . 28.9 ttmt -57.95 -21.5 44.38 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.33 1.452 . . . . 0.0 111.937 177.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -127.6 13.17 6.97 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.86 1.264 . . . . 0.0 110.638 178.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 69.83 19.02 74.78 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 124.667 1.127 . . . . 0.0 113.664 -178.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 96.3 t -82.19 137.93 20.3 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 175.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -153.16 25.02 0.54 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.901 1.28 . . . . 0.0 109.499 168.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 20.4 m -139.51 154.82 47.77 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 126.412 1.885 . . . . 0.0 107.32 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -146.18 160.31 43.13 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 124.345 1.058 . . . . 0.0 109.544 -170.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -66.86 139.24 44.48 Favored 'Cis proline' 0 C--N 1.35 0.632 0 N-CA-C 109.285 -1.083 . . . . 0.0 109.285 -11.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 51.3 m -131.9 118.59 20.01 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 177.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 88.3 mt -96.3 134.27 39.64 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 106.63 -1.619 . . . . 0.0 106.63 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.9 mp -119.54 128.37 53.87 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 104.793 -2.299 . . . . 0.0 104.793 169.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 15.5 t -93.58 125.26 46.18 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 103.104 -2.924 . . . . 0.0 103.104 168.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.7 mp -118.36 159.38 23.52 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 173.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 75.9 tttt -144.22 124.23 13.58 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 174.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.7 t70 45.76 36.76 2.93 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.44 1.496 . . . . 0.0 113.423 175.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 107.45 -2.28 34.62 Favored Glycine 0 CA--C 1.527 0.806 0 CA-C-O 118.089 -1.395 . . . . 0.0 115.365 168.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -130.39 147.36 52.08 Favored 'General case' 0 C--N 1.339 0.126 0 CA-C-N 120.08 1.94 . . . . 0.0 110.246 -178.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 16.8 t -67.66 137.61 24.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 107.813 -1.181 . . . . 0.0 107.813 175.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 29.0 m -119.63 -20.26 4.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 124.827 1.251 . . . . 0.0 110.537 173.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -156.85 162.26 39.69 Favored 'General case' 0 C--N 1.346 0.417 0 CA-C-N 119.642 1.11 . . . . 0.0 111.242 173.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 87.0 m -143.49 137.92 28.86 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.645 1.578 . . . . 0.0 108.356 174.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 29.3 m -145.39 153.22 40.98 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.933 1.693 . . . . 0.0 108.44 -178.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 40.9 t -133.07 145.21 34.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -175.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.91 175.52 46.79 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 124.462 1.029 . . . . 0.0 111.844 178.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -62.29 148.5 44.77 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.727 0.811 . . . . 0.0 110.377 176.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 46.3 mttm -142.01 146.1 38.95 Favored Pre-proline 0 C--O 1.233 0.195 0 C-N-CA 124.93 1.292 . . . . 0.0 107.733 168.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -72.87 161.21 44.28 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 122.746 2.297 . . . . 0.0 110.266 173.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -56.16 -43.78 78.68 Favored 'General case' 0 C--O 1.223 -0.326 0 CA-C-O 118.626 -0.702 . . . . 0.0 110.683 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -65.65 -37.78 87.49 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 119.162 0.892 . . . . 0.0 111.458 -169.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.53 -43.97 71.93 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 122.904 0.481 . . . . 0.0 110.639 174.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 29.6 tp -67.15 -41.77 85.48 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 122.568 0.347 . . . . 0.0 110.76 -175.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.2 pp0? -70.55 -32.69 70.22 Favored 'General case' 0 N--CA 1.456 -0.138 0 O-C-N 121.798 -0.564 . . . . 0.0 109.866 177.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -63.43 -48.05 79.38 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 176.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 51.1 tp -60.17 -44.4 95.07 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 122.824 0.45 . . . . 0.0 110.696 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 26.3 t -58.06 -47.48 86.76 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 175.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.71 -25.09 67.79 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 119.078 0.854 . . . . 0.0 112.675 -177.284 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -66.02 -23.65 66.6 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 119.048 0.84 . . . . 0.0 112.479 169.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -107.85 -16.52 14.29 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 119.478 1.035 . . . . 0.0 113.242 -174.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 80.7 mt . . . . . 0 C--O 1.249 1.068 0 CA-C-N 119.484 1.038 . . . . 0.0 109.681 172.248 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 91.8 mt . . . . . 0 CA--C 1.539 0.551 0 N-CA-C 107.3 -1.371 . . . . 0.0 107.3 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 36.7 t -120.03 170.68 9.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 -174.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 27.8 mtpt -137.31 149.84 47.34 Favored 'General case' 0 CA--C 1.518 -0.268 0 O-C-N 120.732 -1.23 . . . . 0.0 108.679 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -151.01 170.36 19.54 Favored 'General case' 0 C--N 1.331 -0.196 0 O-C-N 123.489 0.493 . . . . 0.0 111.66 176.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.3 p -136.51 174.11 10.97 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.863 1.665 . . . . 0.0 107.205 172.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -47.08 -33.3 4.83 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 119.917 1.235 . . . . 0.0 113.243 -179.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 26.9 mp0 -60.68 -31.45 70.71 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.075 1.75 . . . . 0.0 113.109 -179.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.3 m -140.41 -2.57 1.41 Allowed 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -170.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -54.79 -37.94 66.68 Favored 'General case' 0 CA--C 1.528 0.098 0 C-N-CA 124.191 0.997 . . . . 0.0 111.03 178.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.4 p -63.09 -50.53 70.18 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.653 0.781 . . . . 0.0 110.788 179.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.31 -44.44 92.57 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 122.972 0.509 . . . . 0.0 110.159 178.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -66.58 -37.76 85.6 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-O 119.2 -0.428 . . . . 0.0 111.403 -177.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.517 ' HA ' HG21 ' A' ' 20' ' ' VAL . 34.2 p -80.21 3.35 21.02 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 118.607 0.64 . . . . 0.0 112.451 -178.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 51.2 m -111.73 32.78 5.19 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.598 1.159 . . . . 0.0 112.346 -172.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -132.58 -0.44 3.55 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -177.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 165.92 -167.09 39.01 Favored Glycine 0 C--N 1.334 0.452 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 -174.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 97.4 t -71.91 133.3 32.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 104.56 -2.385 . . . . 0.0 104.56 166.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.517 HG21 ' HA ' ' A' ' 15' ' ' THR . 38.6 t -136.49 121.77 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 -176.307 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 56.6 tp -96.45 98.0 9.89 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 173.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.2 156.16 33.87 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 169.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -139.38 100.04 3.89 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 125.382 1.473 . . . . 0.0 107.547 179.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -75.05 115.52 14.76 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 169.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 8.6 p-90 -137.0 174.72 10.31 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 123.554 0.742 . . . . 0.0 110.237 -174.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -153.96 148.02 18.96 Favored Pre-proline 0 CA--C 1.535 0.402 0 N-CA-C 107.753 -1.202 . . . . 0.0 107.753 169.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -73.52 -22.46 18.31 Favored 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 122.574 2.183 . . . . 0.0 113.22 -169.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -79.43 -5.55 54.94 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 118.623 0.647 . . . . 0.0 112.356 179.047 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 45.2 t -95.12 110.51 22.45 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 -175.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -51.03 -53.21 27.97 Favored Glycine 0 CA--C 1.533 1.215 0 CA-C-O 118.801 -0.999 . . . . 0.0 112.74 176.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_exo -52.34 -34.19 59.32 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 122.858 2.372 . . . . 0.0 114.846 174.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 80.9 m -67.39 -39.8 85.6 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 120.185 1.357 . . . . 0.0 111.146 172.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -59.88 -34.34 73.03 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 121.051 -1.031 . . . . 0.0 110.262 173.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 26.2 mmt -73.88 -37.12 64.83 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 123.043 0.537 . . . . 0.0 111.48 177.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.2 tp -70.68 -23.27 23.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 119.408 1.004 . . . . 0.0 110.935 179.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.81 -54.95 46.28 Favored Pre-proline 0 CA--C 1.543 0.701 0 CA-C-O 117.775 -1.107 . . . . 0.0 113.006 -177.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -66.55 -28.41 45.29 Favored 'Trans proline' 0 C--N 1.349 0.576 0 CA-C-N 121.703 1.644 . . . . 0.0 112.499 177.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 97.8 t -62.87 -43.61 99.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 119.607 1.094 . . . . 0.0 109.335 174.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 89.5 mt -69.28 -35.03 75.63 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-O 118.585 -0.722 . . . . 0.0 111.112 178.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -65.51 -41.23 93.39 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 119.526 1.057 . . . . 0.0 110.883 174.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -59.43 -45.23 92.13 Favored 'General case' 0 N--CA 1.455 -0.196 0 O-C-N 121.479 -0.763 . . . . 0.0 110.4 171.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.2 tp -64.36 -38.93 92.76 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 122.869 0.468 . . . . 0.0 110.698 -178.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -65.3 -41.78 93.72 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.524 0.73 . . . . 0.0 110.611 177.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -66.91 -36.3 81.94 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 122.067 -0.396 . . . . 0.0 111.252 176.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -73.96 -49.66 23.58 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.231 1.013 . . . . 0.0 111.013 -175.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 7.9 ptp -146.06 10.53 1.17 Allowed 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 -167.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.68 52.02 1.54 Allowed Glycine 0 CA--C 1.526 0.764 0 C-N-CA 126.53 2.014 . . . . 0.0 113.156 -178.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -148.66 -39.42 0.16 Allowed 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 128.229 2.612 . . . . 0.0 107.697 169.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 58.7 mtmt -65.95 -29.71 70.16 Favored 'General case' 0 C--N 1.345 0.375 0 C-N-CA 123.58 0.752 . . . . 0.0 110.68 168.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -131.96 162.65 30.18 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 125.138 1.375 . . . . 0.0 110.324 168.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -99.28 154.91 17.8 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.018 1.327 . . . . 0.0 107.538 169.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 12.8 mt -120.83 137.37 54.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 N-CA-C 105.704 -1.961 . . . . 0.0 105.704 170.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 84.6 t -133.61 114.1 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-N 119.048 0.84 . . . . 0.0 108.963 -174.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 56.7 mmtt -73.73 143.29 46.18 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 121.853 -0.529 . . . . 0.0 109.845 170.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 13.0 tt -151.35 149.68 13.86 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 N-CA-C 107.699 -1.222 . . . . 0.0 107.699 170.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -123.33 118.04 26.62 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 120.958 -1.089 . . . . 0.0 109.808 -169.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 30.5 m -55.13 -29.48 22.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 124.233 1.013 . . . . 0.0 113.027 -174.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -69.76 -9.09 53.24 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.874 0.869 . . . . 0.0 112.424 -175.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -132.07 6.05 4.22 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.838 1.255 . . . . 0.0 110.953 176.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 67.1 m-80 -141.21 46.7 1.72 Allowed 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.957 0.903 . . . . 0.0 110.679 -168.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.515 ' NE2' ' H ' ' A' ' 61' ' ' GLN . 0.5 OUTLIER -55.09 -43.94 74.45 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.908 0.883 . . . . 0.0 108.947 173.616 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -68.38 -31.73 71.31 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 125.48 1.512 . . . . 0.0 111.63 -171.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -84.68 -47.54 10.37 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 118.31 0.504 . . . . 0.0 109.918 176.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -64.22 -45.17 89.4 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 119.216 0.916 . . . . 0.0 109.904 -175.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -61.1 -24.97 63.77 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 124.009 0.814 . . . . 0.0 112.409 176.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.4 ttmm -58.99 -26.44 64.5 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 118.348 1.074 . . . . 0.0 111.533 176.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -114.83 10.47 16.48 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.606 1.162 . . . . 0.0 111.146 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 71.15 31.43 66.45 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 123.649 0.642 . . . . 0.0 112.418 -178.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 98.1 t -111.05 138.27 40.03 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 C-N-CA 125.073 1.349 . . . . 0.0 107.835 -178.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 8.6 tpt -153.97 30.75 0.45 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.034 0.934 . . . . 0.0 108.989 167.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 19.3 m -139.21 158.8 43.54 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 126.401 1.88 . . . . 0.0 107.671 -178.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -143.43 158.62 57.17 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 123.956 0.903 . . . . 0.0 110.013 -173.285 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -66.75 138.36 39.85 Favored 'Cis proline' 0 N--CA 1.457 -0.631 0 N-CA-C 108.786 -1.275 . . . . 0.0 108.786 -11.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 99.1 m -132.31 112.73 12.46 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 174.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 95.6 mt -83.46 141.77 31.43 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 175.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -128.8 127.27 41.63 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 104.133 -2.543 . . . . 0.0 104.133 -178.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.0 t -112.57 121.72 65.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 104.235 -2.506 . . . . 0.0 104.235 -176.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.2 mp -127.46 159.32 34.87 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 77.2 tttt -146.08 124.15 12.12 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 177.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.0 t70 45.16 35.94 1.91 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.438 1.495 . . . . 0.0 113.441 175.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 105.54 1.71 40.48 Favored Glycine 0 CA--C 1.527 0.794 0 CA-C-O 118.092 -1.393 . . . . 0.0 115.074 169.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -130.69 145.2 51.87 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 120.082 1.941 . . . . 0.0 109.921 179.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.7 p -69.0 140.67 18.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 C-N-CA 123.769 0.827 . . . . 0.0 109.19 174.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 35.5 m -128.02 -17.95 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 125.69 1.596 . . . . 0.0 110.681 178.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -160.1 167.28 28.14 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 120.389 1.45 . . . . 0.0 111.545 169.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 52.7 m -145.4 141.53 28.52 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.054 1.742 . . . . 0.0 107.549 169.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 14.7 m -145.84 146.55 31.18 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 124.215 1.006 . . . . 0.0 108.631 -178.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 39.8 t -127.41 148.8 32.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 -170.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.99 172.55 39.57 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 124.185 0.897 . . . . 0.0 111.589 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -61.22 153.75 25.31 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.225 0.61 . . . . 0.0 110.762 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -153.41 148.25 19.65 Favored Pre-proline 0 CA--C 1.533 0.301 0 C-N-CA 125.082 1.353 . . . . 0.0 107.677 169.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.51 162.41 41.47 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.644 2.23 . . . . 0.0 111.013 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -53.97 -43.8 70.23 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-O 118.574 -0.727 . . . . 0.0 110.952 177.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -63.59 -42.14 98.3 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 119.059 0.845 . . . . 0.0 111.369 -169.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.58 -41.71 88.11 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 123.096 0.558 . . . . 0.0 110.854 175.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 30.9 tp -68.1 -41.95 81.02 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 119.549 -0.262 . . . . 0.0 110.911 -176.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.7 pp0? -71.15 -30.81 66.92 Favored 'General case' 0 N--CA 1.457 -0.113 0 CA-C-N 118.512 0.596 . . . . 0.0 110.044 177.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -63.1 -50.03 72.12 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 174.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 66.9 tp -58.04 -46.54 85.19 Favored 'General case' 0 C--N 1.334 -0.09 0 C-N-CA 123.723 0.809 . . . . 0.0 110.31 -178.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 42.9 t -63.7 -49.08 83.73 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-O 118.561 -0.733 . . . . 0.0 109.783 179.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.05 -26.89 68.76 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 119.725 1.148 . . . . 0.0 112.268 -176.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -68.22 -26.83 65.91 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 118.323 -0.846 . . . . 0.0 112.384 171.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 77.0 m-70 -95.23 -19.84 19.7 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 119.571 1.078 . . . . 0.0 113.368 178.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 61.3 mt . . . . . 0 C--O 1.248 0.982 0 CA-C-N 119.781 1.173 . . . . 0.0 109.745 175.296 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 90.5 mt . . . . . 0 C--O 1.236 0.384 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 40.9 t -104.38 167.58 2.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 -174.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 5.9 mptt -137.13 138.51 40.37 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 -178.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -144.91 170.22 16.55 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.068 0.461 . . . . 0.0 111.656 -179.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 70.8 p -137.08 173.5 11.63 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.725 1.61 . . . . 0.0 107.48 177.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -49.75 -32.43 13.7 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 119.836 1.198 . . . . 0.0 112.979 -178.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 26.2 mp0 -63.82 -30.75 71.81 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.098 1.759 . . . . 0.0 112.778 -178.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.6 m -138.47 -4.93 1.61 Allowed 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 -169.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -54.92 -37.48 66.43 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 124.039 0.935 . . . . 0.0 110.821 177.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.3 p -62.94 -50.98 68.7 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 123.861 0.865 . . . . 0.0 110.835 178.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.22 -44.29 92.3 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.019 0.527 . . . . 0.0 110.081 178.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -66.03 -38.67 89.0 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-O 119.237 -0.411 . . . . 0.0 111.294 -177.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.551 ' HA ' HG21 ' A' ' 20' ' ' VAL . 28.8 p -78.62 1.41 22.79 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 118.528 0.604 . . . . 0.0 112.58 -179.08 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 50.4 m -110.29 32.61 5.02 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.57 1.148 . . . . 0.0 112.27 -172.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -132.17 -0.17 3.73 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -178.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 165.51 -167.69 39.1 Favored Glycine 0 C--N 1.336 0.54 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 -174.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 97.4 t -71.24 134.23 30.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 N-CA-C 104.687 -2.338 . . . . 0.0 104.687 166.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.551 HG21 ' HA ' ' A' ' 15' ' ' THR . 40.4 t -136.8 120.85 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 -175.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 61.6 tp -95.35 96.91 9.45 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 173.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.24 157.76 32.28 Favored 'General case' 0 N--CA 1.444 -0.732 0 O-C-N 121.831 -0.543 . . . . 0.0 109.7 169.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -139.92 99.26 3.65 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 125.558 1.543 . . . . 0.0 107.436 178.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -73.96 117.14 15.4 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 169.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 8.2 p-90 -138.2 173.4 11.65 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 123.396 0.678 . . . . 0.0 110.883 -174.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -153.47 149.13 20.71 Favored Pre-proline 0 C--O 1.238 0.46 0 C-N-CA 126.416 1.886 . . . . 0.0 105.957 169.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -75.68 -21.97 14.11 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.695 2.263 . . . . 0.0 113.251 -169.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -78.32 -7.84 57.71 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 118.541 0.609 . . . . 0.0 112.521 -176.141 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 37.5 t -100.16 108.78 20.99 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 -178.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -46.47 -51.21 12.53 Favored Glycine 0 CA--C 1.533 1.215 0 CA-C-O 118.425 -1.208 . . . . 0.0 113.767 -178.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -49.81 -31.51 26.41 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 123.443 2.762 . . . . 0.0 115.885 176.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 61.6 m -62.5 -40.94 98.34 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 120.409 1.459 . . . . 0.0 110.782 173.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -67.88 -37.75 82.18 Favored 'General case' 0 N--CA 1.462 0.144 0 O-C-N 121.729 -0.607 . . . . 0.0 109.933 175.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 64.3 mtt -65.66 -40.5 92.5 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 118.202 0.455 . . . . 0.0 111.165 -178.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 10.1 tt -80.87 -19.03 11.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 118.666 0.667 . . . . 0.0 111.619 -177.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -52.35 -51.53 71.55 Favored Pre-proline 0 CA--C 1.543 0.686 0 CA-C-O 117.529 -1.224 . . . . 0.0 113.632 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.1 -30.45 55.87 Favored 'Trans proline' 0 C--N 1.351 0.683 0 CA-C-N 121.874 1.705 . . . . 0.0 112.037 177.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 14.0 t -63.6 -44.61 98.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 119.126 0.875 . . . . 0.0 109.157 176.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 78.5 mt -65.59 -36.38 83.58 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 118.917 -0.563 . . . . 0.0 110.731 177.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -66.05 -38.88 89.47 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 119.266 0.939 . . . . 0.0 111.203 175.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -67.38 -37.52 83.27 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 121.087 -1.008 . . . . 0.0 110.344 174.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 16.0 tp -66.34 -39.11 89.01 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.348 0.659 . . . . 0.0 110.551 177.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -65.1 -40.07 94.03 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.014 0.926 . . . . 0.0 110.708 175.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -66.84 -36.45 82.37 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.942 -0.474 . . . . 0.0 111.306 175.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -72.35 -53.47 12.25 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.921 0.889 . . . . 0.0 110.987 -178.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 11.6 ptp -144.44 15.63 1.64 Allowed 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 114.212 1.189 . . . . 0.0 114.212 -167.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.35 53.94 1.14 Allowed Glycine 0 CA--C 1.529 0.965 0 C-N-CA 126.124 1.821 . . . . 0.0 112.092 175.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -153.51 -40.93 0.1 Allowed 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 129.41 3.084 . . . . 0.0 107.281 172.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -63.95 -35.24 80.03 Favored 'General case' 0 C--N 1.343 0.311 0 C-N-CA 124.04 0.936 . . . . 0.0 110.176 168.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -131.04 165.34 23.43 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 125.34 1.456 . . . . 0.0 110.473 169.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -102.06 154.64 18.8 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 169.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.6 mt -120.58 137.45 54.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 170.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 66.7 t -134.02 115.94 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-N 119.2 0.909 . . . . 0.0 109.502 -175.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 65.7 mmtt -74.89 145.04 43.05 Favored 'General case' 0 C--O 1.235 0.303 0 O-C-N 121.233 -0.917 . . . . 0.0 109.783 169.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 12.4 tt -151.33 141.7 15.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 169.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -98.49 128.08 44.69 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 121.488 -0.757 . . . . 0.0 110.063 -173.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 15.9 m -67.99 -27.42 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 114.51 1.3 . . . . 0.0 114.51 -173.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -80.62 -41.32 24.09 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 120.072 1.305 . . . . 0.0 109.41 -175.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -71.75 -26.26 62.38 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.413 0.685 . . . . 0.0 111.18 175.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 -128.39 43.43 3.14 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.735 1.214 . . . . 0.0 109.864 -170.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.79 -39.67 62.55 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 126.697 1.999 . . . . 0.0 111.049 176.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -64.02 -46.02 86.33 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 123.615 0.766 . . . . 0.0 110.335 176.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.539 ' HA ' ' HE3' ' A' ' 66' ' ' LYS . 0.3 OUTLIER -69.89 -41.93 74.09 Favored 'General case' 0 C--O 1.222 -0.369 0 CA-C-N 118.69 0.677 . . . . 0.0 110.74 -175.979 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.77 -45.16 93.99 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 119.307 0.958 . . . . 0.0 109.273 176.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -57.53 -27.9 59.01 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 123.838 0.733 . . . . 0.0 112.778 174.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.539 ' HE3' ' HA ' ' A' ' 63' ' ' THR . 25.0 ttmt -59.51 -19.94 51.83 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.458 1.503 . . . . 0.0 111.96 178.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -125.3 12.41 8.19 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.659 1.184 . . . . 0.0 110.915 179.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 71.52 32.6 64.52 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 123.713 0.673 . . . . 0.0 112.722 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 90.8 t -111.18 139.05 36.96 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 C-N-CA 125.054 1.342 . . . . 0.0 108.003 -178.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 8.6 tpt -155.26 30.29 0.39 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.408 1.083 . . . . 0.0 108.989 167.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 18.2 m -136.96 158.96 43.27 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 126.181 1.792 . . . . 0.0 107.919 -177.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -144.8 155.57 56.01 Favored Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 123.354 0.662 . . . . 0.0 111.152 -170.293 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -69.73 140.14 58.67 Favored 'Cis proline' 0 N--CA 1.458 -0.599 0 N-CA-C 108.653 -1.326 . . . . 0.0 108.653 -11.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 96.3 m -130.68 113.11 13.76 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 176.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 94.4 mt -81.18 144.71 31.43 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 175.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.9 126.4 36.06 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 103.949 -2.611 . . . . 0.0 103.949 -179.036 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 5.2 t -109.52 122.33 63.96 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.42 0 N-CA-C 104.227 -2.509 . . . . 0.0 104.227 -179.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.4 mp -125.86 159.8 31.55 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 179.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -145.41 126.44 14.6 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 175.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.0 t70 44.41 35.65 1.39 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.368 1.467 . . . . 0.0 113.55 174.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 106.48 0.19 37.35 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-O 118.004 -1.442 . . . . 0.0 115.07 169.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -130.69 145.82 52.02 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-N 120.13 1.965 . . . . 0.0 110.216 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 10.0 p -70.03 140.98 17.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 C-N-CA 123.845 0.858 . . . . 0.0 109.435 174.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 32.5 m -129.94 -17.61 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 125.734 1.613 . . . . 0.0 110.788 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -160.29 168.56 25.05 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 120.422 1.465 . . . . 0.0 111.696 169.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 53.9 m -146.84 141.85 27.06 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.072 1.749 . . . . 0.0 108.023 170.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 18.7 m -146.16 152.86 39.94 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 124.77 1.228 . . . . 0.0 108.864 -177.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 32.8 t -130.15 148.85 33.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-N 119.155 0.888 . . . . 0.0 108.691 -171.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 80.62 179.72 53.0 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 124.098 0.856 . . . . 0.0 111.994 176.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -62.07 150.69 37.58 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.773 0.829 . . . . 0.0 110.759 177.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.41 147.74 29.17 Favored Pre-proline 0 CA--C 1.531 0.233 0 C-N-CA 124.893 1.277 . . . . 0.0 107.739 167.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -74.1 160.71 42.27 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 123.207 2.604 . . . . 0.0 110.452 174.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 75.3 tttt -55.18 -41.32 71.74 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 118.816 -0.612 . . . . 0.0 110.515 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -59.74 -41.7 91.54 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 118.516 0.598 . . . . 0.0 110.871 -174.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.14 -43.36 87.3 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.03 0.532 . . . . 0.0 110.792 176.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 61.1 mt -64.29 -45.88 86.06 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 119.141 -0.457 . . . . 0.0 109.945 -179.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 2.9 pp0? -71.12 -27.57 63.68 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.799 0.727 . . . . 0.0 110.676 -177.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -67.72 -50.16 58.89 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 173.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 60.9 tp -58.26 -47.47 83.48 Favored 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 123.235 0.614 . . . . 0.0 109.975 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 44.4 t -62.66 -46.94 95.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 CA-C-O 117.995 -1.002 . . . . 0.0 109.696 -179.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -60.24 -34.71 74.06 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 120.073 1.306 . . . . 0.0 111.315 -177.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 48.2 mmtm -71.07 -10.09 59.16 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 118.045 -0.978 . . . . 0.0 113.468 175.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -108.17 -17.03 14.13 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 119.982 1.264 . . . . 0.0 113.383 172.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 64.8 mt . . . . . 0 C--O 1.25 1.109 0 CA-C-N 120.239 1.381 . . . . 0.0 109.761 174.293 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 79.5 mt . . . . . 0 CA--C 1.539 0.551 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 31.5 t -114.34 167.56 7.0 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 125.939 1.696 . . . . 0.0 107.104 -174.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 9.2 mtmt -132.75 147.79 52.32 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 176.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -148.59 169.7 19.75 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.545 0.738 . . . . 0.0 110.426 176.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 77.8 p -135.53 174.94 10.06 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.562 1.145 . . . . 0.0 107.918 171.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -47.7 -31.03 4.29 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 119.964 1.256 . . . . 0.0 112.928 178.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -58.76 -33.33 70.17 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.374 1.87 . . . . 0.0 112.791 179.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.7 m -142.95 -3.09 0.99 Allowed 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 114.217 1.192 . . . . 0.0 114.217 -169.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -53.8 -37.45 63.53 Favored 'General case' 0 C--O 1.23 0.065 0 C-N-CA 124.435 1.094 . . . . 0.0 111.105 179.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.4 p -61.53 -53.63 53.8 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.808 0.843 . . . . 0.0 110.658 179.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.25 -43.76 88.01 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.018 0.527 . . . . 0.0 110.28 179.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -65.97 -35.51 80.79 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 119.081 -0.485 . . . . 0.0 111.746 -177.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.537 ' HA ' HG21 ' A' ' 20' ' ' VAL . 32.1 p -85.75 1.14 50.75 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -178.16 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 40.5 m -115.24 32.48 6.02 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -169.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -144.02 17.54 1.76 Allowed 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 177.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 172.6 -169.23 42.37 Favored Glycine 0 C--N 1.339 0.711 0 O-C-N 121.329 -0.857 . . . . 0.0 112.151 174.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 1.8 t -78.65 134.35 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 104.106 -2.553 . . . . 0.0 104.106 168.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.537 HG21 ' HA ' ' A' ' 15' ' ' THR . 25.5 t -139.62 138.4 39.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 -172.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 42.6 tp -114.02 97.6 6.47 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 173.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.95 157.55 33.01 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 169.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -138.31 99.4 3.84 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 125.27 1.428 . . . . 0.0 107.259 177.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -72.5 115.66 12.03 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 169.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 9.3 p-90 -137.19 175.53 9.53 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.704 0.801 . . . . 0.0 110.373 -172.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -152.3 146.58 18.55 Favored Pre-proline 0 CA--C 1.535 0.399 0 C-N-CA 124.491 1.117 . . . . 0.0 107.994 169.227 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.25 -19.3 17.46 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.801 2.334 . . . . 0.0 113.299 -171.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -82.36 -7.47 59.63 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 121.537 -0.727 . . . . 0.0 111.961 177.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 48.6 t -92.07 120.76 32.99 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -57.0 -58.32 15.19 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-O 118.656 -1.08 . . . . 0.0 111.925 177.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -49.63 -36.33 40.5 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 123.653 2.902 . . . . 0.0 115.157 177.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 95.8 m -60.16 -36.66 78.07 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 119.429 1.013 . . . . 0.0 112.313 175.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 46.3 mtmt -80.48 -35.35 34.93 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-O 118.986 -0.53 . . . . 0.0 109.893 177.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 26.4 mmt -64.36 -39.23 93.47 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 118.967 0.803 . . . . 0.0 111.304 178.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 8.4 tt -76.46 -13.21 14.6 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 CA-C-N 118.824 0.738 . . . . 0.0 111.349 179.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -57.17 -52.22 75.79 Favored Pre-proline 0 CA--C 1.541 0.631 0 CA-C-O 117.515 -1.231 . . . . 0.0 113.21 -177.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.71 -28.86 60.06 Favored 'Trans proline' 0 C--N 1.351 0.685 0 CA-C-N 121.873 1.704 . . . . 0.0 112.418 176.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 10.5 t -65.08 -44.17 95.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 177.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 61.6 mt -68.12 -33.22 74.1 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 118.056 -0.973 . . . . 0.0 111.138 175.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -65.48 -43.76 89.23 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 120.036 1.289 . . . . 0.0 110.578 174.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -59.79 -42.57 93.69 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 118.77 0.714 . . . . 0.0 110.031 175.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 37.7 tp -65.0 -39.17 93.06 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 122.529 0.332 . . . . 0.0 110.903 178.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -64.43 -41.86 96.34 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 124.566 1.147 . . . . 0.0 110.477 178.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 65.0 mm-40 -65.73 -26.07 67.58 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.634 -0.666 . . . . 0.0 111.578 176.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -91.98 -31.08 15.75 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.749 1.22 . . . . 0.0 112.908 -177.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.4 ' HA ' ' HE3' ' A' ' 49' ' ' LYS . 19.3 mmt -126.07 -11.26 6.49 Favored 'General case' 0 C--O 1.226 -0.171 0 CA-C-O 117.697 -1.144 . . . . 0.0 113.483 -168.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -45.54 -35.14 5.37 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 126.287 1.899 . . . . 0.0 115.923 -170.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -76.06 -37.97 57.64 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.04 0.936 . . . . 0.0 111.519 -178.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.4 ' HE3' ' HA ' ' A' ' 46' ' ' MET . 29.2 mtmt -83.79 -27.46 28.81 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 125.27 1.428 . . . . 0.0 110.444 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -151.14 122.18 7.68 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 124.542 1.137 . . . . 0.0 109.847 -170.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -74.28 151.92 39.77 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.911 0.885 . . . . 0.0 108.978 174.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.9 mt -122.46 134.02 66.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 N-CA-C 105.985 -1.858 . . . . 0.0 105.985 172.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 41.1 t -131.6 113.26 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -171.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 60.3 mmtt -74.2 143.17 45.3 Favored 'General case' 0 C--O 1.235 0.319 0 O-C-N 121.505 -0.747 . . . . 0.0 109.557 170.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 11.7 tt -150.13 121.38 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 173.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -86.86 116.85 25.21 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 121.393 -0.817 . . . . 0.0 109.384 -174.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 29.9 m -58.69 -28.02 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-N 118.674 0.67 . . . . 0.0 112.713 -176.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -71.99 -7.96 51.74 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 119.26 0.936 . . . . 0.0 112.059 -177.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -123.23 2.38 9.18 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.3 1.44 . . . . 0.0 110.513 173.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -146.54 36.45 0.98 Allowed 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 124.683 1.193 . . . . 0.0 111.026 -168.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.6 pm0 -58.22 -30.41 66.46 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.333 0.653 . . . . 0.0 110.236 173.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 59.3 mp0 -62.16 -55.08 32.35 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.406 1.482 . . . . 0.0 109.685 174.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.86 -43.91 74.41 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 119.377 -0.344 . . . . 0.0 110.164 -174.44 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.83 -45.4 92.79 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 118.71 0.686 . . . . 0.0 109.583 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -59.6 -25.34 60.85 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.122 0.868 . . . . 0.0 112.748 175.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 9.9 ttmm -59.44 -23.54 62.77 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.575 1.187 . . . . 0.0 111.405 175.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -118.8 11.07 12.55 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.162 1.385 . . . . 0.0 110.984 178.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 68.62 20.53 74.03 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 124.23 0.919 . . . . 0.0 113.346 -176.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 91.0 t -90.52 133.67 31.65 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 177.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 7.2 tpt -154.7 30.73 0.42 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.778 0.831 . . . . 0.0 109.621 167.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 45.1 m -135.36 156.79 48.36 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 126.36 1.864 . . . . 0.0 106.834 172.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -145.16 158.27 52.07 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 123.935 0.894 . . . . 0.0 109.992 -170.309 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -67.7 136.78 35.11 Favored 'Cis proline' 0 C--N 1.349 0.591 0 CA-C-N 120.085 1.066 . . . . 0.0 109.784 -10.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 70.4 m -132.26 113.95 13.85 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 176.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 88.5 mt -82.39 145.5 29.85 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 175.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -129.61 124.7 34.38 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 104.263 -2.495 . . . . 0.0 104.263 179.387 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.5 t -106.69 124.34 62.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 N-CA-C 104.031 -2.581 . . . . 0.0 104.031 -178.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.7 mp -127.16 160.21 31.93 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.517 1.127 . . . . 0.0 108.102 178.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -148.18 128.03 13.48 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 174.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.0 t70 42.64 38.3 1.26 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.211 1.404 . . . . 0.0 113.276 179.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.72 6.67 60.62 Favored Glycine 0 CA--C 1.527 0.842 0 CA-C-O 118.777 -1.013 . . . . 0.0 114.726 171.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -121.82 143.05 49.63 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 119.333 1.567 . . . . 0.0 108.881 176.177 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 78.1 t -67.24 139.4 21.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 169.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.1 m -124.95 -21.55 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 CA-C-O 117.513 -1.232 . . . . 0.0 110.484 174.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -158.41 166.67 31.67 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 120.288 1.404 . . . . 0.0 111.846 174.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 72.4 m -144.24 139.5 28.71 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.89 1.676 . . . . 0.0 107.569 169.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 20.2 m -146.13 153.18 40.39 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.588 1.155 . . . . 0.0 109.035 -174.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 30.7 t -131.7 150.53 34.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 CA-C-N 119.04 0.836 . . . . 0.0 108.993 -170.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.8 169.17 45.16 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 124.693 1.139 . . . . 0.0 112.76 170.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -62.16 134.95 57.24 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 172.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 33.2 mttp -144.34 146.99 35.15 Favored Pre-proline 0 C--O 1.233 0.215 0 C-N-CA 125.364 1.466 . . . . 0.0 107.759 176.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -75.28 157.38 41.62 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 123.007 2.471 . . . . 0.0 110.96 -176.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.7 tmpt? -60.47 -33.67 72.91 Favored 'General case' 0 C--O 1.224 -0.266 0 O-C-N 121.698 -0.626 . . . . 0.0 111.241 -175.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -62.58 -37.16 85.13 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 118.967 0.803 . . . . 0.0 111.823 178.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -72.27 -40.63 67.47 Favored 'General case' 0 N--CA 1.452 -0.35 0 O-C-N 121.85 -0.531 . . . . 0.0 110.655 174.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 52.7 mt -65.89 -41.37 91.61 Favored 'General case' 0 N--CA 1.455 -0.201 0 O-C-N 122.057 -0.402 . . . . 0.0 110.253 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.7 pp0? -69.95 -30.17 67.48 Favored 'General case' 0 C--O 1.227 -0.081 0 CA-C-N 118.932 0.787 . . . . 0.0 110.272 178.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -63.86 -49.98 70.63 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 174.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 65.3 tp -57.63 -43.76 85.06 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.804 0.841 . . . . 0.0 110.726 178.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 24.7 t -61.94 -53.56 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 177.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.34 -26.16 68.35 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 119.082 0.856 . . . . 0.0 112.272 -175.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -67.3 -18.69 65.29 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 117.869 -1.062 . . . . 0.0 112.837 172.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -115.88 -13.0 11.35 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 119.929 1.241 . . . . 0.0 113.69 178.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 43.7 mt . . . . . 0 C--O 1.249 1.075 0 CA-C-N 120.284 1.402 . . . . 0.0 109.63 170.903 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 88.3 mt . . . . . 0 C--O 1.236 0.378 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 36.6 t -98.5 166.89 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 125.285 1.434 . . . . 0.0 107.504 -175.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 6.1 mptt -137.07 135.96 37.96 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 179.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -147.17 170.76 16.55 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 122.92 0.488 . . . . 0.0 110.9 -178.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.9 p -137.5 174.6 10.42 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.958 1.303 . . . . 0.0 108.047 177.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -45.99 -34.22 3.87 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.776 1.23 . . . . 0.0 113.17 179.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 26.8 mp0 -62.1 -31.81 72.31 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.901 1.681 . . . . 0.0 113.1 -178.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.5 m -139.98 -5.07 1.32 Allowed 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 -170.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -55.87 -35.61 66.67 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 124.097 0.959 . . . . 0.0 111.236 178.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.4 p -63.53 -48.6 76.85 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.895 0.878 . . . . 0.0 111.097 178.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.71 -44.5 96.5 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 122.938 0.495 . . . . 0.0 109.876 177.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -65.43 -38.41 89.8 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 119.39 -0.338 . . . . 0.0 111.502 -177.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.493 ' HA ' HG21 ' A' ' 20' ' ' VAL . 22.2 p -78.04 -0.16 26.86 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -178.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 60.0 m -108.65 32.87 4.54 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.466 1.106 . . . . 0.0 112.033 -171.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -132.54 -1.98 3.44 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -176.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 167.28 -166.36 39.2 Favored Glycine 0 C--N 1.337 0.593 0 CA-C-N 119.338 0.972 . . . . 0.0 110.854 -173.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 97.1 t -72.81 130.18 35.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 N-CA-C 104.554 -2.387 . . . . 0.0 104.554 166.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.493 HG21 ' HA ' ' A' ' 15' ' ' THR . 38.1 t -134.82 116.85 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 -175.263 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 57.2 tp -84.57 139.6 31.99 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 169.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -133.1 113.61 12.94 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 -177.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -92.38 96.72 10.42 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 178.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -73.46 114.45 11.7 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 105.053 -2.202 . . . . 0.0 105.053 169.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 7.6 p-90 -138.03 175.9 9.17 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 123.499 0.72 . . . . 0.0 110.973 -169.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -152.47 145.15 17.16 Favored Pre-proline 0 CA--C 1.534 0.358 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 168.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -71.92 -23.26 22.28 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 122.421 2.081 . . . . 0.0 113.383 -169.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -80.91 -8.17 59.67 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 118.58 0.627 . . . . 0.0 112.653 179.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 49.1 t -91.62 110.58 21.9 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 -177.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -49.46 -53.92 18.47 Favored Glycine 0 CA--C 1.533 1.218 0 CA-C-O 118.693 -1.059 . . . . 0.0 113.085 179.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_exo -51.65 -32.58 45.43 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 123.223 2.615 . . . . 0.0 115.35 175.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 89.4 m -62.76 -35.46 79.88 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.908 1.231 . . . . 0.0 111.432 173.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -71.01 -41.04 71.42 Favored 'General case' 0 N--CA 1.463 0.191 0 O-C-N 121.642 -0.662 . . . . 0.0 109.626 173.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 26.5 mmt -64.42 -34.94 79.35 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 118.455 0.571 . . . . 0.0 111.75 -176.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 8.8 tt -82.19 -10.36 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-N 118.549 0.613 . . . . 0.0 111.707 178.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -57.04 -49.99 90.79 Favored Pre-proline 0 CA--C 1.543 0.692 0 CA-C-O 117.568 -1.206 . . . . 0.0 112.644 178.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -65.55 -31.46 50.61 Favored 'Trans proline' 0 C--N 1.351 0.687 0 CA-C-N 121.71 1.646 . . . . 0.0 112.476 176.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 23.1 t -59.48 -44.98 94.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 119.679 1.127 . . . . 0.0 109.638 172.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 75.8 mt -67.48 -36.71 81.66 Favored 'General case' 0 C--O 1.226 -0.184 0 CA-C-O 118.925 -0.56 . . . . 0.0 110.671 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -68.0 -37.7 81.76 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 119.369 0.986 . . . . 0.0 111.469 176.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -64.21 -37.08 86.17 Favored 'General case' 0 N--CA 1.456 -0.126 0 O-C-N 121.345 -0.847 . . . . 0.0 110.323 173.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 11.1 tp -72.48 -38.88 68.06 Favored 'General case' 0 N--CA 1.446 -0.633 0 O-C-N 121.816 -0.553 . . . . 0.0 110.556 178.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -65.21 -42.93 93.03 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.748 0.819 . . . . 0.0 110.147 -179.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -74.07 -13.55 60.86 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 -176.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 65.3 mt-10 -103.64 -33.6 8.92 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.52 1.128 . . . . 0.0 113.058 179.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 42.8 mtt -137.77 -0.39 2.13 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 117.997 -1.001 . . . . 0.0 113.027 -169.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.09 43.67 0.84 Allowed Glycine 0 CA--C 1.533 1.157 0 C-N-CA 126.766 2.127 . . . . 0.0 114.695 -172.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -149.0 -39.76 0.15 Allowed 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 128.443 2.697 . . . . 0.0 107.78 169.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -63.56 -34.76 78.51 Favored 'General case' 0 C--N 1.343 0.307 0 C-N-CA 124.623 1.169 . . . . 0.0 110.369 169.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -132.73 164.32 27.03 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 125.719 1.608 . . . . 0.0 109.622 168.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -103.16 151.43 22.61 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 169.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 17.4 mt -119.04 136.37 56.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 N-CA-C 105.301 -2.111 . . . . 0.0 105.301 170.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 45.7 t -128.48 135.04 63.5 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 107.524 -1.288 . . . . 0.0 107.524 -179.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 61.3 mmtt -92.31 142.63 27.25 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 169.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 17.5 tt -147.25 115.52 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-O 121.375 0.607 . . . . 0.0 109.382 171.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -82.27 112.8 19.6 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.827 0.851 . . . . 0.0 109.33 -175.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 32.9 m -59.85 -26.01 34.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-N 118.515 0.598 . . . . 0.0 112.539 -175.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -72.57 -1.59 16.59 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.571 0.749 . . . . 0.0 112.237 -178.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -131.57 6.77 4.43 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.418 1.487 . . . . 0.0 110.498 172.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 67.8 m-80 -143.31 46.44 1.52 Allowed 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.334 1.054 . . . . 0.0 110.645 -168.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.522 ' NE2' ' H ' ' A' ' 61' ' ' GLN . 0.4 OUTLIER -57.45 -44.02 84.45 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.92 0.888 . . . . 0.0 109.082 175.994 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -67.38 -29.9 69.55 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 125.612 1.565 . . . . 0.0 111.55 -173.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.07 -47.33 11.04 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 119.031 -0.509 . . . . 0.0 109.736 175.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.69 -45.89 90.69 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 119.572 1.078 . . . . 0.0 110.304 -176.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -61.81 -22.61 62.34 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 123.728 0.68 . . . . 0.0 112.721 176.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.7 ttmm -61.19 -25.62 67.16 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 118.532 1.166 . . . . 0.0 111.423 177.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -116.51 11.18 14.75 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.758 1.223 . . . . 0.0 110.703 179.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 67.6 26.36 73.72 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.145 0.879 . . . . 0.0 112.781 -176.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 89.3 t -99.1 154.25 4.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-N 118.18 0.99 . . . . 0.0 109.158 179.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -162.57 -24.0 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 127.252 2.221 . . . . 0.0 109.492 167.469 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 8.0 m -63.69 150.58 44.04 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 123.896 0.878 . . . . 0.0 109.112 170.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -145.22 155.9 54.35 Favored Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 124.256 1.022 . . . . 0.0 108.998 176.32 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.39 140.78 50.27 Favored 'Cis proline' 0 N--CA 1.456 -0.678 0 CA-C-N 119.916 1.006 . . . . 0.0 109.541 -10.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 54.4 m -131.93 121.51 24.11 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 176.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 52.7 mt -95.53 102.3 14.09 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 179.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -81.01 143.27 32.64 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 167.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.7 t -125.51 126.1 69.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 104.289 -2.485 . . . . 0.0 104.289 174.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.9 mp -126.79 160.77 29.92 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 124.994 1.318 . . . . 0.0 107.976 -178.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -144.89 125.89 14.51 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 175.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.0 t70 44.81 36.96 2.04 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.279 1.432 . . . . 0.0 113.469 175.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 105.68 -2.26 39.17 Favored Glycine 0 CA--C 1.528 0.885 0 CA-C-O 118.055 -1.414 . . . . 0.0 115.126 169.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -130.58 148.72 52.41 Favored 'General case' 0 C--N 1.338 0.099 0 CA-C-N 120.159 1.98 . . . . 0.0 110.516 -178.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 52.5 t -66.19 140.47 19.49 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 C-N-CA 124.053 0.941 . . . . 0.0 108.773 177.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 35.3 m -124.62 -18.39 3.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 125.398 1.479 . . . . 0.0 110.917 172.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.96 165.4 32.12 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 120.318 1.417 . . . . 0.0 111.429 169.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 56.3 m -144.05 133.05 22.77 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.892 1.677 . . . . 0.0 107.077 169.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 17.8 m -143.61 152.93 42.0 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.875 1.27 . . . . 0.0 108.481 -176.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 28.6 t -131.22 150.29 34.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-N 119.145 0.884 . . . . 0.0 108.794 -170.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.73 174.27 46.33 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 124.518 1.056 . . . . 0.0 112.173 176.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -59.58 152.12 22.88 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 123.623 0.769 . . . . 0.0 110.806 177.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -153.38 146.73 18.03 Favored Pre-proline 0 C--O 1.233 0.232 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 168.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.2 158.18 52.44 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.172 1.915 . . . . 0.0 110.332 177.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 4.8 ttpt -59.3 -33.95 71.71 Favored 'General case' 0 C--O 1.224 -0.288 0 C-N-CA 123.462 0.705 . . . . 0.0 111.551 179.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -64.51 -39.91 94.66 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 119.106 0.866 . . . . 0.0 111.946 -179.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.32 -41.2 70.18 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 122.735 0.414 . . . . 0.0 110.389 175.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 28.0 tp -66.75 -40.3 88.24 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 122.638 0.375 . . . . 0.0 110.744 -177.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.8 pp0? -69.43 -31.17 69.33 Favored 'General case' 0 C--O 1.227 -0.106 0 CA-C-N 118.821 0.737 . . . . 0.0 110.164 176.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -64.91 -47.72 76.73 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 176.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 63.6 tp -57.86 -46.67 84.49 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.354 0.662 . . . . 0.0 110.381 178.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 23.4 t -62.37 -49.27 84.61 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 CA-C-O 119.061 -0.495 . . . . 0.0 110.029 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.46 -26.96 68.67 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 119.171 0.896 . . . . 0.0 112.215 -175.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 61.6 mtpt -67.86 -29.76 68.97 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 118.597 -0.716 . . . . 0.0 112.041 171.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 86.1 m-70 -90.87 -21.35 21.46 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.259 0.936 . . . . 0.0 113.244 179.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 65.9 mt . . . . . 0 C--O 1.249 1.053 0 CA-C-N 119.569 1.077 . . . . 0.0 109.88 175.472 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 79.8 mt . . . . . 0 CA--C 1.54 0.593 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.6 t -119.48 167.53 12.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 125.348 1.459 . . . . 0.0 107.767 -168.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.7 tppp? -128.5 145.88 50.98 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 177.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -146.19 168.73 20.29 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 123.24 0.616 . . . . 0.0 110.332 171.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 72.0 p -135.44 173.57 11.57 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.584 1.553 . . . . 0.0 106.938 174.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -52.44 -30.5 29.92 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 119.701 1.137 . . . . 0.0 113.01 -176.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 26.0 mp0 -62.75 -30.73 71.66 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.097 1.759 . . . . 0.0 112.817 179.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.5 m -139.15 -3.78 1.55 Allowed 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -169.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 61.3 t80 -54.65 -37.79 66.12 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 123.938 0.895 . . . . 0.0 111.035 177.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.4 p -63.04 -50.5 70.42 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.671 0.788 . . . . 0.0 110.76 179.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.21 -44.87 92.26 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.017 0.527 . . . . 0.0 110.081 178.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -66.03 -37.89 87.0 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 119.348 -0.358 . . . . 0.0 111.445 -177.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.481 ' HA ' HG21 ' A' ' 20' ' ' VAL . 27.8 p -79.66 0.44 30.27 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 118.513 0.597 . . . . 0.0 112.549 -178.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.5 m -110.23 32.27 5.27 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.418 1.087 . . . . 0.0 112.312 -172.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 -131.81 2.22 4.04 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -177.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 167.34 -165.62 38.73 Favored Glycine 0 C--N 1.334 0.428 0 O-C-N 121.414 -0.804 . . . . 0.0 111.185 -176.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 1.9 t -76.66 134.86 27.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 104.275 -2.491 . . . . 0.0 104.275 168.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.481 HG21 ' HA ' ' A' ' 15' ' ' THR . 30.2 t -138.34 141.57 37.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -172.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 58.9 tp -113.53 97.96 6.77 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 106.02 -1.844 . . . . 0.0 106.02 173.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.21 149.06 37.29 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 170.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -133.16 99.0 4.42 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 107.2 -1.408 . . . . 0.0 107.2 177.12 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -76.63 114.97 15.96 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 173.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 7.3 p-90 -138.84 175.89 9.17 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 123.401 0.68 . . . . 0.0 110.85 -169.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -151.61 146.66 19.05 Favored Pre-proline 0 CA--C 1.535 0.394 0 C-N-CA 124.53 1.132 . . . . 0.0 107.98 169.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.25 -17.85 18.68 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.962 2.441 . . . . 0.0 113.515 -169.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -84.81 -7.21 59.28 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 118.789 0.722 . . . . 0.0 112.088 177.439 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 54.1 t -87.82 117.08 26.41 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 -178.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -55.82 -55.72 27.52 Favored Glycine 0 CA--C 1.531 1.092 0 CA-C-O 118.691 -1.061 . . . . 0.0 112.201 175.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -51.15 -34.58 48.64 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 123.256 2.637 . . . . 0.0 115.434 176.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 97.7 m -60.92 -35.78 77.58 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 119.96 1.255 . . . . 0.0 111.672 173.097 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.1 mttm -70.14 -40.94 74.51 Favored 'General case' 0 N--CA 1.464 0.266 0 O-C-N 121.52 -0.737 . . . . 0.0 109.692 173.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 26.3 mmt -64.71 -38.17 90.07 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 118.231 0.469 . . . . 0.0 111.487 -176.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 10.8 tt -79.16 -15.97 13.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-N 118.394 0.543 . . . . 0.0 111.51 179.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.9 -48.97 94.46 Favored Pre-proline 0 CA--C 1.541 0.598 0 CA-C-O 117.472 -1.251 . . . . 0.0 113.597 -177.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.06 -27.73 49.67 Favored 'Trans proline' 0 C--N 1.35 0.632 0 CA-C-N 122.087 1.781 . . . . 0.0 112.461 176.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 6.0 t -66.42 -41.13 88.23 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-N 119.346 0.975 . . . . 0.0 109.059 174.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 66.0 mt -67.03 -34.28 77.37 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 118.745 -0.645 . . . . 0.0 110.961 175.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -69.45 -36.55 76.71 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 119.482 1.037 . . . . 0.0 111.496 174.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 44.0 mm-40 -61.17 -46.73 89.3 Favored 'General case' 0 CA--C 1.528 0.098 0 O-C-N 121.137 -0.977 . . . . 0.0 109.233 171.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -62.11 -35.96 80.3 Favored 'General case' 0 C--O 1.224 -0.255 0 C-N-CA 122.857 0.463 . . . . 0.0 111.557 177.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -65.28 -41.88 93.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 119.27 0.941 . . . . 0.0 110.427 176.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -68.01 -36.97 80.87 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 122.823 0.449 . . . . 0.0 111.634 178.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -93.35 -30.1 15.29 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.014 0.926 . . . . 0.0 112.426 -169.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 20.0 mmt -136.95 -3.41 2.02 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.39 1.476 . . . . 0.0 112.706 -169.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -52.12 -28.74 26.88 Favored Glycine 0 CA--C 1.538 1.469 0 CA-C-N 120.945 1.702 . . . . 0.0 113.277 177.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -73.67 -29.32 62.24 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.844 1.658 . . . . 0.0 111.434 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 55.3 mmtt -97.82 -25.97 14.86 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 125.444 1.498 . . . . 0.0 110.651 -177.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -150.58 126.11 10.2 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.095 0.958 . . . . 0.0 110.038 -167.357 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -73.76 152.49 40.34 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 175.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 17.6 mt -125.72 130.97 72.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 N-CA-C 105.645 -1.983 . . . . 0.0 105.645 175.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 22.0 t -132.07 113.66 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -170.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 48.2 mmtt -73.86 143.29 45.92 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 170.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 15.4 tt -149.02 125.34 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 169.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -80.28 128.57 33.69 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 22.5 m -70.02 -31.59 48.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 -173.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -77.6 -35.36 52.95 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 119.136 0.88 . . . . 0.0 109.755 -175.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -72.98 -15.9 61.53 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.861 0.864 . . . . 0.0 111.869 172.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 63.3 m-80 -139.77 51.97 1.72 Allowed 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 119.227 0.921 . . . . 0.0 111.044 -168.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.413 ' CD ' ' H ' ' A' ' 61' ' ' GLN . 0.7 OUTLIER -56.56 -38.66 72.22 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.791 0.836 . . . . 0.0 109.55 179.673 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -66.49 -27.74 68.02 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.946 1.298 . . . . 0.0 112.553 -177.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.425 ' HA ' ' HE2' ' A' ' 66' ' ' LYS . 0.2 OUTLIER -88.42 -45.53 9.89 Favored 'General case' 0 C--O 1.222 -0.373 0 CA-C-N 118.809 0.731 . . . . 0.0 109.725 178.47 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.79 -46.9 85.85 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.271 0.941 . . . . 0.0 109.792 179.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -61.77 -22.37 61.95 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 124.48 1.038 . . . . 0.0 112.746 175.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.425 ' HE2' ' HA ' ' A' ' 63' ' ' THR . 5.7 ttmm -57.84 -23.08 51.16 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 118.778 1.289 . . . . 0.0 111.852 174.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -125.76 13.58 8.01 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.688 1.195 . . . . 0.0 110.375 179.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 68.65 20.12 73.71 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 124.661 1.124 . . . . 0.0 113.689 -178.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 97.9 t -84.83 136.28 23.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 176.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -155.42 29.02 0.39 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.732 1.213 . . . . 0.0 109.258 167.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 20.8 m -138.15 154.41 49.17 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 126.678 1.991 . . . . 0.0 106.864 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -145.31 158.72 50.73 Favored Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 123.866 0.867 . . . . 0.0 110.143 -169.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -67.92 140.74 56.03 Favored 'Cis proline' 0 C--N 1.349 0.573 0 N-CA-C 109.168 -1.128 . . . . 0.0 109.168 -11.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 54.7 m -131.67 118.28 19.8 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 177.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 89.4 mt -93.54 137.98 32.28 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 178.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.0 mp -121.22 130.34 53.64 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 105.238 -2.134 . . . . 0.0 105.238 169.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.8 t -94.35 127.73 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 103.571 -2.751 . . . . 0.0 103.571 168.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.6 mp -125.33 160.42 29.37 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 125.198 1.399 . . . . 0.0 107.792 176.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -149.32 125.08 10.48 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.8 t70 44.88 34.98 1.34 Allowed 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.304 1.441 . . . . 0.0 113.714 177.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 109.71 -1.72 30.5 Favored Glycine 0 CA--C 1.527 0.785 0 CA-C-O 118.033 -1.426 . . . . 0.0 115.588 168.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -131.06 145.18 51.93 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 120.13 1.965 . . . . 0.0 110.288 -178.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.3 p -66.86 138.45 22.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 172.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 27.1 m -127.03 -16.47 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 125.68 1.592 . . . . 0.0 110.682 178.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.44 164.3 38.42 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 119.871 1.214 . . . . 0.0 110.902 169.18 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 93.9 m -146.37 137.83 24.61 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.461 1.505 . . . . 0.0 108.421 176.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 19.7 m -146.24 152.98 40.07 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.413 1.485 . . . . 0.0 108.691 -176.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 40.3 t -133.03 146.43 32.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 -173.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 85.49 178.62 50.51 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 124.451 1.024 . . . . 0.0 111.89 178.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -60.26 152.86 23.83 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.173 0.989 . . . . 0.0 110.575 174.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -141.42 148.2 49.65 Favored Pre-proline 0 C--O 1.234 0.257 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 168.282 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -71.56 158.59 53.38 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 122.381 2.054 . . . . 0.0 110.22 171.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -55.31 -45.97 76.28 Favored 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 123.397 0.679 . . . . 0.0 111.042 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -64.33 -42.04 96.49 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 118.345 0.521 . . . . 0.0 111.248 -169.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.0 -42.51 89.65 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 122.897 0.479 . . . . 0.0 110.878 175.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 43.3 tp -69.16 -41.01 77.8 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 119.233 -0.413 . . . . 0.0 110.744 -176.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.7 pp0? -70.8 -30.12 66.49 Favored 'General case' 0 C--N 1.337 0.058 0 CA-C-N 119.022 0.828 . . . . 0.0 110.303 176.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -64.07 -49.22 73.16 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 175.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 67.6 tp -57.65 -46.1 84.64 Favored 'General case' 0 CA--C 1.527 0.095 0 C-N-CA 123.869 0.867 . . . . 0.0 110.349 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 19.6 t -60.06 -53.45 48.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 177.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -63.35 -28.88 70.3 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 118.78 0.718 . . . . 0.0 112.395 -175.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -68.12 -32.13 72.2 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 118.475 -0.774 . . . . 0.0 111.958 173.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 58.0 m-70 -89.75 -16.73 29.66 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 119.326 0.966 . . . . 0.0 113.296 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 65.5 mt . . . . . 0 C--O 1.249 1.073 0 CA-C-N 119.737 1.153 . . . . 0.0 109.847 173.032 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 21.2 mt . . . . . 0 CA--C 1.539 0.532 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 25.6 t -140.44 167.59 18.04 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 128.069 2.547 . . . . 0.0 105.678 -176.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.0 mtmt -125.62 144.36 50.62 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 173.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -144.8 170.1 16.77 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 122.913 0.485 . . . . 0.0 110.622 176.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 73.7 p -135.63 173.35 11.81 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 176.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -49.27 -32.38 10.75 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 119.669 1.122 . . . . 0.0 113.138 -177.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 25.3 mp0 -62.04 -31.58 71.99 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.408 1.883 . . . . 0.0 112.777 -179.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.3 m -139.92 -4.26 1.38 Allowed 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 -171.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -53.57 -37.59 63.07 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 124.305 1.042 . . . . 0.0 111.006 176.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.0 m -67.29 -38.83 85.66 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 122.49 0.316 . . . . 0.0 111.286 -178.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.18 -45.2 77.68 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 175.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -64.54 -37.12 86.46 Favored 'General case' 0 C--O 1.231 0.116 0 C-N-CA 122.64 0.376 . . . . 0.0 111.374 -175.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.443 ' HA ' HG21 ' A' ' 20' ' ' VAL . 19.9 p -77.28 -1.39 29.52 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 179.532 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 67.9 m -108.65 33.29 4.28 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.448 1.099 . . . . 0.0 111.933 -171.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -132.65 0.62 3.61 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -177.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 166.31 -165.55 38.31 Favored Glycine 0 C--N 1.336 0.535 0 CA-C-N 119.367 0.985 . . . . 0.0 111.424 -175.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 97.3 t -73.77 127.73 35.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 N-CA-C 104.6 -2.37 . . . . 0.0 104.6 166.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.443 HG21 ' HA ' ' A' ' 15' ' ' THR . 39.2 t -133.72 122.64 43.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 -174.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 18.3 tp -87.8 139.22 30.75 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 105.84 -1.911 . . . . 0.0 105.84 168.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -125.01 113.67 18.1 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 -179.032 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -94.1 90.41 6.38 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 125.337 1.455 . . . . 0.0 108.391 -178.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -72.1 113.22 8.89 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 169.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 7.9 p-90 -138.79 176.42 8.71 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 123.561 0.744 . . . . 0.0 111.068 -169.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -151.84 146.6 18.85 Favored Pre-proline 0 CA--C 1.535 0.379 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 169.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.35 -20.17 16.45 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 122.744 2.296 . . . . 0.0 113.494 -171.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -81.95 -7.84 59.63 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 121.526 -0.734 . . . . 0.0 111.823 176.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 52.0 t -88.12 117.32 26.92 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -55.58 -57.92 16.4 Favored Glycine 0 CA--C 1.531 1.067 0 CA-C-O 118.572 -1.126 . . . . 0.0 111.598 173.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -49.89 -36.32 42.96 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 123.569 2.846 . . . . 0.0 115.434 177.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 98.0 m -60.02 -45.51 92.55 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 119.886 1.221 . . . . 0.0 111.418 173.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 46.5 mtmt -70.86 -30.58 67.02 Favored 'General case' 0 CA--C 1.53 0.174 0 O-C-N 121.465 -0.772 . . . . 0.0 110.639 178.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 86.5 mtp -68.37 -42.54 79.03 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 118.685 0.675 . . . . 0.0 111.226 176.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 7.4 tt -76.82 -21.45 14.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-N 119.1 0.863 . . . . 0.0 111.115 -178.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.17 -51.28 64.11 Favored Pre-proline 0 CA--C 1.546 0.823 0 CA-C-N 119.737 1.153 . . . . 0.0 113.915 -177.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.28 -30.5 54.23 Favored 'Trans proline' 0 C--N 1.349 0.59 0 CA-C-N 121.866 1.702 . . . . 0.0 112.364 176.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 6.8 t -65.49 -37.87 81.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-N 119.334 0.97 . . . . 0.0 109.521 174.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 82.6 mt -68.24 -33.41 74.33 Favored 'General case' 0 C--O 1.225 -0.213 0 CA-C-O 118.569 -0.729 . . . . 0.0 110.844 173.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -66.65 -36.13 81.81 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.836 1.198 . . . . 0.0 111.405 172.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 55.4 mm-40 -65.93 -39.05 90.17 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 120.808 -1.182 . . . . 0.0 110.149 172.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 46.9 tp -66.5 -36.66 83.27 Favored 'General case' 0 C--O 1.226 -0.144 0 O-C-N 121.648 -0.658 . . . . 0.0 110.731 175.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -66.29 -37.47 85.5 Favored 'General case' 0 N--CA 1.454 -0.238 0 O-C-N 121.586 -0.696 . . . . 0.0 111.096 176.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -64.36 -33.42 75.8 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.376 -0.828 . . . . 0.0 111.305 171.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -79.0 -39.16 34.83 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.301 1.04 . . . . 0.0 112.139 -177.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 21.2 mmt -133.5 -7.23 2.9 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 -166.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.97 -3.85 12.48 Favored Glycine 0 CA--C 1.531 1.079 0 CA-C-N 120.474 1.488 . . . . 0.0 115.142 -174.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -82.29 -27.5 32.3 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.518 1.527 . . . . 0.0 111.751 172.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -129.04 -1.77 5.19 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.837 1.655 . . . . 0.0 112.624 -172.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -139.38 155.87 47.37 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 126.828 2.051 . . . . 0.0 106.906 177.329 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -110.01 151.35 27.27 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 173.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 18.3 mt -119.72 136.7 56.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 105.064 -2.198 . . . . 0.0 105.064 170.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 99.5 t -126.24 115.14 41.43 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 -176.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 10.3 mmmm -75.19 140.88 43.59 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 171.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 16.6 tt -148.92 113.91 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 173.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 60.6 t0 -77.24 117.18 18.51 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 -178.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 30.6 m -62.88 -27.35 42.93 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -175.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -69.18 -28.87 66.79 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 119.331 0.969 . . . . 0.0 110.768 -178.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -93.62 -7.72 43.16 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.63 1.172 . . . . 0.0 111.073 177.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -141.38 47.12 1.7 Allowed 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 124.549 1.14 . . . . 0.0 109.929 -168.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.485 ' CD ' ' H ' ' A' ' 61' ' ' GLN . 1.4 mp0 -58.39 -40.9 83.6 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.315 1.046 . . . . 0.0 109.024 -177.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -63.21 -45.12 93.17 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.497 1.119 . . . . 0.0 110.399 179.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.477 ' HA ' ' HE3' ' A' ' 66' ' ' LYS . 0.8 OUTLIER -69.01 -43.77 74.14 Favored 'General case' 0 C--O 1.221 -0.433 0 CA-C-N 118.729 0.695 . . . . 0.0 110.362 -176.752 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.16 -45.68 92.31 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 119.166 0.894 . . . . 0.0 109.417 176.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -58.11 -26.37 58.44 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 124.232 0.92 . . . . 0.0 113.081 174.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.477 ' HE3' ' HA ' ' A' ' 63' ' ' THR . 27.4 ttmt -57.82 -21.54 42.84 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.459 1.504 . . . . 0.0 111.908 177.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -127.81 12.84 6.83 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.88 1.272 . . . . 0.0 110.532 179.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 68.95 20.18 74.34 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 124.558 1.075 . . . . 0.0 113.544 -177.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 85.2 t -85.35 137.08 21.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 176.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -157.66 28.9 0.28 Allowed 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.512 1.125 . . . . 0.0 109.523 167.043 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 44.1 m -135.08 154.06 51.81 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 126.317 1.847 . . . . 0.0 106.89 174.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -146.32 160.2 43.04 Favored Pre-proline 0 CA--C 1.543 0.688 0 C-N-CA 124.565 1.146 . . . . 0.0 109.273 -170.15 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -66.93 139.84 47.75 Favored 'Cis proline' 0 C--N 1.349 0.553 0 CA-C-N 120.161 1.093 . . . . 0.0 109.77 -10.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 41.5 m -132.99 133.79 43.61 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 178.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 78.6 mt -119.28 103.08 9.17 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 -172.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.7 mp -84.87 146.01 27.52 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 106.822 -1.548 . . . . 0.0 106.822 168.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.4 t -111.33 127.87 68.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 103.633 -2.728 . . . . 0.0 103.633 169.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.7 mp -127.0 158.62 36.44 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.308 1.443 . . . . 0.0 107.445 179.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -145.77 127.16 14.94 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 175.027 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.9 t70 44.3 37.44 1.98 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.389 1.476 . . . . 0.0 113.616 174.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.87 5.25 47.76 Favored Glycine 0 CA--C 1.527 0.783 0 CA-C-O 118.59 -1.117 . . . . 0.0 114.861 169.138 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 82.1 mm-40 -130.13 141.44 50.68 Favored 'General case' 0 CA--C 1.522 -0.105 0 CA-C-N 119.52 1.66 . . . . 0.0 109.133 178.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.5 p -69.25 137.42 24.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 169.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 25.3 m -125.21 -20.48 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 C-N-CA 124.989 1.316 . . . . 0.0 110.328 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.21 167.1 31.49 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 119.545 1.066 . . . . 0.0 111.454 175.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 80.7 m -148.43 141.05 24.47 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.55 1.54 . . . . 0.0 108.738 176.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 21.3 m -144.63 155.88 43.83 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.988 1.715 . . . . 0.0 108.309 177.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 39.5 t -133.81 149.72 30.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 -176.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.09 172.3 47.08 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 124.385 0.993 . . . . 0.0 112.449 172.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -63.92 131.19 46.93 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 123.59 0.756 . . . . 0.0 109.291 175.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -136.1 143.73 45.23 Favored Pre-proline 0 CA--C 1.534 0.35 0 C-N-CA 126.095 1.758 . . . . 0.0 107.035 179.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -74.68 156.83 44.43 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.691 2.26 . . . . 0.0 110.917 178.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.6 tmpt? -58.98 -36.24 74.54 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 123.449 0.699 . . . . 0.0 111.247 -177.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -67.52 -35.15 78.55 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 118.838 0.744 . . . . 0.0 111.269 -175.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.03 -42.61 72.73 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 122.886 0.474 . . . . 0.0 110.485 173.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 84.5 mt -67.05 -41.39 86.56 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-O 118.902 -0.57 . . . . 0.0 110.392 -178.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.0 pp0? -68.22 -30.8 69.95 Favored 'General case' 0 C--O 1.228 -0.075 0 CA-C-N 119.274 0.943 . . . . 0.0 110.247 177.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -65.41 -47.75 75.21 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 176.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 59.2 tp -58.47 -43.35 88.89 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.269 0.627 . . . . 0.0 110.652 178.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 39.6 t -61.22 -50.63 79.68 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 C-N-CA 123.103 0.561 . . . . 0.0 109.593 176.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -63.88 -26.89 68.81 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 118.975 0.807 . . . . 0.0 112.284 -175.346 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 62.1 mtpt -67.17 -18.55 65.32 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 118.056 -0.973 . . . . 0.0 112.997 171.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -114.34 -10.09 12.71 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 119.856 1.207 . . . . 0.0 113.658 -179.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 80.3 mt . . . . . 0 C--O 1.251 1.161 0 CA-C-N 120.032 1.287 . . . . 0.0 109.723 172.314 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 92.6 mt . . . . . 0 C--O 1.236 0.345 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 40.5 t -105.33 166.48 3.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 -174.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 5.8 mptt -138.55 134.69 34.18 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 -178.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -143.45 170.7 15.3 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 122.935 0.494 . . . . 0.0 110.791 -179.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.1 p -135.29 171.71 14.05 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 178.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -49.5 -32.42 12.2 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 119.808 1.186 . . . . 0.0 113.021 -176.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 25.2 mp0 -63.48 -30.35 71.49 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.716 2.007 . . . . 0.0 112.923 -179.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.6 m -138.61 -6.7 1.5 Allowed 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 114.358 1.244 . . . . 0.0 114.358 -172.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -56.22 -34.83 66.69 Favored 'General case' 0 C--N 1.333 -0.122 0 C-N-CA 124.606 1.162 . . . . 0.0 111.11 178.155 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.4 p -62.75 -48.47 79.07 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 123.649 0.78 . . . . 0.0 111.062 178.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.33 -44.88 96.44 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 122.78 0.432 . . . . 0.0 109.862 177.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -65.14 -37.6 87.93 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 119.274 -0.393 . . . . 0.0 111.546 -176.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.51 ' HA ' HG21 ' A' ' 20' ' ' VAL . 23.3 p -78.93 0.25 28.16 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 118.595 0.634 . . . . 0.0 112.533 -179.146 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 48.8 m -112.03 34.43 4.24 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.406 1.082 . . . . 0.0 111.962 -171.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -131.78 -1.35 3.79 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -178.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 166.41 -167.09 39.27 Favored Glycine 0 C--N 1.335 0.518 0 CA-C-N 119.198 0.908 . . . . 0.0 110.872 -172.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 76.9 t -72.3 134.06 30.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 104.874 -2.269 . . . . 0.0 104.874 167.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.51 HG21 ' HA ' ' A' ' 15' ' ' THR . 38.8 t -137.12 119.25 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 -176.288 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 60.5 tp -88.75 97.44 11.14 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 170.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.47 149.41 36.79 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 169.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -133.21 98.41 4.25 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 176.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -73.97 113.45 11.16 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 172.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 6.0 p-90 -136.26 175.89 9.19 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 123.721 0.808 . . . . 0.0 110.219 -169.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -149.89 144.98 18.22 Favored Pre-proline 0 CA--C 1.534 0.345 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 169.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.37 -21.91 22.38 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 122.438 2.092 . . . . 0.0 113.471 -170.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -83.84 -8.24 59.26 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 118.693 0.679 . . . . 0.0 112.228 178.609 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 53.7 t -85.15 117.63 24.22 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -178.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -54.58 -57.11 18.93 Favored Glycine 0 CA--C 1.532 1.154 0 CA-C-O 118.651 -1.083 . . . . 0.0 112.137 176.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -50.86 -35.87 50.57 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 123.18 2.586 . . . . 0.0 115.093 175.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 90.7 m -62.1 -37.05 83.6 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 119.676 1.126 . . . . 0.0 111.882 173.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -69.63 -42.07 74.79 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 118.804 0.729 . . . . 0.0 109.851 172.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 62.0 mtt -62.36 -38.01 87.9 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 122.948 0.499 . . . . 0.0 111.159 -175.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 10.9 tt -78.86 -16.04 13.54 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-N 118.569 0.622 . . . . 0.0 111.848 -178.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.03 -51.22 82.38 Favored Pre-proline 0 CA--C 1.544 0.728 0 CA-C-N 120.069 1.304 . . . . 0.0 113.57 -178.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -64.3 -30.31 63.69 Favored 'Trans proline' 0 C--N 1.351 0.672 0 CA-C-N 121.769 1.667 . . . . 0.0 111.872 176.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.4 t -64.82 -42.14 94.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-N 118.908 0.776 . . . . 0.0 109.56 176.014 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 66.2 mt -66.88 -32.98 74.59 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 118.347 -0.835 . . . . 0.0 110.734 175.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -68.29 -37.95 81.17 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 120.206 1.366 . . . . 0.0 111.49 173.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -64.62 -31.55 72.82 Favored 'General case' 0 C--N 1.334 -0.095 0 O-C-N 121.225 -0.922 . . . . 0.0 110.99 172.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 18.5 tp -76.82 -38.81 53.17 Favored 'General case' 0 N--CA 1.448 -0.56 0 O-C-N 121.82 -0.55 . . . . 0.0 110.857 174.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -64.73 -36.59 84.77 Favored 'General case' 0 C--O 1.23 0.068 0 C-N-CA 124.354 1.062 . . . . 0.0 110.654 -178.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -76.48 -22.03 55.05 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 121.894 -0.504 . . . . 0.0 111.977 -177.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 89.0 mt-10 -94.33 -34.7 12.71 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.462 1.105 . . . . 0.0 113.158 178.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 32.8 mtt -136.76 -4.55 1.99 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 118.046 -0.978 . . . . 0.0 113.263 -169.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -76.34 49.81 2.7 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 125.878 1.704 . . . . 0.0 113.11 -173.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -154.98 -40.69 0.09 Allowed 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 129.678 3.191 . . . . 0.0 106.915 171.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 57.3 mttp -61.62 -36.98 82.29 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.291 1.436 . . . . 0.0 109.817 168.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -134.02 165.5 24.9 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 126.545 1.938 . . . . 0.0 109.603 170.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -101.48 151.66 21.69 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.428 1.091 . . . . 0.0 108.135 171.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 18.7 mt -116.48 134.75 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 N-CA-C 105.118 -2.178 . . . . 0.0 105.118 170.131 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 87.2 t -132.43 117.57 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -176.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 55.6 mmtt -75.7 144.91 41.31 Favored 'General case' 0 C--O 1.235 0.303 0 O-C-N 121.695 -0.628 . . . . 0.0 109.663 169.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 15.3 tt -148.19 119.13 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 169.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 50.9 t0 -82.72 114.13 20.86 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.969 0.907 . . . . 0.0 109.924 -174.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 25.0 m -63.02 -22.89 31.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 -174.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -66.01 -30.54 71.1 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 119.016 0.826 . . . . 0.0 111.275 -175.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -99.66 -39.29 8.34 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 123.267 0.627 . . . . 0.0 109.73 173.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 -89.45 46.29 1.36 Allowed 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 124.268 1.027 . . . . 0.0 111.245 -169.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -56.11 -43.02 77.73 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 126.624 1.97 . . . . 0.0 108.816 179.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 30.7 mm-40 -67.5 -27.38 66.95 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 125.112 1.365 . . . . 0.0 112.306 -177.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.414 ' HA ' ' HE2' ' A' ' 66' ' ' LYS . 0.2 OUTLIER -88.45 -46.01 9.49 Favored 'General case' 0 C--O 1.222 -0.392 0 CA-C-N 118.599 0.636 . . . . 0.0 109.687 179.519 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.87 -46.03 89.78 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 119.321 0.964 . . . . 0.0 109.624 179.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -60.65 -24.17 61.74 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 124.095 0.855 . . . . 0.0 112.862 175.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.414 ' HE2' ' HA ' ' A' ' 63' ' ' THR . 5.2 ttmm -58.13 -23.49 55.28 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 118.573 1.187 . . . . 0.0 112.056 176.041 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -124.87 13.05 8.5 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.734 1.214 . . . . 0.0 110.487 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 68.96 19.61 73.83 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 124.538 1.066 . . . . 0.0 113.691 -178.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 96.5 t -84.28 135.63 24.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 176.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.18 28.22 0.46 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.586 1.154 . . . . 0.0 109.372 168.019 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 22.5 m -138.12 152.76 49.05 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 126.704 2.002 . . . . 0.0 106.77 178.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -145.72 160.09 45.31 Favored Pre-proline 0 CA--C 1.541 0.602 0 C-N-CA 124.058 0.943 . . . . 0.0 109.905 -169.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -66.94 139.52 46.19 Favored 'Cis proline' 0 C--N 1.349 0.601 0 N-CA-C 109.366 -1.051 . . . . 0.0 109.366 -11.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 51.9 m -132.0 117.74 18.8 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 177.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 95.4 mt -92.8 136.7 33.01 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 179.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.8 mp -121.09 130.92 53.96 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 105.061 -2.2 . . . . 0.0 105.061 169.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.5 t -93.56 124.24 45.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 103.196 -2.89 . . . . 0.0 103.196 168.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.9 mp -118.75 159.01 24.45 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 173.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 73.7 tttt -145.2 126.73 15.06 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 173.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.7 t70 44.33 38.62 2.58 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.395 1.478 . . . . 0.0 113.484 175.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 101.21 5.33 52.86 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-O 118.598 -1.112 . . . . 0.0 114.862 169.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 82.1 mm-40 -130.49 142.31 50.49 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 119.513 1.657 . . . . 0.0 109.142 178.051 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.2 p -68.54 138.32 22.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 169.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 33.0 m -126.75 -20.68 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 125.062 1.345 . . . . 0.0 110.478 179.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -153.08 166.9 31.01 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 119.73 1.15 . . . . 0.0 111.339 171.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 96.1 m -148.67 141.04 24.19 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.577 1.551 . . . . 0.0 108.732 177.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 16.0 m -147.68 156.62 42.96 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.565 1.546 . . . . 0.0 108.611 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 40.6 t -132.99 149.41 31.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -174.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.66 173.99 45.8 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 124.424 1.011 . . . . 0.0 112.299 176.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -59.02 150.74 23.89 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.165 0.986 . . . . 0.0 110.68 177.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -153.94 147.27 18.2 Favored Pre-proline 0 CA--C 1.532 0.279 0 C-N-CA 125.057 1.343 . . . . 0.0 107.514 169.199 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.3 159.28 47.27 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.761 2.307 . . . . 0.0 110.81 179.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 2.9 ttpp -57.44 -36.51 71.49 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.898 0.879 . . . . 0.0 111.51 -177.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -62.4 -36.2 81.59 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.471 0.578 . . . . 0.0 112.059 177.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.79 -40.6 69.11 Favored 'General case' 0 N--CA 1.453 -0.31 0 O-C-N 121.924 -0.485 . . . . 0.0 110.814 174.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 42.7 mt -64.18 -43.44 95.11 Favored 'General case' 0 N--CA 1.457 -0.08 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -179.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.0 pp0? -68.89 -31.66 70.74 Favored 'General case' 0 C--O 1.226 -0.149 0 CA-C-N 118.62 0.645 . . . . 0.0 110.258 178.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -64.23 -49.57 71.41 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 176.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 58.9 tp -57.16 -44.69 83.7 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.372 0.669 . . . . 0.0 110.476 178.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 37.3 t -65.42 -47.34 87.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 CA-C-O 118.946 -0.549 . . . . 0.0 110.638 179.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.29 -25.52 68.09 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 119.606 1.094 . . . . 0.0 112.341 -175.181 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -66.1 -16.42 63.93 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 117.897 -1.049 . . . . 0.0 113.167 171.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -121.64 -10.51 8.77 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 119.96 1.255 . . . . 0.0 113.822 -177.136 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 66.6 mt . . . . . 0 C--O 1.25 1.101 0 CA-C-N 120.114 1.325 . . . . 0.0 109.39 169.958 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 81.8 mt . . . . . 0 CA--C 1.538 0.503 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 20.3 t -124.69 169.45 16.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 106.106 -1.812 . . . . 0.0 106.106 -172.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.82 153.25 49.65 Favored 'General case' 0 C--O 1.234 0.274 0 O-C-N 120.809 -1.182 . . . . 0.0 109.168 171.498 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -147.73 171.15 16.13 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 123.687 0.795 . . . . 0.0 110.047 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 72.9 p -134.62 173.22 11.9 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 175.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -51.69 -30.76 23.33 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 119.644 1.111 . . . . 0.0 112.977 -176.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 26.1 mp0 -62.13 -31.64 72.14 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.061 1.744 . . . . 0.0 112.728 179.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.4 m -139.61 -2.93 1.52 Allowed 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 114.475 1.287 . . . . 0.0 114.475 -169.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 58.2 t80 -53.63 -38.5 64.12 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 123.95 0.9 . . . . 0.0 110.773 176.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.4 m -66.37 -41.82 88.88 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 122.691 0.397 . . . . 0.0 111.205 -178.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.83 -45.26 86.91 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 176.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -65.3 -37.49 87.3 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 122.568 0.347 . . . . 0.0 111.247 -176.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.53 ' HA ' HG21 ' A' ' 20' ' ' VAL . 23.9 p -78.32 0.49 25.26 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 60.0 m -109.34 32.23 5.15 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.375 1.07 . . . . 0.0 112.302 -173.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -132.44 3.72 3.93 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -177.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 166.59 -166.68 39.12 Favored Glycine 0 C--N 1.335 0.498 0 O-C-N 121.339 -0.85 . . . . 0.0 111.162 -177.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.2 t -76.2 136.12 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 103.717 -2.698 . . . . 0.0 103.717 167.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.53 HG21 ' HA ' ' A' ' 15' ' ' THR . 40.5 t -137.29 139.58 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 -172.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -117.73 97.2 5.72 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 105.331 -2.1 . . . . 0.0 105.331 176.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.56 154.83 28.49 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 172.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -135.7 98.95 4.05 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 125.718 1.607 . . . . 0.0 107.015 -179.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -73.87 116.39 14.43 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 169.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 9.1 p-90 -137.47 175.06 9.94 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.015 0.926 . . . . 0.0 110.759 -172.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -151.83 146.8 19.05 Favored Pre-proline 0 CA--C 1.538 0.485 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 169.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.25 -17.14 21.84 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.835 2.357 . . . . 0.0 113.625 -169.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -85.0 -6.49 59.33 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 118.715 0.689 . . . . 0.0 112.494 178.097 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 42.4 t -91.16 117.98 30.06 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 118.997 0.817 . . . . 0.0 109.066 -176.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -56.84 -54.02 39.78 Favored Glycine 0 CA--C 1.532 1.103 0 CA-C-O 118.812 -0.993 . . . . 0.0 112.414 176.139 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -50.53 -36.39 49.27 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 123.19 2.594 . . . . 0.0 115.272 174.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 98.6 m -60.6 -36.62 79.02 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 120.03 1.286 . . . . 0.0 111.831 173.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 59.9 mttm -69.8 -42.94 73.07 Favored 'General case' 0 N--CA 1.464 0.231 0 O-C-N 121.601 -0.687 . . . . 0.0 109.591 174.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 74.2 mtm -64.65 -35.01 79.65 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 118.987 -0.53 . . . . 0.0 111.771 -176.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 11.7 tt -80.94 -16.46 12.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-N 119.095 0.861 . . . . 0.0 111.811 179.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.53 -49.0 91.01 Favored Pre-proline 0 CA--C 1.543 0.709 0 CA-C-O 117.526 -1.226 . . . . 0.0 113.643 -179.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.52 -27.43 46.34 Favored 'Trans proline' 0 C--N 1.35 0.608 0 CA-C-N 122.048 1.767 . . . . 0.0 112.572 176.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.3 t -66.65 -40.41 86.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 119.226 0.921 . . . . 0.0 109.18 174.026 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 62.8 mt -66.94 -35.59 80.32 Favored 'General case' 0 CA--C 1.529 0.159 0 O-C-N 121.688 -0.632 . . . . 0.0 110.888 175.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -68.48 -36.2 78.62 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 119.269 0.941 . . . . 0.0 111.422 174.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -62.04 -43.17 99.42 Favored 'General case' 0 C--N 1.332 -0.158 0 O-C-N 121.122 -0.986 . . . . 0.0 109.903 171.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -65.26 -35.02 79.74 Favored 'General case' 0 N--CA 1.456 -0.171 0 O-C-N 121.93 -0.481 . . . . 0.0 111.509 176.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -65.7 -38.63 89.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 119.044 0.838 . . . . 0.0 110.357 175.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -68.91 -38.03 79.33 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 121.323 -0.861 . . . . 0.0 111.737 175.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -85.99 -36.16 19.96 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.258 1.023 . . . . 0.0 112.064 -171.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.441 ' SD ' ' HE2' ' A' ' 49' ' ' LYS . 19.0 mmt -135.57 -8.37 2.19 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.169 1.387 . . . . 0.0 112.626 -168.042 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.5 -21.41 54.32 Favored Glycine 0 CA--C 1.532 1.123 0 CA-C-N 120.321 1.419 . . . . 0.0 114.577 -171.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -76.79 -18.51 58.37 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.626 1.97 . . . . 0.0 112.134 -179.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.441 ' HE2' ' SD ' ' A' ' 46' ' ' MET . 14.8 pttm -134.02 -2.07 2.93 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 126.56 1.944 . . . . 0.0 112.239 -173.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -145.2 120.22 10.04 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 125.996 1.718 . . . . 0.0 107.424 174.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -73.07 150.99 41.86 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 176.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 16.9 mt -121.97 132.7 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 N-CA-C 105.892 -1.892 . . . . 0.0 105.892 173.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 48.0 t -132.15 111.75 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-N 118.687 0.676 . . . . 0.0 109.495 -170.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 61.2 mmtt -72.86 142.27 47.96 Favored 'General case' 0 C--O 1.234 0.288 0 O-C-N 121.551 -0.718 . . . . 0.0 109.49 171.024 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 11.9 tt -151.26 131.36 3.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 171.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -87.44 129.64 34.98 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 121.375 -0.828 . . . . 0.0 109.579 -177.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.0 m -66.31 -36.21 76.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 -174.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -75.0 -35.44 62.02 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 119.146 0.885 . . . . 0.0 109.762 -173.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -74.14 -15.67 61.02 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.699 0.799 . . . . 0.0 112.043 173.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 60.1 m-80 -141.11 49.61 1.65 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 119.523 1.056 . . . . 0.0 111.558 -167.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.413 ' CD ' ' H ' ' A' ' 61' ' ' GLN . 0.1 OUTLIER -56.82 -38.8 73.12 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.956 0.902 . . . . 0.0 109.478 179.563 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -65.87 -28.2 68.78 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 125.034 1.334 . . . . 0.0 112.572 -178.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.416 ' HA ' ' HE2' ' A' ' 66' ' ' LYS . 0.2 OUTLIER -88.43 -44.23 10.89 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-N 118.673 0.67 . . . . 0.0 109.797 179.036 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.23 -46.58 86.3 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 119.017 0.826 . . . . 0.0 109.731 178.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -60.94 -24.17 62.4 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 124.166 0.889 . . . . 0.0 112.466 175.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.416 ' HE2' ' HA ' ' A' ' 63' ' ' THR . 4.9 ttmm -58.52 -22.07 54.11 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.298 1.039 . . . . 0.0 111.966 175.161 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -122.19 12.03 10.22 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.659 1.184 . . . . 0.0 110.854 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 70.78 31.8 67.22 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 123.743 0.687 . . . . 0.0 112.573 -178.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 94.9 t -111.08 139.22 35.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 C-N-CA 124.962 1.305 . . . . 0.0 107.825 -178.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 9.1 tpt -155.23 30.09 0.39 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.372 1.069 . . . . 0.0 108.807 167.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 19.3 m -138.39 157.01 47.06 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 126.335 1.854 . . . . 0.0 107.456 -177.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -144.33 157.35 56.56 Favored Pre-proline 0 CA--C 1.54 0.569 0 CA-C-O 118.462 -0.78 . . . . 0.0 110.79 -169.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -66.81 139.76 46.91 Favored 'Cis proline' 0 N--CA 1.458 -0.575 0 N-CA-C 109.335 -1.064 . . . . 0.0 109.335 -11.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 85.0 m -133.6 116.07 15.44 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 174.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 72.7 mt -86.46 144.68 27.16 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 175.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -129.24 126.82 39.95 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 104.261 -2.496 . . . . 0.0 104.261 -178.068 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.1 t -111.33 123.52 67.26 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.414 0 N-CA-C 104.367 -2.457 . . . . 0.0 104.367 -175.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.0 mp -129.65 161.75 29.87 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 124.525 1.13 . . . . 0.0 108.236 -177.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 63.0 tttm -149.03 127.34 12.16 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 176.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.8 t70 43.39 35.27 0.87 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.428 1.491 . . . . 0.0 113.684 176.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 105.38 1.74 40.95 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-O 118.11 -1.383 . . . . 0.0 115.224 169.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -130.34 145.79 51.83 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 120.044 1.922 . . . . 0.0 110.089 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.6 p -69.37 141.45 17.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 C-N-CA 123.924 0.89 . . . . 0.0 109.306 174.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 35.6 m -129.42 -18.32 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 C-N-CA 125.709 1.604 . . . . 0.0 110.693 178.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -161.06 169.46 22.41 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 120.543 1.52 . . . . 0.0 111.669 170.149 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 54.5 m -145.82 144.65 30.4 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.07 1.748 . . . . 0.0 108.01 169.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 15.8 m -146.86 150.2 34.78 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 124.636 1.174 . . . . 0.0 108.83 -178.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 39.9 t -129.61 148.21 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -171.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.55 179.06 51.92 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 124.015 0.817 . . . . 0.0 111.708 178.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -62.43 151.58 36.73 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.539 0.736 . . . . 0.0 110.623 176.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.35 145.91 33.98 Favored Pre-proline 0 C--O 1.234 0.253 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 167.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -70.91 163.57 38.73 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.658 2.238 . . . . 0.0 110.173 173.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -54.78 -44.66 73.92 Favored 'General case' 0 C--O 1.224 -0.266 0 CA-C-O 118.585 -0.722 . . . . 0.0 110.694 179.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -63.81 -41.62 97.85 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 118.849 0.75 . . . . 0.0 111.319 -169.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.54 -42.71 82.25 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 123.22 0.608 . . . . 0.0 110.893 176.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 42.4 tp -69.37 -40.25 77.55 Favored 'General case' 0 N--CA 1.451 -0.416 0 O-C-N 122.124 -0.36 . . . . 0.0 110.808 -177.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.5 pp0? -71.71 -29.32 64.43 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 118.888 0.767 . . . . 0.0 110.062 176.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -64.04 -49.29 72.95 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 174.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 59.1 tp -57.33 -44.14 83.96 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 123.751 0.82 . . . . 0.0 110.515 178.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 11.1 t -62.19 -52.1 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 176.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.83 -25.15 67.78 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 119.095 0.861 . . . . 0.0 112.313 -175.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -67.74 -17.14 64.45 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 117.938 -1.03 . . . . 0.0 113.004 171.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -114.2 -15.07 12.25 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 120.017 1.281 . . . . 0.0 113.182 176.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 53.2 mt . . . . . 0 C--O 1.249 1.067 0 CA-C-N 119.403 1.001 . . . . 0.0 109.493 169.387 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 89.8 mt . . . . . 0 C--O 1.236 0.392 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 39.0 t -107.05 167.19 3.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 -174.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 5.7 mptt -138.47 136.53 36.27 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 -177.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -144.84 169.75 17.45 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 123.035 0.534 . . . . 0.0 110.957 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 75.8 p -133.71 176.75 8.27 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.989 1.316 . . . . 0.0 108.162 177.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -51.05 -31.97 20.4 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 120.307 1.412 . . . . 0.0 112.773 -178.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 24.3 mp0 -67.93 -25.9 65.7 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.664 1.985 . . . . 0.0 112.792 -178.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 51.7 p -135.92 -17.56 1.64 Allowed 'General case' 0 C--O 1.234 0.241 0 N-CA-C 115.343 1.608 . . . . 0.0 115.343 -168.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -53.89 -34.81 60.56 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 124.909 1.283 . . . . 0.0 110.869 179.021 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.0 m -70.22 -37.91 75.13 Favored 'General case' 0 N--CA 1.453 -0.282 0 O-C-N 122.303 -0.248 . . . . 0.0 111.116 -176.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.15 -45.82 72.49 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 174.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -64.61 -37.39 87.39 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 119.283 -0.389 . . . . 0.0 111.468 -174.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.509 ' HA ' HG21 ' A' ' 20' ' ' VAL . 24.7 p -78.38 -0.11 27.81 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -178.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 62.1 m -111.38 33.76 4.5 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.228 1.011 . . . . 0.0 111.999 -170.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -132.21 -1.29 3.63 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 -177.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 166.67 -166.87 39.27 Favored Glycine 0 C--N 1.335 0.523 0 N-CA-C 110.686 -0.966 . . . . 0.0 110.686 -173.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 72.9 t -72.01 134.72 29.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 104.695 -2.335 . . . . 0.0 104.695 166.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.509 HG21 ' HA ' ' A' ' 15' ' ' THR . 35.1 t -137.56 124.11 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 -176.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 61.6 tp -94.46 97.94 10.51 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 173.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.97 150.01 35.91 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 170.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -132.89 99.77 4.7 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 125.375 1.47 . . . . 0.0 107.262 175.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -76.95 114.57 15.89 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 172.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 9.1 p-90 -137.7 175.05 9.94 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 123.273 0.629 . . . . 0.0 110.689 -169.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -152.93 146.78 18.34 Favored Pre-proline 0 CA--C 1.535 0.397 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 168.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -73.49 -22.27 18.6 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.613 2.208 . . . . 0.0 113.187 -169.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -81.88 -7.21 59.59 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.398 0.679 . . . . 0.0 112.28 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 48.4 t -93.12 110.61 22.1 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 -177.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -50.09 -52.18 27.69 Favored Glycine 0 CA--C 1.533 1.205 0 CA-C-O 118.852 -0.971 . . . . 0.0 113.024 177.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_exo -51.3 -34.73 50.81 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 123.13 2.553 . . . . 0.0 115.366 173.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 93.6 m -62.53 -37.0 84.38 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 120.182 1.355 . . . . 0.0 111.428 173.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -69.05 -43.14 75.27 Favored 'General case' 0 N--CA 1.463 0.198 0 O-C-N 121.722 -0.611 . . . . 0.0 109.704 173.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 75.1 mtm -65.28 -33.65 76.49 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 118.439 0.563 . . . . 0.0 111.911 -176.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.4 tt -82.0 -15.44 12.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-N 119.152 0.887 . . . . 0.0 111.852 179.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.27 -48.94 93.02 Favored Pre-proline 0 CA--C 1.544 0.725 0 CA-C-O 117.593 -1.194 . . . . 0.0 113.331 179.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.07 -28.68 56.98 Favored 'Trans proline' 0 C--N 1.351 0.665 0 CA-C-N 121.88 1.707 . . . . 0.0 112.412 175.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 16.5 t -65.91 -40.19 86.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 119.569 1.077 . . . . 0.0 109.491 174.06 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 70.3 mt -67.51 -33.25 74.69 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-O 118.657 -0.687 . . . . 0.0 110.855 176.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -68.56 -36.0 78.18 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.443 1.02 . . . . 0.0 111.583 172.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 -61.9 -45.34 94.17 Favored 'General case' 0 C--O 1.227 -0.097 0 O-C-N 120.839 -1.163 . . . . 0.0 109.426 171.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -61.73 -36.22 80.33 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 118.523 0.601 . . . . 0.0 111.511 174.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -66.03 -37.51 86.06 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 118.919 0.781 . . . . 0.0 110.691 178.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -70.7 -45.81 64.28 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 122.993 0.517 . . . . 0.0 111.169 176.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -79.78 -33.2 40.78 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.469 1.107 . . . . 0.0 111.738 -169.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.42 ' HA ' ' HE3' ' A' ' 49' ' ' LYS . 22.2 mmt -139.95 -9.01 1.18 Allowed 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 117.808 -1.092 . . . . 0.0 113.842 -168.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -75.21 47.83 2.03 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 126.134 1.826 . . . . 0.0 114.569 -169.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -150.95 -39.75 0.13 Allowed 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 128.129 2.572 . . . . 0.0 107.584 169.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.42 ' HE3' ' HA ' ' A' ' 46' ' ' MET . 41.4 mtmt -65.22 -30.7 71.61 Favored 'General case' 0 C--N 1.342 0.28 0 C-N-CA 124.492 1.117 . . . . 0.0 110.651 169.041 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -134.25 164.37 27.54 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 125.486 1.514 . . . . 0.0 110.198 169.522 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -99.26 152.46 19.9 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 124.673 1.189 . . . . 0.0 108.182 172.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 19.0 mt -118.41 136.32 55.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 N-CA-C 105.488 -2.041 . . . . 0.0 105.488 172.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 79.1 t -133.17 117.76 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 119.054 0.843 . . . . 0.0 108.802 -176.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 55.1 mmtt -76.29 145.16 39.81 Favored 'General case' 0 C--O 1.234 0.284 0 O-C-N 121.672 -0.642 . . . . 0.0 109.859 169.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 16.0 tt -148.76 119.03 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 169.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -82.24 116.72 21.9 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -177.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 33.9 m -62.19 -25.83 38.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -174.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -66.1 -29.96 70.38 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 119.513 1.051 . . . . 0.0 110.949 -177.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -100.75 -3.27 30.42 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.298 1.039 . . . . 0.0 110.99 179.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 -141.65 43.48 1.73 Allowed 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.715 1.206 . . . . 0.0 109.942 -168.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.5 ' CD ' ' H ' ' A' ' 61' ' ' GLN . 1.0 OUTLIER -58.33 -41.5 84.71 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.804 1.242 . . . . 0.0 108.77 -177.937 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -64.5 -42.97 95.51 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.91 0.884 . . . . 0.0 110.509 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.518 ' HA ' ' HE3' ' A' ' 66' ' ' LYS . 0.5 OUTLIER -68.94 -44.04 73.86 Favored 'General case' 0 C--O 1.221 -0.397 0 CA-C-N 118.776 0.716 . . . . 0.0 110.255 -177.519 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.3 -45.1 94.77 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 119.094 0.861 . . . . 0.0 109.347 176.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -57.46 -27.53 58.41 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 124.077 0.846 . . . . 0.0 112.702 174.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.518 ' HE3' ' HA ' ' A' ' 63' ' ' THR . 25.7 ttmt -58.49 -21.22 51.06 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.656 1.582 . . . . 0.0 111.924 178.566 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -126.61 13.74 7.53 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.657 1.183 . . . . 0.0 110.687 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 71.71 32.56 64.05 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 123.775 0.702 . . . . 0.0 112.754 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 93.6 t -109.85 137.87 40.08 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 C-N-CA 124.806 1.243 . . . . 0.0 107.756 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 8.4 tpt -155.95 31.45 0.35 Allowed 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.355 1.062 . . . . 0.0 108.804 166.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 20.4 m -138.27 152.39 48.5 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 126.779 2.031 . . . . 0.0 106.643 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -146.11 159.08 47.14 Favored Pre-proline 0 CA--C 1.54 0.592 0 C-N-CA 123.95 0.9 . . . . 0.0 110.02 -169.417 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -67.17 138.94 43.95 Favored 'Cis proline' 0 C--N 1.349 0.59 0 CA-C-N 119.956 1.02 . . . . 0.0 109.691 -10.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 54.9 m -132.36 116.9 17.43 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 177.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 81.0 mt -92.45 137.13 32.63 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 177.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.6 mp -122.39 132.47 54.39 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 105.74 -1.948 . . . . 0.0 105.74 169.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 17.0 t -95.58 125.9 48.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 103.09 -2.929 . . . . 0.0 103.09 168.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.8 mp -120.72 159.18 25.91 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 125.422 1.489 . . . . 0.0 107.322 175.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -146.28 125.12 12.66 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 176.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.9 t70 45.81 35.66 2.39 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.311 1.444 . . . . 0.0 113.694 175.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 110.04 -2.53 30.02 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-O 118.055 -1.414 . . . . 0.0 115.484 168.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -131.57 144.43 51.08 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 120.081 1.941 . . . . 0.0 110.2 -178.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 5.3 p -65.72 137.16 25.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 171.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 34.3 m -121.12 -21.5 3.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 125.175 1.39 . . . . 0.0 110.433 176.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -157.31 162.73 39.14 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 119.701 1.137 . . . . 0.0 111.312 174.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 90.6 m -136.57 149.28 47.99 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.383 1.873 . . . . 0.0 108.416 175.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 30.4 m -147.35 152.81 38.82 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 126.267 1.827 . . . . 0.0 107.834 170.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 41.3 t -133.13 144.44 36.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 -175.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 80.22 179.83 52.86 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 123.907 0.765 . . . . 0.0 111.582 -179.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -62.97 147.7 49.78 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.683 0.793 . . . . 0.0 110.667 178.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 69.2 mttt -142.37 147.66 44.28 Favored Pre-proline 0 CA--C 1.531 0.233 0 C-N-CA 125.713 1.605 . . . . 0.0 106.898 168.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -73.2 159.44 47.27 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.581 2.187 . . . . 0.0 110.459 176.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 17.1 ptmt -55.55 -48.94 73.94 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 112.257 0.465 . . . . 0.0 112.257 -177.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -61.9 -39.29 91.46 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 123.59 0.756 . . . . 0.0 110.868 -169.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.64 -42.8 73.78 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 122.823 0.449 . . . . 0.0 110.855 176.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 46.5 tp -68.66 -38.42 80.39 Favored 'General case' 0 N--CA 1.451 -0.41 0 O-C-N 122.039 -0.413 . . . . 0.0 110.857 -178.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.4 pp0? -72.06 -29.47 64.17 Favored 'General case' 0 C--N 1.339 0.118 0 CA-C-N 119.174 0.897 . . . . 0.0 110.314 175.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -63.5 -48.85 75.89 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 174.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 59.3 tp -58.59 -44.97 90.0 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.191 0.596 . . . . 0.0 110.558 179.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.6 t -60.22 -51.43 73.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 C-N-CA 122.898 0.479 . . . . 0.0 109.74 177.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.37 -27.99 69.39 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 118.893 0.77 . . . . 0.0 112.121 -176.57 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -68.56 -25.87 65.12 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 118.303 -0.856 . . . . 0.0 112.345 172.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 75.5 m-70 -96.69 -16.98 20.63 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 119.68 1.127 . . . . 0.0 113.421 178.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 67.8 mt . . . . . 0 C--O 1.25 1.115 0 CA-C-N 119.813 1.188 . . . . 0.0 109.665 173.543 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 86.7 mt . . . . . 0 CA--C 1.537 0.477 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 35.7 t -122.68 167.1 16.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 -175.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 6.1 mtmt -132.34 143.76 50.08 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 176.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -144.89 170.43 16.16 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 123.12 0.568 . . . . 0.0 110.246 175.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 77.4 p -134.62 173.61 11.48 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.915 1.286 . . . . 0.0 107.636 177.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -50.49 -30.65 13.33 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 119.271 0.941 . . . . 0.0 113.132 -177.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 26.9 mp0 -64.25 -32.23 73.74 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.13 1.772 . . . . 0.0 112.794 -179.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.2 m -140.02 -5.57 1.29 Allowed 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 -169.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -52.26 -38.8 59.22 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 124.355 1.062 . . . . 0.0 110.786 175.447 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.4 m -67.75 -36.15 80.01 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 122.675 0.39 . . . . 0.0 111.656 -176.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.92 -45.99 69.41 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 175.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -64.03 -35.23 80.03 Favored 'General case' 0 C--O 1.231 0.11 0 C-N-CA 123.06 0.544 . . . . 0.0 111.721 -174.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.492 ' HA ' HG21 ' A' ' 20' ' ' VAL . 22.3 p -82.44 2.09 34.33 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.611 0.764 . . . . 0.0 112.955 -178.538 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 48.7 m -118.07 35.61 4.67 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 118.891 0.769 . . . . 0.0 112.726 -169.224 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -145.89 14.3 1.34 Allowed 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 176.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 172.08 -168.54 41.64 Favored Glycine 0 C--N 1.34 0.771 0 O-C-N 121.17 -0.956 . . . . 0.0 111.698 176.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 61.0 t -74.81 133.74 30.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 N-CA-C 104.498 -2.408 . . . . 0.0 104.498 167.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.492 HG21 ' HA ' ' A' ' 15' ' ' THR . 38.1 t -139.63 117.32 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 -174.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 64.4 tp -88.25 97.29 10.94 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 173.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.05 147.77 38.46 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 169.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -133.73 98.9 4.31 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 125.172 1.389 . . . . 0.0 107.539 176.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -75.81 114.88 14.91 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 105.893 -1.891 . . . . 0.0 105.893 173.08 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 9.2 p-90 -137.49 175.21 9.81 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.478 0.711 . . . . 0.0 110.81 -169.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -152.92 147.43 19.06 Favored Pre-proline 0 CA--C 1.537 0.446 0 C-N-CA 124.602 1.161 . . . . 0.0 107.897 169.094 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.3 -21.57 17.41 Favored 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 122.8 2.333 . . . . 0.0 113.423 -170.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -81.71 -9.3 59.68 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 118.665 0.666 . . . . 0.0 112.051 178.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 51.0 t -88.28 117.1 26.95 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -179.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -54.4 -57.65 16.34 Favored Glycine 0 CA--C 1.531 1.05 0 CA-C-O 118.565 -1.13 . . . . 0.0 111.888 176.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_exo -49.37 -35.44 35.49 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 123.703 2.935 . . . . 0.0 115.736 177.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 84.5 m -60.56 -37.85 82.61 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 119.941 1.246 . . . . 0.0 111.65 174.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 45.9 mtmt -79.88 -31.21 40.34 Favored 'General case' 0 CA--C 1.529 0.151 0 O-C-N 121.674 -0.641 . . . . 0.0 110.29 177.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 63.6 mtt -65.06 -38.86 92.21 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.994 0.816 . . . . 0.0 111.278 175.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 10.2 tt -80.95 -16.94 12.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 118.887 0.767 . . . . 0.0 111.632 -179.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -52.32 -49.8 83.14 Favored Pre-proline 0 CA--C 1.544 0.716 0 CA-C-O 117.506 -1.235 . . . . 0.0 113.777 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -64.98 -31.52 55.78 Favored 'Trans proline' 0 C--N 1.35 0.649 0 CA-C-N 121.92 1.722 . . . . 0.0 112.236 176.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 20.2 t -63.44 -43.61 98.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-N 119.106 0.866 . . . . 0.0 109.049 175.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 71.9 mt -65.17 -36.16 83.36 Favored 'General case' 0 C--O 1.227 -0.115 0 CA-C-O 118.849 -0.596 . . . . 0.0 110.954 177.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -65.94 -38.09 87.71 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 119.273 0.942 . . . . 0.0 111.279 174.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -68.2 -38.86 82.41 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 121.133 -0.98 . . . . 0.0 110.456 174.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.91 -42.26 99.73 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.001 0.92 . . . . 0.0 109.421 177.15 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -63.15 -45.01 93.9 Favored 'General case' 0 C--O 1.226 -0.132 0 C-N-CA 123.718 0.807 . . . . 0.0 110.449 176.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -61.69 -30.5 70.78 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 121.705 -0.622 . . . . 0.0 111.989 176.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -85.99 -40.01 16.28 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.893 0.877 . . . . 0.0 112.133 -175.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 17.8 mmt -135.68 1.11 2.78 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 -167.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.3 47.51 1.11 Allowed Glycine 0 CA--C 1.53 1.022 0 C-N-CA 127.224 2.345 . . . . 0.0 114.625 -169.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -149.71 -40.1 0.14 Allowed 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 128.552 2.741 . . . . 0.0 108.032 171.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -62.81 -38.8 92.14 Favored 'General case' 0 C--N 1.342 0.263 0 C-N-CA 124.633 1.173 . . . . 0.0 110.218 169.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -133.31 165.22 25.33 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.418 1.487 . . . . 0.0 110.294 173.264 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -104.81 155.11 19.19 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.726 1.61 . . . . 0.0 107.453 171.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 17.9 mt -117.52 135.78 56.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 N-CA-C 105.242 -2.132 . . . . 0.0 105.242 169.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 91.3 t -130.96 113.78 25.27 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -177.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 44.4 mmtt -73.78 144.25 45.69 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 169.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 15.2 tt -148.06 118.03 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 169.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -82.51 115.44 21.5 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 -176.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 27.8 m -62.49 -24.79 36.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 N-CA-C 112.519 0.562 . . . . 0.0 112.519 -175.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -70.48 -10.62 59.65 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 119.318 0.963 . . . . 0.0 112.083 -178.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -122.95 1.09 9.25 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.645 1.178 . . . . 0.0 110.889 175.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -145.65 36.88 1.08 Allowed 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.636 1.174 . . . . 0.0 110.128 -169.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -59.07 -29.25 67.19 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.579 0.752 . . . . 0.0 110.551 177.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 59.6 mp0 -59.97 -49.48 77.5 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.504 1.522 . . . . 0.0 110.041 173.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.63 -41.87 68.32 Favored 'General case' 0 C--O 1.222 -0.392 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 -175.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -61.14 -46.78 89.14 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 119.057 0.844 . . . . 0.0 109.775 176.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -59.19 -24.55 58.9 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 124.312 0.958 . . . . 0.0 112.856 175.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 8.9 ttmm -59.38 -20.82 57.77 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.764 1.225 . . . . 0.0 111.791 176.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -125.6 13.11 8.08 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.199 1.4 . . . . 0.0 110.473 177.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 68.52 21.63 74.59 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 124.554 1.074 . . . . 0.0 113.524 -177.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 87.3 t -89.34 154.39 3.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-N 118.308 1.054 . . . . 0.0 109.372 178.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -162.23 -24.01 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.898 2.079 . . . . 0.0 109.404 167.097 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 8.8 m -63.51 149.3 46.51 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 123.571 0.749 . . . . 0.0 109.114 169.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -144.31 155.46 57.77 Favored Pre-proline 0 CA--C 1.541 0.614 0 C-N-CA 124.176 0.99 . . . . 0.0 108.925 176.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -66.69 140.24 48.84 Favored 'Cis proline' 0 N--CA 1.457 -0.643 0 CA-C-N 120.003 1.037 . . . . 0.0 109.584 -10.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 52.7 m -131.63 117.81 19.19 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 175.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 93.1 mt -93.79 135.24 35.3 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 178.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.5 mp -122.9 129.45 51.64 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 104.713 -2.329 . . . . 0.0 104.713 169.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 48.1 t -94.84 120.94 44.96 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.416 0 N-CA-C 103.361 -2.829 . . . . 0.0 103.361 168.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.9 mp -108.41 159.26 16.81 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 169.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -146.34 123.91 11.78 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 106.738 -1.579 . . . . 0.0 106.738 175.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.0 t70 42.21 40.67 1.82 Allowed 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.032 1.333 . . . . 0.0 113.08 179.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.67 9.66 59.77 Favored Glycine 0 CA--C 1.529 0.962 0 CA-C-O 118.584 -1.12 . . . . 0.0 114.957 171.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -126.55 139.81 52.92 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 119.552 1.676 . . . . 0.0 108.472 177.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 18.5 t -68.01 134.28 30.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 106.711 -1.589 . . . . 0.0 106.711 169.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.6 m -124.89 -18.61 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 124.41 1.084 . . . . 0.0 110.898 177.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.22 165.17 36.55 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 119.619 1.1 . . . . 0.0 110.955 174.065 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 97.5 m -149.32 149.28 30.65 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.209 1.403 . . . . 0.0 109.108 177.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.9 m -149.87 156.25 41.46 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 126.018 1.727 . . . . 0.0 108.929 172.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.9 t -133.58 144.46 35.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 -179.287 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.1 -178.45 53.61 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 123.647 0.641 . . . . 0.0 111.567 -178.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -62.33 149.0 43.39 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.786 0.834 . . . . 0.0 110.678 177.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 25.3 mttp -142.32 142.11 23.0 Favored Pre-proline 0 C--O 1.234 0.248 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 168.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -72.5 162.93 40.04 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 122.646 2.23 . . . . 0.0 110.458 175.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -54.64 -46.2 73.92 Favored 'General case' 0 C--O 1.223 -0.295 0 C-N-CA 123.073 0.549 . . . . 0.0 110.82 -179.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -64.84 -41.13 95.97 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 118.356 0.525 . . . . 0.0 111.05 -169.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.28 -45.45 80.41 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 122.651 0.38 . . . . 0.0 110.539 176.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 46.5 tp -65.75 -42.42 90.93 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 123.037 0.535 . . . . 0.0 110.436 -176.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -68.37 -32.78 73.1 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 118.715 0.689 . . . . 0.0 109.818 178.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -67.64 -46.8 71.39 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 118.835 0.743 . . . . 0.0 109.446 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.0 tt -54.16 -42.75 69.95 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.385 1.074 . . . . 0.0 109.569 175.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 25.2 t -63.84 -50.67 76.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-O 117.499 -1.239 . . . . 0.0 110.548 175.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -56.12 -46.18 79.24 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 120.718 1.599 . . . . 0.0 110.279 -176.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -57.21 -15.0 4.84 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.228 1.011 . . . . 0.0 113.225 178.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 78.8 m-70 -121.09 -5.06 9.51 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 177.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 53.9 mt . . . . . 0 C--O 1.248 1.008 0 CA-C-N 120.106 1.321 . . . . 0.0 109.113 169.959 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 77.3 mt . . . . . 0 CA--C 1.54 0.564 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.4 t -129.22 169.88 19.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 -173.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.26 153.46 50.34 Favored 'General case' 0 C--O 1.233 0.235 0 O-C-N 120.791 -1.193 . . . . 0.0 108.994 169.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -144.71 175.5 10.12 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 123.886 0.874 . . . . 0.0 109.939 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 70.6 p -133.13 177.36 7.73 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.798 1.239 . . . . 0.0 107.947 174.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -53.97 -25.94 23.33 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 119.547 1.067 . . . . 0.0 112.553 176.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 48.2 mm-40 -73.34 -25.17 60.5 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.091 1.356 . . . . 0.0 112.522 -178.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 33.2 p -135.15 -11.99 2.18 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 115.634 1.716 . . . . 0.0 115.634 -167.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -53.96 -35.79 62.17 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 124.194 0.998 . . . . 0.0 110.852 179.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.7 m -70.81 -34.92 72.24 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 122.686 0.394 . . . . 0.0 111.48 -177.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -72.94 -32.74 65.46 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 123.556 0.742 . . . . 0.0 110.625 176.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -79.05 -39.59 33.53 Favored 'General case' 0 N--CA 1.453 -0.319 0 O-C-N 122.003 -0.435 . . . . 0.0 111.505 -177.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.495 ' HA ' HG21 ' A' ' 20' ' ' VAL . 25.2 p -78.11 -0.64 28.97 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -174.026 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 28.7 p -110.46 30.94 6.33 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.269 1.028 . . . . 0.0 112.834 -169.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -131.48 -0.13 4.0 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 113.58 0.955 . . . . 0.0 113.58 -175.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 165.73 -166.29 38.46 Favored Glycine 0 C--N 1.336 0.559 0 CA-C-N 119.358 0.981 . . . . 0.0 110.886 -174.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 88.6 t -71.73 129.82 35.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 N-CA-C 105.212 -2.144 . . . . 0.0 105.212 166.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.495 HG21 ' HA ' ' A' ' 15' ' ' THR . 25.4 t -133.11 116.66 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 -176.516 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 63.9 tp -88.21 96.83 10.7 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 174.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.06 148.54 37.9 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 170.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -133.51 96.76 3.78 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 125.031 1.332 . . . . 0.0 107.419 177.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -74.53 113.81 12.21 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 172.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 6.6 p-90 -137.63 176.72 8.45 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 123.435 0.694 . . . . 0.0 110.532 -169.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -155.72 147.75 17.36 Favored Pre-proline 0 C--O 1.237 0.446 0 C-N-CA 125.793 1.637 . . . . 0.0 106.731 169.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.94 -20.49 15.01 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.99 2.46 . . . . 0.0 113.3 -170.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -79.37 -7.59 58.47 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 118.528 0.604 . . . . 0.0 112.381 -179.616 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 44.0 t -95.56 122.25 38.1 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -178.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -56.87 -57.48 19.44 Favored Glycine 0 CA--C 1.531 1.046 0 CA-C-O 118.623 -1.098 . . . . 0.0 112.098 178.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_exo -48.37 -36.19 29.73 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 123.756 2.971 . . . . 0.0 115.8 177.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 79.8 m -59.6 -31.82 69.83 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 119.875 1.216 . . . . 0.0 112.504 175.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt -88.32 -33.88 17.85 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 123.445 0.698 . . . . 0.0 109.737 177.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 62.3 mtt -61.65 -37.07 82.68 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.935 0.789 . . . . 0.0 111.264 175.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 10.9 tt -80.08 -14.04 13.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-N 118.603 0.638 . . . . 0.0 111.928 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.97 -48.35 94.14 Favored Pre-proline 0 CA--C 1.543 0.685 0 CA-C-O 117.403 -1.284 . . . . 0.0 113.411 -178.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -65.03 -29.15 57.14 Favored 'Trans proline' 0 C--N 1.349 0.592 0 CA-C-N 121.996 1.749 . . . . 0.0 112.607 175.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 12.9 t -66.71 -40.45 86.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 119.343 0.974 . . . . 0.0 109.305 174.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 91.6 mt -66.72 -35.69 80.72 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-O 118.756 -0.64 . . . . 0.0 110.845 175.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -68.04 -36.06 79.28 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 119.481 1.037 . . . . 0.0 111.288 174.501 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 45.3 mm-40 -63.88 -43.91 94.62 Favored 'General case' 0 CA--C 1.529 0.151 0 O-C-N 121.05 -1.031 . . . . 0.0 109.958 171.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -63.3 -36.54 84.0 Favored 'General case' 0 C--O 1.226 -0.181 0 C-N-CA 123.129 0.572 . . . . 0.0 111.109 176.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -64.71 -42.7 95.07 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 118.636 0.653 . . . . 0.0 109.995 176.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -65.91 -33.39 75.72 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.708 -0.62 . . . . 0.0 112.377 175.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -89.27 -32.48 17.37 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.093 0.957 . . . . 0.0 112.274 -172.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.525 ' SD ' ' HE2' ' A' ' 49' ' ' LYS . 22.5 mmt -136.25 -11.54 1.92 Allowed 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.879 1.271 . . . . 0.0 112.663 -168.361 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.42 2.88 18.79 Favored Glycine 0 CA--C 1.53 0.988 0 CA-C-N 120.827 1.649 . . . . 0.0 114.545 -172.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -90.2 -17.15 28.06 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 127.126 2.17 . . . . 0.0 111.766 170.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.525 ' HE2' ' SD ' ' A' ' 46' ' ' MET . 14.9 pttm -138.94 6.4 2.41 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 127.072 2.149 . . . . 0.0 112.466 -174.244 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -145.85 163.96 33.41 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 129.144 2.978 . . . . 0.0 105.998 175.314 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -121.05 154.91 35.46 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 125.231 1.412 . . . . 0.0 107.359 173.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 15.7 mt -123.4 135.28 63.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 N-CA-C 105.179 -2.156 . . . . 0.0 105.179 174.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 88.3 t -132.1 111.19 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -174.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 38.6 mmtt -71.65 142.55 49.9 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 169.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 15.7 tt -148.64 119.78 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 170.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 50.7 t0 -80.26 115.88 20.05 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 123.561 0.745 . . . . 0.0 109.138 -177.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 28.6 m -60.95 -30.25 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-N 118.227 0.467 . . . . 0.0 111.889 -177.268 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -76.16 2.68 12.4 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.986 0.914 . . . . 0.0 112.024 -176.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -129.89 -4.13 4.59 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.69 1.596 . . . . 0.0 110.743 173.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -141.34 47.55 1.69 Allowed 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.287 1.035 . . . . 0.0 109.938 -168.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.509 ' NE2' ' H ' ' A' ' 61' ' ' GLN . 0.3 OUTLIER -52.47 -43.35 64.92 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.587 1.555 . . . . 0.0 109.427 177.958 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 33.3 mp0 -67.35 -27.97 67.57 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 126.206 1.802 . . . . 0.0 111.903 -174.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.439 ' HA ' ' HE2' ' A' ' 66' ' ' LYS . 0.2 OUTLIER -88.39 -46.2 9.36 Favored 'General case' 0 C--O 1.22 -0.481 0 CA-C-N 118.474 0.579 . . . . 0.0 109.614 178.722 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.8 -47.41 83.55 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.859 0.754 . . . . 0.0 109.683 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -61.46 -22.41 61.32 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 124.514 1.054 . . . . 0.0 112.846 175.108 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.439 ' HE2' ' HA ' ' A' ' 63' ' ' THR . 5.9 ttmm -57.61 -24.14 54.8 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 118.811 1.306 . . . . 0.0 111.771 174.669 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -125.4 14.74 8.27 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.851 1.26 . . . . 0.0 110.304 178.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 70.12 19.09 75.34 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 124.849 1.214 . . . . 0.0 114.038 -179.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 84.6 t -81.31 127.63 39.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 177.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 8.6 mmt -147.5 29.42 0.94 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.892 1.677 . . . . 0.0 108.735 169.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 17.0 m -142.85 152.18 41.88 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 126.681 1.993 . . . . 0.0 106.734 179.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -145.64 157.56 51.48 Favored Pre-proline 0 CA--C 1.54 0.576 0 C-N-CA 123.832 0.853 . . . . 0.0 109.914 -171.199 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -67.57 141.73 59.84 Favored 'Cis proline' 0 N--CA 1.459 -0.548 0 CA-C-N 119.852 0.983 . . . . 0.0 109.581 -10.235 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 55.2 m -131.78 116.4 17.22 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 176.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 93.3 mt -91.4 136.84 32.82 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 178.016 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.2 mp -120.68 130.84 54.27 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 105.098 -2.186 . . . . 0.0 105.098 169.133 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 25.5 t -93.72 121.09 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 103.016 -2.957 . . . . 0.0 103.016 169.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.8 mp -115.86 158.62 22.67 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 172.038 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -146.19 126.2 13.68 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 175.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.6 t70 44.75 38.31 2.75 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.263 1.425 . . . . 0.0 113.364 175.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.76 6.89 54.12 Favored Glycine 0 CA--C 1.53 0.982 0 CA-C-O 118.561 -1.133 . . . . 0.0 114.345 169.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -129.01 138.43 51.93 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 119.432 1.616 . . . . 0.0 108.764 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.7 p -68.96 135.91 27.43 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 168.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.4 m -125.3 -19.64 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 C-N-CA 124.543 1.137 . . . . 0.0 110.476 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.18 167.38 30.57 Favored 'General case' 0 C--N 1.344 0.369 0 CA-C-N 119.588 1.086 . . . . 0.0 111.182 174.146 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 97.4 m -147.22 149.32 32.68 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.571 1.548 . . . . 0.0 108.789 178.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 66.2 m -150.59 156.25 41.0 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.494 1.518 . . . . 0.0 108.691 172.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 40.6 t -132.59 144.46 36.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -177.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 83.84 179.4 51.98 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 124.007 0.813 . . . . 0.0 111.711 -179.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -61.89 150.59 37.05 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.845 0.858 . . . . 0.0 110.61 176.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 40.8 mttm -140.68 144.84 37.68 Favored Pre-proline 0 C--O 1.233 0.213 0 C-N-CA 125.007 1.323 . . . . 0.0 107.518 168.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -72.66 161.54 43.68 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.63 2.22 . . . . 0.0 110.327 173.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -55.16 -47.74 74.72 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 123.089 0.556 . . . . 0.0 110.957 -178.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -63.51 -43.6 96.73 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 118.218 0.463 . . . . 0.0 111.516 -168.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.46 -42.81 87.0 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.106 0.563 . . . . 0.0 110.954 178.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 42.7 tp -67.75 -42.46 81.76 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 110.27 -0.27 . . . . 0.0 110.27 -178.163 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.7 pp0? -69.48 -34.35 74.2 Favored 'General case' 0 N--CA 1.454 -0.273 0 O-C-N 121.567 -0.708 . . . . 0.0 109.605 177.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -60.14 -45.94 91.35 Favored 'General case' 0 C--N 1.339 0.115 0 CA-C-N 119.41 1.004 . . . . 0.0 108.532 176.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 61.0 tp -58.09 -39.9 79.78 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.558 0.743 . . . . 0.0 110.888 176.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 56.0 t -63.56 -48.93 84.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-O 118.498 -0.763 . . . . 0.0 110.517 175.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 24.4 m-80 -58.08 -40.8 81.99 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 120.239 1.381 . . . . 0.0 109.908 179.268 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -62.82 -13.83 38.28 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 117.904 -1.046 . . . . 0.0 113.13 -178.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 70.4 m-70 -124.28 -19.57 5.48 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.248 0.978 0 CA-C-N 120.302 1.41 . . . . 0.0 109.914 178.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 81.8 mt . . . . . 0 CA--C 1.535 0.382 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 48.4 t -109.09 167.19 4.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 125.827 1.651 . . . . 0.0 106.915 -173.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 5.7 mptt -138.68 137.84 37.2 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 -176.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -149.01 171.76 15.85 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 122.973 0.509 . . . . 0.0 110.863 -179.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.5 p -136.63 173.23 11.93 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 125.598 1.559 . . . . 0.0 107.695 -176.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -50.55 -27.06 6.01 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.644 1.178 . . . . 0.0 112.634 176.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 49.0 mm-40 -65.18 -32.64 74.43 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 125.15 1.38 . . . . 0.0 112.104 -178.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.4 m -143.4 -5.48 0.84 Allowed 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 115.103 1.52 . . . . 0.0 115.103 -171.169 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -54.04 -35.47 62.0 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 119.48 1.036 . . . . 0.0 111.276 179.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.7 m -67.0 -41.64 86.36 Favored 'General case' 0 N--CA 1.452 -0.345 0 O-C-N 122.065 -0.397 . . . . 0.0 111.197 -178.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.62 -43.82 79.48 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 176.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -62.12 -38.49 89.13 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 123.503 0.721 . . . . 0.0 111.074 -176.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 25.9 p -81.55 3.53 24.64 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -178.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 50.4 m -120.46 36.79 4.45 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.384 1.074 . . . . 0.0 112.156 -169.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -142.5 12.48 1.93 Allowed 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 176.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 174.73 -166.59 38.44 Favored Glycine 0 C--N 1.339 0.709 0 O-C-N 121.191 -0.943 . . . . 0.0 111.629 179.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.1 t -80.09 125.11 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 103.281 -2.859 . . . . 0.0 103.281 167.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 22.9 t -136.8 118.73 19.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 -171.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 35.0 tp -87.93 147.49 25.04 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 168.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -135.34 154.06 51.64 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 176.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -134.48 98.9 4.2 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 -175.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -74.88 117.19 16.45 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 169.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 6.0 p-90 -145.72 179.53 7.38 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.441 0.697 . . . . 0.0 111.205 -170.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -159.96 151.78 16.79 Favored Pre-proline 0 CA--C 1.538 0.51 0 C-N-CA 125.896 1.678 . . . . 0.0 107.024 167.261 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -75.75 -18.46 17.15 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.851 2.367 . . . . 0.0 113.319 -169.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -80.01 -10.92 59.81 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 118.721 0.691 . . . . 0.0 112.044 178.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 50.9 t -88.74 119.19 29.0 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 178.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -56.23 -57.74 17.7 Favored Glycine 0 CA--C 1.531 1.049 0 CA-C-O 118.808 -0.995 . . . . 0.0 111.954 176.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -51.16 -32.9 41.91 Favored 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 123.375 2.717 . . . . 0.0 115.651 177.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 88.2 m -59.57 -42.5 92.6 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 119.905 1.229 . . . . 0.0 111.323 173.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 44.1 mtmt -74.12 -30.39 62.28 Favored 'General case' 0 CA--C 1.529 0.139 0 O-C-N 121.801 -0.562 . . . . 0.0 110.476 177.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 89.8 mtp -65.75 -40.54 92.19 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 119.001 0.819 . . . . 0.0 111.242 175.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 12.3 tt -80.97 -16.27 12.45 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-N 119.158 0.89 . . . . 0.0 111.603 -179.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.9 -50.17 75.91 Favored Pre-proline 0 CA--C 1.545 0.767 0 CA-C-O 117.494 -1.241 . . . . 0.0 114.003 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.68 -28.74 52.1 Favored 'Trans proline' 0 C--N 1.35 0.652 0 CA-C-N 122.044 1.766 . . . . 0.0 112.691 176.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 13.8 t -66.89 -40.56 86.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-N 119.027 0.831 . . . . 0.0 109.143 174.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 46.1 mt -66.88 -36.52 82.48 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 118.604 -0.712 . . . . 0.0 110.694 176.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -65.87 -40.5 91.68 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 119.279 0.945 . . . . 0.0 110.897 173.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 30.6 mm-40 -59.5 -42.21 91.64 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 119.068 0.849 . . . . 0.0 110.406 173.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.65 -36.2 83.03 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 123.263 0.625 . . . . 0.0 111.364 176.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -65.04 -45.44 85.42 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 123.633 0.773 . . . . 0.0 109.918 175.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 73.5 mm-40 -65.44 -27.69 68.7 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.923 -0.486 . . . . 0.0 111.95 178.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -92.12 -37.42 12.76 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.366 1.066 . . . . 0.0 112.193 -175.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.401 ' SD ' ' HE2' ' A' ' 49' ' ' LYS . 20.7 mmt -128.77 -9.67 4.98 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 124.241 1.017 . . . . 0.0 113.372 -167.595 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -50.06 -25.24 7.44 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 126.233 1.873 . . . . 0.0 115.351 -175.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -75.58 -28.29 58.89 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 124.829 1.252 . . . . 0.0 112.07 -176.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.401 ' HE2' ' SD ' ' A' ' 46' ' ' MET . 0.0 OUTLIER -125.63 -4.76 7.09 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 125.665 1.586 . . . . 0.0 112.984 -175.474 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -144.96 123.43 12.38 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 124.499 1.12 . . . . 0.0 108.095 172.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -80.39 154.81 27.47 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 176.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 29.4 mt -127.76 130.91 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 N-CA-C 105.516 -2.031 . . . . 0.0 105.516 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.9 t -129.53 116.84 40.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 118.485 0.584 . . . . 0.0 109.723 -171.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt -74.17 143.89 45.05 Favored 'General case' 0 C--O 1.236 0.347 0 O-C-N 121.477 -0.765 . . . . 0.0 109.558 170.184 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 10.6 tt -150.34 129.8 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 170.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -86.8 126.96 34.97 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 121.411 -0.806 . . . . 0.0 109.69 -176.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 12.4 m -67.72 -32.57 57.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -174.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -75.62 -35.39 60.52 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 119.31 0.959 . . . . 0.0 109.78 -175.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -78.57 -15.17 58.86 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.279 0.632 . . . . 0.0 111.901 175.248 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 48.5 m-80 -140.87 50.78 1.64 Allowed 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 119.194 0.906 . . . . 0.0 110.562 -168.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.477 ' CD ' ' H ' ' A' ' 61' ' ' GLN . 1.1 mp0 -58.69 -43.06 89.87 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.459 1.103 . . . . 0.0 109.49 -174.627 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -64.0 -41.48 97.46 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.327 1.051 . . . . 0.0 110.751 -176.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.05 -43.71 70.68 Favored 'General case' 0 C--O 1.222 -0.348 0 CA-C-N 118.633 0.651 . . . . 0.0 109.821 -177.574 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.27 -44.01 97.52 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 118.94 0.791 . . . . 0.0 109.461 176.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -57.46 -27.69 58.59 Favored Glycine 0 CA--C 1.534 1.233 0 C-N-CA 124.325 0.964 . . . . 0.0 112.635 174.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 24.8 ttmt -59.21 -21.64 59.8 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.983 1.313 . . . . 0.0 111.777 177.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -120.38 10.58 11.26 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.981 1.312 . . . . 0.0 111.009 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 70.21 32.14 68.95 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 123.694 0.664 . . . . 0.0 112.319 -177.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 86.7 t -110.88 134.67 52.43 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 C-N-CA 124.762 1.225 . . . . 0.0 107.92 -178.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 8.4 tpt -155.7 32.16 0.36 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.36 1.064 . . . . 0.0 108.976 167.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 20.2 m -137.47 155.91 48.76 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 126.787 2.035 . . . . 0.0 106.724 179.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 29.8 pt -145.7 157.63 51.15 Favored Pre-proline 0 CA--C 1.541 0.602 0 CA-C-O 118.716 -0.659 . . . . 0.0 111.069 -168.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -67.33 141.71 58.84 Favored 'Cis proline' 0 N--CA 1.458 -0.574 0 N-CA-C 109.022 -1.184 . . . . 0.0 109.022 -11.085 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 58.2 m -136.12 131.0 34.18 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 176.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -103.61 143.94 32.1 Favored 'General case' 0 N--CA 1.437 -1.123 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 -176.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -125.45 137.39 53.98 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 104.382 -2.451 . . . . 0.0 104.382 178.105 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 11.1 t -127.29 127.97 69.71 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.593 0 N-CA-C 105.036 -2.209 . . . . 0.0 105.036 177.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.8 mp -130.15 157.96 41.01 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 -177.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -142.58 121.77 13.0 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 175.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.2 t70 44.06 37.55 1.86 Allowed 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.689 1.196 . . . . 0.0 112.476 -172.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.2 -6.29 82.59 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-O 118.839 -0.978 . . . . 0.0 114.473 174.158 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -90.04 128.51 36.3 Favored 'General case' 0 CA--C 1.522 -0.113 0 CA-C-N 119.407 1.603 . . . . 0.0 106.874 175.206 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 71.0 t -63.99 134.56 28.77 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 168.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 32.9 m -122.94 -20.48 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 124.749 1.219 . . . . 0.0 110.547 176.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.63 161.41 41.6 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 119.999 1.272 . . . . 0.0 111.869 172.13 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 70.7 m -147.63 133.68 19.27 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.249 1.82 . . . . 0.0 106.913 169.02 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 16.9 m -146.13 152.4 39.22 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.018 0.927 . . . . 0.0 109.396 -172.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 42.6 t -129.13 148.94 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-N 119.431 1.014 . . . . 0.0 108.919 -170.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.27 175.38 50.03 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 124.536 1.065 . . . . 0.0 112.358 174.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -57.91 154.37 12.44 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.907 0.883 . . . . 0.0 110.594 176.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -152.28 144.36 16.57 Favored Pre-proline 0 CA--C 1.53 0.207 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 169.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_endo -71.64 163.39 39.13 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.582 2.188 . . . . 0.0 110.339 175.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -54.69 -46.25 74.08 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-O 118.855 -0.593 . . . . 0.0 110.636 -179.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -64.38 -40.24 95.44 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 118.451 0.569 . . . . 0.0 111.122 -169.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.57 -45.13 76.48 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 122.823 0.449 . . . . 0.0 110.688 177.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 50.9 tp -67.59 -40.99 84.77 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 122.899 0.479 . . . . 0.0 110.403 -176.195 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.8 pp0? -71.6 -31.26 66.72 Favored 'General case' 0 N--CA 1.457 -0.121 0 CA-C-N 118.614 0.643 . . . . 0.0 110.127 177.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 20.2 tp10 -65.41 -48.27 73.37 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 176.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 10.3 tt -57.1 -44.88 83.63 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.266 0.626 . . . . 0.0 110.374 178.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 4.8 t -60.55 -48.6 87.84 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 123.056 0.542 . . . . 0.0 110.392 176.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.4 -20.94 66.2 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 118.839 0.745 . . . . 0.0 112.843 -175.214 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 57.5 mmtt -60.62 -35.55 76.43 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 118.386 0.539 . . . . 0.0 111.1 169.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 94.2 m-70 -97.7 -22.49 16.41 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.647 0.779 . . . . 0.0 112.697 -172.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 70.7 mt . . . . . 0 C--O 1.247 0.959 0 CA-C-O 118.237 -0.887 . . . . 0.0 109.485 172.409 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.9 mmt . . . . . 0 N--CA 1.48 1.037 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -153.75 144.11 22.3 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 169.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 89.6 mt -77.39 146.89 7.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 35.8 t -100.81 165.99 2.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 125.691 1.596 . . . . 0.0 107.897 -174.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.31 141.65 50.58 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 177.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -151.73 168.09 26.15 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 122.979 0.511 . . . . 0.0 111.569 176.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 40.0 p -140.55 -176.45 4.64 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.981 2.113 . . . . 0.0 107.204 174.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -48.97 -32.63 9.46 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.687 1.195 . . . . 0.0 113.256 179.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 27.3 mp0 -61.13 -32.85 72.55 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 126.233 1.813 . . . . 0.0 112.5 -177.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 12.3 m -143.78 -6.57 0.77 Allowed 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 115.12 1.526 . . . . 0.0 115.12 -169.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -55.62 -36.1 66.59 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 119.856 1.207 . . . . 0.0 110.98 178.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.0 m -68.71 -38.86 80.56 Favored 'General case' 0 N--CA 1.453 -0.306 0 O-C-N 122.226 -0.296 . . . . 0.0 111.22 -178.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.61 -46.2 76.64 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 175.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -64.03 -38.51 91.33 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 122.995 0.518 . . . . 0.0 111.311 -175.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.409 ' HA ' HG21 ' A' ' 20' ' ' VAL . 29.4 p -79.12 0.73 26.97 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -177.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 59.9 m -112.23 33.16 5.04 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.171 0.988 . . . . 0.0 112.044 -171.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 59.3 mt-10 -132.1 -3.24 3.55 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 -176.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 167.45 -162.3 36.1 Favored Glycine 0 C--N 1.334 0.443 0 CA-C-N 119.346 0.976 . . . . 0.0 111.046 -172.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 40.3 t -74.27 127.56 36.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 N-CA-C 105.55 -2.019 . . . . 0.0 105.55 167.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.409 HG21 ' HA ' ' A' ' 15' ' ' THR . 24.8 t -137.18 115.13 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 -175.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 8.2 tt -88.01 147.01 25.2 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 168.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -132.56 153.35 51.07 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 177.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -132.92 99.12 4.49 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 -178.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -76.37 112.5 12.95 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 173.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 7.1 p-90 -139.36 174.75 10.19 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 123.132 0.573 . . . . 0.0 111.934 -168.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -153.67 147.42 18.53 Favored Pre-proline 0 CA--C 1.538 0.515 0 C-N-CA 125.276 1.43 . . . . 0.0 107.527 168.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.03 -20.57 14.77 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.807 2.338 . . . . 0.0 113.272 -170.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -78.83 -8.21 58.6 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 121.595 -0.691 . . . . 0.0 111.975 178.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 44.5 t -92.94 117.45 30.07 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -53.91 -58.1 13.86 Favored Glycine 0 CA--C 1.531 1.049 0 CA-C-O 118.727 -1.041 . . . . 0.0 112.152 177.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -51.19 -33.33 43.93 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 123.457 2.771 . . . . 0.0 115.607 178.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 90.6 m -60.31 -37.66 81.28 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 119.729 1.15 . . . . 0.0 111.668 174.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 43.2 mtmt -78.61 -33.54 47.33 Favored 'General case' 0 C--N 1.333 -0.118 0 O-C-N 121.764 -0.585 . . . . 0.0 109.98 177.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 26.5 mmt -65.32 -38.73 91.06 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 119.12 0.873 . . . . 0.0 111.439 177.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 12.0 tt -78.17 -14.86 14.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-N 118.877 0.762 . . . . 0.0 111.379 179.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.06 -49.88 89.63 Favored Pre-proline 0 CA--C 1.541 0.62 0 CA-C-O 117.437 -1.268 . . . . 0.0 113.545 -177.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -64.16 -28.49 64.84 Favored 'Trans proline' 0 C--N 1.351 0.662 0 CA-C-N 121.952 1.733 . . . . 0.0 112.401 176.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.2 t -68.37 -39.39 80.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 119.256 0.935 . . . . 0.0 109.457 176.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 48.4 mt -67.69 -34.88 77.77 Favored 'General case' 0 C--O 1.226 -0.15 0 O-C-N 121.517 -0.74 . . . . 0.0 110.636 174.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -68.29 -33.92 75.23 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 119.262 0.937 . . . . 0.0 111.44 173.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 50.2 mm-40 -62.32 -45.61 92.43 Favored 'General case' 0 N--CA 1.457 -0.094 0 O-C-N 120.922 -1.112 . . . . 0.0 109.583 170.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -63.86 -35.34 80.3 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 118.827 0.74 . . . . 0.0 111.668 176.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -66.35 -36.73 83.64 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 119.055 0.843 . . . . 0.0 111.035 177.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -69.8 -44.96 68.97 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 121.643 -0.661 . . . . 0.0 110.907 175.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -81.22 -33.6 32.77 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.983 0.913 . . . . 0.0 112.114 -169.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 52.2 mtt -140.62 -2.94 1.33 Allowed 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.541 1.136 . . . . 0.0 112.884 -169.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -75.14 47.55 1.97 Allowed Glycine 0 CA--C 1.528 0.885 0 C-N-CA 125.671 1.605 . . . . 0.0 113.517 -173.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -150.66 -40.71 0.13 Allowed 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 128.999 2.919 . . . . 0.0 107.176 169.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -63.55 -32.68 74.21 Favored 'General case' 0 C--N 1.343 0.314 0 C-N-CA 124.472 1.109 . . . . 0.0 110.546 168.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -135.67 160.95 36.93 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 125.719 1.608 . . . . 0.0 110.193 172.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -98.73 151.15 21.07 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.968 1.307 . . . . 0.0 107.879 171.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 15.7 mt -122.5 133.8 67.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 N-CA-C 105.839 -1.912 . . . . 0.0 105.839 174.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 8.0 t -128.4 116.12 40.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 C-N-CA 123.396 0.679 . . . . 0.0 109.556 -176.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 64.7 mmtt -75.14 140.41 43.35 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 168.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 8.3 tt -150.89 125.94 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -96.95 123.96 40.8 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 121.044 -1.035 . . . . 0.0 110.382 -168.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 23.3 m -61.67 -22.76 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -171.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -73.33 -28.83 62.29 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 120.052 1.296 . . . . 0.0 110.775 175.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -92.81 -33.98 14.05 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.446 1.099 . . . . 0.0 111.158 -171.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -112.59 33.76 4.76 Favored 'General case' 0 C--O 1.222 -0.344 0 C-N-CA 125.039 1.336 . . . . 0.0 109.914 -177.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.84 -39.89 54.54 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.542 1.137 . . . . 0.0 111.89 -175.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -65.23 -48.82 72.0 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.305 1.042 . . . . 0.0 111.656 174.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.34 -40.48 81.53 Favored 'General case' 0 C--O 1.223 -0.304 0 C-N-CA 123.906 0.882 . . . . 0.0 110.828 -175.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -61.97 -42.95 99.7 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.294 -0.879 . . . . 0.0 109.26 174.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -57.1 -27.42 57.33 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 123.963 0.792 . . . . 0.0 113.137 172.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 14.2 ttmm -60.84 -21.85 63.62 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 118.747 1.274 . . . . 0.0 111.451 176.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -120.06 9.8 11.28 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.206 1.403 . . . . 0.0 110.624 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 68.76 22.74 75.58 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 124.407 1.003 . . . . 0.0 113.33 -177.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 89.8 t -91.58 125.48 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 -179.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 5.9 mmt -148.63 26.85 0.92 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.714 1.605 . . . . 0.0 109.437 169.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 22.3 m -141.1 152.91 45.14 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 126.318 1.847 . . . . 0.0 107.167 -179.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -144.82 156.99 55.55 Favored Pre-proline 0 CA--C 1.54 0.583 0 C-N-CA 123.885 0.874 . . . . 0.0 110.262 -171.155 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -67.8 138.88 45.56 Favored 'Cis proline' 0 C--N 1.349 0.566 0 CA-C-N 119.788 0.96 . . . . 0.0 109.649 -10.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 54.5 m -130.16 118.08 20.89 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 174.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 61.1 mt -90.21 144.03 26.23 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 174.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.5 mp -124.65 155.91 38.39 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 169.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.462 HG11 ' CD2' ' A' ' 103' ' ' HIS . 94.1 t -126.67 130.46 71.63 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 N-CA-C 104.077 -2.564 . . . . 0.0 104.077 168.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.1 mp -127.13 156.23 42.09 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 126.234 1.814 . . . . 0.0 106.732 176.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 75.1 tttt -147.17 119.93 8.64 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 -177.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.7 t70 47.39 35.81 4.36 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.16 1.384 . . . . 0.0 113.588 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 108.88 -2.64 31.83 Favored Glycine 0 CA--C 1.527 0.781 0 CA-C-O 118.154 -1.359 . . . . 0.0 115.971 168.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -129.96 144.43 51.32 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 119.943 1.871 . . . . 0.0 110.208 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.7 p -66.79 138.1 23.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 C-N-CA 123.865 0.866 . . . . 0.0 108.765 173.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 35.7 m -129.12 -17.55 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 C-N-CA 125.346 1.459 . . . . 0.0 110.803 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.34 162.97 40.86 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 119.898 1.226 . . . . 0.0 111.559 172.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 85.1 m -151.08 142.12 23.06 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.118 1.767 . . . . 0.0 108.61 176.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 15.1 m -148.85 155.98 41.68 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.588 1.555 . . . . 0.0 108.869 -178.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 37.1 t -132.89 147.98 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 -174.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.75 175.47 49.39 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 124.426 1.012 . . . . 0.0 112.028 177.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -59.91 155.03 17.35 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.281 1.033 . . . . 0.0 110.566 174.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -141.44 145.65 38.79 Favored Pre-proline 0 C--O 1.233 0.235 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 168.003 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -71.89 160.43 47.81 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 122.62 2.213 . . . . 0.0 109.832 169.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -55.26 -47.52 75.34 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 118.742 -0.647 . . . . 0.0 111.116 -178.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -63.62 -43.5 96.68 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 118.555 0.616 . . . . 0.0 110.679 -170.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.98 -43.44 92.62 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 122.802 0.441 . . . . 0.0 110.743 176.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 45.2 tp -66.44 -42.36 87.75 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 119.307 -0.378 . . . . 0.0 110.346 -177.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.5 pp0? -72.62 -29.24 63.31 Favored 'General case' 0 C--N 1.337 0.064 0 CA-C-N 118.89 0.768 . . . . 0.0 110.505 179.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -65.89 -49.24 68.75 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 174.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 58.8 tp -55.58 -44.45 76.9 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.361 0.664 . . . . 0.0 110.454 178.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.434 ' HA ' ' NE2' ' A' ' 103' ' ' HIS . 48.5 t -68.53 -49.32 66.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 CA-C-O 119.538 -0.268 . . . . 0.0 110.52 -178.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -62.43 -27.18 68.92 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 119.143 0.883 . . . . 0.0 112.004 -173.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -65.15 -20.6 66.53 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 117.703 -1.141 . . . . 0.0 113.196 174.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.462 ' CD2' HG11 ' A' ' 77' ' ' VAL . 8.1 p80 -116.55 2.37 13.04 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 120.32 1.418 . . . . 0.0 113.511 -179.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 80.8 mt . . . . . 0 C--O 1.248 1.012 0 CA-C-N 119.764 1.166 . . . . 0.0 108.144 170.225 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.3 mpp? . . . . . 0 N--CA 1.482 1.17 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -157.8 144.08 17.59 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 125.263 1.425 . . . . 0.0 107.294 168.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 93.7 mt -75.34 153.67 6.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 174.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 32.5 t -123.43 167.03 17.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 -173.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.5 mtmt -135.19 145.38 47.65 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 175.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -147.79 171.02 16.36 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.291 0.636 . . . . 0.0 110.083 176.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.414 HG22 HD21 ' A' ' 60' ' ' ASN . 81.3 p -133.79 178.33 7.03 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 171.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -47.25 -30.49 3.07 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 119.906 1.23 . . . . 0.0 113.187 176.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -58.3 -34.38 70.49 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.691 1.596 . . . . 0.0 112.752 179.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 12.8 m -145.42 -2.83 0.75 Allowed 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 114.833 1.42 . . . . 0.0 114.833 -169.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -54.08 -36.82 63.56 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 119.186 0.903 . . . . 0.0 111.005 178.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.3 m -67.47 -38.67 84.78 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 122.472 0.309 . . . . 0.0 111.387 -178.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.42 -45.25 76.65 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 175.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -64.94 -37.55 88.0 Favored 'General case' 0 C--O 1.231 0.121 0 C-N-CA 122.451 0.3 . . . . 0.0 111.381 -176.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.527 ' HA ' HG21 ' A' ' 20' ' ' VAL . 22.4 p -76.48 -1.65 28.29 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 71.1 m -107.72 33.55 4.01 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.55 1.14 . . . . 0.0 111.977 -171.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -133.39 1.53 3.45 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -177.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 165.66 -165.67 38.08 Favored Glycine 0 C--N 1.336 0.563 0 CA-C-O 118.796 -1.002 . . . . 0.0 111.242 -176.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 88.9 t -73.87 134.25 29.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 N-CA-C 103.678 -2.712 . . . . 0.0 103.678 166.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.527 HG21 ' HA ' ' A' ' 15' ' ' THR . 39.4 t -134.65 117.57 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 -175.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 62.3 tp -87.85 97.33 10.86 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 173.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.59 146.41 40.41 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 170.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -133.93 94.52 3.28 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 124.818 1.247 . . . . 0.0 107.735 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -71.29 113.36 8.24 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 106.301 -1.741 . . . . 0.0 106.301 172.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 6.3 p-90 -138.26 175.12 9.85 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 123.333 0.653 . . . . 0.0 110.962 -169.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -152.16 146.26 18.34 Favored Pre-proline 0 CA--C 1.536 0.431 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 168.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.31 -17.99 18.44 Favored 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 122.833 2.356 . . . . 0.0 113.377 -171.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -82.29 -8.53 59.64 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 121.53 -0.731 . . . . 0.0 111.997 176.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 42.0 t -88.12 126.32 35.05 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -61.42 -59.6 9.63 Favored Glycine 0 CA--C 1.531 1.083 0 CA-C-O 118.491 -1.172 . . . . 0.0 111.661 177.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_exo -49.04 -37.87 38.51 Favored 'Trans proline' 0 CA--C 1.535 0.566 0 C-N-CA 123.683 2.922 . . . . 0.0 115.094 177.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 86.1 m -59.17 -34.16 71.79 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 119.244 0.929 . . . . 0.0 112.793 175.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -84.94 -34.89 22.39 Favored 'General case' 0 N--CA 1.461 0.093 0 CA-C-O 118.942 -0.552 . . . . 0.0 109.996 176.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 85.1 mtp -60.92 -38.56 86.22 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 118.853 0.752 . . . . 0.0 110.993 177.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.0 tt -78.77 -14.62 13.68 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-N 118.549 0.613 . . . . 0.0 111.787 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.58 -50.84 84.65 Favored Pre-proline 0 CA--C 1.544 0.725 0 CA-C-N 120.116 1.325 . . . . 0.0 113.393 -177.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -64.88 -29.24 58.46 Favored 'Trans proline' 0 C--N 1.35 0.645 0 CA-C-N 121.887 1.709 . . . . 0.0 112.179 176.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.5 t -66.11 -42.68 91.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 123.425 0.69 . . . . 0.0 109.327 177.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 85.3 mt -65.62 -36.1 82.73 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 118.715 -0.66 . . . . 0.0 110.432 174.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -65.86 -36.6 83.9 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 119.534 1.061 . . . . 0.0 111.511 175.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -64.94 -43.52 92.49 Favored 'General case' 0 CA--C 1.529 0.146 0 O-C-N 121.162 -0.962 . . . . 0.0 110.086 173.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 31.6 tp -64.58 -38.87 92.5 Favored 'General case' 0 CA--C 1.532 0.276 0 O-C-N 122.252 -0.28 . . . . 0.0 110.522 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -64.32 -43.61 94.15 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 124.164 0.985 . . . . 0.0 110.476 177.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -61.68 -29.07 69.85 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 121.482 -0.761 . . . . 0.0 111.796 174.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -89.88 -35.53 15.57 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.907 0.883 . . . . 0.0 112.698 -174.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 40.6 mtt -136.5 -0.24 2.43 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -169.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -70.19 42.28 0.5 Allowed Glycine 0 CA--C 1.535 1.306 0 C-N-CA 126.914 2.197 . . . . 0.0 115.856 -169.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -143.21 -43.6 0.29 Allowed 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 126.849 2.06 . . . . 0.0 108.789 168.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 58.6 mtmt -72.06 -20.63 61.64 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.73 0.812 . . . . 0.0 111.28 169.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.9 tp -133.32 153.21 51.78 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 128.584 2.753 . . . . 0.0 106.704 -177.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -118.61 154.87 31.94 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 168.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 21.7 mt -122.37 134.7 64.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 104.921 -2.252 . . . . 0.0 104.921 172.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 79.3 t -128.9 109.75 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 -177.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -70.42 138.95 51.67 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 169.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 13.2 tt -144.85 108.25 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 176.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 62.6 t0 -78.44 115.37 18.11 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 123.631 0.772 . . . . 0.0 109.012 -175.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 29.4 m -60.76 -24.85 33.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 123.0 0.52 . . . . 0.0 112.278 -176.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -72.59 -0.79 13.83 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.804 0.842 . . . . 0.0 112.292 179.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -131.07 7.36 4.65 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.189 1.396 . . . . 0.0 110.591 170.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.414 HD21 HG22 ' A' ' 7' ' ' THR . 63.4 m-80 -142.41 44.94 1.64 Allowed 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.599 1.16 . . . . 0.0 110.318 -168.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.498 ' NE2' ' H ' ' A' ' 61' ' ' GLN . 0.4 OUTLIER -56.09 -47.6 77.73 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.266 1.027 . . . . 0.0 108.764 176.885 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 38.5 mp0 -67.17 -47.8 69.9 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 125.231 1.412 . . . . 0.0 109.411 -175.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.53 -47.57 72.48 Favored 'General case' 0 C--O 1.222 -0.356 0 C-N-CA 122.759 0.424 . . . . 0.0 110.168 -176.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.2 -44.03 96.5 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 119.004 0.82 . . . . 0.0 109.313 -179.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -58.1 -27.44 59.96 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 123.948 0.785 . . . . 0.0 112.923 174.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 31.1 ttmt -59.1 -26.21 64.48 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 118.615 1.208 . . . . 0.0 111.448 177.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -117.01 11.56 14.31 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.698 1.199 . . . . 0.0 111.097 179.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 69.82 22.73 77.02 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 124.265 0.936 . . . . 0.0 113.163 -178.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 97.9 t -93.06 135.04 28.9 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 179.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -155.35 28.0 0.4 Allowed 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.33 1.052 . . . . 0.0 109.686 168.104 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 22.8 m -139.06 152.66 47.73 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 126.407 1.883 . . . . 0.0 106.819 178.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -144.13 157.08 57.76 Favored Pre-proline 0 CA--C 1.542 0.641 0 CA-C-O 118.392 -0.813 . . . . 0.0 110.176 -169.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -67.54 137.97 40.35 Favored 'Cis proline' 0 C--N 1.349 0.59 0 CA-C-N 119.933 1.012 . . . . 0.0 109.84 -10.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 53.1 m -129.67 119.5 23.62 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 174.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 96.4 mt -96.61 133.71 40.76 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.6 mp -119.53 130.66 55.29 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 105.203 -2.147 . . . . 0.0 105.203 169.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 16.5 t -93.63 121.35 44.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 103.286 -2.857 . . . . 0.0 103.286 169.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.8 mp -112.23 160.68 17.38 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 170.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -142.28 129.85 21.41 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 169.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.9 t70 42.85 37.55 1.11 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.183 1.393 . . . . 0.0 113.62 175.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 109.81 -6.67 31.26 Favored Glycine 0 CA--C 1.528 0.863 0 CA-C-O 117.97 -1.461 . . . . 0.0 115.482 169.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -132.04 148.41 52.5 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 120.316 2.058 . . . . 0.0 110.901 -175.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.3 t -67.35 137.95 23.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 176.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 35.7 m -127.42 -18.68 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 125.451 1.5 . . . . 0.0 111.051 176.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.62 170.47 22.33 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 120.099 1.318 . . . . 0.0 110.977 171.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 99.4 m -147.51 150.63 34.92 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 125.587 1.555 . . . . 0.0 109.075 177.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 58.6 m -150.06 159.25 44.55 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.931 1.692 . . . . 0.0 108.791 171.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 34.9 t -133.17 145.1 34.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 179.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 85.44 177.18 50.55 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 123.709 0.671 . . . . 0.0 111.897 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -62.83 146.95 51.45 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.049 0.939 . . . . 0.0 110.354 177.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 68.0 mttt -143.78 143.17 22.32 Favored Pre-proline 0 CA--C 1.533 0.306 0 C-N-CA 124.989 1.316 . . . . 0.0 107.714 169.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -74.49 159.85 42.43 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 123.221 2.614 . . . . 0.0 110.691 177.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.9 tmpt? -61.02 -34.44 74.83 Favored 'General case' 0 C--O 1.225 -0.205 0 O-C-N 121.453 -0.779 . . . . 0.0 111.222 -175.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -62.5 -37.42 85.95 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.924 0.783 . . . . 0.0 111.561 178.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.18 -42.89 71.83 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 118.068 0.394 . . . . 0.0 110.442 174.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 91.1 mt -64.75 -41.6 95.78 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-O 119.263 -0.398 . . . . 0.0 110.622 -178.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.2 pp0? -70.25 -31.76 69.3 Favored 'General case' 0 CA--C 1.527 0.073 0 CA-C-N 118.83 0.741 . . . . 0.0 110.305 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -65.37 -49.59 68.73 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 175.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 59.2 tp -56.66 -43.43 80.37 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.945 0.898 . . . . 0.0 110.748 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 43.8 t -68.13 -49.18 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 CA-C-O 118.668 -0.682 . . . . 0.0 110.365 178.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.35 -26.1 68.32 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 120.005 1.275 . . . . 0.0 112.431 -175.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 39.8 mmtm -64.84 -17.05 63.92 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 118.029 -0.986 . . . . 0.0 113.073 171.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 92.0 m-70 -118.45 -12.49 9.83 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 119.777 1.171 . . . . 0.0 113.656 179.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 60.2 mt . . . . . 0 C--O 1.248 1.019 0 CA-C-N 120.464 1.484 . . . . 0.0 109.786 172.737 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.1 ttt . . . . . 0 N--CA 1.483 1.22 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -163.13 162.37 25.6 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 125.536 1.534 . . . . 0.0 108.768 178.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 83.7 mt -75.66 154.18 6.15 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 172.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 42.2 t -131.9 170.59 19.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 125.949 1.699 . . . . 0.0 106.917 -174.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 34.0 ttmt -141.93 147.62 37.34 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 176.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -150.78 173.51 14.12 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 123.725 0.81 . . . . 0.0 110.236 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 76.6 p -131.59 175.13 9.43 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.137 1.375 . . . . 0.0 107.298 172.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -51.78 -30.48 23.09 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 120.134 1.333 . . . . 0.0 112.886 -176.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 25.3 mp0 -65.32 -27.96 68.97 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.738 2.015 . . . . 0.0 113.353 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 36.8 p -133.11 -15.87 2.53 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 114.317 1.228 . . . . 0.0 114.317 -168.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -54.2 -34.7 61.21 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 125.402 1.481 . . . . 0.0 111.019 178.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.4 p -64.89 -49.36 70.79 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 123.589 0.756 . . . . 0.0 110.949 -179.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.78 -44.78 96.34 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 122.908 0.483 . . . . 0.0 109.791 177.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -66.11 -37.89 86.87 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 119.263 -0.399 . . . . 0.0 111.616 -176.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.507 ' HA ' HG21 ' A' ' 20' ' ' VAL . 28.1 p -78.82 -1.48 35.06 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 118.67 0.668 . . . . 0.0 112.473 -178.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 59.1 m -106.06 33.0 4.02 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.421 1.089 . . . . 0.0 111.761 -171.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -133.06 -0.22 3.38 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -177.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 167.21 -167.35 39.8 Favored Glycine 0 C--N 1.337 0.614 0 CA-C-N 119.413 1.006 . . . . 0.0 111.563 -174.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 68.9 t -73.77 125.9 33.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 104.601 -2.37 . . . . 0.0 104.601 166.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.507 HG21 ' HA ' ' A' ' 15' ' ' THR . 35.3 t -129.86 120.93 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 -174.074 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -94.01 105.66 17.66 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 105.851 -1.907 . . . . 0.0 105.851 -179.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -94.9 102.55 14.4 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -177.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -82.4 95.25 7.6 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 123.862 0.865 . . . . 0.0 108.705 175.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 45.8 m-85 -75.53 116.72 16.55 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 169.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 7.5 p-90 -141.61 176.81 8.6 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 123.498 0.719 . . . . 0.0 111.498 -170.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -153.68 146.29 17.48 Favored Pre-proline 0 CA--C 1.538 0.509 0 C-N-CA 124.856 1.262 . . . . 0.0 107.717 168.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.92 -19.02 16.37 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.882 2.388 . . . . 0.0 113.264 -171.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -78.74 -7.13 57.46 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 118.689 0.677 . . . . 0.0 112.067 177.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 46.6 t -94.98 119.1 32.93 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -178.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -55.47 -58.35 14.34 Favored Glycine 0 CA--C 1.531 1.076 0 CA-C-O 118.56 -1.133 . . . . 0.0 111.779 176.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_exo -49.45 -34.7 33.96 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 123.665 2.91 . . . . 0.0 115.603 177.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 92.7 m -60.6 -44.16 96.58 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 119.78 1.173 . . . . 0.0 111.423 173.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 45.2 mtmt -72.27 -30.91 65.28 Favored 'General case' 0 CA--C 1.529 0.146 0 O-C-N 121.682 -0.636 . . . . 0.0 110.427 178.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 63.0 mtt -67.48 -40.98 85.3 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 118.766 0.712 . . . . 0.0 111.302 176.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.7 tt -78.54 -19.25 13.31 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-N 119.168 0.895 . . . . 0.0 111.415 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.18 -51.01 72.28 Favored Pre-proline 0 CA--C 1.546 0.823 0 CA-C-N 119.895 1.225 . . . . 0.0 114.011 -178.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -65.5 -28.56 53.62 Favored 'Trans proline' 0 C--N 1.351 0.663 0 CA-C-N 121.897 1.713 . . . . 0.0 112.44 175.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 6.6 t -67.33 -37.58 79.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 118.903 0.774 . . . . 0.0 109.542 175.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 96.0 mt -67.74 -34.64 77.24 Favored 'General case' 0 C--O 1.226 -0.136 0 O-C-N 121.493 -0.754 . . . . 0.0 110.685 172.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -64.13 -38.29 90.54 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 119.758 1.163 . . . . 0.0 111.229 172.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -65.94 -37.88 87.17 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 121.092 -1.005 . . . . 0.0 110.384 173.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 46.7 tp -66.6 -36.37 82.45 Favored 'General case' 0 C--O 1.227 -0.13 0 CA-C-N 118.56 0.618 . . . . 0.0 110.512 177.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -65.71 -41.5 92.24 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 118.953 0.797 . . . . 0.0 110.28 174.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -63.9 -29.72 70.87 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 121.796 -0.565 . . . . 0.0 112.13 174.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -87.47 -39.32 15.31 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.141 0.976 . . . . 0.0 112.215 -175.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 16.5 mmt -133.58 -1.27 3.13 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 124.527 1.131 . . . . 0.0 113.76 -167.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -62.1 -7.56 13.67 Favored Glycine 0 CA--C 1.535 1.297 0 CA-C-N 121.193 1.815 . . . . 0.0 114.419 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -79.57 -22.29 43.98 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.674 1.99 . . . . 0.0 112.11 173.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -130.4 -10.03 4.13 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 126.46 1.904 . . . . 0.0 111.465 -171.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -135.74 164.08 28.72 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 126.515 1.926 . . . . 0.0 108.306 -177.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -121.54 142.05 50.45 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 169.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 17.0 mt -105.71 137.78 34.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 105.139 -2.171 . . . . 0.0 105.139 170.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 90.2 t -127.38 114.49 36.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 105.785 -1.931 . . . . 0.0 105.785 175.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.65 141.23 44.63 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 169.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 11.8 tt -151.63 125.58 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 175.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -81.97 129.22 34.72 Favored 'General case' 0 N--CA 1.466 0.325 0 O-C-N 121.586 -0.696 . . . . 0.0 109.446 -178.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 15.4 m -67.81 -34.34 66.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -174.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -76.52 -34.58 58.57 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 119.055 0.843 . . . . 0.0 109.768 -174.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -73.04 -16.21 61.5 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.668 0.787 . . . . 0.0 111.958 172.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 62.7 m-80 -140.22 50.85 1.7 Allowed 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 119.312 0.96 . . . . 0.0 111.182 -168.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -57.2 -36.8 71.31 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.533 0.733 . . . . 0.0 109.68 178.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -64.02 -28.51 69.85 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 125.095 1.358 . . . . 0.0 112.466 -178.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.418 ' HA ' ' HE2' ' A' ' 66' ' ' LYS . 0.2 OUTLIER -92.3 -45.65 8.1 Favored 'General case' 0 C--O 1.222 -0.346 0 CA-C-N 118.573 0.624 . . . . 0.0 109.991 179.542 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.53 -45.75 89.17 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 119.484 1.038 . . . . 0.0 110.073 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -62.74 -21.91 63.58 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 124.195 0.902 . . . . 0.0 112.571 175.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.418 ' HE2' ' HA ' ' A' ' 63' ' ' THR . 5.5 ttmm -59.32 -22.07 60.71 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 118.52 1.16 . . . . 0.0 111.617 174.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -121.46 11.34 10.65 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.917 1.287 . . . . 0.0 110.728 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 68.19 27.32 73.77 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 124.147 0.88 . . . . 0.0 112.801 -177.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 65.7 t -100.8 135.71 35.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.54 28.5 0.44 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.546 1.138 . . . . 0.0 109.466 168.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 42.2 m -133.52 156.49 47.69 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 126.257 1.823 . . . . 0.0 107.262 175.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -145.8 159.15 48.02 Favored Pre-proline 0 CA--C 1.539 0.541 0 C-N-CA 124.243 1.017 . . . . 0.0 110.205 -169.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.5 140.05 50.77 Favored 'Cis proline' 0 C--N 1.349 0.583 0 CA-C-N 119.938 1.014 . . . . 0.0 109.923 -10.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 61.5 m -135.0 129.03 33.52 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 106.395 -1.706 . . . . 0.0 106.395 177.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 56.3 mt -108.72 104.07 13.28 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 105.903 -1.888 . . . . 0.0 105.903 -177.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -78.76 141.95 37.39 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 105.374 -2.084 . . . . 0.0 105.374 168.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.2 t -118.95 116.82 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 N-CA-C 103.378 -2.823 . . . . 0.0 103.378 174.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 8.1 mp -111.85 159.86 17.93 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 175.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -141.7 127.9 19.76 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 170.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.8 t70 43.74 38.61 2.09 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.062 1.345 . . . . 0.0 113.323 175.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 104.64 -4.78 43.21 Favored Glycine 0 CA--C 1.53 0.969 0 CA-C-O 117.962 -1.466 . . . . 0.0 115.169 169.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -130.92 150.42 52.09 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 120.269 2.034 . . . . 0.0 110.98 -176.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.2 p -66.08 140.15 20.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 C-N-CA 123.803 0.841 . . . . 0.0 109.476 177.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 28.4 m -127.16 -19.54 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 C-N-CA 125.479 1.512 . . . . 0.0 110.865 173.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.87 168.33 26.03 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 120.399 1.454 . . . . 0.0 111.382 169.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 60.8 m -143.63 136.04 27.03 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.023 1.729 . . . . 0.0 107.216 169.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 38.4 m -140.57 152.51 45.55 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.92 1.288 . . . . 0.0 108.436 -177.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 38.5 t -133.48 147.53 31.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 -171.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.02 174.35 49.54 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 124.25 0.929 . . . . 0.0 112.229 175.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -61.33 148.09 42.52 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 123.784 0.834 . . . . 0.0 110.744 179.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -152.11 142.2 14.87 Favored Pre-proline 0 CA--C 1.533 0.324 0 C-N-CA 125.922 1.689 . . . . 0.0 106.999 -178.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -74.4 156.77 45.69 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 122.44 2.093 . . . . 0.0 110.612 174.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.5 tmpt? -58.31 -36.43 73.34 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 123.636 0.774 . . . . 0.0 110.982 -179.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 23.7 tp10 -65.91 -36.71 84.15 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 118.506 0.594 . . . . 0.0 111.441 -174.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.02 -42.96 79.87 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 122.926 0.49 . . . . 0.0 110.681 174.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 91.3 mt -65.68 -43.98 87.64 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 119.096 -0.478 . . . . 0.0 110.123 -177.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.8 pp0? -68.21 -30.0 68.97 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 118.909 0.777 . . . . 0.0 110.543 179.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -65.99 -50.22 65.04 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 175.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 54.9 tp -56.92 -44.32 82.31 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.063 0.545 . . . . 0.0 110.648 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 42.7 t -63.36 -50.73 77.53 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 C-N-CA 123.461 0.704 . . . . 0.0 109.717 178.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -65.66 -26.19 67.69 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 119.386 0.994 . . . . 0.0 112.403 -175.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -67.22 -36.71 82.24 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 118.78 -0.629 . . . . 0.0 111.214 170.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 79.8 m-70 -80.64 -24.51 38.97 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 118.078 -0.963 . . . . 0.0 113.378 178.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 65.8 mt . . . . . 0 C--O 1.248 1.015 0 CA-C-N 119.707 1.14 . . . . 0.0 110.155 177.699 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.7 mmt . . . . . 0 N--CA 1.485 1.298 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -149.66 158.48 44.21 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 124.993 1.317 . . . . 0.0 108.563 174.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 84.5 mt -71.42 150.23 9.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 124.5 1.12 . . . . 0.0 108.15 178.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 23.3 t -105.85 160.69 5.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 125.573 1.549 . . . . 0.0 107.379 -175.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.41 140.48 52.65 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 176.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -136.98 172.24 13.31 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.041 0.937 . . . . 0.0 110.498 179.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.0 p -129.6 173.56 10.49 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 125.739 1.616 . . . . 0.0 107.861 178.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -52.34 -35.56 51.23 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 119.509 1.049 . . . . 0.0 111.721 174.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 5.4 mp0 -75.86 -31.25 59.21 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -177.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 32.6 p -110.83 -14.93 13.91 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 -169.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -51.0 -39.56 56.03 Favored 'General case' 0 C--N 1.334 -0.078 0 C-N-CA 124.573 1.149 . . . . 0.0 110.224 173.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.2 m -74.09 -23.19 59.3 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -174.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.88 -48.39 18.45 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 169.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -66.96 -36.39 82.1 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 122.807 0.443 . . . . 0.0 111.965 -170.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 42.9 p -82.85 7.8 14.21 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 112.527 0.565 . . . . 0.0 112.527 -176.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 40.8 m -121.68 34.57 5.14 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.596 0.758 . . . . 0.0 112.216 -169.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -135.39 1.75 2.92 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -176.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 169.0 -165.86 39.25 Favored Glycine 0 C--N 1.333 0.408 0 N-CA-C 110.409 -1.076 . . . . 0.0 110.409 -171.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.435 HG22 ' HE3' ' A' ' 79' ' ' LYS . 1.5 t -78.82 133.01 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 N-CA-C 104.324 -2.473 . . . . 0.0 104.324 168.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 23.8 t -139.63 146.15 25.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 -173.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 9.0 tt -122.55 135.87 54.74 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 105.807 -1.923 . . . . 0.0 105.807 169.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -129.67 121.3 26.7 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 -174.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -96.08 102.55 14.36 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 125.504 1.522 . . . . 0.0 108.585 -177.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -76.41 116.84 17.48 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 169.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 6.9 p-90 -145.88 178.82 7.89 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.619 0.767 . . . . 0.0 110.898 -169.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -158.51 150.28 17.08 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 125.606 1.562 . . . . 0.0 107.054 167.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.18 -18.72 20.7 Favored 'Trans proline' 0 CA--C 1.532 0.417 0 C-N-CA 122.754 2.303 . . . . 0.0 113.478 -170.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -79.39 -11.12 59.93 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 118.94 0.791 . . . . 0.0 112.483 176.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 45.8 t -85.53 119.26 25.68 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -57.01 -58.26 15.51 Favored Glycine 0 CA--C 1.531 1.093 0 CA-C-O 118.622 -1.099 . . . . 0.0 111.632 174.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -49.95 -36.14 42.95 Favored 'Trans proline' 0 CA--C 1.536 0.618 0 C-N-CA 123.571 2.848 . . . . 0.0 115.309 176.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 98.4 m -59.39 -46.06 89.73 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 119.87 1.214 . . . . 0.0 111.306 173.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 46.1 mtmt -70.35 -30.26 67.16 Favored 'General case' 0 N--CA 1.462 0.168 0 O-C-N 121.511 -0.743 . . . . 0.0 110.844 178.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 87.2 mtp -67.32 -43.08 82.5 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 118.922 0.783 . . . . 0.0 110.98 175.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 8.3 tt -78.84 -18.91 13.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-N 119.048 0.84 . . . . 0.0 111.378 -178.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.33 -52.44 59.28 Favored Pre-proline 0 CA--C 1.544 0.743 0 CA-C-O 117.5 -1.238 . . . . 0.0 113.986 -178.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.03 -30.35 56.53 Favored 'Trans proline' 0 C--N 1.349 0.58 0 CA-C-N 121.931 1.725 . . . . 0.0 112.103 177.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 6.3 t -64.82 -42.68 95.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 118.762 0.71 . . . . 0.0 109.085 176.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 61.1 mt -67.14 -34.97 78.71 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 118.603 -0.713 . . . . 0.0 110.981 176.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -65.59 -40.39 92.64 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 119.553 1.07 . . . . 0.0 111.004 174.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -63.95 -42.87 97.18 Favored 'General case' 0 CA--C 1.53 0.188 0 O-C-N 121.405 -0.809 . . . . 0.0 109.875 174.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 25.8 tp -62.8 -39.15 93.39 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 122.845 0.458 . . . . 0.0 110.794 178.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -66.83 -38.89 87.28 Favored 'General case' 0 C--N 1.333 -0.116 0 O-C-N 121.448 -0.782 . . . . 0.0 110.856 177.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -64.45 -23.06 67.15 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 121.86 -0.525 . . . . 0.0 111.895 173.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -96.88 -30.9 12.86 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.784 1.234 . . . . 0.0 112.46 -176.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 19.0 mmt -129.73 -9.31 4.49 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 117.825 -1.084 . . . . 0.0 113.606 -168.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -48.49 -30.53 8.42 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 125.955 1.74 . . . . 0.0 115.985 -169.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -79.31 -38.63 34.82 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.296 1.038 . . . . 0.0 111.495 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -85.23 -26.17 26.86 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 124.7 1.2 . . . . 0.0 110.801 -178.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -148.44 124.39 10.66 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 125.016 1.326 . . . . 0.0 108.807 -177.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -72.36 148.14 45.58 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 176.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 22.8 mt -122.07 133.58 67.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 172.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 9.2 t -127.01 153.11 35.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 124.689 1.196 . . . . 0.0 108.196 -173.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 65.4 mmtt -118.9 141.17 48.89 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 126.085 1.754 . . . . 0.0 107.975 177.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 14.9 tt -145.54 120.8 3.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-O 121.358 0.599 . . . . 0.0 109.538 172.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -80.9 110.47 16.46 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 123.911 0.885 . . . . 0.0 108.823 -179.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 24.0 m -64.47 -25.5 38.08 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-O 118.986 -0.53 . . . . 0.0 112.427 -174.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -70.98 -12.94 61.82 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 119.14 0.882 . . . . 0.0 111.68 -178.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -120.03 -5.28 10.04 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.239 1.416 . . . . 0.0 110.979 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 60.9 m-80 -146.06 36.66 1.03 Allowed 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.217 1.007 . . . . 0.0 110.551 -168.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.2 pm0 -59.07 -25.34 63.67 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.973 0.909 . . . . 0.0 111.487 179.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 59.6 mp0 -60.13 -32.44 71.02 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.028 1.731 . . . . 0.0 111.29 175.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.39 -48.81 14.72 Favored 'General case' 0 C--O 1.223 -0.326 0 CA-C-N 118.38 0.536 . . . . 0.0 110.0 172.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.23 -45.99 89.04 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 118.798 0.726 . . . . 0.0 110.278 -171.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -61.92 -23.99 64.22 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 124.166 0.889 . . . . 0.0 112.821 176.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.6 ttmm -59.18 -28.13 66.34 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 118.612 1.206 . . . . 0.0 111.295 175.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -115.84 11.01 15.45 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.776 1.23 . . . . 0.0 111.033 178.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 70.36 18.3 75.08 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 124.603 1.096 . . . . 0.0 113.738 -178.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 98.8 t -84.12 134.23 27.43 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 176.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -155.45 32.2 0.37 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.413 1.085 . . . . 0.0 109.09 166.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 23.3 m -138.01 151.45 47.91 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 126.824 2.05 . . . . 0.0 106.245 176.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 28.2 pt -147.3 159.58 41.73 Favored Pre-proline 0 CA--C 1.542 0.669 0 C-N-CA 124.041 0.937 . . . . 0.0 109.472 -169.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -66.65 142.07 57.91 Favored 'Cis proline' 0 N--CA 1.458 -0.559 0 N-CA-C 109.529 -0.989 . . . . 0.0 109.529 -10.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 26.7 m -132.43 129.07 38.8 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 178.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 50.1 mt -112.05 109.53 19.33 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 -174.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.5 mp -87.51 151.75 22.77 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 106.171 -1.788 . . . . 0.0 106.171 167.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 15.7 t -123.78 132.12 71.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 N-CA-C 104.131 -2.544 . . . . 0.0 104.131 169.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.3 mp -132.99 160.01 38.36 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 125.918 1.687 . . . . 0.0 107.254 -175.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.435 ' HE3' HG22 ' A' ' 19' ' ' VAL . 77.1 tttt -147.2 127.52 13.94 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.1 t70 59.13 -19.26 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 128.052 2.541 . . . . 0.0 116.298 177.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 162.17 -0.91 0.06 OUTLIER Glycine 0 CA--C 1.532 1.102 0 CA-C-O 118.141 -1.366 . . . . 0.0 114.4 173.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -134.26 151.01 51.05 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 120.239 2.02 . . . . 0.0 110.45 -173.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 42.4 t -64.84 139.95 20.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 C-N-CA 124.238 1.015 . . . . 0.0 108.373 175.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 33.6 m -121.17 -21.97 3.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 125.208 1.403 . . . . 0.0 110.593 172.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -158.02 164.2 36.99 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 119.79 1.177 . . . . 0.0 111.584 174.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 69.7 m -144.1 138.45 28.25 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.777 1.631 . . . . 0.0 108.205 172.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 44.6 m -143.38 153.48 42.74 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.695 1.598 . . . . 0.0 108.594 -178.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 40.2 t -133.69 146.46 31.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -174.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.63 174.46 45.81 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 124.633 1.111 . . . . 0.0 112.443 173.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 61.3 t80 -62.66 143.91 56.85 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.597 0.759 . . . . 0.0 109.99 176.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 44.7 mttm -145.29 148.26 37.06 Favored Pre-proline 0 C--O 1.235 0.29 0 C-N-CA 125.226 1.41 . . . . 0.0 107.994 169.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -74.1 159.88 43.61 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 123.062 2.508 . . . . 0.0 110.626 176.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 11.0 ttpt -58.32 -38.54 77.32 Favored 'General case' 0 C--O 1.223 -0.293 0 O-C-N 121.825 -0.547 . . . . 0.0 111.021 -177.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -59.93 -39.27 84.91 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.416 0.686 . . . . 0.0 111.558 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.13 -42.02 73.13 Favored 'General case' 0 N--CA 1.452 -0.346 0 O-C-N 122.17 -0.331 . . . . 0.0 110.483 175.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 90.9 mt -67.83 -37.57 82.08 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 119.014 -0.517 . . . . 0.0 111.056 -178.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.8 pp0? -71.48 -29.62 65.04 Favored 'General case' 0 CA--C 1.526 0.036 0 CA-C-N 119.523 1.056 . . . . 0.0 110.297 177.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -65.46 -49.59 68.55 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 174.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 52.0 tp -54.35 -46.06 72.87 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.831 0.852 . . . . 0.0 110.635 177.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 25.2 t -63.26 -53.06 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.83 -25.4 67.89 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 119.021 0.828 . . . . 0.0 112.457 -174.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 61.3 mtpt -66.74 -23.04 66.04 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 118.024 -0.989 . . . . 0.0 112.552 172.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -110.46 -13.55 14.24 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 119.765 1.166 . . . . 0.0 113.384 -179.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 56.5 mt . . . . . 0 C--O 1.249 1.073 0 CA-C-N 119.871 1.214 . . . . 0.0 109.449 170.041 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 75.9 mtm . . . . . 0 N--CA 1.479 0.997 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -154.99 145.46 22.14 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.93 1.292 . . . . 0.0 107.563 169.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 89.3 mt -76.07 143.61 12.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 179.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 38.7 t -101.18 166.42 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 125.494 1.518 . . . . 0.0 107.581 -173.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.4 mppt? -128.63 143.37 50.93 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 106.079 -1.822 . . . . 0.0 106.079 177.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -144.79 169.72 17.48 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 118.341 0.518 . . . . 0.0 110.976 175.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.6 p -134.01 170.09 16.15 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 172.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -52.66 -25.59 11.31 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 119.98 1.264 . . . . 0.0 112.317 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 69.4 mm-40 -63.71 -33.07 74.84 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.474 1.51 . . . . 0.0 112.516 -179.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.6 m -140.29 -4.93 1.28 Allowed 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -171.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -50.39 -39.74 47.7 Favored 'General case' 0 N--CA 1.457 -0.081 0 C-N-CA 125.328 1.451 . . . . 0.0 110.665 173.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.9 m -66.9 -36.42 82.24 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 118.003 0.365 . . . . 0.0 111.618 -176.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.12 -46.59 70.46 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 174.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -64.07 -38.69 91.99 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 122.784 0.434 . . . . 0.0 111.431 -175.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.551 ' HA ' HG21 ' A' ' 20' ' ' VAL . 30.9 p -79.35 -0.37 32.34 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -176.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 64.8 m -109.28 34.48 3.73 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.456 1.102 . . . . 0.0 111.614 -173.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -132.11 -0.21 3.75 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 -178.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 165.43 -167.97 39.2 Favored Glycine 0 C--N 1.336 0.546 0 CA-C-N 119.16 0.891 . . . . 0.0 111.042 -174.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 94.3 t -71.17 132.42 33.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 N-CA-C 104.558 -2.386 . . . . 0.0 104.558 166.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.551 HG21 ' HA ' ' A' ' 15' ' ' THR . 27.3 t -135.57 118.62 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 -176.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -87.93 124.39 33.64 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 105.372 -2.085 . . . . 0.0 105.372 172.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -117.12 105.53 12.36 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -81.86 99.99 9.35 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 175.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -76.14 116.71 17.1 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 168.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 7.0 p-90 -144.86 179.53 7.27 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.59 0.756 . . . . 0.0 111.415 -169.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -158.48 152.32 19.57 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 125.648 1.579 . . . . 0.0 107.197 167.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -76.83 -16.96 16.0 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.835 2.357 . . . . 0.0 113.467 -169.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -79.14 -11.65 59.98 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.898 0.772 . . . . 0.0 111.986 177.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 41.7 t -87.52 121.46 29.98 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 178.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -58.71 -56.16 26.8 Favored Glycine 0 CA--C 1.532 1.121 0 CA-C-O 118.76 -1.022 . . . . 0.0 111.936 175.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_exo -49.35 -39.51 43.87 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 123.496 2.797 . . . . 0.0 115.077 175.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 69.8 m -58.58 -34.33 70.96 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 119.125 0.875 . . . . 0.0 112.864 175.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 45.6 mtmt -81.29 -42.25 20.9 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 8.2 ptt? -70.64 -24.2 62.66 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 119.358 0.981 . . . . 0.0 112.532 -176.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 8.0 tt -77.16 -18.14 14.43 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-N 119.602 1.092 . . . . 0.0 111.574 173.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.05 -48.51 95.88 Favored Pre-proline 0 CA--C 1.539 0.521 0 CA-C-O 117.287 -1.34 . . . . 0.0 113.417 -177.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -63.28 -31.28 73.93 Favored 'Trans proline' 0 C--N 1.35 0.614 0 CA-C-N 121.938 1.728 . . . . 0.0 112.143 175.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 6.6 t -66.54 -41.13 87.97 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-N 119.249 0.931 . . . . 0.0 109.521 177.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 63.4 mt -66.63 -32.82 74.38 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-O 118.813 -0.613 . . . . 0.0 110.912 174.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -68.66 -35.81 77.73 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 119.669 1.122 . . . . 0.0 111.304 173.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 -64.92 -39.42 93.49 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 120.903 -1.123 . . . . 0.0 109.886 171.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 24.4 tp -66.57 -35.86 81.25 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 121.604 -0.685 . . . . 0.0 110.969 176.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -65.76 -38.56 89.41 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.739 0.815 . . . . 0.0 110.632 175.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -66.71 -38.34 86.52 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.783 -0.573 . . . . 0.0 111.03 173.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -74.48 -43.0 58.04 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.026 0.93 . . . . 0.0 111.764 -174.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 42.6 mtt -142.8 3.03 1.41 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 117.849 -1.072 . . . . 0.0 113.742 -168.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -74.49 50.9 2.15 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 126.056 1.788 . . . . 0.0 113.641 -172.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -154.29 -41.16 0.09 Allowed 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 129.697 3.199 . . . . 0.0 107.327 169.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 48.0 mtpt -64.12 -33.74 76.45 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.599 1.16 . . . . 0.0 110.529 169.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -131.36 165.3 23.77 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.839 1.656 . . . . 0.0 109.679 169.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -102.88 149.68 24.26 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 170.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 20.3 mt -117.84 136.43 55.04 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 N-CA-C 105.036 -2.209 . . . . 0.0 105.036 170.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 63.8 t -129.66 138.56 53.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 -178.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 60.0 mmtt -97.77 139.34 33.79 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.859 1.264 . . . . 0.0 108.219 169.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 12.6 tt -149.17 128.56 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 CA-C-O 121.306 0.574 . . . . 0.0 109.555 175.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -83.73 127.19 33.61 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.546 0.739 . . . . 0.0 110.269 -175.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 13.5 m -67.92 -26.95 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 -173.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -83.54 -41.01 18.41 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 119.903 1.229 . . . . 0.0 109.634 -175.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -70.62 -25.22 62.94 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.355 0.662 . . . . 0.0 111.08 174.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -127.42 43.8 3.05 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.748 1.219 . . . . 0.0 109.74 -172.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.15 -36.44 51.45 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 126.666 1.986 . . . . 0.0 111.285 175.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -65.48 -40.28 92.93 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 124.012 0.925 . . . . 0.0 111.483 176.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.59 -43.32 48.9 Favored 'General case' 0 C--O 1.222 -0.356 0 CA-C-N 119.406 1.003 . . . . 0.0 110.111 -178.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -61.62 -46.17 90.97 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 119.205 0.911 . . . . 0.0 109.719 176.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -60.74 -22.42 59.62 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 124.456 1.027 . . . . 0.0 113.069 175.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 7.7 ttmm -59.92 -20.38 57.05 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 118.629 1.215 . . . . 0.0 111.503 175.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -124.36 10.37 8.59 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.353 1.461 . . . . 0.0 110.627 178.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 64.9 22.85 68.89 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.542 1.067 . . . . 0.0 113.226 -174.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 61.1 t -88.74 153.6 3.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 118.331 1.065 . . . . 0.0 109.198 178.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -161.04 -22.83 0.06 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 127.5 2.32 . . . . 0.0 109.86 167.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.5 m -63.6 153.15 36.8 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 124.312 1.045 . . . . 0.0 109.721 171.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 28.2 pt -146.58 156.25 48.91 Favored Pre-proline 0 CA--C 1.542 0.637 0 C-N-CA 124.141 0.976 . . . . 0.0 109.617 -178.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -68.41 140.49 56.43 Favored 'Cis proline' 0 N--CA 1.457 -0.625 0 N-CA-C 109.011 -1.188 . . . . 0.0 109.011 -11.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 54.4 m -131.17 125.28 32.61 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 178.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 40.6 mt -104.26 104.14 14.0 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 -176.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -78.27 143.64 36.87 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 105.726 -1.953 . . . . 0.0 105.726 168.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.8 t -120.29 118.41 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 103.489 -2.782 . . . . 0.0 103.489 172.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 8.8 mp -114.6 160.12 19.66 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 175.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -143.12 128.15 18.51 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 170.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.8 t70 44.01 37.79 1.94 Allowed 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.102 1.361 . . . . 0.0 113.39 175.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 104.86 -4.48 42.22 Favored Glycine 0 CA--C 1.528 0.857 0 CA-C-O 118.083 -1.398 . . . . 0.0 115.247 169.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -129.82 149.58 51.5 Favored 'General case' 0 C--N 1.34 0.162 0 CA-C-N 120.19 1.995 . . . . 0.0 110.755 -177.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.9 p -66.19 140.77 18.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 C-N-CA 123.765 0.826 . . . . 0.0 109.312 177.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 35.5 m -127.14 -19.54 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 C-N-CA 125.481 1.512 . . . . 0.0 110.8 173.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.35 167.59 28.47 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 120.227 1.376 . . . . 0.0 111.392 169.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 78.0 m -143.71 134.0 24.54 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 126.253 1.821 . . . . 0.0 107.243 169.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 39.0 m -141.41 153.8 45.24 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 124.898 1.279 . . . . 0.0 108.666 -176.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.1 t -132.95 148.67 31.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -172.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.08 170.61 46.08 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 124.407 1.003 . . . . 0.0 112.468 172.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -65.34 133.38 51.27 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 123.475 0.71 . . . . 0.0 109.54 175.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -134.73 144.02 48.89 Favored Pre-proline 0 CA--C 1.534 0.342 0 C-N-CA 126.111 1.764 . . . . 0.0 106.626 176.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -72.12 158.89 51.27 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 122.754 2.303 . . . . 0.0 110.553 176.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 9.9 ttpt -57.42 -37.41 72.71 Favored 'General case' 0 C--O 1.223 -0.321 0 O-C-N 121.719 -0.613 . . . . 0.0 111.133 -177.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -61.05 -37.38 82.41 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 118.528 0.604 . . . . 0.0 111.728 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -72.15 -41.76 66.74 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 122.748 0.419 . . . . 0.0 110.604 175.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 81.2 mt -64.04 -43.36 95.78 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 119.317 -0.373 . . . . 0.0 110.295 -179.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.9 pp0? -70.16 -30.43 67.58 Favored 'General case' 0 C--O 1.228 -0.067 0 CA-C-N 118.835 0.743 . . . . 0.0 110.11 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -64.75 -49.41 70.91 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 175.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 60.2 tp -57.14 -45.73 83.32 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.553 0.741 . . . . 0.0 110.507 178.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 40.0 t -62.88 -49.05 85.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 CA-C-O 119.029 -0.51 . . . . 0.0 109.941 179.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.62 -25.89 68.16 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 119.414 1.006 . . . . 0.0 112.543 -175.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -66.2 -19.36 65.81 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 118.068 -0.968 . . . . 0.0 112.811 171.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -113.07 -16.41 12.63 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 119.877 1.217 . . . . 0.0 113.528 -178.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 70.7 mt . . . . . 0 C--O 1.248 1.019 0 CA-C-N 119.972 1.26 . . . . 0.0 109.713 172.531 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.7 ttt . . . . . 0 N--CA 1.48 1.068 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -164.51 172.82 12.8 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 126.853 2.061 . . . . 0.0 107.58 -174.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 78.0 mt -75.18 148.72 7.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 169.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.7 t -131.49 165.25 32.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 124.877 1.271 . . . . 0.0 107.902 -168.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -127.12 142.43 51.51 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 174.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -148.32 171.19 16.39 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 124.302 1.041 . . . . 0.0 108.807 169.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 70.4 p -133.84 178.37 7.0 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 171.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -45.95 -31.15 2.05 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.487 1.115 . . . . 0.0 113.31 176.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -58.87 -34.46 71.64 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.321 1.848 . . . . 0.0 112.998 179.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.2 m -145.5 -3.61 0.71 Allowed 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 -169.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -54.33 -36.01 63.32 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.305 1.042 . . . . 0.0 110.84 177.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.8 m -67.01 -34.54 77.95 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 122.884 0.474 . . . . 0.0 111.9 -179.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -70.14 -45.85 65.94 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 175.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -64.35 -37.91 89.17 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 119.47 -0.3 . . . . 0.0 111.443 -175.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.505 ' HA ' HG21 ' A' ' 20' ' ' VAL . 20.2 p -75.98 1.16 16.07 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -178.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 52.0 m -117.51 37.12 4.0 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.294 1.037 . . . . 0.0 111.913 -169.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -130.97 -2.17 4.08 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 163.17 -165.88 36.76 Favored Glycine 0 C--N 1.335 0.498 0 N-CA-C 110.149 -1.18 . . . . 0.0 110.149 -172.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 87.5 t -68.53 141.0 18.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 105.758 -1.941 . . . . 0.0 105.758 166.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.505 HG21 ' HA ' ' A' ' 15' ' ' THR . 62.4 t -141.97 142.97 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 107.194 -1.409 . . . . 0.0 107.194 -178.205 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 56.6 tp -112.71 99.22 7.76 Favored 'General case' 0 CA--C 1.521 -0.158 0 N-CA-C 106.573 -1.639 . . . . 0.0 106.573 173.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.06 144.12 40.95 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 170.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -129.26 95.55 4.07 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 125.393 1.477 . . . . 0.0 107.263 178.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -75.31 116.41 16.0 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 173.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 12.1 p-90 -135.72 175.15 9.85 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 124.069 0.947 . . . . 0.0 110.17 -173.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -148.62 146.27 21.92 Favored Pre-proline 0 CA--C 1.533 0.314 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 169.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -74.0 -15.78 23.24 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.808 2.339 . . . . 0.0 113.863 -169.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -93.24 -6.09 48.43 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.812 0.845 . . . . 0.0 112.126 178.13 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 42.3 t -85.41 116.49 23.76 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 -178.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -55.75 -55.03 30.97 Favored Glycine 0 CA--C 1.532 1.15 0 CA-C-O 118.671 -1.072 . . . . 0.0 112.236 175.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -50.26 -36.34 46.55 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 123.254 2.636 . . . . 0.0 115.219 175.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 92.9 m -59.91 -40.28 88.26 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 119.937 1.244 . . . . 0.0 111.713 172.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 61.9 mttm -66.28 -38.9 88.85 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 121.475 -0.766 . . . . 0.0 110.01 175.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 98.5 mmm -67.45 -41.84 84.07 Favored 'General case' 0 N--CA 1.461 0.089 0 C-N-CA 122.84 0.456 . . . . 0.0 111.423 -177.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 8.7 tt -76.63 -20.97 14.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-N 118.511 0.596 . . . . 0.0 111.054 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -52.48 -51.22 74.92 Favored Pre-proline 0 CA--C 1.544 0.749 0 CA-C-N 119.646 1.112 . . . . 0.0 113.88 -175.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -67.24 -26.2 42.26 Favored 'Trans proline' 0 C--N 1.349 0.555 0 CA-C-N 121.925 1.723 . . . . 0.0 112.295 177.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.8 t -67.6 -37.95 79.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-N 119.307 0.958 . . . . 0.0 109.359 173.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 90.1 mt -67.13 -36.14 81.23 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-O 118.621 -0.704 . . . . 0.0 110.663 173.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -62.71 -42.91 99.89 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 119.472 1.033 . . . . 0.0 110.642 172.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -62.86 -37.18 85.82 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 121.307 -0.871 . . . . 0.0 110.651 176.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -65.6 -39.88 92.05 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 123.437 0.695 . . . . 0.0 109.897 176.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -63.7 -42.0 98.04 Favored 'General case' 0 C--N 1.332 -0.152 0 C-N-CA 123.948 0.899 . . . . 0.0 110.586 174.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 62.0 mm-40 -65.96 -28.31 68.81 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 121.361 -0.837 . . . . 0.0 111.536 176.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -86.73 -41.05 14.45 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.238 1.015 . . . . 0.0 112.154 -177.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 75.4 mmm -135.63 -2.81 2.39 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.368 1.067 . . . . 0.0 113.799 -167.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.47 44.0 0.74 Allowed Glycine 0 N--CA 1.471 0.98 0 C-N-CA 127.453 2.454 . . . . 0.0 115.166 -169.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -147.24 -37.49 0.21 Allowed 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 127.09 2.156 . . . . 0.0 108.621 169.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -63.06 -31.3 72.4 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.95 1.3 . . . . 0.0 110.108 168.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -138.29 166.71 23.5 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 126.553 1.941 . . . . 0.0 109.698 170.161 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 15.3 ptpt -109.26 155.39 21.18 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 167.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 15.5 mt -105.8 141.31 21.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 171.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 24.1 t -126.02 107.8 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 177.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 11.7 mmmm -73.75 137.12 43.76 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 173.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 15.6 tt -147.27 115.15 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 49.0 t0 -83.26 115.85 22.15 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.681 0.793 . . . . 0.0 109.031 -175.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 34.1 m -59.14 -26.72 34.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 123.048 0.539 . . . . 0.0 112.416 -176.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -72.05 -2.0 16.76 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.776 0.831 . . . . 0.0 112.493 -178.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -131.78 7.56 4.43 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.878 1.271 . . . . 0.0 110.706 172.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 67.4 m-80 -142.01 45.77 1.66 Allowed 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.117 0.967 . . . . 0.0 110.774 -168.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.547 ' NE2' ' H ' ' A' ' 61' ' ' GLN . 0.4 OUTLIER -57.38 -45.35 84.56 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.043 0.937 . . . . 0.0 108.768 175.647 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -69.46 -31.84 70.39 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.252 1.421 . . . . 0.0 111.598 -172.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -82.09 -49.55 10.06 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 118.411 0.55 . . . . 0.0 109.845 175.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.75 -45.08 91.45 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 119.152 0.887 . . . . 0.0 109.931 -173.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -61.92 -23.55 63.69 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 124.041 0.829 . . . . 0.0 112.778 175.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.5 ttmm -59.32 -27.19 65.67 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 118.798 1.299 . . . . 0.0 111.284 175.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -117.39 12.39 14.23 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.805 1.242 . . . . 0.0 110.932 179.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 69.51 18.66 73.88 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 124.598 1.094 . . . . 0.0 113.719 -179.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 86.0 t -84.35 131.57 33.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 176.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.89 27.25 0.48 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.436 1.094 . . . . 0.0 109.741 168.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 24.7 m -140.39 153.63 46.42 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 126.882 2.073 . . . . 0.0 106.515 177.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -146.59 159.88 43.11 Favored Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 124.159 0.983 . . . . 0.0 109.728 -169.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -66.93 136.93 33.55 Favored 'Cis proline' 0 N--CA 1.457 -0.628 0 CA-C-N 120.081 1.065 . . . . 0.0 109.501 -11.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 52.9 m -132.63 121.17 22.78 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 178.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 82.2 mt -99.34 132.14 44.87 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.4 mp -117.18 129.29 55.85 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 105.444 -2.058 . . . . 0.0 105.444 170.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.2 t -93.44 126.4 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 N-CA-C 103.39 -2.819 . . . . 0.0 103.39 169.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.6 mp -119.24 159.81 23.36 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 174.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -145.84 124.75 12.71 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 173.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.4 t70 44.51 40.15 3.73 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.475 1.51 . . . . 0.0 113.267 174.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 98.57 5.96 56.59 Favored Glycine 0 CA--C 1.527 0.813 0 CA-C-O 118.792 -1.004 . . . . 0.0 114.574 169.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 81.9 mm-40 -128.16 144.09 51.09 Favored 'General case' 0 CA--C 1.521 -0.142 0 CA-C-N 119.262 1.531 . . . . 0.0 108.949 177.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.7 t -68.26 136.47 26.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 169.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 22.9 m -120.15 -20.73 4.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 117.856 -1.068 . . . . 0.0 110.479 174.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.54 164.76 38.24 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 119.711 1.141 . . . . 0.0 111.634 173.379 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 95.8 m -145.3 137.74 25.91 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.546 1.538 . . . . 0.0 108.381 175.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 44.6 m -145.06 153.13 41.13 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.04 1.736 . . . . 0.0 108.176 -178.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 40.6 t -133.19 148.21 31.21 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -174.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.83 177.13 46.81 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 123.858 0.742 . . . . 0.0 112.375 176.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -58.99 147.73 33.34 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 124.491 1.116 . . . . 0.0 110.745 178.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -155.23 147.7 17.7 Favored Pre-proline 0 CA--C 1.533 0.311 0 C-N-CA 125.272 1.429 . . . . 0.0 107.686 169.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.85 157.87 47.11 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.668 2.245 . . . . 0.0 111.34 -177.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 4.7 ttpt -60.68 -34.97 75.13 Favored 'General case' 0 C--O 1.223 -0.312 0 C-N-CA 123.909 0.884 . . . . 0.0 111.673 -178.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -64.67 -42.58 95.27 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 119.425 1.011 . . . . 0.0 111.822 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.14 -43.03 75.2 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 122.828 0.451 . . . . 0.0 110.364 177.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 38.8 tp -67.81 -40.71 83.81 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 119.111 -0.471 . . . . 0.0 110.714 -177.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.5 pp0? -67.79 -32.15 72.51 Favored 'General case' 0 C--O 1.222 -0.393 0 CA-C-O 117.856 -1.068 . . . . 0.0 109.578 175.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -67.34 -43.66 80.98 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 119.436 1.016 . . . . 0.0 109.268 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 58.0 tp -57.05 -51.81 67.8 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.409 0.684 . . . . 0.0 109.681 175.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 28.7 t -58.54 -48.86 84.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 123.461 0.705 . . . . 0.0 110.481 178.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -57.44 -46.43 83.6 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 126.501 1.92 . . . . 0.0 110.699 -176.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -59.41 -34.27 72.25 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 118.656 -0.688 . . . . 0.0 112.368 174.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 79.8 m-70 -81.2 -18.12 47.27 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 82.3 mt . . . . . 0 C--O 1.249 1.064 0 CA-C-N 119.93 1.241 . . . . 0.0 110.185 178.653 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.6 mtt . . . . . 0 N--CA 1.484 1.267 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -159.22 143.74 15.45 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.786 1.635 . . . . 0.0 106.694 169.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 90.8 mt -77.84 147.01 7.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 178.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 38.8 t -110.45 165.18 6.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 -174.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.93 134.93 41.12 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 -179.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -146.66 170.9 16.0 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.106 0.412 . . . . 0.0 111.299 178.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 76.2 p -137.32 174.41 10.63 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.416 1.487 . . . . 0.0 108.111 179.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -47.34 -33.27 5.6 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 119.997 1.271 . . . . 0.0 113.11 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 26.8 mp0 -61.4 -33.71 74.14 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.677 1.591 . . . . 0.0 112.875 -179.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.5 m -142.82 -1.82 1.08 Allowed 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 -169.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -52.72 -41.45 63.96 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.078 0.951 . . . . 0.0 110.13 175.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.6 m -65.45 -27.67 68.68 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.558 0.743 . . . . 0.0 112.433 -178.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -78.49 -27.62 46.22 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.788 0.835 . . . . 0.0 111.088 176.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -81.6 -40.95 22.23 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.031 0.532 . . . . 0.0 111.137 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.527 ' HA ' HG21 ' A' ' 20' ' ' VAL . 39.2 p -74.84 -2.91 28.86 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -174.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.0 p -108.71 29.54 7.34 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.762 1.225 . . . . 0.0 112.883 -169.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -131.27 -0.34 4.07 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 113.588 0.958 . . . . 0.0 113.588 -175.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 166.15 -166.38 38.72 Favored Glycine 0 C--N 1.336 0.547 0 CA-C-N 119.21 0.913 . . . . 0.0 110.848 -174.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 98.3 t -72.4 132.14 33.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 104.829 -2.285 . . . . 0.0 104.829 166.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.527 HG21 ' HA ' ' A' ' 15' ' ' THR . 39.0 t -135.75 118.1 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 -176.062 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 63.1 tp -88.73 97.91 11.4 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 173.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.37 149.37 36.96 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 169.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -133.36 98.24 4.18 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 175.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -73.97 114.95 12.87 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 172.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 7.8 p-90 -138.02 175.03 9.94 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 123.49 0.716 . . . . 0.0 110.754 -169.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -152.14 147.16 19.3 Favored Pre-proline 0 CA--C 1.535 0.399 0 C-N-CA 124.563 1.145 . . . . 0.0 107.934 169.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.45 -21.02 17.65 Favored 'Trans proline' 0 CA--C 1.532 0.397 0 C-N-CA 122.795 2.33 . . . . 0.0 113.348 -171.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -82.74 -8.2 59.6 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 118.685 0.675 . . . . 0.0 112.045 178.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 44.3 t -90.32 120.75 31.72 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 -179.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -57.03 -58.21 15.78 Favored Glycine 0 CA--C 1.531 1.057 0 CA-C-O 118.707 -1.051 . . . . 0.0 112.086 178.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -50.35 -35.07 43.14 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 123.519 2.812 . . . . 0.0 115.271 177.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 97.8 m -60.51 -33.13 72.19 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 119.451 1.023 . . . . 0.0 112.299 175.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 46.2 mtmt -85.04 -34.66 22.25 Favored 'General case' 0 C--N 1.333 -0.12 0 C-N-CA 123.043 0.537 . . . . 0.0 109.914 176.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 26.4 mmt -63.15 -34.96 78.74 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 119.137 0.88 . . . . 0.0 111.593 176.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.7 tt -81.19 -7.87 10.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-N 118.729 0.695 . . . . 0.0 111.667 178.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.44 -50.78 86.16 Favored Pre-proline 0 CA--C 1.541 0.618 0 O-C-N 120.635 -1.291 . . . . 0.0 112.494 178.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -64.07 -33.02 63.48 Favored 'Trans proline' 0 C--N 1.351 0.681 0 CA-C-N 121.844 1.694 . . . . 0.0 112.283 176.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 19.5 t -59.18 -47.76 89.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 119.1 0.864 . . . . 0.0 109.643 173.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 58.9 mt -65.87 -36.89 84.7 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 118.941 -0.552 . . . . 0.0 110.63 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -66.97 -37.6 84.54 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 119.013 0.824 . . . . 0.0 111.303 176.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -68.06 -39.23 83.04 Favored 'General case' 0 C--N 1.331 -0.2 0 O-C-N 121.091 -1.006 . . . . 0.0 110.377 174.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.48 -43.37 97.51 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 176.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -61.23 -42.25 98.28 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.839 0.856 . . . . 0.0 110.519 177.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -67.93 -13.44 62.17 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.703 0.801 . . . . 0.0 112.795 177.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -108.46 -32.09 7.55 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.226 1.01 . . . . 0.0 112.457 -178.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 19.5 mtt -140.2 2.25 1.88 Allowed 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 117.877 -1.059 . . . . 0.0 113.071 -169.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.3 44.63 0.74 Allowed Glycine 0 CA--C 1.532 1.136 0 C-N-CA 126.599 2.047 . . . . 0.0 114.561 -174.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -152.43 -40.3 0.11 Allowed 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 128.951 2.9 . . . . 0.0 107.615 171.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -63.21 -35.94 82.0 Favored 'General case' 0 C--N 1.343 0.319 0 C-N-CA 124.7 1.2 . . . . 0.0 110.451 169.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -133.99 165.29 25.38 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 125.925 1.69 . . . . 0.0 109.75 171.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -106.91 152.52 23.81 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.168 1.387 . . . . 0.0 107.758 170.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.2 mt -117.38 136.22 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 N-CA-C 105.582 -2.007 . . . . 0.0 105.582 171.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 58.1 t -131.65 114.51 25.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 -177.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 48.0 mmtt -74.26 144.56 44.59 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 169.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 13.4 tt -147.77 115.59 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 170.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 44.7 t0 -81.03 112.97 18.91 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.961 0.905 . . . . 0.0 109.224 -175.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 30.5 m -62.27 -21.87 27.86 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-O 118.425 -0.798 . . . . 0.0 113.02 -174.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -72.3 -6.53 43.82 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 120.012 1.278 . . . . 0.0 112.559 -178.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -126.35 4.21 6.99 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.344 1.058 . . . . 0.0 110.505 169.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -142.4 30.8 1.53 Allowed 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.389 1.076 . . . . 0.0 111.528 -168.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.424 ' CD ' ' H ' ' A' ' 61' ' ' GLN . 3.8 pm0 -55.44 -31.56 62.02 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 124.557 1.143 . . . . 0.0 110.435 169.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -65.08 -51.85 59.02 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 124.192 0.997 . . . . 0.0 110.173 176.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -67.17 -43.81 81.32 Favored 'General case' 0 C--O 1.222 -0.357 0 O-C-N 121.965 -0.46 . . . . 0.0 109.924 -178.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -61.63 -45.08 95.61 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 118.611 0.642 . . . . 0.0 109.596 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -59.86 -25.32 61.43 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 124.403 1.001 . . . . 0.0 112.903 175.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 8.5 ttmm -58.41 -23.37 57.1 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 118.621 1.21 . . . . 0.0 111.509 174.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -122.51 12.74 10.08 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.251 1.42 . . . . 0.0 110.894 178.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 70.88 17.45 75.32 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 124.552 1.073 . . . . 0.0 113.914 -179.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 95.4 t -85.55 137.16 21.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 176.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 6.6 tpt -153.49 25.14 0.52 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.092 0.957 . . . . 0.0 109.559 168.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 20.1 m -140.24 154.99 47.06 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 126.403 1.881 . . . . 0.0 107.297 -178.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -145.62 158.26 50.4 Favored Pre-proline 0 CA--C 1.542 0.663 0 C-N-CA 123.743 0.817 . . . . 0.0 110.376 -169.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.14 138.86 43.49 Favored 'Cis proline' 0 C--N 1.35 0.625 0 N-CA-C 109.512 -0.995 . . . . 0.0 109.512 -10.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 53.0 m -131.25 115.93 16.97 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 175.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 90.1 mt -89.86 136.39 33.07 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 176.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.0 mp -122.05 131.06 53.79 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 105.32 -2.104 . . . . 0.0 105.32 169.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 16.1 t -95.21 124.48 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 N-CA-C 103.062 -2.94 . . . . 0.0 103.062 168.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.9 mp -116.96 158.63 23.76 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 173.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 74.2 tttt -144.77 127.51 16.24 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 174.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 29.3 t70 46.83 33.47 2.19 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.248 1.419 . . . . 0.0 113.839 174.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 115.72 -7.97 19.71 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-O 118.096 -1.391 . . . . 0.0 115.082 168.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -133.2 146.09 51.18 Favored 'General case' 0 C--N 1.339 0.119 0 CA-C-N 120.071 1.935 . . . . 0.0 110.598 -174.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 5.8 p -65.48 137.34 25.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 172.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 34.9 m -123.58 -21.38 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 C-N-CA 125.338 1.455 . . . . 0.0 110.573 177.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -156.64 165.55 35.95 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.727 1.149 . . . . 0.0 110.999 174.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 98.9 m -143.74 149.41 37.08 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.761 1.624 . . . . 0.0 108.746 178.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 73.3 m -149.94 155.34 39.8 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.713 1.605 . . . . 0.0 108.306 171.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 40.8 t -132.93 144.93 35.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 -174.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.54 175.85 49.55 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 124.153 0.882 . . . . 0.0 111.716 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -62.47 149.3 43.12 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.428 0.691 . . . . 0.0 110.376 176.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 42.1 mttm -141.5 145.4 37.54 Favored Pre-proline 0 C--O 1.233 0.215 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 168.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -71.63 158.28 53.89 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 122.253 1.969 . . . . 0.0 109.879 172.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.2 tmpt? -62.67 -35.2 78.9 Favored 'General case' 0 N--CA 1.457 -0.117 0 O-C-N 121.686 -0.634 . . . . 0.0 111.601 -176.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -68.3 -35.07 77.27 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 119.125 0.875 . . . . 0.0 111.177 -177.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.9 -41.37 78.35 Favored 'General case' 0 N--CA 1.454 -0.233 0 O-C-N 121.86 -0.525 . . . . 0.0 110.498 171.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 45.7 tp -64.41 -40.18 95.27 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 119.34 -0.362 . . . . 0.0 110.694 -178.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.8 pp0? -70.97 -32.86 69.84 Favored 'General case' 0 C--O 1.226 -0.144 0 CA-C-N 118.994 0.815 . . . . 0.0 110.363 176.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -65.79 -37.17 85.56 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 118.63 0.65 . . . . 0.0 109.445 177.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 61.4 tp -63.33 -55.9 20.82 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.282 0.633 . . . . 0.0 110.055 171.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 25.2 t -61.53 -44.0 97.87 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 C-N-CA 123.384 0.673 . . . . 0.0 110.783 -172.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.78 -28.15 69.25 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 118.769 0.713 . . . . 0.0 112.326 -170.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 35.2 mtmm -73.37 -27.84 61.7 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 118.914 -0.565 . . . . 0.0 112.462 175.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -87.55 -20.57 26.26 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 118.365 -0.826 . . . . 0.0 112.456 -179.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 74.2 mt . . . . . 0 C--O 1.249 1.075 0 CA-C-N 119.192 0.905 . . . . 0.0 109.779 174.152 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.165 0 N-CA-C 110.266 -0.272 . . . . 0.0 110.266 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -157.84 148.22 20.63 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.162 0.985 . . . . 0.0 109.446 174.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 91.2 mt -75.49 154.54 6.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 125.094 1.357 . . . . 0.0 107.994 173.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 25.2 t -124.41 166.32 19.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 125.94 1.696 . . . . 0.0 106.503 -174.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 11.2 mtmt -134.94 146.96 49.63 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 174.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -144.95 170.93 15.19 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 123.32 0.648 . . . . 0.0 110.166 175.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 80.7 p -133.7 175.62 9.28 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 170.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -49.73 -29.67 8.03 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 119.257 0.935 . . . . 0.0 113.32 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -59.02 -34.25 71.67 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.769 2.027 . . . . 0.0 112.477 179.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.4 m -143.17 -2.42 1.0 Allowed 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 114.299 1.222 . . . . 0.0 114.299 -170.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -52.73 -38.82 61.39 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 124.027 0.931 . . . . 0.0 111.038 176.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.6 m -68.36 -39.01 81.98 Favored 'General case' 0 N--CA 1.453 -0.323 0 O-C-N 122.187 -0.321 . . . . 0.0 111.23 -177.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.12 -44.55 79.63 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 175.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 61.8 mm-40 -63.14 -42.29 99.46 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 122.939 0.495 . . . . 0.0 110.856 -177.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 22.4 p -75.7 3.02 10.54 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -177.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 58.2 m -111.8 36.17 3.4 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.758 1.223 . . . . 0.0 111.688 -173.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -128.69 -3.97 5.28 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -179.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 162.88 -164.02 35.64 Favored Glycine 0 C--N 1.336 0.549 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 -172.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 82.0 t -71.51 133.43 31.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 105.095 -2.187 . . . . 0.0 105.095 166.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 31.9 t -137.5 125.52 31.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 107.065 -1.458 . . . . 0.0 107.065 -177.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 63.6 tp -92.61 98.37 11.39 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 173.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.74 145.23 40.99 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 169.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -133.17 96.74 3.81 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 124.993 1.317 . . . . 0.0 107.712 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -75.98 115.29 15.53 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 173.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 6.7 p-90 -138.08 175.76 9.29 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 123.47 0.708 . . . . 0.0 110.453 -171.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -150.19 143.79 16.91 Favored Pre-proline 0 CA--C 1.534 0.351 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 169.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.88 -23.63 21.98 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.334 2.023 . . . . 0.0 113.34 -169.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -81.38 -8.39 59.73 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 118.629 0.65 . . . . 0.0 112.499 178.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 52.7 t -84.86 115.38 22.73 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -178.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -52.35 -56.16 18.69 Favored Glycine 0 CA--C 1.531 1.087 0 CA-C-O 118.685 -1.064 . . . . 0.0 112.231 176.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_exo -51.41 -35.38 54.51 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 123.1 2.533 . . . . 0.0 115.195 174.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 97.5 m -63.26 -40.24 96.86 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 119.85 1.205 . . . . 0.0 111.409 172.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -64.65 -39.74 94.23 Favored 'General case' 0 N--CA 1.465 0.288 0 O-C-N 121.364 -0.835 . . . . 0.0 110.2 173.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 62.2 mtt -65.62 -38.62 89.95 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 123.088 0.555 . . . . 0.0 111.277 -177.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.6 tt -80.43 -18.47 12.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-N 118.819 0.736 . . . . 0.0 111.56 -178.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -52.45 -49.96 82.67 Favored Pre-proline 0 CA--C 1.544 0.749 0 CA-C-N 119.821 1.191 . . . . 0.0 113.567 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -65.69 -30.7 50.49 Favored 'Trans proline' 0 C--N 1.352 0.745 0 CA-C-N 121.873 1.705 . . . . 0.0 112.422 176.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 28.3 t -61.96 -44.48 98.97 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 119.409 1.004 . . . . 0.0 108.98 174.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 92.9 mt -64.44 -38.19 90.14 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-O 118.832 -0.604 . . . . 0.0 110.541 177.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -64.67 -40.37 95.3 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.428 1.013 . . . . 0.0 111.555 175.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -69.61 -35.41 75.25 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 121.16 -0.962 . . . . 0.0 110.69 176.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 9.3 tp -66.89 -39.66 87.55 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.434 0.693 . . . . 0.0 110.381 176.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -64.16 -42.3 96.8 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 123.778 0.831 . . . . 0.0 110.052 176.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -61.8 -31.0 71.19 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 121.629 -0.669 . . . . 0.0 112.229 173.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -85.07 -40.21 17.07 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.792 0.837 . . . . 0.0 112.497 -176.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 38.9 mtt -138.2 4.45 2.46 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 114.025 1.121 . . . . 0.0 114.025 -167.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.38 38.85 0.58 Allowed Glycine 0 CA--C 1.534 1.229 0 C-N-CA 126.487 1.994 . . . . 0.0 115.788 -169.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -140.69 -43.45 0.4 Allowed 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 125.775 1.63 . . . . 0.0 109.421 169.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 52.0 pttt -69.93 -22.74 63.16 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 119.228 -0.415 . . . . 0.0 111.88 170.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -136.96 163.67 30.14 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 125.584 1.554 . . . . 0.0 107.287 165.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 57.2 pttt -124.98 159.94 30.08 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 123.536 0.735 . . . . 0.0 109.069 168.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 22.7 mt -111.87 137.67 43.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 105.503 -2.036 . . . . 0.0 105.503 -178.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 87.2 t -127.06 109.57 20.94 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.13 144.93 44.68 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 171.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 14.7 tt -148.42 117.62 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 173.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -81.2 116.41 21.08 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -176.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 31.0 m -61.78 -26.51 40.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-O 119.061 -0.495 . . . . 0.0 112.031 -177.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -73.4 0.85 11.04 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.917 0.887 . . . . 0.0 112.074 -179.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -130.82 0.75 4.33 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.872 1.269 . . . . 0.0 111.035 170.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -141.39 48.66 1.65 Allowed 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.503 1.121 . . . . 0.0 109.769 -168.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.547 ' NE2' ' H ' ' A' ' 61' ' ' GLN . 0.4 OUTLIER -54.14 -44.94 71.82 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.642 1.577 . . . . 0.0 108.803 177.535 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -64.09 -47.51 79.76 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 125.825 1.65 . . . . 0.0 109.884 -175.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.459 ' HA ' ' HE3' ' A' ' 66' ' ' LYS . 0.7 OUTLIER -69.44 -43.18 73.87 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-O 119.298 -0.382 . . . . 0.0 110.153 -176.006 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -61.76 -46.57 89.04 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 119.239 0.927 . . . . 0.0 109.615 176.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -58.22 -26.39 58.74 Favored Glycine 0 CA--C 1.532 1.094 0 C-N-CA 124.165 0.888 . . . . 0.0 113.053 175.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.459 ' HE3' ' HA ' ' A' ' 63' ' ' THR . 28.9 ttmt -57.95 -21.5 44.38 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.33 1.452 . . . . 0.0 111.937 177.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -127.6 13.17 6.97 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.86 1.264 . . . . 0.0 110.638 178.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 69.83 19.02 74.78 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 124.667 1.127 . . . . 0.0 113.664 -178.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 96.3 t -82.19 137.93 20.3 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 175.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -153.16 25.02 0.54 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.901 1.28 . . . . 0.0 109.499 168.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 20.4 m -139.51 154.82 47.77 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 126.412 1.885 . . . . 0.0 107.32 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -146.18 160.31 43.13 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 124.345 1.058 . . . . 0.0 109.544 -170.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -66.86 139.24 44.48 Favored 'Cis proline' 0 C--N 1.35 0.632 0 N-CA-C 109.285 -1.083 . . . . 0.0 109.285 -11.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 51.3 m -131.9 118.59 20.01 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 177.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 88.3 mt -96.3 134.27 39.64 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 106.63 -1.619 . . . . 0.0 106.63 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.9 mp -119.54 128.37 53.87 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 104.793 -2.299 . . . . 0.0 104.793 169.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 15.5 t -93.58 125.26 46.18 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 103.104 -2.924 . . . . 0.0 103.104 168.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.7 mp -118.36 159.38 23.52 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 173.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 75.9 tttt -144.22 124.23 13.58 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 174.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.7 t70 45.76 36.76 2.93 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.44 1.496 . . . . 0.0 113.423 175.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 107.45 -2.28 34.62 Favored Glycine 0 CA--C 1.527 0.806 0 CA-C-O 118.089 -1.395 . . . . 0.0 115.365 168.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -130.39 147.36 52.08 Favored 'General case' 0 C--N 1.339 0.126 0 CA-C-N 120.08 1.94 . . . . 0.0 110.246 -178.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 16.8 t -67.66 137.61 24.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 107.813 -1.181 . . . . 0.0 107.813 175.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 29.0 m -119.63 -20.26 4.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 124.827 1.251 . . . . 0.0 110.537 173.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -156.85 162.26 39.69 Favored 'General case' 0 C--N 1.346 0.417 0 CA-C-N 119.642 1.11 . . . . 0.0 111.242 173.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 87.0 m -143.49 137.92 28.86 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.645 1.578 . . . . 0.0 108.356 174.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 29.3 m -145.39 153.22 40.98 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.933 1.693 . . . . 0.0 108.44 -178.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 40.9 t -133.07 145.21 34.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -175.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.91 175.52 46.79 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 124.462 1.029 . . . . 0.0 111.844 178.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -62.29 148.5 44.77 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.727 0.811 . . . . 0.0 110.377 176.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 46.3 mttm -142.01 146.1 38.95 Favored Pre-proline 0 C--O 1.233 0.195 0 C-N-CA 124.93 1.292 . . . . 0.0 107.733 168.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -72.87 161.21 44.28 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 122.746 2.297 . . . . 0.0 110.266 173.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -56.16 -43.78 78.68 Favored 'General case' 0 C--O 1.223 -0.326 0 CA-C-O 118.626 -0.702 . . . . 0.0 110.683 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -65.65 -37.78 87.49 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 119.162 0.892 . . . . 0.0 111.458 -169.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.53 -43.97 71.93 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 122.904 0.481 . . . . 0.0 110.639 174.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 29.6 tp -67.15 -41.77 85.48 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 122.568 0.347 . . . . 0.0 110.76 -175.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.2 pp0? -70.55 -32.69 70.22 Favored 'General case' 0 N--CA 1.456 -0.138 0 O-C-N 121.798 -0.564 . . . . 0.0 109.866 177.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -63.43 -48.05 79.38 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 176.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 51.1 tp -60.17 -44.4 95.07 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 122.824 0.45 . . . . 0.0 110.696 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 26.3 t -58.06 -47.48 86.76 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 175.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.71 -25.09 67.79 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 119.078 0.854 . . . . 0.0 112.675 -177.284 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -66.02 -23.65 66.6 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 119.048 0.84 . . . . 0.0 112.479 169.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -107.85 -16.52 14.29 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 119.478 1.035 . . . . 0.0 113.242 -174.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 80.7 mt . . . . . 0 C--O 1.249 1.068 0 CA-C-N 119.484 1.038 . . . . 0.0 109.681 172.248 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.9 tmm? . . . . . 0 N--CA 1.478 0.945 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -156.08 144.56 20.07 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 169.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 91.8 mt -75.51 153.87 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 N-CA-C 107.3 -1.371 . . . . 0.0 107.3 174.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 36.7 t -120.03 170.68 9.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 -174.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 27.8 mtpt -137.31 149.84 47.34 Favored 'General case' 0 CA--C 1.518 -0.268 0 O-C-N 120.732 -1.23 . . . . 0.0 108.679 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -151.01 170.36 19.54 Favored 'General case' 0 C--N 1.331 -0.196 0 O-C-N 123.489 0.493 . . . . 0.0 111.66 176.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.3 p -136.51 174.11 10.97 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.863 1.665 . . . . 0.0 107.205 172.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -47.08 -33.3 4.83 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 119.917 1.235 . . . . 0.0 113.243 -179.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 26.9 mp0 -60.68 -31.45 70.71 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.075 1.75 . . . . 0.0 113.109 -179.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.3 m -140.41 -2.57 1.41 Allowed 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -170.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -54.79 -37.94 66.68 Favored 'General case' 0 CA--C 1.528 0.098 0 C-N-CA 124.191 0.997 . . . . 0.0 111.03 178.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.4 p -63.09 -50.53 70.18 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.653 0.781 . . . . 0.0 110.788 179.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.31 -44.44 92.57 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 122.972 0.509 . . . . 0.0 110.159 178.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -66.58 -37.76 85.6 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-O 119.2 -0.428 . . . . 0.0 111.403 -177.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.517 ' HA ' HG21 ' A' ' 20' ' ' VAL . 34.2 p -80.21 3.35 21.02 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 118.607 0.64 . . . . 0.0 112.451 -178.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 51.2 m -111.73 32.78 5.19 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.598 1.159 . . . . 0.0 112.346 -172.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -132.58 -0.44 3.55 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -177.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 165.92 -167.09 39.01 Favored Glycine 0 C--N 1.334 0.452 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 -174.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 97.4 t -71.91 133.3 32.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 104.56 -2.385 . . . . 0.0 104.56 166.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.517 HG21 ' HA ' ' A' ' 15' ' ' THR . 38.6 t -136.49 121.77 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 -176.307 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 56.6 tp -96.45 98.0 9.89 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 173.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.2 156.16 33.87 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 169.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -139.38 100.04 3.89 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 125.382 1.473 . . . . 0.0 107.547 179.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -75.05 115.52 14.76 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 169.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 8.6 p-90 -137.0 174.72 10.31 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 123.554 0.742 . . . . 0.0 110.237 -174.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -153.96 148.02 18.96 Favored Pre-proline 0 CA--C 1.535 0.402 0 N-CA-C 107.753 -1.202 . . . . 0.0 107.753 169.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -73.52 -22.46 18.31 Favored 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 122.574 2.183 . . . . 0.0 113.22 -169.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -79.43 -5.55 54.94 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 118.623 0.647 . . . . 0.0 112.356 179.047 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 45.2 t -95.12 110.51 22.45 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 -175.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -51.03 -53.21 27.97 Favored Glycine 0 CA--C 1.533 1.215 0 CA-C-O 118.801 -0.999 . . . . 0.0 112.74 176.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_exo -52.34 -34.19 59.32 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 122.858 2.372 . . . . 0.0 114.846 174.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 80.9 m -67.39 -39.8 85.6 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 120.185 1.357 . . . . 0.0 111.146 172.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -59.88 -34.34 73.03 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 121.051 -1.031 . . . . 0.0 110.262 173.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 26.2 mmt -73.88 -37.12 64.83 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 123.043 0.537 . . . . 0.0 111.48 177.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.2 tp -70.68 -23.27 23.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 119.408 1.004 . . . . 0.0 110.935 179.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.81 -54.95 46.28 Favored Pre-proline 0 CA--C 1.543 0.701 0 CA-C-O 117.775 -1.107 . . . . 0.0 113.006 -177.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -66.55 -28.41 45.29 Favored 'Trans proline' 0 C--N 1.349 0.576 0 CA-C-N 121.703 1.644 . . . . 0.0 112.499 177.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 97.8 t -62.87 -43.61 99.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 119.607 1.094 . . . . 0.0 109.335 174.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 89.5 mt -69.28 -35.03 75.63 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-O 118.585 -0.722 . . . . 0.0 111.112 178.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -65.51 -41.23 93.39 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 119.526 1.057 . . . . 0.0 110.883 174.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -59.43 -45.23 92.13 Favored 'General case' 0 N--CA 1.455 -0.196 0 O-C-N 121.479 -0.763 . . . . 0.0 110.4 171.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.2 tp -64.36 -38.93 92.76 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 122.869 0.468 . . . . 0.0 110.698 -178.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -65.3 -41.78 93.72 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.524 0.73 . . . . 0.0 110.611 177.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -66.91 -36.3 81.94 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 122.067 -0.396 . . . . 0.0 111.252 176.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -73.96 -49.66 23.58 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.231 1.013 . . . . 0.0 111.013 -175.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 7.9 ptp -146.06 10.53 1.17 Allowed 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 -167.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.68 52.02 1.54 Allowed Glycine 0 CA--C 1.526 0.764 0 C-N-CA 126.53 2.014 . . . . 0.0 113.156 -178.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -148.66 -39.42 0.16 Allowed 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 128.229 2.612 . . . . 0.0 107.697 169.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 58.7 mtmt -65.95 -29.71 70.16 Favored 'General case' 0 C--N 1.345 0.375 0 C-N-CA 123.58 0.752 . . . . 0.0 110.68 168.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -131.96 162.65 30.18 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 125.138 1.375 . . . . 0.0 110.324 168.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -99.28 154.91 17.8 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.018 1.327 . . . . 0.0 107.538 169.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 12.8 mt -120.83 137.37 54.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 N-CA-C 105.704 -1.961 . . . . 0.0 105.704 170.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 84.6 t -133.61 114.1 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-N 119.048 0.84 . . . . 0.0 108.963 -174.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 56.7 mmtt -73.73 143.29 46.18 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 121.853 -0.529 . . . . 0.0 109.845 170.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 13.0 tt -151.35 149.68 13.86 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 N-CA-C 107.699 -1.222 . . . . 0.0 107.699 170.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -123.33 118.04 26.62 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 120.958 -1.089 . . . . 0.0 109.808 -169.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 30.5 m -55.13 -29.48 22.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 124.233 1.013 . . . . 0.0 113.027 -174.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -69.76 -9.09 53.24 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.874 0.869 . . . . 0.0 112.424 -175.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -132.07 6.05 4.22 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.838 1.255 . . . . 0.0 110.953 176.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 67.1 m-80 -141.21 46.7 1.72 Allowed 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.957 0.903 . . . . 0.0 110.679 -168.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.515 ' NE2' ' H ' ' A' ' 61' ' ' GLN . 0.5 OUTLIER -55.09 -43.94 74.45 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.908 0.883 . . . . 0.0 108.947 173.616 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -68.38 -31.73 71.31 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 125.48 1.512 . . . . 0.0 111.63 -171.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -84.68 -47.54 10.37 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 118.31 0.504 . . . . 0.0 109.918 176.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -64.22 -45.17 89.4 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 119.216 0.916 . . . . 0.0 109.904 -175.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -61.1 -24.97 63.77 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 124.009 0.814 . . . . 0.0 112.409 176.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.4 ttmm -58.99 -26.44 64.5 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 118.348 1.074 . . . . 0.0 111.533 176.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -114.83 10.47 16.48 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.606 1.162 . . . . 0.0 111.146 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 71.15 31.43 66.45 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 123.649 0.642 . . . . 0.0 112.418 -178.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 98.1 t -111.05 138.27 40.03 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 C-N-CA 125.073 1.349 . . . . 0.0 107.835 -178.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 8.6 tpt -153.97 30.75 0.45 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.034 0.934 . . . . 0.0 108.989 167.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 19.3 m -139.21 158.8 43.54 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 126.401 1.88 . . . . 0.0 107.671 -178.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -143.43 158.62 57.17 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 123.956 0.903 . . . . 0.0 110.013 -173.285 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -66.75 138.36 39.85 Favored 'Cis proline' 0 N--CA 1.457 -0.631 0 N-CA-C 108.786 -1.275 . . . . 0.0 108.786 -11.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 99.1 m -132.31 112.73 12.46 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 174.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 95.6 mt -83.46 141.77 31.43 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 175.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -128.8 127.27 41.63 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 104.133 -2.543 . . . . 0.0 104.133 -178.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.0 t -112.57 121.72 65.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 104.235 -2.506 . . . . 0.0 104.235 -176.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.2 mp -127.46 159.32 34.87 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 77.2 tttt -146.08 124.15 12.12 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 177.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.0 t70 45.16 35.94 1.91 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.438 1.495 . . . . 0.0 113.441 175.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 105.54 1.71 40.48 Favored Glycine 0 CA--C 1.527 0.794 0 CA-C-O 118.092 -1.393 . . . . 0.0 115.074 169.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -130.69 145.2 51.87 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 120.082 1.941 . . . . 0.0 109.921 179.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.7 p -69.0 140.67 18.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 C-N-CA 123.769 0.827 . . . . 0.0 109.19 174.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 35.5 m -128.02 -17.95 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 125.69 1.596 . . . . 0.0 110.681 178.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -160.1 167.28 28.14 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 120.389 1.45 . . . . 0.0 111.545 169.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 52.7 m -145.4 141.53 28.52 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.054 1.742 . . . . 0.0 107.549 169.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 14.7 m -145.84 146.55 31.18 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 124.215 1.006 . . . . 0.0 108.631 -178.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 39.8 t -127.41 148.8 32.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 -170.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.99 172.55 39.57 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 124.185 0.897 . . . . 0.0 111.589 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -61.22 153.75 25.31 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.225 0.61 . . . . 0.0 110.762 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -153.41 148.25 19.65 Favored Pre-proline 0 CA--C 1.533 0.301 0 C-N-CA 125.082 1.353 . . . . 0.0 107.677 169.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.51 162.41 41.47 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.644 2.23 . . . . 0.0 111.013 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -53.97 -43.8 70.23 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-O 118.574 -0.727 . . . . 0.0 110.952 177.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -63.59 -42.14 98.3 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 119.059 0.845 . . . . 0.0 111.369 -169.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.58 -41.71 88.11 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 123.096 0.558 . . . . 0.0 110.854 175.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 30.9 tp -68.1 -41.95 81.02 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 119.549 -0.262 . . . . 0.0 110.911 -176.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.7 pp0? -71.15 -30.81 66.92 Favored 'General case' 0 N--CA 1.457 -0.113 0 CA-C-N 118.512 0.596 . . . . 0.0 110.044 177.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -63.1 -50.03 72.12 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 174.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 66.9 tp -58.04 -46.54 85.19 Favored 'General case' 0 C--N 1.334 -0.09 0 C-N-CA 123.723 0.809 . . . . 0.0 110.31 -178.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 42.9 t -63.7 -49.08 83.73 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-O 118.561 -0.733 . . . . 0.0 109.783 179.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.05 -26.89 68.76 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 119.725 1.148 . . . . 0.0 112.268 -176.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -68.22 -26.83 65.91 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 118.323 -0.846 . . . . 0.0 112.384 171.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 77.0 m-70 -95.23 -19.84 19.7 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 119.571 1.078 . . . . 0.0 113.368 178.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 61.3 mt . . . . . 0 C--O 1.248 0.982 0 CA-C-N 119.781 1.173 . . . . 0.0 109.745 175.296 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.8 ttp . . . . . 0 N--CA 1.478 0.963 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -156.87 147.17 21.21 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.891 1.677 . . . . 0.0 106.539 169.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 90.5 mt -75.6 145.05 11.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 40.9 t -104.38 167.58 2.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 -174.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 5.9 mptt -137.13 138.51 40.37 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 -178.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -144.91 170.22 16.55 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.068 0.461 . . . . 0.0 111.656 -179.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 70.8 p -137.08 173.5 11.63 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.725 1.61 . . . . 0.0 107.48 177.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -49.75 -32.43 13.7 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 119.836 1.198 . . . . 0.0 112.979 -178.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 26.2 mp0 -63.82 -30.75 71.81 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.098 1.759 . . . . 0.0 112.778 -178.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.6 m -138.47 -4.93 1.61 Allowed 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 -169.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -54.92 -37.48 66.43 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 124.039 0.935 . . . . 0.0 110.821 177.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.3 p -62.94 -50.98 68.7 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 123.861 0.865 . . . . 0.0 110.835 178.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.22 -44.29 92.3 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.019 0.527 . . . . 0.0 110.081 178.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -66.03 -38.67 89.0 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-O 119.237 -0.411 . . . . 0.0 111.294 -177.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.551 ' HA ' HG21 ' A' ' 20' ' ' VAL . 28.8 p -78.62 1.41 22.79 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 118.528 0.604 . . . . 0.0 112.58 -179.08 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 50.4 m -110.29 32.61 5.02 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.57 1.148 . . . . 0.0 112.27 -172.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -132.17 -0.17 3.73 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -178.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 165.51 -167.69 39.1 Favored Glycine 0 C--N 1.336 0.54 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 -174.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 97.4 t -71.24 134.23 30.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 N-CA-C 104.687 -2.338 . . . . 0.0 104.687 166.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.551 HG21 ' HA ' ' A' ' 15' ' ' THR . 40.4 t -136.8 120.85 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 -175.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 61.6 tp -95.35 96.91 9.45 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 173.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.24 157.76 32.28 Favored 'General case' 0 N--CA 1.444 -0.732 0 O-C-N 121.831 -0.543 . . . . 0.0 109.7 169.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -139.92 99.26 3.65 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 125.558 1.543 . . . . 0.0 107.436 178.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -73.96 117.14 15.4 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 169.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 8.2 p-90 -138.2 173.4 11.65 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 123.396 0.678 . . . . 0.0 110.883 -174.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -153.47 149.13 20.71 Favored Pre-proline 0 C--O 1.238 0.46 0 C-N-CA 126.416 1.886 . . . . 0.0 105.957 169.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -75.68 -21.97 14.11 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.695 2.263 . . . . 0.0 113.251 -169.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -78.32 -7.84 57.71 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 118.541 0.609 . . . . 0.0 112.521 -176.141 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 37.5 t -100.16 108.78 20.99 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 -178.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -46.47 -51.21 12.53 Favored Glycine 0 CA--C 1.533 1.215 0 CA-C-O 118.425 -1.208 . . . . 0.0 113.767 -178.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -49.81 -31.51 26.41 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 123.443 2.762 . . . . 0.0 115.885 176.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 61.6 m -62.5 -40.94 98.34 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 120.409 1.459 . . . . 0.0 110.782 173.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -67.88 -37.75 82.18 Favored 'General case' 0 N--CA 1.462 0.144 0 O-C-N 121.729 -0.607 . . . . 0.0 109.933 175.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 64.3 mtt -65.66 -40.5 92.5 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 118.202 0.455 . . . . 0.0 111.165 -178.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 10.1 tt -80.87 -19.03 11.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 118.666 0.667 . . . . 0.0 111.619 -177.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -52.35 -51.53 71.55 Favored Pre-proline 0 CA--C 1.543 0.686 0 CA-C-O 117.529 -1.224 . . . . 0.0 113.632 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.1 -30.45 55.87 Favored 'Trans proline' 0 C--N 1.351 0.683 0 CA-C-N 121.874 1.705 . . . . 0.0 112.037 177.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 14.0 t -63.6 -44.61 98.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 119.126 0.875 . . . . 0.0 109.157 176.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 78.5 mt -65.59 -36.38 83.58 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 118.917 -0.563 . . . . 0.0 110.731 177.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -66.05 -38.88 89.47 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 119.266 0.939 . . . . 0.0 111.203 175.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -67.38 -37.52 83.27 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 121.087 -1.008 . . . . 0.0 110.344 174.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 16.0 tp -66.34 -39.11 89.01 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.348 0.659 . . . . 0.0 110.551 177.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -65.1 -40.07 94.03 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.014 0.926 . . . . 0.0 110.708 175.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -66.84 -36.45 82.37 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.942 -0.474 . . . . 0.0 111.306 175.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -72.35 -53.47 12.25 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.921 0.889 . . . . 0.0 110.987 -178.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 11.6 ptp -144.44 15.63 1.64 Allowed 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 114.212 1.189 . . . . 0.0 114.212 -167.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.35 53.94 1.14 Allowed Glycine 0 CA--C 1.529 0.965 0 C-N-CA 126.124 1.821 . . . . 0.0 112.092 175.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -153.51 -40.93 0.1 Allowed 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 129.41 3.084 . . . . 0.0 107.281 172.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -63.95 -35.24 80.03 Favored 'General case' 0 C--N 1.343 0.311 0 C-N-CA 124.04 0.936 . . . . 0.0 110.176 168.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -131.04 165.34 23.43 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 125.34 1.456 . . . . 0.0 110.473 169.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -102.06 154.64 18.8 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 169.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.6 mt -120.58 137.45 54.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 170.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 66.7 t -134.02 115.94 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-N 119.2 0.909 . . . . 0.0 109.502 -175.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 65.7 mmtt -74.89 145.04 43.05 Favored 'General case' 0 C--O 1.235 0.303 0 O-C-N 121.233 -0.917 . . . . 0.0 109.783 169.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 12.4 tt -151.33 141.7 15.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 169.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -98.49 128.08 44.69 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 121.488 -0.757 . . . . 0.0 110.063 -173.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 15.9 m -67.99 -27.42 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 114.51 1.3 . . . . 0.0 114.51 -173.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -80.62 -41.32 24.09 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 120.072 1.305 . . . . 0.0 109.41 -175.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -71.75 -26.26 62.38 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.413 0.685 . . . . 0.0 111.18 175.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 -128.39 43.43 3.14 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.735 1.214 . . . . 0.0 109.864 -170.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.79 -39.67 62.55 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 126.697 1.999 . . . . 0.0 111.049 176.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -64.02 -46.02 86.33 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 123.615 0.766 . . . . 0.0 110.335 176.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.539 ' HA ' ' HE3' ' A' ' 66' ' ' LYS . 0.3 OUTLIER -69.89 -41.93 74.09 Favored 'General case' 0 C--O 1.222 -0.369 0 CA-C-N 118.69 0.677 . . . . 0.0 110.74 -175.979 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.77 -45.16 93.99 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 119.307 0.958 . . . . 0.0 109.273 176.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -57.53 -27.9 59.01 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 123.838 0.733 . . . . 0.0 112.778 174.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.539 ' HE3' ' HA ' ' A' ' 63' ' ' THR . 25.0 ttmt -59.51 -19.94 51.83 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.458 1.503 . . . . 0.0 111.96 178.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -125.3 12.41 8.19 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.659 1.184 . . . . 0.0 110.915 179.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 71.52 32.6 64.52 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 123.713 0.673 . . . . 0.0 112.722 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 90.8 t -111.18 139.05 36.96 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 C-N-CA 125.054 1.342 . . . . 0.0 108.003 -178.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 8.6 tpt -155.26 30.29 0.39 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.408 1.083 . . . . 0.0 108.989 167.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 18.2 m -136.96 158.96 43.27 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 126.181 1.792 . . . . 0.0 107.919 -177.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -144.8 155.57 56.01 Favored Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 123.354 0.662 . . . . 0.0 111.152 -170.293 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -69.73 140.14 58.67 Favored 'Cis proline' 0 N--CA 1.458 -0.599 0 N-CA-C 108.653 -1.326 . . . . 0.0 108.653 -11.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 96.3 m -130.68 113.11 13.76 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 176.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 94.4 mt -81.18 144.71 31.43 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 175.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.9 126.4 36.06 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 103.949 -2.611 . . . . 0.0 103.949 -179.036 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 5.2 t -109.52 122.33 63.96 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.42 0 N-CA-C 104.227 -2.509 . . . . 0.0 104.227 -179.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.4 mp -125.86 159.8 31.55 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 179.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -145.41 126.44 14.6 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 175.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.0 t70 44.41 35.65 1.39 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.368 1.467 . . . . 0.0 113.55 174.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 106.48 0.19 37.35 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-O 118.004 -1.442 . . . . 0.0 115.07 169.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -130.69 145.82 52.02 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-N 120.13 1.965 . . . . 0.0 110.216 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 10.0 p -70.03 140.98 17.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 C-N-CA 123.845 0.858 . . . . 0.0 109.435 174.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 32.5 m -129.94 -17.61 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 125.734 1.613 . . . . 0.0 110.788 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -160.29 168.56 25.05 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 120.422 1.465 . . . . 0.0 111.696 169.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 53.9 m -146.84 141.85 27.06 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.072 1.749 . . . . 0.0 108.023 170.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 18.7 m -146.16 152.86 39.94 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 124.77 1.228 . . . . 0.0 108.864 -177.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 32.8 t -130.15 148.85 33.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-N 119.155 0.888 . . . . 0.0 108.691 -171.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 80.62 179.72 53.0 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 124.098 0.856 . . . . 0.0 111.994 176.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -62.07 150.69 37.58 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.773 0.829 . . . . 0.0 110.759 177.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.41 147.74 29.17 Favored Pre-proline 0 CA--C 1.531 0.233 0 C-N-CA 124.893 1.277 . . . . 0.0 107.739 167.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -74.1 160.71 42.27 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 123.207 2.604 . . . . 0.0 110.452 174.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 75.3 tttt -55.18 -41.32 71.74 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 118.816 -0.612 . . . . 0.0 110.515 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -59.74 -41.7 91.54 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 118.516 0.598 . . . . 0.0 110.871 -174.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.14 -43.36 87.3 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.03 0.532 . . . . 0.0 110.792 176.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 61.1 mt -64.29 -45.88 86.06 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 119.141 -0.457 . . . . 0.0 109.945 -179.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 2.9 pp0? -71.12 -27.57 63.68 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.799 0.727 . . . . 0.0 110.676 -177.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -67.72 -50.16 58.89 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 173.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 60.9 tp -58.26 -47.47 83.48 Favored 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 123.235 0.614 . . . . 0.0 109.975 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 44.4 t -62.66 -46.94 95.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 CA-C-O 117.995 -1.002 . . . . 0.0 109.696 -179.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -60.24 -34.71 74.06 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 120.073 1.306 . . . . 0.0 111.315 -177.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 48.2 mmtm -71.07 -10.09 59.16 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 118.045 -0.978 . . . . 0.0 113.468 175.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -108.17 -17.03 14.13 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 119.982 1.264 . . . . 0.0 113.383 172.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 64.8 mt . . . . . 0 C--O 1.25 1.109 0 CA-C-N 120.239 1.381 . . . . 0.0 109.761 174.293 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.9 mmt . . . . . 0 N--CA 1.486 1.335 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.76 159.71 43.11 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 125.618 1.567 . . . . 0.0 108.405 175.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 79.5 mt -69.08 153.92 8.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 124.945 1.298 . . . . 0.0 108.562 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 31.5 t -114.34 167.56 7.0 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 125.939 1.696 . . . . 0.0 107.104 -174.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 9.2 mtmt -132.75 147.79 52.32 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 176.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -148.59 169.7 19.75 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.545 0.738 . . . . 0.0 110.426 176.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 77.8 p -135.53 174.94 10.06 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.562 1.145 . . . . 0.0 107.918 171.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -47.7 -31.03 4.29 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 119.964 1.256 . . . . 0.0 112.928 178.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -58.76 -33.33 70.17 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.374 1.87 . . . . 0.0 112.791 179.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.7 m -142.95 -3.09 0.99 Allowed 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 114.217 1.192 . . . . 0.0 114.217 -169.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -53.8 -37.45 63.53 Favored 'General case' 0 C--O 1.23 0.065 0 C-N-CA 124.435 1.094 . . . . 0.0 111.105 179.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.4 p -61.53 -53.63 53.8 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.808 0.843 . . . . 0.0 110.658 179.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.25 -43.76 88.01 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.018 0.527 . . . . 0.0 110.28 179.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -65.97 -35.51 80.79 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 119.081 -0.485 . . . . 0.0 111.746 -177.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.537 ' HA ' HG21 ' A' ' 20' ' ' VAL . 32.1 p -85.75 1.14 50.75 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -178.16 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 40.5 m -115.24 32.48 6.02 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -169.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -144.02 17.54 1.76 Allowed 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 177.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 172.6 -169.23 42.37 Favored Glycine 0 C--N 1.339 0.711 0 O-C-N 121.329 -0.857 . . . . 0.0 112.151 174.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 1.8 t -78.65 134.35 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 104.106 -2.553 . . . . 0.0 104.106 168.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.537 HG21 ' HA ' ' A' ' 15' ' ' THR . 25.5 t -139.62 138.4 39.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 -172.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 42.6 tp -114.02 97.6 6.47 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 173.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.95 157.55 33.01 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 169.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -138.31 99.4 3.84 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 125.27 1.428 . . . . 0.0 107.259 177.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -72.5 115.66 12.03 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 169.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 9.3 p-90 -137.19 175.53 9.53 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.704 0.801 . . . . 0.0 110.373 -172.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -152.3 146.58 18.55 Favored Pre-proline 0 CA--C 1.535 0.399 0 C-N-CA 124.491 1.117 . . . . 0.0 107.994 169.227 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.25 -19.3 17.46 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.801 2.334 . . . . 0.0 113.299 -171.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -82.36 -7.47 59.63 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 121.537 -0.727 . . . . 0.0 111.961 177.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 48.6 t -92.07 120.76 32.99 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -57.0 -58.32 15.19 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-O 118.656 -1.08 . . . . 0.0 111.925 177.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -49.63 -36.33 40.5 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 123.653 2.902 . . . . 0.0 115.157 177.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 95.8 m -60.16 -36.66 78.07 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 119.429 1.013 . . . . 0.0 112.313 175.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 46.3 mtmt -80.48 -35.35 34.93 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-O 118.986 -0.53 . . . . 0.0 109.893 177.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 26.4 mmt -64.36 -39.23 93.47 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 118.967 0.803 . . . . 0.0 111.304 178.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 8.4 tt -76.46 -13.21 14.6 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 CA-C-N 118.824 0.738 . . . . 0.0 111.349 179.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -57.17 -52.22 75.79 Favored Pre-proline 0 CA--C 1.541 0.631 0 CA-C-O 117.515 -1.231 . . . . 0.0 113.21 -177.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.71 -28.86 60.06 Favored 'Trans proline' 0 C--N 1.351 0.685 0 CA-C-N 121.873 1.704 . . . . 0.0 112.418 176.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 10.5 t -65.08 -44.17 95.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 177.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 61.6 mt -68.12 -33.22 74.1 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 118.056 -0.973 . . . . 0.0 111.138 175.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -65.48 -43.76 89.23 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 120.036 1.289 . . . . 0.0 110.578 174.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -59.79 -42.57 93.69 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 118.77 0.714 . . . . 0.0 110.031 175.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 37.7 tp -65.0 -39.17 93.06 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 122.529 0.332 . . . . 0.0 110.903 178.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -64.43 -41.86 96.34 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 124.566 1.147 . . . . 0.0 110.477 178.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 65.0 mm-40 -65.73 -26.07 67.58 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.634 -0.666 . . . . 0.0 111.578 176.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -91.98 -31.08 15.75 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.749 1.22 . . . . 0.0 112.908 -177.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.4 ' HA ' ' HE3' ' A' ' 49' ' ' LYS . 19.3 mmt -126.07 -11.26 6.49 Favored 'General case' 0 C--O 1.226 -0.171 0 CA-C-O 117.697 -1.144 . . . . 0.0 113.483 -168.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -45.54 -35.14 5.37 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 126.287 1.899 . . . . 0.0 115.923 -170.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -76.06 -37.97 57.64 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.04 0.936 . . . . 0.0 111.519 -178.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.4 ' HE3' ' HA ' ' A' ' 46' ' ' MET . 29.2 mtmt -83.79 -27.46 28.81 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 125.27 1.428 . . . . 0.0 110.444 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -151.14 122.18 7.68 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 124.542 1.137 . . . . 0.0 109.847 -170.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -74.28 151.92 39.77 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.911 0.885 . . . . 0.0 108.978 174.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.9 mt -122.46 134.02 66.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 N-CA-C 105.985 -1.858 . . . . 0.0 105.985 172.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 41.1 t -131.6 113.26 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -171.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 60.3 mmtt -74.2 143.17 45.3 Favored 'General case' 0 C--O 1.235 0.319 0 O-C-N 121.505 -0.747 . . . . 0.0 109.557 170.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 11.7 tt -150.13 121.38 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 173.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -86.86 116.85 25.21 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 121.393 -0.817 . . . . 0.0 109.384 -174.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 29.9 m -58.69 -28.02 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-N 118.674 0.67 . . . . 0.0 112.713 -176.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -71.99 -7.96 51.74 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 119.26 0.936 . . . . 0.0 112.059 -177.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -123.23 2.38 9.18 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.3 1.44 . . . . 0.0 110.513 173.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -146.54 36.45 0.98 Allowed 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 124.683 1.193 . . . . 0.0 111.026 -168.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.6 pm0 -58.22 -30.41 66.46 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.333 0.653 . . . . 0.0 110.236 173.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 59.3 mp0 -62.16 -55.08 32.35 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.406 1.482 . . . . 0.0 109.685 174.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.86 -43.91 74.41 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 119.377 -0.344 . . . . 0.0 110.164 -174.44 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.83 -45.4 92.79 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 118.71 0.686 . . . . 0.0 109.583 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -59.6 -25.34 60.85 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.122 0.868 . . . . 0.0 112.748 175.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 9.9 ttmm -59.44 -23.54 62.77 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.575 1.187 . . . . 0.0 111.405 175.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -118.8 11.07 12.55 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.162 1.385 . . . . 0.0 110.984 178.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 68.62 20.53 74.03 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 124.23 0.919 . . . . 0.0 113.346 -176.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 91.0 t -90.52 133.67 31.65 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 177.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 7.2 tpt -154.7 30.73 0.42 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.778 0.831 . . . . 0.0 109.621 167.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 45.1 m -135.36 156.79 48.36 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 126.36 1.864 . . . . 0.0 106.834 172.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -145.16 158.27 52.07 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 123.935 0.894 . . . . 0.0 109.992 -170.309 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -67.7 136.78 35.11 Favored 'Cis proline' 0 C--N 1.349 0.591 0 CA-C-N 120.085 1.066 . . . . 0.0 109.784 -10.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 70.4 m -132.26 113.95 13.85 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 176.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 88.5 mt -82.39 145.5 29.85 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 175.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -129.61 124.7 34.38 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 104.263 -2.495 . . . . 0.0 104.263 179.387 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.5 t -106.69 124.34 62.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 N-CA-C 104.031 -2.581 . . . . 0.0 104.031 -178.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.7 mp -127.16 160.21 31.93 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.517 1.127 . . . . 0.0 108.102 178.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -148.18 128.03 13.48 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 174.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.0 t70 42.64 38.3 1.26 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.211 1.404 . . . . 0.0 113.276 179.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.72 6.67 60.62 Favored Glycine 0 CA--C 1.527 0.842 0 CA-C-O 118.777 -1.013 . . . . 0.0 114.726 171.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -121.82 143.05 49.63 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 119.333 1.567 . . . . 0.0 108.881 176.177 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 78.1 t -67.24 139.4 21.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 169.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.1 m -124.95 -21.55 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 CA-C-O 117.513 -1.232 . . . . 0.0 110.484 174.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -158.41 166.67 31.67 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 120.288 1.404 . . . . 0.0 111.846 174.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 72.4 m -144.24 139.5 28.71 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.89 1.676 . . . . 0.0 107.569 169.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 20.2 m -146.13 153.18 40.39 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.588 1.155 . . . . 0.0 109.035 -174.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 30.7 t -131.7 150.53 34.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 CA-C-N 119.04 0.836 . . . . 0.0 108.993 -170.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.8 169.17 45.16 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 124.693 1.139 . . . . 0.0 112.76 170.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -62.16 134.95 57.24 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 172.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 33.2 mttp -144.34 146.99 35.15 Favored Pre-proline 0 C--O 1.233 0.215 0 C-N-CA 125.364 1.466 . . . . 0.0 107.759 176.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -75.28 157.38 41.62 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 123.007 2.471 . . . . 0.0 110.96 -176.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.7 tmpt? -60.47 -33.67 72.91 Favored 'General case' 0 C--O 1.224 -0.266 0 O-C-N 121.698 -0.626 . . . . 0.0 111.241 -175.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -62.58 -37.16 85.13 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 118.967 0.803 . . . . 0.0 111.823 178.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -72.27 -40.63 67.47 Favored 'General case' 0 N--CA 1.452 -0.35 0 O-C-N 121.85 -0.531 . . . . 0.0 110.655 174.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 52.7 mt -65.89 -41.37 91.61 Favored 'General case' 0 N--CA 1.455 -0.201 0 O-C-N 122.057 -0.402 . . . . 0.0 110.253 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.7 pp0? -69.95 -30.17 67.48 Favored 'General case' 0 C--O 1.227 -0.081 0 CA-C-N 118.932 0.787 . . . . 0.0 110.272 178.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -63.86 -49.98 70.63 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 174.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 65.3 tp -57.63 -43.76 85.06 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.804 0.841 . . . . 0.0 110.726 178.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 24.7 t -61.94 -53.56 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 177.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.34 -26.16 68.35 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 119.082 0.856 . . . . 0.0 112.272 -175.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -67.3 -18.69 65.29 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 117.869 -1.062 . . . . 0.0 112.837 172.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -115.88 -13.0 11.35 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 119.929 1.241 . . . . 0.0 113.69 178.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 43.7 mt . . . . . 0 C--O 1.249 1.075 0 CA-C-N 120.284 1.402 . . . . 0.0 109.63 170.903 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.7 mtt . . . . . 0 N--CA 1.484 1.246 0 CA-C-O 121.175 0.512 . . . . 0.0 109.742 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -159.3 143.68 15.28 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 126.08 1.752 . . . . 0.0 106.489 168.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 88.3 mt -76.6 138.3 20.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 36.6 t -98.5 166.89 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 125.285 1.434 . . . . 0.0 107.504 -175.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 6.1 mptt -137.07 135.96 37.96 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 179.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -147.17 170.76 16.55 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 122.92 0.488 . . . . 0.0 110.9 -178.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.9 p -137.5 174.6 10.42 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.958 1.303 . . . . 0.0 108.047 177.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -45.99 -34.22 3.87 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.776 1.23 . . . . 0.0 113.17 179.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 26.8 mp0 -62.1 -31.81 72.31 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.901 1.681 . . . . 0.0 113.1 -178.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.5 m -139.98 -5.07 1.32 Allowed 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 -170.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -55.87 -35.61 66.67 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 124.097 0.959 . . . . 0.0 111.236 178.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.4 p -63.53 -48.6 76.85 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.895 0.878 . . . . 0.0 111.097 178.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.71 -44.5 96.5 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 122.938 0.495 . . . . 0.0 109.876 177.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -65.43 -38.41 89.8 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 119.39 -0.338 . . . . 0.0 111.502 -177.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.493 ' HA ' HG21 ' A' ' 20' ' ' VAL . 22.2 p -78.04 -0.16 26.86 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -178.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 60.0 m -108.65 32.87 4.54 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.466 1.106 . . . . 0.0 112.033 -171.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -132.54 -1.98 3.44 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -176.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 167.28 -166.36 39.2 Favored Glycine 0 C--N 1.337 0.593 0 CA-C-N 119.338 0.972 . . . . 0.0 110.854 -173.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 97.1 t -72.81 130.18 35.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 N-CA-C 104.554 -2.387 . . . . 0.0 104.554 166.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.493 HG21 ' HA ' ' A' ' 15' ' ' THR . 38.1 t -134.82 116.85 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 -175.263 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 57.2 tp -84.57 139.6 31.99 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 169.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -133.1 113.61 12.94 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 -177.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -92.38 96.72 10.42 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 178.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -73.46 114.45 11.7 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 105.053 -2.202 . . . . 0.0 105.053 169.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 7.6 p-90 -138.03 175.9 9.17 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 123.499 0.72 . . . . 0.0 110.973 -169.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -152.47 145.15 17.16 Favored Pre-proline 0 CA--C 1.534 0.358 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 168.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -71.92 -23.26 22.28 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 122.421 2.081 . . . . 0.0 113.383 -169.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -80.91 -8.17 59.67 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 118.58 0.627 . . . . 0.0 112.653 179.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 49.1 t -91.62 110.58 21.9 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 -177.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -49.46 -53.92 18.47 Favored Glycine 0 CA--C 1.533 1.218 0 CA-C-O 118.693 -1.059 . . . . 0.0 113.085 179.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_exo -51.65 -32.58 45.43 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 123.223 2.615 . . . . 0.0 115.35 175.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 89.4 m -62.76 -35.46 79.88 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.908 1.231 . . . . 0.0 111.432 173.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -71.01 -41.04 71.42 Favored 'General case' 0 N--CA 1.463 0.191 0 O-C-N 121.642 -0.662 . . . . 0.0 109.626 173.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 26.5 mmt -64.42 -34.94 79.35 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 118.455 0.571 . . . . 0.0 111.75 -176.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 8.8 tt -82.19 -10.36 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-N 118.549 0.613 . . . . 0.0 111.707 178.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -57.04 -49.99 90.79 Favored Pre-proline 0 CA--C 1.543 0.692 0 CA-C-O 117.568 -1.206 . . . . 0.0 112.644 178.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -65.55 -31.46 50.61 Favored 'Trans proline' 0 C--N 1.351 0.687 0 CA-C-N 121.71 1.646 . . . . 0.0 112.476 176.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 23.1 t -59.48 -44.98 94.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 119.679 1.127 . . . . 0.0 109.638 172.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 75.8 mt -67.48 -36.71 81.66 Favored 'General case' 0 C--O 1.226 -0.184 0 CA-C-O 118.925 -0.56 . . . . 0.0 110.671 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -68.0 -37.7 81.76 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 119.369 0.986 . . . . 0.0 111.469 176.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -64.21 -37.08 86.17 Favored 'General case' 0 N--CA 1.456 -0.126 0 O-C-N 121.345 -0.847 . . . . 0.0 110.323 173.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 11.1 tp -72.48 -38.88 68.06 Favored 'General case' 0 N--CA 1.446 -0.633 0 O-C-N 121.816 -0.553 . . . . 0.0 110.556 178.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -65.21 -42.93 93.03 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.748 0.819 . . . . 0.0 110.147 -179.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -74.07 -13.55 60.86 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 -176.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 65.3 mt-10 -103.64 -33.6 8.92 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.52 1.128 . . . . 0.0 113.058 179.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 42.8 mtt -137.77 -0.39 2.13 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 117.997 -1.001 . . . . 0.0 113.027 -169.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.09 43.67 0.84 Allowed Glycine 0 CA--C 1.533 1.157 0 C-N-CA 126.766 2.127 . . . . 0.0 114.695 -172.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -149.0 -39.76 0.15 Allowed 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 128.443 2.697 . . . . 0.0 107.78 169.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -63.56 -34.76 78.51 Favored 'General case' 0 C--N 1.343 0.307 0 C-N-CA 124.623 1.169 . . . . 0.0 110.369 169.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -132.73 164.32 27.03 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 125.719 1.608 . . . . 0.0 109.622 168.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -103.16 151.43 22.61 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 169.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 17.4 mt -119.04 136.37 56.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 N-CA-C 105.301 -2.111 . . . . 0.0 105.301 170.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 45.7 t -128.48 135.04 63.5 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 107.524 -1.288 . . . . 0.0 107.524 -179.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 61.3 mmtt -92.31 142.63 27.25 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 169.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 17.5 tt -147.25 115.52 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-O 121.375 0.607 . . . . 0.0 109.382 171.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -82.27 112.8 19.6 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.827 0.851 . . . . 0.0 109.33 -175.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 32.9 m -59.85 -26.01 34.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-N 118.515 0.598 . . . . 0.0 112.539 -175.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -72.57 -1.59 16.59 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.571 0.749 . . . . 0.0 112.237 -178.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -131.57 6.77 4.43 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.418 1.487 . . . . 0.0 110.498 172.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 67.8 m-80 -143.31 46.44 1.52 Allowed 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.334 1.054 . . . . 0.0 110.645 -168.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.522 ' NE2' ' H ' ' A' ' 61' ' ' GLN . 0.4 OUTLIER -57.45 -44.02 84.45 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.92 0.888 . . . . 0.0 109.082 175.994 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -67.38 -29.9 69.55 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 125.612 1.565 . . . . 0.0 111.55 -173.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.07 -47.33 11.04 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 119.031 -0.509 . . . . 0.0 109.736 175.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.69 -45.89 90.69 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 119.572 1.078 . . . . 0.0 110.304 -176.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -61.81 -22.61 62.34 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 123.728 0.68 . . . . 0.0 112.721 176.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.7 ttmm -61.19 -25.62 67.16 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 118.532 1.166 . . . . 0.0 111.423 177.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -116.51 11.18 14.75 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.758 1.223 . . . . 0.0 110.703 179.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 67.6 26.36 73.72 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.145 0.879 . . . . 0.0 112.781 -176.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 89.3 t -99.1 154.25 4.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-N 118.18 0.99 . . . . 0.0 109.158 179.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -162.57 -24.0 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 127.252 2.221 . . . . 0.0 109.492 167.469 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 8.0 m -63.69 150.58 44.04 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 123.896 0.878 . . . . 0.0 109.112 170.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -145.22 155.9 54.35 Favored Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 124.256 1.022 . . . . 0.0 108.998 176.32 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.39 140.78 50.27 Favored 'Cis proline' 0 N--CA 1.456 -0.678 0 CA-C-N 119.916 1.006 . . . . 0.0 109.541 -10.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 54.4 m -131.93 121.51 24.11 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 176.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 52.7 mt -95.53 102.3 14.09 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 179.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -81.01 143.27 32.64 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 167.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.7 t -125.51 126.1 69.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 104.289 -2.485 . . . . 0.0 104.289 174.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.9 mp -126.79 160.77 29.92 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 124.994 1.318 . . . . 0.0 107.976 -178.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -144.89 125.89 14.51 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 175.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.0 t70 44.81 36.96 2.04 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.279 1.432 . . . . 0.0 113.469 175.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 105.68 -2.26 39.17 Favored Glycine 0 CA--C 1.528 0.885 0 CA-C-O 118.055 -1.414 . . . . 0.0 115.126 169.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -130.58 148.72 52.41 Favored 'General case' 0 C--N 1.338 0.099 0 CA-C-N 120.159 1.98 . . . . 0.0 110.516 -178.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 52.5 t -66.19 140.47 19.49 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 C-N-CA 124.053 0.941 . . . . 0.0 108.773 177.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 35.3 m -124.62 -18.39 3.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 125.398 1.479 . . . . 0.0 110.917 172.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.96 165.4 32.12 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 120.318 1.417 . . . . 0.0 111.429 169.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 56.3 m -144.05 133.05 22.77 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.892 1.677 . . . . 0.0 107.077 169.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 17.8 m -143.61 152.93 42.0 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.875 1.27 . . . . 0.0 108.481 -176.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 28.6 t -131.22 150.29 34.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-N 119.145 0.884 . . . . 0.0 108.794 -170.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.73 174.27 46.33 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 124.518 1.056 . . . . 0.0 112.173 176.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -59.58 152.12 22.88 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 123.623 0.769 . . . . 0.0 110.806 177.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -153.38 146.73 18.03 Favored Pre-proline 0 C--O 1.233 0.232 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 168.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.2 158.18 52.44 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.172 1.915 . . . . 0.0 110.332 177.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 4.8 ttpt -59.3 -33.95 71.71 Favored 'General case' 0 C--O 1.224 -0.288 0 C-N-CA 123.462 0.705 . . . . 0.0 111.551 179.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -64.51 -39.91 94.66 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 119.106 0.866 . . . . 0.0 111.946 -179.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.32 -41.2 70.18 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 122.735 0.414 . . . . 0.0 110.389 175.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 28.0 tp -66.75 -40.3 88.24 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 122.638 0.375 . . . . 0.0 110.744 -177.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.8 pp0? -69.43 -31.17 69.33 Favored 'General case' 0 C--O 1.227 -0.106 0 CA-C-N 118.821 0.737 . . . . 0.0 110.164 176.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -64.91 -47.72 76.73 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 176.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 63.6 tp -57.86 -46.67 84.49 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.354 0.662 . . . . 0.0 110.381 178.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 23.4 t -62.37 -49.27 84.61 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 CA-C-O 119.061 -0.495 . . . . 0.0 110.029 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.46 -26.96 68.67 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 119.171 0.896 . . . . 0.0 112.215 -175.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 61.6 mtpt -67.86 -29.76 68.97 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 118.597 -0.716 . . . . 0.0 112.041 171.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 86.1 m-70 -90.87 -21.35 21.46 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.259 0.936 . . . . 0.0 113.244 179.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 65.9 mt . . . . . 0 C--O 1.249 1.053 0 CA-C-N 119.569 1.077 . . . . 0.0 109.88 175.472 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.0 tpt . . . . . 0 N--CA 1.483 1.21 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.81 163.85 38.31 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 125.782 1.633 . . . . 0.0 108.359 176.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 79.8 mt -66.42 154.25 8.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 124.906 1.282 . . . . 0.0 107.783 177.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.6 t -119.48 167.53 12.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 125.348 1.459 . . . . 0.0 107.767 -168.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.7 tppp? -128.5 145.88 50.98 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 177.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -146.19 168.73 20.29 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 123.24 0.616 . . . . 0.0 110.332 171.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 72.0 p -135.44 173.57 11.57 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.584 1.553 . . . . 0.0 106.938 174.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -52.44 -30.5 29.92 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 119.701 1.137 . . . . 0.0 113.01 -176.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 26.0 mp0 -62.75 -30.73 71.66 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.097 1.759 . . . . 0.0 112.817 179.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.5 m -139.15 -3.78 1.55 Allowed 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -169.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 61.3 t80 -54.65 -37.79 66.12 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 123.938 0.895 . . . . 0.0 111.035 177.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.4 p -63.04 -50.5 70.42 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.671 0.788 . . . . 0.0 110.76 179.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.21 -44.87 92.26 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.017 0.527 . . . . 0.0 110.081 178.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -66.03 -37.89 87.0 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 119.348 -0.358 . . . . 0.0 111.445 -177.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.481 ' HA ' HG21 ' A' ' 20' ' ' VAL . 27.8 p -79.66 0.44 30.27 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 118.513 0.597 . . . . 0.0 112.549 -178.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.5 m -110.23 32.27 5.27 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.418 1.087 . . . . 0.0 112.312 -172.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 -131.81 2.22 4.04 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -177.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 167.34 -165.62 38.73 Favored Glycine 0 C--N 1.334 0.428 0 O-C-N 121.414 -0.804 . . . . 0.0 111.185 -176.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 1.9 t -76.66 134.86 27.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 104.275 -2.491 . . . . 0.0 104.275 168.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.481 HG21 ' HA ' ' A' ' 15' ' ' THR . 30.2 t -138.34 141.57 37.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -172.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 58.9 tp -113.53 97.96 6.77 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 106.02 -1.844 . . . . 0.0 106.02 173.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.21 149.06 37.29 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 170.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -133.16 99.0 4.42 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 107.2 -1.408 . . . . 0.0 107.2 177.12 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -76.63 114.97 15.96 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 173.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 7.3 p-90 -138.84 175.89 9.17 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 123.401 0.68 . . . . 0.0 110.85 -169.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -151.61 146.66 19.05 Favored Pre-proline 0 CA--C 1.535 0.394 0 C-N-CA 124.53 1.132 . . . . 0.0 107.98 169.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.25 -17.85 18.68 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.962 2.441 . . . . 0.0 113.515 -169.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -84.81 -7.21 59.28 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 118.789 0.722 . . . . 0.0 112.088 177.439 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 54.1 t -87.82 117.08 26.41 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 -178.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -55.82 -55.72 27.52 Favored Glycine 0 CA--C 1.531 1.092 0 CA-C-O 118.691 -1.061 . . . . 0.0 112.201 175.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -51.15 -34.58 48.64 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 123.256 2.637 . . . . 0.0 115.434 176.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 97.7 m -60.92 -35.78 77.58 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 119.96 1.255 . . . . 0.0 111.672 173.097 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.1 mttm -70.14 -40.94 74.51 Favored 'General case' 0 N--CA 1.464 0.266 0 O-C-N 121.52 -0.737 . . . . 0.0 109.692 173.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 26.3 mmt -64.71 -38.17 90.07 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 118.231 0.469 . . . . 0.0 111.487 -176.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 10.8 tt -79.16 -15.97 13.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-N 118.394 0.543 . . . . 0.0 111.51 179.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.9 -48.97 94.46 Favored Pre-proline 0 CA--C 1.541 0.598 0 CA-C-O 117.472 -1.251 . . . . 0.0 113.597 -177.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.06 -27.73 49.67 Favored 'Trans proline' 0 C--N 1.35 0.632 0 CA-C-N 122.087 1.781 . . . . 0.0 112.461 176.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 6.0 t -66.42 -41.13 88.23 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-N 119.346 0.975 . . . . 0.0 109.059 174.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 66.0 mt -67.03 -34.28 77.37 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 118.745 -0.645 . . . . 0.0 110.961 175.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -69.45 -36.55 76.71 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 119.482 1.037 . . . . 0.0 111.496 174.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 44.0 mm-40 -61.17 -46.73 89.3 Favored 'General case' 0 CA--C 1.528 0.098 0 O-C-N 121.137 -0.977 . . . . 0.0 109.233 171.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -62.11 -35.96 80.3 Favored 'General case' 0 C--O 1.224 -0.255 0 C-N-CA 122.857 0.463 . . . . 0.0 111.557 177.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -65.28 -41.88 93.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 119.27 0.941 . . . . 0.0 110.427 176.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -68.01 -36.97 80.87 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 122.823 0.449 . . . . 0.0 111.634 178.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -93.35 -30.1 15.29 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.014 0.926 . . . . 0.0 112.426 -169.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 20.0 mmt -136.95 -3.41 2.02 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.39 1.476 . . . . 0.0 112.706 -169.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -52.12 -28.74 26.88 Favored Glycine 0 CA--C 1.538 1.469 0 CA-C-N 120.945 1.702 . . . . 0.0 113.277 177.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -73.67 -29.32 62.24 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.844 1.658 . . . . 0.0 111.434 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 55.3 mmtt -97.82 -25.97 14.86 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 125.444 1.498 . . . . 0.0 110.651 -177.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -150.58 126.11 10.2 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.095 0.958 . . . . 0.0 110.038 -167.357 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -73.76 152.49 40.34 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 175.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 17.6 mt -125.72 130.97 72.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 N-CA-C 105.645 -1.983 . . . . 0.0 105.645 175.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 22.0 t -132.07 113.66 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -170.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 48.2 mmtt -73.86 143.29 45.92 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 170.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 15.4 tt -149.02 125.34 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 169.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -80.28 128.57 33.69 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 22.5 m -70.02 -31.59 48.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 -173.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -77.6 -35.36 52.95 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 119.136 0.88 . . . . 0.0 109.755 -175.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -72.98 -15.9 61.53 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.861 0.864 . . . . 0.0 111.869 172.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 63.3 m-80 -139.77 51.97 1.72 Allowed 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 119.227 0.921 . . . . 0.0 111.044 -168.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.413 ' CD ' ' H ' ' A' ' 61' ' ' GLN . 0.7 OUTLIER -56.56 -38.66 72.22 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.791 0.836 . . . . 0.0 109.55 179.673 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -66.49 -27.74 68.02 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.946 1.298 . . . . 0.0 112.553 -177.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.425 ' HA ' ' HE2' ' A' ' 66' ' ' LYS . 0.2 OUTLIER -88.42 -45.53 9.89 Favored 'General case' 0 C--O 1.222 -0.373 0 CA-C-N 118.809 0.731 . . . . 0.0 109.725 178.47 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.79 -46.9 85.85 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.271 0.941 . . . . 0.0 109.792 179.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -61.77 -22.37 61.95 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 124.48 1.038 . . . . 0.0 112.746 175.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.425 ' HE2' ' HA ' ' A' ' 63' ' ' THR . 5.7 ttmm -57.84 -23.08 51.16 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 118.778 1.289 . . . . 0.0 111.852 174.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -125.76 13.58 8.01 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.688 1.195 . . . . 0.0 110.375 179.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 68.65 20.12 73.71 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 124.661 1.124 . . . . 0.0 113.689 -178.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 97.9 t -84.83 136.28 23.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 176.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -155.42 29.02 0.39 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.732 1.213 . . . . 0.0 109.258 167.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 20.8 m -138.15 154.41 49.17 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 126.678 1.991 . . . . 0.0 106.864 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -145.31 158.72 50.73 Favored Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 123.866 0.867 . . . . 0.0 110.143 -169.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -67.92 140.74 56.03 Favored 'Cis proline' 0 C--N 1.349 0.573 0 N-CA-C 109.168 -1.128 . . . . 0.0 109.168 -11.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 54.7 m -131.67 118.28 19.8 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 177.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 89.4 mt -93.54 137.98 32.28 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 178.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.0 mp -121.22 130.34 53.64 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 105.238 -2.134 . . . . 0.0 105.238 169.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.8 t -94.35 127.73 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 103.571 -2.751 . . . . 0.0 103.571 168.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.6 mp -125.33 160.42 29.37 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 125.198 1.399 . . . . 0.0 107.792 176.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -149.32 125.08 10.48 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.8 t70 44.88 34.98 1.34 Allowed 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.304 1.441 . . . . 0.0 113.714 177.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 109.71 -1.72 30.5 Favored Glycine 0 CA--C 1.527 0.785 0 CA-C-O 118.033 -1.426 . . . . 0.0 115.588 168.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -131.06 145.18 51.93 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 120.13 1.965 . . . . 0.0 110.288 -178.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.3 p -66.86 138.45 22.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 172.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 27.1 m -127.03 -16.47 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 125.68 1.592 . . . . 0.0 110.682 178.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.44 164.3 38.42 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 119.871 1.214 . . . . 0.0 110.902 169.18 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 93.9 m -146.37 137.83 24.61 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.461 1.505 . . . . 0.0 108.421 176.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 19.7 m -146.24 152.98 40.07 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.413 1.485 . . . . 0.0 108.691 -176.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 40.3 t -133.03 146.43 32.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 -173.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 85.49 178.62 50.51 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 124.451 1.024 . . . . 0.0 111.89 178.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -60.26 152.86 23.83 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.173 0.989 . . . . 0.0 110.575 174.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -141.42 148.2 49.65 Favored Pre-proline 0 C--O 1.234 0.257 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 168.282 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -71.56 158.59 53.38 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 122.381 2.054 . . . . 0.0 110.22 171.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -55.31 -45.97 76.28 Favored 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 123.397 0.679 . . . . 0.0 111.042 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -64.33 -42.04 96.49 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 118.345 0.521 . . . . 0.0 111.248 -169.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.0 -42.51 89.65 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 122.897 0.479 . . . . 0.0 110.878 175.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 43.3 tp -69.16 -41.01 77.8 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 119.233 -0.413 . . . . 0.0 110.744 -176.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.7 pp0? -70.8 -30.12 66.49 Favored 'General case' 0 C--N 1.337 0.058 0 CA-C-N 119.022 0.828 . . . . 0.0 110.303 176.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -64.07 -49.22 73.16 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 175.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 67.6 tp -57.65 -46.1 84.64 Favored 'General case' 0 CA--C 1.527 0.095 0 C-N-CA 123.869 0.867 . . . . 0.0 110.349 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 19.6 t -60.06 -53.45 48.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 177.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -63.35 -28.88 70.3 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 118.78 0.718 . . . . 0.0 112.395 -175.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -68.12 -32.13 72.2 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 118.475 -0.774 . . . . 0.0 111.958 173.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 58.0 m-70 -89.75 -16.73 29.66 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 119.326 0.966 . . . . 0.0 113.296 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 65.5 mt . . . . . 0 C--O 1.249 1.073 0 CA-C-N 119.737 1.153 . . . . 0.0 109.847 173.032 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.4 mmt . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 118.202 -0.904 . . . . 0.0 111.257 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 64.73 -178.38 0.17 Allowed 'General case' 0 C--O 1.238 0.481 0 C-N-CA 125.589 1.556 . . . . 0.0 113.332 177.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 21.2 mt -75.69 143.72 12.85 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 169.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 25.6 t -140.44 167.59 18.04 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 128.069 2.547 . . . . 0.0 105.678 -176.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.0 mtmt -125.62 144.36 50.62 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 173.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -144.8 170.1 16.77 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 122.913 0.485 . . . . 0.0 110.622 176.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 73.7 p -135.63 173.35 11.81 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 176.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -49.27 -32.38 10.75 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 119.669 1.122 . . . . 0.0 113.138 -177.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 25.3 mp0 -62.04 -31.58 71.99 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.408 1.883 . . . . 0.0 112.777 -179.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.3 m -139.92 -4.26 1.38 Allowed 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 -171.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -53.57 -37.59 63.07 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 124.305 1.042 . . . . 0.0 111.006 176.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.0 m -67.29 -38.83 85.66 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 122.49 0.316 . . . . 0.0 111.286 -178.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.18 -45.2 77.68 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 175.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -64.54 -37.12 86.46 Favored 'General case' 0 C--O 1.231 0.116 0 C-N-CA 122.64 0.376 . . . . 0.0 111.374 -175.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.443 ' HA ' HG21 ' A' ' 20' ' ' VAL . 19.9 p -77.28 -1.39 29.52 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 179.532 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 67.9 m -108.65 33.29 4.28 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.448 1.099 . . . . 0.0 111.933 -171.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -132.65 0.62 3.61 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -177.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 166.31 -165.55 38.31 Favored Glycine 0 C--N 1.336 0.535 0 CA-C-N 119.367 0.985 . . . . 0.0 111.424 -175.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 97.3 t -73.77 127.73 35.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 N-CA-C 104.6 -2.37 . . . . 0.0 104.6 166.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.443 HG21 ' HA ' ' A' ' 15' ' ' THR . 39.2 t -133.72 122.64 43.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 -174.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 18.3 tp -87.8 139.22 30.75 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 105.84 -1.911 . . . . 0.0 105.84 168.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -125.01 113.67 18.1 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 -179.032 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -94.1 90.41 6.38 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 125.337 1.455 . . . . 0.0 108.391 -178.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -72.1 113.22 8.89 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 169.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 7.9 p-90 -138.79 176.42 8.71 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 123.561 0.744 . . . . 0.0 111.068 -169.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -151.84 146.6 18.85 Favored Pre-proline 0 CA--C 1.535 0.379 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 169.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.35 -20.17 16.45 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 122.744 2.296 . . . . 0.0 113.494 -171.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -81.95 -7.84 59.63 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 121.526 -0.734 . . . . 0.0 111.823 176.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 52.0 t -88.12 117.32 26.92 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -55.58 -57.92 16.4 Favored Glycine 0 CA--C 1.531 1.067 0 CA-C-O 118.572 -1.126 . . . . 0.0 111.598 173.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -49.89 -36.32 42.96 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 123.569 2.846 . . . . 0.0 115.434 177.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 98.0 m -60.02 -45.51 92.55 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 119.886 1.221 . . . . 0.0 111.418 173.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 46.5 mtmt -70.86 -30.58 67.02 Favored 'General case' 0 CA--C 1.53 0.174 0 O-C-N 121.465 -0.772 . . . . 0.0 110.639 178.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 86.5 mtp -68.37 -42.54 79.03 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 118.685 0.675 . . . . 0.0 111.226 176.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 7.4 tt -76.82 -21.45 14.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-N 119.1 0.863 . . . . 0.0 111.115 -178.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.17 -51.28 64.11 Favored Pre-proline 0 CA--C 1.546 0.823 0 CA-C-N 119.737 1.153 . . . . 0.0 113.915 -177.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.28 -30.5 54.23 Favored 'Trans proline' 0 C--N 1.349 0.59 0 CA-C-N 121.866 1.702 . . . . 0.0 112.364 176.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 6.8 t -65.49 -37.87 81.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-N 119.334 0.97 . . . . 0.0 109.521 174.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 82.6 mt -68.24 -33.41 74.33 Favored 'General case' 0 C--O 1.225 -0.213 0 CA-C-O 118.569 -0.729 . . . . 0.0 110.844 173.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -66.65 -36.13 81.81 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.836 1.198 . . . . 0.0 111.405 172.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 55.4 mm-40 -65.93 -39.05 90.17 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 120.808 -1.182 . . . . 0.0 110.149 172.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 46.9 tp -66.5 -36.66 83.27 Favored 'General case' 0 C--O 1.226 -0.144 0 O-C-N 121.648 -0.658 . . . . 0.0 110.731 175.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -66.29 -37.47 85.5 Favored 'General case' 0 N--CA 1.454 -0.238 0 O-C-N 121.586 -0.696 . . . . 0.0 111.096 176.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -64.36 -33.42 75.8 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.376 -0.828 . . . . 0.0 111.305 171.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -79.0 -39.16 34.83 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.301 1.04 . . . . 0.0 112.139 -177.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 21.2 mmt -133.5 -7.23 2.9 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 -166.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.97 -3.85 12.48 Favored Glycine 0 CA--C 1.531 1.079 0 CA-C-N 120.474 1.488 . . . . 0.0 115.142 -174.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -82.29 -27.5 32.3 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.518 1.527 . . . . 0.0 111.751 172.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -129.04 -1.77 5.19 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.837 1.655 . . . . 0.0 112.624 -172.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -139.38 155.87 47.37 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 126.828 2.051 . . . . 0.0 106.906 177.329 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -110.01 151.35 27.27 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 173.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 18.3 mt -119.72 136.7 56.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 105.064 -2.198 . . . . 0.0 105.064 170.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 99.5 t -126.24 115.14 41.43 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 -176.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 10.3 mmmm -75.19 140.88 43.59 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 171.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 16.6 tt -148.92 113.91 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 173.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 60.6 t0 -77.24 117.18 18.51 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 -178.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 30.6 m -62.88 -27.35 42.93 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -175.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -69.18 -28.87 66.79 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 119.331 0.969 . . . . 0.0 110.768 -178.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -93.62 -7.72 43.16 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.63 1.172 . . . . 0.0 111.073 177.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -141.38 47.12 1.7 Allowed 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 124.549 1.14 . . . . 0.0 109.929 -168.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.485 ' CD ' ' H ' ' A' ' 61' ' ' GLN . 1.4 mp0 -58.39 -40.9 83.6 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.315 1.046 . . . . 0.0 109.024 -177.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -63.21 -45.12 93.17 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.497 1.119 . . . . 0.0 110.399 179.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.477 ' HA ' ' HE3' ' A' ' 66' ' ' LYS . 0.8 OUTLIER -69.01 -43.77 74.14 Favored 'General case' 0 C--O 1.221 -0.433 0 CA-C-N 118.729 0.695 . . . . 0.0 110.362 -176.752 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.16 -45.68 92.31 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 119.166 0.894 . . . . 0.0 109.417 176.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -58.11 -26.37 58.44 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 124.232 0.92 . . . . 0.0 113.081 174.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.477 ' HE3' ' HA ' ' A' ' 63' ' ' THR . 27.4 ttmt -57.82 -21.54 42.84 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.459 1.504 . . . . 0.0 111.908 177.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -127.81 12.84 6.83 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.88 1.272 . . . . 0.0 110.532 179.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 68.95 20.18 74.34 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 124.558 1.075 . . . . 0.0 113.544 -177.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 85.2 t -85.35 137.08 21.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 176.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -157.66 28.9 0.28 Allowed 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.512 1.125 . . . . 0.0 109.523 167.043 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 44.1 m -135.08 154.06 51.81 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 126.317 1.847 . . . . 0.0 106.89 174.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -146.32 160.2 43.04 Favored Pre-proline 0 CA--C 1.543 0.688 0 C-N-CA 124.565 1.146 . . . . 0.0 109.273 -170.15 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -66.93 139.84 47.75 Favored 'Cis proline' 0 C--N 1.349 0.553 0 CA-C-N 120.161 1.093 . . . . 0.0 109.77 -10.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 41.5 m -132.99 133.79 43.61 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 178.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 78.6 mt -119.28 103.08 9.17 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 -172.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.7 mp -84.87 146.01 27.52 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 106.822 -1.548 . . . . 0.0 106.822 168.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.4 t -111.33 127.87 68.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 103.633 -2.728 . . . . 0.0 103.633 169.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.7 mp -127.0 158.62 36.44 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.308 1.443 . . . . 0.0 107.445 179.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -145.77 127.16 14.94 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 175.027 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.9 t70 44.3 37.44 1.98 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.389 1.476 . . . . 0.0 113.616 174.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.87 5.25 47.76 Favored Glycine 0 CA--C 1.527 0.783 0 CA-C-O 118.59 -1.117 . . . . 0.0 114.861 169.138 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 82.1 mm-40 -130.13 141.44 50.68 Favored 'General case' 0 CA--C 1.522 -0.105 0 CA-C-N 119.52 1.66 . . . . 0.0 109.133 178.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.5 p -69.25 137.42 24.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 169.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 25.3 m -125.21 -20.48 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 C-N-CA 124.989 1.316 . . . . 0.0 110.328 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.21 167.1 31.49 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 119.545 1.066 . . . . 0.0 111.454 175.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 80.7 m -148.43 141.05 24.47 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.55 1.54 . . . . 0.0 108.738 176.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 21.3 m -144.63 155.88 43.83 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.988 1.715 . . . . 0.0 108.309 177.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 39.5 t -133.81 149.72 30.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 -176.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.09 172.3 47.08 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 124.385 0.993 . . . . 0.0 112.449 172.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -63.92 131.19 46.93 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 123.59 0.756 . . . . 0.0 109.291 175.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -136.1 143.73 45.23 Favored Pre-proline 0 CA--C 1.534 0.35 0 C-N-CA 126.095 1.758 . . . . 0.0 107.035 179.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -74.68 156.83 44.43 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.691 2.26 . . . . 0.0 110.917 178.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.6 tmpt? -58.98 -36.24 74.54 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 123.449 0.699 . . . . 0.0 111.247 -177.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -67.52 -35.15 78.55 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 118.838 0.744 . . . . 0.0 111.269 -175.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.03 -42.61 72.73 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 122.886 0.474 . . . . 0.0 110.485 173.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 84.5 mt -67.05 -41.39 86.56 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-O 118.902 -0.57 . . . . 0.0 110.392 -178.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.0 pp0? -68.22 -30.8 69.95 Favored 'General case' 0 C--O 1.228 -0.075 0 CA-C-N 119.274 0.943 . . . . 0.0 110.247 177.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -65.41 -47.75 75.21 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 176.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 59.2 tp -58.47 -43.35 88.89 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.269 0.627 . . . . 0.0 110.652 178.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 39.6 t -61.22 -50.63 79.68 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 C-N-CA 123.103 0.561 . . . . 0.0 109.593 176.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -63.88 -26.89 68.81 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 118.975 0.807 . . . . 0.0 112.284 -175.346 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 62.1 mtpt -67.17 -18.55 65.32 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 118.056 -0.973 . . . . 0.0 112.997 171.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -114.34 -10.09 12.71 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 119.856 1.207 . . . . 0.0 113.658 -179.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 80.3 mt . . . . . 0 C--O 1.251 1.161 0 CA-C-N 120.032 1.287 . . . . 0.0 109.723 172.314 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.477 0.892 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -155.47 144.36 20.64 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 169.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 92.6 mt -75.93 144.29 12.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 177.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 40.5 t -105.33 166.48 3.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 -174.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 5.8 mptt -138.55 134.69 34.18 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 -178.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -143.45 170.7 15.3 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 122.935 0.494 . . . . 0.0 110.791 -179.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.1 p -135.29 171.71 14.05 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 178.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -49.5 -32.42 12.2 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 119.808 1.186 . . . . 0.0 113.021 -176.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 25.2 mp0 -63.48 -30.35 71.49 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.716 2.007 . . . . 0.0 112.923 -179.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.6 m -138.61 -6.7 1.5 Allowed 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 114.358 1.244 . . . . 0.0 114.358 -172.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -56.22 -34.83 66.69 Favored 'General case' 0 C--N 1.333 -0.122 0 C-N-CA 124.606 1.162 . . . . 0.0 111.11 178.155 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.4 p -62.75 -48.47 79.07 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 123.649 0.78 . . . . 0.0 111.062 178.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.33 -44.88 96.44 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 122.78 0.432 . . . . 0.0 109.862 177.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -65.14 -37.6 87.93 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 119.274 -0.393 . . . . 0.0 111.546 -176.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.51 ' HA ' HG21 ' A' ' 20' ' ' VAL . 23.3 p -78.93 0.25 28.16 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 118.595 0.634 . . . . 0.0 112.533 -179.146 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 48.8 m -112.03 34.43 4.24 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.406 1.082 . . . . 0.0 111.962 -171.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -131.78 -1.35 3.79 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -178.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 166.41 -167.09 39.27 Favored Glycine 0 C--N 1.335 0.518 0 CA-C-N 119.198 0.908 . . . . 0.0 110.872 -172.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 76.9 t -72.3 134.06 30.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 104.874 -2.269 . . . . 0.0 104.874 167.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.51 HG21 ' HA ' ' A' ' 15' ' ' THR . 38.8 t -137.12 119.25 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 -176.288 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 60.5 tp -88.75 97.44 11.14 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 170.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.47 149.41 36.79 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 169.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -133.21 98.41 4.25 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 176.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -73.97 113.45 11.16 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 172.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 6.0 p-90 -136.26 175.89 9.19 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 123.721 0.808 . . . . 0.0 110.219 -169.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -149.89 144.98 18.22 Favored Pre-proline 0 CA--C 1.534 0.345 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 169.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.37 -21.91 22.38 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 122.438 2.092 . . . . 0.0 113.471 -170.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -83.84 -8.24 59.26 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 118.693 0.679 . . . . 0.0 112.228 178.609 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 53.7 t -85.15 117.63 24.22 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -178.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -54.58 -57.11 18.93 Favored Glycine 0 CA--C 1.532 1.154 0 CA-C-O 118.651 -1.083 . . . . 0.0 112.137 176.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -50.86 -35.87 50.57 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 123.18 2.586 . . . . 0.0 115.093 175.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 90.7 m -62.1 -37.05 83.6 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 119.676 1.126 . . . . 0.0 111.882 173.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -69.63 -42.07 74.79 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 118.804 0.729 . . . . 0.0 109.851 172.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 62.0 mtt -62.36 -38.01 87.9 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 122.948 0.499 . . . . 0.0 111.159 -175.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 10.9 tt -78.86 -16.04 13.54 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-N 118.569 0.622 . . . . 0.0 111.848 -178.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.03 -51.22 82.38 Favored Pre-proline 0 CA--C 1.544 0.728 0 CA-C-N 120.069 1.304 . . . . 0.0 113.57 -178.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -64.3 -30.31 63.69 Favored 'Trans proline' 0 C--N 1.351 0.672 0 CA-C-N 121.769 1.667 . . . . 0.0 111.872 176.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.4 t -64.82 -42.14 94.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-N 118.908 0.776 . . . . 0.0 109.56 176.014 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 66.2 mt -66.88 -32.98 74.59 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 118.347 -0.835 . . . . 0.0 110.734 175.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -68.29 -37.95 81.17 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 120.206 1.366 . . . . 0.0 111.49 173.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -64.62 -31.55 72.82 Favored 'General case' 0 C--N 1.334 -0.095 0 O-C-N 121.225 -0.922 . . . . 0.0 110.99 172.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 18.5 tp -76.82 -38.81 53.17 Favored 'General case' 0 N--CA 1.448 -0.56 0 O-C-N 121.82 -0.55 . . . . 0.0 110.857 174.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -64.73 -36.59 84.77 Favored 'General case' 0 C--O 1.23 0.068 0 C-N-CA 124.354 1.062 . . . . 0.0 110.654 -178.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -76.48 -22.03 55.05 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 121.894 -0.504 . . . . 0.0 111.977 -177.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 89.0 mt-10 -94.33 -34.7 12.71 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.462 1.105 . . . . 0.0 113.158 178.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 32.8 mtt -136.76 -4.55 1.99 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 118.046 -0.978 . . . . 0.0 113.263 -169.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -76.34 49.81 2.7 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 125.878 1.704 . . . . 0.0 113.11 -173.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -154.98 -40.69 0.09 Allowed 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 129.678 3.191 . . . . 0.0 106.915 171.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 57.3 mttp -61.62 -36.98 82.29 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.291 1.436 . . . . 0.0 109.817 168.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -134.02 165.5 24.9 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 126.545 1.938 . . . . 0.0 109.603 170.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -101.48 151.66 21.69 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.428 1.091 . . . . 0.0 108.135 171.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 18.7 mt -116.48 134.75 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 N-CA-C 105.118 -2.178 . . . . 0.0 105.118 170.131 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 87.2 t -132.43 117.57 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -176.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 55.6 mmtt -75.7 144.91 41.31 Favored 'General case' 0 C--O 1.235 0.303 0 O-C-N 121.695 -0.628 . . . . 0.0 109.663 169.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 15.3 tt -148.19 119.13 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 169.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 50.9 t0 -82.72 114.13 20.86 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.969 0.907 . . . . 0.0 109.924 -174.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 25.0 m -63.02 -22.89 31.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 -174.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -66.01 -30.54 71.1 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 119.016 0.826 . . . . 0.0 111.275 -175.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -99.66 -39.29 8.34 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 123.267 0.627 . . . . 0.0 109.73 173.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 -89.45 46.29 1.36 Allowed 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 124.268 1.027 . . . . 0.0 111.245 -169.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -56.11 -43.02 77.73 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 126.624 1.97 . . . . 0.0 108.816 179.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 30.7 mm-40 -67.5 -27.38 66.95 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 125.112 1.365 . . . . 0.0 112.306 -177.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.414 ' HA ' ' HE2' ' A' ' 66' ' ' LYS . 0.2 OUTLIER -88.45 -46.01 9.49 Favored 'General case' 0 C--O 1.222 -0.392 0 CA-C-N 118.599 0.636 . . . . 0.0 109.687 179.519 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.87 -46.03 89.78 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 119.321 0.964 . . . . 0.0 109.624 179.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -60.65 -24.17 61.74 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 124.095 0.855 . . . . 0.0 112.862 175.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.414 ' HE2' ' HA ' ' A' ' 63' ' ' THR . 5.2 ttmm -58.13 -23.49 55.28 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 118.573 1.187 . . . . 0.0 112.056 176.041 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -124.87 13.05 8.5 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.734 1.214 . . . . 0.0 110.487 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 68.96 19.61 73.83 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 124.538 1.066 . . . . 0.0 113.691 -178.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 96.5 t -84.28 135.63 24.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 176.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.18 28.22 0.46 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.586 1.154 . . . . 0.0 109.372 168.019 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 22.5 m -138.12 152.76 49.05 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 126.704 2.002 . . . . 0.0 106.77 178.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -145.72 160.09 45.31 Favored Pre-proline 0 CA--C 1.541 0.602 0 C-N-CA 124.058 0.943 . . . . 0.0 109.905 -169.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -66.94 139.52 46.19 Favored 'Cis proline' 0 C--N 1.349 0.601 0 N-CA-C 109.366 -1.051 . . . . 0.0 109.366 -11.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 51.9 m -132.0 117.74 18.8 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 177.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 95.4 mt -92.8 136.7 33.01 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 179.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.8 mp -121.09 130.92 53.96 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 105.061 -2.2 . . . . 0.0 105.061 169.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.5 t -93.56 124.24 45.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 103.196 -2.89 . . . . 0.0 103.196 168.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.9 mp -118.75 159.01 24.45 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 173.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 73.7 tttt -145.2 126.73 15.06 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 173.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.7 t70 44.33 38.62 2.58 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.395 1.478 . . . . 0.0 113.484 175.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 101.21 5.33 52.86 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-O 118.598 -1.112 . . . . 0.0 114.862 169.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 82.1 mm-40 -130.49 142.31 50.49 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 119.513 1.657 . . . . 0.0 109.142 178.051 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.2 p -68.54 138.32 22.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 169.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 33.0 m -126.75 -20.68 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 125.062 1.345 . . . . 0.0 110.478 179.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -153.08 166.9 31.01 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 119.73 1.15 . . . . 0.0 111.339 171.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 96.1 m -148.67 141.04 24.19 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.577 1.551 . . . . 0.0 108.732 177.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 16.0 m -147.68 156.62 42.96 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.565 1.546 . . . . 0.0 108.611 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 40.6 t -132.99 149.41 31.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -174.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.66 173.99 45.8 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 124.424 1.011 . . . . 0.0 112.299 176.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -59.02 150.74 23.89 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.165 0.986 . . . . 0.0 110.68 177.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -153.94 147.27 18.2 Favored Pre-proline 0 CA--C 1.532 0.279 0 C-N-CA 125.057 1.343 . . . . 0.0 107.514 169.199 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.3 159.28 47.27 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.761 2.307 . . . . 0.0 110.81 179.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 2.9 ttpp -57.44 -36.51 71.49 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.898 0.879 . . . . 0.0 111.51 -177.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -62.4 -36.2 81.59 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.471 0.578 . . . . 0.0 112.059 177.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.79 -40.6 69.11 Favored 'General case' 0 N--CA 1.453 -0.31 0 O-C-N 121.924 -0.485 . . . . 0.0 110.814 174.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 42.7 mt -64.18 -43.44 95.11 Favored 'General case' 0 N--CA 1.457 -0.08 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -179.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.0 pp0? -68.89 -31.66 70.74 Favored 'General case' 0 C--O 1.226 -0.149 0 CA-C-N 118.62 0.645 . . . . 0.0 110.258 178.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -64.23 -49.57 71.41 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 176.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 58.9 tp -57.16 -44.69 83.7 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.372 0.669 . . . . 0.0 110.476 178.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 37.3 t -65.42 -47.34 87.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 CA-C-O 118.946 -0.549 . . . . 0.0 110.638 179.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.29 -25.52 68.09 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 119.606 1.094 . . . . 0.0 112.341 -175.181 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -66.1 -16.42 63.93 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 117.897 -1.049 . . . . 0.0 113.167 171.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -121.64 -10.51 8.77 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 119.96 1.255 . . . . 0.0 113.822 -177.136 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 66.6 mt . . . . . 0 C--O 1.25 1.101 0 CA-C-N 120.114 1.325 . . . . 0.0 109.39 169.958 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.5 ttt . . . . . 0 N--CA 1.479 0.995 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -158.64 143.99 16.43 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 125.166 1.386 . . . . 0.0 107.837 168.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 81.8 mt -78.09 154.51 5.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 173.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 20.3 t -124.69 169.45 16.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 106.106 -1.812 . . . . 0.0 106.106 -172.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.82 153.25 49.65 Favored 'General case' 0 C--O 1.234 0.274 0 O-C-N 120.809 -1.182 . . . . 0.0 109.168 171.498 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -147.73 171.15 16.13 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 123.687 0.795 . . . . 0.0 110.047 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 72.9 p -134.62 173.22 11.9 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 175.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -51.69 -30.76 23.33 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 119.644 1.111 . . . . 0.0 112.977 -176.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 26.1 mp0 -62.13 -31.64 72.14 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.061 1.744 . . . . 0.0 112.728 179.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.4 m -139.61 -2.93 1.52 Allowed 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 114.475 1.287 . . . . 0.0 114.475 -169.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 58.2 t80 -53.63 -38.5 64.12 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 123.95 0.9 . . . . 0.0 110.773 176.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.4 m -66.37 -41.82 88.88 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 122.691 0.397 . . . . 0.0 111.205 -178.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.83 -45.26 86.91 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 176.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -65.3 -37.49 87.3 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 122.568 0.347 . . . . 0.0 111.247 -176.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.53 ' HA ' HG21 ' A' ' 20' ' ' VAL . 23.9 p -78.32 0.49 25.26 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 60.0 m -109.34 32.23 5.15 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.375 1.07 . . . . 0.0 112.302 -173.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -132.44 3.72 3.93 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -177.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 166.59 -166.68 39.12 Favored Glycine 0 C--N 1.335 0.498 0 O-C-N 121.339 -0.85 . . . . 0.0 111.162 -177.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.2 t -76.2 136.12 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 103.717 -2.698 . . . . 0.0 103.717 167.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.53 HG21 ' HA ' ' A' ' 15' ' ' THR . 40.5 t -137.29 139.58 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 -172.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -117.73 97.2 5.72 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 105.331 -2.1 . . . . 0.0 105.331 176.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.56 154.83 28.49 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 172.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -135.7 98.95 4.05 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 125.718 1.607 . . . . 0.0 107.015 -179.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -73.87 116.39 14.43 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 169.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 9.1 p-90 -137.47 175.06 9.94 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.015 0.926 . . . . 0.0 110.759 -172.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -151.83 146.8 19.05 Favored Pre-proline 0 CA--C 1.538 0.485 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 169.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.25 -17.14 21.84 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.835 2.357 . . . . 0.0 113.625 -169.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -85.0 -6.49 59.33 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 118.715 0.689 . . . . 0.0 112.494 178.097 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 42.4 t -91.16 117.98 30.06 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 118.997 0.817 . . . . 0.0 109.066 -176.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -56.84 -54.02 39.78 Favored Glycine 0 CA--C 1.532 1.103 0 CA-C-O 118.812 -0.993 . . . . 0.0 112.414 176.139 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -50.53 -36.39 49.27 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 123.19 2.594 . . . . 0.0 115.272 174.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 98.6 m -60.6 -36.62 79.02 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 120.03 1.286 . . . . 0.0 111.831 173.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 59.9 mttm -69.8 -42.94 73.07 Favored 'General case' 0 N--CA 1.464 0.231 0 O-C-N 121.601 -0.687 . . . . 0.0 109.591 174.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 74.2 mtm -64.65 -35.01 79.65 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 118.987 -0.53 . . . . 0.0 111.771 -176.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 11.7 tt -80.94 -16.46 12.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-N 119.095 0.861 . . . . 0.0 111.811 179.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.53 -49.0 91.01 Favored Pre-proline 0 CA--C 1.543 0.709 0 CA-C-O 117.526 -1.226 . . . . 0.0 113.643 -179.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.52 -27.43 46.34 Favored 'Trans proline' 0 C--N 1.35 0.608 0 CA-C-N 122.048 1.767 . . . . 0.0 112.572 176.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.3 t -66.65 -40.41 86.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 119.226 0.921 . . . . 0.0 109.18 174.026 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 62.8 mt -66.94 -35.59 80.32 Favored 'General case' 0 CA--C 1.529 0.159 0 O-C-N 121.688 -0.632 . . . . 0.0 110.888 175.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -68.48 -36.2 78.62 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 119.269 0.941 . . . . 0.0 111.422 174.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -62.04 -43.17 99.42 Favored 'General case' 0 C--N 1.332 -0.158 0 O-C-N 121.122 -0.986 . . . . 0.0 109.903 171.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -65.26 -35.02 79.74 Favored 'General case' 0 N--CA 1.456 -0.171 0 O-C-N 121.93 -0.481 . . . . 0.0 111.509 176.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -65.7 -38.63 89.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 119.044 0.838 . . . . 0.0 110.357 175.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -68.91 -38.03 79.33 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 121.323 -0.861 . . . . 0.0 111.737 175.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -85.99 -36.16 19.96 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.258 1.023 . . . . 0.0 112.064 -171.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.441 ' SD ' ' HE2' ' A' ' 49' ' ' LYS . 19.0 mmt -135.57 -8.37 2.19 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.169 1.387 . . . . 0.0 112.626 -168.042 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.5 -21.41 54.32 Favored Glycine 0 CA--C 1.532 1.123 0 CA-C-N 120.321 1.419 . . . . 0.0 114.577 -171.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -76.79 -18.51 58.37 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.626 1.97 . . . . 0.0 112.134 -179.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.441 ' HE2' ' SD ' ' A' ' 46' ' ' MET . 14.8 pttm -134.02 -2.07 2.93 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 126.56 1.944 . . . . 0.0 112.239 -173.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -145.2 120.22 10.04 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 125.996 1.718 . . . . 0.0 107.424 174.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -73.07 150.99 41.86 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 176.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 16.9 mt -121.97 132.7 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 N-CA-C 105.892 -1.892 . . . . 0.0 105.892 173.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 48.0 t -132.15 111.75 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-N 118.687 0.676 . . . . 0.0 109.495 -170.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 61.2 mmtt -72.86 142.27 47.96 Favored 'General case' 0 C--O 1.234 0.288 0 O-C-N 121.551 -0.718 . . . . 0.0 109.49 171.024 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 11.9 tt -151.26 131.36 3.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 171.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -87.44 129.64 34.98 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 121.375 -0.828 . . . . 0.0 109.579 -177.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.0 m -66.31 -36.21 76.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 -174.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -75.0 -35.44 62.02 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 119.146 0.885 . . . . 0.0 109.762 -173.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -74.14 -15.67 61.02 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.699 0.799 . . . . 0.0 112.043 173.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 60.1 m-80 -141.11 49.61 1.65 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 119.523 1.056 . . . . 0.0 111.558 -167.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.413 ' CD ' ' H ' ' A' ' 61' ' ' GLN . 0.1 OUTLIER -56.82 -38.8 73.12 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.956 0.902 . . . . 0.0 109.478 179.563 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -65.87 -28.2 68.78 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 125.034 1.334 . . . . 0.0 112.572 -178.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.416 ' HA ' ' HE2' ' A' ' 66' ' ' LYS . 0.2 OUTLIER -88.43 -44.23 10.89 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-N 118.673 0.67 . . . . 0.0 109.797 179.036 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.23 -46.58 86.3 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 119.017 0.826 . . . . 0.0 109.731 178.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -60.94 -24.17 62.4 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 124.166 0.889 . . . . 0.0 112.466 175.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.416 ' HE2' ' HA ' ' A' ' 63' ' ' THR . 4.9 ttmm -58.52 -22.07 54.11 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.298 1.039 . . . . 0.0 111.966 175.161 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -122.19 12.03 10.22 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.659 1.184 . . . . 0.0 110.854 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 70.78 31.8 67.22 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 123.743 0.687 . . . . 0.0 112.573 -178.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 94.9 t -111.08 139.22 35.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 C-N-CA 124.962 1.305 . . . . 0.0 107.825 -178.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 9.1 tpt -155.23 30.09 0.39 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.372 1.069 . . . . 0.0 108.807 167.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 19.3 m -138.39 157.01 47.06 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 126.335 1.854 . . . . 0.0 107.456 -177.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -144.33 157.35 56.56 Favored Pre-proline 0 CA--C 1.54 0.569 0 CA-C-O 118.462 -0.78 . . . . 0.0 110.79 -169.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -66.81 139.76 46.91 Favored 'Cis proline' 0 N--CA 1.458 -0.575 0 N-CA-C 109.335 -1.064 . . . . 0.0 109.335 -11.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 85.0 m -133.6 116.07 15.44 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 174.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 72.7 mt -86.46 144.68 27.16 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 175.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -129.24 126.82 39.95 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 104.261 -2.496 . . . . 0.0 104.261 -178.068 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.1 t -111.33 123.52 67.26 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.414 0 N-CA-C 104.367 -2.457 . . . . 0.0 104.367 -175.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.0 mp -129.65 161.75 29.87 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 124.525 1.13 . . . . 0.0 108.236 -177.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 63.0 tttm -149.03 127.34 12.16 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 176.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.8 t70 43.39 35.27 0.87 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.428 1.491 . . . . 0.0 113.684 176.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 105.38 1.74 40.95 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-O 118.11 -1.383 . . . . 0.0 115.224 169.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -130.34 145.79 51.83 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 120.044 1.922 . . . . 0.0 110.089 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.6 p -69.37 141.45 17.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 C-N-CA 123.924 0.89 . . . . 0.0 109.306 174.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 35.6 m -129.42 -18.32 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 C-N-CA 125.709 1.604 . . . . 0.0 110.693 178.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -161.06 169.46 22.41 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 120.543 1.52 . . . . 0.0 111.669 170.149 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 54.5 m -145.82 144.65 30.4 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.07 1.748 . . . . 0.0 108.01 169.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 15.8 m -146.86 150.2 34.78 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 124.636 1.174 . . . . 0.0 108.83 -178.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 39.9 t -129.61 148.21 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -171.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.55 179.06 51.92 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 124.015 0.817 . . . . 0.0 111.708 178.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -62.43 151.58 36.73 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.539 0.736 . . . . 0.0 110.623 176.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.35 145.91 33.98 Favored Pre-proline 0 C--O 1.234 0.253 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 167.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -70.91 163.57 38.73 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.658 2.238 . . . . 0.0 110.173 173.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -54.78 -44.66 73.92 Favored 'General case' 0 C--O 1.224 -0.266 0 CA-C-O 118.585 -0.722 . . . . 0.0 110.694 179.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -63.81 -41.62 97.85 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 118.849 0.75 . . . . 0.0 111.319 -169.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.54 -42.71 82.25 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 123.22 0.608 . . . . 0.0 110.893 176.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 42.4 tp -69.37 -40.25 77.55 Favored 'General case' 0 N--CA 1.451 -0.416 0 O-C-N 122.124 -0.36 . . . . 0.0 110.808 -177.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.5 pp0? -71.71 -29.32 64.43 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 118.888 0.767 . . . . 0.0 110.062 176.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -64.04 -49.29 72.95 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 174.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 59.1 tp -57.33 -44.14 83.96 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 123.751 0.82 . . . . 0.0 110.515 178.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 11.1 t -62.19 -52.1 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 176.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.83 -25.15 67.78 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 119.095 0.861 . . . . 0.0 112.313 -175.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -67.74 -17.14 64.45 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 117.938 -1.03 . . . . 0.0 113.004 171.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -114.2 -15.07 12.25 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 120.017 1.281 . . . . 0.0 113.182 176.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 53.2 mt . . . . . 0 C--O 1.249 1.067 0 CA-C-N 119.403 1.001 . . . . 0.0 109.493 169.387 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 N--CA 1.478 0.941 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -155.11 144.6 21.25 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.73 1.212 . . . . 0.0 107.78 169.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 89.8 mt -78.2 146.16 8.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 177.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 39.0 t -107.05 167.19 3.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 -174.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 5.7 mptt -138.47 136.53 36.27 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 -177.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -144.84 169.75 17.45 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 123.035 0.534 . . . . 0.0 110.957 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 75.8 p -133.71 176.75 8.27 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.989 1.316 . . . . 0.0 108.162 177.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -51.05 -31.97 20.4 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 120.307 1.412 . . . . 0.0 112.773 -178.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 24.3 mp0 -67.93 -25.9 65.7 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.664 1.985 . . . . 0.0 112.792 -178.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 51.7 p -135.92 -17.56 1.64 Allowed 'General case' 0 C--O 1.234 0.241 0 N-CA-C 115.343 1.608 . . . . 0.0 115.343 -168.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -53.89 -34.81 60.56 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 124.909 1.283 . . . . 0.0 110.869 179.021 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.0 m -70.22 -37.91 75.13 Favored 'General case' 0 N--CA 1.453 -0.282 0 O-C-N 122.303 -0.248 . . . . 0.0 111.116 -176.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.15 -45.82 72.49 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 174.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -64.61 -37.39 87.39 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 119.283 -0.389 . . . . 0.0 111.468 -174.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.509 ' HA ' HG21 ' A' ' 20' ' ' VAL . 24.7 p -78.38 -0.11 27.81 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -178.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 62.1 m -111.38 33.76 4.5 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.228 1.011 . . . . 0.0 111.999 -170.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -132.21 -1.29 3.63 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 -177.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 166.67 -166.87 39.27 Favored Glycine 0 C--N 1.335 0.523 0 N-CA-C 110.686 -0.966 . . . . 0.0 110.686 -173.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 72.9 t -72.01 134.72 29.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 104.695 -2.335 . . . . 0.0 104.695 166.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.509 HG21 ' HA ' ' A' ' 15' ' ' THR . 35.1 t -137.56 124.11 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 -176.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 61.6 tp -94.46 97.94 10.51 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 173.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.97 150.01 35.91 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 170.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -132.89 99.77 4.7 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 125.375 1.47 . . . . 0.0 107.262 175.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -76.95 114.57 15.89 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 172.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 9.1 p-90 -137.7 175.05 9.94 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 123.273 0.629 . . . . 0.0 110.689 -169.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -152.93 146.78 18.34 Favored Pre-proline 0 CA--C 1.535 0.397 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 168.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -73.49 -22.27 18.6 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.613 2.208 . . . . 0.0 113.187 -169.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -81.88 -7.21 59.59 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.398 0.679 . . . . 0.0 112.28 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 48.4 t -93.12 110.61 22.1 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 -177.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -50.09 -52.18 27.69 Favored Glycine 0 CA--C 1.533 1.205 0 CA-C-O 118.852 -0.971 . . . . 0.0 113.024 177.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_exo -51.3 -34.73 50.81 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 123.13 2.553 . . . . 0.0 115.366 173.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 93.6 m -62.53 -37.0 84.38 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 120.182 1.355 . . . . 0.0 111.428 173.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -69.05 -43.14 75.27 Favored 'General case' 0 N--CA 1.463 0.198 0 O-C-N 121.722 -0.611 . . . . 0.0 109.704 173.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 75.1 mtm -65.28 -33.65 76.49 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 118.439 0.563 . . . . 0.0 111.911 -176.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.4 tt -82.0 -15.44 12.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-N 119.152 0.887 . . . . 0.0 111.852 179.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.27 -48.94 93.02 Favored Pre-proline 0 CA--C 1.544 0.725 0 CA-C-O 117.593 -1.194 . . . . 0.0 113.331 179.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.07 -28.68 56.98 Favored 'Trans proline' 0 C--N 1.351 0.665 0 CA-C-N 121.88 1.707 . . . . 0.0 112.412 175.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 16.5 t -65.91 -40.19 86.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 119.569 1.077 . . . . 0.0 109.491 174.06 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 70.3 mt -67.51 -33.25 74.69 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-O 118.657 -0.687 . . . . 0.0 110.855 176.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -68.56 -36.0 78.18 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.443 1.02 . . . . 0.0 111.583 172.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 -61.9 -45.34 94.17 Favored 'General case' 0 C--O 1.227 -0.097 0 O-C-N 120.839 -1.163 . . . . 0.0 109.426 171.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -61.73 -36.22 80.33 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 118.523 0.601 . . . . 0.0 111.511 174.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -66.03 -37.51 86.06 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 118.919 0.781 . . . . 0.0 110.691 178.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -70.7 -45.81 64.28 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 122.993 0.517 . . . . 0.0 111.169 176.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -79.78 -33.2 40.78 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.469 1.107 . . . . 0.0 111.738 -169.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.42 ' HA ' ' HE3' ' A' ' 49' ' ' LYS . 22.2 mmt -139.95 -9.01 1.18 Allowed 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 117.808 -1.092 . . . . 0.0 113.842 -168.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -75.21 47.83 2.03 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 126.134 1.826 . . . . 0.0 114.569 -169.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -150.95 -39.75 0.13 Allowed 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 128.129 2.572 . . . . 0.0 107.584 169.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.42 ' HE3' ' HA ' ' A' ' 46' ' ' MET . 41.4 mtmt -65.22 -30.7 71.61 Favored 'General case' 0 C--N 1.342 0.28 0 C-N-CA 124.492 1.117 . . . . 0.0 110.651 169.041 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -134.25 164.37 27.54 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 125.486 1.514 . . . . 0.0 110.198 169.522 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -99.26 152.46 19.9 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 124.673 1.189 . . . . 0.0 108.182 172.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 19.0 mt -118.41 136.32 55.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 N-CA-C 105.488 -2.041 . . . . 0.0 105.488 172.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 79.1 t -133.17 117.76 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 119.054 0.843 . . . . 0.0 108.802 -176.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 55.1 mmtt -76.29 145.16 39.81 Favored 'General case' 0 C--O 1.234 0.284 0 O-C-N 121.672 -0.642 . . . . 0.0 109.859 169.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 16.0 tt -148.76 119.03 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 169.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -82.24 116.72 21.9 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -177.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 33.9 m -62.19 -25.83 38.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -174.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -66.1 -29.96 70.38 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 119.513 1.051 . . . . 0.0 110.949 -177.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -100.75 -3.27 30.42 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.298 1.039 . . . . 0.0 110.99 179.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 -141.65 43.48 1.73 Allowed 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.715 1.206 . . . . 0.0 109.942 -168.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.5 ' CD ' ' H ' ' A' ' 61' ' ' GLN . 1.0 OUTLIER -58.33 -41.5 84.71 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.804 1.242 . . . . 0.0 108.77 -177.937 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -64.5 -42.97 95.51 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.91 0.884 . . . . 0.0 110.509 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.518 ' HA ' ' HE3' ' A' ' 66' ' ' LYS . 0.5 OUTLIER -68.94 -44.04 73.86 Favored 'General case' 0 C--O 1.221 -0.397 0 CA-C-N 118.776 0.716 . . . . 0.0 110.255 -177.519 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.3 -45.1 94.77 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 119.094 0.861 . . . . 0.0 109.347 176.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -57.46 -27.53 58.41 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 124.077 0.846 . . . . 0.0 112.702 174.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.518 ' HE3' ' HA ' ' A' ' 63' ' ' THR . 25.7 ttmt -58.49 -21.22 51.06 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.656 1.582 . . . . 0.0 111.924 178.566 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -126.61 13.74 7.53 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.657 1.183 . . . . 0.0 110.687 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 71.71 32.56 64.05 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 123.775 0.702 . . . . 0.0 112.754 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 93.6 t -109.85 137.87 40.08 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 C-N-CA 124.806 1.243 . . . . 0.0 107.756 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 8.4 tpt -155.95 31.45 0.35 Allowed 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.355 1.062 . . . . 0.0 108.804 166.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 20.4 m -138.27 152.39 48.5 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 126.779 2.031 . . . . 0.0 106.643 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -146.11 159.08 47.14 Favored Pre-proline 0 CA--C 1.54 0.592 0 C-N-CA 123.95 0.9 . . . . 0.0 110.02 -169.417 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -67.17 138.94 43.95 Favored 'Cis proline' 0 C--N 1.349 0.59 0 CA-C-N 119.956 1.02 . . . . 0.0 109.691 -10.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 54.9 m -132.36 116.9 17.43 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 177.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 81.0 mt -92.45 137.13 32.63 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 177.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.6 mp -122.39 132.47 54.39 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 105.74 -1.948 . . . . 0.0 105.74 169.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 17.0 t -95.58 125.9 48.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 103.09 -2.929 . . . . 0.0 103.09 168.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.8 mp -120.72 159.18 25.91 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 125.422 1.489 . . . . 0.0 107.322 175.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -146.28 125.12 12.66 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 176.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.9 t70 45.81 35.66 2.39 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.311 1.444 . . . . 0.0 113.694 175.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 110.04 -2.53 30.02 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-O 118.055 -1.414 . . . . 0.0 115.484 168.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -131.57 144.43 51.08 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 120.081 1.941 . . . . 0.0 110.2 -178.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 5.3 p -65.72 137.16 25.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 171.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 34.3 m -121.12 -21.5 3.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 125.175 1.39 . . . . 0.0 110.433 176.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -157.31 162.73 39.14 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 119.701 1.137 . . . . 0.0 111.312 174.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 90.6 m -136.57 149.28 47.99 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.383 1.873 . . . . 0.0 108.416 175.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 30.4 m -147.35 152.81 38.82 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 126.267 1.827 . . . . 0.0 107.834 170.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 41.3 t -133.13 144.44 36.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 -175.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 80.22 179.83 52.86 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 123.907 0.765 . . . . 0.0 111.582 -179.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -62.97 147.7 49.78 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.683 0.793 . . . . 0.0 110.667 178.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 69.2 mttt -142.37 147.66 44.28 Favored Pre-proline 0 CA--C 1.531 0.233 0 C-N-CA 125.713 1.605 . . . . 0.0 106.898 168.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -73.2 159.44 47.27 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.581 2.187 . . . . 0.0 110.459 176.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 17.1 ptmt -55.55 -48.94 73.94 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 112.257 0.465 . . . . 0.0 112.257 -177.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -61.9 -39.29 91.46 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 123.59 0.756 . . . . 0.0 110.868 -169.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.64 -42.8 73.78 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 122.823 0.449 . . . . 0.0 110.855 176.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 46.5 tp -68.66 -38.42 80.39 Favored 'General case' 0 N--CA 1.451 -0.41 0 O-C-N 122.039 -0.413 . . . . 0.0 110.857 -178.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.4 pp0? -72.06 -29.47 64.17 Favored 'General case' 0 C--N 1.339 0.118 0 CA-C-N 119.174 0.897 . . . . 0.0 110.314 175.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -63.5 -48.85 75.89 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 174.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 59.3 tp -58.59 -44.97 90.0 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.191 0.596 . . . . 0.0 110.558 179.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.6 t -60.22 -51.43 73.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 C-N-CA 122.898 0.479 . . . . 0.0 109.74 177.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.37 -27.99 69.39 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 118.893 0.77 . . . . 0.0 112.121 -176.57 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -68.56 -25.87 65.12 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 118.303 -0.856 . . . . 0.0 112.345 172.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 75.5 m-70 -96.69 -16.98 20.63 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 119.68 1.127 . . . . 0.0 113.421 178.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 67.8 mt . . . . . 0 C--O 1.25 1.115 0 CA-C-N 119.813 1.188 . . . . 0.0 109.665 173.543 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mpt? . . . . . 0 N--CA 1.482 1.125 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -158.26 142.38 15.75 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.309 1.443 . . . . 0.0 107.374 168.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 86.7 mt -76.24 154.01 5.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 174.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 35.7 t -122.68 167.1 16.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 -175.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 6.1 mtmt -132.34 143.76 50.08 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 176.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -144.89 170.43 16.16 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 123.12 0.568 . . . . 0.0 110.246 175.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 77.4 p -134.62 173.61 11.48 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.915 1.286 . . . . 0.0 107.636 177.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -50.49 -30.65 13.33 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 119.271 0.941 . . . . 0.0 113.132 -177.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 26.9 mp0 -64.25 -32.23 73.74 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.13 1.772 . . . . 0.0 112.794 -179.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.2 m -140.02 -5.57 1.29 Allowed 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 -169.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -52.26 -38.8 59.22 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 124.355 1.062 . . . . 0.0 110.786 175.447 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.4 m -67.75 -36.15 80.01 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 122.675 0.39 . . . . 0.0 111.656 -176.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.92 -45.99 69.41 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 175.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -64.03 -35.23 80.03 Favored 'General case' 0 C--O 1.231 0.11 0 C-N-CA 123.06 0.544 . . . . 0.0 111.721 -174.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.492 ' HA ' HG21 ' A' ' 20' ' ' VAL . 22.3 p -82.44 2.09 34.33 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.611 0.764 . . . . 0.0 112.955 -178.538 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 48.7 m -118.07 35.61 4.67 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 118.891 0.769 . . . . 0.0 112.726 -169.224 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -145.89 14.3 1.34 Allowed 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 176.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 172.08 -168.54 41.64 Favored Glycine 0 C--N 1.34 0.771 0 O-C-N 121.17 -0.956 . . . . 0.0 111.698 176.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 61.0 t -74.81 133.74 30.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 N-CA-C 104.498 -2.408 . . . . 0.0 104.498 167.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.492 HG21 ' HA ' ' A' ' 15' ' ' THR . 38.1 t -139.63 117.32 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 -174.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 64.4 tp -88.25 97.29 10.94 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 173.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.05 147.77 38.46 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 169.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -133.73 98.9 4.31 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 125.172 1.389 . . . . 0.0 107.539 176.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -75.81 114.88 14.91 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 105.893 -1.891 . . . . 0.0 105.893 173.08 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 9.2 p-90 -137.49 175.21 9.81 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.478 0.711 . . . . 0.0 110.81 -169.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -152.92 147.43 19.06 Favored Pre-proline 0 CA--C 1.537 0.446 0 C-N-CA 124.602 1.161 . . . . 0.0 107.897 169.094 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.3 -21.57 17.41 Favored 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 122.8 2.333 . . . . 0.0 113.423 -170.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -81.71 -9.3 59.68 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 118.665 0.666 . . . . 0.0 112.051 178.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 51.0 t -88.28 117.1 26.95 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -179.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -54.4 -57.65 16.34 Favored Glycine 0 CA--C 1.531 1.05 0 CA-C-O 118.565 -1.13 . . . . 0.0 111.888 176.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_exo -49.37 -35.44 35.49 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 123.703 2.935 . . . . 0.0 115.736 177.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 84.5 m -60.56 -37.85 82.61 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 119.941 1.246 . . . . 0.0 111.65 174.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 45.9 mtmt -79.88 -31.21 40.34 Favored 'General case' 0 CA--C 1.529 0.151 0 O-C-N 121.674 -0.641 . . . . 0.0 110.29 177.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 63.6 mtt -65.06 -38.86 92.21 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.994 0.816 . . . . 0.0 111.278 175.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 10.2 tt -80.95 -16.94 12.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 118.887 0.767 . . . . 0.0 111.632 -179.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -52.32 -49.8 83.14 Favored Pre-proline 0 CA--C 1.544 0.716 0 CA-C-O 117.506 -1.235 . . . . 0.0 113.777 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -64.98 -31.52 55.78 Favored 'Trans proline' 0 C--N 1.35 0.649 0 CA-C-N 121.92 1.722 . . . . 0.0 112.236 176.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 20.2 t -63.44 -43.61 98.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-N 119.106 0.866 . . . . 0.0 109.049 175.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 71.9 mt -65.17 -36.16 83.36 Favored 'General case' 0 C--O 1.227 -0.115 0 CA-C-O 118.849 -0.596 . . . . 0.0 110.954 177.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -65.94 -38.09 87.71 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 119.273 0.942 . . . . 0.0 111.279 174.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -68.2 -38.86 82.41 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 121.133 -0.98 . . . . 0.0 110.456 174.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.91 -42.26 99.73 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.001 0.92 . . . . 0.0 109.421 177.15 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -63.15 -45.01 93.9 Favored 'General case' 0 C--O 1.226 -0.132 0 C-N-CA 123.718 0.807 . . . . 0.0 110.449 176.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -61.69 -30.5 70.78 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 121.705 -0.622 . . . . 0.0 111.989 176.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -85.99 -40.01 16.28 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.893 0.877 . . . . 0.0 112.133 -175.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 17.8 mmt -135.68 1.11 2.78 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 -167.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.3 47.51 1.11 Allowed Glycine 0 CA--C 1.53 1.022 0 C-N-CA 127.224 2.345 . . . . 0.0 114.625 -169.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -149.71 -40.1 0.14 Allowed 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 128.552 2.741 . . . . 0.0 108.032 171.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -62.81 -38.8 92.14 Favored 'General case' 0 C--N 1.342 0.263 0 C-N-CA 124.633 1.173 . . . . 0.0 110.218 169.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -133.31 165.22 25.33 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.418 1.487 . . . . 0.0 110.294 173.264 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -104.81 155.11 19.19 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.726 1.61 . . . . 0.0 107.453 171.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 17.9 mt -117.52 135.78 56.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 N-CA-C 105.242 -2.132 . . . . 0.0 105.242 169.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 91.3 t -130.96 113.78 25.27 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -177.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 44.4 mmtt -73.78 144.25 45.69 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 169.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 15.2 tt -148.06 118.03 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 169.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -82.51 115.44 21.5 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 -176.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 27.8 m -62.49 -24.79 36.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 N-CA-C 112.519 0.562 . . . . 0.0 112.519 -175.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -70.48 -10.62 59.65 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 119.318 0.963 . . . . 0.0 112.083 -178.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -122.95 1.09 9.25 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.645 1.178 . . . . 0.0 110.889 175.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -145.65 36.88 1.08 Allowed 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.636 1.174 . . . . 0.0 110.128 -169.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -59.07 -29.25 67.19 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.579 0.752 . . . . 0.0 110.551 177.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 59.6 mp0 -59.97 -49.48 77.5 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.504 1.522 . . . . 0.0 110.041 173.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.63 -41.87 68.32 Favored 'General case' 0 C--O 1.222 -0.392 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 -175.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -61.14 -46.78 89.14 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 119.057 0.844 . . . . 0.0 109.775 176.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -59.19 -24.55 58.9 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 124.312 0.958 . . . . 0.0 112.856 175.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 8.9 ttmm -59.38 -20.82 57.77 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.764 1.225 . . . . 0.0 111.791 176.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -125.6 13.11 8.08 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.199 1.4 . . . . 0.0 110.473 177.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 68.52 21.63 74.59 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 124.554 1.074 . . . . 0.0 113.524 -177.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 87.3 t -89.34 154.39 3.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-N 118.308 1.054 . . . . 0.0 109.372 178.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -162.23 -24.01 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.898 2.079 . . . . 0.0 109.404 167.097 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 8.8 m -63.51 149.3 46.51 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 123.571 0.749 . . . . 0.0 109.114 169.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -144.31 155.46 57.77 Favored Pre-proline 0 CA--C 1.541 0.614 0 C-N-CA 124.176 0.99 . . . . 0.0 108.925 176.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -66.69 140.24 48.84 Favored 'Cis proline' 0 N--CA 1.457 -0.643 0 CA-C-N 120.003 1.037 . . . . 0.0 109.584 -10.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 52.7 m -131.63 117.81 19.19 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 175.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 93.1 mt -93.79 135.24 35.3 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 178.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.5 mp -122.9 129.45 51.64 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 104.713 -2.329 . . . . 0.0 104.713 169.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 48.1 t -94.84 120.94 44.96 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.416 0 N-CA-C 103.361 -2.829 . . . . 0.0 103.361 168.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.9 mp -108.41 159.26 16.81 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 169.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -146.34 123.91 11.78 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 106.738 -1.579 . . . . 0.0 106.738 175.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.0 t70 42.21 40.67 1.82 Allowed 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.032 1.333 . . . . 0.0 113.08 179.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.67 9.66 59.77 Favored Glycine 0 CA--C 1.529 0.962 0 CA-C-O 118.584 -1.12 . . . . 0.0 114.957 171.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -126.55 139.81 52.92 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 119.552 1.676 . . . . 0.0 108.472 177.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 18.5 t -68.01 134.28 30.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 106.711 -1.589 . . . . 0.0 106.711 169.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.6 m -124.89 -18.61 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 124.41 1.084 . . . . 0.0 110.898 177.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.22 165.17 36.55 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 119.619 1.1 . . . . 0.0 110.955 174.065 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 97.5 m -149.32 149.28 30.65 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.209 1.403 . . . . 0.0 109.108 177.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.9 m -149.87 156.25 41.46 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 126.018 1.727 . . . . 0.0 108.929 172.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.9 t -133.58 144.46 35.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 -179.287 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.1 -178.45 53.61 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 123.647 0.641 . . . . 0.0 111.567 -178.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -62.33 149.0 43.39 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.786 0.834 . . . . 0.0 110.678 177.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 25.3 mttp -142.32 142.11 23.0 Favored Pre-proline 0 C--O 1.234 0.248 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 168.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -72.5 162.93 40.04 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 122.646 2.23 . . . . 0.0 110.458 175.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -54.64 -46.2 73.92 Favored 'General case' 0 C--O 1.223 -0.295 0 C-N-CA 123.073 0.549 . . . . 0.0 110.82 -179.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -64.84 -41.13 95.97 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 118.356 0.525 . . . . 0.0 111.05 -169.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.28 -45.45 80.41 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 122.651 0.38 . . . . 0.0 110.539 176.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 46.5 tp -65.75 -42.42 90.93 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 123.037 0.535 . . . . 0.0 110.436 -176.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -68.37 -32.78 73.1 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 118.715 0.689 . . . . 0.0 109.818 178.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -67.64 -46.8 71.39 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 118.835 0.743 . . . . 0.0 109.446 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.0 tt -54.16 -42.75 69.95 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.385 1.074 . . . . 0.0 109.569 175.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 25.2 t -63.84 -50.67 76.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-O 117.499 -1.239 . . . . 0.0 110.548 175.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -56.12 -46.18 79.24 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 120.718 1.599 . . . . 0.0 110.279 -176.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -57.21 -15.0 4.84 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.228 1.011 . . . . 0.0 113.225 178.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 78.8 m-70 -121.09 -5.06 9.51 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 177.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 53.9 mt . . . . . 0 C--O 1.248 1.008 0 CA-C-N 120.106 1.321 . . . . 0.0 109.113 169.959 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.4 ttp . . . . . 0 N--CA 1.483 1.222 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -160.23 157.51 28.32 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.48 1.512 . . . . 0.0 108.261 175.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 77.3 mt -75.29 153.84 6.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 172.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.4 t -129.22 169.88 19.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 -173.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.26 153.46 50.34 Favored 'General case' 0 C--O 1.233 0.235 0 O-C-N 120.791 -1.193 . . . . 0.0 108.994 169.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -144.71 175.5 10.12 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 123.886 0.874 . . . . 0.0 109.939 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 70.6 p -133.13 177.36 7.73 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.798 1.239 . . . . 0.0 107.947 174.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -53.97 -25.94 23.33 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 119.547 1.067 . . . . 0.0 112.553 176.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 48.2 mm-40 -73.34 -25.17 60.5 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.091 1.356 . . . . 0.0 112.522 -178.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 33.2 p -135.15 -11.99 2.18 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 115.634 1.716 . . . . 0.0 115.634 -167.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -53.96 -35.79 62.17 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 124.194 0.998 . . . . 0.0 110.852 179.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.7 m -70.81 -34.92 72.24 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 122.686 0.394 . . . . 0.0 111.48 -177.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -72.94 -32.74 65.46 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 123.556 0.742 . . . . 0.0 110.625 176.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -79.05 -39.59 33.53 Favored 'General case' 0 N--CA 1.453 -0.319 0 O-C-N 122.003 -0.435 . . . . 0.0 111.505 -177.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.495 ' HA ' HG21 ' A' ' 20' ' ' VAL . 25.2 p -78.11 -0.64 28.97 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -174.026 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 28.7 p -110.46 30.94 6.33 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.269 1.028 . . . . 0.0 112.834 -169.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -131.48 -0.13 4.0 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 113.58 0.955 . . . . 0.0 113.58 -175.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 165.73 -166.29 38.46 Favored Glycine 0 C--N 1.336 0.559 0 CA-C-N 119.358 0.981 . . . . 0.0 110.886 -174.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 88.6 t -71.73 129.82 35.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 N-CA-C 105.212 -2.144 . . . . 0.0 105.212 166.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.495 HG21 ' HA ' ' A' ' 15' ' ' THR . 25.4 t -133.11 116.66 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 -176.516 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 63.9 tp -88.21 96.83 10.7 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 174.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.06 148.54 37.9 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 170.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -133.51 96.76 3.78 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 125.031 1.332 . . . . 0.0 107.419 177.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -74.53 113.81 12.21 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 172.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 6.6 p-90 -137.63 176.72 8.45 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 123.435 0.694 . . . . 0.0 110.532 -169.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -155.72 147.75 17.36 Favored Pre-proline 0 C--O 1.237 0.446 0 C-N-CA 125.793 1.637 . . . . 0.0 106.731 169.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.94 -20.49 15.01 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.99 2.46 . . . . 0.0 113.3 -170.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -79.37 -7.59 58.47 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 118.528 0.604 . . . . 0.0 112.381 -179.616 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 44.0 t -95.56 122.25 38.1 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -178.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -56.87 -57.48 19.44 Favored Glycine 0 CA--C 1.531 1.046 0 CA-C-O 118.623 -1.098 . . . . 0.0 112.098 178.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_exo -48.37 -36.19 29.73 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 123.756 2.971 . . . . 0.0 115.8 177.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 79.8 m -59.6 -31.82 69.83 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 119.875 1.216 . . . . 0.0 112.504 175.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt -88.32 -33.88 17.85 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 123.445 0.698 . . . . 0.0 109.737 177.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 62.3 mtt -61.65 -37.07 82.68 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.935 0.789 . . . . 0.0 111.264 175.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 10.9 tt -80.08 -14.04 13.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-N 118.603 0.638 . . . . 0.0 111.928 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.97 -48.35 94.14 Favored Pre-proline 0 CA--C 1.543 0.685 0 CA-C-O 117.403 -1.284 . . . . 0.0 113.411 -178.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -65.03 -29.15 57.14 Favored 'Trans proline' 0 C--N 1.349 0.592 0 CA-C-N 121.996 1.749 . . . . 0.0 112.607 175.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 12.9 t -66.71 -40.45 86.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 119.343 0.974 . . . . 0.0 109.305 174.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 91.6 mt -66.72 -35.69 80.72 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-O 118.756 -0.64 . . . . 0.0 110.845 175.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -68.04 -36.06 79.28 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 119.481 1.037 . . . . 0.0 111.288 174.501 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 45.3 mm-40 -63.88 -43.91 94.62 Favored 'General case' 0 CA--C 1.529 0.151 0 O-C-N 121.05 -1.031 . . . . 0.0 109.958 171.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -63.3 -36.54 84.0 Favored 'General case' 0 C--O 1.226 -0.181 0 C-N-CA 123.129 0.572 . . . . 0.0 111.109 176.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -64.71 -42.7 95.07 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 118.636 0.653 . . . . 0.0 109.995 176.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -65.91 -33.39 75.72 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.708 -0.62 . . . . 0.0 112.377 175.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -89.27 -32.48 17.37 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.093 0.957 . . . . 0.0 112.274 -172.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.525 ' SD ' ' HE2' ' A' ' 49' ' ' LYS . 22.5 mmt -136.25 -11.54 1.92 Allowed 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.879 1.271 . . . . 0.0 112.663 -168.361 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.42 2.88 18.79 Favored Glycine 0 CA--C 1.53 0.988 0 CA-C-N 120.827 1.649 . . . . 0.0 114.545 -172.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -90.2 -17.15 28.06 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 127.126 2.17 . . . . 0.0 111.766 170.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.525 ' HE2' ' SD ' ' A' ' 46' ' ' MET . 14.9 pttm -138.94 6.4 2.41 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 127.072 2.149 . . . . 0.0 112.466 -174.244 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -145.85 163.96 33.41 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 129.144 2.978 . . . . 0.0 105.998 175.314 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -121.05 154.91 35.46 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 125.231 1.412 . . . . 0.0 107.359 173.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 15.7 mt -123.4 135.28 63.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 N-CA-C 105.179 -2.156 . . . . 0.0 105.179 174.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 88.3 t -132.1 111.19 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -174.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 38.6 mmtt -71.65 142.55 49.9 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 169.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 15.7 tt -148.64 119.78 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 170.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 50.7 t0 -80.26 115.88 20.05 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 123.561 0.745 . . . . 0.0 109.138 -177.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 28.6 m -60.95 -30.25 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-N 118.227 0.467 . . . . 0.0 111.889 -177.268 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -76.16 2.68 12.4 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.986 0.914 . . . . 0.0 112.024 -176.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -129.89 -4.13 4.59 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.69 1.596 . . . . 0.0 110.743 173.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -141.34 47.55 1.69 Allowed 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.287 1.035 . . . . 0.0 109.938 -168.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.509 ' NE2' ' H ' ' A' ' 61' ' ' GLN . 0.3 OUTLIER -52.47 -43.35 64.92 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.587 1.555 . . . . 0.0 109.427 177.958 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 33.3 mp0 -67.35 -27.97 67.57 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 126.206 1.802 . . . . 0.0 111.903 -174.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.439 ' HA ' ' HE2' ' A' ' 66' ' ' LYS . 0.2 OUTLIER -88.39 -46.2 9.36 Favored 'General case' 0 C--O 1.22 -0.481 0 CA-C-N 118.474 0.579 . . . . 0.0 109.614 178.722 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.8 -47.41 83.55 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.859 0.754 . . . . 0.0 109.683 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -61.46 -22.41 61.32 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 124.514 1.054 . . . . 0.0 112.846 175.108 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.439 ' HE2' ' HA ' ' A' ' 63' ' ' THR . 5.9 ttmm -57.61 -24.14 54.8 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 118.811 1.306 . . . . 0.0 111.771 174.669 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -125.4 14.74 8.27 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.851 1.26 . . . . 0.0 110.304 178.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 70.12 19.09 75.34 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 124.849 1.214 . . . . 0.0 114.038 -179.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 84.6 t -81.31 127.63 39.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 177.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 8.6 mmt -147.5 29.42 0.94 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.892 1.677 . . . . 0.0 108.735 169.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 17.0 m -142.85 152.18 41.88 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 126.681 1.993 . . . . 0.0 106.734 179.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -145.64 157.56 51.48 Favored Pre-proline 0 CA--C 1.54 0.576 0 C-N-CA 123.832 0.853 . . . . 0.0 109.914 -171.199 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -67.57 141.73 59.84 Favored 'Cis proline' 0 N--CA 1.459 -0.548 0 CA-C-N 119.852 0.983 . . . . 0.0 109.581 -10.235 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 55.2 m -131.78 116.4 17.22 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 176.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 93.3 mt -91.4 136.84 32.82 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 178.016 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.2 mp -120.68 130.84 54.27 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 105.098 -2.186 . . . . 0.0 105.098 169.133 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 25.5 t -93.72 121.09 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 103.016 -2.957 . . . . 0.0 103.016 169.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.8 mp -115.86 158.62 22.67 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 172.038 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -146.19 126.2 13.68 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 175.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.6 t70 44.75 38.31 2.75 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.263 1.425 . . . . 0.0 113.364 175.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.76 6.89 54.12 Favored Glycine 0 CA--C 1.53 0.982 0 CA-C-O 118.561 -1.133 . . . . 0.0 114.345 169.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -129.01 138.43 51.93 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 119.432 1.616 . . . . 0.0 108.764 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.7 p -68.96 135.91 27.43 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 168.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.4 m -125.3 -19.64 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 C-N-CA 124.543 1.137 . . . . 0.0 110.476 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.18 167.38 30.57 Favored 'General case' 0 C--N 1.344 0.369 0 CA-C-N 119.588 1.086 . . . . 0.0 111.182 174.146 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 97.4 m -147.22 149.32 32.68 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.571 1.548 . . . . 0.0 108.789 178.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 66.2 m -150.59 156.25 41.0 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.494 1.518 . . . . 0.0 108.691 172.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 40.6 t -132.59 144.46 36.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -177.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 83.84 179.4 51.98 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 124.007 0.813 . . . . 0.0 111.711 -179.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -61.89 150.59 37.05 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.845 0.858 . . . . 0.0 110.61 176.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 40.8 mttm -140.68 144.84 37.68 Favored Pre-proline 0 C--O 1.233 0.213 0 C-N-CA 125.007 1.323 . . . . 0.0 107.518 168.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -72.66 161.54 43.68 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.63 2.22 . . . . 0.0 110.327 173.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -55.16 -47.74 74.72 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 123.089 0.556 . . . . 0.0 110.957 -178.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -63.51 -43.6 96.73 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 118.218 0.463 . . . . 0.0 111.516 -168.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.46 -42.81 87.0 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.106 0.563 . . . . 0.0 110.954 178.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 42.7 tp -67.75 -42.46 81.76 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 110.27 -0.27 . . . . 0.0 110.27 -178.163 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.7 pp0? -69.48 -34.35 74.2 Favored 'General case' 0 N--CA 1.454 -0.273 0 O-C-N 121.567 -0.708 . . . . 0.0 109.605 177.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -60.14 -45.94 91.35 Favored 'General case' 0 C--N 1.339 0.115 0 CA-C-N 119.41 1.004 . . . . 0.0 108.532 176.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 61.0 tp -58.09 -39.9 79.78 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.558 0.743 . . . . 0.0 110.888 176.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 56.0 t -63.56 -48.93 84.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-O 118.498 -0.763 . . . . 0.0 110.517 175.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 24.4 m-80 -58.08 -40.8 81.99 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 120.239 1.381 . . . . 0.0 109.908 179.268 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -62.82 -13.83 38.28 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 117.904 -1.046 . . . . 0.0 113.13 -178.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 70.4 m-70 -124.28 -19.57 5.48 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.248 0.978 0 CA-C-N 120.302 1.41 . . . . 0.0 109.914 178.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.1 ttm . . . . . 0 N--CA 1.483 1.224 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -157.68 159.92 37.43 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.88 1.672 . . . . 0.0 107.916 173.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 81.8 mt -74.68 149.55 7.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 179.017 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 48.4 t -109.09 167.19 4.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 125.827 1.651 . . . . 0.0 106.915 -173.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 5.7 mptt -138.68 137.84 37.2 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 -176.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -149.01 171.76 15.85 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 122.973 0.509 . . . . 0.0 110.863 -179.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.5 p -136.63 173.23 11.93 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 125.598 1.559 . . . . 0.0 107.695 -176.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -50.55 -27.06 6.01 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.644 1.178 . . . . 0.0 112.634 176.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 49.0 mm-40 -65.18 -32.64 74.43 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 125.15 1.38 . . . . 0.0 112.104 -178.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.4 m -143.4 -5.48 0.84 Allowed 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 115.103 1.52 . . . . 0.0 115.103 -171.169 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -54.04 -35.47 62.0 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 119.48 1.036 . . . . 0.0 111.276 179.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.7 m -67.0 -41.64 86.36 Favored 'General case' 0 N--CA 1.452 -0.345 0 O-C-N 122.065 -0.397 . . . . 0.0 111.197 -178.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.62 -43.82 79.48 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 176.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -62.12 -38.49 89.13 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 123.503 0.721 . . . . 0.0 111.074 -176.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 25.9 p -81.55 3.53 24.64 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -178.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 50.4 m -120.46 36.79 4.45 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.384 1.074 . . . . 0.0 112.156 -169.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -142.5 12.48 1.93 Allowed 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 176.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 174.73 -166.59 38.44 Favored Glycine 0 C--N 1.339 0.709 0 O-C-N 121.191 -0.943 . . . . 0.0 111.629 179.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.1 t -80.09 125.11 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 103.281 -2.859 . . . . 0.0 103.281 167.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 22.9 t -136.8 118.73 19.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 -171.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 35.0 tp -87.93 147.49 25.04 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 168.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -135.34 154.06 51.64 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 176.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -134.48 98.9 4.2 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 -175.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -74.88 117.19 16.45 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 169.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 6.0 p-90 -145.72 179.53 7.38 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.441 0.697 . . . . 0.0 111.205 -170.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -159.96 151.78 16.79 Favored Pre-proline 0 CA--C 1.538 0.51 0 C-N-CA 125.896 1.678 . . . . 0.0 107.024 167.261 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -75.75 -18.46 17.15 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.851 2.367 . . . . 0.0 113.319 -169.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -80.01 -10.92 59.81 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 118.721 0.691 . . . . 0.0 112.044 178.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 50.9 t -88.74 119.19 29.0 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 178.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -56.23 -57.74 17.7 Favored Glycine 0 CA--C 1.531 1.049 0 CA-C-O 118.808 -0.995 . . . . 0.0 111.954 176.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -51.16 -32.9 41.91 Favored 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 123.375 2.717 . . . . 0.0 115.651 177.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 88.2 m -59.57 -42.5 92.6 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 119.905 1.229 . . . . 0.0 111.323 173.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 44.1 mtmt -74.12 -30.39 62.28 Favored 'General case' 0 CA--C 1.529 0.139 0 O-C-N 121.801 -0.562 . . . . 0.0 110.476 177.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 89.8 mtp -65.75 -40.54 92.19 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 119.001 0.819 . . . . 0.0 111.242 175.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 12.3 tt -80.97 -16.27 12.45 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-N 119.158 0.89 . . . . 0.0 111.603 -179.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.9 -50.17 75.91 Favored Pre-proline 0 CA--C 1.545 0.767 0 CA-C-O 117.494 -1.241 . . . . 0.0 114.003 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.68 -28.74 52.1 Favored 'Trans proline' 0 C--N 1.35 0.652 0 CA-C-N 122.044 1.766 . . . . 0.0 112.691 176.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 13.8 t -66.89 -40.56 86.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-N 119.027 0.831 . . . . 0.0 109.143 174.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 46.1 mt -66.88 -36.52 82.48 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 118.604 -0.712 . . . . 0.0 110.694 176.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -65.87 -40.5 91.68 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 119.279 0.945 . . . . 0.0 110.897 173.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 30.6 mm-40 -59.5 -42.21 91.64 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 119.068 0.849 . . . . 0.0 110.406 173.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.65 -36.2 83.03 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 123.263 0.625 . . . . 0.0 111.364 176.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -65.04 -45.44 85.42 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 123.633 0.773 . . . . 0.0 109.918 175.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 73.5 mm-40 -65.44 -27.69 68.7 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.923 -0.486 . . . . 0.0 111.95 178.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -92.12 -37.42 12.76 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.366 1.066 . . . . 0.0 112.193 -175.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.401 ' SD ' ' HE2' ' A' ' 49' ' ' LYS . 20.7 mmt -128.77 -9.67 4.98 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 124.241 1.017 . . . . 0.0 113.372 -167.595 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -50.06 -25.24 7.44 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 126.233 1.873 . . . . 0.0 115.351 -175.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -75.58 -28.29 58.89 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 124.829 1.252 . . . . 0.0 112.07 -176.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.401 ' HE2' ' SD ' ' A' ' 46' ' ' MET . 0.0 OUTLIER -125.63 -4.76 7.09 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 125.665 1.586 . . . . 0.0 112.984 -175.474 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -144.96 123.43 12.38 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 124.499 1.12 . . . . 0.0 108.095 172.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -80.39 154.81 27.47 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 176.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 29.4 mt -127.76 130.91 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 N-CA-C 105.516 -2.031 . . . . 0.0 105.516 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.9 t -129.53 116.84 40.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 118.485 0.584 . . . . 0.0 109.723 -171.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt -74.17 143.89 45.05 Favored 'General case' 0 C--O 1.236 0.347 0 O-C-N 121.477 -0.765 . . . . 0.0 109.558 170.184 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 10.6 tt -150.34 129.8 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 170.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -86.8 126.96 34.97 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 121.411 -0.806 . . . . 0.0 109.69 -176.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 12.4 m -67.72 -32.57 57.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -174.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -75.62 -35.39 60.52 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 119.31 0.959 . . . . 0.0 109.78 -175.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -78.57 -15.17 58.86 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.279 0.632 . . . . 0.0 111.901 175.248 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 48.5 m-80 -140.87 50.78 1.64 Allowed 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 119.194 0.906 . . . . 0.0 110.562 -168.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.477 ' CD ' ' H ' ' A' ' 61' ' ' GLN . 1.1 mp0 -58.69 -43.06 89.87 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.459 1.103 . . . . 0.0 109.49 -174.627 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -64.0 -41.48 97.46 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.327 1.051 . . . . 0.0 110.751 -176.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.05 -43.71 70.68 Favored 'General case' 0 C--O 1.222 -0.348 0 CA-C-N 118.633 0.651 . . . . 0.0 109.821 -177.574 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.27 -44.01 97.52 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 118.94 0.791 . . . . 0.0 109.461 176.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -57.46 -27.69 58.59 Favored Glycine 0 CA--C 1.534 1.233 0 C-N-CA 124.325 0.964 . . . . 0.0 112.635 174.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 24.8 ttmt -59.21 -21.64 59.8 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.983 1.313 . . . . 0.0 111.777 177.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -120.38 10.58 11.26 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.981 1.312 . . . . 0.0 111.009 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 70.21 32.14 68.95 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 123.694 0.664 . . . . 0.0 112.319 -177.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 86.7 t -110.88 134.67 52.43 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 C-N-CA 124.762 1.225 . . . . 0.0 107.92 -178.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 8.4 tpt -155.7 32.16 0.36 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.36 1.064 . . . . 0.0 108.976 167.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 20.2 m -137.47 155.91 48.76 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 126.787 2.035 . . . . 0.0 106.724 179.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 29.8 pt -145.7 157.63 51.15 Favored Pre-proline 0 CA--C 1.541 0.602 0 CA-C-O 118.716 -0.659 . . . . 0.0 111.069 -168.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -67.33 141.71 58.84 Favored 'Cis proline' 0 N--CA 1.458 -0.574 0 N-CA-C 109.022 -1.184 . . . . 0.0 109.022 -11.085 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 58.2 m -136.12 131.0 34.18 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 176.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -103.61 143.94 32.1 Favored 'General case' 0 N--CA 1.437 -1.123 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 -176.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -125.45 137.39 53.98 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 104.382 -2.451 . . . . 0.0 104.382 178.105 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 11.1 t -127.29 127.97 69.71 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.593 0 N-CA-C 105.036 -2.209 . . . . 0.0 105.036 177.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.8 mp -130.15 157.96 41.01 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 -177.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -142.58 121.77 13.0 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 175.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.2 t70 44.06 37.55 1.86 Allowed 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.689 1.196 . . . . 0.0 112.476 -172.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.2 -6.29 82.59 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-O 118.839 -0.978 . . . . 0.0 114.473 174.158 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -90.04 128.51 36.3 Favored 'General case' 0 CA--C 1.522 -0.113 0 CA-C-N 119.407 1.603 . . . . 0.0 106.874 175.206 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 71.0 t -63.99 134.56 28.77 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 168.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 32.9 m -122.94 -20.48 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 124.749 1.219 . . . . 0.0 110.547 176.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.63 161.41 41.6 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 119.999 1.272 . . . . 0.0 111.869 172.13 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 70.7 m -147.63 133.68 19.27 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.249 1.82 . . . . 0.0 106.913 169.02 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 16.9 m -146.13 152.4 39.22 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.018 0.927 . . . . 0.0 109.396 -172.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 42.6 t -129.13 148.94 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-N 119.431 1.014 . . . . 0.0 108.919 -170.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.27 175.38 50.03 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 124.536 1.065 . . . . 0.0 112.358 174.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -57.91 154.37 12.44 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.907 0.883 . . . . 0.0 110.594 176.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -152.28 144.36 16.57 Favored Pre-proline 0 CA--C 1.53 0.207 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 169.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_endo -71.64 163.39 39.13 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.582 2.188 . . . . 0.0 110.339 175.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -54.69 -46.25 74.08 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-O 118.855 -0.593 . . . . 0.0 110.636 -179.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -64.38 -40.24 95.44 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 118.451 0.569 . . . . 0.0 111.122 -169.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.57 -45.13 76.48 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 122.823 0.449 . . . . 0.0 110.688 177.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 50.9 tp -67.59 -40.99 84.77 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 122.899 0.479 . . . . 0.0 110.403 -176.195 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.8 pp0? -71.6 -31.26 66.72 Favored 'General case' 0 N--CA 1.457 -0.121 0 CA-C-N 118.614 0.643 . . . . 0.0 110.127 177.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 20.2 tp10 -65.41 -48.27 73.37 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 176.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 10.3 tt -57.1 -44.88 83.63 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.266 0.626 . . . . 0.0 110.374 178.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 4.8 t -60.55 -48.6 87.84 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 123.056 0.542 . . . . 0.0 110.392 176.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.4 -20.94 66.2 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 118.839 0.745 . . . . 0.0 112.843 -175.214 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 57.5 mmtt -60.62 -35.55 76.43 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 118.386 0.539 . . . . 0.0 111.1 169.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 94.2 m-70 -97.7 -22.49 16.41 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.647 0.779 . . . . 0.0 112.697 -172.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 70.7 mt . . . . . 0 C--O 1.247 0.959 0 CA-C-O 118.237 -0.887 . . . . 0.0 109.485 172.409 . . . . . . . . 0 0 . 1 stop_ save_